Citrus Sinensis ID: 015615

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400---
Protein Sequence
MASVSVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Secondary Structure (PSIPRED)
ccccccccccccccccccccHHHcccccccccccccEEEccccccccEEEEEEEccccccccEEEEEEEEEEEEcccEEEEEEEEEcccccEEEEEEccccccHHHHHHHHHHHcccccEEEccEEEEcccccccEEEEEEEEcccccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccccccccccEEEEEEcccccHHHHccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccHHcccccHHHHHHccHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccHHccccccccccccccEEccccccccEEEEEEEEcccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHHcHHHHHHHcccccc
Coil and Loop (DISEMBL)
masvsvvpasgntvgvdrlpeemndmkirddkemeatvvdgngteAGHIIVTTiggkngqpkqTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQtmrlldhpnvvslkhcffstteKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTigvchrdikpqnllvnphthqlklcdfgsakvlvkgepnisyicsryyrapelifgateyTAAIDIWSAGCVLAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikahpwhkifqkrmppeAVDLVSRLLQYSPNLRSTALEALIhpffdelrdpntrlpngrflpplfnfkphelkgvpvDMLVKLIPEHARKQCAFLGL
Flexible Loop (DISEMBL)
masvsvvpasgntvgvdrlpeemNDMKIRDDKEMEATVVDGNGTEAGHIIVTtiggkngqpKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIkkvlqdkrykNRELQtmrlldhpnvvSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHhykmsqrmPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Low Complexity Region (SEG)
MASVSVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Disordered region (IsUnstruct)
*****************************************NGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAF***
Disordered Region (DISOPRED)
*************************************************IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC*F***
Disordered Region (DISEMBL)
********ASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Disordered Region (DISPRO)
************************************TVVD***TEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASVSVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	403	2.2.26 [Sep-21-2011]
P51139	411	Glycogen synthase kinase-	N/A	no	0.997	0.978	0.899	0.0
P43288	405	Shaggy-related protein ki	yes	no	1.0	0.995	0.901	0.0
P43289	409	Shaggy-related protein ki	no	no	1.0	0.985	0.872	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	1.0	0.980	0.880	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.997	0.978	0.865	0.0
Q40518	409	Shaggy-related protein ki	N/A	no	1.0	0.985	0.872	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	1.0	0.982	0.856	0.0
Q96287	472	Shaggy-related protein ki	no	no	0.980	0.836	0.766	0.0
Q9FVS6	420	Shaggy-related protein ki	no	no	0.997	0.957	0.740	0.0
O04160	468	Shaggy-related protein ki	N/A	no	0.940	0.809	0.768	0.0

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  769 bits (1986), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/409 (89%), Positives = 386/409 (94%), Gaps = 7/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++VGV++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEAL+HPF+D+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFYDD 360

Query: 354 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 402
           +RDPNTRLPNGRFLPPLFNFK +ELKGVP +MLVKL+P HARKQCA  G
Sbjct: 361 VRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCALFG 409

Medicago sativa (taxid: 3879)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  768 bits (1983), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/405 (90%), Positives = 384/405 (94%), Gaps = 2/405 (0%)

Query: 1   MASVSVVPASG--NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKN 58
           MASV + P  G  ++ GVD+LPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTIGG+N
Sbjct: 1   MASVGIAPNPGARDSTGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRN 60

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           GQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRLLDHP
Sbjct: 61  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHP 120

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQI RA
Sbjct: 121 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRA 180

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPEL
Sbjct: 181 LSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 240

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           IFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN
Sbjct: 241 IFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 300

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           YTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRS AL+ L+HPFFDELRDPN
Sbjct: 301 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPN 360

Query: 359 TRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
            RLPNGRFLPPLFNFKPHELKGVP++M+ KL+PEHARKQC +LGL
Sbjct: 361 ARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  754 bits (1946), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/409 (87%), Positives = 380/409 (92%), Gaps = 6/409 (1%)

Query: 1   MASVSVVPA------SGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASV + P+      +GN    DRLPEEM DMKI+DDKEMEAT+V+GN TE GHIIVTTI
Sbjct: 1   MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPL+YVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  AL++L+HPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           RDPN RLPNGRFLPPLFNFKPHELKGVPV+M+ KL+PEHARKQC +L L
Sbjct: 361 RDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  750 bits (1936), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/411 (88%), Positives = 377/411 (91%), Gaps = 8/411 (1%)

Query: 1   MASVSVVPASG-------NTVGVDR-LPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVT 52
           MASV V P SG         +GVD  LPEEM+DMKIRDD+EMEATVVDGNGTE GHIIVT
Sbjct: 1   MASVGVAPTSGFREVLGDGEIGVDDILPEEMSDMKIRDDREMEATVVDGNGTETGHIIVT 60

Query: 53  TIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM 112
           TIGG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTM
Sbjct: 61  TIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 120

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMP+IYVKLY 
Sbjct: 121 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLYT 180

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           YQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRY
Sbjct: 181 YQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 240

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           YRAPELIFGATEYT AID+WS GCVLAELLLGQPLFPGE GVDQLVEIIKVLGTPTREEI
Sbjct: 241 YRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGTPTREEI 300

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
           KCMNPNYTEFKFPQIKAHPWHKIF KRMP EAVDLVSRLLQYSPNLR  AL+ L HPFFD
Sbjct: 301 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCLTHPFFD 360

Query: 353 ELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           ELRDPN RLP GRFLPPLFNFKPHELKGVPV+ L+KL+PEHARKQC FLGL
Sbjct: 361 ELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHARKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  749 bits (1933), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/409 (86%), Positives = 377/409 (92%), Gaps = 7/409 (1%)

Query: 1   MASVSVVPASG-------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTT 53
           MA+  V PASG       + + VD+LP+E+  M+I+DDKEMEA VVDGN TEAGH+IVTT
Sbjct: 1   MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKDDKEMEAHVVDGNSTEAGHVIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAER VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVV+LKHCFFSTTEKDELYLNLVLE+VPETVHRVI+H+ KM+QRMPLIYVKLY Y
Sbjct: 121 LLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLYSY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICR+LAYIHN +GV HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT+AIDIWSAGCVL ELLLGQPLFPG SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTPTREEIK 300

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           CMNPNYTEFKFPQIKAHPWHKIF+KRMPPEAVDLVSRLLQYSPNLRSTALEAL+HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFFDE 360

Query: 354 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 402
           LRDPNTRLPNGR LPPLFNFK +ELKGVP +MLVKL+P HARKQC+   
Sbjct: 361 LRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHARKQCSLFA 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  745 bits (1924), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/409 (87%), Positives = 377/409 (92%), Gaps = 6/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           M SV + P SG      ++VGVDRLPEEMNDM+IRDDKE+EA +VDGNGTE GHIIVTTI
Sbjct: 1   MTSVGLAPVSGLRESSSHSVGVDRLPEEMNDMRIRDDKEIEAAIVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG++GQPKQTISYMAER+VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVV LKHCFFSTTEKDE+YLNLVLEYVPETVHRVIKH+ K++QRMPLI VKLY YQ
Sbjct: 121 LDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I RAL+YIH+TIGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TALEA+ H FFDEL
Sbjct: 301 MNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           RDPNTRLPNGR LPPLFNFK HELKGV  + L+KL+PEHARKQC  LGL
Sbjct: 361 RDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPEHARKQCPSLGL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  744 bits (1920), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/410 (85%), Positives = 376/410 (91%), Gaps = 7/410 (1%)

Query: 1   MASVSVVPASG-------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTT 53
           MASV  +PAS         ++  ++LPE +N+MKI+DDKEMEA VVDGNGTE GHIIVTT
Sbjct: 1   MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAER+VG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+RV KH+ + +QRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           CMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLRSTA+EA++HPFFDE
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360

Query: 354 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           LRDPNTRLPNGR LPPLFNFKP ELKG  +++L KLIP+HARKQC+FL L
Sbjct: 361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  654 bits (1686), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 308/402 (76%), Positives = 343/402 (85%), Gaps = 7/402 (1%)

Query: 1   MASVSVVPASGNTVGVDRLPEEMNDMKIRD-------DKEMEATVVDGNGTEAGHIIVTT 53
           +A  S VPA       D+LP+ M +MKIRD       DK+ME TVV+G+GTE G +I TT
Sbjct: 65  VAGTSNVPAVSEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTT 124

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           +GG++G+PKQTISYMA+RVVG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MR
Sbjct: 125 VGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMR 184

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R  KH+ KM+Q MP+I+V+LY Y
Sbjct: 185 LQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTY 244

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPNISYICSRYY
Sbjct: 245 QICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYY 304

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+
Sbjct: 305 RAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIR 364

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TALEA  HPFFD+
Sbjct: 365 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDD 424

Query: 354 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
           LRDPN  LPNGR LPPLFNF   EL G   ++  +LIP H +
Sbjct: 425 LRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1

 Score =  641 bits (1653), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 302/408 (74%), Positives = 343/408 (84%), Gaps = 6/408 (1%)

Query: 2   ASVSVVPASGNTVGVDRLPEEMNDMKIRD------DKEMEATVVDGNGTEAGHIIVTTIG 55
           +S S       +  VD L  +M +MKIRD      +++ E  ++DG G E GH+I TT+ 
Sbjct: 11  SSRSAKNTKNTSSSVDWLSRDMLEMKIRDKTEADEERDSEPDIIDGVGAEPGHVITTTLP 70

Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           G+NGQ +QT+SY+AE VVG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M++L
Sbjct: 71  GRNGQSRQTVSYIAEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQML 130

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           DHPNVV LKH F+S TE +E+YLNLVLE+VPETV+R  + + +M+Q MPLIYVKLY YQI
Sbjct: 131 DHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNRTARSYSRMNQLMPLIYVKLYTYQI 190

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           CR LAY+HN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYYRA
Sbjct: 191 CRGLAYLHNCCGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYYRA 250

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PELIFGATEYT AIDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM
Sbjct: 251 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 310

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
           NPNYTEFKFPQIK HPWHK+FQKR+PPEAVDL+ R  QYSPNLR TA+EA IHPFFDELR
Sbjct: 311 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAVEACIHPFFDELR 370

Query: 356 DPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           DPN RLPNGR LPPLFNFKP EL G+P + + +L+PEHARKQ  F+ L
Sbjct: 371 DPNARLPNGRPLPPLFNFKPQELSGIPPETVDRLVPEHARKQNHFMAL 418

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2

 Score =  640 bits (1650), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 299/389 (76%), Positives = 335/389 (86%), Gaps = 10/389 (2%)

Query: 17  DRLPEEMNDMKIRDD----------KEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTIS 66
           D+LPE MNDM++R+D          K+ME  +V+G GTE G +I TT+GG++G+PKQTIS
Sbjct: 74  DQLPEVMNDMRLREDEPHANRGEEDKDMEPPIVNGCGTETGQVITTTVGGRDGKPKQTIS 133

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           YMA+RVVG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H 
Sbjct: 134 YMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHS 193

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           FFSTT+KDELYLNLVLE+VPETV+R +KH+ KM+Q MP+I V+LY YQICRAL Y+H  +
Sbjct: 194 FFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQHMPIILVQLYTYQICRALNYLHRVV 253

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           GVCHRDIKPQNLLVN HTHQLK+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT
Sbjct: 254 GVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 313

Query: 247 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 306
            AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQ
Sbjct: 314 NAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQ 373

Query: 307 IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRF 366
           IKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TALEA  HPFFD+LR PN  LPNGR 
Sbjct: 374 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRAPNVSLPNGRA 433

Query: 367 LPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
           LPPLFNF   EL G   ++  +LIP H +
Sbjct: 434 LPPLFNFTAQELAGASTELRQRLIPAHCQ 462

May mediate extracellular signals to regulate transcription in differentiating cells.

Brassica napus (taxid: 3708)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	403
224068663	409	predicted protein [Populus trichocarpa]	1.0	0.985	0.946	0.0
224128207	409	predicted protein [Populus trichocarpa]	1.0	0.985	0.943	0.0
255548323	409	Glycogen synthase kinase-3 beta, putativ	1.0	0.985	0.943	0.0
225437683	409	PREDICTED: glycogen synthase kinase-3 ho	1.0	0.985	0.941	0.0
449461703	409	PREDICTED: glycogen synthase kinase-3 ho	0.997	0.982	0.928	0.0
164521171	409	serine/threonine protein kinase [Adonis	1.0	0.985	0.929	0.0
225450484	409	PREDICTED: shaggy-related protein kinase	1.0	0.985	0.907	0.0
313148	412	protein kinase [Medicago sativa]	0.997	0.975	0.899	0.0
11182434	411	RecName: Full=Glycogen synthase kinase-3	0.997	0.978	0.899	0.0
297812879	409	hypothetical protein ARALYDRAFT_489503 [	1.0	0.985	0.894	0.0

>gi|224068663|ref|XP_002302794.1| predicted protein [Populus trichocarpa] gi|222844520|gb|EEE82067.1| predicted protein [Populus trichocarpa]

 Score =  806 bits (2083), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 387/409 (94%), Positives = 394/409 (96%), Gaps = 6/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVSVVPASG      NT GVD+LPEEMNDMKI DDKEMEA VVDGNGTE GHIIVTTI
Sbjct: 1   MASVSVVPASGLRDTLGNTTGVDKLPEEMNDMKISDDKEMEAAVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGLVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HRVIKH+YKMSQRMPLIYVKLYFYQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHRVIKHYYKMSQRMPLIYVKLYFYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           RDPN RLPNGR LPPLFNFKPHELKGVPV+MLVKLIPEHARKQCAFLGL
Sbjct: 361 RDPNARLPNGRILPPLFNFKPHELKGVPVEMLVKLIPEHARKQCAFLGL 409

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224128207|ref|XP_002320270.1| predicted protein [Populus trichocarpa] gi|222861043|gb|EEE98585.1| predicted protein [Populus trichocarpa]

 Score =  806 bits (2081), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/409 (94%), Positives = 397/409 (97%), Gaps = 6/409 (1%)

Query: 1   MASVSVVPA------SGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVSVVPA      SGN+ GVD+LP+EMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSVVPATGLRDRSGNSAGVDKLPDEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HRVIKH+ KMSQRMPLIYVKLYFY+
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHRVIKHYSKMSQRMPLIYVKLYFYE 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT+AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTSAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           RDPNTRLPNGRFLPPLFNFKPHELKGVP++MLVKLIPEHARKQCAFLGL
Sbjct: 361 RDPNTRLPNGRFLPPLFNFKPHELKGVPLEMLVKLIPEHARKQCAFLGL 409

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255548323|ref|XP_002515218.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223545698|gb|EEF47202.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis]

 Score =  801 bits (2069), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/409 (94%), Positives = 393/409 (96%), Gaps = 6/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVSV P SG      N  GVDRLP+EMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSVAPTSGIRDPGGNAAGVDRLPDEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ KM QRMPLIYVKLYFYQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKMGQRMPLIYVKLYFYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIHN+IGVCHRDIKP NLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHNSIGVCHRDIKPHNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTAL+ALIHPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALDALIHPFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           RDPNTRLPNGRFLPPLFNF+PHELKGVPV++LVKLIPEHARKQCAFLGL
Sbjct: 361 RDPNTRLPNGRFLPPLFNFRPHELKGVPVEVLVKLIPEHARKQCAFLGL 409

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225437683|ref|XP_002279596.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3 [Vitis vinifera] gi|147767229|emb|CAN75652.1| hypothetical protein VITISV_017659 [Vitis vinifera]

 Score =  796 bits (2057), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 385/409 (94%), Positives = 392/409 (95%), Gaps = 6/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVS+ PASG      NTVGVDRLP+EMNDMKIRDDKEME TVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSIAPASGLREPNGNTVGVDRLPDEMNDMKIRDDKEMEDTVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEK+ELYLNLVLEYVPETVHRVIKH+ KM+QRMP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKEELYLNLVLEYVPETVHRVIKHYNKMNQRMPMIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIH  IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE NISYICSRYYR
Sbjct: 181 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGELNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           R+PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Sbjct: 361 REPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 409

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461703|ref|XP_004148581.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus] gi|449511511|ref|XP_004163975.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus]

 Score =  792 bits (2045), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/408 (92%), Positives = 391/408 (95%), Gaps = 6/408 (1%)

Query: 1   MASVSVVPAS------GNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           M SVSV PAS      G+T+GVDRLP+EMNDMKIRDDKE+EATVVDGNGTE GHIIVTTI
Sbjct: 1   MTSVSVAPASMIRDHGGSTIGVDRLPDEMNDMKIRDDKEIEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GGKNGQPKQTISYMAER VGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGKNGQPKQTISYMAERAVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ KM+QRMPLIYVKLYFYQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKMNQRMPLIYVKLYFYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRAL+YIHN+IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV+GEPNI+YICSRYYR
Sbjct: 181 ICRALSYIHNSIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVRGEPNIAYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 402
           RDPNTRLPNGRFLPPLFNFK HELKGVP +MLV+LIPEHARKQC FLG
Sbjct: 361 RDPNTRLPNGRFLPPLFNFKAHELKGVPPEMLVRLIPEHARKQCNFLG 408

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|164521171|gb|ABY60447.1| serine/threonine protein kinase [Adonis aestivalis var. palaestina]

 Score =  788 bits (2035), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 380/409 (92%), Positives = 388/409 (94%), Gaps = 6/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASVS+ P SG      N  G DRLPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVSMAPPSGLRDPTGNAGGADRLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET HRVIKH+ KM+QRMPLIYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETAHRVIKHYNKMNQRMPLIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           ICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 ICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTAL+ALIHPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALDALIHPFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           RDP TRLPNGRFLPPLFNFKPHELKGVPV++L KLIPEHARKQCAFLGL
Sbjct: 361 RDPTTRLPNGRFLPPLFNFKPHELKGVPVEILGKLIPEHARKQCAFLGL 409

Source: Adonis aestivalis var. palaestina

Species: Adonis aestivalis

Genus: Adonis

Family: Ranunculaceae

Order: Ranunculales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225450484|ref|XP_002280673.1| PREDICTED: shaggy-related protein kinase alpha [Vitis vinifera]

 Score =  773 bits (1995), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/409 (90%), Positives = 385/409 (94%), Gaps = 6/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASV + P SG      +  GVDRLPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVGIAPTSGLREPSGHNAGVDRLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I RAL+YIH +IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AIDIWSAGCVLAEL+LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TA++AL H FFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAMDALTHSFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           RD +TRLPNGRFLPPLFNFKPHELKGVPV++LVKLIPEHARKQC FLGL
Sbjct: 361 RDSSTRLPNGRFLPPLFNFKPHELKGVPVEILVKLIPEHARKQCPFLGL 409

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|313148|emb|CAA48472.1| protein kinase [Medicago sativa]

 Score =  770 bits (1987), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/409 (89%), Positives = 386/409 (94%), Gaps = 7/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++VGV++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 2   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 61

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 62  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 121

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 122 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 181

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 182 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 241

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 242 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 301

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEAL+HPF+D+
Sbjct: 302 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFYDD 361

Query: 354 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 402
           +RDPNTRLPNGRFLPPLFNFK +ELKGVP +MLVKL+P HARKQCA  G
Sbjct: 362 VRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCALFG 410

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|11182434|sp|P51139.2|MSK3_MEDSA RecName: Full=Glycogen synthase kinase-3 homolog MsK-3

 Score =  769 bits (1986), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/409 (89%), Positives = 386/409 (94%), Gaps = 7/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEA-TVVDGNGTEAGHIIVTT 53
           MAS  V PASG      ++VGV++LPEEMNDMKIRDDKEMEA T+VDGNGTE GHIIVTT
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 60

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
           IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 180

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 240

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEAL+HPF+D+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFYDD 360

Query: 354 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 402
           +RDPNTRLPNGRFLPPLFNFK +ELKGVP +MLVKL+P HARKQCA  G
Sbjct: 361 VRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCALFG 409

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297812879|ref|XP_002874323.1| hypothetical protein ARALYDRAFT_489503 [Arabidopsis lyrata subsp. lyrata] gi|297320160|gb|EFH50582.1| hypothetical protein ARALYDRAFT_489503 [Arabidopsis lyrata subsp. lyrata]

 Score =  769 bits (1985), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/409 (89%), Positives = 384/409 (93%), Gaps = 6/409 (1%)

Query: 1   MASVSVVPASG------NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
           MASV + P  G      + +GVD+LPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTI
Sbjct: 1   MASVGIAPNPGARDSTTHAIGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
           GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRS AL+ L+HPFFDEL
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDEL 360

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           RDPN RLPNGRFLPPLFNFKPHELKGVPV+M+ KL+PEHARKQC +LGL
Sbjct: 361 RDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLGL 409

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	403
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	1.0	0.995	0.901	2.4e-202
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	1.0	0.985	0.872	1.4e-197
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	1.0	0.982	0.858	2.5e-193
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.980	0.836	0.766	2e-168
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.962	0.921	0.751	1.4e-165
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.918	0.909	0.789	4.3e-164
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.965	0.944	0.763	4.3e-164
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.918	0.973	0.783	1.5e-161
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.942	0.867	0.721	2e-152
UNIPROTKB|F1NPL8	390	GSK3B "Uncharacterized protein	0.883	0.912	0.664	1.7e-128

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1958 (694.3 bits), Expect = 2.4e-202, P = 2.4e-202
 Identities = 365/405 (90%), Positives = 384/405 (94%)

Query:     1 MASVSVVPASG--NTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKN 58
             MASV + P  G  ++ GVD+LPEEMNDMKIRDDKEMEATVVDGNGTE GHIIVTTIGG+N
Sbjct:     1 MASVGIAPNPGARDSTGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRN 60

Query:    59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
             GQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRLLDHP
Sbjct:    61 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHP 120

Query:   119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY YQI RA
Sbjct:   121 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRA 180

Query:   179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
             L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPEL
Sbjct:   181 LSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 240

Query:   239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
             IFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN
Sbjct:   241 IFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 300

Query:   299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
             YTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRS AL+ L+HPFFDELRDPN
Sbjct:   301 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPN 360

Query:   359 TRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
              RLPNGRFLPPLFNFKPHELKGVP++M+ KL+PEHARKQC +LGL
Sbjct:   361 ARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1913 (678.5 bits), Expect = 1.4e-197, P = 1.4e-197
 Identities = 357/409 (87%), Positives = 380/409 (92%)

Query:     1 MASVSVVPAS------GNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTI 54
             MASV + P++      GN    DRLPEEM DMKI+DDKEMEAT+V+GN TE GHIIVTTI
Sbjct:     1 MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query:    55 GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL 114
             GG+NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGE VAIKKVLQD+RYKNRELQTMRL
Sbjct:    61 GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query:   115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPL+YVKLY YQ
Sbjct:   121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query:   175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
             I R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct:   181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query:   235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
             APELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC
Sbjct:   241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query:   295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
             MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  AL++L+HPFFDEL
Sbjct:   301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDEL 360

Query:   355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
             RDPN RLPNGRFLPPLFNFKPHELKGVPV+M+ KL+PEHARKQC +L L
Sbjct:   361 RDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLSL 409

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1873 (664.4 bits), Expect = 2.5e-193, P = 2.5e-193
 Identities = 352/410 (85%), Positives = 377/410 (91%)

Query:     1 MASVSVVPASG------N-TVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTT 53
             MASV  +PAS       N ++  ++LPE +N+MKI+DDKEMEA VVDGNGTE GHIIVTT
Sbjct:     1 MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query:    54 IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
             IGGKNGQPKQTISYMAER+VG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQTMR
Sbjct:    61 IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query:   114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
             LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+RV KH+ + +QRMP+IYVKLY Y
Sbjct:   121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query:   174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
             QICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYY
Sbjct:   181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query:   234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
             RAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct:   241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query:   294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
             CMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLRSTA+EA++HPFFDE
Sbjct:   301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360

Query:   354 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
             LRDPNTRLPNGR LPPLFNFKP ELKG  +++L KLIP+HARKQC+FL L
Sbjct:   361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1638 (581.7 bits), Expect = 2.0e-168, P = 2.0e-168
 Identities = 308/402 (76%), Positives = 343/402 (85%)

Query:     1 MASVSVVPASGNTVGVDRLPEEMNDMKIRD-------DKEMEATVVDGNGTEAGHIIVTT 53
             +A  S VPA       D+LP+ M +MKIRD       DK+ME TVV+G+GTE G +I TT
Sbjct:    65 VAGTSNVPAVSEKPVDDQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTT 124

Query:    54 IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR 113
             +GG++G+PKQTISYMA+RVVG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MR
Sbjct:   125 VGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMR 184

Query:   114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
             L DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R  KH+ KM+Q MP+I+V+LY Y
Sbjct:   185 LQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTY 244

Query:   174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
             QICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPNISYICSRYY
Sbjct:   245 QICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYY 304

Query:   234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
             RAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+
Sbjct:   305 RAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIR 364

Query:   294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
             CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TALEA  HPFFD+
Sbjct:   365 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDD 424

Query:   354 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
             LRDPN  LPNGR LPPLFNF   EL G   ++  +LIP H +
Sbjct:   425 LRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1611 (572.2 bits), Expect = 1.4e-165, P = 1.4e-165
 Identities = 296/394 (75%), Positives = 341/394 (86%)

Query:    16 VDRLPEEMNDMKIRD------DKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMA 69
             VD L  ++ + +IRD      +++ E  ++DG G E GH+I TT+ G+NGQ +QT+SY++
Sbjct:    26 VDWLTRDLAETRIRDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYIS 85

Query:    70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
             E VVG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LDHPN V+LKH FFS
Sbjct:    86 EHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFS 145

Query:   130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
              T+ +E+YLNLVLE+VPETV+RV + + + +Q MPLIYVKLY YQICRALAYIHN+ G+C
Sbjct:   146 RTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLC 205

Query:   190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI 249
             HRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+SYICSRYYRAPELIFGA+EYT AI
Sbjct:   206 HRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAI 265

Query:   250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 309
             DIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 
Sbjct:   266 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 325

Query:   310 HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPP 369
             HPWHK+FQKR+PPEAVDL+ R  QYSPNLR TALEA IHP FDELRDPNTRLPNGR LPP
Sbjct:   326 HPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPP 385

Query:   370 LFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
             LFNFKP EL G+P +++ +L+PEHARKQ  F+ L
Sbjct:   386 LFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1597 (567.2 bits), Expect = 4.3e-164, P = 4.3e-164
 Identities = 293/371 (78%), Positives = 332/371 (89%)

Query:    27 KIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKC 86
             ++  DKEM A V++GN    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKC
Sbjct:    30 ELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKC 89

Query:    87 LETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP 146
             LETGE+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVP
Sbjct:    90 LETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVP 149

Query:   147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ 206
             ET++RV++H+   +QRMP+ YVKLY YQI R LAYIH   GVCHRD+KPQNLLV+P THQ
Sbjct:   150 ETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 209

Query:   207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
             +KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA+IDIWSAGCVLAELLLGQP
Sbjct:   210 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQP 269

Query:   267 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD 326
             LFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+D
Sbjct:   270 LFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 329

Query:   327 LVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDML 386
             L SRLLQYSP+LR TALEA  HPFF+ELR+PN RLPNGR LPPLFNFK  EL G  ++++
Sbjct:   330 LASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELGGASMELI 388

Query:   387 VKLIPEHARKQ 397
              +LIPEH R+Q
Sbjct:   389 NRLIPEHVRRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1597 (567.2 bits), Expect = 4.3e-164, P = 4.3e-164
 Identities = 300/393 (76%), Positives = 338/393 (86%)

Query:     5 SVVPASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQT 64
             S+ P   +  G D L    +   I +DKEM A V++GN    GHII TTIGGKNG+PKQT
Sbjct:    13 SLAPQPPHLHGGDSLKRRPD---IDNDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQT 69

Query:    65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 124
             ISYMAERVVG GSFG+VFQAKCLETGE+VAIKKVLQD+RYKNRELQ MRL+DHPNVVSLK
Sbjct:    70 ISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLK 129

Query:   125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             HCFFSTT +DEL+LNLV+EYVPET++RV+KH+   +QRMP+ YVKLY YQI R LAYIH 
Sbjct:   130 HCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHT 189

Query:   185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
               GVCHRD+KPQNLLV+P THQ KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATE
Sbjct:   190 APGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 249

Query:   245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
             YT++IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+F
Sbjct:   250 YTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 309

Query:   305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNG 364
             PQIKAHPWHK+F KRMPPEA+DL SRLLQYSP+LR TALEA  HPFF+ELR+PN RLPNG
Sbjct:   310 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNG 369

Query:   365 RFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQ 397
             R LPPLFNFK  EL G   +++ +LIPEH R+Q
Sbjct:   370 RPLPPLFNFK-QELSGASPELINRLIPEHVRRQ 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1573 (558.8 bits), Expect = 1.5e-161, P = 1.5e-161
 Identities = 293/374 (78%), Positives = 329/374 (87%)

Query:    30 DDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLET 89
             DDKEM A VVDG+    GHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLET
Sbjct:     3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62

Query:    90 GEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 149
             GE VAIKKVLQD+RYKNRELQ MR++DHPNVV LKHCFFSTT KDEL+LNLV+EYVPE++
Sbjct:    63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122

Query:   150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
             +RV+KH+   +QRMPL+YVKLY YQI R LAYIHN  GVCHRD+KPQNLLV+P THQ+K+
Sbjct:   123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182

Query:   210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP 269
             CDFGSAK LVKGE NISYICSR+YRAPELIFGATEYT +IDIWSAGCVLAELLLGQPLFP
Sbjct:   183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242

Query:   270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS 329
             GE+ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIF KRMPPEA+D  S
Sbjct:   243 GENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFAS 302

Query:   330 RLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKL 389
             RLLQYSP+LR TALEA  HPFFDELR+PN RLPNGR  PPLFNFK  E+ G   +++ KL
Sbjct:   303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEVAGSSPELVNKL 361

Query:   390 IPEHARKQCAFLGL 403
             IP+H ++Q   LGL
Sbjct:   362 IPDHIKRQ---LGL 372

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1487 (528.5 bits), Expect = 2.0e-152, P = 2.0e-152
 Identities = 274/380 (72%), Positives = 318/380 (83%)

Query:    17 DRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHG 76
             D LP+E+ ++ + DDK+M+  ++ GNGTE+G II T   G N Q  +TISY AE V+G G
Sbjct:    59 DHLPKEIREVGLGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTG 118

Query:    77 SFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL 136
             SFGVVFQAKCLET E VAIKKVLQDKRYKNRELQ MR+LDHPNVV LKH FFSTTEKDEL
Sbjct:   119 SFGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDEL 178

Query:   137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ 196
             YLNLVLEYVPET++R  + + KM+Q MPLIY++LY YQICRA+ Y+H  +GVCHRDIKPQ
Sbjct:   179 YLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQ 238

Query:   197 NLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGC 256
             NLLVN  TH++K+CDFGSAK+L+ GEPNISYICSRYYRAPELIFGATEYT+AID+WS GC
Sbjct:   239 NLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGC 298

Query:   257 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 316
             V+AEL LG PLFPGE+ VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIKA PWHKIF
Sbjct:   299 VMAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIF 358

Query:   317 QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPH 376
             ++++ PEA+DL SRLLQYSPNLR TALEA  HPFFD+LRDP   LPNGR LPPLF+F   
Sbjct:   359 RRQVSPEAMDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQ 418

Query:   377 ELKGVPVDMLVKLIPEHARK 396
             EL G  V++  +LIPEHARK
Sbjct:   419 ELAGASVELRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|F1NPL8 GSK3B "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
 Identities = 240/361 (66%), Positives = 290/361 (80%)

Query:    40 DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
             D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct:     1 DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 58

Query:   100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
             QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct:    59 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 118

Query:   159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
               Q +P+IYVKLY YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct:   119 AKQTLPMIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177

Query:   219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
             V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct:   178 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237

Query:   279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
             EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct:   238 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 297

Query:   339 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 398
             R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct:   298 RLTPLEACAHSFFDELRDPNVKLPNGREKPALFNFTTQELSSNP-SLASILIPAHARNQA 356

Query:   399 A 399
             A
Sbjct:   357 A 357

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000320 "re-entry into mitotic cell cycle" evidence=IEA

GO:0001085 "RNA polymerase II transcription factor binding" evidence=IEA

GO:0001837 "epithelial to mesenchymal transition" evidence=IEA

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IEA

GO:0002039 "p53 binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005977 "glycogen metabolic process" evidence=IEA

GO:0006349 "regulation of gene expression by genetic imprinting" evidence=IEA

GO:0006611 "protein export from nucleus" evidence=IEA

GO:0006983 "ER overload response" evidence=IEA

GO:0007409 "axonogenesis" evidence=IEA

GO:0007520 "myoblast fusion" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0009887 "organ morphogenesis" evidence=IEA

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0021766 "hippocampus development" evidence=IEA

GO:0030426 "growth cone" evidence=IEA

GO:0030529 "ribonucleoprotein complex" evidence=IEA

GO:0030877 "beta-catenin destruction complex" evidence=IEA

GO:0031333 "negative regulation of protein complex assembly" evidence=IEA

GO:0031334 "positive regulation of protein complex assembly" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0032091 "negative regulation of protein binding" evidence=IEA

GO:0032092 "positive regulation of protein binding" evidence=IEA

GO:0032855 "positive regulation of Rac GTPase activity" evidence=IEA

GO:0032886 "regulation of microtubule-based process" evidence=IEA

GO:0033138 "positive regulation of peptidyl-serine phosphorylation" evidence=IEA

GO:0034236 "protein kinase A catalytic subunit binding" evidence=IEA

GO:0035372 "protein localization to microtubule" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0043198 "dendritic shaft" evidence=IEA

GO:0044027 "hypermethylation of CpG island" evidence=IEA

GO:0044337 "canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process" evidence=IEA

GO:0045444 "fat cell differentiation" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0050321 "tau-protein kinase activity" evidence=IEA

GO:0051059 "NF-kappaB binding" evidence=IEA

GO:0051534 "negative regulation of NFAT protein import into nucleus" evidence=IEA

GO:0071109 "superior temporal gyrus development" evidence=IEA

GO:2000738 "positive regulation of stem cell differentiation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.8728	1.0	0.9853	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.9012	1.0	0.9950	yes	no
Q96287	KSG8_ARATH	2, ., 7, ., 1, 1, ., 1	0.7661	0.9801	0.8368	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6079	0.8461	0.8811	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7855	0.9230	0.9140	no	no
A8X5H5	GSK3_CAEBR	2, ., 7, ., 1, 1, ., 2, 6	0.6479	0.8337	0.9359	N/A	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7972	0.9156	0.8956	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.7834	0.9181	0.9736	no	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.7418	0.9751	0.9334	no	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5841	0.7196	0.7837	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6656	0.7965	0.8867	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.7401	0.9975	0.9571	no	no
O23145	KSG2_ARATH	2, ., 7, ., 1, 1, ., 1	0.7102	0.9429	0.8816	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.8728	1.0	0.9853	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6404	0.9106	0.8738	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6287	0.8213	0.7087	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8807	1.0	0.9805	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8655	0.9975	0.9781	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8997	0.9975	0.9781	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7686	0.9404	0.8098	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6404	0.9106	0.8738	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8560	1.0	0.9829	no	no
Q91757	GSK3B_XENLA	2, ., 7, ., 1, 1, ., 2, 6	0.6404	0.9106	0.8738	N/A	no
Q5YJC2	GSK3B_SPECI	2, ., 7, ., 1, 1, ., 1	0.6377	0.9106	0.8738	N/A	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6404	0.9106	0.8738	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.993
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pm.C_LG_II0912 hypothetical protein (409 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	403
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-135
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-96
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-87
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-84
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-84
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-81
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-79
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-77
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-77
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-75
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-75
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-72
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-70
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-70
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-69
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-68
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-66
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-64
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-63
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-63
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-63
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-63
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-60
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-59
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-58
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-57
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-56
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-56
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-55
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-55
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-55
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-54
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-54
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-54
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-54
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-54
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-53
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-53
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-53
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-52
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-52
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-51
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-48
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-48
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-48
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-48
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-48
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-47
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-45
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-45
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-45
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-44
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-41
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-39
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-38
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-38
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-37
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-37
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-37
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-36
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-35
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-35
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-35
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-34
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-32
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-31
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-31
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-30
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-30
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-30
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-29
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-28
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-28
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-27
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-26
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-26
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-24
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-23
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-23
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-22
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-22
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-22
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-20
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-19
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-19
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-18
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-16
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-16
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-16
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-16
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-16
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-15
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-15
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-15
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-14
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-09
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-08
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-04
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-04
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-04
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	0.001
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.002
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.002
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	0.003
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.004
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.004

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  394 bits (1012), Expect = e-135
 Identities = 175/331 (52%), Positives = 245/331 (74%), Gaps = 5/331 (1%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           SY    ++G+GSFGVV++A C++T E VAIKKVLQD +YKNREL  M+ L+H N++ LK 
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 126 CFFSTT-EKDE--LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            +++   +K+E  ++LN+V+E++P+TVH+ +KH+ + +  +PL  VKLY YQ+CRALAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   +CHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
           T YT  ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MNPNY + 
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           KFP +K     K+F K  P +A++ +S+ L+Y P  R   +EAL  PFFD+LRDP  +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365

Query: 363 NG-RFLPPLFNFKPHELKGVPVDMLVKLIPE 392
                LP LFNF   E+K +      K+IP+
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  289 bits (742), Expect = 8e-96
 Identities = 124/339 (36%), Positives = 186/339 (54%), Gaps = 28/339 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + +G G++GVV  A    TG  VAIKK+      L D +   RE++ +R L H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 121 VSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           + L       S  + +++Y+  V E +   +H+VIK      Q +   +++ + YQI R 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRG 115

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYR 234
           L Y+H +  V HRD+KP N+LVN     LK+CDFG A+ +   E        Y+ +R+YR
Sbjct: 116 LKYLH-SANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++K 
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 295 M-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           + +     +    P+    P  K+F     PEA+DL+ ++L + P  R TA EAL HP+ 
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Query: 352 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
            +L DP    P      P F+F   +   +  + L +LI
Sbjct: 293 AQLHDPE-DEPVA---KPPFDFDFFDDDELTEEELKELI 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  265 bits (681), Expect = 3e-87
 Identities = 112/295 (37%), Positives = 170/295 (57%), Gaps = 35/295 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHPNVVSLK 124
           +G G++GVV++A+  +TGE VA+KK+  D   +         RE+  ++ L HPN+V L 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               +   + +LYL  V EY    + + +    K    +    +K   YQ+ R LAY H 
Sbjct: 65  DVIHT---ERKLYL--VFEYCDMDLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
           +  + HRD+KPQN+L+N     LKL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 116 SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           +  Y+ A+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E      P  T+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVTK 228

Query: 302 FK-----FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                  FP+       K+   R+ PE +DL+S++LQY+P  R +A EAL HP+F
Sbjct: 229 LPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  259 bits (663), Expect = 1e-84
 Identities = 111/292 (38%), Positives = 167/292 (57%), Gaps = 23/292 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
             +G G+ G+VF+AK  ETGE VA+KKV   +          RE++ ++   HP VV L 
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F            LV+EY+P  +  V++      + +P   VK Y   + + +AY+H 
Sbjct: 66  DVF-----PHGSGFVLVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELIFGA 242
             G+ HRD+KP NLL++     LK+ DFG A++  + EP +    + +R+YRAPEL++GA
Sbjct: 118 N-GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 299
            +Y   +D+W+ GC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDY 234

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            +  FP+ K  P  +IF     PEA+DL+  LL Y P+ R +A EAL HP+F
Sbjct: 235 NKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  257 bits (658), Expect = 8e-84
 Identities = 114/294 (38%), Positives = 170/294 (57%), Gaps = 20/294 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKN---RELQTMRLLDHPNV 120
           Y     +G G++GVV++A+   TGE VAIKK+              RE++ ++ L+HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + L   F     K +LYL  V E++   ++++IK   +    +P   +K Y YQ+ + LA
Sbjct: 61  IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLA 112

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           + H+  G+ HRD+KP+NLL+N     LKL DFG A+       P   Y+ +R+YRAPEL+
Sbjct: 113 FCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 298
            G   Y+  +DIWS GC+ AELL  +PLFPG+S +DQL +I + LGTP  E         
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 299 -YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
              +F FP+    P  K+F     P+A+DL+S++L Y P+ R TA +AL HP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  250 bits (640), Expect = 2e-81
 Identities = 104/291 (35%), Positives = 154/291 (52%), Gaps = 43/291 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 121
           Y     +G GSFG V+ A+  +TG+ VAIK +      +D+    RE++ ++ L HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L   F    ++D+LYL  V+EY     +  ++K   ++S+       + Y  QI  AL 
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKKRGRLSEDE----ARFYLRQILSALE 111

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           Y+H+  G+ HRD+KP+N+L++   H +KL DFG A+ L  GE   +++ +  Y APE++ 
Sbjct: 112 YLHS-KGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           G   Y  A+DIWS G +L ELL G+P FPG+   DQL+E+ K +G P             
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPPEWD--- 222

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                              + PEA DL+ +LL   P  R TA EAL HPFF
Sbjct: 223 -------------------ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  246 bits (630), Expect = 1e-79
 Identities = 113/291 (38%), Positives = 165/291 (56%), Gaps = 21/291 (7%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 125
           VVG G++GVV + +   TGE VAIKK  +   D+  K    RE++ +R L H N+V+LK 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F     K  LYL  V EYV  T+  +++        +P   V+ Y +Q+ +A+AY H+ 
Sbjct: 68  AFRR---KGRLYL--VFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYICSRYYRAPELIFGAT 243
             + HRDIKP+N+LV+     LKLCDFG A+ L      P   Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 301
            Y   +D+W+ GC++AELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP +  
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 302 FKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
             FP+        + +  ++   A+D +   L+  P  R T  E L HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  241 bits (617), Expect = 2e-77
 Identities = 115/299 (38%), Positives = 163/299 (54%), Gaps = 29/299 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDH 117
           Y   + +G G++ VV++A+  ETG  VAIKK+   +R +          RE++ ++ L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN++ L   F     K    +NLV E++   + +VIK     S  +    +K Y     R
Sbjct: 62  PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SRYYR 234
            L Y+H+   + HRD+KP NLL+      LKL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APEL+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 295 MN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           +   P+Y EFK       P  +IF      +A+DL+ RLL  +PN R TA +AL HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  238 bits (609), Expect = 8e-77
 Identities = 95/289 (32%), Positives = 142/289 (49%), Gaps = 39/289 (13%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
            R +G GSFG V++AK   TG+ VA+K + +            RE++ +R L HPN+V L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F    +KD LYL  V+EY           +      +     K    QI R L Y+H
Sbjct: 64  IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGA 242
           +  G+ HRD+KP+N+L++     +K+ DFG AK L+K      +++ + +Y APE++ G 
Sbjct: 116 S-NGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y   +D+WS G +L ELL G+P F GE+ +DQL  I ++LG P   +    +      
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS----- 228

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                               EA DL+ + L   P+ R TA E L HP+F
Sbjct: 229 -----------------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  235 bits (603), Expect = 7e-75
 Identities = 113/309 (36%), Positives = 178/309 (57%), Gaps = 31/309 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRE---LQTMRLLDH 117
           Y   + +G G++G+V++A    T E VA+KK+        D +   RE   LQ +   DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG--DH 66

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L +   +  +KD +YL  V EY+   +H VI+    + + +   Y+    YQ+ +
Sbjct: 67  PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRA--NILEDVHKRYI---MYQLLK 118

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------YICSR 231
           AL YIH +  V HRD+KP N+L+N     +KL DFG A+ L + E N        Y+ +R
Sbjct: 119 ALKYIH-SGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           +YRAPE++ G+T YT  +D+WS GC+L E+LLG+PLFPG S ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 292 IKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
           I+ +   +        P     P  ++   +   +A+DL+ +LL ++PN R TA EAL H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 349 PFFDELRDP 357
           P+  +  +P
Sbjct: 296 PYVAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  233 bits (598), Expect = 7e-75
 Identities = 112/293 (38%), Positives = 175/293 (59%), Gaps = 26/293 (8%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVS 122
           + +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++++R L +HPN+V 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           LK  F    E DELY   V EY+   +++++K      +      ++   YQI + LA+I
Sbjct: 63  LKEVF---RENDELYF--VFEYMEGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHI 115

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H   G  HRD+KP+NLLV+     +K+ DFG A+ +    P   Y+ +R+YRAPE++  +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPN 298
           T Y++ +DIW+ GC++AEL   +PLFPG S +DQL +I  VLGTPT+++     K  +  
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK- 232

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
              F+FPQ      H++      PEA+DL+  +L++ P  R TA +AL HP+F
Sbjct: 233 -LGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  227 bits (581), Expect = 4e-72
 Identities = 97/292 (33%), Positives = 159/292 (54%), Gaps = 24/292 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 125
           +G G++G V++A+  +TGE VA+KK+  +   K        RE++ ++ L HPN+V LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIHN 184
                T K +  + +V EY+   +  ++     K ++      +K Y  Q+   L Y+H+
Sbjct: 66  I---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES----QIKCYMKQLLEGLQYLHS 118

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGA 242
             G+ HRDIK  N+L+N     LKL DFG A+   K       + + + +YR PEL+ GA
Sbjct: 119 -NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 299
           T Y   +D+WS GC+LAEL LG+P+F G + ++QL +I ++ G+PT E    +  + P +
Sbjct: 177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWF 235

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
              K  +       + F+  + P A+DL+ +LL   P  R +A +AL H +F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  224 bits (574), Expect = 1e-70
 Identities = 107/307 (34%), Positives = 178/307 (57%), Gaps = 26/307 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A    TG  VAIKK+   + + +  R L+ +++L    H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 122 SLKHCFFSTT--EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +       +    +++Y+  V E +   ++++IK     +Q +   +++ + YQI R L
Sbjct: 67  GILDIIRPPSFESFNDVYI--VQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRA 235
            YIH+   V HRD+KP NLL+N     LK+CDFG A++      +      Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++  +  YT AIDIWS GC+LAE+L  +PLFPG+  + QL  I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 296 -NP---NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            +    NY +   P     PW+K+F     P+A+DL+ ++L ++P+ R T  EAL HP+ 
Sbjct: 238 ISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Query: 352 DELRDPN 358
           ++  DP+
Sbjct: 296 EQYHDPS 302

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  224 bits (572), Expect = 3e-70
 Identities = 109/307 (35%), Positives = 165/307 (53%), Gaps = 24/307 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPN 119
            Y     +G G++GVV  A    +G+ VAIKK      V    +   REL+ +R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +++++         D   + +V++ +   +H +I       Q +   +++ + YQ+ R L
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGL 120

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYR 234
            YIH+   V HRD+KP NLLVN     L++ DFG A+ L             Y+ +R+YR
Sbjct: 121 KYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APEL+    EYT AID+WS GC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E +  
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 295 MNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +       Y +   P+ +  PW KIF K   PEA+DL+S++LQ+ P  R T  +AL HPF
Sbjct: 239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPF 296

Query: 351 FDELRDP 357
             +  DP
Sbjct: 297 LAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  221 bits (564), Expect = 4e-69
 Identities = 118/336 (35%), Positives = 187/336 (55%), Gaps = 26/336 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y+  + +G G++G+V  AK  ET E VAIKK+        D +   RE++ +R LDH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 121 VSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++K        +  +++Y+  V E +   +H++I+     SQ +   + + + YQ+ R 
Sbjct: 67  IAIKDIMPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRG 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPE 237
           L YIH+   V HRD+KP NLL+N +   LK+CDFG A+    KG+    Y+ +R+YRAPE
Sbjct: 121 LKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-N 296
           L+   +EYT AID+WS GC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + N
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238

Query: 297 PNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                +    P      + ++F     P A+DL+ ++L + P+ R T  EAL HP+   L
Sbjct: 239 EKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
            DP+         P  F+F+   L     + + +LI
Sbjct: 298 HDPSDEPVCQT--PFSFDFEEDALTE---EDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  218 bits (557), Expect = 7e-68
 Identities = 106/305 (34%), Positives = 166/305 (54%), Gaps = 26/305 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y     VG G++G V  A   +TG  VAIKK+ +        KR Y  REL+ ++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 119 NVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+ L   F   +  ++   + LV   +   ++ ++K      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L YIH+  G+ HRD+KP N+ VN    +LK+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 298 ----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
               NY +   PQ+    + ++F     P A+DL+ ++L   P+ R TA EAL HP+  E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 354 LRDPN 358
             DP 
Sbjct: 304 YHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  212 bits (541), Expect = 3e-66
 Identities = 101/291 (34%), Positives = 163/291 (56%), Gaps = 26/291 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  +   +       RE+  ++ L+HPN+V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +   LYL  V E++   + + +         +    +K Y YQ+ + +AY H + 
Sbjct: 67  VHSENK---LYL--VFEFLDLDLKKYMDSSPLTG--LDPPLIKSYLYQLLQGIAYCH-SH 118

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL++     LKL DFG A+    G P  +Y   + + +YRAPE++ G+ 
Sbjct: 119 RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGSR 175

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 300
           +Y+  +DIWS GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+Y 
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
              FP+       K+    +  + +DL+S++L Y P  R +A  AL HP+F
Sbjct: 235 P-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  207 bits (529), Expect = 2e-64
 Identities = 109/292 (37%), Positives = 167/292 (57%), Gaps = 30/292 (10%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHCFFS 129
           G++GVV++A+  +TGE VA+KK+  +K  +       RE+  +  L HPN+V++K     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
           +   D++Y+  V+EYV   +  +++    M Q      VK    Q+   +A++H+   + 
Sbjct: 76  SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN-WIL 128

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYT 246
           HRD+K  NLL+N +   LK+CDFG A+    G P   Y   + + +YRAPEL+ GA EY+
Sbjct: 129 HRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEYS 185

Query: 247 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 306
            AID+WS GC+ AELL  +PLFPG+S +DQL +I K+LGTPT +      P ++E    +
Sbjct: 186 TAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPGAK 241

Query: 307 IKAHPWHKIFQ--KRMPP-----EAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            K    +   Q  K+ P         DL++RLL Y P  R +A +AL HP+F
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  207 bits (528), Expect = 1e-63
 Identities = 122/314 (38%), Positives = 178/314 (56%), Gaps = 29/314 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y  + V+G GS+GVV  A    TGE VAIKK+      + D     RE++ +RLL HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V +KH     + ++   + +V E +   +H+VIK +  ++      + + + YQ+ RAL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRALK 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAP 236
           YIH T  V HRD+KP+N+L N    +LK+CDFG A+V     P       Y+ +R+YRAP
Sbjct: 118 YIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 237 ELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-K 293
           EL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E I +
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMP---PEAVDLVSRLLQYSPNLRSTALEALIHPF 350
             N     +     K  P    F ++ P   P A+ L+ RLL + P  R TA EAL  P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 351 FDEL----RDPNTR 360
           F  L    R+P+ +
Sbjct: 293 FKGLAKVEREPSAQ 306

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  205 bits (523), Expect = 1e-63
 Identities = 104/289 (35%), Positives = 152/289 (52%), Gaps = 25/289 (8%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLKH 125
           G G+F  V +A+  +TG+  AIK +   K +K+       RE+Q +R L  HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIK--HHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F         L LV E +   ++ +IK        +R     VK Y YQ+ ++L ++H
Sbjct: 66  VLFDRKTGR---LALVFELMDMNLYELIKGRKRPLPEKR-----VKSYMYQLLKSLDHMH 117

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
              G+ HRDIKP+N+L+      LKL DFGS + +    P   YI +R+YRAPE +    
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEF 302
            Y   +DIW+ GCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  +
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            FP  K     K+       E +DL+ +LL Y P+ R TA +AL HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  205 bits (523), Expect = 3e-63
 Identities = 111/304 (36%), Positives = 177/304 (58%), Gaps = 25/304 (8%)

Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDH 117
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK+++        +   REL+ ++ L H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N++SL   F S  E  ++Y   V E +   +HR++      S+ +   +++ + YQI R
Sbjct: 69  ENIISLSDIFISPLE--DIYF--VTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILR 119

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 236
            L Y+H+  GV HRD+KP N+L+N +   LK+CDFG A++    +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAP 174

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 295
           E++    +Y   +DIWSAGC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234

Query: 296 NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           + N   F    P+ +  P+ + F+    P A+DL+ ++L + P  R +A EAL HP+   
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293

Query: 354 LRDP 357
             DP
Sbjct: 294 YHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  203 bits (519), Expect = 4e-63
 Identities = 114/295 (38%), Positives = 169/295 (57%), Gaps = 31/295 (10%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 125
           +VG GS+G+V + K  ETG+ VAIKK L+   DK  K    RE++ ++ L H N+V+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLIYVKLYFYQICRALA 180
            F     K  LYL  V E+V  TV   ++ +         ++        Y +QI R + 
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESRVRK--------YLFQILRGIE 114

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELI 239
           + H+   + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE    Y+ +R+YRAPEL+
Sbjct: 115 FCHSH-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL 172

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNP 297
            G T+Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232

Query: 298 NYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            +   + P++K   P  K F K +    +DL  + L+  P+ R ++ + L H FF
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  198 bits (505), Expect = 2e-60
 Identities = 111/304 (36%), Positives = 159/304 (52%), Gaps = 27/304 (8%)

Query: 73  VGHGSFGVVFQAKCLET--GEAVAIKK---VLQDKRYKNRELQTMRLL----DHPNVVSL 123
           +G G++G+V  A+  ET   E VAIKK   V   K    R L+ ++LL     H N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 124 KHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                      +ELYL    E +   +H++I+      Q +   + + + YQI   L YI
Sbjct: 68  YDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYI 121

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNIS-YICSRYYRAPE 237
           H+   V HRD+KP NLLVN    +LK+CDFG A+       +    ++ Y+ +R+YRAPE
Sbjct: 122 HSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKC 294
           ++     YT AID+WS GC+LAELL  +P+F G+  VDQL +I++VLGTP  E    I  
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                     P I   P+  IF     P A+DL+ +LL + P  R +  EAL HP+    
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298

Query: 355 RDPN 358
            DP+
Sbjct: 299 HDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  192 bits (491), Expect = 6e-59
 Identities = 106/291 (36%), Positives = 162/291 (55%), Gaps = 25/291 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 126
           +G GS+GVVF+ +  ETG+ VAIKK ++       K+   RE++ ++ L HPN+V+L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--N 184
           F     + +  L+LV EY   TV   ++ +    + +P   +K   +Q  +A+ + H  N
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGAT 243
            I   HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+ G T
Sbjct: 121 CI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 301
           +Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  +  
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236

Query: 302 FKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
              P+ +   P    F   +   A+  +   LQ  P  R +  E L HP+F
Sbjct: 237 LSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  191 bits (486), Expect = 4e-58
 Identities = 100/295 (33%), Positives = 160/295 (54%), Gaps = 23/295 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G V++A+   TG+ VA+KK   +   +       RE+  +++L     +     
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 127 FFSTTEKD-ELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHN 184
                EK+ +  L LV EY+   + + +  + +   R +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
             GV HRD+KPQNLLV+     LK+ D G  +      P  SY   I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           +T Y+  +DIWS GC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241

Query: 302 FK----FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
            +    FPQ K     +     + PE +DL+ ++L+Y P  R +A  AL HP+FD
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  188 bits (478), Expect = 6e-57
 Identities = 103/289 (35%), Positives = 165/289 (57%), Gaps = 22/289 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G G++  V++ +   TGE VA+K++  D          RE+  M+ L H N+V L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
             T  K    L LV EY+ + + + +  H  +   +    VK + YQ+ + +A+ H    
Sbjct: 67  IHTENK----LMLVFEYMDKDLKKYMDTH-GVRGALDPNTVKSFTYQLLKGIAFCHEN-R 120

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE 244
           V HRD+KPQNLL+N    +LKL DFG A+    G P  ++   + + +YRAP+++ G+  
Sbjct: 121 VLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEF 302
           Y+ +IDIWS GC++AE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y + 
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-KP 236

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            FP+       ++F     P  +DL+ RLLQ +P LR +A +AL HP+F
Sbjct: 237 TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  187 bits (476), Expect = 1e-56
 Identities = 110/298 (36%), Positives = 166/298 (55%), Gaps = 40/298 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL  V E++    H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 68  IHT---ENKLYL--VFEFL----HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 119 H-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       + P  T 
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230

Query: 302 FK-----FPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                  FP+         F K +PP   +  DL+S++L Y PN R +A  AL HPFF
Sbjct: 231 LPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  187 bits (476), Expect = 2e-56
 Identities = 101/298 (33%), Positives = 160/298 (53%), Gaps = 24/298 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 120
           +Y     +G GS+  V++ +   TG+ VA+K++ L+ +        RE   ++ L H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L H    T +     L LV EY+   + + +         + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLA 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL++    +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 294
           ++ G+TEY+ ++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E      
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            NP +  + FP     P      +    P   +L  + LQY P  R +A EA+ HP+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  185 bits (471), Expect = 1e-55
 Identities = 105/295 (35%), Positives = 155/295 (52%), Gaps = 28/295 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G+V++A+   +GE VA+KKV  D           RE+  +  L HPN+V LK  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                  D ++L  V+EY  + +  ++     M        VK    Q+ R L Y+H   
Sbjct: 75  VVGK-HLDSIFL--VMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            + HRD+K  NLL+      LK+ DFG A+    G P       + + +YRAPEL+ G T
Sbjct: 129 -IIHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCT 184

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            YT AID+W+ GC+LAELL  +PL PG+S ++QL  II++LGTP        +  P   +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244

Query: 302 FKFPQIKAHPWHKIFQKRMP--PEA-VDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           F  P+    P++ +  K  P   EA + L++ LL Y P  R+TA EAL   +F E
Sbjct: 245 FTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  183 bits (467), Expect = 3e-55
 Identities = 105/301 (34%), Positives = 168/301 (55%), Gaps = 23/301 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G++GVV++A+   T E +A+KK+  ++  +       RE+  ++ + H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L+    S     E  L LV EY+   + + +      ++   LI  K Y YQI R +A
Sbjct: 64  VRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI--KTYLYQILRGIA 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H+   V HRD+KPQNLL++  T+ LKL DFG A+    G P  ++   + + +YRAPE
Sbjct: 117 YCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 296
           ++ G+  Y+  +DIWS GC+ AE++  +PLFPG+S +D+L +I ++LGTP  E    +  
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233

Query: 297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
            P+Y    FP+        +    + P  VDL+S++L+  P+ R TA  AL H +F +L 
Sbjct: 234 LPDYKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291

Query: 356 D 356
           D
Sbjct: 292 D 292

Length = 294

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  181 bits (462), Expect = 8e-55
 Identities = 93/290 (32%), Positives = 133/290 (45%), Gaps = 44/290 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLK 124
            ++G GSFG V+ A   +TGE +A+K V L     +      RE++ +  L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             + S  ++++  LN+ LEYV       +    K   ++P   ++ Y  QI   LAY+H+
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSG---GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIFG 241
             G+ HRDIK  N+LV+     +KL DFG AK L   E        R   Y+ APE+I G
Sbjct: 120 N-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
             EY  A DIWS GC + E+  G+P +         +  I   G P              
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------------- 222

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
              P+I  H         +  EA D + + L+  P  R TA E L HPF 
Sbjct: 223 ---PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  181 bits (462), Expect = 2e-54
 Identities = 98/303 (32%), Positives = 159/303 (52%), Gaps = 46/303 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 119
           +G G++G V++A+ L TG  VA+KKV    R             RE+  ++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 120 VVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +V L   C    T++ EL L LV E+V + +   +    K    +P   +K    Q+ R 
Sbjct: 63  IVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRG 119

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + ++H +  + HRD+KPQN+LV     Q+K+ DFG A++        S + + +YRAPE+
Sbjct: 120 VDFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +  ++ Y   +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE       
Sbjct: 178 LLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE------- 229

Query: 299 YTEFKFPQIKAHPWH-------KIFQKRMP---PEAVDLVSRLLQYSPNLRSTALEALIH 348
                +P+  + P         + F+  +P    E +DL+ ++L ++P+ R +A EAL H
Sbjct: 230 -----WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284

Query: 349 PFF 351
           P+F
Sbjct: 285 PYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  182 bits (464), Expect = 2e-54
 Identities = 106/304 (34%), Positives = 164/304 (53%), Gaps = 25/304 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL---DHPNV 120
           Y + + VG G++G V  A    TGE VAIKK+    Q + +  R  + + LL    H NV
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L   F S    DE     LV+ Y+   + +++ H     +      V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLCGL 130

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 238
            YIH+  G+ HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE+
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-- 296
           I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +   
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 297 --PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
              +Y +   P+     +  +F  +  P+AVDL+ ++L+   + R TA EAL HP+FD  
Sbjct: 246 AAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303

Query: 355 RDPN 358
           RD +
Sbjct: 304 RDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  183 bits (464), Expect = 6e-54
 Identities = 93/321 (28%), Positives = 138/321 (42%), Gaps = 48/321 (14%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHP 118
           SY   R +G GSFG V+ A+  +    VA+K + +    K+       RE+Q +  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 119 -NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N+V L   F     +DE  L LV+EYV       +         +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-------SYICS 230
           AL Y+H + G+ HRDIKP+N+L++     +KL DFG AK+L              + + +
Sbjct: 113 ALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 231 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLG 285
             Y APE++ G +    +++ DIWS G  L ELL G P F GE       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
           TP                     A P      + +   A DL+ +LL   P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 346 LIHPFFDELRDPNTRLPNGRF 366
           L H     L+   + L +   
Sbjct: 273 LSHDLLAHLKLKESDLSDLLK 293

Length = 384

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  181 bits (462), Expect = 6e-54
 Identities = 98/315 (31%), Positives = 168/315 (53%), Gaps = 48/315 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKR---YKNRELQTMRLLDHPNVVS 122
           YM  R +G GS G+VF A   +  + VA+KK VL D +   +  RE++ +R LDH N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 123 LKHCFFST-----------TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           +      +           TE + +Y+  V EY+   +  V++        +   + +L+
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYI--VQEYMETDLANVLEQ-----GPLSEEHARLF 119

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---- 227
            YQ+ R L YIH+   V HRD+KP N+ +N     LK+ DFG A+++   +P+ S+    
Sbjct: 120 MYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYL 175

Query: 228 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL---VEII 281
              + +++YR+P L+     YT AID+W+AGC+ AE+L G+PLF G   ++Q+   +E +
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235

Query: 282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPW--HKIFQKRMP---PEAVDLVSRLLQYSP 336
            V+    R E+  + P++       ++       +  +  +P   PEA+D + ++L ++P
Sbjct: 236 PVVREEDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288

Query: 337 NLRSTALEALIHPFF 351
             R TA EAL+HP+ 
Sbjct: 289 MDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (452), Expect = 7e-54
 Identities = 69/247 (27%), Positives = 121/247 (48%), Gaps = 40/247 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G G FG V+ A+  +TG+ VAIK + ++          RE++ ++ L+HPN+V L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                +DE +L LV+EY    ++  ++K +     ++    +     QI   L Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-N 111

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           G+ HRD+KP+N+L++    ++KL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 304
           +   DIWS G +L EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 305 PQIKAHP 311
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  179 bits (456), Expect = 9e-54
 Identities = 105/292 (35%), Positives = 159/292 (54%), Gaps = 28/292 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +     L LV EY  + +    K+    +  +    VK + +Q+ + LA+ H+  
Sbjct: 68  LHSDKK-----LTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N +  +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 300
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTPT E    ++  P+Y 
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 301 EF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            +  +P   +     +   ++     DL+  LL  +P  R +A EAL HP+F
Sbjct: 236 PYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  180 bits (459), Expect = 1e-53
 Identities = 114/317 (35%), Positives = 158/317 (49%), Gaps = 46/317 (14%)

Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           +G G++G V++AK      G+  AIKK   DK           RE+  +R L H NVVSL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYI 182
              F    +K  +YL  + +Y    + ++IK H       +P   VK   +QI   + Y+
Sbjct: 68  VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 183 HNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKGEPNISYICSRY 232
           H+   V HRD+KP N+LV    P    +K+ D G A       K L   +P +  I   +
Sbjct: 125 HSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKV 283
           YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G             DQL  I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 284 LGTPTREE---IKCMNPNY----TEFKFPQIKAHPWHKIFQKRMP--PEAVDLVSRLLQY 334
           LGTPT ++   IK M P Y     +FK     ++   K  +K      +  DL+ +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299

Query: 335 SPNLRSTALEALIHPFF 351
            P  R TA EAL HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  180 bits (458), Expect = 3e-53
 Identities = 106/297 (35%), Positives = 160/297 (53%), Gaps = 22/297 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 126
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 127 FFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F      D  +   LV+ ++   + +++KH      R     ++   YQ+ + L YIH  
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIHAA 137

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            G+ HRD+KP NL VN    +LK+ DFG A+          Y+ +R+YRAPE+I     Y
Sbjct: 138 -GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMHY 193

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 301
           T  +DIWS GC++AE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY +
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
            K P+ +   +  +      P AV+++ ++L      R TA EAL HP+F+E  DP 
Sbjct: 254 -KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  177 bits (449), Expect = 9e-53
 Identities = 115/292 (39%), Positives = 164/292 (56%), Gaps = 24/292 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 125
           VVG G++GVV + +  ET E VAIKK          K    REL+ +R L   N+V LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F     + +LYL  V EYV + +  +++        +P   V+ Y YQ+ +A+ + H  
Sbjct: 68  AF---RRRGKLYL--VFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNIS-YICSRYYRAPELIFGAT 243
             + HRDIKP+NLL++ H   LKLCDFG A+ L +G   N + Y+ +R+YR+PEL+ GA 
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTE 301
            Y  A+D+WS GC+L EL  GQPLFPGES +DQL  I KVLG    E++K    NP +  
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 302 FKFPQIKAHP--WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            +FP +  HP    + +   +    +DL+  LL+ +P  R    + L HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  178 bits (453), Expect = 3e-52
 Identities = 111/309 (35%), Positives = 164/309 (53%), Gaps = 41/309 (13%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK---VLQD----KRYKNRELQTMRLLDHPNVVS 122
           +R +G+G+FGVV+       G+ VA+KK   V Q+    KR   REL+ +    H NV+S
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 123 --------LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
                       F      +E+Y+  V E +   +H++I       Q +   +VK++ YQ
Sbjct: 64  ALDILQPPHIDPF------EEIYV--VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQ 111

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-----IC 229
           I R L Y+H + G+ HRDIKP NLLVN +   LK+CDFG A+V    EP+ S      + 
Sbjct: 112 ILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVV 166

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           ++YYRAPE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + QL  I  +LGTP+ 
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEAL 346
           E ++                 P   +          EAV L+ R+L + P+ R +A +AL
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286

Query: 347 IHPFFDELR 355
            HP+ DE R
Sbjct: 287 AHPYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  175 bits (445), Expect = 5e-52
 Identities = 98/294 (33%), Positives = 162/294 (55%), Gaps = 31/294 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLDHPNVVS 122
           +G G++GVV++ +  +TG+ VA+KK+    R ++          RE+  ++ L HPN+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L+       ++  LYL  + E++   + + +       Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM---QESRLYL--IFEFLSMDLKKYLDS-LPKGQYMDAELVKSYLYQILQGILFC 117

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
           H+   V HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 297
            G+  Y+  +DIWS G + AE+   +PLF G+S +DQL  I ++LGTPT +    +   P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           +Y    FP+ K     +   K +  + +DL+ ++L Y P  R +A +AL HP+F
Sbjct: 234 DYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  174 bits (444), Expect = 1e-51
 Identities = 99/313 (31%), Positives = 146/313 (46%), Gaps = 53/313 (16%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHC 126
           G G+FG V++A+ ++TG  VA+KK+L     K+       RE++ ++ L HPNVV L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 127 FFSTTEKDELYLNLVLEYVPETVH---------RVIKHHYKMSQRMPLIYVKLYFYQICR 177
                +K +     V    P   H          V       SQ      +K Y  Q+  
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV---KLTESQ------IKCYMLQLLE 126

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---------- 227
            + Y+H    + HRDIK  N+L++ +   LK+ DFG A+      PN             
Sbjct: 127 GINYLHEN-HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 228 --ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             + +R+YR PEL+ G   YT A+DIW  GCV AE+   +P+  G+S +DQL  I K+ G
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ-------KRMPPEAVDLVSRLLQYSPNL 338
           TPT E      P +     P  +       +         ++ PE +DL+S+LL   P  
Sbjct: 245 TPTEETW----PGWR--SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298

Query: 339 RSTALEALIHPFF 351
           R TA +AL HP+F
Sbjct: 299 RLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  168 bits (426), Expect = 1e-48
 Identities = 101/316 (31%), Positives = 154/316 (48%), Gaps = 53/316 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------------RELQTMR 113
           +G G++G V +A    TG+ VAIKKV +     N                   REL+ M 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            + H N++ L   +    E D  ++NLV++ +   + +V+    ++++      VK    
Sbjct: 76  EIKHENIMGLVDVY---VEGD--FINLVMDIMASDLKKVVDRKIRLTES----QVKCILL 126

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----VLVKGEPNISYI 228
           QI   L  +H    + HRD+ P N+ +N      K+ DFG A+                +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 229 CSR----------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
             R          +YRAPEL+ GA +Y  A+D+WS GC+ AELL G+PLFPGE+ +DQL 
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 279 EIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            I ++LGTP  +   + K + P YTEF   + K      IF      +A+DL+  LL+ +
Sbjct: 245 RIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD--LKTIFPNA-SDDAIDLLQSLLKLN 300

Query: 336 PNLRSTALEALIHPFF 351
           P  R +A EAL H +F
Sbjct: 301 PLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  167 bits (426), Expect = 2e-48
 Identities = 107/321 (33%), Positives = 165/321 (51%), Gaps = 48/321 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKR-YKNRELQTMRLLDHP 118
           Y   + +G G+ G+V  A    TG+ VAIKK       V   KR Y  REL  M+L++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 119 NVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYF 172
           N++ L + F    S  E  ++YL  V+E +   + +VI+    H +MS          Y 
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYL--VMELMDANLCQVIQMDLDHERMS----------YL 123

Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
            YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +R
Sbjct: 124 LYQMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTR 181

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           YYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  +II+ LGTP+ E 
Sbjct: 182 YYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240

Query: 292 IKCMNP---NYTEFKFPQIKAHPWHKIF------------QKRMPPEAVDLVSRLLQYSP 336
           +  + P   NY E + P+   + + ++F             K    +A DL+S++L   P
Sbjct: 241 MSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299

Query: 337 NLRSTALEALIHPFFDELRDP 357
             R +  +AL HP+ +   DP
Sbjct: 300 EKRISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  167 bits (423), Expect = 2e-48
 Identities = 102/304 (33%), Positives = 161/304 (52%), Gaps = 24/304 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y     VG G++G V  A      + VA+KK+      L   R   REL+ ++ + H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 121 VSLKHCFFSTT---EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           + L   F   T     +E+YL  V   +   ++ ++K      Q++   +V+   YQ+ R
Sbjct: 77  IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLR 129

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L YIH+  G+ HRD+KP N+ VN    +L++ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +K ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 298 NYTEFKF---PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
            +        P +      KIF +   P A+DL+ ++L    + R +A EAL HP+F + 
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Query: 355 RDPN 358
            DP 
Sbjct: 305 HDPE 308

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  165 bits (418), Expect = 4e-48
 Identities = 105/298 (35%), Positives = 162/298 (54%), Gaps = 24/298 (8%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 120
           SY+    +G GS+  V++      G+ VA+K +             RE   ++ L H N+
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L H    T E     L  V EY+   + + +  H      +    V+L+ +Q+ R LA
Sbjct: 66  VLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLA 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           YIH    + HRD+KPQNLL++ +  +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 296
           ++ GAT+Y++A+DIW AGC+  E+L GQP FPG S V +QL +I  VLG PT +    ++
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233

Query: 297 --PNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
             PNY    F   K      ++++   PP+A DL S++L   P  R +A +AL+HP+F
Sbjct: 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  163 bits (414), Expect = 7e-48
 Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 42/285 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
             +G G FG V++A+   TG+ VAIK + L+ K  K     E+Q ++   HPN+V     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           +    +KDEL+  +V+E+    ++  ++K     +Q +    +     ++ + L Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            G+ HRDIK  N+L+     ++KL DFG +  L   +   + + + Y+ APE+I G   Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
               DIWS G    EL  G+P +  E    + +  I   G P               + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPG-------------LRNP 220

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                       ++   E  D + + LQ +P  R TA + L HPF
Sbjct: 221 ------------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  165 bits (420), Expect = 9e-48
 Identities = 102/298 (34%), Positives = 160/298 (53%), Gaps = 24/298 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 126 CFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F      +E   + LV   +   ++ ++K      Q++   +V+   YQI R L YIH+
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 138

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 300
           Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  164 bits (416), Expect = 1e-47
 Identities = 99/308 (32%), Positives = 166/308 (53%), Gaps = 23/308 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  V++ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L       TEK    L LV EY+ + + + +         + +  VKL+ +Q+ R L 
Sbjct: 67  VTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNSINMHNVKLFLFQLLRGLN 118

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
           N  +  + +P+ +A   H     R+  +  +L+S+LLQ+    R +A EA+ HP+F  L 
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293

Query: 356 DPNTRLPN 363
           +   +LP+
Sbjct: 294 ERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  158 bits (400), Expect = 2e-45
 Identities = 98/296 (33%), Positives = 158/296 (53%), Gaps = 23/296 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L H    T    E  L LV EY+   + + + +       M +  VK++ +Q+ R L+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLS 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 118 YCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CM 295
           ++ G+TEY+  ID+W  GC+L E+  G+P+FPG +  ++L  I ++LGTPT E       
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           N  +  + FPQ +A P       R+  + +DL+S LL Y    R +A  AL H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  158 bits (401), Expect = 2e-45
 Identities = 100/299 (33%), Positives = 161/299 (53%), Gaps = 23/299 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L H    T +     L LV EY+ + + + +         M +  VK++ YQI R LA
Sbjct: 67  VTL-HDIVHTDKS----LTLVFEYLDKDLKQYMD---DCGNIMSMHNVKIFLYQILRGLA 118

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++ G++EY+  ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 298 N--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           N  +  + FP+ K  P       R+  E ++L+++ LQY    R +A EA+ H +F  L
Sbjct: 235 NDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  156 bits (397), Expect = 8e-45
 Identities = 91/307 (29%), Positives = 149/307 (48%), Gaps = 47/307 (15%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 125
            +G G++G V++A+  +TGE VA+KKV  D   +       RE++ +R L+H N+V+LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 126 CFFSTTE-----KDELYLNLVLEYVPETVHRVIKH---HYKMSQRMPLIYVKLYFYQICR 177
                 +     KD+    LV EY+   +  +++    H+          +K +  Q+  
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH------IKSFMKQLLE 127

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRA 235
            L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E  P  + + + +YR 
Sbjct: 128 GLNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PEL+ G   Y  AID+WS GC+L EL   +P+F     + QL  I ++ G+P       +
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PAV 241

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRM------------PPEAVDLVSRLLQYSPNLRSTAL 343
            P+  +  +       ++ +  K+             P  A+DL+  +L   P+ R TA 
Sbjct: 242 WPDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 344 EALIHPF 350
           EAL  P+
Sbjct: 295 EALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  153 bits (388), Expect = 6e-44
 Identities = 90/292 (30%), Positives = 137/292 (46%), Gaps = 55/292 (18%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V   +  +TG+  A+K     K+++ K   +   E   +  ++HP +V L +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F     + E  L LVLEY P  E +   +    + S+       + Y  +I  AL Y+H
Sbjct: 61  AF-----QTEEKLYLVLEYAPGGE-LFSHLSKEGRFSEER----ARFYAAEIVLALEYLH 110

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
           + +G+ +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 S-LGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y  A+D WS G +L E+L G+P F  E    ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA-LI--HPFF 351
           +FP            + + PEA DL+S LLQ  P  R  +  A  I  HPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  152 bits (386), Expect = 1e-43
 Identities = 86/301 (28%), Positives = 131/301 (43%), Gaps = 60/301 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + +G GSFG V+  +    G+   +K++       +++     E++ ++ L+HPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +     F    EK    L +V+EY     + + IK   K  +  P   +  +F Q+C AL
Sbjct: 62  IKYYESFE---EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYICS 230
            Y+H +  + HRDIKPQN+ +      +KL DFG +KVL         V G P       
Sbjct: 117 KYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP------- 167

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            YY +PEL      Y    DIWS GCVL EL   +  F GE+ + +L    K+L    + 
Sbjct: 168 -YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KG 218

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +   +   Y                       E  +LVS LLQ  P  R +  + L  PF
Sbjct: 219 QYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPF 257

Query: 351 F 351
            
Sbjct: 258 I 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  145 bits (369), Expect = 4e-41
 Identities = 91/292 (31%), Positives = 138/292 (47%), Gaps = 54/292 (18%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYK-NRELQTMRLLDHPNVVSLKHC 126
           V+G GS GVV++ +   TG+  A+KK+     ++ R +  REL+T+R  + P VV     
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F+      E  +++VLEY+   ++  ++K   K+ + +    +     QI + L Y+H  
Sbjct: 68  FYK-----EGEISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTK 118

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIF 240
             + HRDIKP NLL+N    ++K+ DFG +KVL     N    C+ +     Y +PE I 
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           G + Y+ A DIWS G  L E  LG+ P L PG+    +L++ I            C    
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CD--- 217

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                 P            +   PE  D +S  LQ  P  R +A E L HPF
Sbjct: 218 -----GPPPSLPA------EEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  142 bits (358), Expect = 3e-39
 Identities = 103/304 (33%), Positives = 157/304 (51%), Gaps = 30/304 (9%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 120
           SY     +G GS+  V++ K    G+ VA+K + LQ++        RE   ++ L H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L H    T E     L LV EYV   + + +  H      +    VKL+ +Q+ R L+
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLS 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           YIH    + HRD+KPQNLL++  T +LKL DFG A+   K  P+ +Y   + + +YR P+
Sbjct: 118 YIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPD 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 296
           ++ G+TEY+  +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    ++
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233

Query: 297 --PNYTEFKFPQIKA----HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
             P++   +F           W+K+        A DL S+LLQ  P  R +A  AL H +
Sbjct: 234 SLPHFKPERFTLYSPKNLRQAWNKL---SYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290

Query: 351 FDEL 354
           F +L
Sbjct: 291 FSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  140 bits (355), Expect = 1e-38
 Identities = 91/302 (30%), Positives = 143/302 (47%), Gaps = 34/302 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH- 125
           +G G+FG VF+A+  +T + VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 126 CFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    T     K   YL  V E+    +  ++ +    + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYY 134

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 295
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E      
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252

Query: 296 N-PNYTEFKFPQ-----IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
               + + + PQ     +K      +      P A+DL+ +LL   P  R  A  AL H 
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYV----KDPHALDLIDKLLVLDPAKRIDADTALNHD 308

Query: 350 FF 351
           FF
Sbjct: 309 FF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  137 bits (347), Expect = 5e-38
 Identities = 88/290 (30%), Positives = 136/290 (46%), Gaps = 48/290 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL---QDKRYK------NRELQTMRLLDHPNVV 121
            ++G GSFG V++   L+ G+  A+K+V      +  +       +E+  +  L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                 +  TE++E  L + LE VP  ++ ++     K     P   ++LY  QI   L 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGGSLAKL----LKKYGSFPEPVIRLYTRQILLGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           Y+H+     HRDIK  N+LV+     +KL DFG AK +V+     S+  S Y+ APE+I 
Sbjct: 117 YLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               Y  A DIWS GC + E+  G+P +   S ++ +  + K+  +     I        
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     P H      +  EA D + + LQ  P+LR TA E L HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  136 bits (346), Expect = 1e-37
 Identities = 86/321 (26%), Positives = 141/321 (43%), Gaps = 79/321 (24%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTM-RLLDHP 118
           +   +++G GSF  V  AK  ET +  AIK     +++++K+  Y   E + + RL  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            ++ L + F     +DE  L  VLEY P   + + I+ +  + ++      + Y  +I  
Sbjct: 63  GIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEILL 113

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRY- 232
           AL Y+H+  G+ HRD+KP+N+L++   H +K+ DFG+AKVL                   
Sbjct: 114 ALEYLHS-KGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 233 ----------------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 276
                           Y +PEL+        + D+W+ GC++ ++L G+P F G +  + 
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EY 228

Query: 277 LV--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
           L   +I+K                  E+ FP               PP+A DL+ +LL  
Sbjct: 229 LTFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVL 259

Query: 335 SPNLRSTALEALI----HPFF 351
            P  R    E       HPFF
Sbjct: 260 DPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  138 bits (348), Expect = 3e-37
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 136

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253

Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + PQ     + ++F   + P           +A DL+S++L   P+ R +  EA
Sbjct: 254 RNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 346 LIHPFFDELRDP 357
           L HP+     DP
Sbjct: 313 LRHPYITVWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  135 bits (341), Expect = 4e-37
 Identities = 88/292 (30%), Positives = 142/292 (48%), Gaps = 50/292 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKHC 126
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++ + LL HPN+V     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           +     ++++Y+   +EY    T+  +++H   + + +    +++Y  Q+   LAY+H +
Sbjct: 65  YGVEVHREKVYI--FMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLH-S 117

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIF 240
            G+ HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+I 
Sbjct: 118 HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 241 GAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           G     +  A DIWS GCV+ E+  G+  +   S +D   +I+  +G          +  
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA--------GHK- 224

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                 P I           ++ PE  D + R L+  P  R TA E L HPF
Sbjct: 225 ------PPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  135 bits (342), Expect = 5e-37
 Identities = 85/288 (29%), Positives = 137/288 (47%), Gaps = 16/288 (5%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---LL------DHPNVVSL 123
           +G G++G V++A+   +G  VA+K V          L T+R   LL      DHPN+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                ++    E  + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
               + HRD+KP+N+LV     Q+KL DFG A++          + + +YRAPE++  +T
Sbjct: 126 -ANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +       
Sbjct: 184 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTLPRGA 241

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           F      P        +      L+  +L ++P+ R +A  AL HPFF
Sbjct: 242 FSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  133 bits (338), Expect = 1e-36
 Identities = 87/295 (29%), Positives = 133/295 (45%), Gaps = 62/295 (21%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKH 125
           ++G G+FGVV++   LETG+ VAIK++ L+  + +      +E+  ++ L HPN+V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                  +    L ++LEY    ++ ++IK      + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 243
             GV HRDIK  N+L       +KL DFG A  L     +  S + + Y+ APE+I   +
Sbjct: 118 Q-GVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
             + A DIWS GC + ELL G P +                          +NP      
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYD------------------------LNP------ 204

Query: 304 FPQIKAHPWHKIFQKRMPP-------EAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                     +I Q   PP       E  D + +  Q  PNLR TA + L HP+ 
Sbjct: 205 -----MAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  134 bits (337), Expect = 1e-35
 Identities = 100/315 (31%), Positives = 161/315 (51%), Gaps = 37/315 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS  +         YQ+ 
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL---------YQML 129

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 247 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 343 LEALIHPFFDELRDP 357
            EAL HP+ +   DP
Sbjct: 306 DEALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  132 bits (333), Expect = 4e-35
 Identities = 97/315 (30%), Positives = 160/315 (50%), Gaps = 37/315 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS  +         YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---------YQML 136

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253

Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312

Query: 343 LEALIHPFFDELRDP 357
            EAL HP+ +   DP
Sbjct: 313 DEALQHPYINVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  129 bits (327), Expect = 5e-35
 Identities = 94/298 (31%), Positives = 143/298 (47%), Gaps = 63/298 (21%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNR------ELQTMRLLDHPNVVSLKHCFF 128
           G++G VF AK   TG+  AIK +   D   KN+      E   +     P VV L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           S   K  LYL  V+EY+P   +  ++++   + + +     ++Y  +I  AL Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHS-NG 113

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISY--------ICSRYYRAPEL 238
           + HRD+KP N+L++ + H LKL DFG +KV LV+ + N++         + +  Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           I G   ++  +D WS GC+L E L+G P F GE                T EEI      
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI------ 209

Query: 299 YTEFKFPQIKAH--PWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFF 351
                F  I      W +  +  +  EA+DL+S+LL   P  R    +  E   HPFF
Sbjct: 210 -----FQNILNGKIEWPEDVE--VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  128 bits (322), Expect = 3e-34
 Identities = 95/292 (32%), Positives = 149/292 (51%), Gaps = 23/292 (7%)

Query: 73  VGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 122
           +G G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 123 L-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   C  S T++ E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDF 125

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++  
Sbjct: 126 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+     P    
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVA 238

Query: 302 FKFPQIKAHPWHKI--FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                  +     I  F   +     DL+ + L ++P  R +A  AL HP+F
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  121 bits (306), Expect = 4e-32
 Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 47/291 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL--QDKRYKN---RELQTMRLLDHPNVVSLKH 125
             +G G+ GVV +     TG+ +A+K +    ++  +    REL  +   + P +V    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F++  +     +++ +EY+       I    ++  R+P   +      + + L Y+H  
Sbjct: 67  AFYNNGD-----ISICMEYMDGGSLDKILK--EVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYT 300
           +   DIWS G  L EL  G+  +P E+       + L  I+               P   
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               P++ +  +         P+  D V+  L   P  R +  E L HPF 
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  119 bits (302), Expect = 4e-31
 Identities = 82/296 (27%), Positives = 141/296 (47%), Gaps = 60/296 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 123
           + +G GSFG V   +   +G+  A+K     K+++ K+ +    E + ++ + HP +V+L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D+  L LV+EYVP  E     +  H + S R P    + Y  Q+  AL Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H+ + + +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I 
Sbjct: 117 LHS-LDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               Y  A+D W+ G ++ E+L G P F  ++   Q+ E I          ++       
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKI----------LEG------ 213

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPFF 351
           + +FP                P+A DL+  LLQ        NL++   +   HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  120 bits (302), Expect = 5e-31
 Identities = 101/319 (31%), Positives = 153/319 (47%), Gaps = 50/319 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEA--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++AK  +  +    A+K++          RE+  +R L HPNV+SL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLIYVKLYFYQICRALAYIH 183
           S  ++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 184 NTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNISYICSRYY 233
               V HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF---------PGESGVDQLVEIIKVL 284
           RAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 285 GTPTR---EEIKCMNPNYTEFK---------FPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
           G P     E+IK M  + T  K            IK    HK+   +   +A  L+ +LL
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLL 298

Query: 333 QYSPNLRSTALEALIHPFF 351
              P  R T+ +A+  P+F
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  119 bits (301), Expect = 5e-31
 Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 56/292 (19%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 128
            +G G+ G V++A    TG+ VAIKK+ L+ +  +    E+  M+   HPN+V     + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY- 84

Query: 129 STTEKDELYLNLVLEY--------VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                    L +V+EY        +      + ++  +M++   + YV     ++ + L 
Sbjct: 85  ----LVGDELWVVMEYMDGGSLTDI------ITQNFVRMNEPQ-IAYVCR---EVLQGLE 130

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELI 239
           Y+H+   V HRDIK  N+L++     +KL DFG A  L K +    S + + Y+ APE+I
Sbjct: 131 YLHSQ-NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P    +K      
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK------ 237

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                       W   F+        D +++ L   P  R +A E L HPF 
Sbjct: 238 --------NPEKWSPEFK--------DFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  118 bits (297), Expect = 1e-30
 Identities = 74/214 (34%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNR---ELQTMRLLDHPN 119
           +  E+ +G G F VV++A CL  G  VA+KKV    + D + +     E+  ++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+     F    E     LN+VLE      + R+IKH  K  + +P   +  YF Q+C A
Sbjct: 64  VIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPE 237
           L ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMHSK-RIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  119 bits (298), Expect = 1e-30
 Identities = 99/317 (31%), Positives = 156/317 (49%), Gaps = 46/317 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEA--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++AK  +  +    A+K++          RE+  +R L HPNV++L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLIYVKLYFYQICRALAYIH 183
           S +++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 184 NTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV-------LVKGEPNISYICSRYY 233
               V HRD+KP N+LV    P   ++K+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF---------PGESGVDQLVEIIKVL 284
           RAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 285 GTPTR---EEIKCMNPNY----TEFKFPQIKAHPWHKIFQK-RMPPEA--VDLVSRLLQY 334
           G P     E+I+ M P Y     +F+          K  +K ++ P++    L+ +LL  
Sbjct: 242 GFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTM 300

Query: 335 SPNLRSTALEALIHPFF 351
            P  R T+ +AL  P+F
Sbjct: 301 DPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  116 bits (293), Expect = 4e-30
 Identities = 79/296 (26%), Positives = 123/296 (41%), Gaps = 52/296 (17%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHC 126
           V+G G+  VV+ A CL   E VAIK++  +K   +     +E+Q M   +HPNVV   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS-QRMPLIYVKLYFYQICRALAYIHN 184
            F     DEL+  LV+ Y+   ++  ++K  Y        +I   L   ++ + L Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----YICSRYYRAPELI 239
             G  HRDIK  N+L+      +K+ DFG +  L  G          ++ +  + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCM 295
                Y    DIWS G    EL  G        P +     L+  ++    P+ E     
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQN-DPPSLETGADY 233

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                 F+                       ++S  LQ  P+ R TA E L H FF
Sbjct: 234 KKYSKSFR----------------------KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  116 bits (291), Expect = 5e-30
 Identities = 88/291 (30%), Positives = 128/291 (43%), Gaps = 58/291 (19%)

Query: 76  GSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           G+FG V+ AK   TG+  AIK      ++   +  N + +   ++   + P V  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 128 FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +S   KD  YL LV+EY+      ++        K    +P  + K Y  ++   +  +H
Sbjct: 64  YSFQSKD--YLYLVMEYLNGGDCASL-------IKTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
              G+ HRDIKP+NLL++   H LKL DFG ++    G  N  ++ +  Y APE I G  
Sbjct: 115 QR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           +     D WS GCV+ E L G P F  E+  D + + I          I     N+ E  
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRI-----NWPEEV 216

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEALIHPFF 351
                             PEAVDL++RLL   P  R  A    E   HPFF
Sbjct: 217 KEFCS-------------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  115 bits (289), Expect = 1e-29
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 49/293 (16%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
            +G GSFG V + +    G+ +  K++       ++K+    E+  +R L HPN+V    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                + +    L +V+EY     + ++I+   K  + +   ++     Q+  AL   HN
Sbjct: 67  RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 185 TIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 237
                  V HRD+KP N+ ++   + +KL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +   + Y    DIWS GC++ EL    P F       QL   IK               
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK--------------- 223

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
              E KF +I           R   E  +++  +L   P+ R +  E L  P 
Sbjct: 224 ---EGKFRRIPY---------RYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  112 bits (281), Expect = 2e-28
 Identities = 88/304 (28%), Positives = 146/304 (48%), Gaps = 55/304 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYK------NRELQTM 112
           ++   ++G G++G V+ A  + TGE +A+K+V          D R K        E++T+
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLY 171
           + LDH N+V          E  E YL++ LEYVP  ++   ++ + +  +++    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNISYI 228
             Q+   LAY+H+  G+ HRD+K  NLLV+      K+ DFG +K    +   + N+S  
Sbjct: 114 TEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 229 CSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
            S ++ APE+I   ++ Y+A +DIWS GCV+ E+  G+  +  E                
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---------------- 215

Query: 288 TREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
             E I  M      FK   +  A P        + P A+D ++     +P+ R TA E L
Sbjct: 216 --EAIAAM------FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267

Query: 347 IHPF 350
            HPF
Sbjct: 268 QHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  111 bits (279), Expect = 3e-28
 Identities = 69/237 (29%), Positives = 113/237 (47%), Gaps = 47/237 (19%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            + +G G+FG V++ K      +    VA+K + +D   +      RE + MR LDHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYF-YQICR 177
           V L       TE++ LY  +V+EY+     +  + K+  K+S         L F  QI R
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYMEGGDLLSYLRKNRPKLSLSD-----LLSFALQIAR 113

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +         YYR   
Sbjct: 114 GMEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRG 162

Query: 235 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
                   APE +    ++T+  D+WS G +L E+  LG+  +PG S  ++++E +K
Sbjct: 163 GKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  110 bits (278), Expect = 5e-28
 Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 44/236 (18%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            + +G G+FG V++             VA+K + +D   +      RE + MR LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V L       TE++ L   +V+EY+P    +  + K+  K    + L  +  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMPGGDLLDYLRKNRPK---ELSLSDLLSFALQIARG 115

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +         YY+    
Sbjct: 116 MEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164

Query: 235 -------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 282
                  APE +    ++T+  D+WS G +L E+  LG+  +PG S   +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 8e-28
 Identities = 88/320 (27%), Positives = 136/320 (42%), Gaps = 79/320 (24%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-------LDHPNVVSLK 124
           V+G G+FG V+  +  +TG+  A+K + +    K  ++  +R         D P +V L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +  F    +DE +L LV+EY+P  + ++ +I+         P    + Y  ++  AL  +
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSV 117

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------------------VLV 219
           H  +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 220 KGEPNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           +   +               Y APE++ G T Y    D WS G +L E+L G P F  ++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 273 GVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               L E        T  +I     N+ E  +FP              + PEA+DL+ RL
Sbjct: 235 ----LQE--------TYNKII----NWKESLRFPP----------DPPVSPEAIDLICRL 268

Query: 332 LQYSPNLRSTALEALIHPFF 351
           L    +   +  E   HPFF
Sbjct: 269 LCDPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  110 bits (276), Expect = 8e-28
 Identities = 89/307 (28%), Positives = 137/307 (44%), Gaps = 65/307 (21%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-------QDKRYKN------RELQTMR 113
           ++   ++G GSFG V+      +GE +A+K+V           R ++      RE+  ++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L H N+V            D  +LN+ LEYVP      + ++Y          V+ +  
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVR 113

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-------- 225
           QI + L Y+HN  G+ HRDIK  N+LV+ +   +K+ DFG +K   K E N         
Sbjct: 114 QILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNGA 168

Query: 226 --SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K+
Sbjct: 169 RPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI 224

Query: 284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 343
                            E   P+I ++         +  EA+D + +  +   N R TA 
Sbjct: 225 ----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTAA 259

Query: 344 EALIHPF 350
           E L HPF
Sbjct: 260 ELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  109 bits (274), Expect = 1e-27
 Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 50/292 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           RV+G G+FG V   +  +T +  A+K     K ++    +N   E + ++ L+HP +V+L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQICRALAY 181
            + F     +DE  + LV++ +     R     Y +SQ++      VK +  +I  AL Y
Sbjct: 66  WYSF-----QDEENMYLVVDLLLGGDLR-----YHLSQKVKFSEEQVKFWICEIVLALEY 115

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +H+  G+ HRDIKP N+L++   H + + DF  A  +       S   +  Y APE++  
Sbjct: 116 LHSK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y+ A+D WS G    E L G+  + G S                R++I+        
Sbjct: 174 QG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK------ 213

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALI-HPFF 351
               Q  A     ++      EA+D +++LL+  P  R    L+ L  HP+F
Sbjct: 214 ----QETADV---LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  108 bits (272), Expect = 3e-27
 Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 41/284 (14%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 129
            +G GS+G V++A   ETG+ VAIK V  ++  +   +E+  ++  D P +V     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 130 TTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
            T+     L +V+EY    +V  ++K     ++ +    +    YQ  + L Y+H+    
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN-KK 120

Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTA 247
            HRDIK  N+L+N    Q KL DFG +  L        + I + ++ APE+I     Y  
Sbjct: 121 IHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNN 178

Query: 248 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 307
             DIWS G    E+  G+P +     +  +  I                P  T    P  
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KPPPT-LSDP-- 222

Query: 308 KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                     ++  PE  D V + L   P  R +A++ L HPF 
Sbjct: 223 ----------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  108 bits (271), Expect = 4e-27
 Identities = 76/293 (25%), Positives = 126/293 (43%), Gaps = 50/293 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G FG V   K        A+K V          + +   E + +   +HP +V L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 126 CFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    KD+ Y+ +++EY     +  +++      +       + Y   +  A  Y+HN
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARFYIACVVLAFEYLHN 111

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
             G+ +RD+KP+NLL++     +KL DFG AK L  G+   ++  +  Y APE+I     
Sbjct: 112 -RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG- 168

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           Y  ++D WS G +L ELL G+P F GE   D +             +I   N      +F
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL---EF 215

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPFFD 352
           P              +   A DL+ +LL+ +P     NL+    +   H +F+
Sbjct: 216 PNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  108 bits (272), Expect = 7e-27
 Identities = 82/298 (27%), Positives = 128/298 (42%), Gaps = 49/298 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           K C+       E    LV+EY   +   +++ H K  Q + +  +        + LAY+H
Sbjct: 81  KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH---GALQGLAYLH 132

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +     HRDIK  N+L+      +KL DFGSA ++    P  S++ + Y+ APE+I    
Sbjct: 133 S-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILAMD 187

Query: 244 E--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           E  Y   +D+WS G    EL   +P     + +  L  I                    +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 228

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 359
              P + ++ W   F         + V   LQ  P  R ++ E L H F    R P  
Sbjct: 229 NDSPTLSSNDWSDYF--------RNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTV 278

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  107 bits (268), Expect = 1e-26
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 49/296 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYKN--RELQTMRLLDHPNV 120
           + +G G+F   +QA+ ++TG  +A+K+V         Q++  +   +E++ M  L+HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +       +T E    + NL +E++       +   Y   +   +I    Y  Q+ R L+
Sbjct: 66  I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN---YTEQLLRGLS 117

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNISYICSRYYRA 235
           Y+H    + HRD+K  NLL++    +L++ DFG+A  L       GE     + +  + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K         I   
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IASA 226

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                    P I  H         + P   D+  R L+  P  R  + E L HP F
Sbjct: 227 TTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  105 bits (264), Expect = 4e-26
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 43/228 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           + +G G+FG V++      GE     VA+K + +    +       E   M+ L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALA 180
            L       T+ + LY  +V EY+P      +    +       +   L    QI + + 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------ 234
           Y+ +     HRD+  +N LV      +K+ DFG ++ + + +         YYR      
Sbjct: 117 YLES-KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165

Query: 235 ------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 APE +    ++T+  D+WS G +L E+  LG+  +PG S  +
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 6e-26
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV--------LQDKRYKNRELQTMRLLDHPNVVSL 123
           ++G G++G V++ K + TG  VA+K +        + D + +   L  +R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +          L +++EY      R +     ++++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 242
             +GV HRDIK  N+LV  +T  +KLCDFG A +L +      +++ + Y+ APE+I   
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
             Y    DIWS G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  102 bits (257), Expect = 3e-25
 Identities = 88/300 (29%), Positives = 123/300 (41%), Gaps = 62/300 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNR-----ELQTMRLLDHPNV 120
           Y+  RV+G G+FG     +  E    V  K+V L     K R     E+  + LL HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++  + F      D+  L + +EY    T++  I       Q      V  Y +QI  A+
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAV 114

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYICS 230
           +YIH   G+ HRDIK  N+ +      +KL DFG +K+L         V G P       
Sbjct: 115 SYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------- 165

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            YY +PEL  G  +Y    DIW+ GCVL ELL  +  F         + ++         
Sbjct: 166 -YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDA----TNPLNLV--------- 210

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            +K +  NYT                      E + LV  LLQ  P  R TA E L  P 
Sbjct: 211 -VKIVQGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 5e-25
 Identities = 75/295 (25%), Positives = 134/295 (45%), Gaps = 53/295 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR------ELQTMRLLDHPNVV 121
           +++G G+FG V+    ++TG  +A+K+V         K        E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               C      +D+  L++ +EY+P  +V   +K +  +++ +     + Y  QI   + 
Sbjct: 68  QYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRYYRAP 236
           Y+H+ + + HRDIK  N+L +     +KL DFG++K L      G    S   + Y+ +P
Sbjct: 119 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT        
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                   PQ+ +H         + P+A + + R    +   R +A E L H F 
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  101 bits (253), Expect = 2e-24
 Identities = 87/297 (29%), Positives = 141/297 (47%), Gaps = 47/297 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    TG  VA+KK+  D R + R      E+  MR   HPN+V +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           + S    DEL++  V+E++       I  H +M++   +  V L    + +AL+++H   
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ-IATVCL---AVLKALSFLHAQ- 134

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 245
           GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I     Y
Sbjct: 135 GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPY 192

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  E  +  +            + I+   P       P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP-------P 233

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           ++K    HK+      P     + R+L   P  R+TA E L HPF  +   P++ +P
Sbjct: 234 KLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  100 bits (250), Expect = 3e-24
 Identities = 81/284 (28%), Positives = 121/284 (42%), Gaps = 46/284 (16%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRE--LQTMRLL---DHPNVVSLKHCF 127
           G GS+G V++ K L   +  A+K+V L     K RE  +  +R+L   +HPN++S K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 128 FSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 D   L +V+EY P   + + I    K  + +P   +   F Q+ R L  +H   
Sbjct: 69  L-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122

Query: 187 GVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            + HRD+K  N LLV      +K+ D G +KVL K     + I + +Y APE ++    Y
Sbjct: 123 KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
           +   DIWS GC+L E+    P F   S  D      KV                   K+P
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KVQRG----------------KYP 219

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
            I               +  + +  +LQ  P LR    + L  P
Sbjct: 220 PIPP---------IYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 4e-24
 Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 59/297 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 121
           +     +G GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                F   ++     L +++EY    +   ++K       ++   Y+     ++   L 
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLE 112

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-------YY 233
           Y+H   G  HRDIK  N+L++     +KL DFG     V G+   S +  R       ++
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFW 164

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
            APE+I   + Y    DIWS G    EL  G+P  P  S +  +    +VL        K
Sbjct: 165 MAPEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPK 212

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
             NP       P ++ + + K F+        D VS  L   P  R +A E L H F
Sbjct: 213 N-NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =   99 bits (250), Expect = 4e-24
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 46/228 (20%)

Query: 71  RVVGHGSFGVVFQAKC---LETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 122
           + +G G+FG V++ K          VA+K + +D   + R     E + M+ L HPNVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETV-------HRVIKHHYKMSQRMPLIYVKLYFYQI 175
           L       TE++ LY  LVLEY+            R           + L  +  +  QI
Sbjct: 61  LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRP-VFPSPEKSTLSLKDLLSFAIQI 114

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + + Y+ +     HRD+  +N LV      +K+ DFG ++ +   +         YYR 
Sbjct: 115 AKGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 235 -----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                      APE +     +T+  D+WS G +L E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 99.7 bits (248), Expect = 7e-24
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 118
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+     F    E     LN+VLE      + R+IKH  K  + +P   V  YF Q+C 
Sbjct: 63  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 236
           AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 16/213 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNV 120
           Y   RVVG G+FG+V   +     + V IK++  ++  K+       E Q ++LL HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +     F          L +V+EY P  T+   I+   + +  +    +  +F QI  AL
Sbjct: 62  IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLAL 114

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H  + + HRD+K QN+L++ H   +K+ DFG +K+L       + + +  Y +PEL 
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            G   Y    DIW+ GCVL EL   +  F   +
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 98.3 bits (245), Expect = 3e-23
 Identities = 91/330 (27%), Positives = 150/330 (45%), Gaps = 71/330 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVV 121
           +++ +G++G V+  +  ET +  A+KK+ +          + +  R++ T    ++P VV
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVV 64

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           S+  C F T      +L +V+EYV       ++K+       +P+   ++YF +   AL 
Sbjct: 65  SM-FCSFETKR----HLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALE 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNI-------------- 225
           Y+HN  G+ HRD+KP NLL+    H +KL DFG +K+ L+    N+              
Sbjct: 116 YLHN-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 226 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
             +C +  Y APE+I     Y   +D W+ G +L E L+G   F G++  +   ++I   
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-- 230

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---ST 341
                ++I    P   E                  +P +A DL+SRLL+ +P  R     
Sbjct: 231 -----DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGG 266

Query: 342 ALEALIHPFFDELRDPNTRL-PNGRFLPPL 370
           A E   H FF  L D N  L     F+P L
Sbjct: 267 AFEVKQHRFFLGL-DWNGLLRQKAEFIPQL 295

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 98.6 bits (245), Expect = 3e-23
 Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 49/294 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 125
           +GHGSFG V+ A    T E VA+KK+    +  N       +E++ ++ L HPN +  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           C+       E    LV+EY   +   +++ H K  Q + +  +    +   + LAY+H+ 
Sbjct: 89  CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT---HGALQGLAYLHSH 140

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 244
             + HRDIK  N+L+     Q+KL DFGSA       P  S++ + Y+ APE+I    E 
Sbjct: 141 NMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEG 195

Query: 245 -YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            Y   +D+WS G    EL   +P     + +  L  I                    +  
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQND 236

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
            P ++++ W   F+          V   LQ  P  R  + E L H F    R  
Sbjct: 237 SPTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 97.1 bits (242), Expect = 6e-23
 Identities = 81/298 (27%), Positives = 131/298 (43%), Gaps = 41/298 (13%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           G G++GVV + + + TG  +A+K++       + KR       +MR +D P  V+     
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           F   E D   + + +E +  ++ +  K  Y     +P   +      I +AL Y+H+ + 
Sbjct: 70  FR--EGD---VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--- 244
           V HRD+KP N+L+N    Q+KLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           Y    D+WS G  + EL  G+  FP +S             TP  +++K           
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTPF-QQLK----------- 218

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
            Q+   P  ++  ++  PE  D V++ L+ +   R    E L HPFF+     NT + 
Sbjct: 219 -QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 97.5 bits (242), Expect = 8e-23
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 49/289 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           K C+       E    LV+EY   +   +++ H K  Q + +  +    +   + LAY+H
Sbjct: 91  KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT---HGALQGLAYLH 142

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRDIK  N+L+     Q+KL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 SH-NMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 244 E--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           E  Y   +D+WS G    EL   +P     + +  L  I                    +
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 238

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + P ++++ W   F+        + V   LQ  P  R T+ E L H F
Sbjct: 239 NESPTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMF 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 96.2 bits (239), Expect = 9e-23
 Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 118
           ++  E+ +G G F  V++A CL   + VA+KKV    + D + +    +E+  ++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+     F    E     LN+VLE      + ++IK+  K  + +P   V  YF Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 236
           A+ ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 66/298 (22%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDK---RYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G++G V++A+ + TGE VAIK + L+         +E+  ++   HPN+V+    + 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 129 STTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALA 180
               +D+L+  +V+EY      + +++V +      Q   + YV       CR     LA
Sbjct: 71  R---RDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV-------CRETLKGLA 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPEL 238
           Y+H T G  HRDIK  N+L+      +KL DFG +  L     +   S+I + Y+ APE+
Sbjct: 116 YLHET-GKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEV 172

Query: 239 IFGATE----YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK 293
              A E    Y    DIW+ G    EL   Q P+F         +  ++ L   ++    
Sbjct: 173 A--AVERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS--- 219

Query: 294 CMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                   F  P++K    W  +F         D + + L   P  R TA + L HPF
Sbjct: 220 -------NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 96.7 bits (240), Expect = 1e-22
 Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 49/294 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 132

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 187

Query: 244 E--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           E  Y   +D+WS G    EL   +P     + +  L  I                    +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 228

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
            + P +++  W + F+        + V   LQ  P  R T+   L H F    R
Sbjct: 229 NESPALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 88/320 (27%), Positives = 131/320 (40%), Gaps = 71/320 (22%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTMRLL---DHPNVVSLKH 125
           VG G +G VF AK  +TGE VA+K     +L         L    +L       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 126 CFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            F     +D+ YL L +EYVP            V+   +           + Y  ++  A
Sbjct: 69  AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----------ARFYMAEMFEA 113

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +  +H  +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE+
Sbjct: 114 VDALHE-LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEV 169

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           + G   Y   +D WS GC+L E L G P F G                          PN
Sbjct: 170 LRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGS------------------------TPN 204

Query: 299 YTEFKFPQIKAHPWHKIFQK--------RMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            T   +  +K   W +  Q+         +  EA DL+++L+        +  +   HPF
Sbjct: 205 ET---WENLKY--WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259

Query: 351 FDELRDPNTRLPNGRFLPPL 370
           F E+     R     F+P L
Sbjct: 260 FKEVDWNELRELKPPFVPEL 279

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 95.3 bits (237), Expect = 2e-22
 Identities = 88/318 (27%), Positives = 136/318 (42%), Gaps = 57/318 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 124
           +G G FG V   +   TG+  A KK L  KR K R+ + M L +           +VSL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALAYI 182
           + F +   KD+L L + L    +     +K+H Y + +   P      Y  QI   L ++
Sbjct: 60  YAFET---KDDLCLVMTLMNGGD-----LKYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H    + +RD+KP+N+L++ H + +++ D G A  L  G+       +  Y APE++ G 
Sbjct: 112 HQR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y  ++D ++ GC L E++ G+  F       Q  E ++      +EE+K         
Sbjct: 170 -VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR------- 209

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELRDP 357
                        +  +  PEA DL   LLQ  P  R      +A E   HP F +L   
Sbjct: 210 ----TLEMAVE--YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263

Query: 358 NTRLPNGRFLPPLFNFKP 375
             RL  G   PP   F P
Sbjct: 264 --RLEAGMLEPP---FIP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 93/315 (29%), Positives = 143/315 (45%), Gaps = 55/315 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  C F T E    +L  V+EY+       +  H + S R      + Y  +I   L ++
Sbjct: 61  L-FCTFQTKE----HLFFVMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE++ G
Sbjct: 113 H-KKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
             +Y  ++D WS G +L E+L+GQ  F GE   D+L + I         +          
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR--------- 212

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALIHPFFDELRDPNTR 360
                    P    F + +  EA D +S+L +  P  R     +   HPFF  +     R
Sbjct: 213 ---------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID--WER 258

Query: 361 LPNGRFLPPLFNFKP 375
           L      PP   FKP
Sbjct: 259 LEKREIPPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 83/298 (27%), Positives = 129/298 (43%), Gaps = 54/298 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+   T E  A+K + +D   ++ +++ TM   R+L     HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L H  F T  KD L+   V+EYV       +  H + S R      + Y  +I   L ++
Sbjct: 61  L-HSCFQT--KDRLFF--VMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++  
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y  A+D W+ G +L E+L GQ  F G+   D+L                        
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL------------------------ 204

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA-----LIHPFFDEL 354
             F  I        + + +  EA  ++   L  +P  R   L         HPFF E+
Sbjct: 205 --FQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.7 bits (233), Expect = 8e-22
 Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 43/290 (14%)

Query: 70  ERVV-GHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK---NRELQTMRLLDHPNVVSLK 124
           ERVV G G++G+V+ A+ L T   +AIK++  +D RY    + E+     L H N+V   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYI 182
                 +E    +  + +E VP  ++  +++  +  +      I    Y  QI   L Y+
Sbjct: 72  GSD---SENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELI-F 240
           H+   + HRDIK  N+LVN ++  +K+ DFG++K L    P   ++  +  Y APE+I  
Sbjct: 125 HDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           G   Y A  DIWS GC + E+  G+P F                       I+   P   
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAA 220

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FK    K HP      + +  EA + + R  +  P+ R++A + L  PF
Sbjct: 221 MFKVGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (235), Expect = 8e-22
 Identities = 90/314 (28%), Positives = 137/314 (43%), Gaps = 56/314 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 125
           +G GSFG V Q +  +T    A+K + +       E+         +  ++ P +V LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             FS    ++LYL L      E     + HH +   R  L   + Y  ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLH-K 111

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATE 244
             V +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           YT A+D W+ G +L E+L G P F  E+ V+++    K+L  P R               
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR--------------- 211

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFFDELRDPNTRL 361
                      F      +A DL+  LL   P  R   + A E   HPFF +L     +L
Sbjct: 212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WKKL 258

Query: 362 PNGRFLPPLFNFKP 375
                 PP   FKP
Sbjct: 259 LMKGIQPP---FKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 53/297 (17%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLL-DHPNVVSLKH 125
           V+G G++G V++A+  +TG+ VAIK  + D           E   +R   +HPN+ +   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 126 CFF---STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            F         D+L+  LV+E     +V  ++K   K  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 240
           +H    V HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I 
Sbjct: 129 LHEN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185

Query: 241 GATE------YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
            A +      Y A  D+WS G    EL  G+P       +  L +I +            
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------------ 232

Query: 295 MNPNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            NP       P +K    W K F         D +S  L  +   R    E L HPF
Sbjct: 233 -NPP------PTLKSPENWSKKFN--------DFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTM-------RLLDHPNVV 121
           +V+G GSFG V  AK    G+  A+ KVLQ K    K  +   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L H  F T +K    L  VL+YV       +  H +  +  P    + Y  +I  AL Y
Sbjct: 60  GL-HYSFQTADK----LYFVLDYVNGG---ELFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE++ 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y   +D W  G VL E+L G P F
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 90.6 bits (225), Expect = 8e-21
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQ--DKRYKNRELQTMRLL---DHPNVVSLKHC 126
           +G GSFGVVF+          A+K++ L   ++R +   +   R+L   D   ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F      D+  LN+V+EY     +H+++K      + +P   V  +F QI   LA++H+ 
Sbjct: 68  FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFG 241
             + HRDIK  NL ++ +   +K+ D G AK+L     N ++    + + YY +PEL   
Sbjct: 121 -KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC-E 174

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
              Y    D+W+ G VL E   G+  F   +    +++II+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 79/291 (27%), Positives = 130/291 (44%), Gaps = 49/291 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           + +G GSFG ++ AK     E   IK++      +++K    +E+  +  + HPN+V+  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F S  E   L++  V+EY    + + R+ +    +     ++    +F QI   L +I
Sbjct: 65  --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIF 240
           H+   + HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE I 
Sbjct: 118 HDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               Y    DIWS GCVL EL   +  F G + + QLV  I       +     ++PN++
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKI------CQGYFAPISPNFS 227

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                                 +   L+S+L + SP  R +    L  PF 
Sbjct: 228 R---------------------DLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 82/305 (26%), Positives = 124/305 (40%), Gaps = 47/305 (15%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDK-RYKN---RELQTMRLLDHPNVVSLKHC 126
            +G G+ GVV +     +G  +A K + L+ K   +N   REL+ +   + P +V     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 127 FFSTTE-------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           F+S  E        D   L+ VL               K + R+P   +      + R L
Sbjct: 68  FYSDGEISICMEHMDGGSLDQVL---------------KKAGRIPENILGKISIAVLRGL 112

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE +
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 170

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G T YT   DIWS G  L E+ +G+   P         E+  + G P  E     +   
Sbjct: 171 QG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRP 225

Query: 300 TEFKFPQ-------------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
                P              I   P  K+       E  D V + L+ +P  R+   E  
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285

Query: 347 IHPFF 351
            HPF 
Sbjct: 286 KHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 87/307 (28%), Positives = 138/307 (44%), Gaps = 63/307 (20%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNRELQTMRLLDH---------- 117
           RV+G G++G VF  + +   + G+  A+K VL+    K   +Q  +  +H          
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLK----KATIVQKAKTAEHTRTERQVLEA 60

Query: 118 ----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
               P +V+L H  F T  K    L+L+L+YV      +  H Y+  +      V++Y  
Sbjct: 61  VRRCPFLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIA 112

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSR 231
           +I  AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E     S+  + 
Sbjct: 113 EIVLALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTI 170

Query: 232 YYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            Y APE+I G +  +  A+D WS G +  ELL G   F  +   +   EI       +R 
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRR 223

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALI 347
            +K   P                  F K M  EA D + +LL+  P  R   + A E   
Sbjct: 224 ILKSKPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265

Query: 348 HPFFDEL 354
           HPFF  +
Sbjct: 266 HPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 91/315 (28%), Positives = 150/315 (47%), Gaps = 55/315 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+    GE  A+K + +D    + +++ TM   R+L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L +C F T  K+ L+   V+E++       +  H +   R  L     Y  +I   L ++
Sbjct: 61  L-YCTFQT--KEHLFF--VMEFLNGGD---LMFHIQDKGRFDLYRATFYAAEIVCGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ G
Sbjct: 113 HSK-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
             +YT ++D WS G +L E+L+GQ  F G+   D+L E I+V  TP              
Sbjct: 171 -LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP-------------- 213

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-IHPFFDELRDPNTR 360
             +P+     W       +  E+ D++ +L +  P  R   +  +  HPFF  +    T 
Sbjct: 214 -HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN--WTA 258

Query: 361 LPNGRFLPPLFNFKP 375
           L      PP   FKP
Sbjct: 259 LEKRELDPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 33/211 (15%)

Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKK-----VLQDKRYKNRELQTMRLLDHPNV 120
           + +G G FG V      +     TGE VA+K        Q +    RE++ +R LDH N+
Sbjct: 10  KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRA 178
           V  K        +    L L++EY+P    R     Y  +   ++ L  + L+  QIC+ 
Sbjct: 69  VKYKGVCEKPGGRS---LRLIMEYLPSGSLR----DYLQRHRDQINLKRLLLFSSQICKG 121

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSR 231
           + Y+ +     HRD+  +N+LV      +K+ DFG AKVL +        EP  S I   
Sbjct: 122 MDYLGSQ-RYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--F 177

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           +Y APE +  +   +A+ D+WS G  L EL 
Sbjct: 178 WY-APECLRTSKFSSAS-DVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 87/297 (29%), Positives = 138/297 (46%), Gaps = 47/297 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 86  YLV---GDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLKALSVLHAQ- 135

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 245
           GV HRDIK  ++L+  H  ++KL DFG    + K  P   S + + Y+ APELI     Y
Sbjct: 136 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPY 193

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 234

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           ++K    HK+      P     + RLL   P  R+TA E L HPF  +   P+  +P
Sbjct: 235 KLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 87/316 (27%), Positives = 142/316 (44%), Gaps = 57/316 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +++G GSFG VF A+   T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L +C F T E     L  V+EY+       +  H +   +  L     Y  +I   L ++
Sbjct: 61  L-YCTFQTKE----NLFFVMEYLNGGD---LMFHIQSCHKFDLPRATFYAAEIICGLQFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G
Sbjct: 113 HSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
             +Y  ++D WS G +L E+L+GQ  F G    +              + I+  NP Y  
Sbjct: 171 -QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCYPR 217

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDELRDPNT 359
           +                 +  EA D++ +L    P  R   ++  I  HPFF E+    +
Sbjct: 218 W-----------------LTREAKDILVKLFVREPE-RRLGVKGDIRQHPFFREID--WS 257

Query: 360 RLPNGRFLPPLFNFKP 375
            L      PP   FKP
Sbjct: 258 ALEEREIEPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 85/331 (25%), Positives = 134/331 (40%), Gaps = 88/331 (26%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 123
           +V+G G+FG V   +  +TG   A+KK+ + +  +  ++  +R    +L   D+P VV L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +DE YL L++EY+P  + +  ++K     ++     Y+     +   A+  
Sbjct: 67  YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIA----ETILAIDS 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNISYIC 229
           IH  +G  HRDIKP NLL++   H +KL DFG              ++L    P+     
Sbjct: 117 IH-KLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 230 SR--------------------Y-------YRAPELIFGATEYTAAIDIWSAGCVLAELL 262
                                 Y       Y APE +F  T Y    D WS G ++ E+L
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEML 233

Query: 263 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP 322
           +G P F  +               P     K +N   T  +FP           +  + P
Sbjct: 234 VGYPPFCSD--------------NPQETYRKIINWKET-LQFPD----------EVPLSP 268

Query: 323 EAVDLVSRLLQYSPNL--RSTALEALIHPFF 351
           EA DL+ RL   +      +   E   HPFF
Sbjct: 269 EAKDLIKRLCCEAERRLGNNGVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 83/297 (27%), Positives = 135/297 (45%), Gaps = 47/297 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           + S    +EL++  ++E++       I    ++++      +      + +AL Y+H+  
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHSQ- 136

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 245
           GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+ APE+I   T Y
Sbjct: 137 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPY 194

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  +S V  +  +        R+              P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------P 233

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
             K    HKI      P   D + R+L   P  R+TA E L HPF  +   P   +P
Sbjct: 234 PPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 85/291 (29%), Positives = 133/291 (45%), Gaps = 54/291 (18%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSLKH 125
           +G GSFG V  AK   TGE  AIK     ++L+ K+ +   +E   +  L HP +V++  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F    +++ +Y   +LE+V   V   +  H + + R P    K Y  ++  A  Y+H+ 
Sbjct: 86  SF---QDENRVYF--LLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + +RD+KP+NLL++   H +K+ DFG AK +   +   +   +  Y APE+I  +  +
Sbjct: 138 -DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKGH 192

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
             A+D W+ G +L E + G P F  +              TP R   K +       KFP
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLKFP 235

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI-----HPFF 351
                 W   F  R    A DLV  LLQ     R   L+  +     HP+F
Sbjct: 236 N-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 73/299 (24%), Positives = 127/299 (42%), Gaps = 48/299 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           +G G++G V++     TG  +A+K++   L + ++     EL  +     P +V     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           F      E  + + +EY+       +      ++ +P   ++   Y + + L ++     
Sbjct: 69  FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-----FGA 242
           + HRD+KP N+LVN +  Q+KLCDFG +  LV      +  C  Y  APE I        
Sbjct: 124 IIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPNY 299
             YT   D+WS G  + E+ LG+  +P E+  +   QL  I+   G P       +   Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           +                      +A D V++ L   PN R T  + L HP+  + ++ +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 71/304 (23%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYK--NRELQTMRLLDHPNVV 121
           V+G G++G V+       G+ +A+K+V  D        K Y+    E+  ++ L H N+V
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                 +  T  D+  +++ +E+VP  ++  ++         +P      Y  QI   +A
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVA 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI-------CSRYY 233
           Y+HN   V HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 117 YLHNN-CVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
            APE+I   + Y    DIWS GC + E+  G+P     + +D+L  +             
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF------------ 218

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPP-------EAVDLVSRLLQYSPNLRSTALEAL 346
                        I AH      +  MP         A+D V+  L    + R +AL+ L
Sbjct: 219 ------------YIGAH------RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260

Query: 347 IHPF 350
            H F
Sbjct: 261 RHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 91/318 (28%), Positives = 137/318 (43%), Gaps = 51/318 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 121
           +V+G GSFG V  AK    G+  A+K VLQ K   NR+ Q          ++ + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L H  F TTEK    L  VL++V       +  H +  +  P    + Y  +I  AL Y
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H +I + +RD+KP+N+L++   H + L DFG  K  +      +  C +  Y APE+I 
Sbjct: 112 LH-SINIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI- 168

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-KVL----GTPT------R 289
               Y   +D W  G VL E+L G P F      +    I+ K L    G          
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228

Query: 290 EEIKCMNPNYTEFK--FPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           E ++         K  F +I+ HP      W  + QK++PP           ++PN+   
Sbjct: 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP----------FNPNVEGP 278

Query: 342 ALEALIHPFFDELRDPNT 359
              +     F E   P +
Sbjct: 279 DDISNFDAVFTEETVPYS 296

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 84.6 bits (209), Expect = 1e-18
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y   RVVG GSFG     + + + +  A+K++   K         +E   +  + HPN+V
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + K  F     + + +L +V+EY    + + ++     K+    P   +  +F Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPEL 238
            +IH    V HRDIK +N+ +     ++KL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 239 IFGATEYTAAIDIWSAGCVLAEL 261
           I+    Y    DIWS GC+L EL
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 88/321 (27%), Positives = 133/321 (41%), Gaps = 59/321 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 122
           RV+G G FG V   +   TG+  A KK L+ KR K R+ + M L        ++   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 180
           L + +     KD L L L L    +     +K H Y M            Y  +I   L 
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGD-----LKFHIYNMGNPGFDEERAVFYAAEITCGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
            +H    + +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++ 
Sbjct: 117 DLHRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               YT + D W  GC++ E++ G+  F          E +K      REE++       
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERRVKEDQ 221

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELR 355
           E              + ++    A  +  +LL   P  R       A E   HPFF   R
Sbjct: 222 E-------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF---R 265

Query: 356 DPN-TRLPNGRFLPPLFNFKP 375
             N  RL  G   PP   F P
Sbjct: 266 TANFKRLEAGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 34/214 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G+FG V   +   +    A+K +       L+ +++ + E + ++ + HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                TE D+ +L +++EYVP   +   +++  + S    L Y      +I  AL Y+H 
Sbjct: 68  ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS----EIVCALEYLH- 118

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRAPEL 238
           +  + +RD+KP+N+L++   H +KL DFG AK L        G P         Y APE+
Sbjct: 119 SKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPEV 169

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I  +  +  A+D W+ G ++ E+L+G P F  ++
Sbjct: 170 I-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 69/208 (33%), Positives = 103/208 (49%), Gaps = 34/208 (16%)

Query: 73  VGHGSFGVVFQAKCL------ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 122
           +G G+FG V    C        TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            K   +S   ++   L LV+EY+P    R  + KH  ++  R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYY 233
           Y+ +   V HRD+  +N+LV      +K+ DFG  KVL          EP  S I   ++
Sbjct: 123 YLGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAEL 261
            APE +   ++++ A D+WS G VL EL
Sbjct: 178 YAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 90/311 (28%), Positives = 146/311 (46%), Gaps = 49/311 (15%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTM 112
           G P++ +    +  +G GS G+V  A    TG+ VA+KK+  D R + R      E+  M
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R   H NVV +   + S    DEL++  V+E++       I  H +M++      +    
Sbjct: 74  RDYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVC 124

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 231
             + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P   S + + 
Sbjct: 125 LSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTP 182

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           Y+ APE+I     Y   +DIWS G ++ E++ G+P +  E  +  +  I        R+ 
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDN 233

Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           +            P++K    HK+    +    +DL   +L   P+ R+TA E L HPF 
Sbjct: 234 LP-----------PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275

Query: 352 DELRDPNTRLP 362
                P+  +P
Sbjct: 276 KLAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 83.4 bits (206), Expect = 7e-18
 Identities = 96/339 (28%), Positives = 153/339 (45%), Gaps = 69/339 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           RV+G GSFG V  A+  E+G   A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L +C F T ++    L  V+E+V       +  H + S+R      + Y  +I  AL ++
Sbjct: 61  L-YCCFQTPDR----LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I  
Sbjct: 113 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQ 169

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y  ++D W+ G +L E+L G   F  E+  D L E I        +E+         
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV--------- 213

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR--STAL---EALI-HPFFDELR 355
                        ++   +  +AVD++   +  +P +R  S  L   EA++ HPFF EL 
Sbjct: 214 -------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL- 259

Query: 356 DPNTRLPNGRFLPPLF-----------NFKPHELKGVPV 383
             +    N R + P F           NF P  +K  PV
Sbjct: 260 --DWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPV 296

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 93/307 (30%), Positives = 144/307 (46%), Gaps = 62/307 (20%)

Query: 71  RVVGHGSFGVVF---QAKCLETGEAVAIKKVLQD----KRYKNRE-LQTMR-LLDH---- 117
           +V+G G++G VF   +    +TG+  A+K VLQ     ++ K  E  +T R +L+H    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQS 64

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPET---VHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           P +V+L H  F T  K    L+L+L+YV       H   + ++   +      V+ Y  +
Sbjct: 65  PFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE------VRFYSGE 113

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRY 232
           I  AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E   +Y  C +  
Sbjct: 114 IILALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIE 171

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE+I G   +  A+D WS G ++ ELL G   F  E   +   E+       +R  +
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRIL 224

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALI 347
           KC  P                  F   + PEA DL+ +LL+  P  R       A E   
Sbjct: 225 KCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266

Query: 348 HPFFDEL 354
           HPFF  L
Sbjct: 267 HPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 104/403 (25%), Positives = 163/403 (40%), Gaps = 110/403 (27%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 123
           +V+G G+FG V   +  +TG+  A+K +L+ + +K  +L  ++    +L   D P VVSL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +D  YL L++E++P  + +  +IK+    S+ +     + Y  +   A+  
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYD-TFSEDV----TRFYMAECVLAIEA 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKGEPNISYIC 229
           +H  +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I 
Sbjct: 117 VHK-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174

Query: 230 SRY------------------------------------YRAPELIFGATEYTAAIDIWS 253
           +R                                     Y APE IF    Y    D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233

Query: 254 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPW 312
            G ++ E L+G P F  E+  +   +II                N+ E   FP       
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD------ 271

Query: 313 HKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDPNTRLPNGRFLPPL 370
                  +  EA DL+ RL+  + N   R  A E   HPFF  +     R     F+P L
Sbjct: 272 ----DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQL 327

Query: 371 FN------FKPHELKGVPVDMLVKL-----IPEHARKQCAFLG 402
            +      F   EL+ VP    +K        E      AF+G
Sbjct: 328 KSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIG 370

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 81.3 bits (200), Expect = 2e-17
 Identities = 77/300 (25%), Positives = 136/300 (45%), Gaps = 52/300 (17%)

Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLL 115
           I++   +++G G+FG V+    ++TG  +A K+V  D               E+Q ++ L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
            H  +V    C     EK    L + +EY+P  +V   +K +  +++ +   Y +    Q
Sbjct: 62  QHERIVQYYGCLRDRAEKT---LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR----Q 114

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICS 230
           I   ++Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S   +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            Y+ +PE+I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT  
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTN- 227

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                         PQ+ +H         +   A D +  +   + + R +A E L HPF
Sbjct: 228 --------------PQLPSH---------ISEHARDFLGCIFVEARH-RPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 82/302 (27%), Positives = 134/302 (44%), Gaps = 53/302 (17%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             HPN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 119

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-- 233

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                      E + P+            ++     D ++R L+     R +A E L HP
Sbjct: 234 -----------ELQNPE------------KLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270

Query: 350 FF 351
           F 
Sbjct: 271 FL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 36/286 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G G+ G V + K + TG  +A K V    +        RELQ M     P +VS    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
            +     E  + + +E++   ++ R+    YK    +P+  +      +   L Y++N  
Sbjct: 73  LN-----ENNICMCMEFMDCGSLDRI----YKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
            + HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 247 AAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              D+WS G  + EL LG+ P        D   + + +L                     
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           QI   P  ++     P +  D V   L   P  R T  +    P F
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 81/296 (27%), Positives = 136/296 (45%), Gaps = 46/296 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           ++  +V GH S G ++  K L+    V   K  +  R + + L+ +R    P +V+L + 
Sbjct: 17  FLVRKVSGHDS-GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--QSPFLVTLHYA 73

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           F + T+     L+L+L+Y+       +  H    +R     V++Y  +I  AL ++H  +
Sbjct: 74  FQTDTK-----LHLILDYINGGE---LFTHLSQRERFKEQEVQIYSGEIVLALEHLHK-L 124

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELIFGA-T 243
           G+ +RDIK +N+L++ + H + L DFG +K   + E   +Y  C    Y AP+++ G   
Sbjct: 125 GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            +  A+D WS G ++ ELL G   F  +   +   EI       +R  +K   P      
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSEPP------ 230

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDEL 354
           +PQ             M   A D++ RLL   P  R     S A E   HPFF ++
Sbjct: 231 YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 94/320 (29%), Positives = 141/320 (44%), Gaps = 57/320 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 122
           RV+G G FG V   +   TG+  A KK L+ KR K R+ ++M L     L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 180
           L + +     KD L L L L    +     +K H Y M +          Y  +IC  L 
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGD-----LKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
            +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++ 
Sbjct: 117 DLHQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               YT + D W+ GC+L E++ GQ  F       Q  + IK      REE++ +     
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQ 221

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELR 355
           E              + ++  P+A  L   LL   P  R       A E   HP F ++ 
Sbjct: 222 E-------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268

Query: 356 DPNTRLPNGRFLPPLFNFKP 375
               RL  G   PP   FKP
Sbjct: 269 --FKRLEAGMLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 81/325 (24%), Positives = 147/325 (45%), Gaps = 63/325 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLL-----DHPNVV 121
           RV+G GS+  V   +  +T    A+ KV++ +   + E    +QT + +     +HP +V
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAM-KVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L  CF + +      L  V+E+V       +  H +  +++P  + + Y  +I  AL +
Sbjct: 60  GLHSCFQTESR-----LFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNF 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIF 240
           +H   G+ +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII--KVLGTPTRE 290
           G  +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I  K +  P   
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228

Query: 291 EIKC-------MNPNYTE-------FKFPQIKAHP------WHKIFQKRMPPEAVDLVSR 330
            +K        +N +  E         F  IK+HP      W  + QK++ P        
Sbjct: 229 SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP------- 281

Query: 331 LLQYSPNLRST-ALEALIHPFFDEL 354
              Y PN+ S   L+     F DE 
Sbjct: 282 ---YKPNIESDRDLDNFDPQFTDEP 303

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 47/296 (15%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHC 126
           ++GHG+ G V++A  L T   +A+K +  D     ++    EL+ +   D P ++     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 127 FFSTTEKDELYLNLVLEYVPE---TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           FF      E  +++  E++      V+R I  H  +  R+ +  VK         L Y+ 
Sbjct: 68  FFV-----ENRISICTEFMDGGSLDVYRKIPEH--VLGRIAVAVVK--------GLTYLW 112

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + HRD+KP N+LVN    Q+KLCDFG +  LV      +Y+ +  Y APE I G  
Sbjct: 113 -SLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-E 168

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           +Y    D+WS G    EL LG+  +P        +  +++L     E+            
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP----------- 217

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 359
            P +    + + F        V  +++ ++  P  R      + HPF  +  D N 
Sbjct: 218 -PVLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 77/305 (25%), Positives = 123/305 (40%), Gaps = 70/305 (22%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           G G+FG V++A+  ETG   A K +       L+D      E+  +    HPN+V L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 127 FFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +F    +++L+  +++E+      +++   ++      Q   +        Q+  AL ++
Sbjct: 71  YFY---ENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVC------RQMLEALNFL 119

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI-- 239
           H+   V HRD+K  N+L+      +KL DFG SAK     +   ++I + Y+ APE++  
Sbjct: 120 HSHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 240 --FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
             F    Y    DIWS G  L EL   +P                    P  E    +NP
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNP 213

Query: 298 NYTEFKFPQ------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                K  +       +   W   F         D +   L   P+ R TA E L HPF 
Sbjct: 214 MRVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFV 265

Query: 352 DELRD 356
            +  D
Sbjct: 266 SDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 84/301 (27%), Positives = 130/301 (43%), Gaps = 63/301 (20%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHP 118
           +V+G G +G VFQ + +   +TG+  A+K VL+         D  +   E   +  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V L    F T  K    L L+LEY+   E    + +    M           Y  +I 
Sbjct: 61  FIVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEIS 110

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRA 235
            AL ++H   G+ +RD+KP+N+L++   H +KL DFG  K  +         C    Y A
Sbjct: 111 LALEHLH-QQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE I   + +  A+D WS G ++ ++L G P F  E+    + +I+K          K  
Sbjct: 169 PE-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLN 218

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPF 350
            P Y                    + PEA DL+ +LL+ +P+ R       A E   HPF
Sbjct: 219 LPPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258

Query: 351 F 351
           F
Sbjct: 259 F 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 56/296 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 121
           +++G G+FG V+     +TG  +A+K+V  D               E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               C     E+    L++ +E++P  ++   +K +  +++ +     + Y  QI   ++
Sbjct: 68  QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNISYICSRYYRAP 236
           Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y    DIWS GC + E+L  +P +   +  + +  I K+   PT        
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 227

Query: 297 PNYTEFKFPQIKAH--PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                   P +  H     + F KR+  EA             LR +A E L H F
Sbjct: 228 --------PVLPPHVSDHCRDFLKRIFVEA------------KLRPSADELLRHTF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 50/287 (17%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----------LDHPNV 120
           ++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRA 178
           V + + F  T +K    L+L+              HY +SQ       ++ FY  +I   
Sbjct: 60  VCMSYAF-HTPDKLSFILDLM---------NGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLF----------------------PGESGVDQ 276
           +     Y ++ D +S GC+L +LL G   F                      P     + 
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226

Query: 277 LVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 322
              +  +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 41/214 (19%)

Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           RV+G G FG V    +      TGE VA+K + ++   +N      E+  ++ L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K C    +E+    L L++EYVP    R  + KH   ++Q +      L+  QIC  +
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE-- 237
           AY+H+   + HRD+  +N+L++ +   +K+ DFG AK + +G          YYR  E  
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170

Query: 238 ---LIFGATE------YTAAIDIWSAGCVLAELL 262
              + + A E      ++ A D+WS G  L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (195), Expect = 9e-17
 Identities = 61/236 (25%), Positives = 117/236 (49%), Gaps = 27/236 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 121
           +++G G+FG V+     +TG  +A+K+V  D   +           E+Q ++ L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               C     EK    L++ +EY+P  ++   +K +  +++ +     + Y  QI + ++
Sbjct: 68  QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNISYICSRYYRAP 236
           Y+H+ + + HRDIK  N+L +     +KL DFG++K    + + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           E+I G   Y    D+WS  C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 73/283 (25%), Positives = 119/283 (42%), Gaps = 50/283 (17%)

Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFF 128
           G G+ G V + +   TG   A+K +  D     ++   REL+  +    P +V     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 129 STTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              ++    + + +EY     +     +V K   ++ ++   +  K+    + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK---VLGKIAE-SVLKGLSYLH 122

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELI 239
            +  + HRDIKP N+L+     Q+KLCDFG     V GE   S    +  + +Y APE I
Sbjct: 123 -SRKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 288
            G   Y+   D+WS G  L E+   +  FP E     G  +L+  I  +  P        
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 289 ----REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFQKRMP 321
                EE K     C+  + T    P  +  HPW K   K+  
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           +V+G G+FG V   +   + +  A+K + + +  K         E   M   +   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            H  F    +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  AL  IH
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WARFYTAEVVLALDAIH 159

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 238
           + +G  HRD+KP N+L++   H LKL DFG+    +K + N    C        Y +PE+
Sbjct: 160 S-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPEV 214

Query: 239 IF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           +    G   Y    D WS G  L E+L+G   F  +S V
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 80/328 (24%), Positives = 136/328 (41%), Gaps = 58/328 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----------LQTMRLLDHPNVVS 122
           +G G+FG V+Q +  +T    A+K + + +    +E          L    L + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           LK   FS     +LYL  V +Y+       +  H +   R      K Y  ++  AL ++
Sbjct: 61  LK---FSFQTDSDLYL--VTDYMSGGE---LFWHLQKEGRFSEDRAKFYIAELVLALEHL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 241
           H    + +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++  
Sbjct: 113 HKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII---------KVLGTPTREEI 292
              YT  +D WS G ++ E+  G   F  E    Q+   I          VL    R+ +
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNVLSDEGRQFV 229

Query: 293 KCM---NPNY---TEFKFPQIKAHP------WHKIFQKRMPPEAVDLVSRLLQYSPNLRS 340
           K +   NP +         ++K HP      W  + +K++ P           + P + S
Sbjct: 230 KGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPP----------FKPIVDS 279

Query: 341 TALEALIHPFFDELRDPNTRLPNGRFLP 368
               +   P F      N+ L N   +P
Sbjct: 280 DEDVSNFDPEFT-----NSSLLNAGIVP 302

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 24/207 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHPNV 120
           Y+  + +G GSFG     K  E G+   IK++    +  K  +   +E+  +  + HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQR---MPLIYVKLYFYQIC 176
           V  +  F    E   LY+  V++Y     +++ I      +QR    P   +  +F QIC
Sbjct: 62  VQYQESF---EENGNLYI--VMDYCEGGDLYKKIN-----AQRGVLFPEDQILDWFVQIC 111

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRA 235
            AL ++H+   + HRDIK QN+ +      +KL DFG A+VL    E   + I + YY +
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I     Y    DIW+ GCVL E+ 
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 45/284 (15%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNRELQTMRL-------LDHPNV 120
           +V+G GSFG VF  + +   + G+  A+ KVL+    K R+    ++       ++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAM-KVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L H  F T  K  LYL L      +   R+ K      +      VK Y  ++  AL 
Sbjct: 61  VKL-HYAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALALD 112

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPELI 239
           ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE++
Sbjct: 113 HLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPT---------- 288
                +T + D WS G ++ E+L G   F G+   + +  I+K  LG P           
Sbjct: 171 -NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 229

Query: 289 REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFQKRMPP 322
           R   K  NP       P     IK HP      W+K++++ + P
Sbjct: 230 RALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 66/224 (29%), Positives = 116/224 (51%), Gaps = 28/224 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     ++R+P   +      + R LAY+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 287
           Y+   DIWS G  L EL +G+ P+ P ++      E+  + G P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 42/289 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQ----TMRLLDHPNVVSLKHC 126
           +G G+FG V +     +G  +A+K++    D++ + R L      MR  D P +V     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 127 FFSTTEKD-----ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            F   E D     EL +++ L+   + V+ V+K        +P   +        +AL Y
Sbjct: 72  LF--REGDCWICMEL-MDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNY 122

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-- 239
           +   + + HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I  
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR---EEIKCM 295
                Y    D+WS G  L E+  G+  +P   S  DQL +++K  G P      E +  
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPILSNSEEREF 239

Query: 296 NPNYTEF-------------KFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           +P++  F             K+ ++  HP+ K +++R    A  +   L
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQRIL 288

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 43/292 (14%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 119
           +Y   RVVG GS+G V   +    G+   IKK+       ++++   +E Q +  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V+ +  +    E   LY+ +      +  H++ +   K+   +P   V  +F QI  AL
Sbjct: 61  IVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKL---LPENQVVEWFVQIAMAL 115

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 238
            Y+H    + HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHEK-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
            F    Y    D+W+ GC + E+   +  F  +     +  II                 
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII----------------- 215

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
             E K P +          K   PE  +L++ +L   P  R +    L  P+
Sbjct: 216 --EGKLPPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 82/323 (25%), Positives = 137/323 (42%), Gaps = 68/323 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F      D   L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF---QTHD--RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 213

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                             F + + PEA  L++ LL+  P  R       A E + H FF 
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255

Query: 353 ELRDPNTRLPNGRFLPPLFNFKP 375
            +      +   +  PP   FKP
Sbjct: 256 SIN--WQDVVQKKLEPP---FKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 99/381 (25%), Positives = 155/381 (40%), Gaps = 106/381 (27%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           + +G G+FG V  A  ++T    A+K  L+ K   NR        E   +   D+  VV 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   ++S  +KD LY   V++Y+P  + +  +I+      +  P +  + Y  ++  A+ 
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIE 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG--------EP 223
            +H  +G  HRDIKP N+L++   H +KL DFG         ++K   KG        EP
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173

Query: 224 NI-------------------------------SYICSRYYRAPELIFGATEYTAAIDIW 252
           +                                S + +  Y APE++     YT   D W
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWW 232

Query: 253 SAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 312
           S G +L E+L+GQP F              +  TPT  ++K +N   T    PQ+K    
Sbjct: 233 SVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK---- 274

Query: 313 HKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDEL-------RDPNTRLPN 363
                  + PEAVDL+++L   +     R+ A +   HPFF E+         P   +P 
Sbjct: 275 -------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPK 327

Query: 364 GRFLPPLFNFKPHELKGVPVD 384
                   NF P E +    D
Sbjct: 328 ISHPMDTSNFDPVEEESPWND 348

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 83/302 (27%), Positives = 134/302 (44%), Gaps = 53/302 (17%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR----ELQTMRL 114
           G PK+   Y     +G G+ G VF A  + TG+ VAIK++   K+ K      E+  M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           L +PN+V+    F      DEL+  +V+EY+       +     M +             
Sbjct: 73  LKNPNIVNFLDSFLV---GDELF--VVMEYLAGGSLTDVVTETCMDEAQ--------IAA 119

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H    V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-- 233

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
              +  NP                    +++ P   D ++R L+     R +A E L HP
Sbjct: 234 ---ELQNP--------------------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270

Query: 350 FF 351
           F 
Sbjct: 271 FL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 82/324 (25%), Positives = 133/324 (41%), Gaps = 79/324 (24%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR----ELQTMRLLDHPNVVSL 123
           +++G G  G VF  +   TG+  A+K   K    KR K +    E + +  LDHP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F + T     YL LV++Y P   + R+++      + +     + Y  ++  AL Y+
Sbjct: 67  YASFQTET-----YLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYL 119

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDF-------------------GSAKVLVKGEP 223
           H  +G+ +RD+KP+N+L++   H + L DF                   GS +  V   P
Sbjct: 120 HL-LGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 224 NISYICS-----------RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           + ++                Y APE+I G   + +A+D W+ G +L E+L G   F G +
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
             +    I+K                  E  FP              +   A DL+ +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269

Query: 333 QYSPNLR----STALEALIHPFFD 352
              P+ R      A E   HPFF 
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 22/208 (10%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 121
           +V+G GSFG V  AK    G   A+K VLQ K    ++ Q          ++ L HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L H  F T EK    L  VL+YV       +  H +  +       + Y  ++  A+ Y
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYVNGGE---LFFHLQRERCFLEPRARFYAAEVASAIGY 111

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H ++ + +RD+KP+N+L++   H + L DFG  K  V+ E   S  C +  Y APE + 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VL 168

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y   +D W  G VL E+L G P F
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 82/292 (28%), Positives = 124/292 (42%), Gaps = 54/292 (18%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   +HP +V L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIH 183
           +   +     L +++E+ P      I          P I V      ICR    AL Y+H
Sbjct: 79  YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV------ICRQMLEALQYLH 127

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 242
            ++ + HRD+K  N+L+      +KL DFG SAK +   +   S+I + Y+ APE++   
Sbjct: 128 -SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 243 T----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           T     Y    DIWS G  L E+   +P                    P  E    +NP 
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEP--------------------PHHE----LNPM 221

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
               K    K+ P       +   E  D +   L   P  R +A + L HPF
Sbjct: 222 RVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 72/315 (22%), Positives = 120/315 (38%), Gaps = 38/315 (12%)

Query: 79  GVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHCFFSTTE 132
            +V  AK   T   VA+KK+  D   K        E+ T R L HPN++     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
             ELY+  V   +   +   ++K H+     +P + +      +  AL YIH+  G  HR
Sbjct: 71  DSELYV--VSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSK-GFIHR 125

Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------EPNISYICSRYYRAPELIFGAT 243
            +K  ++L++     + L     +  ++K         +   S + +  + +PE++    
Sbjct: 126 SVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 244 E-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--------EEIKC 294
           + Y    DI+S G    EL  G   F        L+E  KV GT                
Sbjct: 185 QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLDKSTYPLYEDS 242

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           M+ + +  + P  +       + +         V   LQ  P  R +A + L H FF + 
Sbjct: 243 MSQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301

Query: 355 RDPNTRLPNGRFLPP 369
           +  NT L +   L P
Sbjct: 302 KRRNTSLLD--LLKP 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 66/229 (28%), Positives = 119/229 (51%), Gaps = 23/229 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K   ++ +++ L  V +    + + L Y+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI-LGKVSI---AVIKGLTYLRE 121

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y+   DIWS G  L E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 124
           V+G GSFG V  A+   T E  AIK      V+QD   +    E + + L D P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +H +   +        Y  +I   L ++H 
Sbjct: 67  HSCFQTV--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I    
Sbjct: 120 R-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AYQ 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 69/222 (31%), Positives = 115/222 (51%), Gaps = 25/222 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +V+G GSFG V  A+   T E  AIK + +D   ++ ++  TM   R+L     HP + +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L HC F T ++    L  V+EYV   + + ++ +     S++      + Y  ++  AL 
Sbjct: 61  L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALM 110

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELI 239
           ++H   GV +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y APE I
Sbjct: 111 FLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-I 167

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               EY  ++D W+ G ++ E++ GQP F  ++  D L E I
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 67/242 (27%), Positives = 103/242 (42%), Gaps = 47/242 (19%)

Query: 73  VGHGSFGVVFQAKCLETGE---AVAIK-----KVLQDKRYKNRELQTMRLLDHPNVVSLK 124
           +GHG+FG V +   L        VA+K      +   K+   RE   M  LDHP +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                  + + L   LV+E  P   + + +K      + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLE 112

Query: 184 NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 234
           +   V HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SKHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 235 ----APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 287
               APE I     +++  D+WS G  L E    G   +    G +   ++E  + L  P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Query: 288 TR 289
             
Sbjct: 221 EE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 73/295 (24%), Positives = 131/295 (44%), Gaps = 58/295 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 61  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229

Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 322
                     L    +E + C      +  F  I+ HP      W  + QK++ P
Sbjct: 230 VKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQVVP 280

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 75/302 (24%), Positives = 122/302 (40%), Gaps = 69/302 (22%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM----RLLD------HPNVV 121
           V+G G FG V  A+  +TGE  AIK + +       E++++    R+ +      HP +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           +L  CF     +D +    V+EY         +H                    Y   + 
Sbjct: 66  NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHT---------DVFSEPRAVFYAACVV 111

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
             L Y+H    + +RD+K  NLL++     +K+ DFG  K  +      S  C +  + A
Sbjct: 112 LGLQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++   T YT A+D W  G ++ E+L+G+  FPG+                  EE+   
Sbjct: 170 PEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGD----------------DEEEV--- 209

Query: 296 NPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHP 349
                   F  I      +  F   +  EA+ ++ RLL+ +P  R       A +    P
Sbjct: 210 --------FDSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258

Query: 350 FF 351
           FF
Sbjct: 259 FF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 28/234 (11%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVS 122
           RV+G GS+  V   +  +  +  A+K V ++  + + ++  ++   H        P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF +T+      L LV+EYV       +  H +  +++P  + + Y  +IC AL ++
Sbjct: 61  LHSCFQTTSR-----LFLVIEYVNGGD---LMFHMQRQRKLPEEHARFYAAEICIALNFL 112

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 289
             EY  ++D W+ G ++ E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 171 -EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 53/302 (17%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL+  +V+EY+       +     M +             
Sbjct: 73  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQ--------IAA 119

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-- 233

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
              +  NP                    +R+     D ++R L+   + R +A E L HP
Sbjct: 234 ---ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270

Query: 350 FF 351
           F 
Sbjct: 271 FL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 27/210 (12%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-----------DHPNV 120
           ++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRA 178
           V + + F +    D+L   L L    +        HY +SQ       ++ FY  +I   
Sbjct: 60  VCMTYAFHT---PDKLCFILDLMNGGDL-------HYHLSQHGVFSEKEMRFYATEIILG 109

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +   T Y ++ D +S GC+L +LL G   F
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 39/235 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 119
           Y   +V+G G+FG V   +   + +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y  ++  AL
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYTAEVVLAL 155

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYIC 229
             IH ++G+ HRD+KP N+L++ H H LKL DFG+   + +          G P+     
Sbjct: 156 DAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD----- 208

Query: 230 SRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 80/289 (27%), Positives = 128/289 (44%), Gaps = 49/289 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G++G V++A+ + TGE  AIK +     +D     +E+  M+   H N+V+    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
           S   +D+L++   +E+      + I H         + YV     +  + L Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVS---RETLQGLYYLHSK-GK 127

Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 244
            HRDIK  N+L+  + H +KL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 245 -YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            Y    DIW+ G    EL  L  P+F         +  ++ L   T+          + F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFD--------LHPMRALFLMTK----------SNF 226

Query: 303 KFPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           + P++K    W   F           V   L  +P  R TA + L HPF
Sbjct: 227 QPPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 48/284 (16%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM------RLLDHPNVVSLK 124
           V+G GSFG V  A+   T E  AIK + +D   ++ +++ TM       L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +H +   +    +   Y  +I   L ++H+
Sbjct: 67  HSCFQTM--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I    
Sbjct: 120 K-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-AYQ 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGE-------SGVDQLVEIIKVLGTPTREEIKCMN 296
            Y  ++D W+ G +L E+L GQP F GE       S ++  V   K L   ++E +    
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL---SKEAVSICK 233

Query: 297 PNYTEFKFP------------QIKAHP------WHKIFQKRMPP 322
              T  K P             I+ H       W K+ ++ + P
Sbjct: 234 GLLT--KHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQP 275

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 85/325 (26%), Positives = 136/325 (41%), Gaps = 73/325 (22%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKK----VLQDKR---YKNRELQTMRLLDHPNVVSLK 124
           +VG G FG V   +   TG+  A+K     VL  +    +   E   + + + P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           + F    +KD LYL  V+EY P  + +  + ++  +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-------KVLVK---GEPNISYICSRY 232
           H  +G  HRDIKP+N+L++   H +KL DFGSA        V  K   G P+        
Sbjct: 119 H-QMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPD-------- 168

Query: 233 YRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           Y APE++      G   Y    D WS G +  E++ G+  F   +       I+      
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------ 222

Query: 288 TREEIKCMNPNYTEF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
                     N+  F KFP+            ++  + +DL+  LL      R    E L
Sbjct: 223 ----------NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKER-LGYEGL 260

Query: 347 -IHPFFDELRDPNTRLPNGRFLPPL 370
             HPFF ++   N R     F+P L
Sbjct: 261 CCHPFFSKIDWNNIRNSLPPFVPTL 285

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 60/240 (25%), Positives = 108/240 (45%), Gaps = 30/240 (12%)

Query: 73  VGHGSFGVVFQAKCLETGEA-VAIKKVL-------QDKRYKNRELQTM--------RLLD 116
           +G G+FG V++ +    G+  +A+K++        +DKR +++ +  +          L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVL-EYVPETVHRVI---KHHYKMSQRMPLIYVKLYF 172
           HPN+V     F    E D LY+ + L E  P   H      K      +R+  I+V    
Sbjct: 68  HPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV---- 120

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            Q+  AL Y+H    + HRD+ P N+++     ++ + DFG AK         S + +  
Sbjct: 121 -QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y  PE++     Y    D+W+ GC+L ++   QP F   + +    +I++ +  P  E +
Sbjct: 179 YSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 39/235 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 119
           Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  AL
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLAL 155

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYIC 229
             IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+     
Sbjct: 156 DAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD----- 208

Query: 230 SRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 209 ---YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 26/210 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY--KNRELQTM-------RLLDHPNVV 121
           +V+G GSFG V  A+  +  E     KVLQ K    K  E   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L H  F T +K    L  VL+Y+   E  + + +    +  R      + Y  +I  AL
Sbjct: 60  GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
            Y+H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y APE+
Sbjct: 110 GYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +     Y   +D W  G VL E+L G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 87/316 (27%), Positives = 134/316 (42%), Gaps = 56/316 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 122
           RV+G G FG V   +   TG+  A K+ L+ KR K R+ ++M L     L+  N   VV+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALA 180
           L + +     KD L L L +    +     +K H Y M            Y  +I   L 
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGD-----LKFHIYNMGNPGFEEERALFYAAEILCGLE 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
            +H      +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++ 
Sbjct: 117 DLHRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               YT + D W  GC++ E++ GQ  F G        E +K      REE+        
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV-------- 213

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELR 355
                  +     +++  +   EA  +   LL   P  R       A E   HPFF   R
Sbjct: 214 -----DRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF---R 265

Query: 356 DPN-TRLPNGRFLPPL 370
           + N  RL  G   PP 
Sbjct: 266 NMNFKRLEAGMLDPPF 281

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 81/299 (27%), Positives = 129/299 (43%), Gaps = 62/299 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 351
                             F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 86/319 (26%), Positives = 137/319 (42%), Gaps = 60/319 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-----LL--DHPNVVSL 123
           +V+G G+FG V   K   TG+  A+K + + +  K  E    R     L+  D   + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 124 KHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            + F     +DE  L LV++Y V   +  ++    K   R+P    + Y  ++  A+  +
Sbjct: 67  HYAF-----QDENNLYLVMDYYVGGDLLTLLS---KFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYICSRY 232
           H  +G  HRDIKP N+L++ + H ++L DFGS   L+           G P+  YI    
Sbjct: 119 HQ-LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPEI 174

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
            +A E   G   Y    D WS G  + E+L G+  F  ES V+   +I+           
Sbjct: 175 LQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------- 221

Query: 293 KCMNPNYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHP 349
                N+ E F+FP              +  EA DL+ RL+        R+   +   HP
Sbjct: 222 -----NHKEHFQFPPD---------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267

Query: 350 FFDELRDPNTRLPNGRFLP 368
           FF+ +   N R     ++P
Sbjct: 268 FFEGIDWDNIRNSTAPYVP 286

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 31/214 (14%)

Query: 71  RVVGHGSFGVVFQAK-CLETGE--AVAIKKVLQDKRYKNREL-----QTMRLLDHPNVVS 122
           R +G G FG V+Q        E  AVA+K          RE        MR  DHP++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++  V+E  P    R      K    + L  + LY YQ+  ALAY+
Sbjct: 72  L----IGVITENPVWI--VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYL 123

Query: 183 HNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
            +   V HRDI  +N+LV +P    +KL DFG ++ L   E    Y  S+      + AP
Sbjct: 124 ESKRFV-HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAP 177

Query: 237 ELIFGATEYTAAIDIWSAG-CVLAELLLG-QPLF 268
           E I     +T+A D+W  G C+   L+LG +P  
Sbjct: 178 ESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 70/277 (25%), Positives = 128/277 (46%), Gaps = 45/277 (16%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD-------H--PNVVSL 123
           +G G+ G V++ +  +TG  +A+K++   +R  N+E     L+D       H  P +V  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLYFYQICRALAYI 182
              F + ++     + + +E +   + +++K   ++   +P  I  K+    I +AL Y+
Sbjct: 80  YGYFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMT-VAIVKALHYL 130

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFG 241
               GV HRD+KP N+L++  +  +KLCDFG +  LV  +    S  C+ Y  APE I  
Sbjct: 131 KEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDP 188

Query: 242 AT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT-----PTREE-- 291
                +Y    D+WS G  L EL  GQ  FP ++   +   + K+L       P  E   
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246

Query: 292 -------IKCMNPNYTEF-KFPQIKAHPWHKIFQKRM 320
                    C+  ++ +  K+ ++  HP+ + ++   
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 88/335 (26%), Positives = 135/335 (40%), Gaps = 66/335 (19%)

Query: 56  GKNGQPKQTISYMA-ERV--VGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNR 107
                P    S    ERV  +G G+ G V++     TG   A+K +  +     +R   R
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR 121

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRM 163
           E++ +R ++HPNVV     F    E     + ++LE++     E  H  I     ++   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGE-----IQVLLEFMDGGSLEGTH--IADEQFLAD-- 172

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-E 222
                     QI   +AY+H    + HRDIKP NLL+N     +K+ DFG +++L +  +
Sbjct: 173 -------VARQILSGIAYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD 223

Query: 223 PNISYICSRYYRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQ 276
           P  S + +  Y +PE I      GA +  A  DIWS G  + E  LG+ P   G  G D 
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGRFPFGVGRQG-DW 281

Query: 277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 336
              +  +          CM+        P+  A             E    +S  LQ  P
Sbjct: 282 ASLMCAI----------CMSQP------PEAPAT---------ASREFRHFISCCLQREP 316

Query: 337 NLRSTALEALIHPFFDELRDPNTRLPNGR--FLPP 369
             R +A++ L HPF    +    +        LPP
Sbjct: 317 AKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPP 351

Length = 353

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.5 bits (177), Expect = 1e-13
 Identities = 69/248 (27%), Positives = 115/248 (46%), Gaps = 37/248 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G+G FG VF  K   T E    K +      +R K++   E+  MR L H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V     F +   + +LY+  ++E+     + R I+  YKM  ++    +     Q+  AL
Sbjct: 75  VRYIDRFLNKANQ-KLYI--LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 180 AYIHNTIG------VCHRDIKPQNLLVNPHTHQL----------------KLCDFGSAKV 217
           AY HN         V HRD+KPQN+ ++     +                K+ DFG +K 
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 218 LVKGEPNISYIC--SRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           +  G  ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   +  
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249

Query: 275 DQLVEIIK 282
            QL+  +K
Sbjct: 250 SQLISELK 257

Length = 1021

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 85/324 (26%), Positives = 140/324 (43%), Gaps = 68/324 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG          E +  K  +     ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 57

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 58  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 107

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 213

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255

Query: 353 ELRDPNTRLPNGRFLPPLFNFKPH 376
            +   +  +   + LPP   FKP 
Sbjct: 256 SINWQD--VVQKKLLPP---FKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 71  RVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDKRYKNR-------ELQTMRLLDHPNVVS 122
           R +G GSFG V  A    E    VAIK+  + K  K +       E + +  ++HP  V+
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   F     KDE YL LVLE+V   +        + ++R P      Y  QI     Y+
Sbjct: 96  LYGSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
             ++ + +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++  
Sbjct: 148 Q-SLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF 268
                AA D W+ G  + E+L+G P F
Sbjct: 203 VGHGKAA-DWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 87/311 (27%), Positives = 137/311 (44%), Gaps = 44/311 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 130
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 131 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           T     +DE YL LV++Y       ++    K   R+P    + Y  ++  A+  IH   
Sbjct: 65  TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF---- 240
            V HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+                N+ 
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 224

Query: 301 E-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDELRDP 357
           E F+FP   +H         +  EA DL+ RL+      L    +E    H FF+ +   
Sbjct: 225 ERFQFP---SH------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275

Query: 358 NTRLPNGRFLP 368
           N R     ++P
Sbjct: 276 NIRNLEAPYIP 286

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 69.1 bits (170), Expect = 3e-13
 Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 64/271 (23%)

Query: 95  IKKVLQDKRYKNREL---QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----- 146
           ++K+++ K +   E    Q M+  D+PN + L +    TT K  +   L+++Y+      
Sbjct: 45  VQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLF 97

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ 206
           + +        K   ++    VK    Q+  AL  +H    + H DIK +N+L +    +
Sbjct: 98  DLL--------KKEGKLSEAEVKKIIRQLVEALNDLHKHNII-HNDIKLENVLYDRAKDR 148

Query: 207 LKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAEL 261
           + LCD+G  K  + G P      S Y     Y +PE I G   Y  + D W+ G +  EL
Sbjct: 149 IYLCDYGLCK--IIGTP------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYEL 199

Query: 262 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP 321
           L G+   P +   D   E +         +++ +     + K P          F K + 
Sbjct: 200 LTGK--HPFKEDED---EEL---------DLESLLKRQ-QKKLP----------FIKNVS 234

Query: 322 PEAVDLVSRLLQYSPNLRSTALEALI-HPFF 351
             A D V  +L+Y+ N R T    +I HPF 
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 25/239 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 124
           +G G FG V   +   TG+  A KK L  KR K +  + M LL+         P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQICRALAYI 182
           + F S T     +L LV+  +       +K+H Y + +R + +  V  Y  QI   + ++
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGD---LKYHIYNVGERGLEMERVIHYSAQITCGILHL 111

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H ++ + +RD+KP+N+L++      +L D G A  L  G+       +  Y APE I   
Sbjct: 112 H-SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
             Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  + N+TE
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.0 bits (168), Expect = 4e-13
 Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 28/253 (11%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL+  +V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTETCMDEGQ--------IAA 120

Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236

Query: 290 EEIKCMNPNYTEF 302
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 32/213 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-----RLLDHPN---VVS 122
           RV+G G FG V   +   TG+  A KK L+ KR K R+ + M     R+L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKM------SQRMPLIYVKLYFYQI 175
           L + +     KD L L L +    +     +K H Y M       QR        Y  ++
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGD-----LKFHIYNMGNPGFDEQR-----AIFYAAEL 111

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           C  L  +     + +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y A
Sbjct: 112 CCGLEDLQRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMA 169

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           PE+I    +YT + D W  GC++ E++ GQ  F
Sbjct: 170 PEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 87/376 (23%), Positives = 131/376 (34%), Gaps = 118/376 (31%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           + +G G+FG V   + ++T    A+K  L+      R        E   +   D+  VV 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   ++S  +KD LY   V++Y+P  + +  +I+              + Y  ++  A+ 
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRLGI-----FEEDLARFYIAELTCAIE 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPH----------------THQLKL--------------- 209
            +H  +G  HRDIKP N+L++                  TH  K                
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 210 --------CDFGSAKVLVK------------GEPNISYICSRYYRAPELIFGATEYTAAI 249
                   C     +   K            G PN        Y APE++   T YT   
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLC 225

Query: 250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 309
           D WS G +L E+L+GQP F  +              TP   ++K +N   T    P    
Sbjct: 226 DWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE-TTLHIP---- 266

Query: 310 HPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFF-------DELRDPNT 359
                  Q ++  EA DL+ RL       R   + A E   HPFF          R    
Sbjct: 267 ------SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAP 319

Query: 360 RLPNGRFLPPLFNFKP 375
            +P         NF P
Sbjct: 320 YIPKITHPTDTSNFDP 335

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 77/288 (26%), Positives = 119/288 (41%), Gaps = 46/288 (15%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ETG  +A  KV+  K  +       E+  +   DHPN+V L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    +     P I  ++   Q   AL Y+H    
Sbjct: 72  YY-----ENNLWILIEFCAGGAVDAVMLELERPLTEPQI--RVVCKQTLEALNYLHEN-K 123

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 124 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 245 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y    D+WS G  L E+   +P                    P  E    +NP     
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLL 218

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           K    K+ P       R   E  D + + L+ + + R T  + L HPF
Sbjct: 219 KIA--KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++A+ L TGE  A+K +      D     +E+  ++   H N+V+    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIHN 184
           S   +++L+  + +EY      + I H       + + YV       CR     LAY+H 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYV-------CRETLQGLAYLH- 123

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           + G  HRDIK  N+L+  +   +KL DFG +AK+        S+I + Y+ APE+   A 
Sbjct: 124 SKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAV 180

Query: 244 E----YTAAIDIWSAGCVLAELLLGQP 266
           E    Y    DIW+ G    EL   QP
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 83/343 (24%), Positives = 145/343 (42%), Gaps = 60/343 (17%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---ELQTM---RLLDHPNVVSLKH 125
           ++G G+FG V +A   +  E  A+K V    +Y      E+Q M   R  D  +   L  
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 126 C--FFSTTEKDELYLNLVL-EYVPETVHRVIKH----HYKMSQRMPLIYVKLYFYQICRA 178
              +F   + +  ++ +V+ +Y P  +  ++KH    H  ++Q           +Q   A
Sbjct: 196 IQRYF---QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ---------IIFQTGVA 243

Query: 179 LAYIHNTIGVCHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKVLVKGEP 223
           L Y H  + + H D+KP+N+L       V+P T++        +++CD G      +   
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHS 301

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
             + + +R+YR+PE++ G   +  + D+WS GC++ EL  G+ L+     ++ L  + K 
Sbjct: 302 RTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360

Query: 284 LGT-PTREEIKCMNPN----YTEFKFPQIKAHPWH--KIFQKRMPPEAV------DLVSR 330
           LG  P+    +C        Y      +    P H  +I + R   E +      DL+  
Sbjct: 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420

Query: 331 LLQYSPNLRSTALEALIHP----FFDELRDPNTRLPNGRFLPP 369
           LL Y    R  A +   HP    ++ E R       N   L P
Sbjct: 421 LLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRP 463

Length = 467

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 61/206 (29%), Positives = 86/206 (41%), Gaps = 34/206 (16%)

Query: 88  ETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN 139
            TG  VAIK +  D         R++ RE      L HPN+V+L      + E     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
            V EYVP    R ++        +P         Q+  ALA  HN  G+ HRD+KPQN++
Sbjct: 56  AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 200 VN-----PHTHQLKLCDFGSAKVLVKGEPNI--------SYICSRYYRAPELIFGATEYT 246
           V+     PH    K+ DFG   +L                 + +  Y APE + G    T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167

Query: 247 AAIDIWSAGCVLAELLLGQPLFPGES 272
              D+++ G +  E L GQ +  G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 49/302 (16%)

Query: 82  FQAKCLE--TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN 139
           F   C++  T E V IK     +     E   +R ++HP+++ LK  F         Y  
Sbjct: 107 FAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--------TYNK 156

Query: 140 LVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
                +P   ++   + Y  ++R + +  +      + RA+ Y+H    + HRDIK +N+
Sbjct: 157 FTCLILPR--YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENI 213

Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY--------RAPELIFGATEYTAAID 250
            +N H   + L DFG+A   V    N      +YY         APEL+     Y  A+D
Sbjct: 214 FIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGPAVD 265

Query: 251 IWSAGCVLAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           IWSAG VL E+         + G+D       Q+  II+  GT   E       N  E  
Sbjct: 266 IWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIY 325

Query: 304 FPQIK-------AHP-WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               K       + P W  +++  +P +   L+ ++L +  + R +A   L    F ++ 
Sbjct: 326 IGLAKKSSRKPGSRPLWTNLYE--LPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383

Query: 356 DP 357
           DP
Sbjct: 384 DP 385

Length = 391

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 71/303 (23%), Positives = 123/303 (40%), Gaps = 46/303 (15%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE--- 132
           GS G VF A      + V +K  +  K     E   ++ ++HP+V+ +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134

Query: 133 -----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
                  +LY  L                   S+ +P+    +   QI   L Y+H    
Sbjct: 135 VLPHYSSDLYTYLTKR----------------SRPLPIDQALIIEKQILEGLRYLHAQ-R 177

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
           + HRD+K +N+ +N    Q+ + D G+A+  V     +    +    APE +    +Y +
Sbjct: 178 IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNS 235

Query: 248 AIDIWSAGCVLAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEI 292
             DIWSAG VL E+L             P    +S    L++II  L       P     
Sbjct: 236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           + +   + E+   + + +  +  FQ+  +P +   LV ++L +   +R +A E L +P F
Sbjct: 296 R-LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354

Query: 352 DEL 354
            +L
Sbjct: 355 AQL 357

Length = 357

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 19/218 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 124
           V+G GSFG V  A+   T E  AIK      V+QD   +    E + + L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +  +   R    +   Y  +I   L ++H+
Sbjct: 67  HSCFQTM--DRLYF--VMEYVNGGD---LMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I    
Sbjct: 120 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-AYQ 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 21/217 (9%)

Query: 67  YMAERVVGHGSFGVVFQA-KCLETGEAVAIKKV-LQDKR---YKNRELQTMRLLDHPNVV 121
           Y+   +VG       F A +  +  E V  K V L D+R   Y   EL  +   DH  +V
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 122 SLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRA 178
             KH  F   + D+  L L++EY     +++ IK   ++ + +P     V L FYQI  A
Sbjct: 129 --KH--FDDFKSDDKLL-LIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLA 181

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRA 235
           L  +H+   + HRD+K  N+ + P T  +KL DFG +K     V  +   S+  + YY A
Sbjct: 182 LDEVHSR-KMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL +    Y+   D+WS G +L ELL     F G S
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 73/302 (24%), Positives = 123/302 (40%), Gaps = 42/302 (13%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-----MRLL 115
           P  + ++     +G G++G VF+    + G   A+K +L      + E++        L 
Sbjct: 14  PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           DHPNVV     ++    K+   L LVLE     +V  ++K   K  +RM    +    ++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYY 233
               L ++H    + HRD+K  N+L+      +KL DFG SA++        + + + ++
Sbjct: 133 ALMGLQHLHVNKTI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 234 RAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
            APE+I       + Y A  D+WS G    EL  G P                    P  
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP--------------------PLA 230

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLVSRLLQYSPNLRSTALEALIH 348
           +    ++P    FK P+   +P   + Q  +   E  D + + L      R T  + L H
Sbjct: 231 D----LHPMRALFKIPR---NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283

Query: 349 PF 350
            F
Sbjct: 284 VF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 16/219 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   RV+G G+ G V  AK +  GE  A+K V        DK     E+  +   D  ++
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 121 VSLKHCFFSTTEKDE---LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           V     F     ++    L + LVL+Y     + + IK   K ++        L F Q+ 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYY 233
            A+ ++H+   + HRDIK  N+L+  +   +KL DFG +K+    V  +   ++  + YY
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            APE I+    Y+   D++S G +L ELL  +  F GE+
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 82/315 (26%), Positives = 138/315 (43%), Gaps = 52/315 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-----LLDHPN--VVSL 123
           +V+G G+FG V   K     +  A+K + + +  K  E    R     L++  N  + +L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            + F     +DE  L LV++Y       ++    K   R+P    + Y  ++  A+  +H
Sbjct: 67  HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF- 240
             +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 120 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 241 ---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
              G  +Y    D WS G  + E+L G+  F  ES V+   +I+                
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------------- 221

Query: 298 NYTE-FKFP-QIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDE 353
           N+ E F+FP Q+            +  +A DL+ RL+      L    +E    HPFF  
Sbjct: 222 NHKERFQFPAQV----------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271

Query: 354 LRDPNTRLPNGRFLP 368
           +   N R     ++P
Sbjct: 272 IDWDNIRNCEAPYIP 286

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 68/295 (23%), Positives = 128/295 (43%), Gaps = 48/295 (16%)

Query: 67  YMAERVVGHGSFGVVF--QAKCLETGEAVAIKKVL-------QDKRYKNRELQTMRLLDH 117
           Y+ ++ +G GSFG V+  + K     E + + K +        +    N+E Q +  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           P +V     F    E+D   +  + EY     +   ++      + +    V  +F Q+ 
Sbjct: 62  PAIVKFHASFL---ERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRA 235
             + Y+H    + HRD+K +N+ +    + LK+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE +     Y +  DIWS GC+L E+      F G+   + L  +++++  PT       
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPT------- 222

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            P+  E                     +   ++  +L   P+LR +A E L +PF
Sbjct: 223 -PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             K      TE     + L++E++P     E + R  K+   + Q++       Y  QIC
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLK------YAVQIC 119

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----- 231
           + + Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   E +  Y   +     
Sbjct: 120 KGMDYLGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDS 174

Query: 232 --YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             ++ APE +  +  Y A+ D+WS G  L ELL
Sbjct: 175 PVFWYAPECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 84/326 (25%), Positives = 133/326 (40%), Gaps = 79/326 (24%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 126
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   +   +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIHQ 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------------------------- 213
            +G  HRDIKP NLL++   H +KL DFG                               
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 214 ---SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               A+   K    ++Y  + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 269 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLV 328
             E              TP     K MN   T   FP     P   I +K     A DL+
Sbjct: 237 CSE--------------TPQETYRKVMNWKET-LVFP-----PEVPISEK-----AKDLI 271

Query: 329 SRLLQYSPN-LRSTALEALI-HPFFD 352
            R    S N + S  +E +  HPFF+
Sbjct: 272 LRFCTDSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 14/205 (6%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 127
           +G G++G V++    + G   A+K +L      + E++        L +HPNVV     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +   +     L LVLE     +V  ++K      QR+    +    Y     L ++HN  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            + HRD+K  N+L+      +KL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 246 T----AAIDIWSAGCVLAELLLGQP 266
                A  D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHC 126
            VVG+G++G V++ + ++TG+  AIK   V +D+  + +    M  +   H N+ +    
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 127 FFSTT---EKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           F   +     D+L+  LV+E+     V + V     +  K        ++     +I R 
Sbjct: 82  FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED------WIAYICREILRG 133

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAP 236
           LA++H    V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ AP
Sbjct: 134 LAHLH-AHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAP 190

Query: 237 ELIF----GATEYTAAIDIWSAGCVLAELLLGQP 266
           E+I         Y    DIWS G    E+  G P
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 50/286 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  P     +     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLGG------GSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           Y +  DIWS G    EL  G+P                    P  +    M+P    F  
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--------------------PNSD----MHPMRVLFLI 213

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           P+         F K       + +   L   P+ R TA E L H F
Sbjct: 214 PKNNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 69/301 (22%), Positives = 126/301 (41%), Gaps = 50/301 (16%)

Query: 76  GSFGVVFQAKCLETGEAV---AIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           GS G VF   C + G+      I K +   +   RE+  ++ + H  +++L H +     
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155

Query: 133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD 192
               + + V   +P+    +  +  +    +PL        ++  ALAY+H   G+ HRD
Sbjct: 156 ---RWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHGR-GIIHRD 210

Query: 193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTA 247
           +K +N+ ++   + + L DFG+A  L       +  C  +       +PEL+     Y A
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266

Query: 248 AIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---- 302
             DIWSAG VL E+ +    LF  +         +K   +  R  I+CM  +  EF    
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQ---------VKSSSSQLRSIIRCMQVHPLEFPQNG 317

Query: 303 ---------KFPQIKAHPWH--KIFQKRMPPEAVD-LVSRLLQYSPNLRSTALEALIHPF 350
                    ++  +   P+    + +K      V+ L++++L +    R +A + L  P 
Sbjct: 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377

Query: 351 F 351
           F
Sbjct: 378 F 378

Length = 392

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKK-----VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
             +G G+FG V++   L+    VA+K          KR   +E + ++  DHPN+V L  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-- 183
                 +K  +Y+  V+E VP     ++    K   R+ +  +          + Y+   
Sbjct: 58  -IGVCVQKQPIYI--VMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------AP 236
           N I   HRD+  +N LV    + LK+ DFG    + + E    Y  S   +       AP
Sbjct: 113 NCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 272
           E L +G   YT+  D+WS G +L E   LG   +PG S
Sbjct: 165 EALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 48/293 (16%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 127
           +VG+G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 128 FSTTE---KDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    D+L+  LV+E+    +V  +IK+       +   ++     +I R L+++H
Sbjct: 73  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH 128

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 240
               V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 129 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185

Query: 241 ---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
                  Y    D+WS G    E+  G P       +  L  I +             NP
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------------NP 232

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                  P++K+  W K FQ          +   L  + + R T  + + HPF
Sbjct: 233 A------PRLKSKKWSKKFQS--------FIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 52/244 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 126
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    +L   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------------------- 224
            +G  HRDIKP NLL++   H +KL DFG    L K                        
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 225 ----------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
                            S + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 269 PGES 272
             E+
Sbjct: 237 CSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 58.9 bits (142), Expect = 7e-10
 Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 50/286 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 72  LKDTK-----LWIIMEYLGG------GSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATE 244
             + HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + ++ APE+I   + 
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           Y +  DIWS G    EL  G+P                    P  E    ++P    F  
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--------------------PHSE----LHPMKVLFLI 213

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           P+         + K +     + V   L   P+ R TA E L H F
Sbjct: 214 PKNNPPTLEGNYSKPLK----EFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 57/248 (22%)

Query: 73  VGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKN-----RELQTMRLL-DHPNVV 121
           +G G+FG V +A+ +          VA+K +  D   K+      E++ M+++  H N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYF-- 172
           +L       T++  LY+  V+EY             R    +       P     L    
Sbjct: 80  NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE-TLTQKD 133

Query: 173 -----YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
                YQ+ R + ++ +     HRD+  +N+LV    H +K+ DFG A+       +I +
Sbjct: 134 LVSFAYQVARGMEFLASK-KCIHRDLAARNVLVT-EDHVMKIADFGLAR-------DIHH 184

Query: 228 ICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
           I   YYR            APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 185 I--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V 240

Query: 275 DQLVEIIK 282
           ++L +++K
Sbjct: 241 EELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 37/228 (16%)

Query: 73  VGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 124
           +G GSFGVV + +   +G     VA+K +  DK         +E   M  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 125 HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
               +        L +V E  P     + + +    H+       +  +  Y  QI   +
Sbjct: 63  GVVLTHP------LMMVTELAPLGSLLDRLRKDALGHF------LISTLCDYAVQIANGM 110

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
            Y+ +   + HRD+  +N+L+     ++K+ DFG  + L + E +  Y+   + +     
Sbjct: 111 RYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAW 166

Query: 235 -APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 280
            APE +   T ++ A D+W  G  L E+   G+  + G SG   L +I
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 30/226 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE     VAIK + ++   K       E   M  +DHP+VV
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     S+       + L+ + +P    +  V  H   +  +  L +      QI + +
Sbjct: 73  RLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV----QIAKGM 122

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
           +Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 123 SYLEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 181 ESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 70/297 (23%), Positives = 119/297 (40%), Gaps = 65/297 (21%)

Query: 70  ERVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 119
            R +G GSFG+V++  AK +  GE    VAIK V ++   + R     E   M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR---------MPLIYVKL 170
           VV L      +T +  L   +V+E + +   +     Y  S+R          P    K 
Sbjct: 71  VVRLLG--VVSTGQPTL---VVMELMAKGDLK----SYLRSRRPEAENNPGLGPPTLQKF 121

Query: 171 YFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
                +I   +AY+       HRD+  +N +V      +K+ DFG  +       +I   
Sbjct: 122 IQMAAEIADGMAYLAAK-KFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DIYE- 171

Query: 229 CSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
            + YYR            APE +     +T   D+WS G VL E+  L +  + G S  +
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-E 228

Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
           ++++ +   G     E  C +      +        W   +  +M P  +++VS L 
Sbjct: 229 EVLKFVIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 26/207 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     +K+ ++   E   M   DHPN++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     T  K  +   +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMK 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 177

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 66/242 (27%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIK--------KVLQDKRYKNR 107
           P   + ++ E  +G G+FG V++ +        +  +VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQ----- 161
           E + M  L HPN+V    C      K++    L  EY+    +H  +  +   S      
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 162 -----RMPLIYVKLY--FYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 212
                +  L          QI   + Y+  H+     HRD+  +N LV      +K+ DF
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISDF 168

Query: 213 GSAKVLVKGEPNISYICSRYYR------------APELI-FGATEYTAAIDIWSAGCVLA 259
           G ++ +   +         YYR             PE I +G  ++T   DIWS G VL 
Sbjct: 169 GLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLW 217

Query: 260 EL 261
           E+
Sbjct: 218 EI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 67/221 (30%)

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             QI  AL  +H+T G+ HRD+KPQN++ +  +   K+ D G+A  L  G   I+YI   
Sbjct: 261 MRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKE 316

Query: 232 Y-----YRAPELIFGATEYTAA---------------------IDIWSAGCVLAELLLGQ 265
           +     Y APE    +T+  +A                      DI+SAG     L+  Q
Sbjct: 317 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQ 371

Query: 266 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP--- 322
             FP       L++           ++K  + +             W K+ + R  P   
Sbjct: 372 MAFPNLRSDSNLIQF--------NRQLKRNDYDLVA----------WRKLVEPRASPDLR 413

Query: 323 ---EAVD--------LVSRLLQYSPNLRSTALEALIHPFFD 352
              E +D        L+  ++++    R +A  AL HP+FD
Sbjct: 414 RGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 44/229 (19%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDH 117
           P++++    ER +G G FG V+      T + VA+K +           +E Q M+ L H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYV-----------PETVHRVIKHHYKMSQRMPLI 166
             +V L   +   +E++ +Y+  V EY+            E     +     M+      
Sbjct: 61  DKLVQL---YAVCSEEEPIYI--VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA----- 110

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
                  QI   +AY+ +     HRD+  +N+LV  +    K+ DFG A+++   E   +
Sbjct: 111 -------QIAEGMAYLESR-NYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTA 160

Query: 227 YICSRY---YRAPELI-FGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
              +++   + APE   +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 161 REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 72/296 (24%), Positives = 113/296 (38%), Gaps = 70/296 (23%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG V++     T E VAIK + L++   +     +E+  +   D P +      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL   Y+     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLGG------GSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 121 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           Y    DIWS G    EL  G+P                                      
Sbjct: 178 YDFKADIWSLGITAIELAKGEP-------------------------------------- 199

Query: 305 PQIKAHPWHKIF--QKRMPPEA--------VDLVSRLLQYSPNLRSTALEALIHPF 350
           P    HP   +F   K  PP           + V   L   P  R TA E L H F
Sbjct: 200 PNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.6 bits (134), Expect = 9e-09
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 32/229 (13%)

Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVV 121
           +++M E  +G G FGVV   K       VAIK + +    +     E + M  L HP +V
Sbjct: 6   LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L   +   T++  LY+  V E++     ++ + +   K+S+ M L   +     +C  +
Sbjct: 63  QL---YGVCTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGM 113

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YY 233
            Y+       HRD+  +N LV+  T  +K+ DFG  + ++  E    Y  S        +
Sbjct: 114 EYLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKW 167

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII 281
             PE +F  ++Y++  D+WS G ++ E+   G+  F  +S   ++VE+I
Sbjct: 168 SPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 19/161 (11%)

Query: 76  GSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKN--RELQTMR----LLDHPNVVSLKHCFF 128
           G+FG V+  +     +  A+K V + D   KN   ++Q  R    L   P +V L   ++
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           S    + +YL  V+EY+     + + H Y    + M + Y+     ++  AL Y+H   G
Sbjct: 72  SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-G 124

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           + HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 60/217 (27%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 72  VVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 121
            +G G FG VF AK      E GE + + K LQ  + +N      REL   R L H NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYV-KLYF-YQI 175
            L        E +  Y  ++LEY      +   R  K   +  +  PL    K+    QI
Sbjct: 72  RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
              + ++ N   V HRD+  +N LV   + Q +       KV +       Y  S YY+ 
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLV---SSQRE------VKVSLLSLSKDVY-NSEYYKL 175

Query: 235 ----------APELIFGATEYTAAIDIWSAGCVLAEL 261
                     APE +    +++   D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 60/235 (25%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRL---LDHPNVVSL 123
           R++G G  G V+ A        VA+KK+ +D       K R L+  ++   L HP +V +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIK-----------HHYKMSQRMPLIYVKLY 171
              +   ++ D +Y    + Y+   T+  ++K              K S       V  +
Sbjct: 68  ---YSICSDGDPVYYT--MPYIEGYTLKSLLKSVWQKESLSKELAEKTS-------VGAF 115

Query: 172 ---FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV----------L 218
              F++IC  + Y+H+  GV HRD+KP N+L+      + L D+G+A            +
Sbjct: 116 LSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDI 173

Query: 219 VKGEPNISY---------ICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELL 262
              E NI Y         + +  Y APE + G  A+E T   DI++ G +L ++L
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 16/165 (9%)

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 286
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
             +E  +   P+YT  +  Q     WH    +R  P   +LV  L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 56/244 (22%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKC--LETGEA---VAIKKVLQD------KRYKNREL 109
            + TI     R +G G+FG VF  +C  LE       VA+ K L++      ++   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-------YKMSQ 161
           + +    H N+V         TE D     +V EY+    +++ ++ H            
Sbjct: 60  ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 162 RM-PLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            M  L   +L     QI   + Y+ +   V HRD+  +N LV  +   +K+ DFG ++ +
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV-HRDLATRNCLVG-YDLVVKIGDFGMSRDV 172

Query: 219 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELLL--G 264
                   Y    YYR             PE I     +T   D+WS G VL E+     
Sbjct: 173 --------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGK 222

Query: 265 QPLF 268
           QP +
Sbjct: 223 QPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 16/95 (16%)

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           Q+  A+ YIH   G+ HRDIK +N+LVN     + L DFG+A    +G    S+    +Y
Sbjct: 268 QLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320

Query: 234 --------RAPELIFGATEYTAAIDIWSAGCVLAE 260
                    APE++ G   YT ++DIWSAG V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 15/168 (8%)

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 286
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQ 333
             ++  +   P     +  +I    W    ++R      V+++  LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 38/227 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 127
           R +G G FG V++     T   VA+K +            E Q M+ L HP ++ L   +
Sbjct: 12  RKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---Y 67

Query: 128 FSTTEKDELYL-------NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
              T ++ +Y+         +LEY+     R +    K+ Q   LI +     Q+   +A
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL----KLPQ---LIDMAA---QVASGMA 117

Query: 181 YI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           Y+   N I   HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + A
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTA 172

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
           PE       ++   D+WS G +L E++  G+  +PG +   V Q V+
Sbjct: 173 PEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 36/217 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR----ELQTMRLLDHPNVVSLKH 125
           ER +G G FG V++         VAIK +  D   K +    E+Q ++ L H +++SL  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHY------KMSQRMPLIYVKLYFYQICRAL 179
            F   +  + +Y+      + E + +     +      ++     LI +     Q+   +
Sbjct: 68  -FAVCSVGEPVYI------ITELMEKGSLLAFLRSPEGQVLPVASLIDMA---CQVAEGM 117

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSRYYR 234
           AY+       HRD+  +N+LV       K+ DFG A+++     +  +  I Y     + 
Sbjct: 118 AYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWT 171

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 270
           APE       ++   D+WS G +L E+   GQ  +PG
Sbjct: 172 APEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 26/207 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++V+G G FG VF+      G    AVAIK +      K R     E   M    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     T  K  +   ++ EY+    + + ++ H        L+ +      I   + 
Sbjct: 70  RLEGVV--TKFKPAM---IITEYMENGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMK 121

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +   HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S       + A
Sbjct: 122 YLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTA 178

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 179 PEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 52.2 bits (125), Expect = 9e-08
 Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 55/241 (22%)

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L     S   +D ++L  VL++        +  H      +P   VK +  ++  
Sbjct: 45  PNMVCLHKYIVS---EDSVFL--VLQHAEGGK---LWSHISKFLNIPEECVKRWAAEMVV 96

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAP 236
           AL  +H    VC RD+ P N+L++   H ++L  F       + E +         Y AP
Sbjct: 97  ALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYCAP 151

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCM 295
           E + G +E T A D WS G +L ELL G+ L     SG++                    
Sbjct: 152 E-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT------------------- 191

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI-----HPF 350
              +T    P+             +  EA  L+ +LLQ++P  R  A  A +     HPF
Sbjct: 192 ---HTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236

Query: 351 F 351
           F
Sbjct: 237 F 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 29/208 (13%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V + +    G+    VAIK +     DK+  +   E   M   DHPN++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + ++ EY+   ++ + ++ +    +      V +    I   + 
Sbjct: 69  RLEGVVTKSRP-----VMIITEYMENGSLDKFLREN--DGKFTVGQLVGM-LRGIASGMK 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY------ICSRYYR 234
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+  
Sbjct: 121 YLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW-T 175

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 176 APEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 54/242 (22%)

Query: 71  RVVGHGSFGVVFQAKCLE-----TGEA-VAIKK-----VLQDKRYKNRELQTMRLLDHPN 119
             +G G+FG V++    +     +G   VA+K        Q+K+   +E   M   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 120 VVS-LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF---Y 173
           +V  L  C       +  Y  +++E +   + +   ++         PL+ +K       
Sbjct: 61  IVKLLGVCL----LNEPQY--IIMELMEGGDLLS-YLRDARVERFGPPLLTLKELLDICL 113

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNISYIC 229
            + +   Y+     + HRD+  +N LV+   +     +K+ DFG A+ + K         
Sbjct: 114 DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--------- 163

Query: 230 SRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
           S YYR            APE L+ G   +T   D+WS G ++ E+L LGQ  +P  +  +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221

Query: 276 QL 277
            L
Sbjct: 222 VL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 23/202 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPN---VVSLK 124
           +G G FG V   +   TG+  A KK L  KR K R+     +   R+L   +   +VSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP-LIYVKLYFY--QICRALAY 181
           + F + T+     L LV+  +     R   H Y + +  P     +  FY  QI   L +
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRY--HIYNVDEENPGFPEPRACFYTAQIISGLEH 112

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 240
           +H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + APEL+ 
Sbjct: 113 LHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 241 GATEYTAAIDIWSAGCVLAELL 262
           G  EY  ++D ++ G  L E++
Sbjct: 171 G-EEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 30/201 (14%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FGVV   K     + VAIK + +    ++    E + M  L HPN+V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67

Query: 130 TTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            T++  ++  +V EY+         R  K        + +         +C A+ Y+ + 
Sbjct: 68  CTKQRPIF--IVTEYMANGCLLNYLRERKGKLGTEWLLDMC------SDVCEAMEYLESN 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-----APELIF 240
            G  HRD+  +N LV    + +K+ DFG A+ ++  +    Y  S+  +     AP  +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173

Query: 241 GATEYTAAIDIWSAGCVLAEL 261
             + +++  D+WS G ++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYK-NREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE     VAIK++ +    K N+E+      M  +D+P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E    +   +           +  +  QI + 
Sbjct: 73  RLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-----------LLNWCVQIAKG 121

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+     V HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 122 MNYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 180 LESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 41/281 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEA---VAIKKV-----LQDKRYKNRELQTMRLLDHPNVVS 122
           RV+G G FG V+    +++       A+K +     L++     +E   M+   HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAY 181
           L           E    +VL Y+    H  +++  +     P +   + F  Q+ + + Y
Sbjct: 61  L----LGICLPSEGSPLVVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL--I 239
           + +   V HRD+  +N +++  +  +K+ DFG A+ +   E    Y     +   +L   
Sbjct: 114 LASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVK 167

Query: 240 FGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           + A E      +T   D+WS G +L EL+  G P +P     D  V +++  G    +  
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQPE 225

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 333
            C +P Y      ++    WH   +  M P   +LVSR+ Q
Sbjct: 226 YCPDPLY------EVMLSCWHP--KPEMRPTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEA-----VAIKKVLQDKRYKNR-----ELQTMRLL-DHPN 119
           + +G G+FG V +A      ++     VA+K +        R     EL+ M  L +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRA 178
           +V+L     + T    + +  + EY       ++    +  +    +   L F YQ+ + 
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           +A++ +   + HRD+  +N+L+  H   +K+CDFG A+ ++     +    +R    + A
Sbjct: 154 MAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           PE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 212 PESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 37/216 (17%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHC 126
           ++G G+FG VF+   L+    VA+K   +D  +  K + L   R+L   DHPN+V L   
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 127 FFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
               T++  +Y  +V+E VP     +  R  K   K  Q +       +       +AY+
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAP 236
            +     HRD+  +N LV    + LK+ DFG    + + E +  Y  S        + AP
Sbjct: 110 ESK-NCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAP 163

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           E L +G   Y++  D+WS G +L E   LG   +PG
Sbjct: 164 EALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 26/199 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 130 TTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            T++  +Y  +V EY+         R     ++ SQ + +         +C  +AY+ + 
Sbjct: 68  CTKQRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQLLEMC------KDVCEGMAYLESK 119

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 242
               HRD+  +N LV+     +K+ DFG ++ ++  E   S + S++   +  PE +   
Sbjct: 120 -QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLY 175

Query: 243 TEYTAAIDIWSAGCVLAEL 261
           +++++  D+W+ G ++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 50/237 (21%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQ 110
           P+  I Y   R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 3   PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 111 TMRLLDHPNVVSL--------KHC----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
            M   DHPN+V L          C    + +  + +E   +          H        
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 159 MSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
               +PL   +      Q+   +AY+     V HRD+  +N LV  +   +K+ DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSR 178

Query: 217 VLVKGEPNISYICSRYYRA------------PELIFGATEYTAAIDIWSAGCVLAEL 261
                  NI    + YY+A            PE IF    YT   D+W+ G VL E+
Sbjct: 179 -------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 19/108 (17%)

Query: 173 YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 223
            Q+ + + ++   N I   HRD+  +N+L+       K+CDFG A+        +VKG  
Sbjct: 219 SQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            +       + APE IF    YT   D+WS G +L E+  LG+  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 54/290 (18%)

Query: 71  RVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 121
           R++G G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNV+
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ------RMPLIYVKLYFYQI 175
            L      +  K  L + +V+  +P   H  +     MS+       +PL  +  +   I
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSRYY 233
              + Y+ +     HRD+  +N ++N     + +C  DFG +K +  G+         YY
Sbjct: 123 ASGMEYLSSK-NFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD---------YY 169

Query: 234 R---APELIFG--ATE------YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEII 281
           R   A +L     A E      YT   D+W+ G  + E++  GQ  + G    +    +I
Sbjct: 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229

Query: 282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
           K  G   ++   C+   Y      ++    W    + R  P    L  +L
Sbjct: 230 K--GNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 73/300 (24%), Positives = 132/300 (44%), Gaps = 55/300 (18%)

Query: 73  VGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 119
           +G G FG V  A+ L       +    VA+K +  D   K+      E++ M+++  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV---------IKHHYKMSQ--RMPLIYV 168
           +++L     + T+   LY+  ++EY  +   R          +++ Y +++     + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 169 KLY--FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
            L    YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +   NI 
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFG----LARDVNNID 191

Query: 227 YICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
           Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF 249

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQYSPN 337
           +++K  G    +   C N  Y   +        WH I   R    + V+ + R+L  + N
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.1 bits (119), Expect = 7e-07
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            L     S T      + LV + +P     + VH   +H   +  ++ L +      QI 
Sbjct: 73  RLLGVCLSPT------IQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWC----VQIA 119

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---Y 233
           + + Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    +
Sbjct: 120 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLL--GQP 266
            A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 178 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 53/238 (22%), Positives = 105/238 (44%), Gaps = 49/238 (20%)

Query: 71  RVVGHGSFGVVFQAKCLE-TGEA----VAIKKVLQDK-----RYKNRELQTMRLLDHPNV 120
           + +G G FG V +A      G A    VA+K + ++      R    E   ++ ++HP+V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL---------- 170
           + L   + + ++   L L  ++EY     +  ++   + S+++   Y+            
Sbjct: 66  IKL---YGACSQDGPLLL--IVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 171 --------------YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
                         + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 217 VLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            + + +  +     R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 36/202 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---ELQTMRLLDHPNVVSLKHCFFS 129
           +G G FG V        G+ VA+K +  D         E   M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 130 TTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             + + LY  +V EY+      + +    +    ++Q++       +   +C  + Y+  
Sbjct: 71  --QGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQL------GFALDVCEGMEYLEE 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 239
                HRD+  +N+LV   +  L  K+ DFG AK     E +      +    + APE +
Sbjct: 121 K-NFVHRDLAARNVLV---SEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171

Query: 240 FGATEYTAAIDIWSAGCVLAEL 261
               +++   D+WS G +L E+
Sbjct: 172 -REKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 45/222 (20%)

Query: 72  VVGHGSFGVVFQAKCLETG----EAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 122
           ++  G+FG +F    ++      E V +K V              E   +  L H N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 123 LKHCFFSTTEKDELYL------NLVL-----EYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           + H      E   +        NL L             + +      S +  L+++ + 
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL------STQQ-LVHMAI- 124

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 229
             QI   ++Y+H   GV H+DI  +N +++    Q+K+ D   ++ L   +    Y C  
Sbjct: 125 --QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCLG 176

Query: 230 ---SRYYR--APELIFGATEYTAAIDIWSAGCVLAELL-LGQ 265
              +R  +  A E +    EY++A D+WS G +L EL+ LGQ
Sbjct: 177 DNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 22/168 (13%)

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K +P+  Y+  
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK-DPD--YVRK 232

Query: 231 RYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKV 283
              R      APE IF    YT   D+WS G +L E+  LG   +PG       V+I + 
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284

Query: 284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                +E  +   P Y   +   I    WH   + R  P   +LV  L
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR--PTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 81/348 (23%), Positives = 135/348 (38%), Gaps = 87/348 (25%)

Query: 72  VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 123
           V+G G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +  F +  E     L +V  ++     + +I  H+     M  + +      + +AL YI
Sbjct: 65  RATFIADNE-----LWVVTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYI 117

Query: 183 HNTIGVCHRDIKPQNLLVN-----------------PHTHQLKLC-DFG--SAKVLVKGE 222
           H+ +G  HR +K  ++L++                  H  +L++  DF   S KVL    
Sbjct: 118 HH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL---- 172

Query: 223 PNISYICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           P +S         PE++    + Y A  DI+S G    EL  G   F        L+E  
Sbjct: 173 PWLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-- 221

Query: 282 KVLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHPWHKI 315
           K+ GT                  P+R        E      P  +     +  +HP+++ 
Sbjct: 222 KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRT 278

Query: 316 FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL-RDPNTRLP 362
           F     P     V + LQ +P+ R +A   L H FF ++ R  +  LP
Sbjct: 279 FS----PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 21/152 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNR------ELQTMRLLDHPNVVSL 123
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E   +   D+  VV L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              ++S  +KD LY   V++Y+P  + +  +I+         P    + Y  ++  A+  
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMGI-----FPEDLARFYIAELTCAVES 116

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 213
           +H  +G  HRDIKP N+L++   H +KL DFG
Sbjct: 117 VHK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 19/108 (17%)

Query: 173 YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 223
           YQ+ + ++++   N I   HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 221 YQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            +       + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL------ 123
           +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F+  TE    Y NL L+Y+ E             Q +  + +     QI  A+ Y+ 
Sbjct: 74  EPPFYIITEF-MTYGNL-LDYLREC----------NRQEVNAVVLLYMATQISSAMEYLE 121

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 240
                 HRD+  +N LV  + H +K+ DFG ++ L+ G+   ++  +++   + APE + 
Sbjct: 122 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL- 177

Query: 241 GATEYTAAIDIWSAGCVLAEL-LLGQPLFPG 270
              +++   D+W+ G +L E+   G   +PG
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 7/116 (6%)

Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            S+ +  + +  + YQ+ R + ++ +   V HRD+  +N+L+      +K+CDFG A+ +
Sbjct: 230 GSEGLTTLDLLSFTYQVARGMEFLASKNCV-HRDLAARNVLLA-QGKIVKICDFGLARDI 287

Query: 219 VKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           +     +S         + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 122
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 123 --LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
             L  C  ST +       LV + +P     ++ +  +   R+    +  +  QI + ++
Sbjct: 73  RLLGICLTSTVQ-------LVTQLMPYGC--LLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 237
           Y+   + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E
Sbjct: 124 YLEE-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            I     +T   D+WS G  + EL+
Sbjct: 182 SIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 46.4 bits (110), Expect = 9e-06
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 37/225 (16%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDH 117
           P++T+     + +G G FG V+          VAIK + Q          E   M+ L H
Sbjct: 4   PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQI 175
           P +V L    ++   ++ +Y+  + EY+    +  +    K  + + L   KL     QI
Sbjct: 61  PRLVRL----YAVVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQI 111

Query: 176 CRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 231
              +A+I   N I   HRD++  N+LV+  T   K+ DFG A+++   E    Y      
Sbjct: 112 AEGMAFIERKNYI---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGA 163

Query: 232 ----YYRAPELI-FGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                + APE I +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 164 KFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 26/208 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E V+G G FG V + +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALA 180
            L+     T  +  + +   +E      +  +    + +  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 234
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S        + 
Sbjct: 121 YLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 122
           + +G G FG V + +  +       AV   K+    R +      E   M+  DHPNV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-------MPLIYVKLYFYQI 175
           L      T E +     +V+  +P   H  + H + +  R       +P   +  +   I
Sbjct: 65  LIGVCLQTVESEGYPSPVVI--LPFMKHGDL-HSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
              + Y+ ++    HRD+  +N ++N + + + + DFG +K +  G+    Y   R  + 
Sbjct: 122 ASGMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKM 176

Query: 236 PELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPG 270
           P + + A E      YT   D+WS G  + E+   GQ  +PG
Sbjct: 177 P-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 55/248 (22%)

Query: 73  VGHGSFGVVFQAKCLETGE-------AVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 119
           +G G FG V  A+ +   +        VA+K +  D   K+      E++ M+++  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP----------LIYVK 169
           +++L     + T+   LY+  ++EY  +   R     Y  ++R P          L   +
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLR----EYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 170 LYF-------YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L F       YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +  
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFG----LARDV 184

Query: 223 PNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
            NI Y            + APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V 242

Query: 275 DQLVEIIK 282
           ++L +++K
Sbjct: 243 EELFKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 75/309 (24%), Positives = 133/309 (43%), Gaps = 73/309 (23%)

Query: 73  VGHGSFGVVFQAKCLETGE-------AVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 119
           +G G FG V  A+ +   +        VA+K +  D   K+      E++ M+++  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP--------------L 165
           +++L     + T+   LY+  ++EY  +   R     Y  ++R P               
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLR----EYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 166 IYVKLYF---YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           +  K      YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG A+      
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR------ 188

Query: 223 PNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFP 269
            +I +I   YY+            APE +F    YT   D+WS G +L E+  LG   +P
Sbjct: 189 -DIHHI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYP 244

Query: 270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLV 328
           G   V++L +++K  G    +   C N  Y   +        WH +  +R    + V+ +
Sbjct: 245 GVP-VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDL 296

Query: 329 SRLLQYSPN 337
            R+L  + N
Sbjct: 297 DRILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 17/175 (9%)

Query: 165 LIYVKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L Y+ L  + YQ+   + ++ +   V HRD+  +N+L+      +K+CDFG A+ +++  
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGLARDIMRDS 293

Query: 223 PNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             IS         + APE IF    YT   D+WS G +L E+  LG   +P     +Q  
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLL 332
             IK          +   P +   +  +I    W + F+ R    + V LV  LL
Sbjct: 353 NAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 78/331 (23%), Positives = 137/331 (41%), Gaps = 85/331 (25%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQ 110
            ++ I+ + E  +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLI 166
            M+     +VV L         K +  L +V+E +     ++  R ++   + +   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 167 YVKLYFY---QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            ++       +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAEL--LLGQPLFP 269
                   YYR            APE +     +T + D+WS G VL E+  L  QP + 
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223

Query: 270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS 329
           G S  +Q+++ +             M+  Y +         P         P    DL+ 
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255

Query: 330 RLLQYSPNLRSTALEAL------IHPFFDEL 354
              Q++P +R T LE +      +HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 47/192 (24%), Positives = 75/192 (39%), Gaps = 46/192 (23%)

Query: 94  AIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------KHCFFSTTEKDELY-LNLVL-EY 144
           A     +D     +E++ +  L  PN+  L               E  E   LN  L ++
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCM-IMEYMENGDLNQFLQKH 113

Query: 145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNP 202
           V ET    +  + K      L+Y+     QI   + Y+   N +   HRD+  +N LV  
Sbjct: 114 VAETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK 165

Query: 203 HTHQLKLCDFGSAKVLVKGEPNISYICSRYY----RAP--------ELIFGATEYTAAID 250
             + +K+ DFG ++ L        Y    YY    RAP        E +    ++T   D
Sbjct: 166 -NYTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSD 214

Query: 251 IWSAGCVLAELL 262
           +W+ G  L E+L
Sbjct: 215 VWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 52/231 (22%), Positives = 97/231 (41%), Gaps = 48/231 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ-------TMRLLDHPNV 120
           +++G G FG V + + L   +   +K   K ++   +   E++        M+  DHPNV
Sbjct: 5   KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM-------PLIYVKLYFY 173
           + L    F  +   ++   +V+  +P   H  + H + +  R+       PL  +  +  
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVI--LPFMKHGDL-HSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSR 231
            I   + Y+ N     HRD+  +N ++      + +C  DFG +K +  G+         
Sbjct: 121 DIALGMEYLSNR-NFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGD--------- 167

Query: 232 YYRAPELI-----FGATE------YTAAIDIWSAGCVLAELL-LGQPLFPG 270
           YYR   +      + A E      YT+  D+W+ G  + E+   GQ  +PG
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 61/248 (24%), Positives = 112/248 (45%), Gaps = 55/248 (22%)

Query: 73  VGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDKRYKN-----RELQTMRLLD-HPN 119
           +G G FG V +A+         +    VA+K +  +   K+      E++ M+L+  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP--------------- 164
           +++L       T++  LY+  ++EY  +   R     +  ++R P               
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLR----EFLRARRPPGPDYTFDITKVPEEQ 130

Query: 165 LIYVKLY--FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           L +  L    YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +G 
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFG----LARGV 184

Query: 223 PNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
            +I Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP-V 242

Query: 275 DQLVEIIK 282
           ++L ++++
Sbjct: 243 EELFKLLR 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 43/196 (21%)

Query: 93  VAIKKVLQD--KRYKN---RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 147
           VA+K +  D  K  +N   +E++ M  L +PN++ L          D+  L ++ EY+  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL----LGVCVSDDP-LCMITEYMEN 101

Query: 148 ------TVHRVIKHHYKMSQRMPLIYVKLYFY---QICRALAYIHNTIGVCHRDIKPQNL 198
                    R I+  +  +  +P + +    Y   QI   + Y+  ++   HRD+  +N 
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-ASLNFVHRDLATRNC 160

Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------------APELIFGATEYT 246
           LV  H + +K+ DFG ++ L  G+         YYR            A E I    ++T
Sbjct: 161 LVGNH-YTIKIADFGMSRNLYSGD---------YYRIQGRAVLPIRWMAWESIL-LGKFT 209

Query: 247 AAIDIWSAGCVLAELL 262
            A D+W+ G  L E+ 
Sbjct: 210 TASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 11/186 (5%)

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSR 231
           Q+  A+ YIH+   + HRDIK +N+ +N    ++ L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPT 288
              +PE++ G   Y    DIWS G +L ++L       G+ G     QL++II  L    
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD 391

Query: 289 RE--EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL-VSRLLQYSPNLRSTALEA 345
            E  +  C   +Y +        H    + +    P   +  + ++L +  +LR  A E 
Sbjct: 392 EEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451

Query: 346 LIHPFF 351
           L  P F
Sbjct: 452 LALPLF 457

Length = 501

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 46/208 (22%), Positives = 90/208 (43%), Gaps = 31/208 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 121
           +++G G FG V +   +  G+++ I    K +QD+  +         +  M  LDH  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 122 SLKH-CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ++       L LV +  P    +  V +H   +  +  L +      QI + 
Sbjct: 73  RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC----VQIAKG 121

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYR 234
           + Y+     + HR++  +N+L+   +  +++ DFG A +L   +    Y       ++  
Sbjct: 122 MYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
              ++FG   YT   D+WS G  + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 129
           ++G G FG V Q +   TG+ VA+K +  D   +    E   M  L H N+V L      
Sbjct: 13  IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
                   L +V+E + +  + V     +    + +I +  +   +   + Y+ +   + 
Sbjct: 71  NG------LYIVMELMSKG-NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLV 122

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI 249
           HRD+  +N+LV+      K+ DFG A+V   G  N        + APE +    ++++  
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKS 178

Query: 250 DIWSAGCVLAELL-LGQPLFP 269
           D+WS G +L E+   G+  +P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 158 KMSQRMP-----LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 212
           K+   MP     +  +K    Q+   L  +H  IG+ HRDIKP+NLLV     Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVTVDG-QVKIIDF 353

Query: 213 GSAKVLVKG---EPNISYICSRYYRAPELI 239
           G+A  +  G    P    +  RY    EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 61/291 (20%), Positives = 102/291 (35%), Gaps = 57/291 (19%)

Query: 71  RVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +GHG+FG V++              VA+K + +    ++      E   M   +H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V        + E+   +  ++LE +     +      +     P            R +A
Sbjct: 72  V---RLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 181 ----YIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYR 234
               Y+       HRDI  +N L+         K+ DFG A+ + +         + YYR
Sbjct: 127 KGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------ASYYR 176

Query: 235 -----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVEI 280
                       P   F    +T+  D+WS G +L E+  LG   +PG +   V + V  
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236

Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
              L  P      C  P Y      +I    W    + R  P    ++ R+
Sbjct: 237 GGRLDPPK----GCPGPVY------RIMTDCWQHTPEDR--PNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 50/223 (22%)

Query: 73  VGHGSFGVVFQAKCL-------ETGEAV-AIKKVLQDKRYK-NRELQTMRLLDHPNVVSL 123
           +G G+FG VF A+C        +   AV A+K+  +  R    RE + + +L H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH---------YKMSQRMPLIYVKLYFY 173
              F+    +    L +V EY+    ++R ++ H          +      L   ++   
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 174 --QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             QI   + Y+  ++   HRD+  +N LV      +K+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYL-ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 232 YYRA------------PELIFGATEYTAAIDIWSAGCVLAELL 262
           YYR             PE I    ++T   DIWS G VL E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 34/207 (16%)

Query: 73  VGHGSFGVVFQA--KCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           +G G+FG V +   K  +    VAIK VL+++  K+      RE + M  LD+P +V + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                  E + L   LV+E      +++ +         + +  V    +Q+   + Y+ 
Sbjct: 61  ---IGVCEAEALM--LVMEMASGGPLNKFLS---GKKDEITVSNVVELMHQVSMGMKYLE 112

Query: 184 NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-------YRA 235
               V HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + A
Sbjct: 113 GKNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYA 166

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++++  D+WS G  + E  
Sbjct: 167 PECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 28/201 (13%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 59

Query: 128 FSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              T+K  +Y  +V+E V      T  R      K+ + + ++            + Y+ 
Sbjct: 60  GVCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQMV------ENAAAGMEYLE 111

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE-LI 239
           +   + HRD+  +N LV    + LK+ DFG ++    G    +    +    + APE L 
Sbjct: 112 SKHCI-HRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 240 FGATEYTAAIDIWSAGCVLAE 260
           +G   Y++  D+WS G +L E
Sbjct: 170 YG--RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 29/121 (23%)

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QI   + Y+ +++   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 234 R------------APELIFGATEYTAAIDIWSAGCVLAELLL---GQPLFPGESGVDQLV 278
           R            A E I    ++T A D+W+ G  L E+L+    QP   GE   +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251

Query: 279 E 279
           E
Sbjct: 252 E 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 35/217 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G  +  AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHH------YKMSQRMPLIYV 168
           +L        E    YL L +EY P           RV++           +  +    +
Sbjct: 72  NL----LGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
             +   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 127 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 182

Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 183 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVS 122
           S    + +G+G FG V+        + VA+K +            E Q M+ L H  +V 
Sbjct: 7   SLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L    ++   ++ +Y+  V EY+ + ++   +K     + ++P + V +   Q+   +AY
Sbjct: 66  L----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMA-AQVAAGMAY 117

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 238
           I   +   HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE 
Sbjct: 118 IER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEA 174

Query: 239 -IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 270
            ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 51/225 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           E V+G G+FG V +A   + G  +  AIK + +     D R    EL+ + +L  HPN++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 122 SL-KHCFFSTTEKDELYLNLVLEYVP--------------ETVHRVIKHH---YKMSQRM 163
           +L   C      ++  YL + +EY P              ET     K H     ++ + 
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            L +       +   + Y+     + HRD+  +N+LV  +    K+ DFG    L +GE 
Sbjct: 121 LLQFAS----DVATGMQYLSEKQFI-HRDLAARNVLVGENLAS-KIADFG----LSRGEE 170

Query: 224 NISYICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELL 262
              Y+     R P + + A E      YT   D+WS G +L E++
Sbjct: 171 --VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 37/214 (17%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FG V+      T + VAIK +           +E Q M+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 130 TTEKDELYLNLVLEYVPE-TVHRVIKH----HYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              ++ +Y+  V E++ + ++   +K     + K+ Q + +        QI   +AYI  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA------QIADGMAYIER 120

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYRAPEL 238
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +       + APE 
Sbjct: 121 -MNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 174

Query: 239 -IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 270
            ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 175 ALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 44/249 (17%)

Query: 64  TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMR 113
           T+ +M E  +G   FG V++         E  +AVAIK  L+DK     R + +    MR
Sbjct: 6   TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62

Query: 114 L-LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHR--VIKHHYK----------- 158
             L HPN+V    C      K++  L+++  Y   + +H   V++  +            
Sbjct: 63  SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            S   P  +V +   QI   + ++ ++  V H+D+  +N+LV    + +K+ D G  + +
Sbjct: 118 KSTLEPADFVHI-VTQIAAGMEFL-SSHHVVHKDLATRNVLVFDKLN-VKISDLGLFREV 174

Query: 219 VKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 273
              +       S +  R+     +++G  +++   DIWS G VL E+   G   + G S 
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232

Query: 274 VDQLVEIIK 282
            D ++E+I+
Sbjct: 233 QD-VIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 69/296 (23%), Positives = 111/296 (37%), Gaps = 63/296 (21%)

Query: 73  VGHGSFGVVFQAKCLETGEAVA--IKKVLQDKRYKN------RELQTMRLLDHPNVVS-L 123
           +G+G FG V   +    G + A  + K L+     +      +E+Q  R L+HPNV+  L
Sbjct: 3   IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 124 KHCFFSTTEKDELYLNLVLEYVP----------ETVHRVIKHHYKMSQRMPLIYVKLYFY 173
             C  S       YL LVLE+ P                      + QRM          
Sbjct: 62  GQCIESIP-----YL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMA--------C 107

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 232
           ++   L ++H    + H D+  +N  +      +K+ D+G A      +  I+  C    
Sbjct: 108 EVASGLLWLHQADFI-HSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVP 165

Query: 233 --YRAPEL--IFGATEYTAAI----DIWSAGCVLAEL--LLGQPLFPGESGVDQLVEIIK 282
             + APEL  I G            +IWS G  + EL     QP +P  S    L ++++
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVVR 224

Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ-KRMPPE---AVDLVSRLLQY 334
                  ++IK   P           +  W+++ Q   + PE     + V  LL Y
Sbjct: 225 ------EQDIKLPKPQ-----LDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	403
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
PRK10345	210	hypothetical protein; Provisional	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.83
smart00090	237	RIO RIO-like kinase.	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
KOG1243	690	consensus Protein kinase [General function predict	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.35
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.32
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.31
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.02
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.02
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.84
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.71
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.68
PRK09902	216	hypothetical protein; Provisional	98.68
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.64
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.55
PF01636	239	APH: Phosphotransferase enzyme family This family	98.35
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.23
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.2
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.11
PLN02876	822	acyl-CoA dehydrogenase	97.99
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.97
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.87
KOG2270	520	consensus Serine/threonine protein kinase involved	97.79
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.77
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.76
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.7
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.65
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.64
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.64
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.51
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.43
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.41
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.4
PRK05231	319	homoserine kinase; Provisional	97.35
PRK10593	297	hypothetical protein; Provisional	97.35
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.34
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.99
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.98
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.85
PRK12396	409	5-methylribose kinase; Reviewed	96.81
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.69
PLN02236	344	choline kinase	96.67
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.62
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.46
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.33
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.16
PLN02756	418	S-methyl-5-thioribose kinase	96.01
PTZ00384	383	choline kinase; Provisional	95.98
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.66
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	95.47
PRK11768	325	serine/threonine protein kinase; Provisional	94.85
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.55
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.71
KOG2269	531	consensus Serine/threonine protein kinase [Signal	93.59
PRK10271	188	thiK thiamine kinase; Provisional	93.55
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.8

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.4e-71  Score=498.96  Aligned_cols=351  Identities=73%  Similarity=1.181  Sum_probs=329.5

Q ss_pred             CCceEEeecCCCCCCCccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecce
Q 015615           46 AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH  125 (403)
Q Consensus        46 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~  125 (403)
                      .+....+...+..+......+|.-.+++|+|+||.||+|....+++.||||++..+.+...+|+.+|+.++|||||++..
T Consensus         5 ~~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~   84 (364)
T KOG0658|consen    5 SGHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLY   84 (364)
T ss_pred             ceeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEE
Confidence            34455556666667777788999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC
Q 015615          126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (403)
Q Consensus       126 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  205 (403)
                      +|....+.+..|+.+|||||+.+|.+.+++....+..++...++.|++||++||+|||+. ||+||||||.|+|+|.+.+
T Consensus        85 ~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg  163 (364)
T KOG0658|consen   85 FFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTG  163 (364)
T ss_pred             EEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCC
Confidence            888777666788999999999999999998777778899999999999999999999997 9999999999999999988


Q ss_pred             ceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015615          206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  285 (403)
Q Consensus       206 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  285 (403)
                      .+||||||+|+.+..++++.++.+|.+|+|||.+.+...|+.+.||||.||++.||+-|++.|+|.+..+++..|.+.+|
T Consensus       164 ~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG  243 (364)
T KOG0658|consen  164 VLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG  243 (364)
T ss_pred             eEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCC
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR  365 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~  365 (403)
                      .|..+++.++++.+.+..+|++...+|...+.+..++++.+|+.++|+++|.+|.++.+++.||||+++++++.+++++.
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~  323 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGR  323 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCC
Confidence            99999999999999999999999999999899999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCChhhcCCCChHHHhhcchHHHHhhh
Q 015615          366 FLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC  398 (403)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (403)
                      ..|++++|++.+ .+...+.+..++|++.+.+.
T Consensus       324 ~lp~lf~f~~~e-~~~~~~~~~~l~p~~~~~~~  355 (364)
T KOG0658|consen  324 PLPPLFNFKRAE-LGISPELVNVLIPEHLREQE  355 (364)
T ss_pred             cCCCccCchHHH-hccchHHHHhhccHhhhhhc
Confidence            999999999884 45678999999999988764

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.4e-59  Score=409.81  Aligned_cols=278  Identities=37%  Similarity=0.701  Sum_probs=245.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .|+...++|+|+||.||+|+++.||+.||||++....      ....||+.+|+.++|+|+|.++++|     .....++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence            5888889999999999999999999999999985432      2335899999999999999999998     5556688


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|+|||+.++++.|.+.   ....+...++.|++|++.|+.|+|++ ++|||||||+||||+.++ .+||||||+|+.+.
T Consensus        78 LVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNG-VVKLCDFGFARTLS  152 (396)
T ss_pred             EEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCC-cEEeccchhhHhhc
Confidence            99999999988888775   47789999999999999999999998 999999999999999988 89999999999886


Q ss_pred             -cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh--ccC
Q 015615          220 -KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CMN  296 (403)
Q Consensus       220 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--~~~  296 (403)
                       .++..+.++.|.+|+|||.+.++..|+..+||||+||++.||++|.+.|++.++.+++..|.+.+|...+....  ..+
T Consensus       153 ~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  153 APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence             56666788999999999999998899999999999999999999999999999999999999999998876544  456


Q ss_pred             cCcccccCCCccCC-CcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          297 PNYTEFKFPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       297 ~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      +-|....+|..... +....+ ++++.-+.||+++||..||.+|++.+++|.||||+.+
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            77777777776553 333333 5678899999999999999999999999999999764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-59  Score=435.28  Aligned_cols=282  Identities=37%  Similarity=0.677  Sum_probs=253.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|.+.++||.|.||.||+|+.+.+|+.||||++++.     .....||+..|++|+ |||||++.+++.+..    ..
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~   84 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI   84 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence            35799999999999999999999999999999998654     233458999999999 999999999884322    16


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++|||||+.+|.++++.+   ...|++..++.|+.||+.||+|+|.+ |+.|||+||+|||+..+. .|||+|||+|+.
T Consensus        85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~-~iKiaDFGLARe  159 (538)
T KOG0661|consen   85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGND-VIKIADFGLARE  159 (538)
T ss_pred             EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccc-eeEecccccccc
Confidence            9999999999999999987   57899999999999999999999998 999999999999999766 799999999999


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc--
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  295 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  295 (403)
                      .....+.+.++.|.+|+|||++.....|+.+.||||+|||++|+.+-++.|+|.++.+++.+|..++|.|....|...  
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            988888889999999999999998889999999999999999999999999999999999999999999998877542  


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      ....-.+.+|+....++...++. .++++.+||.+||.|||.+||||.++|+||||+.-.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            12234567888888888888766 899999999999999999999999999999998743

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-58  Score=414.09  Aligned_cols=317  Identities=40%  Similarity=0.689  Sum_probs=268.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .|...+.||+|+||.|+.|.++.+|+.||||++..      ......||+.+|+.++|+||+.+++++.......-.-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            46667899999999999999999999999999852      224455899999999999999999988653333344588


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|+|+|+.+|.+.++..    +.++...+..+++||++||.|+|+. +|+||||||+|+|++.+. .+||||||+|+...
T Consensus       103 iV~elMetDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADC-DLKICDFGLARYLD  176 (359)
T ss_pred             EehhHHhhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCC-CEEeccccceeecc
Confidence            99999999999998863    4599999999999999999999997 999999999999999998 79999999999875


Q ss_pred             c---CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          220 K---GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       220 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .   ....+.++.|.+|+|||++.....|+.+.||||+|||+.||++|++.|+|.+..+++..|...+|.|..+.+....
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            3   3334567889999999999888889999999999999999999999999999999999999999999998887655


Q ss_pred             cCc-cc--ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCC
Q 015615          297 PNY-TE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNF  373 (403)
Q Consensus       297 ~~~-~~--~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  373 (403)
                      ... ..  ...|..+..+|...|+ +.++.+.||+.+||.+||.+|+|++|+|+||||..+.+|.+....    ++.+..
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~----~~~~~~  331 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC----QPIFDS  331 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC----CCCCcc
Confidence            221 11  2577888889999886 899999999999999999999999999999999999988764322    121111


Q ss_pred             ChhhcCCCChHHHhhcchHHHHh
Q 015615          374 KPHELKGVPVDMLVKLIPEHARK  396 (403)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~  396 (403)
                        .+.. .+.+.|+.++++|...
T Consensus       332 --~~~~-~~~~~~r~~i~~e~~~  351 (359)
T KOG0660|consen  332 --FEHE-LTEEELRELIYKEILD  351 (359)
T ss_pred             --cccc-ccHHHHHHHHHHHHHh
Confidence              3333 6789999999888653

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.9e-56  Score=440.75  Aligned_cols=332  Identities=52%  Similarity=0.963  Sum_probs=288.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCC---CCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~l  140 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++||||++++++|+....   ....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            357999999999999999999999999999999987776677789999999999999999887754321   33457889


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||+++++.+.+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.+++.+||+|||+|+....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            999999998888876555567899999999999999999999998 9999999999999997765799999999987655


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.|..+.+..+.+.+.
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence            55555678899999999987766689999999999999999999999999999999999999999999998888888888


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCC-CCCCCCCCCChhhcC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNG-RFLPPLFNFKPHELK  379 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  379 (403)
                      ...++......+...++...|+++.+||.+||++||.+|||+.++|+||||+.++++....+.. ...|++++|...++.
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK  383 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence            8888887777777777778899999999999999999999999999999999998876555542 345778889888888


Q ss_pred             CCChHHHhhcchHHHHh
Q 015615          380 GVPVDMLVKLIPEHARK  396 (403)
Q Consensus       380 ~~~~~~~~~~~~~~~~~  396 (403)
                      .+..+..++.+|.....
T Consensus       384 ~~~~~~~~~~~~~~~~~  400 (440)
T PTZ00036        384 EMSDACRRKIIPKCTYE  400 (440)
T ss_pred             hCCHHHHHHHhhHHHHH
Confidence            88888888888876665

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5e-57  Score=389.76  Aligned_cols=280  Identities=39%  Similarity=0.722  Sum_probs=243.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|...+.||+|.||.||+|++..+|+.||||+++...      ....||++.|+.++|+||+.+.++|     .....+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            36888999999999999999999999999999996432      2345899999999999999999999     555558


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      .||+|||+.+|...++..   ...++...++.|+.+++.||+|||++ .|+||||||.|+|++++| .+||+|||+|+..
T Consensus        77 ~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDG-QLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCC-cEEeecccchhcc
Confidence            899999999999988865   46789999999999999999999998 999999999999999998 8999999999987


Q ss_pred             ccCCCc-ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC-
Q 015615          219 VKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  296 (403)
Q Consensus       219 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  296 (403)
                      ...... ...+.|.+|+|||.++|...|+..+||||.|||+.||+.|.+.|+|.++.+++..|+..+|.|.++.|+.+. 
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            554433 334789999999999999999999999999999999999999999999999999999999999999998753 


Q ss_pred             -cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                       ++|..+.  ..+..+....| ...+.++.||+.+||.+||.+|+|+.|+|+|+||+..-.|
T Consensus       232 lpdY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  232 LPDYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             cccHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence             6666554  23333333344 4578899999999999999999999999999999985433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-56  Score=427.45  Aligned_cols=252  Identities=33%  Similarity=0.553  Sum_probs=223.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+.       .....+|+++.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            5799999999999999999999999999999998652       23446899999999999999999999     77888


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +|||.|+|. ++|..+++.    ...++|.+++.+++||+.||.|||++ +|+|||||..|+|++++. +|||+|||+|.
T Consensus        93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcC-cEEecccceee
Confidence            999999999 577777764    37899999999999999999999998 999999999999999988 79999999998


Q ss_pred             ecc-cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ... +++...+.+|||.|+|||++... ..+..+||||+|||||-|++|+|||...+-.+.+..|...            
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------------  233 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------------  233 (592)
T ss_pred             eecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------------
Confidence            876 44777899999999999999754 4899999999999999999999999988887888777663            


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                           +|.            ++..+|.+++|||.+||+.||.+|||++++|.|+||+..-.|
T Consensus       234 -----~Y~------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  234 -----EYS------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             -----Ccc------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence                 222            334689999999999999999999999999999999654444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-58  Score=416.99  Aligned_cols=256  Identities=34%  Similarity=0.520  Sum_probs=212.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----------hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ..|.+.+.||+|+||.|-+|..+.+|+.||||++.+..           ....+|+++|++|+|||||+++++|     .
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----~  246 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----E  246 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----e
Confidence            46999999999999999999999999999999985431           2235899999999999999999988     3


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEe
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLC  210 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~  210 (403)
                      ...+.||||||++| .|.+.+-.    .+.+.+...+.+++|++.|+.|||++ ||+||||||+|||+..+.  -.+||+
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEec
Confidence            44457899999995 67666654    36677888899999999999999998 999999999999997651  269999


Q ss_pred             ecCCceecccCCCcceeeecccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Q 015615          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTP  287 (403)
Q Consensus       211 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~  287 (403)
                      |||+|+...++....+.+|||.|.|||++.+..  .++.++|+|||||+||-+++|.+||.+..... ...+|.+.-   
T Consensus       322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~---  398 (475)
T KOG0615|consen  322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR---  398 (475)
T ss_pred             ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc---
Confidence            999999988777778899999999999996442  34558999999999999999999998865444 444444421   


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                    |        .+....+..+|.++++||.+||..||++|||++|+|+||||+...
T Consensus       399 --------------y--------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  399 --------------Y--------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             --------------c--------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence                          0        011112356899999999999999999999999999999999754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-56  Score=418.37  Aligned_cols=284  Identities=36%  Similarity=0.614  Sum_probs=241.2

Q ss_pred             CccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      +.....|+.+++||+|.||.||+|++..+|+.||+|+++.+.      ....||+.+|++|+||||+++.+.....   .
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~  189 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L  189 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence            344567999999999999999999999999999999996543      3446899999999999999999877543   3


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...+|||+|||+.+|..++...   .-.|++.+++.|+.||+.||.|||++ ||+|||||.+|||||.+| .+||+|||+
T Consensus       190 ~~siYlVFeYMdhDL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G-~LKiaDFGL  264 (560)
T KOG0600|consen  190 SGSIYLVFEYMDHDLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNG-VLKIADFGL  264 (560)
T ss_pred             CceEEEEEecccchhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCC-CEEeccccc
Confidence            4568999999999988887653   35799999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecccCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          215 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       215 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      |+++....  ..++.+.|.+|+|||.+.+...|+.++|+||+||||.||++|++.|++.++.+++..|.+..|.|....|
T Consensus       265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            99774443  3567788999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             hccCc-CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          293 KCMNP-NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       293 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                      ..... .+..+....--...+.+. -+.+++.+.+|+..||+.||.+|.||.++|+|+||..
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            73332 222222111112233333 3568999999999999999999999999999999954

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-56  Score=396.96  Aligned_cols=286  Identities=34%  Similarity=0.569  Sum_probs=249.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh------hhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ...|+....|++|.||.||+|+|+.+++.||+|+++.+..      ...||+.+|.+++|||||.+..+.....   -..
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cce
Confidence            3579999999999999999999999999999999865432      2358999999999999999998765433   223


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|||||||+.+|..++...   .+++...+++.++.|++.|++|||.+ .|+||||||+|+|++..| .+||+|||+|+.
T Consensus       152 iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~  226 (419)
T KOG0663|consen  152 IYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKG-ILKIADFGLARE  226 (419)
T ss_pred             eeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCC-cEEecccchhhh
Confidence            7899999999998888764   47899999999999999999999998 999999999999999887 799999999998


Q ss_pred             cccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       218 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      +.... +.+..+.|.+|+|||.+.+...|+++.|+||+|||+.||+++++.|+|....+++.+|++.+|.|....|+...
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            86553 34567889999999999999999999999999999999999999999999999999999999999998886543


Q ss_pred             --cCcccccCCCccCCCcccccccC-CChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          297 --PNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       297 --~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                        +.+..+.++..+...+...|... ++....+|+..+|.+||.+|.||+|+|+|.||.+.-.|
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence              33345667777777777777654 78999999999999999999999999999999995444

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-56  Score=402.90  Aligned_cols=257  Identities=31%  Similarity=0.551  Sum_probs=214.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +.+..+.||+|..|+||+|+|+.+++.+|+|.+...     .+...+|+++++..+||+||.+|++|+....    .++|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~isI  155 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EISI  155 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEEe
Confidence            567788999999999999999999999999999332     3445689999999999999999999976442    3789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||++ +|...++..    +++++..+..++.++++||.|||+..+||||||||+|||+++.| +|||||||.++.+.
T Consensus       156 ~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lv  230 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILV  230 (364)
T ss_pred             ehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhh
Confidence            9999995 777766653    78999999999999999999999634999999999999999988 89999999999887


Q ss_pred             cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE--SGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      +. ...+++||..|||||.+.+.. |+.++||||||++++|+.+|+.||...  .....+.........|++.       
T Consensus       231 nS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~-------  301 (364)
T KOG0581|consen  231 NS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR-------  301 (364)
T ss_pred             hh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC-------
Confidence            66 556889999999999998765 999999999999999999999999874  1222333333322222211       


Q ss_pred             CcccccCCCccCCCccccccc-CCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                                        ++. ..|+++++|+..||++||.+|+|+.++++|||+++...++
T Consensus       302 ------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  302 ------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             ------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence                              222 3799999999999999999999999999999999876554

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-56  Score=400.87  Aligned_cols=255  Identities=33%  Similarity=0.523  Sum_probs=220.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.++||+|+||+||+++.+.+++.+|+|++++.       ......|..+|..++||+||+++..|     ++.
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence            345799999999999999999999999999999988653       34455799999999999999998777     566


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+|+|+||+.| .|...|.+    .+.+++..++.|+.+|+.||.|||+. |||||||||+|||+|.+|| ++|+|||+
T Consensus        98 ~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GH-i~LtDFgL  171 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGH-IKLTDFGL  171 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCc-EEEecccc
Confidence            669999999996 67666665    47899999999999999999999998 9999999999999999995 99999999


Q ss_pred             ceeccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      |+.... +....+.+||+.|||||++.+.+ |+..+|+||||+++|||++|.+||.+.+......+|.+.-..       
T Consensus       172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~-------  243 (357)
T KOG0598|consen  172 CKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-------  243 (357)
T ss_pred             chhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC-------
Confidence            985543 44556679999999999998765 999999999999999999999999999988888888763100       


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC----CHHHHhcCCCCccCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS----TALEALIHPFFDELRDP  357 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~----s~~ell~hp~f~~~~~~  357 (403)
                                           ..+..++.++++||+++|..||++|.    .+.++.+||||..+.+.
T Consensus       244 ---------------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  244 ---------------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             ---------------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence                                 11233799999999999999999996    68999999999998764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-54  Score=405.58  Aligned_cols=255  Identities=32%  Similarity=0.568  Sum_probs=224.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|..++.||.|+|++|++|+++.+++.||||++.+.       ..+..+|-.+|..| .||.|+++|..|     ++
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD  145 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD  145 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence            345799999999999999999999999999999987543       34556799999999 899999998777     55


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+|+|+||++ |.|+++|.+.    +.|++..++.|+.||+.||+|||++ |||||||||+|||+|.|+ .+||+|||
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dm-hikITDFG  219 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDG-HIKITDFG  219 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCC-cEEEeecc
Confidence            666899999999 6899998875    7899999999999999999999998 999999999999999999 69999999


Q ss_pred             CceecccCCC--------------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 015615          214 SAKVLVKGEP--------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (403)
Q Consensus       214 ~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  279 (403)
                      .|+.+.....              ..+++||..|.+||++... ..++.+|+|+||||+|+|+.|.+||.+.++.-.+++
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk  298 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK  298 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence            9988743211              1458999999999999654 489999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      |++..                 |            .|++.+++.++||++++|..||.+|+|+.++.+||||.++.+.+
T Consensus       299 I~~l~-----------------y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  299 IQALD-----------------Y------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHhc-----------------c------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            98741                 1            24567899999999999999999999999999999999998765

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-54  Score=374.68  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=222.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.+.||.|+||.|.+++++.+|..+|+|++.+..       +...+|..+|+.+.||+++++++.|     .+.
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~  116 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDN  116 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccC
Confidence            3457999999999999999999999999999999986543       3345799999999999999998887     677


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      .++||||||++| .|..++++    .+++++..+++|+.||+.||+|||+. +|++|||||+|||+|.+| .+||+|||+
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G-~iKitDFGF  190 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNG-HIKITDFGF  190 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCC-cEEEEeccc
Confidence            789999999995 67777766    47899999999999999999999987 999999999999999999 599999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      |+.....  ..+.+|||.|+|||++.+.+ |+.++|+||||+++|||+.|.+||.+.+...++.+|.+.           
T Consensus       191 AK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-----------  256 (355)
T KOG0616|consen  191 AKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-----------  256 (355)
T ss_pred             eEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-----------
Confidence            9976433  66889999999999997665 999999999999999999999999999999999988873           


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCC-----CCHHHHhcCCCCccCCCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELRDPN  358 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R-----~s~~ell~hp~f~~~~~~~  358 (403)
                            .+            .|+..+++++++||+++|+.|-.+|     ....++.+||||+++.+..
T Consensus       257 ------~v------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  257 ------KV------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             ------cc------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence                  11            2445689999999999999999999     3578999999999987653

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.6e-53  Score=381.96  Aligned_cols=292  Identities=35%  Similarity=0.688  Sum_probs=245.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh------hhHHHHHHHHHcCCCC-eeecceeeeecCC-CCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPN-VVSLKHCFFSTTE-KDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~  136 (403)
                      ..|...++||+|+||+||+|+++.+|+.||+|+++.+..      ...+|+.+|+.++|+| |+.+++++..... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            357777889999999999999999999999999865432      3368999999999999 9999998865442 3344


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+++|+||++.+|..++.........++...++.+++||+.||+|||++ +|+||||||.||||+++| .+||+|||+|+
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr  168 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSG-VLKLADFGLAR  168 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCC-cEeeeccchHH
Confidence            6889999999999999987654435677789999999999999999998 999999999999999987 79999999998


Q ss_pred             ecc-cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ... ........++|.+|+|||++.+...|+...||||+|||++||+++++.|++..+.+++..|...+|.|....|+..
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            664 3444567789999999999999988999999999999999999999999999999999999999999999888754


Q ss_pred             C--cCcccccCCCcc-CCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCC
Q 015615          296 N--PNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR  360 (403)
Q Consensus       296 ~--~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~  360 (403)
                      .  ++|.. .++... ...+.... +..+++..+++.+||+++|.+|.|+..+|.||||.++..+..+
T Consensus       249 ~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~  314 (323)
T KOG0594|consen  249 SSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQ  314 (323)
T ss_pred             cccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhh
Confidence            2  33332 333333 22333322 4456899999999999999999999999999999998666544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.6e-53  Score=397.23  Aligned_cols=267  Identities=34%  Similarity=0.551  Sum_probs=222.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|.+++.||+|+||.||+|+-+.||..+|+|++++..       .....|..+|...++|.||++|..|     ++..
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~~  214 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDKE  214 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCCC
Confidence            457999999999999999999999999999999986543       3345688999999999999999888     7778


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++||||||++| ++..+|..    .+.|++..+++|+.+++.|+..||+. |+|||||||+|+|||..|| +||+|||+|
T Consensus       215 ~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GH-iKLSDFGLs  288 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGH-IKLSDFGLS  288 (550)
T ss_pred             eeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCC-Eeecccccc
Confidence            89999999996 56666654    47899999999999999999999987 9999999999999999995 999999998


Q ss_pred             eeccc----------------------C-CC-------------------------cceeeecccccccccccCCCCCCC
Q 015615          216 KVLVK----------------------G-EP-------------------------NISYICSRYYRAPELIFGATEYTA  247 (403)
Q Consensus       216 ~~~~~----------------------~-~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~  247 (403)
                      ..+..                      . ..                         ..+.+|||.|||||++.+.. |+.
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~  367 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGK  367 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCc
Confidence            54311                      0 00                         01357999999999998766 999


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHH
Q 015615          248 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL  327 (403)
Q Consensus       248 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  327 (403)
                      .+|+||||||+||||.|.+||.+.+..+...+|+.....               +.+|.          ...++++++||
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~----------~~~~s~eA~DL  422 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPE----------EVDLSDEAKDL  422 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCC----------cCcccHHHHHH
Confidence            999999999999999999999999999999998874211               01111          13468999999


Q ss_pred             HHHhhccCCCCCCC---HHHHhcCCCCccCCCCCCCCCCCCCCC
Q 015615          328 VSRLLQYSPNLRST---ALEALIHPFFDELRDPNTRLPNGRFLP  368 (403)
Q Consensus       328 l~~~L~~dP~~R~s---~~ell~hp~f~~~~~~~~~~~~~~~~~  368 (403)
                      |.+||+ ||++|..   ++|+.+||||+++.+..-+-....+.|
T Consensus       423 I~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP  465 (550)
T KOG0605|consen  423 ITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVP  465 (550)
T ss_pred             HHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCC
Confidence            999999 9999975   999999999999988765433333333

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.1e-52  Score=402.64  Aligned_cols=280  Identities=36%  Similarity=0.597  Sum_probs=231.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhH---HHHHHHHHcC-C-----CCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLD-H-----PNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~~  136 (403)
                      +|.|.+.||+|.||+|.+|.|..|++.||||+++.......   .|+.+|..|+ |     -|+|+++++|.     ...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-----fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-----FRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-----ccc
Confidence            78999999999999999999999999999999988776654   4888888886 3     48999999994     445


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC-CCCceEEeecCCc
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~DfG~a  215 (403)
                      ++|||+|.++.+|.++++.+.  ..+++...++.++.||+.||.+||+. ||||+|||||||||.. +...|||+|||+|
T Consensus       262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccc
Confidence            699999999999999999865  45699999999999999999999987 9999999999999954 3347999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      +....  ...+++-+.+|+|||++.+.+ |+.+.||||||||++||++|.+.|+|.++.+++..|++.+|.|+...+...
T Consensus       339 c~~~q--~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQ--RVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCC--cceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            87533  334788899999999999876 999999999999999999999999999999999999999999999876533


Q ss_pred             CcCcccccC----CC----------------------------c--cCCCcccccccCCChHHHHHHHHhhccCCCCCCC
Q 015615          296 NPNYTEFKF----PQ----------------------------I--KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  341 (403)
Q Consensus       296 ~~~~~~~~~----~~----------------------------~--~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s  341 (403)
                      ......+.-    +.                            .  ....+...+.......+.|||++||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            221111111    00                            0  1112222222234456899999999999999999


Q ss_pred             HHHHhcCCCCccCCC
Q 015615          342 ALEALIHPFFDELRD  356 (403)
Q Consensus       342 ~~ell~hp~f~~~~~  356 (403)
                      +.++|+||||.....
T Consensus       496 p~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  496 PAQALNHPFLTGTSL  510 (586)
T ss_pred             HHHHhcCcccccccc
Confidence            999999999996543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-52  Score=381.81  Aligned_cols=254  Identities=31%  Similarity=0.540  Sum_probs=218.1

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..++|.+.+.||+|+||+||+|+++.++..||||.+...      ......|+.+|+.++|||||.+++++     ....
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            345799999999999999999999999999999998654      23446799999999999999999988     4455


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC-C----CceEEe
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-T----HQLKLC  210 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~-~----~~vkl~  210 (403)
                      ++|+|||||. |+|..++..+    +.+++..++.++.||+.||++||++ +||||||||.|||++.. +    ..+||+
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEec
Confidence            7999999999 5888888775    6899999999999999999999998 99999999999999764 1    369999


Q ss_pred             ecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       211 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      |||+|+.+..+.-..+.+|+|.|||||++... .|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.....   
T Consensus       158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~---  233 (429)
T KOG0595|consen  158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV---  233 (429)
T ss_pred             ccchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc---
Confidence            99999999887777889999999999999654 59999999999999999999999999888777766444421111   


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                             ..++..+++...+|+...|+.+|..|.+..+-+.|+++..
T Consensus       234 -----------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  234 -----------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             -----------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                                   1122346778889999999999999999999999998876

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-52  Score=398.66  Aligned_cols=255  Identities=33%  Similarity=0.514  Sum_probs=225.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+-|++++.||+|+.|.|.+|++..||+.+|||++...       ...+++|+-+|+.+.|||++++|+++     .+..
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence            34699999999999999999999999999999999765       45677999999999999999999998     5566


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++|+|.||++ |.|++++...    +++++.+++.+++||+.|+.|||.. +|+||||||+|+|+|..+ ++||+|||.|
T Consensus        86 ~lylvlEyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~-nIKIADFGMA  159 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKN-NIKIADFGMA  159 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhccc-CEeeecccee
Confidence            7999999999 5788877764    7899999999999999999999987 999999999999999888 5999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....++.-..+.||+|.|.|||++.+.++.+.++||||+|+|||.|+||+.||.+.+-...+.++...            
T Consensus       160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G------------  227 (786)
T KOG0588|consen  160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG------------  227 (786)
T ss_pred             ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC------------
Confidence            88777776778899999999999999998899999999999999999999999987766666555442            


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                           .|.+            +..+|+++++||.+||..||++|+|.+|+++|||+.......
T Consensus       228 -----~f~M------------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  228 -----VFEM------------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             -----cccC------------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence                 2222            246899999999999999999999999999999999865543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-51  Score=389.93  Aligned_cols=251  Identities=35%  Similarity=0.522  Sum_probs=216.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---------hhhhHHHHHHHHHcC-CCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  132 (403)
                      ..+.|.+++.||+|+||+|++|.+..+|..||+|.+...         .....+|+.+++.+. ||||+++++++.    
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~----   90 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA----   90 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe----
Confidence            345799999999999999999999999999999976543         223457999999999 999999999883    


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC-CCceEEe
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLC  210 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~  210 (403)
                       ....+++|||||.| .|++.+..    .+++.+..++.+++|++.|++|||++ ||+||||||+|||++.+ + ++||+
T Consensus        91 -t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~-~~Kl~  163 (370)
T KOG0583|consen   91 -TPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEG-NLKLS  163 (370)
T ss_pred             -cCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCC-CEEEe
Confidence             33348899999996 88888776    37789999999999999999999998 99999999999999998 6 89999


Q ss_pred             ecCCceec-ccCCCcceeeecccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          211 DFGSAKVL-VKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       211 DfG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      |||++... .......+.+||+.|+|||++.+.. .-+.++||||+|++||.|++|+.||.+.+....+..|.+.     
T Consensus       164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-----  238 (370)
T KOG0583|consen  164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-----  238 (370)
T ss_pred             ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----
Confidence            99999887 4556667889999999999998766 4578999999999999999999999997777666665442     


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCC-ChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                  .+.            ++..+ |+++.+|+++||..||.+|+|+.++++||||+.
T Consensus       239 ------------~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 ------------EFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ------------Ccc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                        111            23345 999999999999999999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-53  Score=370.85  Aligned_cols=246  Identities=32%  Similarity=0.520  Sum_probs=206.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..|.|.++||+|.||+||++.+..+|..||.|.+.-      ..+....|+.+|+.|+|||||++++.-+.   ++...+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence            369999999999999999999999999999998852      23444579999999999999999883322   233347


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC-C--ccccCCCCCceEecCCCCceEEeecCC
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-G--VCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-~--ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      +||||||+ |+|.+.+++.....+.+++..++.++.|+|.||..||++. .  |+||||||.||+++.+| .|||+|||+
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL  174 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGL  174 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchh
Confidence            89999999 6899999988888889999999999999999999999821 4  99999999999999888 799999999


Q ss_pred             ceecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ++.+..... ..+.+|||+||+||.+.+.+ |+.++||||+||++|||+.-.+||.+.+-.+.-.+|.++--.|.+.   
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~---  250 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD---  250 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH---
Confidence            998755443 34689999999999997765 9999999999999999999999999986555555555431111111   


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  342 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~  342 (403)
                                              ..+|.++..+|..|+..||+.||+.
T Consensus       251 ------------------------~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 ------------------------EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             ------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence                                    3468899999999999999999986

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.7e-50  Score=374.70  Aligned_cols=277  Identities=33%  Similarity=0.636  Sum_probs=228.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|.+.+.||.|+||.||+|.+..++..||+|.+...     .....+|+.+++.++||||+++++++     ....+.
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence            34699999999999999999999999999999988532     22345799999999999999999887     334468


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||++++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~  153 (288)
T cd07871          79 TLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARAK  153 (288)
T ss_pred             EEEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEECcCcceeec
Confidence            899999999888877643   34578889999999999999999998 999999999999999887 7999999998764


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC-
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  296 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  296 (403)
                      .... ......+|+.|+|||++.+...++.++||||+||++|+|+||++||.+.+..+.+..+....+.|..+.++... 
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            3222 22345679999999998765668999999999999999999999999999889999999999999888776543 


Q ss_pred             -cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                       ..+..+.++.....++... ...++.++++||++||++||.+|||++|+|+||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             chhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence             2233333343333333322 24578999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-51  Score=393.10  Aligned_cols=263  Identities=30%  Similarity=0.486  Sum_probs=222.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.++||+|.||+|++|..+.+++.+|||.++++.       .....|..++... +||+++.++.+|     +.
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence            3457999999999999999999999999999999987653       2334577777666 499999999998     56


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..++|+||||+.|+.   +. +....+.+++..++.|++.++.||+|||++ ||||||||.+|||+|.+|| +||+|||+
T Consensus       441 ~~~l~fvmey~~Ggd---m~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh-~kiADFGl  514 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGD---LM-HHIHTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGH-VKIADFGL  514 (694)
T ss_pred             CCeEEEEEEecCCCc---EE-EEEecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCc-EEeccccc
Confidence            667999999999863   22 222357899999999999999999999998 9999999999999999995 99999999


Q ss_pred             ceecc-cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ++... .+....+.+|||.|||||++.+.. |+.++|+|||||+|||||.|..||++.++.+.+..|...          
T Consensus       515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------  583 (694)
T KOG0694|consen  515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------  583 (694)
T ss_pred             ccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Confidence            98764 566777899999999999997654 999999999999999999999999999999999888762          


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCCCCCCCCCCCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDPNTRLPNGRFLP  368 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~~~~~~~~~~~~~  368 (403)
                             +.            .++..+|.++.++++++|..||++|..     ++++.+||||+.+.+.  .+.+....|
T Consensus       584 -------~~------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~--~L~~r~i~P  642 (694)
T KOG0694|consen  584 -------EV------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD--DLLNRRIKP  642 (694)
T ss_pred             -------CC------------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH--HHhhccCCC
Confidence                   11            133458999999999999999999976     5789999999999754  444434433

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-53  Score=359.81  Aligned_cols=256  Identities=32%  Similarity=0.452  Sum_probs=219.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+.|.+.+.||+|.|+.||++.+..+|+.+|+|.+..      +.+.+++|+.+-+.|+|||||++.+.+     ....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence            34579999999999999999999999999999997732      345667999999999999999998877     6677


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC--CCCceEEeecC
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFG  213 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG  213 (403)
                      +.|||+|+|.| .|...+-.+    .-+++..+..+++||+++|.|+|.+ ||||||+||+|+++.+  ++.-+||+|||
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccc
Confidence            88999999996 555444433    3478888999999999999999998 9999999999999954  34469999999


Q ss_pred             CceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      +|.....+.......|||.|||||++...+ |+..+|||+.|+|||-|+.|.+||.+.+....+++|++..-        
T Consensus       159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y--------  229 (355)
T KOG0033|consen  159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY--------  229 (355)
T ss_pred             eEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc--------
Confidence            999888777777889999999999997766 99999999999999999999999999888888888887421        


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                               .++.        ..++++++++++|+++||..||.+|+|+.|+|+|||+++-
T Consensus       230 ---------d~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  230 ---------DYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             ---------CCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence                     1111        1235789999999999999999999999999999999874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-51  Score=374.74  Aligned_cols=258  Identities=33%  Similarity=0.527  Sum_probs=209.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..+|...+.||+|+||.||++.+..+|..+|||.+...    .....+|+.+|+.++|||||++++.......   ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence            34688899999999999999999999999999998665    3446899999999999999999886422221   4678


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC-CCCceEEeecCCcee
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKV  217 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~DfG~a~~  217 (403)
                      +.|||+++ +|.+++....   ..+++..++.+.+||+.||.|||++ |||||||||+|||++. ++ .+||+|||+++.
T Consensus        93 i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~  167 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNG-DVKLADFGLAKK  167 (313)
T ss_pred             eeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCC-eEEeccCccccc
Confidence            99999995 7888877652   2799999999999999999999998 9999999999999998 46 799999999886


Q ss_pred             ccc----CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHH
Q 015615          218 LVK----GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       218 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ...    ........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+....        
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------  239 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------  239 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--------
Confidence            653    222346789999999999975332345999999999999999999999873 3222222222110        


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                ..|         .++..+|.++++||.+||..||++||||+++|+|||.+.-..
T Consensus       240 ----------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 ----------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ----------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                      011         244568999999999999999999999999999999987543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-49  Score=377.43  Aligned_cols=286  Identities=40%  Similarity=0.701  Sum_probs=226.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||+|.+..+|..||||.+...      .....+|+.+++.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            599999999999999999999999999999988532      12345799999999999999999987654444445678


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|||||+++|.+.+...    ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            99999998888877643    5689999999999999999999998 999999999999999887 79999999987543


Q ss_pred             cCCC----cceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          220 KGEP----NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       220 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ....    .....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2211    1235689999999998542 3589999999999999999999999999888888888888888887765543


Q ss_pred             cCcCcc-cc--cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          295 MNPNYT-EF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       295 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      ....-. .+  ........++...+ +.+++++.+||.+||+.||++|||++++++||||+.+....
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence            221100 00  00000111111112 34688999999999999999999999999999999876643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.7e-49  Score=370.06  Aligned_cols=282  Identities=32%  Similarity=0.559  Sum_probs=218.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||.+....     ....+|+.+++.++||||+++++++.     +..+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence            357999999999999999999999999999999885322     23457999999999999999998873     34468


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||+.+++.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTG-ELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECCCCcceec
Confidence            899999999888877653   35688889999999999999999998 999999999999999877 7999999998754


Q ss_pred             ccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+..+ .+.+..+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            222 2223456789999999987666689999999999999999999999988644 35556666666766655443321


Q ss_pred             c--CcccccCCCccCCCcccccc-cCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          297 P--NYTEFKFPQIKAHPWHKIFQ-KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       297 ~--~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      .  .+....+.......+...+. ...++++.+|+++||+.||++|||+.++|+||||+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            1  11110111111111111111 13567899999999999999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-50  Score=371.92  Aligned_cols=257  Identities=30%  Similarity=0.459  Sum_probs=211.3

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------------hhhHHHHHHHHHcCCCCeeec
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------RYKNRELQTMRLLDHPNVVSL  123 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h~niv~~  123 (403)
                      +...+|++.+.||+|.||.|-+|++..+++.||||++.+..                  +...+|+.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            45568999999999999999999999999999999985421                  234579999999999999999


Q ss_pred             ceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCC-CCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC
Q 015615          124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (403)
Q Consensus       124 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~-l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~  202 (403)
                      +++.-+   .....+|||+|||..+-   +.... .... +.+.+++.|+++++.||.|||.+ |||||||||+|+|+++
T Consensus       174 iEvLDD---P~s~~~YlVley~s~G~---v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  174 IEVLDD---PESDKLYLVLEYCSKGE---VKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEeecC---cccCceEEEEEeccCCc---cccCC-CCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcC
Confidence            998633   44456899999998431   12222 2334 89999999999999999999999 9999999999999999


Q ss_pred             CCCceEEeecCCceecccCC------CcceeeecccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc
Q 015615          203 HTHQLKLCDFGSAKVLVKGE------PNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGESG  273 (403)
Q Consensus       203 ~~~~vkl~DfG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~  273 (403)
                      +| .|||+|||.+.....+.      .....+|||.|+|||.+.+.   ...+.+.||||+|++||.|+.|+.||.+...
T Consensus       246 ~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  246 DG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            87 79999999997663221      12347899999999999763   3457899999999999999999999999988


Q ss_pred             HHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                      .+.+.+|.+.                 ...+|.          .+.+..+++|||++||++||++|++..++..|||...
T Consensus       325 ~~l~~KIvn~-----------------pL~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  325 LELFDKIVND-----------------PLEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHHhcC-----------------cccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            8888887762                 111121          1346889999999999999999999999999999876


Q ss_pred             C
Q 015615          354 L  354 (403)
Q Consensus       354 ~  354 (403)
                      -
T Consensus       378 ~  378 (576)
T KOG0585|consen  378 D  378 (576)
T ss_pred             C
Confidence            3

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-49  Score=362.21  Aligned_cols=274  Identities=27%  Similarity=0.462  Sum_probs=223.4

Q ss_pred             CCCCCccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecC
Q 015615           57 KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (403)
Q Consensus        57 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (403)
                      ....+.....|++...||.|..++||+|++..+++.||||++..++     ..+.+|+..++.++||||++++-+|....
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            3445555668999999999999999999999999999999985432     45678999999999999999998885433


Q ss_pred             CCCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                           .+|+||+||. |+++++++..+.  ..+++..+..++++++.||.|||.+ |.||||||+.||||+.+| .|||+
T Consensus        98 -----~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG-~VkLa  168 (516)
T KOG0582|consen   98 -----ELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDG-TVKLA  168 (516)
T ss_pred             -----eeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCC-cEEEc
Confidence                 4999999999 689999988774  5599999999999999999999998 999999999999999998 79999


Q ss_pred             ecCCceecccCCC-c----ceeeecccccccccc-cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015615          211 DFGSAKVLVKGEP-N----ISYICSRYYRAPELI-FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (403)
Q Consensus       211 DfG~a~~~~~~~~-~----~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  284 (403)
                      |||.+..+..+.. .    .+.+||++|||||++ .....|+.|+||||||++..||.+|..||....+.+.+..-++  
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--  246 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--  246 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--
Confidence            9998755533222 1    345799999999995 4445699999999999999999999999998887776654433  


Q ss_pred             CCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      +.|+......                 ....-.+.++..++.++..||+.||.+|||++++|+|+||+..+...
T Consensus       247 n~pp~~~t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  247 NDPPTLLTSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             CCCCCccccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence            4443221100                 00001134678999999999999999999999999999999876543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-50  Score=380.68  Aligned_cols=250  Identities=30%  Similarity=0.500  Sum_probs=216.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .|...+.||+|+.|.||.|+...+++.||||++...    ++...+|+.+|+..+|+|||.+++.|+...     .+|+|
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d-----eLWVV  348 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD-----ELWVV  348 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc-----eeEEE
Confidence            588889999999999999999999999999998543    345568999999999999999999986653     38999


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||+| +|.+.+..     ..+++.+++.++++++.||+|||.+ ||+|||||.+|||++.++ .+||+|||++..+..
T Consensus       349 MEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCC-cEEEeeeeeeecccc
Confidence            999996 66666654     4589999999999999999999998 999999999999999888 799999999987755


Q ss_pred             CC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       221 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      .. ...+.+|||+|||||++... .|+++.||||||++++||+-|.+||-..+....+..|... |.|...         
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk---------  490 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK---------  490 (550)
T ss_pred             ccCccccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC---------
Confidence            44 55678999999999999654 5999999999999999999999999988888777776653 332211         


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                      .+..+|+.++|||.+||+.|+++|++|.|||+||||+..
T Consensus       491 ----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  491 ----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             ----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                            235689999999999999999999999999999999553

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.2e-50  Score=379.76  Aligned_cols=248  Identities=32%  Similarity=0.532  Sum_probs=214.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|.+.+.||+|.||.||+|+.+.+.+.||||.+.+..      ....+|+++++.++|||||.++++|     +....+|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~~   77 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHLW   77 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceEE
Confidence            6888899999999999999999999999999985543      2356899999999999999999998     5566699


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|.|||.|+|..++..    ++.++++.++.++.|++.||.|||+. +|+|||+||.|||++..+ .+|+||||+|+.+.
T Consensus        78 vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   78 VVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGG-TLKLCDFGLARAMS  151 (808)
T ss_pred             EEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCC-ceeechhhhhhhcc
Confidence            9999999999988876    47899999999999999999999998 999999999999999877 79999999999875


Q ss_pred             cCCCc-ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .+... .+..|||.|||||++.+.+ |+..+|+||||||+|||++|++||....-.+....|.+.   |.          
T Consensus       152 ~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v----------  217 (808)
T KOG0597|consen  152 TNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV----------  217 (808)
T ss_pred             cCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC----------
Confidence            54332 3557999999999997655 999999999999999999999999876555554444431   11          


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                      .++..+|..+..||+.+|.+||.+|.|..+++.|||.++-
T Consensus       218 ----------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  218 ----------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ----------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                            1223579999999999999999999999999999999863

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-49  Score=359.75  Aligned_cols=273  Identities=28%  Similarity=0.453  Sum_probs=224.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||.|.-|+||+|+...++..+|+|++.+..       .....|.+||+.++||.++.+|..|     +...
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence            347899999999999999999999999999999996542       2234589999999999999999998     6677


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      +.|++||||+| +|..++.++  ....+++..+++|+.+++.||+|||.. |||+|||||+||||..+|| |.|+||.++
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredGH-IMLsDFDLS  226 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDGH-IMLSDFDLS  226 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCCc-EEeeecccc
Confidence            89999999996 555544433  467899999999999999999999976 9999999999999999995 999999986


Q ss_pred             eeccc---------------------------------C-C-----------------------Ccceeeeccccccccc
Q 015615          216 KVLVK---------------------------------G-E-----------------------PNISYICSRYYRAPEL  238 (403)
Q Consensus       216 ~~~~~---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~  238 (403)
                      .....                                 . .                       ...+++||-.|.|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            43200                                 0 0                       0124578999999999


Q ss_pred             ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCccccccc
Q 015615          239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK  318 (403)
Q Consensus       239 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (403)
                      +.+.. .+.++|+|+||+++|||+.|..||.|.+..+.+..|+..                 ...+|..          +
T Consensus       307 I~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~----------~  358 (459)
T KOG0610|consen  307 IRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE----------P  358 (459)
T ss_pred             eecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------C
Confidence            98766 799999999999999999999999999999999887752                 1112211          2


Q ss_pred             CCChHHHHHHHHhhccCCCCCCC----HHHHhcCCCCccCCCCCCCCCCCCCCCCCCCC
Q 015615          319 RMPPEAVDLVSRLLQYSPNLRST----ALEALIHPFFDELRDPNTRLPNGRFLPPLFNF  373 (403)
Q Consensus       319 ~~s~~~~~ll~~~L~~dP~~R~s----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  373 (403)
                      .++..++|||+++|.+||++|..    |+|+.+||||++++|.-.+....+.+|...+.
T Consensus       359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~  417 (459)
T KOG0610|consen  359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG  417 (459)
T ss_pred             cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence            57899999999999999999998    99999999999999876555544455554444

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-49  Score=323.97  Aligned_cols=277  Identities=36%  Similarity=0.671  Sum_probs=235.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .|.-.++||+|.||+||+|++..+++.||+|.++.+.      ....+|+.+|+.++|.|||+++++.     .....+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence            3555678999999999999999999999999986543      3456899999999999999999876     3334478


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|+|||...|..++...   ++.+..+.++.++.|+++||.|+|++ ++.||||||.|.||+.+| .+|++|||+++...
T Consensus        78 lvfe~cdqdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ng-elkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNG-ELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence            99999999888777654   57789999999999999999999998 999999999999999998 89999999998763


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC-
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  296 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  296 (403)
                      -.-. ....+.|.+|++|.++++..-|++..|+||.|||+.|+.. |++.|++.+-.+++..|+..+|.|..+.|+.+. 
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            3322 2344679999999999999999999999999999999996 999999999999999999999999999887653 


Q ss_pred             -cCcccccCCCccCC-CcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          297 -PNYTEFKFPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       297 -~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                       ++|..  +|.++.. .|..+. ++++...+||++++|..+|.+|++++++|+||||.+..
T Consensus       233 lpdyk~--yp~ypattswsqiv-p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  233 LPDYKP--YPIYPATTSWSQIV-PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCCCcc--cCCccccchHHHHh-hhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence             44433  3443333 344433 56788899999999999999999999999999998754

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3e-48  Score=362.62  Aligned_cols=279  Identities=34%  Similarity=0.584  Sum_probs=221.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEcc-CCcEEEEEEeccch------hhhHHHHHHHHHc---CCCCeeecceeeeecCCCCc
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~  135 (403)
                      +|++.+.||+|+||.||+|++.. +|..||+|.+....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            69999999999999999999854 46889999875321      2334677777665   69999999998754333344


Q ss_pred             eEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       136 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..+++||||++++|.+.+....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            5688999999998888876532  34588999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .............+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            876544444456789999999998654 4899999999999999999999999999988999999888887776655332


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      .. .....+......+... +.+.++..+.+|+.+||+.||++|||+.++|+||||
T Consensus       237 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VA-LPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hc-ccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            11 1111111111122222 224578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.4e-48  Score=365.05  Aligned_cols=283  Identities=34%  Similarity=0.639  Sum_probs=230.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++||||+++++++.     .....+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence            46999999999999999999999999999999885332     23457999999999999999999873     334578


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||+++++.+.+...   ...++...++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence            99999999888777543   34578889999999999999999998 999999999999999877 79999999987543


Q ss_pred             cCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+....+.+....++.....
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            222 2223467899999999876566899999999999999999999999999888889999999998888776554321


Q ss_pred             --cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          299 --YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       299 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                        +..+.++.....++... .+.+++++.+||.+||+.||.+|||++|+++||||+.+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  296 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINH-APRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI  296 (309)
T ss_pred             hhhhhhhcCccCCCchhhh-ccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence              22223333322222221 245789999999999999999999999999999999875443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.6e-48  Score=360.83  Aligned_cols=275  Identities=40%  Similarity=0.717  Sum_probs=219.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.++||||+++++++     ....+++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            699999999999999999999999999999988543      22345799999999999999999887     3344688


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||+++++...+...   ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            99999998776665443   35689999999999999999999987 999999999999999887 79999999997653


Q ss_pred             cCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc--
Q 015615          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  295 (403)
Q Consensus       220 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  295 (403)
                      ...  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+....+..+...+...  
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            322  122456899999999997654 899999999999999999999999998888877777777777666554322  


Q ss_pred             CcCcccccCCCcc-CCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          296 NPNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       296 ~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      .+.+.....+... ...+...+...+|.++.+||++||++||++|||++++|+||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1222111111111 1112223334578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1e-47  Score=370.15  Aligned_cols=286  Identities=31%  Similarity=0.554  Sum_probs=223.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|.+..+|..||||.+...      .....+|+.+++.++||||+++++++..... ....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            35799999999999999999999999999999998532      2234579999999999999999998743321 1223


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+|+||||+++++.+.+.      ..++...+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~  171 (359)
T cd07876         100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  171 (359)
T ss_pred             eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEecCCCcc
Confidence            578999999998777653      3478888999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...++.|.........
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            65444334456789999999999764 48999999999999999999999999998888888888888877765432211


Q ss_pred             ----------cCcccccCCCcc-C--CCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          297 ----------PNYTEFKFPQIK-A--HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       297 ----------~~~~~~~~~~~~-~--~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                                +.+....+...- .  .+.........++++++||.+||+.||++|||+.|+|+||||+...++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  325 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA  325 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence                      111111100000 0  0000111223578899999999999999999999999999999765554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.8e-50  Score=347.00  Aligned_cols=258  Identities=28%  Similarity=0.459  Sum_probs=219.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------------hhhhHHHHHHHHHc-CCCCeeecceeeeecC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (403)
                      ..|.-.+.||.|..+.|.++.++.+|..+|+|++...            .....+|+.+|+++ .||+|+++.++|    
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----   92 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----   92 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec----
Confidence            3577888999999999999999999999999988321            12234699999998 599999999988    


Q ss_pred             CCCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                       +...++++|+|.|+ |.|.++|...    -.+++...+.+++|++.|+.|||.+ +||||||||+|||+|.+. ++||+
T Consensus        93 -es~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~-~i~is  165 (411)
T KOG0599|consen   93 -ESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNM-NIKIS  165 (411)
T ss_pred             -cCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeecccc-ceEEe
Confidence             66777999999999 7899888763    5689999999999999999999987 999999999999999877 79999


Q ss_pred             ecCCceecccCCCcceeeeccccccccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015615          211 DFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  285 (403)
Q Consensus       211 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  285 (403)
                      |||+|+.+..++.....+|||.|.|||.+.     +.+.|+..+|+||+|+|||.|+.|.+||......-++..|++..-
T Consensus       166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky  245 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY  245 (411)
T ss_pred             ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence            999999999999889999999999999984     345689999999999999999999999987766666666665311


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                                       .+        .+.-+.++|...+|||++||+.||.+|.|++|+|.||||..+....
T Consensus       246 -----------------qF--------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~  293 (411)
T KOG0599|consen  246 -----------------QF--------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ  293 (411)
T ss_pred             -----------------cc--------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence                             11        1112346899999999999999999999999999999998765443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-49  Score=336.60  Aligned_cols=252  Identities=30%  Similarity=0.451  Sum_probs=219.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++++.||+|.||.||+|+.++++..||+|++.+..       ....+|+++...|+||||+++|++|     .+.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence            4467999999999999999999999999999999985543       4456899999999999999999998     455


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+|+++||.+ |++...|....  ..++++..+..|+.|++.||.|+|.. +|+||||||+|+|++.++ .+||+|||.
T Consensus        95 ~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~-~lkiAdfGw  170 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAG-ELKIADFGW  170 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCC-CeeccCCCc
Confidence            55899999998 68888776432  46688889999999999999999987 999999999999999988 799999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.... .....+.+||..|.+||...+.. ++..+|+|++|++.||++.|.+||...+..+.+..|.+.-          
T Consensus       171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~----------  238 (281)
T KOG0580|consen  171 SVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD----------  238 (281)
T ss_pred             eeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc----------
Confidence            87654 45567889999999999997655 8999999999999999999999999998778888777631          


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                             +            .++..++.++.|||.+||..+|.+|.+..|++.|||+...
T Consensus       239 -------~------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  239 -------L------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -------c------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                   1            1345689999999999999999999999999999998764

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.8e-47  Score=356.85  Aligned_cols=279  Identities=30%  Similarity=0.539  Sum_probs=221.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHc---CCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4899999999999999999999999999999885321      2334677777665   799999999987554444456


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .++++|||+.+++...+....  ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            688999999998887776532  24589999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ............+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+.++....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            76544444456789999999999654 48999999999999999999999999988888888888887777665543211


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      . .....+......++.. +.+.++..+.+||.+||+.||++|||+.+++.||||
T Consensus       236 ~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 T-LPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             c-ccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0 0011111111112222 224578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.3e-47  Score=368.35  Aligned_cols=287  Identities=31%  Similarity=0.556  Sum_probs=227.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            35799999999999999999999999999999998542      1234579999999999999999987643221 2234


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+|+||||+++++.+.+..      .++...+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       103 ~~~lv~e~~~~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCCCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCC-cEEEEeCCCcc
Confidence            5789999999988776642      477888999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|..+.+....
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            65444333456789999999999765 48999999999999999999999999999888888888888888776544333


Q ss_pred             cC----------cccccCCCc---cCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          297 PN----------YTEFKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       297 ~~----------~~~~~~~~~---~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                      +.          +..+.+...   ...++........+..+++||.+||+.||.+|||+.++|+||||..+.++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~  329 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE  329 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence            21          111111000   0011122222334678999999999999999999999999999998766644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.6e-48  Score=365.87  Aligned_cols=250  Identities=29%  Similarity=0.425  Sum_probs=208.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||.+....       ....+|+.+++.++||||+++++++     .+..
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            457999999999999999999999999999999985432       2345799999999999999999887     3344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  165 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKG-HVKVTDFGFA  165 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence            68899999985 77777664    35688999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+...  .+        
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~--------  232 (329)
T PTZ00263        166 KKVPDR--TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RL--------  232 (329)
T ss_pred             eEcCCC--cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--Cc--------
Confidence            865332  23467899999999997654 799999999999999999999999887665554444321  00        


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                         .++..++..+.+||++||+.||.+|++     ++++++||||++..+
T Consensus       233 -------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~  279 (329)
T PTZ00263        233 -------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW  279 (329)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence                               012346889999999999999999997     799999999988543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.4e-48  Score=359.77  Aligned_cols=256  Identities=24%  Similarity=0.375  Sum_probs=206.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++|+||+++++++     .+..++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            3888999999999999999999999999999875321       2345799999999999999998877     333458


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++ +|...+....  ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRG-HIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeCCCcEE
Confidence            899999985 6665554321  34688999999999999999999987 999999999999999877 799999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.......          
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05631         152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------  220 (285)
T ss_pred             cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------
Confidence            6444444456789999999999755 48999999999999999999999998765433332222211100          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                     ...++..++.++.+||++||+.||.+|++     ++++++||||+++.+
T Consensus       221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                           00123457899999999999999999997     899999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.6e-47  Score=356.68  Aligned_cols=287  Identities=32%  Similarity=0.616  Sum_probs=230.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|.+.+.||.|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++.     ...+.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence            457999999999999999999999999999999885321     23457999999999999999999873     34458


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||++++|.+.+...   ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++...
T Consensus        80 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence            899999999888777653   34688899999999999999999997 999999999999999887 7999999998754


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+....+.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            3222 122345688999999987666688999999999999999999999999888888888888888877766544321


Q ss_pred             --CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCC
Q 015615          298 --NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL  361 (403)
Q Consensus       298 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~  361 (403)
                        .+....++........ .....+++++.+||.+||+.||.+|||++++|+||||+.+......+
T Consensus       235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~  299 (301)
T cd07873         235 NEEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKL  299 (301)
T ss_pred             cccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcC
Confidence              1222223322221111 22346789999999999999999999999999999999887654443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=364.56  Aligned_cols=257  Identities=33%  Similarity=0.517  Sum_probs=219.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  135 (403)
                      ...|.+.+.||.|.||.||+|+++.+|+.+|+|.+.+..       ....+|+.+|+.++ |||||.+++.|     ++.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcC
Confidence            346999999999999999999999999999999986532       36678999999999 99999999998     444


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC---CceEEee
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLCD  211 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~---~~vkl~D  211 (403)
                      .++++|||+|.| .|.+.+...     .+++..+..++.|++.++.|||+. ||+||||||+|+|+....   +.+|++|
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEee
Confidence            468999999995 777777654     399999999999999999999997 999999999999996542   2799999


Q ss_pred             cCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       212 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ||++.....+......+||+.|+|||++... .|+..+||||+|+++|.|++|.+||.+.+.......+...-       
T Consensus       183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~-------  254 (382)
T KOG0032|consen  183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD-------  254 (382)
T ss_pred             CCCceEccCCceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC-------
Confidence            9999988776666788999999999999644 49999999999999999999999999998887777665521       


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                           .             .+....+..++..+++|+++||..||.+|+|+.++|+|||++.....
T Consensus       255 -----~-------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  255 -----F-------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             -----C-------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence                 0             11112335679999999999999999999999999999999986433

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4e-47  Score=365.48  Aligned_cols=285  Identities=32%  Similarity=0.554  Sum_probs=225.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            45799999999999999999999999999999988542      1234479999999999999999998754322 2234


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ..++||||+++++.+.+.      ..++...+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~-~~kl~Dfg~~~  167 (355)
T cd07874          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  167 (355)
T ss_pred             eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCC-CEEEeeCcccc
Confidence            578999999998777664      2478888999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+....
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            65444444456789999999999665 48999999999999999999999999998888888888888887766554433


Q ss_pred             cCc----------ccccCCCcc---CCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          297 PNY----------TEFKFPQIK---AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       297 ~~~----------~~~~~~~~~---~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      +..          ....++...   ..+.........+.++++||.+||..||++|||+.|+|+||||+...++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            221          111111100   0111122233456789999999999999999999999999999876554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-47  Score=370.71  Aligned_cols=284  Identities=36%  Similarity=0.578  Sum_probs=224.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++|+||+++++++..........+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            377889999999999999999999999999988532      12345799999999999999999987443322223578


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||+.++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            9999999888777654    35689999999999999999999998 999999999999999887 79999999997653


Q ss_pred             cCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       220 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+...++.+..+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            222  122346788999999997766689999999999999999999999999999999999999999888766543221


Q ss_pred             CcccccCCCccCC-Ccc--cccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          298 NYTEFKFPQIKAH-PWH--KIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       298 ~~~~~~~~~~~~~-~~~--~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      ............. .+.  ..+....++++.+||.+||+.||++|||+.++|+||||++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            1100000000000 000  012345688999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-47  Score=358.40  Aligned_cols=248  Identities=26%  Similarity=0.396  Sum_probs=207.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+...       .....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            589999999999999999999999999999998532       22345799999999999999998876     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++ +|.+.+...    ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            899999985 777777653    5688999999999999999999998 999999999999999887 799999999876


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+....             
T Consensus       151 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------  214 (291)
T cd05612         151 LRDR--TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-------------  214 (291)
T ss_pred             ccCC--cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            5332  23457899999999986544 8999999999999999999999999877666555544310             


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                      ..++..+++.+++||++||+.||.+|++     ++++++||||+.+.+
T Consensus       215 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         215 ----------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             ----------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence                            0123456889999999999999999995     999999999998654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-47  Score=369.44  Aligned_cols=277  Identities=24%  Similarity=0.329  Sum_probs=212.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEec
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      .+|.+.+.||+|+||.||+|.+..+++.||||....  ....+|+.+++.++||||++++++|..     ..+.++|||+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEec
Confidence            479999999999999999999999999999997543  345689999999999999999998733     3457899999


Q ss_pred             ccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC--C
Q 015615          145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--E  222 (403)
Q Consensus       145 ~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~--~  222 (403)
                      +.++|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.....  .
T Consensus       165 ~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 YKTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCC-CEEEEeCCccccccccccc
Confidence            998887777543    5688999999999999999999998 999999999999999887 7999999998753222  1


Q ss_pred             CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-------SGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       223 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...       ....++..+....+.++.+.....
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             ccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            22345789999999999665 4899999999999999999999877543       234556666666665443211000


Q ss_pred             CcCcc-------c-ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          296 NPNYT-------E-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       296 ~~~~~-------~-~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .....       . ..........|...  ..++.++.+||.+||++||.+|||+.|+|+||||+++..+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            00000       0 00000000111111  1357789999999999999999999999999999987544

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-47  Score=363.66  Aligned_cols=285  Identities=35%  Similarity=0.625  Sum_probs=226.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|.+.+.||+|+||.||+|.+..++..||||.+....      ....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            46999999999999999999999999999999986432      234479999999999999999987743221 22234


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .|++|++++++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        95 ~~~~~~~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCC-CEEEcCCcccee
Confidence            689999998888776642     5689999999999999999999998 999999999999999887 799999999986


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..........
T Consensus       168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            5332  33457899999999997655689999999999999999999999999888888888888877777655433221


Q ss_pred             Ccccc---cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       298 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                      .....   ..+......+...+ ...++.+.+||.+||..||.+|||+.++|+||||.....+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~  309 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED  309 (343)
T ss_pred             hhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCcc
Confidence            11100   11111111222222 346788999999999999999999999999999998776643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.6e-47  Score=361.97  Aligned_cols=245  Identities=27%  Similarity=0.432  Sum_probs=201.1

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      +.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++     ....++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            36999999999999999999999999986432       2334689999999999999998877     33446889999


Q ss_pred             cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc-C
Q 015615          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  221 (403)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-~  221 (403)
                      |+++ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9985 66666654    35789999999999999999999998 999999999999999887 799999999875322 2


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                      .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+...  .               
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~---------------  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--E---------------  211 (323)
T ss_pred             CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--C---------------
Confidence            233456789999999999654 4899999999999999999999999887655444433221  0               


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                      .            .++..+++++.+||++||+.||++||     ++.++++||||+.+.+
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~  259 (323)
T cd05571         212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW  259 (323)
T ss_pred             C------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            0            12345789999999999999999999     8999999999988643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-46  Score=356.23  Aligned_cols=278  Identities=32%  Similarity=0.553  Sum_probs=209.6

Q ss_pred             EeEeeeCCcEEEEEEEEc--cCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           70 ERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      +++||+|+||.||+|++.  .+++.||+|.+....  ....+|+.+++.++||||+++++++...   ...+++++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            457999999999999965  467899999986432  3456899999999999999999887542   234578999999


Q ss_pred             cchHHHHHHhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC---CCCceEEeecCCcee
Q 015615          146 PETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  217 (403)
Q Consensus       146 ~~~l~~~l~~~~~-----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~DfG~a~~  217 (403)
                      ++++...+.....     ....+++..++.++.||+.||+|||++ ||+||||||+|||++.   ..+.+||+|||+++.
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9988887764321     123589999999999999999999998 9999999999999942   223799999999976


Q ss_pred             cccCC----CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHh
Q 015615          218 LVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKVL  284 (403)
Q Consensus       218 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~~  284 (403)
                      .....    ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+...         .+++..+....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            54322    123457799999999997766689999999999999999999999975432         35677788888


Q ss_pred             CCCCHHHHhccCcC--cc----ccc---CCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          285 GTPTREEIKCMNPN--YT----EFK---FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       285 ~~~~~~~~~~~~~~--~~----~~~---~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      +.|....+.....-  ..    .+.   ........+........+.++.+||++||++||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            88877665432210  00    000   000000001111112346789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.6e-46  Score=368.23  Aligned_cols=279  Identities=23%  Similarity=0.378  Sum_probs=213.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCC------CeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~  134 (403)
                      ..+|++.+.||+|+||+||+|.+..+++.||||++....   .....|+.+++.++|.      +++.++++|..    +
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            467999999999999999999999999999999985432   2345688888877654      47777776532    2


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC---------
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---------  205 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---------  205 (403)
                      ..++|+||++++++|.+.+...    ..+++..++.++.||+.||+|||++.|||||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            3457899999988888877653    568999999999999999999997349999999999999986542         


Q ss_pred             ------ceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 015615          206 ------QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (403)
Q Consensus       206 ------~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  279 (403)
                            .+||+|||.+....  .......||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  49999999876432  2234567899999999997654 89999999999999999999999999888888888


Q ss_pred             HHHHhCCCCHHHHhccCcC-cccc-c-----CCCcc---------CCCcccccccCCChHHHHHHHHhhccCCCCCCCHH
Q 015615          280 IIKVLGTPTREEIKCMNPN-YTEF-K-----FPQIK---------AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  343 (403)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~-~~~~-~-----~~~~~---------~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~  343 (403)
                      +.+.++.++.......... ...+ .     .+...         ...+...   ..++.+.|||.+||++||.+|||++
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV---IRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh---hchHHHHHHHHHhCCcChhhCCCHH
Confidence            8888887765433211000 0000 0     00000         0000000   1246788999999999999999999


Q ss_pred             HHhcCCCCccCCC
Q 015615          344 EALIHPFFDELRD  356 (403)
Q Consensus       344 ell~hp~f~~~~~  356 (403)
                      |+|+||||.....
T Consensus       434 e~L~Hp~~~~~~~  446 (467)
T PTZ00284        434 QMTTHPYVLKYYP  446 (467)
T ss_pred             HHhcCccccccCC
Confidence            9999999998644

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=355.89  Aligned_cols=259  Identities=30%  Similarity=0.442  Sum_probs=229.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+-|.+.+.||+|.|+.|-+|++.-+|+.||||++.+.+      ..+.+|+..|+.++|||||++|++..     ...
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQT   90 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQT   90 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccc
Confidence            3346999999999999999999999999999999986532      34568999999999999999999872     333


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|+|+|+-++ +|.+++..+   ...+.+..++.|++||+.|+.|||.- .+|||||||+||.+-..-+-|||+|||++
T Consensus        91 KlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeecccc
Confidence            48999999985 899988776   57899999999999999999999975 99999999999988766668999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ..+..+....+.+|+..|.|||++.+..+-.+++||||||+|||-|++|.+||...++.+.+..|+.+-           
T Consensus       167 Nkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-----------  235 (864)
T KOG4717|consen  167 NKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-----------  235 (864)
T ss_pred             ccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-----------
Confidence            999889888999999999999999999877889999999999999999999999999999999988752           


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                            |..            +..+|.++++||..||..||.+|.|.+++..|+|++.+..+..
T Consensus       236 ------Ytv------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  236 ------YTV------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             ------ccC------------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence                  222            2457999999999999999999999999999999999876543

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-46  Score=362.89  Aligned_cols=253  Identities=27%  Similarity=0.424  Sum_probs=203.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||+|+||+||+|.+..+++.||||++....       ....+|+.++..++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            5899999999999999999999999999999986432       2345799999999999999999887     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+|||||++ +|.+.+..    ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            999999985 67777654    35789999999999999999999997 999999999999999887 799999999875


Q ss_pred             cccCC------------------------------------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHH
Q 015615          218 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (403)
Q Consensus       218 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  261 (403)
                      .....                                    .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence            42210                                    01235789999999999765 489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCC---C
Q 015615          262 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN---L  338 (403)
Q Consensus       262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~---~  338 (403)
                      ++|++||.+.+..+....+.......               .++.          ...+++++++||.+|+. +|.   .
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKETL---------------IFPP----------EVPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcCcc---------------cCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence            99999999887666665554321100               0110          02368899999999876 454   4


Q ss_pred             CCCHHHHhcCCCCccCCC
Q 015615          339 RSTALEALIHPFFDELRD  356 (403)
Q Consensus       339 R~s~~ell~hp~f~~~~~  356 (403)
                      ||+++++++||||+++.+
T Consensus       284 r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         284 APGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCCHHHHhCCCCCCCCCH
Confidence            589999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-46  Score=357.96  Aligned_cols=251  Identities=29%  Similarity=0.426  Sum_probs=207.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCC-cEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|.+.+.||+|+||.||+|.+..++ ..||+|.+...       .....+|+.+++.++||||+++++++     .+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence            3457999999999999999999976654 68999988542       12345799999999999999999987     33


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ..++++||||+.+ +|.+.+...    ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~ikL~DFG  176 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDG-FIKMTDFG  176 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEecCC
Confidence            4468899999975 777777543    5689999999999999999999998 999999999999999877 79999999


Q ss_pred             CceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+....         
T Consensus       177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------  244 (340)
T PTZ00426        177 FAKVVDT--RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------  244 (340)
T ss_pred             CCeecCC--CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence            9986532  234567899999999997644 7999999999999999999999999877655555443310         


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                                          ..++..+++.+.++|++||+.||.+|+     |++++++||||+.+.+
T Consensus       245 --------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        245 --------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                                012345788999999999999999995     8999999999998654

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.4e-46  Score=346.22  Aligned_cols=276  Identities=35%  Similarity=0.564  Sum_probs=216.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+....      ....+|+.+++.++||||+++++++     .+..+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            4889999999999999999999999999999885321      2345799999999999999999887     3444588


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|+||+++++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            99999999888776643   35689999999999999999999987 999999999999999887 79999999987553


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .... .....+++.|+|||++.+...++.++|||||||++|+|+||..| |.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            3221 22345688999999987666679999999999999999998877 555666677777777777776655443221


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      ......++............+.+++++.+||.+||+.||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111111111111111111234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-46  Score=356.77  Aligned_cols=256  Identities=30%  Similarity=0.469  Sum_probs=209.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.++..++||||+++++++     .+..++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            5999999999999999999999999999999986432       2345799999999999999998877     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            999999985 77777754    35688999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......          
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  217 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL----------  217 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------
Confidence            533  23456789999999999765 58999999999999999999999999877666555544321100          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                           ..+..      ......++.++.+||.+||..+|.+||++.++++||||.....
T Consensus       218 -----~~~~~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         218 -----QRPVY------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             -----cCCCC------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence                 00000      0001246899999999999999999999999999999998644

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-47  Score=349.11  Aligned_cols=248  Identities=26%  Similarity=0.439  Sum_probs=221.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|.||+|-+|.+...|+.||||.++++.       -.+++|+++|..|+||||+++|.+|     ++..
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence            357999999999999999999999999999999886543       2356899999999999999999998     5555


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+.|||||.. |.|.+++..+    +.+++..++.+++||..|+.|||.+ +++|||||.+|||+|.++ ++||+|||++
T Consensus       127 KIvivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~-NiKIADFGLS  200 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNN-NIKIADFGLS  200 (668)
T ss_pred             eEEEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCC-Ceeeeccchh
Confidence            6889999998 5899998875    7899999999999999999999988 999999999999999988 7999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ..+.......+++|+|-|.+||++.+.++-++.+|.||||++||.|+.|..||.+.+....+.+|.....          
T Consensus       201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY----------  270 (668)
T KOG0611|consen  201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY----------  270 (668)
T ss_pred             hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc----------
Confidence            9888888788999999999999998888789999999999999999999999999988777777665311          


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                                          +.+.-+.++.-||+.||..||++|.|++++..|=|.+
T Consensus       271 --------------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  271 --------------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             --------------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                                1234578999999999999999999999999998765

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=352.71  Aligned_cols=317  Identities=35%  Similarity=0.635  Sum_probs=239.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||.+...     .....+|+.+++.++|+||+++++++...........+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            4799999999999999999999999999999988532     12244699999999999999999876544434445678


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +++||+++++.+.+..     ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        85 lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~  157 (336)
T cd07849          85 IVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD  157 (336)
T ss_pred             EEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence            9999999887776643     5689999999999999999999998 999999999999999887 79999999987653


Q ss_pred             cCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          220 KGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       220 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .....    ....+|+.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+...++.+..+.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32211    23467889999998766556899999999999999999999999988877777778787887777665432


Q ss_pred             CcCccc-c--cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCC
Q 015615          296 NPNYTE-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFN  372 (403)
Q Consensus       296 ~~~~~~-~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  372 (403)
                      ...... +  ..+.....++.. ..+.+++++.+|+.+||+.||++|||+.++++||||+...++....    ..++..-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~----~~~~~~~  312 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP----VAEEPFP  312 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc----cCCCCCC
Confidence            211100 0  011111112211 1234688999999999999999999999999999999987764321    1112222


Q ss_pred             CChhhcCCCChHHHhhcchHH
Q 015615          373 FKPHELKGVPVDMLVKLIPEH  393 (403)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~  393 (403)
                      |.-.....++.+.++.++.++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~  333 (336)
T cd07849         313 FDFELFDDLPKEKLKELIFEE  333 (336)
T ss_pred             hhhccccccCHHHHHHHHHHH
Confidence            333344555566666665544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-46  Score=362.72  Aligned_cols=253  Identities=32%  Similarity=0.509  Sum_probs=205.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            6999999999999999999999999999999986431       2345799999999999999999887     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+||||+++ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            999999985 67777654    35689999999999999999999998 999999999999999888 799999999875


Q ss_pred             cccCCC---------------------------------------cceeeecccccccccccCCCCCCCchhHHHHHHHH
Q 015615          218 LVKGEP---------------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  258 (403)
Q Consensus       218 ~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  258 (403)
                      ......                                       ....+||+.|+|||++.+. .++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence            422110                                       0124689999999998654 489999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC
Q 015615          259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  338 (403)
Q Consensus       259 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~  338 (403)
                      |+|++|.+||.+.+..+....+......               ..++.          ...+++++.+||++||. +|.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWKET---------------LQFPD----------EVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCCCc---------------cCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence            9999999999988766555544331100               00000          12468999999999997 9999


Q ss_pred             CCC---HHHHhcCCCCccCCC
Q 015615          339 RST---ALEALIHPFFDELRD  356 (403)
Q Consensus       339 R~s---~~ell~hp~f~~~~~  356 (403)
                      |++   ++++++||||+...+
T Consensus       284 R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         284 RLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             cCCCCCHHHHhcCCCcCCCCH
Confidence            998   999999999998654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2e-47  Score=336.64  Aligned_cols=286  Identities=37%  Similarity=0.631  Sum_probs=229.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCC----cEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..|++...||+|.||.||+|....++    ..+|||+++..+      ...-||+.+++.++|||++.+..+|+..    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            36999999999999999999765443    368999986542      3345899999999999999999988653    


Q ss_pred             ceEEEEEEecccchHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC----CCceEE
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----THQLKL  209 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~----~~~vkl  209 (403)
                      ...+++++||.+.+|...++.+.. ....++...++.++.||+.|+.|||++ -|+||||||.|||+..+    | +|||
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG-~VKI  177 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERG-RVKI  177 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccC-eeEe
Confidence            456899999999999999987654 345689999999999999999999998 89999999999999876    5 8999


Q ss_pred             eecCCceecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------cHHH
Q 015615          210 CDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---------GVDQ  276 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---------~~~~  276 (403)
                      +|||+++.+.+.-..    ...+.|.+|+|||.+.+...|+.+.||||+|||+.||+|-.+.|.+..         ..++
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            999999987544322    245679999999999999999999999999999999999999997642         4568


Q ss_pred             HHHHHHHhCCCCHHHHhccC--cCcccccCCCccCCCccc-----cc--ccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          277 LVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHK-----IF--QKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~--~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      +..|++.+|.|....|+.+.  |.+.. ...+++...+..     .+  .+.-++.+.+|+.+||.+||.+|+|++++|+
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~-~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQT-LLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHH-HHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            89999999999999887653  33311 011111111111     11  1223566999999999999999999999999


Q ss_pred             CCCCccCCCC
Q 015615          348 HPFFDELRDP  357 (403)
Q Consensus       348 hp~f~~~~~~  357 (403)
                      |+||.+-.-|
T Consensus       337 h~yF~~d~lp  346 (438)
T KOG0666|consen  337 HPYFTEDPLP  346 (438)
T ss_pred             ccccccCCCC
Confidence            9999985444

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.8e-46  Score=360.64  Aligned_cols=254  Identities=29%  Similarity=0.464  Sum_probs=201.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|++.+.||+|+||+||+|++..+++.||||++....       ....+|+.+++.++||||+++++++.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            4899999999999999999999999999999985432       23457999999999999999998873     34468


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++ +|.+.+...    ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            899999985 777776543    5688999999999999999999987 999999999999999887 799999998753


Q ss_pred             cccCC------------------------------------------------CcceeeecccccccccccCCCCCCCch
Q 015615          218 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTAAI  249 (403)
Q Consensus       218 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~  249 (403)
                      .....                                                ......||+.|+|||++.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCcc
Confidence            21000                                                012346899999999996544 89999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHH
Q 015615          250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  329 (403)
Q Consensus       250 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  329 (403)
                      |||||||++|||++|.+||...+..+....+.......               ..+          ....+++++.+||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~----------~~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------HIP----------PQVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------CCC----------CCCCCCHHHHHHHH
Confidence            99999999999999999998877655544443211000               000          01247899999999


Q ss_pred             Hhhcc--CCCCCCCHHHHhcCCCCccCCC
Q 015615          330 RLLQY--SPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       330 ~~L~~--dP~~R~s~~ell~hp~f~~~~~  356 (403)
                      +|++.  +|..|++++++++||||+++.+
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            97655  4445999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-46  Score=362.96  Aligned_cols=253  Identities=30%  Similarity=0.496  Sum_probs=202.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|.+.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++||||++++++|     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence            5999999999999999999999999999999885432       2345699999999999999999887     344568


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+||||++ ++|.+.+..    ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            99999998 477777654    35688999999999999999999987 999999999999999887 799999999863


Q ss_pred             cccCCC------------------------------------------------cceeeecccccccccccCCCCCCCch
Q 015615          218 LVKGEP------------------------------------------------NISYICSRYYRAPELIFGATEYTAAI  249 (403)
Q Consensus       218 ~~~~~~------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~  249 (403)
                      ......                                                .....||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence            211000                                                0124689999999999654 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHH
Q 015615          250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  329 (403)
Q Consensus       250 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  329 (403)
                      |||||||++|||++|.+||.+.+..+.+..+......               ..++.          ...++.++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~dli~  284 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------LYFPD----------DIHLSVEAEDLIR  284 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------cCCCC----------CCCCCHHHHHHHH
Confidence            9999999999999999999887766555554431100               00110          0246889999999


Q ss_pred             HhhccCCCCC---CCHHHHhcCCCCccCCC
Q 015615          330 RLLQYSPNLR---STALEALIHPFFDELRD  356 (403)
Q Consensus       330 ~~L~~dP~~R---~s~~ell~hp~f~~~~~  356 (403)
                      +||. +|.+|   +|+.++++||||++..+
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            9998 77765   59999999999987643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-45  Score=343.24  Aligned_cols=276  Identities=34%  Similarity=0.633  Sum_probs=216.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|++|.||+|.+..+|..||||.+...      .....+|+.+++.++||||+++++++.     +..+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            488999999999999999999999999999987532      133567999999999999999999873     334588


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||+.+++.+.+.... ....+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999988877775432 235689999999999999999999987 999999999999999887 79999999987543


Q ss_pred             cCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ... ......+++.|+|||++.+...++.++|+|||||++|+|+||++||.+....+....+....+.+....+..... 
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  231 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS-  231 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh-
Confidence            221 112345688899999987655678999999999999999999999998887777777777776665554432110 


Q ss_pred             cccc--cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          299 YTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       299 ~~~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      ...+  ..+........ .....+++++.+||++||+.||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         232 LPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0000  01111111111 1123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-46  Score=359.00  Aligned_cols=254  Identities=32%  Similarity=0.525  Sum_probs=209.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|.+.+.||+|+||.||+|++..+|+.||||++...       .....+|+.++..++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            699999999999999999999999999999998643       23345799999999999999998877     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            999999985 777777653    5789999999999999999999997 999999999999999887 799999999876


Q ss_pred             cccCC------------------------------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 015615          218 LVKGE------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  267 (403)
Q Consensus       218 ~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  267 (403)
                      .....                              ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence            54332                              12345689999999999765 589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-HHHHh
Q 015615          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-ALEAL  346 (403)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-~~ell  346 (403)
                      |.+.+..+....+......               ..++.          ...+++++.+||.+||. ||.+|++ +++++
T Consensus       230 f~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         230 FYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            9988766555554431100               00110          12368999999999998 9999999 99999


Q ss_pred             cCCCCccCCCC
Q 015615          347 IHPFFDELRDP  357 (403)
Q Consensus       347 ~hp~f~~~~~~  357 (403)
                      +||||+.+.+.
T Consensus       284 ~hp~~~~~~~~  294 (350)
T cd05573         284 SHPFFKGIDWE  294 (350)
T ss_pred             cCCCcCCCCHH
Confidence            99999987553

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.5e-46  Score=362.36  Aligned_cols=253  Identities=29%  Similarity=0.466  Sum_probs=203.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|++.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            5899999999999999999999999999999986432       23457999999999999999998873     34468


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+|||||++ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            999999985 677776542    5688999999999999999999987 999999999999999888 799999999753


Q ss_pred             cccC------------------------------------------------CCcceeeecccccccccccCCCCCCCch
Q 015615          218 LVKG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTAAI  249 (403)
Q Consensus       218 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~  249 (403)
                      ....                                                .......||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001134689999999999765 489999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHH
Q 015615          250 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  329 (403)
Q Consensus       250 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~  329 (403)
                      |||||||++|||++|++||.+.+..+....+.......               ..+          ....+++++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p----------~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------HIP----------PQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------CCC----------CcccCCHHHHHHHH
Confidence            99999999999999999999877665555444311000               000          11347899999999


Q ss_pred             HhhccCCCCCCC---HHHHhcCCCCccCCC
Q 015615          330 RLLQYSPNLRST---ALEALIHPFFDELRD  356 (403)
Q Consensus       330 ~~L~~dP~~R~s---~~ell~hp~f~~~~~  356 (403)
                      +|+ .||.+|++   ++++++||||+.+..
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            976 59999997   999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-45  Score=355.50  Aligned_cols=277  Identities=24%  Similarity=0.370  Sum_probs=205.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEec
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      ..|++.+.||+|+||.||+|++..++..||+|.....  ....|+.+++.++||||+++++++..     ..+.++||||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEc
Confidence            4699999999999999999999999999999975433  33569999999999999999998743     3357899999


Q ss_pred             ccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc
Q 015615          145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (403)
Q Consensus       145 ~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~  224 (403)
                      +.+++.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.........
T Consensus       139 ~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        139 YSSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             cCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence            999888887653   35689999999999999999999998 999999999999999887 7999999999754433334


Q ss_pred             ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCc---------HHHHHHHHHHhCCCCHHHHhc
Q 015615          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESG---------VDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       225 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ....||+.|+|||++.+. .++.++|||||||++|||+++. ++|.....         ...+..+...++..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            456789999999999765 4899999999999999999854 44443221         123333344333322111000


Q ss_pred             cCcCc--ccccCCCccCCCc---ccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          295 MNPNY--TEFKFPQIKAHPW---HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       295 ~~~~~--~~~~~~~~~~~~~---~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      .....  ....+......++   ...-...++.++.+||.+||+.||.+|||+.|+|+||||+.+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            00000  0000000111111   111123568889999999999999999999999999999864

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-46  Score=351.40  Aligned_cols=242  Identities=31%  Similarity=0.520  Sum_probs=198.8

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      ||+|+||.||+|++..+++.||+|.+....       ....+|+.+++.++||||+++++++     .+..++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999999999999885421       2234699999999999999998877     3344588999999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC-CC
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  223 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~-~~  223 (403)
                      ++ +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            85 67777654    35689999999999999999999997 999999999999999887 7999999998754222 22


Q ss_pred             cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccccc
Q 015615          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  303 (403)
Q Consensus       224 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+...   +                
T Consensus       150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---~----------------  209 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---P----------------  209 (312)
T ss_pred             cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---C----------------
Confidence            2345789999999999764 4899999999999999999999999887665544443321   0                


Q ss_pred             CCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC---CHHHHhcCCCCccCC
Q 015615          304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS---TALEALIHPFFDELR  355 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~---s~~ell~hp~f~~~~  355 (403)
                                ..++..+++++.+||.+||..||.+||   ++.++++||||.+..
T Consensus       210 ----------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         210 ----------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                      012345789999999999999999997   589999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.4e-45  Score=350.63  Aligned_cols=319  Identities=35%  Similarity=0.631  Sum_probs=243.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|.+.+.||+|+||.||+|.+..+|..||||.+...      .....+|+.+++.++|+||+++++++..........+
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4699999999999999999999999999999987532      2234469999999999999999987754433333457


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +++|||+.++|.+.+..    ...+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++...
T Consensus        85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~  158 (337)
T cd07858          85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTT  158 (337)
T ss_pred             EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence            89999999888777754    35689999999999999999999987 999999999999999887 7999999998765


Q ss_pred             ccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ... .......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+....+.+..+.+.....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            433 2223456788999999986544589999999999999999999999998887777888888888777665532111


Q ss_pred             C-cccc--cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015615          298 N-YTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFK  374 (403)
Q Consensus       298 ~-~~~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  374 (403)
                      . ...+  ..+......+.. ..+.+++++.+||++||+.||++|||++++++||||..+..+.....    .+..+.|.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~----~~~~~~~~  313 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV----CQTPFSFD  313 (337)
T ss_pred             hhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc----CCCccchh
Confidence            1 0000  011111111111 22468999999999999999999999999999999999877654222    22333333


Q ss_pred             hhhcCCCChHHHhhcchHHHH
Q 015615          375 PHELKGVPVDMLVKLIPEHAR  395 (403)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~  395 (403)
                       .+..++..+.++.++-.|+.
T Consensus       314 -~~~~~~~~~~~~~~~~~~~~  333 (337)
T cd07858         314 -FEEDALTEEDIKELIYNEML  333 (337)
T ss_pred             -hhhhhcCHHHHHHHHHHHHh
Confidence             44444677888888776653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-46  Score=349.94  Aligned_cols=246  Identities=30%  Similarity=0.467  Sum_probs=200.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcE-EEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEA-VAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~-vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ...+.+.||+|+||+||+|.+  .|.. ||+|++...      ...+.+|+.+|.+++|||||++++++.....    .+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~  115 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL  115 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence            345566799999999999998  5666 999998643      2366789999999999999999998843321    47


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC-ccccCCCCCceEecCCCCceEEeecCCce
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~-ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +|||||++ |+|.+++...  ....++...+..++.||++||.|||++ + ||||||||+|||++.+...+||+|||+++
T Consensus       116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            89999999 5777777653  357799999999999999999999998 8 99999999999999875369999999998


Q ss_pred             ecccC-CCcceeeecccccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          217 VLVKG-EPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       217 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ..... .......||+.|||||++.+ ...|+.++||||||+++|||+||+.||.+....+....+.....+|.      
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~------  266 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP------  266 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------
Confidence            76544 23334789999999999974 24599999999999999999999999999887444444433222221      


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                           ++...++.+..|+.+||..||.+||+..+++.
T Consensus       267 ---------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 ---------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ---------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                 22347889999999999999999999988763

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=343.94  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=206.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++     ....++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            3889999999999999999999899999999885431       2334699999999999999998877     333468


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+.+ +|...+...  ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            899999985 666555432  234689999999999999999999998 999999999999999877 799999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........|++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+........         
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------  221 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------
Confidence            6444433445789999999999654 489999999999999999999999987655443333322211000         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  357 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~~  357 (403)
                                      ..++..++..+.+|+.+||..||++||     +++++++||||......
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                            012234788999999999999999999     99999999999985443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-48  Score=355.13  Aligned_cols=250  Identities=27%  Similarity=0.431  Sum_probs=208.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..|+..++||+|.||.||+|.+..+++.||||++..+     ...+++|+.+|..++++||.++|++|+...     .++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cHH
Confidence            4588889999999999999999999999999998543     345668999999999999999999986543     389


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||.| ++.+.++.    ...+.+..+..++++++.||.|||.+ +.+|||||+.|||+..++ .+||+|||.+..+
T Consensus        88 iiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESG-DVKLADFGVAGQL  161 (467)
T ss_pred             HHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccC-cEEEEecceeeee
Confidence            99999995 66776654    24447788888999999999999998 999999999999999886 7999999999776


Q ss_pred             ccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ..... ..+++|||+|||||++.. ..|+.++||||||++.+||++|.+|+....++..+..|.+.  .           
T Consensus       162 ~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~--~-----------  227 (467)
T KOG0201|consen  162 TNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS--A-----------  227 (467)
T ss_pred             echhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC--C-----------
Confidence            54433 367899999999999974 45999999999999999999999999877653333322221  0           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                            .         ..+....|+.+++|+..||.+||+.||||.++|+|+|++..
T Consensus       228 ------P---------P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  228 ------P---------PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             ------C---------CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                  0         01223578999999999999999999999999999999873

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.2e-45  Score=346.51  Aligned_cols=277  Identities=32%  Similarity=0.563  Sum_probs=207.0

Q ss_pred             EeEeeeCCcEEEEEEEEcc--CCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           70 ERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      +.+||+|+||.||+|.+..  ++..||+|.+....  ....+|+.+++.++||||+++++++...   ....+++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence            3579999999999999654  56889999886542  3456899999999999999999987542   334578999999


Q ss_pred             cchHHHHHHhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec----CCCCceEEeecCCce
Q 015615          146 PETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAK  216 (403)
Q Consensus       146 ~~~l~~~l~~~~~-----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~----~~~~~vkl~DfG~a~  216 (403)
                      ++++.+.+.....     ....+++..++.++.||+.||.|||++ ||+||||||+|||+.    .++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence            9988887754321     123588899999999999999999998 999999999999993    334 79999999998


Q ss_pred             ecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHH
Q 015615          217 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQLVEIIKV  283 (403)
Q Consensus       217 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~  283 (403)
                      .......    .....+|+.|+|||++.+...++.++|||||||++|+|+||++||.....         ...+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6543321    22456799999999987656689999999999999999999999975432         3456666777


Q ss_pred             hCCCCHHHHhccC--cCcccc----cCCCccC---CCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          284 LGTPTREEIKCMN--PNYTEF----KFPQIKA---HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       284 ~~~~~~~~~~~~~--~~~~~~----~~~~~~~---~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      ++.+....+....  +.+...    .......   ...........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            7776665554321  111000    0000000   001111122356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.8e-46  Score=352.23  Aligned_cols=245  Identities=27%  Similarity=0.412  Sum_probs=200.1

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      +.||+|+||.||+|++..+|..||+|.+....       ....+|+.+++.++||||++++++|.     ...++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence            46999999999999999999999999986431       22346899999999999999988873     3345889999


Q ss_pred             cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC-
Q 015615          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  221 (403)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~-  221 (403)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9985 66555543    35689999999999999999999998 999999999999999887 7999999998753222 


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....                 
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-----------------  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-----------------  211 (323)
T ss_pred             CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence            222345789999999999655 48999999999999999999999998876655444433210                 


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                      .            .++..+++++.+||.+||+.||++|+     ++.++++||||.+..+
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             C------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            0            12345789999999999999999998     8999999999988643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-45  Score=343.09  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=199.5

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      ||+|+||+||+|.+..+|+.||+|.+....       .....|+.+++.++|+||+++.+++     .....+++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999985432       2234689999999999999998877     3344588999999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCC-
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-  223 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~-  223 (403)
                      ++ +|...+.........+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            85 66666544333456789999999999999999999998 999999999999999877 799999999976544332 


Q ss_pred             cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccccc
Q 015615          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  303 (403)
Q Consensus       224 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                      .....||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...........+....-..                
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  216 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------  216 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence            2235689999999999765 48999999999999999999999998654322222221110000                


Q ss_pred             CCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCCC
Q 015615          304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  357 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~~  357 (403)
                               ...++..++.++.+|+.+||+.||++|+     +++++++||||+++.+.
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence                     0012345789999999999999999999     88999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-45  Score=357.10  Aligned_cols=257  Identities=26%  Similarity=0.438  Sum_probs=208.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+...       .....+|+.+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            345799999999999999999999999999999998532       12345799999999999999998877     344


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      .++++||||+++ +|.+.+..     ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~~kL~DfG~  188 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCC-CEEEEeccc
Confidence            568999999985 67776643     3578889999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCC--CcceeeecccccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          215 AKVLVKGE--PNISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       215 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +.......  ......||+.|+|||++.+..   .++.++|||||||++|+|++|++||.+.+....+..+......   
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---  265 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS---  265 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc---
Confidence            97654322  123457899999999986432   3788999999999999999999999988766655555431100   


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC--CCCHHHHhcCCCCccCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  356 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~s~~ell~hp~f~~~~~  356 (403)
                                  ..++.          ...+|.++.+||++||+.+|.+  |+|++++++||||+...+
T Consensus       266 ------------~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         266 ------------LTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             ------------CCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                        00110          1247899999999999999998  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.4e-46  Score=360.96  Aligned_cols=252  Identities=28%  Similarity=0.456  Sum_probs=202.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||+|+||.||+|++..+++.||||.+...       .....+|+.+++.++||||+++++.|     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            599999999999999999999999999999998542       23345799999999999999998887     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+|||||++ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|..
T Consensus        77 ~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            899999985 777777553    5688999999999999999999998 999999999999999887 799999999742


Q ss_pred             cccC--------------------------------------------CCcceeeecccccccccccCCCCCCCchhHHH
Q 015615          218 LVKG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWS  253 (403)
Q Consensus       218 ~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  253 (403)
                      ....                                            .......||+.|+|||++.+.. ++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeee
Confidence            2100                                            0001246899999999996554 899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhc
Q 015615          254 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  333 (403)
Q Consensus       254 lG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~  333 (403)
                      |||++|+|++|+.||.+.+..+....+......               ...+          ....+++++.+||.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh-
Confidence            999999999999999887765544433221000               0000          11347899999999976 


Q ss_pred             cCCCCCC---CHHHHhcCCCCccCC
Q 015615          334 YSPNLRS---TALEALIHPFFDELR  355 (403)
Q Consensus       334 ~dP~~R~---s~~ell~hp~f~~~~  355 (403)
                      .+|.+|+   |+.++++||||+.+.
T Consensus       284 ~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         284 CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            5999999   999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.8e-46  Score=352.96  Aligned_cols=245  Identities=26%  Similarity=0.420  Sum_probs=199.1

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++     .+...+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            36899999999999999999999999986432       2334689999999999999998877     33445889999


Q ss_pred             cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC-
Q 015615          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-  221 (403)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~-  221 (403)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..... 
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9985 66655543    35689999999999999999999998 999999999999999887 7999999998754222 


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D  211 (328)
T ss_pred             cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence            222345689999999999654 4899999999999999999999999877654443332210                 0


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                      .            .++..+++++.+||++||+.||++|+     ++.++++||||....+
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         212 I------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             c------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            0            12345789999999999999999997     8999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.3e-46  Score=353.59  Aligned_cols=256  Identities=26%  Similarity=0.436  Sum_probs=208.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|.+.+.||+|+||.||+|++..+|+.||||.+....       ....+|+.+++.++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            5999999999999999999999999999999986432       2345789999999999999998877     334458


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++ +|.+.+...   ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            899999974 777777653   35689999999999999999999998 999999999999999887 799999999986


Q ss_pred             cccCCCc--ceeeecccccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          218 LVKGEPN--ISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       218 ~~~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      .......  ....||+.|+|||++..     ...++.++|||||||++|+|++|..||...+....+..+......    
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~----  227 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF----  227 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc----
Confidence            6433322  23468999999999853     334788999999999999999999999887766655554432100    


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                 ..++          ....+++++.+||.+||+ ||.+|||++++++||||+.+.+.
T Consensus       228 -----------~~~~----------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         228 -----------LKFP----------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             -----------cCCC----------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence                       0011          013478999999999998 99999999999999999986543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.5e-45  Score=355.79  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=207.0

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+...       .....+|+.+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            345799999999999999999999999999999988532       23345799999999999999999887     344


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      .++|+|||||++ +|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~-~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHG-HLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEEeccc
Confidence            568999999985 77777653     3578899999999999999999997 999999999999999887 799999999


Q ss_pred             ceecccCCC--cceeeecccccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          215 AKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       215 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      |........  .....||+.|+|||++.+..   .++.++|||||||++|+|++|.+||.+.+....+..+.......  
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--  266 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL--  266 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc--
Confidence            986533221  23457899999999986432   37889999999999999999999999887666665554321100  


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC--CCCHHHHhcCCCCccCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  356 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~s~~ell~hp~f~~~~~  356 (403)
                                   .++.          ...++..+++++.+||..++.+  |+|++++++||||+...+
T Consensus       267 -------------~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         267 -------------NFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             -------------CCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence                         0000          1246889999999999866544  899999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.5e-45  Score=348.58  Aligned_cols=250  Identities=28%  Similarity=0.432  Sum_probs=202.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCC-CeeecceeeeecCCCCceE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  137 (403)
                      +|++.+.||+|+||.||+|.+..+++.||||++....       .....|..++..+.|+ +|+++++++.     +..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            4899999999999999999999999999999986432       2334688888888775 5777777662     3345


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +|+||||+++ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            8899999985 67666654    35688999999999999999999998 999999999999999887 79999999987


Q ss_pred             eccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .... ........||+.|+|||++.+.. ++.++||||+||++|+|+||+.||.+.+..+.+..+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            5322 22233457899999999997654 8999999999999999999999998877666555543310           


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH-----HHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~-----~ell~hp~f~~~~~  356 (403)
                                        ..++..+++++.+++++||..||.+|++.     +++++||||+.+.+
T Consensus       218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                              01224578999999999999999999986     89999999998654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-45  Score=350.05  Aligned_cols=245  Identities=30%  Similarity=0.510  Sum_probs=199.5

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+++.||||.+....       ....+|..++..+ +||||+++++++     .+...+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999986432       2234577777766 699999999887     3344588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc-
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-  220 (403)
                      ||+++ +|...+..    ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99985 66666654    35689999999999999999999988 999999999999999887 799999999875422 


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....  +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~-------------  213 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--V-------------  213 (320)
T ss_pred             CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--C-------------
Confidence            2223345789999999998654 48999999999999999999999999887666555543310  0             


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH------HHHhcCCCCccCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~------~ell~hp~f~~~~~  356 (403)
                                    .++..++.++.+||++||+.||++|+++      +++++||||+.+.+
T Consensus       214 --------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         214 --------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             --------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence                          0123478999999999999999999998      89999999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.4e-45  Score=342.29  Aligned_cols=285  Identities=35%  Similarity=0.579  Sum_probs=225.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|++.+.||.|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++|+||+++++++...   ....
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            347999999999999999999999999999999885332      1234799999999999999999887432   2234


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++||||+.++|.+++...   ...+++..+..++.||+.||+|||+. |++||||||+||+++.++ .+||+|||++..
T Consensus        83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~  157 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKG-CLKIADFGLART  157 (309)
T ss_pred             EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccceeee
Confidence            7899999998887777653   25688999999999999999999997 999999999999999877 799999999986


Q ss_pred             cccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       218 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ..... ......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            64332 22233457889999998766668999999999999999999999999999889999888888877765543221


Q ss_pred             --cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          297 --PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       297 --~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                        +....+..+......+...+ ...++.+.+||++||++||++|||+.++++||||++...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence              11112222221111121111 2368899999999999999999999999999999986555

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.9e-45  Score=349.33  Aligned_cols=248  Identities=27%  Similarity=0.455  Sum_probs=200.4

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHH---HHcCCCCeeecceeeeecCCCCce
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTM---RLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      |++.+.||+|+||.||+|.+..+|+.||||.+....       ....+|+.++   +.++||||+++++++.     ...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            788999999999999999999999999999986432       2233455444   5668999999999873     344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++|+||||+++ +|...+.     ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            58899999996 5544443     25689999999999999999999997 999999999999999887 7999999998


Q ss_pred             eeccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          216 KVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       216 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....         
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~---------  218 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV---------  218 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            75322 2223346789999999998654 489999999999999999999999998776665554433100         


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                                          .++..+++++.+||.+||..||.+||     ++.++++||||+.+..
T Consensus       219 --------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         219 --------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                                12245789999999999999999999     7999999999988643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-46  Score=354.37  Aligned_cols=252  Identities=30%  Similarity=0.483  Sum_probs=221.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|..++.+|+|+||.+++++++..+..+++|.+.-.      ++...+|+.+++++.|||||.+++.|.    .+..++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            4699999999999999999999999999999998532      335568999999999999999999884    344559


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|||+||+| ++.+.+....  ...++++.+..|+.||+.|+.|||++ +|+|||||+.|||++.++ .|||+|||+|+.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~  155 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDK-KVKLGDFGLAKI  155 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccC-ceeecchhhhhh
Confidence            999999996 7777777654  56799999999999999999999987 999999999999999988 689999999999


Q ss_pred             cccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       218 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      +.... ...+..|||+||+||++.+.+ |+.++|||||||++|||++-+++|.+.+-.....+|.+....|.+       
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp-------  227 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP-------  227 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-------
Confidence            87766 567889999999999997655 999999999999999999999999999888888888876544332       


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                           ...+.+++.+++.||..+|..||++.++|.+|.+..
T Consensus       228 ---------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  228 ---------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             ---------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                                 346899999999999999999999999999998874

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.3e-45  Score=348.74  Aligned_cols=286  Identities=33%  Similarity=0.592  Sum_probs=224.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||.+...      .....+|+.+++.++||||++++++|..... .+..
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            35799999999999999999999999999999987532      1233469999999999999999988743321 2233


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +.|+||||+.+++.+.+..      .++...+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~  166 (353)
T cd07850          95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  166 (353)
T ss_pred             cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCccce
Confidence            5789999999988877643      278888999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ............+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+...++.|..+......
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            76444333445678899999999765 48999999999999999999999999988888888888888888765443322


Q ss_pred             cCcccc--cCCCccCCCccccc------------ccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          297 PNYTEF--KFPQIKAHPWHKIF------------QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       297 ~~~~~~--~~~~~~~~~~~~~~------------~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      .....+  ..+.....++...+            +...+..+.+||.+||+.||++|||+.++|+||||+.+-++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~  321 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS  321 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence            111111  00111111111111            223567899999999999999999999999999999765543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-45  Score=350.77  Aligned_cols=255  Identities=30%  Similarity=0.457  Sum_probs=200.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccch--------hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (403)
                      +|++.+.||+|+||.||+|++.   .+|+.||+|++....        ....+|+.+++.+ .||||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4899999999999999999864   478999999885421        2345689999999 499999998877     3


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      ...++++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCC-CEEEeeC
Confidence            44568899999985 77776654    35689999999999999999999987 999999999999999887 7999999


Q ss_pred             CCceecccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          213 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       213 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      |+++.......  .....||+.|+|||++.+...++.++|||||||++|+|+||..||...........+....      
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------  223 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI------  223 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH------
Confidence            99876433222  2345789999999999765557899999999999999999999997543221111111110      


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                        ....                 ..++..+++.+.+||.+||+.||++||     +++++++||||+...+
T Consensus       224 --~~~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         224 --LKCD-----------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             --hcCC-----------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence              0000                 012345789999999999999999999     8899999999998643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.5e-45  Score=346.33  Aligned_cols=245  Identities=28%  Similarity=0.474  Sum_probs=197.1

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHH-cCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+|+.||+|.+....       .....|..++.. ++||||+++++++     .+..++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986432       223456777765 4899999999887     3445689999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc-
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-  220 (403)
                      ||+.+ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99985 66666654    35688999999999999999999998 999999999999999887 799999999875322 


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...  .+             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~-------------  213 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP-------------  213 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence            2223346789999999999765 4899999999999999999999999887665444433221  00             


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH-HHHhcCCCCccCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-LEALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~-~ell~hp~f~~~~~  356 (403)
                                    .++..++.++.+||++||+.||++|+++ +++++||||+....
T Consensus       214 --------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         214 --------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence                          0123468899999999999999999997 58889999998654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=345.93  Aligned_cols=274  Identities=27%  Similarity=0.412  Sum_probs=221.8

Q ss_pred             CccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      +.....|+.-++||+||||.||-++.+.||+.+|+|++.+..       ....+|-.+|.+++.++||.+-..|     +
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----e  255 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----E  255 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----c
Confidence            334456888999999999999999999999999999874332       2334699999999999999997777     3


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      ....+|+||..|+| +|.-.|.+..  +..+++..+++|+.+|+.||.+||+. +||+|||||+|||+|..| .|+|+|+
T Consensus       256 Tkd~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~G-hvRISDL  331 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHG-HVRISDL  331 (591)
T ss_pred             CCCceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCC-CeEeecc
Confidence            33348999999996 4544443332  35799999999999999999999988 999999999999999998 5999999


Q ss_pred             CCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       213 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      |+|..+..+.+....+||..|||||++.+.. |+...|+|||||++|||+.|+.||........-.++.+..-..     
T Consensus       332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-----  405 (591)
T KOG0986|consen  332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-----  405 (591)
T ss_pred             ceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-----
Confidence            9999998888888889999999999997766 9999999999999999999999998754433332332211110     


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCCCCCCCCCCCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDPNTRLPNGRFL  367 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~~~~~~~~~~~~  367 (403)
                                          ...++..+|+++++|++.+|+.||.+|.     .++++.+||||+.+++.  ++..+.+.
T Consensus       406 --------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~--rleagml~  463 (591)
T KOG0986|consen  406 --------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR--RLEAGMLE  463 (591)
T ss_pred             --------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh--HHhccCCC
Confidence                                1124467899999999999999999996     57899999999998765  56555555


Q ss_pred             CCCC
Q 015615          368 PPLF  371 (403)
Q Consensus       368 ~~~~  371 (403)
                      ||+.
T Consensus       464 PPfi  467 (591)
T KOG0986|consen  464 PPFI  467 (591)
T ss_pred             CCCC
Confidence            5543

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-44  Score=338.78  Aligned_cols=285  Identities=34%  Similarity=0.602  Sum_probs=221.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||.|+||.||+|.+..+|+.||||.+....      ....+|+.+++.+. ||||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5999999999999999999999999999999875432      23457999999995 6999999988755444344567


Q ss_pred             EEEEecccchHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++++.+.+...... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.+++.+||+|||++..
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999999888887654332 35689999999999999999999998 9999999999999998344899999999875


Q ss_pred             cccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          218 LVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       218 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .... .......+++.|+|||++.+...++.++|+||||+++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            4322 112233568889999998665557999999999999999999999999988888888888777766655432211


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                      .......++........ ...+.++.++.+||.+||..||.+|||+.+++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            11111111111111111 11245789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.1e-45  Score=346.47  Aligned_cols=275  Identities=26%  Similarity=0.442  Sum_probs=206.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|++.+.||+|+||.||+|++..+|..||+|.+...     .....+|+++++.++||||+++++++..     ...++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEEE
Confidence            5799999999999999999999999999999988543     1345679999999999999999998743     33578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+...    ..+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  154 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (331)
T ss_pred             EEeecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence            99999995 777777543    46889999999999999999999853699999999999999887 7999999998765


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh----c
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK----C  294 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----~  294 (403)
                      ... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+. ..+   ++.+......    .
T Consensus       155 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~---~~~~~~~~~~~~~~~  228 (331)
T cd06649         155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAI---FGRPVVDGEEGEPHS  228 (331)
T ss_pred             ccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH---hcccccccccCCccc
Confidence            332 22345789999999999765 489999999999999999999999987654332 222   2211110000    0


Q ss_pred             cCcC-------cccccCCC------------ccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          295 MNPN-------YTEFKFPQ------------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       295 ~~~~-------~~~~~~~~------------~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      ..+.       ........            +............+++++++||.+||++||++|||+.++++||||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence            0000       00000000            0000000001124688999999999999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-45  Score=351.26  Aligned_cols=246  Identities=28%  Similarity=0.432  Sum_probs=199.0

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      +.||+|+||.||+|.+..+|..||+|.+....       ....+|+.+++.++||||+++++++     ....++|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986431       2234688899999999999998877     33446889999


Q ss_pred             cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc-C
Q 015615          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-G  221 (403)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-~  221 (403)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||+..||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC
Confidence            9985 56555543    356899999999999999999999723999999999999999887 799999999875432 2


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~  212 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  212 (325)
T ss_pred             cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            222345789999999999654 4899999999999999999999999887654444333221                 0


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                      .            .++..+++++.+||++||+.||++|+     ++.++++||||....+
T Consensus       213 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         213 I------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             C------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            0            12345789999999999999999997     9999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.8e-45  Score=346.47  Aligned_cols=250  Identities=28%  Similarity=0.421  Sum_probs=203.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      +|.+.+.||+|+||.||+|++..+++.||||.+....       .....|..++..+ .|++|+++++++     .+...
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4889999999999999999999999999999986432       1223466777666 588899988877     33345


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +++||||+++ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            8899999984 67666654    35688999999999999999999987 999999999999999888 79999999987


Q ss_pred             eccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .... ........||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            5432 22233457899999999997654 8999999999999999999999999877666655554310           


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                        ..++..++.++.+|+.+||+.||++|++     ..++++||||+.+.+
T Consensus       218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence                              0123457899999999999999999998     489999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-45  Score=347.12  Aligned_cols=257  Identities=28%  Similarity=0.436  Sum_probs=204.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||+|+||.||+|++..+++.||+|.+...       .....+|+.++..++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence            699999999999999999999999999999998542       12345788999999999999999887     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+||||+.+ +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            999999974 777777543   35689999999999999999999998 999999999999999887 799999999876


Q ss_pred             cccCCCc--ceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          218 LVKGEPN--ISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       218 ~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......  ....||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+..+....+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH-----  226 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc-----
Confidence            5433222  22468999999999863    234788999999999999999999999887665555544321100     


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC--CCCHHHHhcCCCCccCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  356 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~s~~ell~hp~f~~~~~  356 (403)
                                +.++.         ....++..+++||++||+.++++  |+++.++++||||....+
T Consensus       227 ----------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         227 ----------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             ----------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence                      00000         11247899999999999765554  789999999999988654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.8e-44  Score=336.08  Aligned_cols=276  Identities=41%  Similarity=0.764  Sum_probs=225.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||.|+||.||+|.+..+|..||+|.+....      ....+|+.+++.++||||+++++++.     ...+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence            4899999999999999999999999999999885432      34567999999999999999998873     345678


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||+.++|.+.+....   ..+++..++.++.||+.||+|||+. |++|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            999999778888776542   5689999999999999999999998 999999999999999877 79999999987654


Q ss_pred             cCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC-
Q 015615          220 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  296 (403)
Q Consensus       220 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  296 (403)
                      ....  .....++..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..+....+.+....+.... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            3321  2345678899999998766657899999999999999999999999888888888888888888776655422 


Q ss_pred             -cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                       ..+....++.....++...+ +..+.++.+||++||..||++|||++++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             22223333333333333322 45679999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.2e-45  Score=347.36  Aligned_cols=245  Identities=29%  Similarity=0.475  Sum_probs=199.6

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+|+.||||.+....       .....|..++..+ +||||+++++++.     +...+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence            36899999999999999999999999986432       2234577788765 7999999999873     344588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99985 66666654    35688999999999999999999998 999999999999999887 7999999998754222


Q ss_pred             -CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------  212 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------  212 (321)
T ss_pred             CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223345689999999998654 48999999999999999999999999887666665544310                


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-------CHHHHhcCCCCccCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-------TALEALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-------s~~ell~hp~f~~~~~  356 (403)
                       .            .++..++.++.+||.+||+.||++|+       +++++++||||..+.+
T Consensus       213 -~------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         213 -V------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             -C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence             0            02234689999999999999999999       9999999999988644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.8e-45  Score=353.25  Aligned_cols=253  Identities=28%  Similarity=0.440  Sum_probs=204.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.++..++||||+++++.+     .+..++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            5899999999999999999999999999999985421       2345689999999999999999887     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            999999985 67777654    35689999999999999999999987 999999999999999887 799999999864


Q ss_pred             cccCC------------------------------------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHH
Q 015615          218 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (403)
Q Consensus       218 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  261 (403)
                      .....                                    .....+||+.|+|||++.+.. ++.++|||||||++|||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeec
Confidence            42110                                    011346899999999997654 89999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-
Q 015615          262 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-  340 (403)
Q Consensus       262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-  340 (403)
                      ++|++||.+.+.......+......               ..++.          ...++.++++||.+|+ .||.+|+ 
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~  283 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWKET---------------LVFPP----------EVPISEKAKDLILRFC-TDSENRIG  283 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCCc---------------eecCC----------CCCCCHHHHHHHHHhc-cChhhcCC
Confidence            9999999988766655554431100               00000          0136889999999977 4999998 


Q ss_pred             --CHHHHhcCCCCccCCC
Q 015615          341 --TALEALIHPFFDELRD  356 (403)
Q Consensus       341 --s~~ell~hp~f~~~~~  356 (403)
                        +++++++||||+++.+
T Consensus       284 ~~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         284 SNGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             CCCHHHHhcCCCCCCCCH
Confidence              4899999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.7e-45  Score=343.93  Aligned_cols=245  Identities=29%  Similarity=0.471  Sum_probs=199.3

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|.+..+++.||||.+....       ....+|..++..+ +||||+++++++.     ...++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999986432       2234677888877 6999999999873     344588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc-
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-  220 (403)
                      ||+++ +|...+..    ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99985 66666544    35789999999999999999999987 999999999999999887 799999999875322 


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      ........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+....                
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~----------------  212 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE----------------  212 (318)
T ss_pred             CCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            22233456899999999997654 8999999999999999999999998876555444433210                


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH-----HHHhcCCCCccCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~-----~ell~hp~f~~~~~  356 (403)
                                   ..++..++.++.+||++||..||.+|||+     .++++||||+...+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         213 -------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             -------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                         01224578999999999999999999999     99999999988644

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-44  Score=351.94  Aligned_cols=277  Identities=23%  Similarity=0.348  Sum_probs=210.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEc--cCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      .+|.+.+.||.|+||.||+|...  .++..||+|.+... ....+|+.+++.++||||+++++++     .....+|++|
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv~  165 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMVM  165 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEEe
Confidence            46999999999999999999754  35678999987643 3456899999999999999999877     3344588999


Q ss_pred             ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      |++.+++.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.......
T Consensus       166 e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEccCccccccCccc
Confidence            9999988887743    36789999999999999999999988 999999999999999887 79999999987654332


Q ss_pred             C---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCHHHHhccC
Q 015615          223 P---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       223 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .   .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..   ....+..+.+.++..+.+......
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            2   22457899999999996554 8999999999999999999999997753   345566666665543322110000


Q ss_pred             ----cCcccccCCCccCCCccccc-ccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          297 ----PNYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       297 ----~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                          ..+..+....-....+...+ ...++.++.+||++||..||++|||+.++|+||||++.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                00000111000000111111 12467889999999999999999999999999999874

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.7e-44  Score=337.20  Aligned_cols=282  Identities=37%  Similarity=0.645  Sum_probs=222.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh---------hhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +|.+.+.||+|+||.||+|.+..+|+.||||.+.....         ....|+++++.++|+||+++++++.     +..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            48889999999999999999998999999999864321         2346899999999999999999873     345


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +.++||||+.++|.+.+....   ..+++..+..++.||+.||+|||++ ||+|+||||+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            688999999778888776431   3689999999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....... .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            6644322 223456788999999866556789999999999999999999999988887878777777777766554322


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      ...............+... .....+..+.+||.+||..||++|||+.++++||||++...++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            1110111111111111111 2245688999999999999999999999999999999977665

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.4e-45  Score=345.17  Aligned_cols=244  Identities=29%  Similarity=0.496  Sum_probs=198.5

Q ss_pred             eEeeeCCcEEEEEEEEc---cCCcEEEEEEeccch--------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           71 RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +.||+|+||.||+|++.   .+++.||||.+....        ....+|+.+++.++||||++++++|.     ....+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence            57999999999999864   478899999885421        22357999999999999999998873     334588


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus        77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            99999985 67666654    35678888999999999999999987 999999999999999887 7999999998754


Q ss_pred             ccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+....             
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------  216 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------  216 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            322 2223457899999999996544 7899999999999999999999998877655554443210             


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELR  355 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~  355 (403)
                          .            .++..+++++.+||++||+.||++||     +++++++||||+...
T Consensus       217 ----~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         217 ----L------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             ----C------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence                0            02245789999999999999999999     899999999998753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.3e-45  Score=345.65  Aligned_cols=246  Identities=25%  Similarity=0.469  Sum_probs=195.3

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+++.||||.+....       ....+|..+++.+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46899999999999999999999999986431       2245688888888 699999999887     3344588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc-c
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  220 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~-~  220 (403)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++... .
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99985 66666543    35799999999999999999999988 999999999999999887 79999999987532 2


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHH
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  292 (403)
                      ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.....        .+...+....  .      
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~------  220 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--K------  220 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc--C------
Confidence            2333456789999999999764 489999999999999999999999963211        1111111110  0      


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC------HHHHhcCCCCccCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST------ALEALIHPFFDELRD  356 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s------~~ell~hp~f~~~~~  356 (403)
                              .            ..++..++.++.+||++||+.||.+|+|      ++++++||||..+.+
T Consensus       221 --------~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         221 --------Q------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             --------C------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                    0            0123457899999999999999999987      789999999987644

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.1e-45  Score=346.95  Aligned_cols=245  Identities=29%  Similarity=0.446  Sum_probs=196.5

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccchh-------hhHHHH-HHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNREL-QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||+||+|++..+|+.||||++.....       ...+|. .+++.++||||+++++++.     +...+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            469999999999999999999999999864321       112333 3567899999999988773     334578999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99985 66666654    35688999999999999999999998 999999999999999887 7999999998754222


Q ss_pred             -CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P-------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence             223345789999999998765 4899999999999999999999999887665554444321   0             


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH----HHHhcCCCCccCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~----~ell~hp~f~~~~~  356 (403)
                                   ..+.+.+++.+.+||++||+.||.+||++    .++++||||....+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence                         00224578999999999999999999997    69999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-44  Score=359.91  Aligned_cols=259  Identities=27%  Similarity=0.383  Sum_probs=211.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC---CCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~  135 (403)
                      .+|.+.+.||+|+||.||+|++..+|+.||||.+...      .....+|+..+..++|+|++++...+.....   ...
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            4799999999999999999999999999999998543      1234578999999999999998876643322   222


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+++||||+. ++|.+.+.........+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~-~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence            35789999998 588888876655567799999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccC---CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          215 AKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       215 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ++.....   .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......     
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-----  263 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-----  263 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-----
Confidence            9765322   122345789999999999764 4899999999999999999999999887655544443321000     


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                             .++..+++++.+|+.+||+.||.+||++.++++|||++..
T Consensus       264 -----------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        264 -----------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                   1234578999999999999999999999999999998864

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.5e-44  Score=341.86  Aligned_cols=245  Identities=29%  Similarity=0.502  Sum_probs=197.3

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHH-cCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+++.||||.+....       .....|..++.. ++||||+++++++.     +..++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986432       223356777765 48999999998873     334588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+++ +|...+..    ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99985 77777654    25688889999999999999999998 999999999999999887 7999999998754222


Q ss_pred             -CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                       .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+....+...  .+             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~-------------  213 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP-------------  213 (316)
T ss_pred             CCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence             2234567899999999996554 899999999999999999999999887655544433221  00             


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHH-HHhcCCCCccCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-EALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~-ell~hp~f~~~~~  356 (403)
                                    .++..++.++.+||.+||+.||++|+++. ++++||||+.+.+
T Consensus       214 --------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         214 --------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             --------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence                          01234688999999999999999999996 8999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-44  Score=350.07  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=205.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.+.||+|+||.||+|++..+++.||+|.+...       .....+|+.+++.++||||+++++++     .+.
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  115 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            346799999999999999999999999999999998532       22345789999999999999999887     344


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      .++++||||+++ +|.+++..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~-~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCC-CEEEEeCCc
Confidence            568999999985 67776653     3588889999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCC--cceeeecccccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          215 AKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       215 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +........  .....||+.|+|||++.+..   .++.++|||||||++|+|++|.+||.+.+.......+.......  
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--  266 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--  266 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc--
Confidence            986543221  23457899999999986432   37889999999999999999999999877666655554321100  


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC--CCCHHHHhcCCCCccCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  356 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~s~~ell~hp~f~~~~~  356 (403)
                                   .++          ....++..+++||.+||..++.+  |++++++++||||++...
T Consensus       267 -------------~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         267 -------------TFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             -------------cCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence                         011          01357899999999999844443  789999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-44  Score=342.96  Aligned_cols=245  Identities=31%  Similarity=0.501  Sum_probs=196.5

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHH-cCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|.+..+++.||||.+....       .....|..++.. .+||||+++++++     ....++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999886432       122345556654 4899999998877     3344688999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+++ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99985 66666654    35689999999999999999999998 999999999999999887 7999999999764332


Q ss_pred             C-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      . ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+...  .          +   
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~----------~---  213 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--R----------P---  213 (316)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C----------C---
Confidence            2 233457899999999997654 899999999999999999999999987765555444321  0          0   


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH-HHHhcCCCCccCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-LEALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~-~ell~hp~f~~~~~  356 (403)
                                    .++..++.++.+||.+||..||++|+++ .++++||||....+
T Consensus       214 --------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         214 --------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence                          1223478899999999999999999986 58889999998643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-46  Score=325.24  Aligned_cols=262  Identities=30%  Similarity=0.464  Sum_probs=210.1

Q ss_pred             ccceEEE-eEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEE
Q 015615           64 TISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        64 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      +.+|.+. ++||-|-.|.|..|.++.+|+.+|+|++. +....++|+++--.. .|||||.++++|-. ...+..++.+|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rkcLLiV  137 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYEN-SYQGRKCLLIV  137 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCceeeEee
Confidence            3467765 57999999999999999999999999774 444556788775444 69999999998743 33567889999


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEeecCCceec
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKVL  218 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~a~~~  218 (403)
                      ||.|+| .|+.-+..+.  ...+++.++..|++||+.|+.|||+. +|.||||||+|+|.....  ..+||+|||+|+..
T Consensus       138 mE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             eecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEeccccccccc
Confidence            999996 6776666543  46799999999999999999999997 999999999999996432  36999999999987


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCHHHHhc
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      .......+.+.||+|.|||++ +...|+..+|+||+|+++|-|++|.+||.....    ..+...|....          
T Consensus       215 ~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq----------  283 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ----------  283 (400)
T ss_pred             CCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC----------
Confidence            655566678899999999999 455699999999999999999999999987542    22222332211          


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                             |.||.   ..|     ..+|.+++|+|+++|..+|.+|.|++++++|||+.+...
T Consensus       284 -------y~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  284 -------YEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             -------ccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence                   11221   112     347999999999999999999999999999999988543

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-44  Score=342.58  Aligned_cols=314  Identities=38%  Similarity=0.659  Sum_probs=243.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|.+.+.||.|+||.||+|++..+|+.||||.+...      .....+|+.+++.++|+||+++.+++..........+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            589999999999999999999888999999988542      23456799999999999999999987554322334578


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ++|||+++++.+.+...    ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            99999998887777542    4789999999999999999999998 999999999999999887 79999999998764


Q ss_pred             cCC----CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          220 KGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       220 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ...    ......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            443    1234567889999999977646899999999999999999999999999988888888888888887655421


Q ss_pred             Cc-Ccccc--cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCC
Q 015615          296 NP-NYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFN  372 (403)
Q Consensus       296 ~~-~~~~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  372 (403)
                      .. ....+  ..+.....++... .+.++.++.+||.+||++||++|||+++++.||||+++..+....+.    ...++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~----~~~~~  309 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVA----KPPFD  309 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCC----CCccc
Confidence            11 11111  0111112222222 24578999999999999999999999999999999998877544332    22334


Q ss_pred             CChhhcCCCChHHHhhcc
Q 015615          373 FKPHELKGVPVDMLVKLI  390 (403)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~  390 (403)
                      +.+.+-+.+..+..++.+
T Consensus       310 ~~~~~~~~~~~~~~~~~~  327 (330)
T cd07834         310 FDFFDDDELTEEELKELI  327 (330)
T ss_pred             ccccchhhcCHHHHhHHh
Confidence            544455555555555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.3e-44  Score=336.98  Aligned_cols=279  Identities=37%  Similarity=0.630  Sum_probs=223.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|++.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+.+++.++||||+++++++...   +..+.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            46999999999999999999999899999999885332      1234799999999999999999877442   12458


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      |+||||++++|.+.+....   ..+++..++.++.||+.||+|||++ |++|+||||+||+++.++ .+||+|||++...
T Consensus        82 ~lv~e~~~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRG-ILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcCcCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence            8999999988887776532   3689999999999999999999987 999999999999999887 7999999998866


Q ss_pred             ccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC-
Q 015615          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  296 (403)
Q Consensus       219 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  296 (403)
                      ... .......+++.|+|||.+.+...++.++|+||||+++|+|++|.+||......+....+....+.|....+.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            443 222345678889999998765557899999999999999999999999998888888888888888777665321 


Q ss_pred             -cCcccccCCCccCCCcccccccC-CChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          297 -PNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                       +..............+...++.. +++.+.+||++||+.||++|||+.|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence             11111111111222233334443 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-44  Score=335.71  Aligned_cols=251  Identities=23%  Similarity=0.352  Sum_probs=197.1

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      ||+|+||.||++.+..+|+.||+|.+....       .....|+++++.++||||+++++++     .+..++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999885321       2234589999999999999998877     3345688999999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~  224 (403)
                      ++ +|...+....  ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            85 6666654322  34578888899999999999999987 999999999999999877 7999999998876544433


Q ss_pred             ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccC
Q 015615          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  304 (403)
Q Consensus       225 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  304 (403)
                      ....+++.|+|||++.+.. ++.++|+||+||++|+|++|+.||.+.........+....-.          ..   .. 
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----------~~---~~-  216 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE----------DE---VK-  216 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc----------cc---cc-
Confidence            4456899999999997655 899999999999999999999999765432222222111000          00   00 


Q ss_pred             CCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH----HHHhcCCCCccCCCC
Q 015615          305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELRDP  357 (403)
Q Consensus       305 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~----~ell~hp~f~~~~~~  357 (403)
                                .....++.++.+|+++||+.||++||++    +++++||||+.+..+
T Consensus       217 ----------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~  263 (277)
T cd05607         217 ----------FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP  263 (277)
T ss_pred             ----------cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence                      0112478899999999999999999999    678899999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.7e-44  Score=333.90  Aligned_cols=275  Identities=37%  Similarity=0.678  Sum_probs=216.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||.|++|.||+|++..+|+.||||.+..+.      ....+|+++++.++||||+++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            4889999999999999999999999999999885432      2456799999999999999999887     3344578


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||+.+++...+....  ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++ .+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            999999888777765432  35688999999999999999999987 999999999999999887 79999999987553


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC--
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  296 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  296 (403)
                      .... .....+++.|+|||.+.+...++.++|||||||++|+|+||+.||.+.+..+...++....+.+....+....  
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            3221 2233567889999998765556889999999999999999999999988888888888877777654332111  


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      +.+. ..++......... ..+.++++++++|.+||+.||++|||++++++||||
T Consensus       232 ~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYK-PSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHH-hhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0000 0111111111111 123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.6e-44  Score=332.63  Aligned_cols=275  Identities=37%  Similarity=0.644  Sum_probs=216.9

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |++.+.||+|+||.||+|.+..++..||+|.+....     ....+|+.++.++. |+|++++++++...   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            678899999999999999999999999999886431     12236888888885 99999999987432   1235789


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||+++++.+.+...   ...+++..+..++.|++.||.|||+. |++||||+|+||+++. + .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            9999999888877653   24689999999999999999999988 9999999999999998 5 799999999987654


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC-c
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y  299 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  299 (403)
                      ........+++.|+|||.+.....++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            444444567889999998755555789999999999999999999999998888888888887777776543222111 1


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      ..+.++......+ ..+...++.++.+||.+||..||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1112222111111 11224578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-46  Score=329.92  Aligned_cols=254  Identities=28%  Similarity=0.421  Sum_probs=215.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh-------hhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|...++||+|.||+|-+++.+.+|+.+|||+++++..       ....|-.+|+..+||.+..+...|     +...
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence            3578899999999999999999999999999998866532       223577899999999999987776     3344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|+||||+.| .|.-.|.+    ...+++..+++|..+|+.||.|||++ +||+||||.+|.|+|.+|| +||+|||++
T Consensus       242 rlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGH-IKitDFGLC  315 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGH-IKITDFGLC  315 (516)
T ss_pred             eEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCc-eEeeecccc
Confidence            58999999996 45444443    46799999999999999999999998 9999999999999999995 999999999


Q ss_pred             eec-ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          216 KVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       216 ~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.. ..+....+++|||.|.|||++.. ..|+.++|+|.+|+++|||++|+.||...+....+..|+..           
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------  383 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------  383 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence            864 33455567899999999999954 55999999999999999999999999998877777666542           


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDPN  358 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~~~  358 (403)
                            +            -.|+..++++++.|+..+|.+||.+|..     +.|+.+|+||..+.+..
T Consensus       384 ------d------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 ------D------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             ------h------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                  1            1255689999999999999999999964     78999999999987753

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.6e-44  Score=335.43  Aligned_cols=256  Identities=27%  Similarity=0.411  Sum_probs=203.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+|++.+++.+     ....++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence            3788899999999999999999999999999885421       2234699999999999999998877     333468


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+.+ +|.+.+....  ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHG-HIRISDLGLAVH  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeccceee
Confidence            899999985 6766664422  34688999999999999999999987 999999999999999877 799999999876


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........|++.|+|||++.+.. ++.++|+||+||++|+|++|+.||...................          
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05630         152 VPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------  220 (285)
T ss_pred             cCCCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh----------
Confidence            54443333457899999999997654 8999999999999999999999998754321111111110000          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                     ...+...+++++.+|+.+||+.||++|||     ++++++||||+++..
T Consensus       221 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         221 ---------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             ---------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence                           00122457889999999999999999999     999999999998644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-43  Score=330.49  Aligned_cols=275  Identities=36%  Similarity=0.664  Sum_probs=212.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++|+|++++++++.     ...+.+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEEE
Confidence            6999999999999999999999899999999875321      23457999999999999999999873     334578


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||++++++..+...   ...+++..++.++.|++.||.|||+. |++||||||+||+++.++ .+||+|||++....
T Consensus        77 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07847          77 LVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQG-QIKLCDFGFARILT  151 (286)
T ss_pred             EEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCC-cEEECccccceecC
Confidence            99999998655544332   34689999999999999999999997 999999999999999887 79999999998664


Q ss_pred             cCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC--
Q 015615          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  296 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  296 (403)
                      ... ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+..+....+.+..+...........  
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            433 22234578889999998765568899999999999999999999999888777777666655544332211110  


Q ss_pred             cCcccccCCCccC-CCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          297 PNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       297 ~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      .-+.....+.... .+... ....++..+.+|+.+||+.||++|||+.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         232 QFFKGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0001111111111 11111 123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-44  Score=332.63  Aligned_cols=277  Identities=34%  Similarity=0.643  Sum_probs=216.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|++.+.||.|++|.||+|.+..+++.||||.+....     ....+|+.+++.++|+||+++++++     .+..+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence            357999999999999999999998899999999885432     2345799999999999999999887     334468


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||+.++|.+.+...   ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  153 (291)
T cd07844          79 TLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERG-ELKLADFGLARAK  153 (291)
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCC-CEEECcccccccc
Confidence            899999999888777643   24688999999999999999999987 999999999999999887 7999999998654


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .... ......++..|+|||++.+...++.++||||+|+++|+|++|..||.+.. ..+.+..+.+..+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence            2211 11223467889999998765558899999999999999999999998765 456666677777777766554332


Q ss_pred             c--CcccccCCCccCCCcccccccCCC--hHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          297 P--NYTEFKFPQIKAHPWHKIFQKRMP--PEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       297 ~--~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      .  .+.....+.....+....+ ..++  .++.+++.+||+.||++|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            2  1111122211111111111 1234  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.5e-44  Score=334.04  Aligned_cols=282  Identities=35%  Similarity=0.637  Sum_probs=220.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|++.+.||.|++|.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++.     +..+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            36999999999999999999999899999999875321      23457999999999999999999873     33468


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||+++++.+.+....  ...+++..+..++.||+.||+|||++ +++||||+|+||+++.++..+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            8999999988877775432  23467888889999999999999998 99999999999999866557999999998754


Q ss_pred             ccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC-
Q 015615          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  296 (403)
Q Consensus       219 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  296 (403)
                      ..... .....+++.|+|||.+.+...++.++||||+||++|+|+||.+||...+..+.+.++....+.|....+.... 
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            32221 2234568899999998765557899999999999999999999999888888888887777777655443211 


Q ss_pred             -cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                       +.+. ...+..... ......+.+++++.+++.+||..||++||++.++++||||.+++.
T Consensus       234 ~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        234 LPDYK-SAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             chhhh-hhcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence             1110 001111101 011123457899999999999999999999999999999998753

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-44  Score=353.19  Aligned_cols=275  Identities=26%  Similarity=0.348  Sum_probs=205.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....  ....+|+.++++++|+||+++++++..     ....++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence            3469999999999999999999999999999996432  235689999999999999999987633     334789999


Q ss_pred             cccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCC
Q 015615          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (403)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~  223 (403)
                      ++.++|...+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.......
T Consensus       241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS  315 (461)
T ss_pred             ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence            9998888877653   24689999999999999999999988 999999999999999877 799999999976533221


Q ss_pred             ---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCHHH--
Q 015615          224 ---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREE--  291 (403)
Q Consensus       224 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~--  291 (403)
                         .....||+.|+|||++.+.. ++.++|||||||++|||++|..|+....       ...++..+++..+....+.  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence               12356899999999997654 8999999999999999999876543321       1234444444433221110  


Q ss_pred             ------HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          292 ------IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       292 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                            .............+......|....  .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                  0000000000011111122233221  46789999999999999999999999999999975

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-44  Score=358.07  Aligned_cols=254  Identities=29%  Similarity=0.387  Sum_probs=208.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccC-CcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..|.+.+.||+|+||.||+|.+..+ +..||+|.+....    ....+|+.+++.++||||+++++++.     ...++|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEE
Confidence            3599999999999999999998777 7889999764322    34457999999999999999999873     334588


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      |||||++ ++|.+.+.........+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTG-IIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCC-cEEEEeCcCceec
Confidence            9999998 588887766555556789999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .....   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......         
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------  289 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------  289 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            43321   2345689999999998654 4899999999999999999999999887665555544331100         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                         .++..++.++.+||.+||..||++|||+++++.|||++..
T Consensus       290 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 -------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                               0123478899999999999999999999999999998653

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-44  Score=330.17  Aligned_cols=252  Identities=35%  Similarity=0.586  Sum_probs=203.8

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh------hhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |++.+.||+|+||+||+|++..+++.||+|.+.....      ...+|+.+++.++||||+++++++..     ..+.++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            8899999999999999999999999999999865432      12348999999999999999988744     445789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec-
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-  218 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~-  218 (403)
                      ||||+.+ +|.+.+..    ...++...+..++.||+.||.+||++ ||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             cccccccccccccccc----cccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccccc
Confidence            9999997 88888873    36789999999999999999999997 999999999999999777 7999999999763 


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ..........+++.|+|||++.....++.++|+||||+++|+|++|..||......+....+.+...........     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence            222333456779999999998634558999999999999999999999999874444444444332221111110     


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                       .....+..+.++|++||+.||++|||+.++++||||
T Consensus       225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                             001123799999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-44  Score=342.03  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=204.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|.+.+.||+|+||.||++++..+++.||+|.+.+..       ....+|+.++..++|+||+++++++     .+...+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence            5999999999999999999999999999999985421       2245688899999999999998877     334458


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            89999998 5787777653   35689999999999999999999987 999999999999999877 799999999875


Q ss_pred             cccCCCc--ceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          218 LVKGEPN--ISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       218 ~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......  ....||+.|+|||++.+    ...++.++|||||||++|||++|+.||.+.+..+.+..+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-----  226 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc-----
Confidence            5332221  23468999999999852    334789999999999999999999999987766665554431100     


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC--CCCHHHHhcCCCCccCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  356 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~s~~ell~hp~f~~~~~  356 (403)
                                ..++.         ....+++++.+||++||+.++.+  |++++++++||||+++.+
T Consensus       227 ----------~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         227 ----------FQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             ----------ccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence                      00110         11347899999999999765555  689999999999998654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-44  Score=336.53  Aligned_cols=281  Identities=37%  Similarity=0.637  Sum_probs=214.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEcc--CCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|.+....       ....+|+.+++.++||||+++++++..   ....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            48899999999999999999988  89999999986522       334579999999999999999998743   2224


Q ss_pred             EEEEEEecccchHHHHHHhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC----CCCceEEee
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----HTHQLKLCD  211 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~----~~~~vkl~D  211 (403)
                      .+++||||+++++.+.+........ .+++..++.++.||+.||+|||+. +|+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            6889999999888887765443333 789999999999999999999987 9999999999999998    66 799999


Q ss_pred             cCCceecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---------HHHH
Q 015615          212 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---------DQLV  278 (403)
Q Consensus       212 fG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~~  278 (403)
                      ||++........    .....+++.|+|||++.+...++.++|||||||++|+|++|++||.+....         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876533221    123456888999999876656899999999999999999999999865432         3455


Q ss_pred             HHHHHhCCCCHHHHhccC--cCcccc----cCCCccCCCccccccc--CCChHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 015615          279 EIIKVLGTPTREEIKCMN--PNYTEF----KFPQIKAHPWHKIFQK--RMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  350 (403)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~--~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~  350 (403)
                      .+...++.+....+....  +.+...    .............+..  ..+.++.+++.+||+.||++|||+.++++|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            566666666554442211  111110    0000110111111111  57889999999999999999999999999999


Q ss_pred             C
Q 015615          351 F  351 (403)
Q Consensus       351 f  351 (403)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5e-44  Score=339.42  Aligned_cols=250  Identities=28%  Similarity=0.430  Sum_probs=201.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCC-CCeeecceeeeecCCCCceE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~  137 (403)
                      +|+..+.||+|+||.||+|.+..+|+.||||++....       .....|..++..+.| ++|+++++++     .+...
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            3778899999999999999999999999999886432       223457788888764 6677787776     23345


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +|+||||+++ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~-~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEecccccc
Confidence            8899999985 67666654    35689999999999999999999998 999999999999999887 79999999987


Q ss_pred             ecccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ..... .......||+.|+|||++.+.. ++.++||||+||++|+|++|.+||.+.+.......+.....          
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----------  218 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----------  218 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence            54222 2223456899999999996554 89999999999999999999999998776655555443100          


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                         .++..++.++.+++.+||+.||.+|++     .+++++||||+.+.+
T Consensus       219 -------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         219 -------------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             -------------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                               122457889999999999999999997     578999999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.6e-44  Score=342.21  Aligned_cols=246  Identities=26%  Similarity=0.478  Sum_probs=193.5

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+++.||+|.+....       ....+|+.++..+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986431       2234677777766 7999999999873     334588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc-
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-  220 (403)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99995 66555543    35789999999999999999999998 999999999999999888 799999999875322 


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHH
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~  292 (403)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....        ...+.+....  .      
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~------  220 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--K------  220 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--C------
Confidence            2223346789999999999765 489999999999999999999999953211        1111111100  0      


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC------HHHHhcCCCCccCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST------ALEALIHPFFDELRD  356 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s------~~ell~hp~f~~~~~  356 (403)
                                          ...++..++..+.+||++||..||++|++      ++++++||||+...+
T Consensus       221 --------------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         221 --------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                                00123457899999999999999999998      589999999987643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.6e-44  Score=345.58  Aligned_cols=255  Identities=27%  Similarity=0.360  Sum_probs=197.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ...+|...+.||+|+||.||+|.+..+|+.||||.+...     .....+|+.+++.++|+||+++++++     .....
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  146 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE  146 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence            345789999999999999999999999999999998543     23456799999999999999999887     34445


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++||||+.++.+.   .    ....++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       147 ~~lv~e~~~~~~L~---~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~  217 (353)
T PLN00034        147 IQVLLEFMDGGSLE---G----THIADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAK-NVKIADFGVSRI  217 (353)
T ss_pred             EEEEEecCCCCccc---c----cccCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEccccccee
Confidence            88999999964221   1    13356677888999999999999998 999999999999999887 799999999986


Q ss_pred             cccCC-CcceeeecccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          218 LVKGE-PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       218 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ..... ......||..|+|||++...    ...+.++|||||||++|||++|+.||......+....+.......     
T Consensus       218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----  292 (353)
T PLN00034        218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-----  292 (353)
T ss_pred             cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----
Confidence            54322 22345789999999987432    224568999999999999999999997433222111111110000     


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                          .......++.++.+||.+||..||++|||+.|+++||||..-..
T Consensus       293 --------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        293 --------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             --------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence                                00012357889999999999999999999999999999998543

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.8e-44  Score=340.16  Aligned_cols=288  Identities=36%  Similarity=0.673  Sum_probs=229.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|.+.+.||.|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.... ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            57999999999999999999999999999999885431      23346999999999999999998764433 344568


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||+.++|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            89999999887777653    35589999999999999999999987 999999999999999887 7999999998765


Q ss_pred             ccCCCc-----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          219 VKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       219 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ......     ....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+....+.|+...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            332211     234678899999998665558999999999999999999999999998888888888888888776554


Q ss_pred             ccCcCccc---ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCC
Q 015615          294 CMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR  360 (403)
Q Consensus       294 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~  360 (403)
                      ........   ..++.....+|.. +.+..+.++.++|++||+.||++|||+++++.||||.+...+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~  306 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE  306 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence            32211100   0112222222322 224578999999999999999999999999999999998777653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.8e-43  Score=328.42  Aligned_cols=277  Identities=36%  Similarity=0.626  Sum_probs=211.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|++.+.||+|+||.||+|.+..+|..||+|.+....     ....+|+.+++.++|+||+++++++.     +..+.+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEE
Confidence            57999999999999999999999999999999885432     23457999999999999999998873     334578


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||+.+++...+...   ...++...++.++.|++.||.|||+. ||+|+||||+||+++.++ .+||+|||+++...
T Consensus        80 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  154 (291)
T cd07870          80 FVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence            99999998887766543   24577888899999999999999987 999999999999999877 79999999987542


Q ss_pred             cCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhccC-
Q 015615          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN-  296 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~-  296 (403)
                      ... ......+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.+. .+.+.++....+.|......... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            221 123345688999999987655578899999999999999999999987543 35556666666666655433221 


Q ss_pred             -cCcccccCCCccCCCcccccc-cCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          297 -PNYTEFKFPQIKAHPWHKIFQ-KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                       +.+.....+............ ...+.++.+++.+||..||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             111111111111111111110 0236789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=330.06  Aligned_cols=296  Identities=28%  Similarity=0.485  Sum_probs=227.3

Q ss_pred             CCCCCceEEeecCCCCCCCccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhh---hHHHHHHHHHcCC--
Q 015615           43 GTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY---KNRELQTMRLLDH--  117 (403)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h--  117 (403)
                      ....|+++.....      ....+|.+.+.+|+|.||.|..+.|..++..||||+++.-.++   ..-|+++|.++.+  
T Consensus        73 dD~dGH~v~~~gD------~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~D  146 (415)
T KOG0671|consen   73 DDKDGHYVYQVGD------ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESD  146 (415)
T ss_pred             CCCCceEEEEecc------ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcC
Confidence            3445655554321      1245899999999999999999999999999999988654333   3358999999842  


Q ss_pred             C----CeeecceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 015615          118 P----NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI  193 (403)
Q Consensus       118 ~----niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dl  193 (403)
                      |    -+|++.++|     ...++.|||+|.++-++.+++..+.  ..+++...++.+++|++.+++|||+. +++|.||
T Consensus       147 P~g~~rcv~m~~wF-----dyrghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDL  218 (415)
T KOG0671|consen  147 PNGKFRCVQMRDWF-----DYRGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDL  218 (415)
T ss_pred             CCCceEEEeeehhh-----hccCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc-ceeecCC
Confidence            2    377777777     5556689999999989999998753  46789999999999999999999997 9999999


Q ss_pred             CCCceEecCC-------------------CCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHH
Q 015615          194 KPQNLLVNPH-------------------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSA  254 (403)
Q Consensus       194 kp~NIll~~~-------------------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  254 (403)
                      ||+|||+.+.                   ...|+|+|||.|....  +...+.+.|..|+|||++.+-+ ++.++||||+
T Consensus       219 KPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSi  295 (415)
T KOG0671|consen  219 KPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSI  295 (415)
T ss_pred             ChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccC-cCCccCceee
Confidence            9999998321                   1148999999998653  3346778899999999998765 9999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC---------cCcccccCCC------ccCCCcccccc--
Q 015615          255 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN---------PNYTEFKFPQ------IKAHPWHKIFQ--  317 (403)
Q Consensus       255 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~---------~~~~~~~~~~------~~~~~~~~~~~--  317 (403)
                      ||||+|+.||...|+..++.+.++.+...+|..+...+....         .+|.+.....      -...+......  
T Consensus       296 GCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~  375 (415)
T KOG0671|consen  296 GCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD  375 (415)
T ss_pred             eeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence            999999999999999999999998888899977776665441         1111111100      00011111111  


Q ss_pred             cCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          318 KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       318 ~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      .....++.|||++||.+||.+|+|+.|+|.||||+.+.
T Consensus       376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  376 DLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             cHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            11124589999999999999999999999999999864

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6e-44  Score=368.44  Aligned_cols=264  Identities=29%  Similarity=0.418  Sum_probs=212.1

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|.+.+.||.|+||.||+|.+..++..||+|.+...      ...+..|+.+++.++||||++++++|...   ...
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~~   87 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---ANQ   87 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CCC
Confidence            445799999999999999999999999999999988532      23345799999999999999999987543   234


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc------CCccccCCCCCceEecCC------
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT------IGVCHRDIKPQNLLVNPH------  203 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~------~~ivH~Dlkp~NIll~~~------  203 (403)
                      .+||||||++ ++|.+.+.........+++..++.|+.||+.||+|||+.      .+||||||||+||||+.+      
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            5789999998 488888876555556799999999999999999999974      149999999999999642      


Q ss_pred             ----------CCceEEeecCCceecccCCCcceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015615          204 ----------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (403)
Q Consensus       204 ----------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~  272 (403)
                                ...+||+|||++.............||+.|+|||++.+. ..++.++||||||||||+|+||..||...+
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      124899999999866444333456789999999998643 347899999999999999999999998766


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                      ....+.......  +.                  +        .....+.++.+||.+||..+|.+||++.++|.||||+
T Consensus       248 ~~~qli~~lk~~--p~------------------l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        248 NFSQLISELKRG--PD------------------L--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             cHHHHHHHHhcC--CC------------------C--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            555444333211  00                  0        0123588999999999999999999999999999998


Q ss_pred             cCCCC
Q 015615          353 ELRDP  357 (403)
Q Consensus       353 ~~~~~  357 (403)
                      .+..+
T Consensus       300 ~i~~p  304 (1021)
T PTZ00266        300 NVGPP  304 (1021)
T ss_pred             hcCCC
Confidence            77554

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-43  Score=339.00  Aligned_cols=287  Identities=31%  Similarity=0.542  Sum_probs=217.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCC-------
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-------  133 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-------  133 (403)
                      .+|.+.+.||.|+||.||+|.+..+|..||+|.+....    ....+|+.+++.++||||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57999999999999999999999999999999885432    3355799999999999999998876432211       


Q ss_pred             --CceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          134 --DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       134 --~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                        +..+.++||||++++|.+.+..     ..+++..++.++.||+.||.|||+. ||+||||||+||+++.++..+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECC
Confidence              1235789999999887766642     4688999999999999999999987 9999999999999986665799999


Q ss_pred             cCCceecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          212 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       212 fG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      ||++........    .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999876532211    1223568889999987655558899999999999999999999999888777776666554443


Q ss_pred             CHHHHhccCcCccccc--CCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          288 TREEIKCMNPNYTEFK--FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      ................  .......+... +.+.++.++.+||.+||+.||.+|||+.++++||||+.+..|.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  310 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF  310 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence            3322211110000000  00011111111 2245789999999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.4e-45  Score=343.74  Aligned_cols=244  Identities=28%  Similarity=0.472  Sum_probs=199.4

Q ss_pred             eEeeeCCcEEEEEEEEc---cCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      +.||+|+||.||++++.   .+|+.||+|++....      ....+|+.+++.++||||+++++++.     +...+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            57999999999999863   578999999986432      23346999999999999999988873     34458899


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+. ++|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            99998 477766644    35689999999999999999999997 999999999999999887 799999999876543


Q ss_pred             C-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          221 G-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       221 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      . .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....               
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------  214 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------  214 (318)
T ss_pred             CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            3 223345789999999998654 47899999999999999999999998877655555443210               


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCC
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELR  355 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~  355 (403)
                        .            .++..+++++.+||++||+.||++||+     ++++++||||+.+.
T Consensus       215 --~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         215 --L------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             --C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence              0            022347899999999999999999999     78899999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.9e-43  Score=328.96  Aligned_cols=276  Identities=35%  Similarity=0.650  Sum_probs=220.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|++.+.||.|++|.||+|++..+|..||||.+...     .....+|+.+++.++|+||+++++++..     ....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            489999999999999999999999999999988543     2334579999999999999999998743     334789


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||+++++.+.+..... ...+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            999999988887765432 34689999999999999999999987 999999999999999877 799999999875432


Q ss_pred             CC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       221 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      .. ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+....+......|....+.... ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            21 12234568889999998766567899999999999999999999999998888888888887777766554322 11


Q ss_pred             cc--ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          300 TE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       300 ~~--~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      ..  ..++......... +.+..++.+.+++.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11  1112111111211 223568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.4e-43  Score=330.45  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=206.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+.+.+++     ......
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence            3788899999999999999999999999999885321       2345799999999999999998877     333458


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++|||+.+ +|...+...  ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~  151 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYG-HIRISDLGLAVK  151 (285)
T ss_pred             EEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCC-CEEEecCCccee
Confidence            899999996 565555432  134689999999999999999999987 999999999999999887 799999999876


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........|++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.........+........         
T Consensus       152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05632         152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------  221 (285)
T ss_pred             cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------
Confidence            5444333455789999999999665 489999999999999999999999987765444433332211100         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                      ..+...++.++.+|+.+||+.||++||+     +.++++|+||+....
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         222 ----------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence                            0122457889999999999999999999     899999999998744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.6e-44  Score=338.77  Aligned_cols=246  Identities=26%  Similarity=0.474  Sum_probs=195.5

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|+.++..+ .||||+++++++     .+...+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986432       2244688888887 699999999887     3334588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc-c
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-K  220 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~-~  220 (403)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.... .
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99985 66665543    35689999999999999999999998 999999999999999887 79999999987532 2


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||....      ..+.+.+....  .+       
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~-------  219 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP-------  219 (327)
T ss_pred             CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC-------
Confidence            2233456789999999999654 48999999999999999999999996422      11222221110  00       


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC------HHHHhcCCCCccCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST------ALEALIHPFFDELRD  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s------~~ell~hp~f~~~~~  356 (403)
                                         ..++..++..+.++|++||..||++|++      .+++++||||+.+.+
T Consensus       220 -------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~  268 (327)
T cd05617         220 -------------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW  268 (327)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence                               0123457899999999999999999998      579999999998753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.4e-44  Score=340.35  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=204.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|.+.+.||+|+||.||+|++..+++.||+|.+....       ....+|+.++..++|+||+++++++     .+..+.
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999885421       2245688899999999999998887     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+||||+.+ +|.+.+...   ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~  151 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNG-HIRLADFGSCLK  151 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence            999999985 777777653   35688999999999999999999987 999999999999999877 799999999976


Q ss_pred             cccCCCc--ceeeecccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          218 LVKGEPN--ISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       218 ~~~~~~~--~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......  ....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+.+..+.+..+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER-----  226 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc-----
Confidence            5433221  234689999999998542    34788999999999999999999999887765555544331100     


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC--CCCHHHHhcCCCCccCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRD  356 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~s~~ell~hp~f~~~~~  356 (403)
                                ..++.         ....++.++.+||.+||+.++++  |++++++++||||+...+
T Consensus       227 ----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         227 ----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             ----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence                      00010         01246899999999999976655  578999999999998654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.2e-44  Score=342.24  Aligned_cols=244  Identities=29%  Similarity=0.484  Sum_probs=195.2

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHH-HHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|.. +++.++||||+++++.+     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46899999999999999999999999985431       11223433 56779999999998877     3334578999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc-
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-  220 (403)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||+. ||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99986 56555543    35789999999999999999999997 999999999999999888 799999999875322 


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~---~-------------  212 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK---P-------------  212 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence            22233457899999999996654 899999999999999999999999887665555444321   0             


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH----HHHhcCCCCccCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELR  355 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~----~ell~hp~f~~~~  355 (403)
                                   ..+.+..+..+.++|++||+.||.+||++    .++++||||....
T Consensus       213 -------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         213 -------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             -------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence                         00123478899999999999999999976    5899999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.5e-44  Score=340.87  Aligned_cols=244  Identities=27%  Similarity=0.438  Sum_probs=195.8

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccchh-------hhHHH-HHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRE-LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E-~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+++.||+|++.....       ...+| ..+++.++||||+++++++     .....+++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            369999999999999999999999999864321       11223 3356788999999998877     3334588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc-
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-  220 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-  220 (403)
                      ||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99996 66666654    35688889999999999999999998 999999999999999887 799999999875422 


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P-------------  212 (325)
T ss_pred             CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------
Confidence            2223355789999999999764 4899999999999999999999999987766655544331   0             


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHH----HHhcCCCCccCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL----EALIHPFFDELR  355 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~----ell~hp~f~~~~  355 (403)
                                   ..+.+.++..+.++|.+||+.||.+|+++.    ++++|+||....
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence                         002245789999999999999999999876    899999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.5e-43  Score=330.45  Aligned_cols=284  Identities=30%  Similarity=0.515  Sum_probs=216.7

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC---C
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---K  133 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~  133 (403)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.++||||+++++++.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999999999999999875321      123469999999999999999987754322   2


Q ss_pred             CceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       134 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      .....++||||+.+++.+.+...   ...+++..++.++.||+.||+|||++ |++|+||||+||+++.++ .+||+|||
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDG-ILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCC-cEEECcCC
Confidence            23457899999998887776543   24689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCc-----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          214 SAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       214 ~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      ++.........     ....++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+.......+....+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            98765332211     2345678899999986655578899999999999999999999998887777777777666655


Q ss_pred             HHHHhccC--cCcccccCCCccCCCccccc-ccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          289 REEIKCMN--PNYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       289 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      .+.++...  ..+....++........... ....+..+.+||.+||..||.+|||++++++||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            54332211  01111112211111111111 11246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=369.24  Aligned_cols=260  Identities=29%  Similarity=0.474  Sum_probs=220.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEecc-------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|.+.++||+|+||.|.+++++.+++.||+|++.+       +...+..|..+|..-+.+=|+++...|     .+..
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~  148 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER  148 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence            3579999999999999999999999999999998854       235566799999999999999998777     7888


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      |+|+||||++| +|..++..+    .++|+.++++|+..|+.||+-||+. |+|||||||+|||+|..|| +||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GH-ikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGH-IKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCc-EeeccchhH
Confidence            99999999995 777777764    4899999999999999999999986 9999999999999999995 999999999


Q ss_pred             eecccCCCc--ceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          216 KVLVKGEPN--ISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       216 ~~~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      -.+......  ...+|||.|++||++..    ...|++.+|+||+||++|||+.|..||...+-.+.+.+|+..-     
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk-----  297 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK-----  297 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh-----
Confidence            877533322  34689999999999842    2458999999999999999999999999988888888888641     


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC---HHHHhcCCCCccCCCCCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRDPNTR  360 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s---~~ell~hp~f~~~~~~~~~  360 (403)
                                ..+.+|+.          ..+|.++++||+++++ +|+.|..   ++++.+||||.++.|.+.|
T Consensus       298 ----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR  350 (1317)
T KOG0612|consen  298 ----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIR  350 (1317)
T ss_pred             ----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhh
Confidence                      11222211          3489999999999887 7889988   9999999999998875544

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-43  Score=338.73  Aligned_cols=278  Identities=26%  Similarity=0.420  Sum_probs=204.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|++.+.||.|+||.||+|.+..+|..+|+|.+....     ....+|+++++.++||||++++++|..     ..+++
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence            57999999999999999999999999999999875431     335689999999999999999998843     33588


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+.+ +|.+.+...    ..+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~  154 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (333)
T ss_pred             EEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence            99999985 787777653    56888999999999999999999743799999999999999887 7999999998755


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH--hCCCCHHHHhccC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV--LGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~  296 (403)
                      ... ......+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||......+.. .+...  .+.+.........
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCccc
Confidence            322 22345688999999999654 4899999999999999999999999876543222 11110  0000000000000


Q ss_pred             -------cCcccccCCCc---------cCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          297 -------PNYTEFKFPQI---------KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       297 -------~~~~~~~~~~~---------~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                             ..+.....+..         ............++.++++|+.+||++||++|||+.+++.||||+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                   00000000000         000000000123578899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-44  Score=343.66  Aligned_cols=244  Identities=27%  Similarity=0.472  Sum_probs=194.3

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccchh-------hhHHHHHHHHHc---CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      ||+|+||.||+|++..+|+.||||++.....       ....|..++...   .||||++++.++     .....+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            6999999999999999999999999854321       112355566554   699999998877     3344588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99985 66666654    36789999999999999999999998 999999999999999887 7999999998754322


Q ss_pred             -CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                       .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------  213 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK----------------  213 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223346789999999998765558999999999999999999999998876555444332210                


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC----CHHHHhcCCCCccCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS----TALEALIHPFFDELR  355 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~----s~~ell~hp~f~~~~  355 (403)
                       ..++           ...+++++.+||++||+.||.+||    +++++++||||....
T Consensus       214 -~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         214 -VRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             -CCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence             0000           123688999999999999999998    799999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-43  Score=326.53  Aligned_cols=274  Identities=35%  Similarity=0.661  Sum_probs=216.7

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |++.+.||.|++|.||+|.+..+|..||+|++..+.      ....+|+++++.++|||++++++++.     +..+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            677889999999999999999999999999885332      23457999999999999999999873     3356889


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      +|||++++|.+.+....  ...+++..+..++.|++.||+|||++ +++||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            99999888887776532  14688999999999999999999998 999999999999999877 799999999875432


Q ss_pred             CC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC--c
Q 015615          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P  297 (403)
Q Consensus       221 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~  297 (403)
                      .. ......+++.|+|||++.+...++.++|+||||+++|+|++|.+||.+.+....+..+.+..+.|....+....  +
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            21 12233568889999988665557899999999999999999999999988888888888877777765543211  1


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      ++.. .++........ ...+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus       232 ~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKP-TFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhh-hcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            1100 11111111111 1234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-43  Score=335.86  Aligned_cols=316  Identities=34%  Similarity=0.610  Sum_probs=237.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|.+.+.||+|++|.||+|++..++..||||.+...      .....+|+.+++.++|||++++.+++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            4699999999999999999999999999999987532      1233469999999999999999887643222 22334


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .++|+||++++|.+.+..     ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~  167 (343)
T cd07851          95 VYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH  167 (343)
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEcccccccc
Confidence            789999998888777753     5689999999999999999999987 999999999999999877 799999999876


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+.....
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            5332  23456788899999986554578999999999999999999999999888888888888777766554432221


Q ss_pred             Ccc-cc--cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015615          298 NYT-EF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFK  374 (403)
Q Consensus       298 ~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  374 (403)
                      ... .+  ..+......+... ...++..+.+||.+||..||++|||+.++++||||++...+.....     ++.++ .
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~-----~~~~~-~  318 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV-----APPYD-Q  318 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc-----ccccC-c
Confidence            100 00  0111111111111 1346899999999999999999999999999999999876643221     22222 1


Q ss_pred             hhhcCCCChHHHhhcchHHHHh
Q 015615          375 PHELKGVPVDMLVKLIPEHARK  396 (403)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~  396 (403)
                      +..-..+..+.|+.++-.+..+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~  340 (343)
T cd07851         319 SFESRDLTVDEWKELVYKEIMN  340 (343)
T ss_pred             chhhhhcCHHHHHHHhHHHHHh
Confidence            2233335567777776665543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-43  Score=322.18  Aligned_cols=247  Identities=28%  Similarity=0.478  Sum_probs=201.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .|.+.+.||+|++|.||+|.+..+++.||+|.+....         ....+|+.+++.++||||+++++++.     +..
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DDE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCC
Confidence            5899999999999999999999999999999875321         23457999999999999999999873     334


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+++|+||+++ +|.+.+...    ..+++..+..++.|++.||+|||+. ||+||||+|+||+++.++ .++|+|||++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~-~~~l~dfg~~  151 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  151 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence            68899999985 677776543    5688889999999999999999987 999999999999999877 7999999998


Q ss_pred             eecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       216 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .........    ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+.....      
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------  224 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT------  224 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC------
Confidence            765332111    2345678899999997654 89999999999999999999999987655444333222100      


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                           ...++..++.++.++|.+||..+|.+|||+.++++||||
T Consensus       225 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 ---------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ---------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                 001234578899999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.7e-44  Score=337.93  Aligned_cols=245  Identities=29%  Similarity=0.431  Sum_probs=194.3

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHH-HHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNREL-QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|++..+|+.||+|.+....       ....+|. .+++.++||||+++++++     .+....++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            36999999999999999999999999985432       1122333 467889999999998877     3334588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99985 66555543    35688999999999999999999987 999999999999999887 7999999998753222


Q ss_pred             -CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 -EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+...   +.            
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~------------  213 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---PL------------  213 (321)
T ss_pred             CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---CC------------
Confidence             222345689999999998654 4899999999999999999999999887655444433221   00            


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH----HHHhcCCCCccCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~----~ell~hp~f~~~~~  356 (403)
                                    .++...+.++.++|.+||+.||.+|+++    .++++||||..+.+
T Consensus       214 --------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         214 --------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence                          1223468899999999999999999875    49999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-43  Score=327.51  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=202.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHH-HHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||+|.+..+|+.||||.+....     .....|+. .++.++||||+++++++..     ...++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcEE
Confidence            5899999999999999999999999999999885432     12223444 3667789999999998743     33478


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ++|||++++|.+++.........+++..+..++.||+.||+|||++.+++||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence            99999999888888765545567999999999999999999999855999999999999999887 79999999987654


Q ss_pred             cCCCcceeeecccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhcc
Q 015615          220 KGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .........++..|+|||.+.+.   ..++.++|+|||||++|+|++|..||.... ..+.+..+...  .+        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~--------  225 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PS--------  225 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CC--------
Confidence            33333335678889999988542   236889999999999999999999997532 22333222211  00        


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                       +        .        .....+|.++.+||.+||..+|++||++.++++||||....
T Consensus       226 -~--------~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         226 -P--------Q--------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             -C--------C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence             0        0        01123688999999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8e-43  Score=325.33  Aligned_cols=276  Identities=39%  Similarity=0.702  Sum_probs=219.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            699999999999999999999999999999987532      2345679999999999999999998843     33578


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ++|||+++++...+...   ...++...+..++.||+.||+|||++ +++|+||+|+||+++.++ .+||+|||++....
T Consensus        77 iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            99999998766655432   35588999999999999999999998 999999999999999877 79999999987664


Q ss_pred             cCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC-
Q 015615          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  296 (403)
Q Consensus       220 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  296 (403)
                      ...  ......++..|+|||++.+...++.++|+||||+++|+|++|++||.+.+..+.+..+....+........... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            433  22345678889999999776468999999999999999999999999888777777777766665554332221 


Q ss_pred             -cCcccccCCCcc-CCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          297 -PNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       297 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                       +.+....++... ...+...++..++.++.+||++||..||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             112111111111 1122233444568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.4e-43  Score=328.44  Aligned_cols=281  Identities=34%  Similarity=0.619  Sum_probs=218.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC---CC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  134 (403)
                      ..+|++.+.||.|+||.||+|.+..+++.||||.+....      ....+|+++++.++||||+++++.+.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999999999999999874321      234679999999999999999987654332   23


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..++++||||+.+++...+...   ...+++..+..++.|++.||+|||++ ||+|+||||+||+++.++ .+||+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            4467899999998877666542   35689999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCC------------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015615          215 AKVLVKGEP------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (403)
Q Consensus       215 a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  282 (403)
                      +........            .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            875532221            12235688899999986655588999999999999999999999999888888888887


Q ss_pred             HhCCCCHHHHhccC--cCccc-ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          283 VLGTPTREEIKCMN--PNYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       283 ~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      ..+.+....+....  +.... ......+ ......+ ..+++.+.+||.+||..||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCC-ccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            77766655443211  11100 0000000 1111111 2456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=309.68  Aligned_cols=265  Identities=25%  Similarity=0.422  Sum_probs=214.5

Q ss_pred             CCCCCCCccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh--hhH---HHHHHH-HHcCCCCeeecceeee
Q 015615           55 GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--YKN---RELQTM-RLLDHPNVVSLKHCFF  128 (403)
Q Consensus        55 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~---~E~~~l-~~l~h~niv~~~~~~~  128 (403)
                      ++....+....+......||+|.-|.||+++.+.+|...|||.+.+...  ...   ..+.++ +.-+.|+||+.+++|.
T Consensus        82 ~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   82 GGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             cCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            3333444455567778899999999999999999999999999965431  111   233332 2335899999999997


Q ss_pred             ecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceE
Q 015615          129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (403)
Q Consensus       129 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  208 (403)
                      ...+     +++.||.|......+++...   +++|+..+-.+...++.||.||.++.||+|||+||+|||+|..| ++|
T Consensus       162 ~n~d-----V~IcMelMs~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niK  232 (391)
T KOG0983|consen  162 TNTD-----VFICMELMSTCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIK  232 (391)
T ss_pred             eCch-----HHHHHHHHHHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEE
Confidence            6544     67899999987777777653   67999999999999999999999877999999999999999888 799


Q ss_pred             EeecCCceecccCCCcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhC
Q 015615          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLG  285 (403)
Q Consensus       209 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~  285 (403)
                      |||||++.++.+........|.+.|||||.+..  .+.|+.++||||||++++||.||..||.+. .+.+.+.++.+.  
T Consensus       233 lCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--  310 (391)
T KOG0983|consen  233 LCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--  310 (391)
T ss_pred             eecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--
Confidence            999999999988888888899999999999853  346899999999999999999999999984 455666666552  


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      .|+.     +         +          ....+|+++++|+..||.+|+.+||...++|+|||+...
T Consensus       311 ePP~-----L---------~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  311 EPPL-----L---------P----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             CCCC-----C---------C----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            1111     0         0          112379999999999999999999999999999998764

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.4e-43  Score=333.13  Aligned_cols=277  Identities=35%  Similarity=0.574  Sum_probs=218.1

Q ss_pred             cceE-EEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh------------------hhHHHHHHHHHcCCCCeeecce
Q 015615           65 ISYM-AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVVSLKH  125 (403)
Q Consensus        65 ~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~h~niv~~~~  125 (403)
                      .+|. +.+.||.|+||.||+|.+..+++.||||.+.....                  ...+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4575 45789999999999999999999999998854211                  2457999999999999999999


Q ss_pred             eeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC
Q 015615          126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (403)
Q Consensus       126 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  205 (403)
                      ++.     ...+.++||||+.+++.+.+..    ...+++..+..++.|++.||+|||+. ||+|+||+|+||+++.++ 
T Consensus        88 ~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~-  156 (335)
T PTZ00024         88 VYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKG-  156 (335)
T ss_pred             EEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCC-
Confidence            873     3345889999999988887764    35688999999999999999999987 999999999999999887 


Q ss_pred             ceEEeecCCceecccC---------------CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015615          206 QLKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (403)
Q Consensus       206 ~vkl~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  270 (403)
                      .++|+|||++......               .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            7999999998765311               1111234578899999987655579999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccC--cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          271 ESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .+..+.+..+...++.|....+....  +.+..+.  ......... .....+.++.++|.+||+.||++|||++++|.|
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT--PRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCHHHHHHHHHHHhCCCchhhCcchhhcccccccC--cCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            98888888888888877765443221  1111110  000011111 123468899999999999999999999999999


Q ss_pred             CCCccCC
Q 015615          349 PFFDELR  355 (403)
Q Consensus       349 p~f~~~~  355 (403)
                      |||+...
T Consensus       314 ~~~~~~~  320 (335)
T PTZ00024        314 EYFKSDP  320 (335)
T ss_pred             cccCCCC
Confidence            9998753

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-42  Score=331.34  Aligned_cols=287  Identities=37%  Similarity=0.626  Sum_probs=224.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccC--CcEEEEEEeccc------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLET--GEAVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +|.+.+.||+|+||.||+|.+..+  +..||||.+...      .....+|+.+++.+ +||||+++++.+.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            488999999999999999999887  899999987532      12345799999998 5999999988654322 2234


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .++++++|++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            4678999999888877754    35689999999999999999999987 999999999999999887 79999999997


Q ss_pred             ecccCCC-----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......     .....+|+.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+..+...++.+..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6533221     12346789999999886655589999999999999999999999999888888899999888887765


Q ss_pred             HhccCcCcc-c--ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCC
Q 015615          292 IKCMNPNYT-E--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR  360 (403)
Q Consensus       292 ~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~  360 (403)
                      +........ .  .........++.. ..+..+..+.+|+.+||+.||++|||+.+++.||||++++++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~  304 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDE  304 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccc
Confidence            443221100 0  0111111112221 123468899999999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.3e-44  Score=306.49  Aligned_cols=314  Identities=30%  Similarity=0.566  Sum_probs=249.3

Q ss_pred             CCCCCCccccccCcccCcccccceecCCCCCCCCceEEeecCCCCCCCccccceEEEeEeeeCCcEEEEEEEEccCCcEE
Q 015615           14 VGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAV   93 (403)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v   93 (403)
                      .++.++..+.+..+.++-.+.|..+.+-.                    ...+|++.+++|+|.|+.||.|.+..+++.+
T Consensus         7 ~s~ARvya~vn~~rp~eYWdYE~~~i~wg--------------------~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~   66 (338)
T KOG0668|consen    7 PSVARVYADVNEERPREYWDYESLVIDWG--------------------NQDDYEIVRKVGRGKYSEVFEGINITNNEKC   66 (338)
T ss_pred             chhhhhhhhccccCchhhcchhheeeecc--------------------ccchHHHHHHHcCccHhhHhcccccCCCceE
Confidence            34556666666666666666665433311                    2347999999999999999999999999999


Q ss_pred             EEEEeccc-hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHH
Q 015615           94 AIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY  171 (403)
Q Consensus        94 aiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~  171 (403)
                      +||.++.- ..-+.+|+.+|..|. ||||++++++...   .......+|+||+...-...+      .+.++...++.+
T Consensus        67 ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaLiFE~v~n~Dfk~l------y~tl~d~dIryY  137 (338)
T KOG0668|consen   67 VIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSLIFEYVNNTDFKQL------YPTLTDYDIRYY  137 (338)
T ss_pred             EEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchhHhhhhccccHHHH------hhhhchhhHHHH
Confidence            99998653 455679999999997 9999999987643   333345689999986433333      255777889999


Q ss_pred             HHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhH
Q 015615          172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDI  251 (403)
Q Consensus       172 ~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  251 (403)
                      +.|++.||.|||+. ||.|||+||.|++||.....++|+|+|+|.++..+....-.+.+.+|..||.+..-..|+..-|+
T Consensus       138 ~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~  216 (338)
T KOG0668|consen  138 IYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDM  216 (338)
T ss_pred             HHHHHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHH
Confidence            99999999999998 99999999999999988778999999999998887777777889999999999888889999999


Q ss_pred             HHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHh-----ccCcCcccccCCCccCCCccccccc----CCC
Q 015615          252 WSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIK-----CMNPNYTEFKFPQIKAHPWHKIFQK----RMP  321 (403)
Q Consensus       252 wslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~----~~s  321 (403)
                      |||||++..|++.+-| |.|.++.+++.+|.+.+|........     .+++.+... ..+....+|....+.    -++
T Consensus       217 WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~  295 (338)
T KOG0668|consen  217 WSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI-LGRHSRKPWSRFINSENQHLVS  295 (338)
T ss_pred             HHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhH-hhccccccHHHhCCccccccCC
Confidence            9999999999998755 57788999999999999876554321     123333321 233445566665543    257


Q ss_pred             hHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          322 PEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       322 ~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      +++.|||.++|.+|..+|+||.|++.||||..+.+..
T Consensus       296 peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~  332 (338)
T KOG0668|consen  296 PEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE  332 (338)
T ss_pred             hHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence            9999999999999999999999999999999876543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-45  Score=317.05  Aligned_cols=283  Identities=31%  Similarity=0.540  Sum_probs=231.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC---CCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~  136 (403)
                      .|.-..+||+|.||.||+|+++.+|+.||+|++.-+      .....+|+.+|..++|+|++.+++.+-+...   .+..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            577778999999999999999999999999876321      1234589999999999999999887754332   4455


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+|+||.+|+.+|..++.+.   ..+++...+..++.+++.||.|+|+. .|+|||+||+|+||+.++ .+||+|||+++
T Consensus        98 t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dg-ilklADFGlar  172 (376)
T KOG0669|consen   98 TFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDG-ILKLADFGLAR  172 (376)
T ss_pred             eeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCc-eEEeecccccc
Confidence            68999999999998888754   36789999999999999999999988 999999999999999988 79999999997


Q ss_pred             ecccCC-----CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ......     ..+..+.|.+|++||.+.+...|+++.|||..|||+.||+||.+.|.+.++..++..|...+|....+.
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            653322     123456799999999999999999999999999999999999999999999999999999999999888


Q ss_pred             HhccC--cCcccccCCCccCCCcc---ccccc-CCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          292 IKCMN--PNYTEFKFPQIKAHPWH---KIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       292 ~~~~~--~~~~~~~~~~~~~~~~~---~~~~~-~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                      |+.+.  +-|..++.+.++.....   ....+ .-++++.||+.+||..||.+|+.++++|+|.||..
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            77553  22333322222222111   11111 12568999999999999999999999999999976

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.1e-43  Score=325.44  Aligned_cols=276  Identities=37%  Similarity=0.671  Sum_probs=212.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||+++++++     .+..+.+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            5999999999999999999998899999999874321      2345799999999999999999987     3445688


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||+++++.+.+...   ...++...+..++.||+.||+|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            99999997655444332   34588999999999999999999998 999999999999999887 79999999987653


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc--C
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--N  296 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~  296 (403)
                      .... .....++..|+|||++.+...++.++||||||+++|+|++|++||......+....+....+..........  .
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            3322 223457888999999876555788999999999999999999999888777777777666554433211111  0


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      +.......+......-.....+.++..+.+|+.+||..||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            1011111111111111111224678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-45  Score=343.48  Aligned_cols=250  Identities=30%  Similarity=0.494  Sum_probs=213.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|.-.+.||.|+||.||-|+|..+.+.||||++.-..       ..+.+|+..|+.++|||++.+.+||+....     .
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence            4677789999999999999999999999999985432       345689999999999999999999965433     6


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      |+|||||-|+-.+++.-+.   .++-+..+..|+.+.+.||+|||++ +.||||||..|||++..| .|||+|||.|...
T Consensus       102 WLVMEYClGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPG-LVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCC-eeeeccccchhhc
Confidence            8999999998878877663   6788889999999999999999998 999999999999999888 8999999999765


Q ss_pred             ccCCCcceeeeccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKGEPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                         .+..+++|||+|||||++.  ....|+-++||||||++..||.-.+||+.+.+....+.-|.+. ..|.        
T Consensus       177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPt--------  244 (948)
T KOG0577|consen  177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPT--------  244 (948)
T ss_pred             ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCC--------
Confidence               3456789999999999985  3346999999999999999999999999999988888877653 1111        


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                +..        ..-|..++.|+..||++-|.+|||.+++|+|+|...-+
T Consensus       245 ----------Lqs--------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  245 ----------LQS--------NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             ----------CCC--------chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                      111        12366889999999999999999999999999987644

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-42  Score=330.41  Aligned_cols=285  Identities=34%  Similarity=0.593  Sum_probs=223.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            57999999999999999999999999999999885421      234569999999999999999987643221 22234


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .++++++++++|.+.+..     ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||++..
T Consensus        97 ~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~  169 (345)
T cd07877          97 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  169 (345)
T ss_pred             EEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence            678999998887766643     4588999999999999999999987 999999999999999887 799999999876


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+..........
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            432  223456788999999986655588999999999999999999999998888777888877777776655443322


Q ss_pred             Ccccc---cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       298 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                      .....   ..+..+...+...+ ...++++.+||.+||+.||.+|+|+.++++||||++...+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~  311 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  311 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence            11000   01111111121111 246889999999999999999999999999999999776653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.8e-42  Score=323.80  Aligned_cols=261  Identities=25%  Similarity=0.375  Sum_probs=207.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.+|+|.+...   .....+|+.+++.+ +|||++++++++...........+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            46799999999999999999999999999999988543   23455789999988 899999999988654433345678


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+.........+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            99999985 77777765444456789999999999999999999987 999999999999999877 7999999998765


Q ss_pred             ccCC-CcceeeecccccccccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      .... ......++..|+|||.+....    .++.++|+|||||++|+|++|++||........+..+...  .+.     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~-----  251 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN--PPP-----  251 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC--CCC-----
Confidence            3322 122346788899999975432    2578999999999999999999999876654444433221  000     


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                                  .       .......+..+.+||.+||..||++||++.++++||||+
T Consensus       252 ------------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         252 ------------T-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ------------C-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                        0       001124567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-43  Score=329.52  Aligned_cols=259  Identities=29%  Similarity=0.486  Sum_probs=209.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||+|+||.||+|.+..+++.||||.+....       ....+|+++++.++|+||+++++.+     .+..+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            5999999999999999999999999999999886432       2345799999999999999998877     344568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+||||+.+ +|.+.+...  ....+++..+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            899999985 777776532  235689999999999999999999987 999999999999999887 799999999865


Q ss_pred             cccCCC------------------------------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 015615          218 LVKGEP------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  267 (403)
Q Consensus       218 ~~~~~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p  267 (403)
                      ......                              .....||..|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence            422111                              1123578889999999654 479999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC----HH
Q 015615          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST----AL  343 (403)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s----~~  343 (403)
                      |.+.+....+..+....            ..     ++          ....++..+.++|.+||+.||++|||    ++
T Consensus       232 f~~~~~~~~~~~~~~~~------------~~-----~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKKE------------VT-----FP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcCC------------cc-----CC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            98877665554443210            00     00          00126899999999999999999999    99


Q ss_pred             HHhcCCCCccCCCCCCCC
Q 015615          344 EALIHPFFDELRDPNTRL  361 (403)
Q Consensus       344 ell~hp~f~~~~~~~~~~  361 (403)
                      ++|+||||+...++..++
T Consensus       285 ~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         285 EIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HHHcCchhhcCChhhccc
Confidence            999999999988776554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=345.58  Aligned_cols=248  Identities=28%  Similarity=0.474  Sum_probs=205.1

Q ss_pred             EeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecccc
Q 015615           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE  147 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  147 (403)
                      +||+|.||+||-|+|..+...+|||.+...    .+-..+|+.+-+.|+|.|||++.+++     ...+++-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            699999999999999999999999998543    23445799999999999999999987     555678899999995


Q ss_pred             -hHHHHHHhhcccCCCC--CHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc
Q 015615          148 -TVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (403)
Q Consensus       148 -~l~~~l~~~~~~~~~l--~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~  224 (403)
                       +|..+++..   .+++  ++..+.+|..||++||.|||++ .|||||||-+|||++...+.+||+|||.++.+..-.+.
T Consensus       657 GSLSsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             777777664   3566  7889999999999999999998 99999999999999988779999999999887554443


Q ss_pred             -ceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccc
Q 015615          225 -ISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  302 (403)
Q Consensus       225 -~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  302 (403)
                       .++.||..|||||++..+ ..|+.++|||||||++.||.||++||......+..  ++++..       .+        
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkVGm-------yK--------  795 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKVGM-------YK--------  795 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhhcc-------ee--------
Confidence             367899999999999643 45999999999999999999999999875443321  111100       00        


Q ss_pred             cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      ..|.         ++..+|.+++.||.+|+.+||.+||+|.++|..||++..
T Consensus       796 vHP~---------iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  796 VHPP---------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             cCCC---------CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            0111         335678999999999999999999999999999999875

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-45  Score=345.77  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +.|.|+..||.|+||+||+|..+.++-..|.|++....    ....-|+++|..++||+||++++.||..+.     ++|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEE
Confidence            45889999999999999999999898888899875332    233459999999999999999999866443     899


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc-
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-  219 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~-  219 (403)
                      ..|||+|+-.+.+.-.  .+..+++.++..+++|+|.||.|||++ +|||||||..|||++.+| .++|+|||.+.... 
T Consensus       107 liEFC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEeecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecC-cEeeecccccccchh
Confidence            9999998654444322  257899999999999999999999998 999999999999999998 79999999875432 


Q ss_pred             cCCCcceeeeccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          220 KGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .-....++.|||+|||||+..    ....|+.++||||||++|.||..+.+|-...+....+.+|.+-- .|..      
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-PPTL------  255 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPTL------  255 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-CCcc------
Confidence            223345789999999999974    33459999999999999999999999999888877776665521 1110      


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                         .-+..-+..+.|||++||..||..||+++++|+||||+.+
T Consensus       256 -------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  256 -------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             -------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                               0112346789999999999999999999999999999853

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=324.06  Aligned_cols=277  Identities=34%  Similarity=0.619  Sum_probs=217.6

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |.+.+.||.|+||.||+|.+..+|+.+|+|.+....      ....+|+.+++.++|+|++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            678899999999999999999999999999986542      23457999999999999999998874321   245889


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||+++++...+...   ...+++..+..++.||+.||+|||+. |++|+||+|+||+++.++ .+||+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            9999998877776543   24688999999999999999999987 999999999999999887 799999999986644


Q ss_pred             CC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          221 GE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       221 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ..  ......++..|+|||.+.+...++.++||||||+++|+|++|+.||...+....+..+....+.+....+.....-
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            32  1223456788999998866555789999999999999999999999998888888888887777766554332110


Q ss_pred             --cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          299 --YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       299 --~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                        +................+...+++.+.+++++||..||++||++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00000000000111122222348999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-42  Score=331.00  Aligned_cols=285  Identities=35%  Similarity=0.655  Sum_probs=220.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC-Cce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~  136 (403)
                      ..+|.+.+.||+|+||.||+|.+..+|..||||.+...      .....+|+.+++.++||||+++++++...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            34699999999999999999999999999999988532      12345799999999999999999887432211 123


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+++||||+++++...+..     ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            4689999998777766643     4689999999999999999999987 999999999999999877 79999999987


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .....  .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+....+..+.+..+.++........
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            65322  2334678899999998654458899999999999999999999999888777777777766665544332221


Q ss_pred             cCcc-cc--cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          297 PNYT-EF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       297 ~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      .... .+  ..+......+ ..+.+.+++.+.++|.+||+.||++|||+.+++.||||+..+.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~  308 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE  308 (343)
T ss_pred             chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcc
Confidence            1100 00  0011110111 112346788999999999999999999999999999999986654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-44  Score=337.12  Aligned_cols=241  Identities=26%  Similarity=0.369  Sum_probs=199.4

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      +...+.||+|.||.||.|.+.. ...||+|.++..   ...+.+|+++|+.|+|+|||++++++....     -+|||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVtE  281 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVTE  281 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEEE
Confidence            5567889999999999999832 347999988652   345568999999999999999999984322     3789999


Q ss_pred             ccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          144 YVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       144 ~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      ||+ |+|+++|+..  ....+.......++.|||+|++||+++ ++|||||-..||||+.+. .+||+|||+|+...++.
T Consensus       282 ~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDL-VVKISDFGLARLIGDDE  357 (468)
T ss_pred             ecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCc-eEEEcccccccccCCCc
Confidence            999 7899999872  356788899999999999999999998 999999999999999887 89999999999543333


Q ss_pred             Cccee--eecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          223 PNISY--ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       223 ~~~~~--~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      .....  -....|.|||.+... .++.+|||||||++||||+| |+.||.+.+..+.+..+.+...-|.           
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~-----------  425 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR-----------  425 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-----------
Confidence            22211  124569999999654 59999999999999999998 9999999998888887766432221           


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                                       +...|+++.+++..|+..+|++|||.+.+.
T Consensus       426 -----------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  426 -----------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -----------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                             246899999999999999999999999765

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.3e-43  Score=333.09  Aligned_cols=285  Identities=37%  Similarity=0.712  Sum_probs=224.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|.+.+.||.|+||.||+|.+..+|+.+|+|++...      .....+|+.+++.+ +||||+++++++..   .+..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence            35799999999999999999999889999999987432      22344799999999 99999999987633   2334


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ..++||||++++|...+..     ..++...+..++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++.
T Consensus        83 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~-~~kl~d~g~~~  155 (337)
T cd07852          83 DIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDC-RVKLADFGLAR  155 (337)
T ss_pred             eEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccchh
Confidence            5789999999888777653     2577888888999999999999987 999999999999999888 79999999987


Q ss_pred             ecccCC------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          217 VLVKGE------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       217 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ......      ......+|+.|+|||.+.+...++.++|+||||+++|+|++|++||.+....+....+....+.+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            653322      11234678899999988765667899999999999999999999999988888888888887777765


Q ss_pred             HHhccCcCcccc---cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          291 EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       291 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                      .+..+.......   ..+.....+....+ +.++.++.+||.+||+.||++|||+.++++||||+.+..++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~  306 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD  306 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC
Confidence            544332111110   01111111112222 347899999999999999999999999999999999876654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.9e-43  Score=322.41  Aligned_cols=257  Identities=25%  Similarity=0.402  Sum_probs=202.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCCC-CceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK-DELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~  138 (403)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.+...   .....+|+.+++.+ +|+||+++++.+...... ....+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            35689999999999999999999999999999998543   23456789999988 699999999987654322 23467


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++|||+++ +|.+.+...  ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||++..
T Consensus        85 ~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~  160 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCC-CEEEccCCCcee
Confidence            899999985 777776643  235688999999999999999999998 999999999999999887 799999999876


Q ss_pred             cccCC-CcceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          218 LVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       218 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ..... ......|++.|+|||++.+    ...++.++|+||+||++|+|++|..||...........+...   +     
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~-----  232 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P-----  232 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence            53322 2234568899999999853    224788999999999999999999999765443332222110   0     


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                         ........++.++.+|+.+||..||.+|||+.++++||||
T Consensus       233 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 -------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                               0001123467899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-42  Score=322.87  Aligned_cols=261  Identities=26%  Similarity=0.373  Sum_probs=206.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ...+|++.+.||+|+||.||+|.+..+++.+|+|.+...   .....+|+.+++.+ +||||+++++++......+..+.
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            456799999999999999999999999999999987542   23456789999999 69999999998765544455678


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++ +|.+.+.........+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||++..
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~~  173 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEG-GVKLVDFGVSAQ  173 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCC-CEEEccCCceee
Confidence            899999985 77777765444456788999999999999999999987 999999999999999887 699999999876


Q ss_pred             cccCC-CcceeeecccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          218 LVKGE-PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       218 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ..... ......+++.|+|||++...    ..++.++||||+||++|+|++|..||........+..+...  .+     
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~-----  246 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP-----  246 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC-----
Confidence            53322 22344688999999987432    33788999999999999999999999876543332221110  00     


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                  +       ....+...+.++.+|+.+||+.||++|||+.++++|+||
T Consensus       247 ------------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 ------------P-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ------------C-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                        0       000112357789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=320.61  Aligned_cols=310  Identities=27%  Similarity=0.434  Sum_probs=236.4

Q ss_pred             ecCCCCCCCCceEEeecCCCCCCCccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhH---HHHHHHHH
Q 015615           38 VVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRL  114 (403)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~  114 (403)
                      ..+.+....|.+..+.++..    ...++|.+.++||-|.|++||+|.|..+.+.||+|+++....+.+   .|+++|+.
T Consensus        55 qE~~~dY~kGGYHpV~IGD~----F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~  130 (590)
T KOG1290|consen   55 QEDPEDYRKGGYHPVRIGDV----FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQ  130 (590)
T ss_pred             ccChhhhhcCCCceeecccc----ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHH
Confidence            34555566777777766554    344689999999999999999999999999999999987665544   58999988


Q ss_pred             cC--------CCCeeecceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 015615          115 LD--------HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI  186 (403)
Q Consensus       115 l~--------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  186 (403)
                      ++        ..+||++++.|-. ...+..++|||+|+++.+|+.++....  .+.++...++.|++||+.||.|||+.+
T Consensus       131 v~~~Dp~~~~~~~VV~LlD~Fkh-sGpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec  207 (590)
T KOG1290|consen  131 VREGDPNDPGKKCVVQLLDHFKH-SGPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC  207 (590)
T ss_pred             HHhcCCCCCCCceeeeeecccee-cCCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc
Confidence            83        2479999998744 446677899999999999999988654  577999999999999999999999999


Q ss_pred             CccccCCCCCceEecCC---------------------------------------------------------------
Q 015615          187 GVCHRDIKPQNLLVNPH---------------------------------------------------------------  203 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~---------------------------------------------------------------  203 (403)
                      ||||.||||+|||+..+                                                               
T Consensus       208 gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~  287 (590)
T KOG1290|consen  208 GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEAS  287 (590)
T ss_pred             CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhh
Confidence            99999999999998200                                                               


Q ss_pred             -----------------------C--------------------------------------------------------
Q 015615          204 -----------------------T--------------------------------------------------------  204 (403)
Q Consensus       204 -----------------------~--------------------------------------------------------  204 (403)
                                             +                                                        
T Consensus       288 l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s  367 (590)
T KOG1290|consen  288 LAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSS  367 (590)
T ss_pred             hcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccC
Confidence                                   0                                                        


Q ss_pred             -----------------------CceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHH
Q 015615          205 -----------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  261 (403)
Q Consensus       205 -----------------------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  261 (403)
                                             .+|||+|||.|+....  ..+.-..|..|+|||++.+.. |++.+||||++|++|||
T Consensus       368 ~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FEL  444 (590)
T KOG1290|consen  368 PSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFEL  444 (590)
T ss_pred             cCCccccccccccCCCCCCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHh
Confidence                                   0145555555543311  112334588899999999876 99999999999999999


Q ss_pred             HhCCCCCCC------CCcHHHHHHHHHHhCCCCHHHHhccCcCccccc----CC---CccCCCccccc------ccCCCh
Q 015615          262 LLGQPLFPG------ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----FP---QIKAHPWHKIF------QKRMPP  322 (403)
Q Consensus       262 ltg~~pf~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~~------~~~~s~  322 (403)
                      +||...|..      ..+.+.++.|++.+|..+......-.-.-..|.    +.   .++..++..++      +.....
T Consensus       445 aTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~  524 (590)
T KOG1290|consen  445 ATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQ  524 (590)
T ss_pred             hcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHH
Confidence            999999854      247789999999999988876543322212221    11   12222222221      223346


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          323 EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       323 ~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      ++.+||.-||+++|++|+||.++|+|||+..+..+
T Consensus       525 ~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  525 QFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            78999999999999999999999999999987654

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-43  Score=324.08  Aligned_cols=274  Identities=40%  Similarity=0.734  Sum_probs=220.1

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |.+.+.||.|++|.||+|.+..+|+.+++|.+....      ....+|+.+++.++|+||+++++.+.     +....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            567789999999999999998899999999885432      23457999999999999999998773     3345789


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||+++++.+.+...   ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            9999999888777653   25788999999999999999999998 999999999999999877 799999999876644


Q ss_pred             CC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc--
Q 015615          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  297 (403)
Q Consensus       221 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  297 (403)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|+||+.||.+.+..+.+..+...++.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            33 222345778899999987664689999999999999999999999999988888888888888777665544332  


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      ......++........ ...+.++.++.+||.+||..||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPLP-KLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCHH-HhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            1111122221111111 1224578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.1e-43  Score=334.12  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=192.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||+|+||.||+|.+.     .++..||||.+....     ....+|+.++..+ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP--   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence            357999999999999999999752     345789999886422     2345799999999 899999999876422  


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhccc----------------------------------------------------
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYKM----------------------------------------------------  159 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~----------------------------------------------------  159 (403)
                        ...+++||||++ |+|.+++......                                                    
T Consensus        84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence              234789999998 5787777643210                                                    


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCC---cceeeec
Q 015615          160 ------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICS  230 (403)
Q Consensus       160 ------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt  230 (403)
                            ...++...+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.......   .....++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence                  13477888899999999999999998 999999999999999877 799999999976532221   1123456


Q ss_pred             ccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccC
Q 015615          231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  309 (403)
Q Consensus       231 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (403)
                      +.|+|||++.+. .++.++|||||||++|||++ |.+||.+....+.+.........+                      
T Consensus       240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------  296 (338)
T cd05102         240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM----------------------  296 (338)
T ss_pred             ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC----------------------
Confidence            789999998655 48999999999999999997 999998765443333322210000                      


Q ss_pred             CCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          310 HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       310 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                           ..+...++++.+|+.+||+.||++|||+.++++
T Consensus       297 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         297 -----RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                 012356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-42  Score=330.16  Aligned_cols=282  Identities=35%  Similarity=0.622  Sum_probs=220.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||.+...      .....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4799999999999999999999889999999988542      1234579999999999999999998744322 12234


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++|+||+..++...+      ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence            6899999987655443      24588899999999999999999998 999999999999999887 799999999875


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+..........
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            422  223456788999999986655588999999999999999999999999887788888888777776655433221


Q ss_pred             Ccc-c--ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          298 NYT-E--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       298 ~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      ... .  ...+......+... .+..++++.+||.+||+.||++||++++++.||||+..++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cchHHHHhhcCCcccchHHHH-hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            100 0  01111111222221 13468899999999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=321.78  Aligned_cols=275  Identities=39%  Similarity=0.705  Sum_probs=219.8

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |.+.+.||.|++|.||+|.+..+++.||||.+....     ....+|+..++.++ |+|++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            678899999999999999998899999999875432     23346889999999 9999999998743     345789


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||+.+++.+.+....  ...++...+..++.|++.+|.|||++ |++|+||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888888776542  24689999999999999999999987 999999999999999877 799999999987654


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC--
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--  298 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--  298 (403)
                      ........++..|+|||++.+...++.++|+||||+++++|++|++||.+....+.+..+...++.+....+......  
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            444445567889999999866556899999999999999999999999999888888888888888776554322110  


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      .....++..........+ +..+.++.+||++||+.||++|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            011111111111111112 2347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.2e-43  Score=332.14  Aligned_cols=277  Identities=23%  Similarity=0.379  Sum_probs=198.8

Q ss_pred             EEeEeeeC--CcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           69 AERVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        69 ~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +.++||+|  +||+||++.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++..     ....++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence            45679999  78999999999999999999986431      345579999999999999999988743     335789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ ++.+++..+.  ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            9999984 7777775442  24588999999999999999999987 999999999999999877 79999998654332


Q ss_pred             cCCC--------cceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC---
Q 015615          220 KGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP---  287 (403)
Q Consensus       220 ~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~---  287 (403)
                      ....        .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||............... ..+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~  231 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLL  231 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC-Cccccc
Confidence            1111        1123456779999998653 34889999999999999999999999876544433332211 001   


Q ss_pred             -----CHHHHhccC------cCcccccC----CCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          288 -----TREEIKCMN------PNYTEFKF----PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       288 -----~~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                           +.+......      ..+.....    ...........+...+++.+.+||++||+.||++|||++++++||||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                 000000000      00000000    000000001112345688999999999999999999999999999998


Q ss_pred             cCC
Q 015615          353 ELR  355 (403)
Q Consensus       353 ~~~  355 (403)
                      .+.
T Consensus       312 ~~~  314 (327)
T cd08227         312 QIK  314 (327)
T ss_pred             hcc
Confidence            864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.1e-42  Score=323.33  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=206.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...       .....+|+++++.++||||+++++++.     +..++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence            599999999999999999999999999999988542       123457999999999999999999873     34458


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||++ ++|.+.+...    ..+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999996 5787777653    5789999999999999999999997 999999999999999887 799999999887


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  .....+++.|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+...  .+          
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~----------  215 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KV----------  215 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc----------
Confidence            6443  3345678999999998655 4789999999999999999999999877644433333210  00          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  357 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~~  357 (403)
                                       .++..++..+.++|.+||..||.+|+     +++++++||||+.+.+.
T Consensus       216 -----------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         216 -----------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             -----------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                             02234688999999999999999999     99999999999987643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.1e-42  Score=324.57  Aligned_cols=283  Identities=38%  Similarity=0.734  Sum_probs=222.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .++|.+.+.||.|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++.++|...    ...
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CCc
Confidence            45799999999999999999999999999999987431      23455799999999999999999887432    224


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .+++|||++++|...+..     ..++...+..++.|++.||+|||+. ||+||||+|+||+++.++ .++|+|||.+..
T Consensus        85 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI  157 (328)
T ss_pred             EEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence            679999998887766643     4578888899999999999999987 999999999999999877 799999999875


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.........+.+.++.++.+.......
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            422  223456788899999986645689999999999999999999999998887777777778778777654432211


Q ss_pred             C-cccc--cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCC
Q 015615          298 N-YTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR  360 (403)
Q Consensus       298 ~-~~~~--~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~  360 (403)
                      . -..+  ..+.....++...+ +.++..+.++|++||+.+|++|||+++++.||||.....+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence            0 0000  01111111122111 3578899999999999999999999999999999988776543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=319.00  Aligned_cols=262  Identities=29%  Similarity=0.422  Sum_probs=208.4

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHc-CCCCeeecceeeeecCC-CCce
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-KDEL  136 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~  136 (403)
                      ...++|++.+.||.|++|.||+|.+..+++.+++|.+....   ....+|+.+++.+ +|+||+++++++..... ....
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            34578999999999999999999998899999999886432   3456799999998 79999999998865443 3456


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++++||||+++ +|.+.+.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .+||+|||++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~-~~~l~d~~~~  160 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNA-EVKLVDFGVS  160 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCC-eEEECCCccc
Confidence            68899999996 67777665443456789999999999999999999987 999999999999999887 7999999998


Q ss_pred             eecccCCC-cceeeecccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          216 KVLVKGEP-NISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       216 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ........ .....+++.|+|||++...    ..++.++|||||||++|+|++|.+||...........+....   .  
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~--  235 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---P--  235 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---C--
Confidence            76533222 2345678899999987432    346789999999999999999999998765544444332210   0  


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                    +..       ......+.++.+||.+||..||++|||+.++++|||+
T Consensus       236 --------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 --------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             --------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                          000       0112357899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.9e-42  Score=323.09  Aligned_cols=282  Identities=32%  Similarity=0.521  Sum_probs=219.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-----
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-----  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  132 (403)
                      ..+|.+.+.||.|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++....+     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            357999999999999999999999999999999885432      234579999999999999999987754321     


Q ss_pred             CCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      .+..++++|+||+++++...+...   ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .+||+||
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~kl~df  160 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKG-QIKLADF  160 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-cEEeCcc
Confidence            123368899999999877776543   34689999999999999999999998 999999999999999887 7999999


Q ss_pred             CCceecccCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          213 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       213 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      |++.......  ......++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9987654332  11223557789999988655557899999999999999999999999888888888888877777665


Q ss_pred             HHhccCc--CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          291 EIKCMNP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       291 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      .++....  .+............+... ...++..+.+++.+||..||++|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            4432211  111000000000111111 13468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-42  Score=324.46  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=203.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+...     .....+|+.+++.++||||+++++++.     ...++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence            588999999999999999999989999999987542     123457999999999999999999873     3446889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|..++... .....+++..+..++.||+.||.|||++.+|+||||||+||+++.++ .+||+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence            9999996 666655442 12346899999999999999999999644999999999999999877 79999999987653


Q ss_pred             cCCCcceeeecccccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          220 KGEPNISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ... .....+++.|+|||.+.+..     .++.++|+|||||++|+|++|..||...........+......+..     
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  228 (286)
T cd06622         155 ASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP-----  228 (286)
T ss_pred             CCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC-----
Confidence            322 22345788899999985432     2578999999999999999999999765543333322221111000     


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                          .++..++.++.+||.+||+.+|++||+++++++||||...+..
T Consensus       229 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         229 --------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             --------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                                1223478999999999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-43  Score=333.55  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=197.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..|++.+.||+||.+.||++.. .+...||+|++....      ....+|+..|.+|+ |.+||+++++-     -.+.+
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~  434 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY  434 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence            4699999999999999999985 445668888764322      33458999999995 99999999865     34678


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +||||||-+.+|...|.+..   ...+...++.|..||+.|+.++|.+ ||||.||||.|+|+-. | .+||+|||+|..
T Consensus       435 lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlVk-G-~LKLIDFGIA~a  508 (677)
T KOG0596|consen  435 LYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLVK-G-RLKLIDFGIANA  508 (677)
T ss_pred             EEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEEe-e-eEEeeeechhcc
Confidence            99999999999999988753   3344458999999999999999998 9999999999999974 5 799999999988


Q ss_pred             cccCCCc---ceeeecccccccccccCCC----------CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015615          218 LVKGEPN---ISYICSRYYRAPELIFGAT----------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (403)
Q Consensus       218 ~~~~~~~---~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  284 (403)
                      +......   .+.+||+.||+||.+....          ..++++||||||||||+|+.|++||.....  .+.+ +..+
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aK-l~aI  585 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAK-LHAI  585 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHH-HHhh
Confidence            7554433   3678999999999984221          257899999999999999999999965321  1222 2222


Q ss_pred             CCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      ..|.           .+..||.++           -..++.++++.||.+||.+|||+.++|+|||++-..-+
T Consensus       586 ~~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~  636 (677)
T KOG0596|consen  586 TDPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP  636 (677)
T ss_pred             cCCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence            2221           112233321           11239999999999999999999999999999875433

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-46  Score=324.71  Aligned_cols=253  Identities=26%  Similarity=0.402  Sum_probs=210.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      -|.+..+||+|+||.||+|.++.+|..+|||.+.-+  -+.+.+|+.++++++.|++|++|+.|+...+     ++||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence            478889999999999999999999999999998644  4556689999999999999999999876544     899999


Q ss_pred             ccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          144 YVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       144 ~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      ||+ |++.+.++.+   ..++++..+..+++..+.||+|||.. .-||||||..|||++.+| ..||+|||.|..+.+..
T Consensus       109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccc-hhhhhhccccchhhhhH
Confidence            999 6888888765   47899999999999999999999986 889999999999999998 59999999997664432


Q ss_pred             -CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          223 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       223 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                       ...+..|||.|||||++..- .|+.++||||||++..||..|++||.+..+...+..|-   ..|++            
T Consensus       184 AKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---T~PPP------------  247 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---TKPPP------------  247 (502)
T ss_pred             HhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---CCCCC------------
Confidence             23467899999999999754 49999999999999999999999998765443322211   11111            


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                               .+.  -+..-|.++.||+++||.++|++|.|+.++++|||++...
T Consensus       248 ---------TF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  248 ---------TFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             ---------CCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence                     010  0123478899999999999999999999999999998753

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.7e-42  Score=313.38  Aligned_cols=249  Identities=28%  Similarity=0.461  Sum_probs=201.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .|++.+.||+|++|.||+|.+..+++.||+|.+..+.      ....+|+.+++.++|+|++++++.+.    ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4899999999999999999999999999999985321      23457899999999999999887652    2234578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++|||+++ ++.+.+....  ...+++..+..++.|++.||++||+. |++||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999985 7777776532  34589999999999999999999988 999999999999999877 7999999998766


Q ss_pred             ccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ..... .....+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+....  .          
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------  219 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L----------  219 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C----------
Confidence            43222 2234678899999998654 47899999999999999999999998766544443332210  0          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                             +         ..+..+++++.+|+.+||+.||++|||+.++++||||
T Consensus       220 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 -------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                   0         0123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=336.31  Aligned_cols=236  Identities=25%  Similarity=0.434  Sum_probs=200.3

Q ss_pred             EEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEeccc-c
Q 015615           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-E  147 (403)
Q Consensus        69 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~  147 (403)
                      -++.||+|+.|.||+|+.  .++.||||+++.   ..+.+++-|++|+||||+.+.++|     ....++|||||||. |
T Consensus       128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeeccccc
Confidence            356799999999999986  678999998753   344689999999999999999998     66778999999999 6


Q ss_pred             hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCccee
Q 015615          148 TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY  227 (403)
Q Consensus       148 ~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~  227 (403)
                      -|...|+.    .+.++......|..+|+.|+.|||.+ .|||||||.-||||..+. .|||+|||.++...+.....++
T Consensus       198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhh
Confidence            78888876    36778888999999999999999998 999999999999999877 7999999999988777777789


Q ss_pred             eecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCc
Q 015615          228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI  307 (403)
Q Consensus       228 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (403)
                      +||..|||||++.+.+ .+.|+||||||||||||+||..||.+-+...++..+    |.                     
T Consensus       272 aGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----Gs---------------------  325 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----GS---------------------  325 (904)
T ss_pred             hhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEec----cC---------------------
Confidence            9999999999998766 899999999999999999999999876554433211    10                     


Q ss_pred             cCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          308 KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       308 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                        +.+.-..+...+..++=||+.||.-.|..||+..++|.|
T Consensus       326 --NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  326 --NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             --CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence              111111334578889999999999999999999999998

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-43  Score=347.68  Aligned_cols=249  Identities=27%  Similarity=0.469  Sum_probs=198.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcC-CCCeeeccee-eeecCCCC-ceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHC-FFSTTEKD-ELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~~-~~~  137 (403)
                      .+++|.+.|.+|||+.||+|.+...|..||+|++....    ....+|+++|+.|+ |+|||.+++. ........ ..-
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            46899999999999999999998888999999875432    34568999999997 9999999993 33332233 355


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCCceEEeecCC
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      +.|.||||. |+|.+++..+..  .+|++.+++.|++|+++|+++||.. .  |||||||-|||||+.++ .+||||||.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g-~~KLCDFGS  192 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADG-NYKLCDFGS  192 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCC-CEEeCcccc
Confidence            779999999 699999987764  4499999999999999999999975 6  99999999999999888 799999999


Q ss_pred             ceecccCCC----------cceeeeccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015615          215 AKVLVKGEP----------NISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (403)
Q Consensus       215 a~~~~~~~~----------~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  282 (403)
                      |........          ......|+.|+|||++.  +....++|+|||||||+||-|+....||.......++     
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl-----  267 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL-----  267 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-----
Confidence            864322211          12234589999999983  3334899999999999999999999999875332211     


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                   +.   .|.+|.          .+.++..+.+||+.||+.||++||++.+++.+
T Consensus       268 -------------ng---~Y~~P~----------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  268 -------------NG---NYSFPP----------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             -------------ec---cccCCC----------CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                         11   122322          14578999999999999999999999998753

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.4e-42  Score=320.81  Aligned_cols=257  Identities=27%  Similarity=0.415  Sum_probs=203.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..|++.+.||.|+||.||+|++..++..||+|.+....    ....+|+.+++.++||||+++++++..     ....++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            46999999999999999999999999999999986432    234568999999999999999998743     335789


Q ss_pred             EEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||++++ +...+...   ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++....
T Consensus        87 v~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            99999964 44444332   34688999999999999999999987 999999999999999777 79999999986542


Q ss_pred             cCC-CcceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          220 KGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ... ......+++.|+|||.+.+    ...++.++|+|||||++|+|++|.+||...+......++... ..+       
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~-------  233 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPP-------  233 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC-CCc-------
Confidence            221 1234567889999999852    233688999999999999999999999876654433333211 000       


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                 .       ...+..++.++.++|.+||..||++||+++++++||||..+...
T Consensus       234 -----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         234 -----------T-------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             -----------c-------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                       0       00123467899999999999999999999999999999887654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-42  Score=322.35  Aligned_cols=253  Identities=26%  Similarity=0.454  Sum_probs=197.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..+.     ....+|+.+++.++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            5788899999999999999999999999999885431     234579999999999999999998743     234779


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||++++.+...       ..+++..+..++.|++.||+|||+. ||+|+||||+|||++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999997543322       3467888999999999999999987 999999999999999887 799999999976533


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL---VEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~  297 (403)
                      . ......+|..|+|||++.+.. ++.++|+|||||++|+|++|+.||......+..   .........+          
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  215 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE----------  215 (279)
T ss_pred             c-cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc----------
Confidence            3 223457899999999997554 899999999999999999999999753221110   0111110000          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .     .+        .......++++.+|+.+||+.||++||+++++++||||......
T Consensus       216 ~-----~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~  262 (279)
T cd06619         216 D-----PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG  262 (279)
T ss_pred             C-----CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence            0     00        00112467899999999999999999999999999999887544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.7e-42  Score=323.78  Aligned_cols=279  Identities=25%  Similarity=0.384  Sum_probs=203.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|++.+.||+|+||.||+|.+..+|..+|+|.+....     ....+|+++++.++||||+++++++.     ...++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEEE
Confidence            5999999999999999999999999999999875431     23457999999999999999999884     3345889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+...    ..+++..+..++.|++.||.|||+..+++||||||+|||++.++ .+||+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 777777643    56889999999999999999999744899999999999999877 79999999987553


Q ss_pred             cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      ... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+... .......................
T Consensus       152 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DSM-ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ccc-cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence            322 2345678999999998654 48899999999999999999999997655322 22222111000000000000000


Q ss_pred             ccccCCC----------ccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          300 TEFKFPQ----------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       300 ~~~~~~~----------~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .....+.          +............++.++.+|+.+||..||++|||+.++++||||.....+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence            0000000          000000000112367889999999999999999999999999999875433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-42  Score=318.07  Aligned_cols=274  Identities=39%  Similarity=0.700  Sum_probs=222.7

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |++.+.||+|++|.||+|++..+++.||+|.+....      ....+|+.+++.++|+|++++++++.     +..+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            567789999999999999999999999999886531      23456999999999999999998873     3345889


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||++++|.+.+....   ..+++..+..++.|++.||+|||++ ||+||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            99999998888887642   4688999999999999999999998 999999999999999877 799999999876543


Q ss_pred             CC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC-
Q 015615          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  298 (403)
Q Consensus       221 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  298 (403)
                      .. ......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....+...... 
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 2223455778999999876646899999999999999999999999999888888888888888887766543221 


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      +....++..........+ +.++..+.++|++||..||++||+++++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            122233333333333333 3458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.1e-42  Score=317.13  Aligned_cols=252  Identities=26%  Similarity=0.496  Sum_probs=200.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+....          ....+|+.+++.++|+||+++++++     .+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            4788899999999999999999999999999885322          3445799999999999999999987     344


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...++||||+.+ +|.+.+...    ..+++..+..++.|++.||.|||++ |++|+||+|+||+++.++..+||+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            457899999995 677776542    5688899999999999999999998 9999999999999987765799999999


Q ss_pred             ceecccCCC-----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          215 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       215 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +........     .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...........+......   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  226 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---  226 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence            876543211     1234578899999998654 4789999999999999999999999765433222222211000   


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                                           .....++..+++++.+++.+||..||++|||+.++++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                 000112345789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=317.06  Aligned_cols=278  Identities=34%  Similarity=0.608  Sum_probs=216.4

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHc---CCCCeeecceeeeecCCCCceE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      |++.+.||.|+||.||+|++..++..||+|.+....      ....+|+.+++.+   +|+|++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999998889999999985321      2234577777666   5999999999886654444456


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++++|||+.+++.+.+....  ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .+||+|||++..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            88999999988887776532  23589999999999999999999997 999999999999999887 799999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........++..|+|||++.+.. ++.++|+|||||++|+|++|.+||.+....+.+..+....+.+....+.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV-  234 (287)
T ss_pred             ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence            65444444456788899999997654 8899999999999999999999999988888888887766655443322111 


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                      ......++.....++.. ..+.++..+.++|.+||+.||++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhh-hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            00001111111122211 123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-42  Score=319.30  Aligned_cols=250  Identities=27%  Similarity=0.433  Sum_probs=204.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+|++++.+++..     ..++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEEE
Confidence            5888999999999999999999999999999885432     234679999999999999999988743     346889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      |+||+++ +|.+.+..     ..+++..+..++.|++.||.|||++ +++||||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  149 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEG-DVKLADFGVSGQLT  149 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence            9999985 67666653     2788999999999999999999988 999999999999999877 79999999998764


Q ss_pred             cC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .. .......+++.|+|||.+.+.. ++.++|||||||++|+|+||.+||...+.......+.....             
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------  215 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-------------  215 (274)
T ss_pred             ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC-------------
Confidence            43 2223456788899999997655 89999999999999999999999987654443333222100             


Q ss_pred             cccccCCCccCCCccccccc-CCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                            +         .+.. .++.++.+++.+||..||++|||++++++||||+....
T Consensus       216 ------~---------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         216 ------P---------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             ------C---------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence                  0         0111 26889999999999999999999999999999988543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5e-42  Score=319.30  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=202.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHc-CCCCeeecceeeeecCC-CCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-KDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~  138 (403)
                      .+.|++.+.||.|+||.||+|.+..+++.+|+|.+....   .....|+.+++++ +|+||+++++++..... ....++
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            357999999999999999999999999999999885432   3445688888888 69999999998754322 234568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++|||+++ +|.+++....  ...+++..+..++.||+.||+|||++ ||+|+||||+||+++.++ .++|+|||++..
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~-~~~l~dfg~~~~  170 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCcchhh
Confidence            899999985 7777765432  34578888999999999999999998 999999999999999887 799999999875


Q ss_pred             cccC-CCcceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          218 LVKG-EPNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       218 ~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      .... .......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||...........+...   +.    
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----  243 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP----  243 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC----
Confidence            4321 12234568899999999852    234788999999999999999999999766543333222110   00    


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                          .......++.++.+||.+||..||.+|||+.++++||||
T Consensus       244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                000113468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.6e-41  Score=318.45  Aligned_cols=253  Identities=29%  Similarity=0.466  Sum_probs=204.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||.|+||.||+|.+..+|+.||+|.+...    .....+|+.+++.++|||++++++.+.     ....+++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence            4699999999999999999999999999999988543    233457999999999999999999873     3345889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      |+||+.+ +|...+..     ..+++..+..++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++....
T Consensus        94 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~  166 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccchhcc
Confidence            9999986 66655542     4588999999999999999999998 999999999999999877 79999999987553


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+.......+... ..+..         
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~---------  235 (296)
T cd06655         167 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPEL---------  235 (296)
T ss_pred             cccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCccc---------
Confidence            3322 2234678899999998654 4789999999999999999999999887665544333221 00000         


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                      ..+..+++.+.+||++||..||++|||+.+++.||||+..+.
T Consensus       236 ----------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         236 ----------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             ----------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                            012347889999999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-42  Score=323.88  Aligned_cols=261  Identities=23%  Similarity=0.381  Sum_probs=201.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|...+.||+|+||.||++.+..+|+.||+|.+...     .....+|+.++.++. |+||+++++++..     ....+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence            466678899999999999999999999999988542     223457888898886 9999999997743     23467


Q ss_pred             EEEecccchHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~-~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++|||+..++.++..... .....+++..+..++.|++.||+|||+..+++||||||+||+++.++ .+||+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            899999876655443221 12367899999999999999999999744999999999999999877 7999999998765


Q ss_pred             ccCCCcceeeecccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ..........+++.|+|||++.+.  ..++.++||||+||++|+|++|++||.....  ....+.+......        
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~--------  228 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP--------  228 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC--------
Confidence            444434445678899999998655  3588999999999999999999999976541  2222222111000        


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                              +.+     .......++.++.+|+.+||..||++|||++++++||||+...
T Consensus       229 --------~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         229 --------PIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             --------CcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence                    000     0001134788999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5e-42  Score=316.14  Aligned_cols=255  Identities=29%  Similarity=0.447  Sum_probs=203.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|++.+.||.|+||.||+|.+..++..+|+|++...     .....+|+..++.++|+|++++++.+.     .....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEEE
Confidence            699999999999999999999889999999988543     234567999999999999999988763     2345789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||++++ +|.+.+..... ...+++..+..++.|++.||+|||+. |++||||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence            9999985 67777654322 24688999999999999999999987 999999999999999877 79999999987654


Q ss_pred             cCCCc-----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          220 KGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       220 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      .....     ....++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.+....  .+.      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------  225 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP------  225 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC------
Confidence            33222     23467889999999876545899999999999999999999999877655544443321  000      


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                         .+     +.   .    .....+++.+.+++.+||..||++|||+.++++||||
T Consensus       226 ---~~-----~~---~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         226 ---SL-----ET---G----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ---Cc-----CC---c----cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence               00     00   0    0013578899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.5e-42  Score=320.23  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=202.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||.|+||.||+|.+..++..||+|.+...    .....+|+.+++.++|+|++++++.+..     ..+.++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence            4799999999999999999999999999999988543    2345579999999999999999988743     335789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+..     ..++...+..++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        95 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~  167 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (296)
T ss_pred             eecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEECccccchhcc
Confidence            9999985 67776643     4578888999999999999999987 999999999999999877 79999999987543


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+... +.+.          
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~----------  235 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE----------  235 (296)
T ss_pred             ccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC----------
Confidence            3221 2234678899999998654 4789999999999999999999999876554333222110 0000          


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                     ...+..++..+.+|+.+||..||++|||+.++++||||...+
T Consensus       236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             ---------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence                           001234788999999999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.3e-42  Score=315.53  Aligned_cols=249  Identities=28%  Similarity=0.475  Sum_probs=197.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +|.+.+.||+|+||.||+|.+..++..||+|.+...         .....+|+.+++.++||||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence            689999999999999999999999999999987532         1235579999999999999999887633   2234


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .++++|||+++ +|.+.+...    ..++......++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~-~~~l~dfg~~  153 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence            57899999985 777777542    4578888999999999999999987 999999999999999877 7999999998


Q ss_pred             eecccCC----CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          216 KVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       216 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......    ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||...........+...   +.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~---  226 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT---  226 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC---
Confidence            7543211    11224578889999998654 4889999999999999999999999876544433322111   00   


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                                           ...++..+++.+.+++ +||..+|++||+++++++||||+
T Consensus       227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                 0012234678899999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1e-41  Score=313.43  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=205.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||.|+||.||+|.+..+|..||+|.+...      .....+|+.+++.++||||+++++.+..   .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            488999999999999999999999999999987532      1234468999999999999999887643   2334578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH-----~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ++|||+++ +|.+.+.........+++..+..++.||+.||+|||     +. +++|+||||+||+++.++ .+||+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCC-CEEEeccc
Confidence            99999985 788888766555677899999999999999999999     77 999999999999999877 79999999


Q ss_pred             CceecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          214 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       214 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------  226 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--------  226 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------
Confidence            9887644332 33456889999999986544 8899999999999999999999998876433332222110        


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                 .+         .++...+..+.+++.+||..+|++|||+.++++|||+
T Consensus       227 -----------~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         227 -----------FR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -----------CC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                       00         1223568899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-41  Score=311.21  Aligned_cols=249  Identities=29%  Similarity=0.476  Sum_probs=204.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...      .....+|+.+++.++|||++++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            489999999999999999999999999999988543      234557999999999999999988763     334578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+....  ...+++..+..++.|++.||+|||++ |++|+||+|+||+++.++..+||+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999985 7877776532  34578899999999999999999998 99999999999999876657899999999876


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ..........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+.......+......            
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA------------  219 (256)
T ss_pred             CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC------------
Confidence            554444456678899999998654 4789999999999999999999999877655444433321000            


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                      .+...++.++.+++.+||..||++|||+.++++||||
T Consensus       220 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         220 ----------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ----------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                            0123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.1e-42  Score=315.50  Aligned_cols=246  Identities=33%  Similarity=0.546  Sum_probs=198.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      +|.+...||.|+||.||+|.+..++..||+|.+....             ....+|+.+++.++||||+++++++.    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence            4778899999999999999998899999999875321             23457899999999999999998773    


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                       +..+.+++|||+++ +|.+.+...    ..+++..+..++.|++.||+|||+. |++||||+|+||+++.++ .++|+|
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          77 -DADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             -eCCccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCC-CEEecc
Confidence             33457899999985 677777543    5678888999999999999999987 999999999999999877 799999


Q ss_pred             cCCceecccCCC-------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015615          212 FGSAKVLVKGEP-------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (403)
Q Consensus       212 fG~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  284 (403)
                      ||+++.......       .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA  228 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence            999876542111       1123578889999998654 47899999999999999999999998765544333222210


Q ss_pred             CCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                         .+         .++..++..+.++|++||+.||.+||++.++++||||
T Consensus       229 -------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 -------------------SP---------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -------------------CC---------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                               00         1223578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-41  Score=310.28  Aligned_cols=248  Identities=27%  Similarity=0.441  Sum_probs=202.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|.+.+.||+|++|.||+|.+..+|+.|++|.+...      .....+|+.+++.++|||++++++++.     +....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            488899999999999999999999999999987532      233457899999999999999998873     334678


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+....  ...++...+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            99999975 7777776532  35688889999999999999999987 999999999999999887 7999999998865


Q ss_pred             ccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ..... .....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+..+....+....             
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------------  217 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            43322 22346788999999987654 7899999999999999999999998776544444332210             


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                            .+         .+...++.++.+++.+||+.+|++||++.++++|||+
T Consensus       218 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 ------FP---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------CC---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                  00         0112468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.4e-42  Score=321.22  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=203.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..+|.+.+.||.|+||.||+|.+..+|+.||+|.+...    .....+|+.+++.++|+||+++++++.     ...+.+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence            35799999999999999999999999999999988543    233457899999999999999999873     344578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+..     ..+++..+..++.|++.||.|||+. |++||||||+|||++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~  165 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (297)
T ss_pred             EeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEECcCccceEc
Confidence            99999985 66666643     4578889999999999999999987 999999999999999877 7999999998765


Q ss_pred             ccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+.. .+.+.         
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~---------  234 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------  234 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------
Confidence            33322 2234678899999998654 478999999999999999999999977654332221111 00000         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                      ...+..++..+.+|+.+||..||++||+++++++||||+..+..
T Consensus       235 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         235 ----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence                            00123468889999999999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-41  Score=313.89  Aligned_cols=247  Identities=28%  Similarity=0.470  Sum_probs=197.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      +|++.+.||.|+||.||+|.+ .+|+.+|+|.+....          ....+|+.+++.++|+||+++.+++     .+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            488899999999999999986 578899999875321          2345799999999999999999887     334


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      .+.+++|||+++ +|.+.+...    ..+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCC-eEEeccchh
Confidence            568899999985 777776543    4678899999999999999999987 999999999999999877 799999999


Q ss_pred             ceecccC-------CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          215 AKVLVKG-------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       215 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      +......       .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  227 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM  227 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC
Confidence            8754211       111234578899999998654 47899999999999999999999998765444333222210000


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                                ..++..++.++.++|++||..+|++||++.++++||||
T Consensus       228 --------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         228 --------------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                      01224578899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-42  Score=318.48  Aligned_cols=255  Identities=27%  Similarity=0.404  Sum_probs=203.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||.|+||.||+|.+..++..||+|.+....    ....+|+.+++.++||||+++++.+.     .....++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence            46999999999999999999998899999999885432    23457999999999999999999873     3345789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+...   ...+++..++.++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDG-DVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCC-CEEEccCccchhhc
Confidence            9999996 666666543   35689999999999999999999998 999999999999999887 79999999886543


Q ss_pred             cCC-CcceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          220 KGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ... ......+++.|+|||.+..    ...++.++|+|||||++|+|++|++||.+.+.......+...  .+       
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------  225 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP-------  225 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC-------
Confidence            222 2234567899999999742    233678999999999999999999999876654443333221  00       


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                +..       ..+..++.++.++|.+||+.||.+||++.++++||||....
T Consensus       226 ----------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 ----------PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             ----------CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                      000       01234688999999999999999999999999999998863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.4e-42  Score=318.22  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=201.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      -|++.+.||.|+||.||+|.+..++..+++|.+....    ....+|+.+++.++|||++++++.+..     ..+.++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence            3788899999999999999999999999999885432    234569999999999999999988743     3357899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+++ ++...+...   ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .+||+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~  155 (282)
T cd06643          81 IEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  155 (282)
T ss_pred             EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCC-CEEEccccccccccc
Confidence            999996 454444332   35689999999999999999999998 999999999999999877 799999999865432


Q ss_pred             CC-CcceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          221 GE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       221 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .. ......+++.|+|||++..    ...++.++|+||+||++|+|++|.+||...+..+....+.......        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--------  227 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------
Confidence            21 1223467889999999742    2346789999999999999999999998876555544443311000        


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                        ...+..++.++.+||.+||..||.+||+++++++||||+..
T Consensus       228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         228 ------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                              00123468899999999999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.1e-42  Score=316.56  Aligned_cols=251  Identities=27%  Similarity=0.394  Sum_probs=197.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||+|+||.||+|++..+|+.||+|++...    .....+|+.+++.++||||+++++++..     ...+++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence            4699999999999999999999999999999988543    2345679999999999999999988743     335789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNG-DVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence            9999995 67666653    35688999999999999999999987 999999999999999887 79999999997653


Q ss_pred             cCC-CcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          220 KGE-PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ... ......+++.|+|||.+..  ...++.++|+||+||++|+|++|..||......+....+...             
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------  224 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------  224 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence            322 1234567889999998742  233678999999999999999999999655432222111110             


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  350 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~  350 (403)
                          .+..+..       .....++..+.+|+++||..||++|||++++++|+|
T Consensus       225 ----~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 ----NFQPPKL-------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ----CCCCCCC-------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                0000000       011246789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=307.68  Aligned_cols=256  Identities=27%  Similarity=0.461  Sum_probs=201.5

Q ss_pred             eEE-EeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMA-ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~-~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |.+ .+.||+|+|+.|--+....+|..||||++.+.    .....+|++++...+ |+||++++++|     ++...+|+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYL  153 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYL  153 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEE
Confidence            444 36899999999999999999999999998654    344568999999985 99999999988     55666899


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC--ceEEeecCCcee
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKV  217 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~DfG~a~~  217 (403)
                      |||-|.| .|+..+..+    ..+++.++..+..+|+.||.|||.+ ||.||||||+|||-....+  -||||||.+..-
T Consensus       154 VfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999985 677777654    5689999999999999999999988 9999999999999854332  599999998754


Q ss_pred             cccCC--------Ccceeeeccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH----------
Q 015615          218 LVKGE--------PNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD----------  275 (403)
Q Consensus       218 ~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------  275 (403)
                      .....        ...+.+|+..|||||+..    ....|+.++|.||||+|+|-|+.|.+||.+....+          
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            32211        123457788899999963    22358999999999999999999999998753211          


Q ss_pred             -----HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 015615          276 -----QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  350 (403)
Q Consensus       276 -----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~  350 (403)
                           .+..|...                 .|.+|+   .     -+..+|.+++||++.+|..|+..|.++.++++|||
T Consensus       309 ~CQ~~LFesIQEG-----------------kYeFPd---k-----dWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  309 VCQNKLFESIQEG-----------------KYEFPD---K-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             HHHHHHHHHHhcc-----------------CCcCCh---h-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence                 11111111                 122222   1     12468999999999999999999999999999999


Q ss_pred             CccCCCC
Q 015615          351 FDELRDP  357 (403)
Q Consensus       351 f~~~~~~  357 (403)
                      ++.....
T Consensus       364 ~~~~~~e  370 (463)
T KOG0607|consen  364 VQRCAPE  370 (463)
T ss_pred             ccccchh
Confidence            9987654

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-41  Score=310.50  Aligned_cols=248  Identities=34%  Similarity=0.554  Sum_probs=200.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +|+..+.||+|+||.||+|.+..++..|++|.+....         ....+|+.+++.++|+||+++++++     .+..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            4778899999999999999998899999999875422         3355799999999999999998876     3334


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .++++|||+++ +|.+.+...    ..+++..+..++.||+.||+|||+. |++|+||+|+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            57899999985 777776542    4578889999999999999999987 999999999999999887 7999999998


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .............+++.|+|||.+.....++.++|+|||||++|+|++|..||......+....+......         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  220 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---------  220 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence            76644433344567889999999854434789999999999999999999999876543333332221000         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                               +         .++..+++++.+|+.+||..+|++||++.+++.|||+
T Consensus       221 ---------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         221 ---------P---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ---------C---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                     0         1224578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=296.64  Aligned_cols=257  Identities=29%  Similarity=0.401  Sum_probs=203.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||.|||+.||+++...++..||+|++...    .....+|++.-++++|||+++++++.+..........||
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            4799999999999999999999999999999998543    344458999999999999999998776655556677899


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++|.. |+|.+.+.........+++..+..|+.+|++||.+||+. .  ++||||||.|||+.+.+ .++|.|||++..
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSG-LPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCC-ceEEEeccCccc
Confidence            999987 789999988777777899999999999999999999986 7  99999999999999866 899999999875


Q ss_pred             cccCC----------CcceeeecccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015615          218 LVKGE----------PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  285 (403)
Q Consensus       218 ~~~~~----------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  285 (403)
                      ..-.-          ......+|..|+|||.+.-.  ...++++|||||||+||.|+.|..||...         .+..+
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~Gg  249 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQGG  249 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcCC
Confidence            42111          11234578899999998422  23688999999999999999999999531         11111


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .....   -.+.   .+.+|.          ...+|..+.+||+.||+.||.+||++.+++.+
T Consensus       250 SlaLA---v~n~---q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 SLALA---VQNA---QISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eEEEe---eecc---ccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11000   0000   111111          12378999999999999999999999999865

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-41  Score=311.66  Aligned_cols=250  Identities=30%  Similarity=0.473  Sum_probs=202.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      .+|++.+.||+|+||.||+|.+..++..+++|.+....  ....+|+.+++.++||||+++++++..     ..++|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence            46999999999999999999998889999999986543  456689999999999999999998743     34588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+++ +|.+.+...   ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            99995 677766542   35688999999999999999999987 999999999999999887 7999999998765443


Q ss_pred             C-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      . ......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+...   ..            
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~------------  216 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP------------  216 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC------------
Confidence            3 22234578899999998655 4899999999999999999999999876543322211110   00            


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                          +       ....+..++.++.++|.+||+.||++|||+.++|.||||
T Consensus       217 ----~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         217 ----P-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ----C-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                0       000123467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-42  Score=344.02  Aligned_cols=282  Identities=22%  Similarity=0.309  Sum_probs=197.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCC-cEEEEE------------------Eeccc---hhhhHHHHHHHHHcCCCCee
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETG-EAVAIK------------------KVLQD---KRYKNRELQTMRLLDHPNVV  121 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK------------------~~~~~---~~~~~~E~~~l~~l~h~niv  121 (403)
                      ..+|++.+.||+|+||+||+|..+... ...++|                  .+...   .....+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            357999999999999999998764332 222222                  11111   22345799999999999999


Q ss_pred             ecceeeeecCCCCceEEEEEEecccchHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe
Q 015615          122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (403)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll  200 (403)
                      ++++++..     ..+.|+|++++.+++...+..... .........++.++.||+.||.|||++ |||||||||+|||+
T Consensus       227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEE
Confidence            99998733     334789999999888777654321 123344667888999999999999998 99999999999999


Q ss_pred             cCCCCceEEeecCCceecccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCC--CcHH
Q 015615          201 NPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP-LFPGE--SGVD  275 (403)
Q Consensus       201 ~~~~~~vkl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~-pf~~~--~~~~  275 (403)
                      +.++ .+||+|||+++.......  .....||+.|+|||++.+.. ++.++|||||||++|||++|.. ||.+.  ....
T Consensus       301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9887 799999999987644322  22457899999999997654 8999999999999999999875 44332  3345


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcC---c-ccccCCCccCCCccccc-ccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPN---Y-TEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  350 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~  350 (403)
                      .+.++...++.+..+ +......   + ....+.... ......+ ...++.++.++|.+||++||.+|||+.|+|.|||
T Consensus       379 ~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        379 QLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            555555544432221 1000000   0 000000000 0111111 1246788999999999999999999999999999


Q ss_pred             CccCC
Q 015615          351 FDELR  355 (403)
Q Consensus       351 f~~~~  355 (403)
                      |....
T Consensus       457 f~~~~  461 (501)
T PHA03210        457 FSAEE  461 (501)
T ss_pred             hhcCC
Confidence            98753

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-43  Score=333.96  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=204.9

Q ss_pred             EEEeEeeeCCcEEEEEEEEccCCcEEEEEEec------cc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        68 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~------~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +...+||+|+|-+||+|.|..+|..||.-.++      ..  ...+..|+++|+.|+||||+++|.++.+...   .++.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            34568999999999999999999998864331      11  2456689999999999999999998866433   5678


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc-CCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|+|.+. |+|..+++++    ++.+...++.|++||+.||.|||++ ..|||||||.+||||+.+.+.|||+|+|+|..
T Consensus       120 ~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            9999998 6888888776    5677888999999999999999985 25999999999999999988999999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...... ....|||.|||||++.  ..|+..+||||||+.+.||+|+..||..-....++.+...- |..+..       
T Consensus       196 ~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~s-------  264 (632)
T KOG0584|consen  196 LRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAA-------  264 (632)
T ss_pred             hhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHH-------
Confidence            654443 3489999999999984  46999999999999999999999999886655555443331 222211       


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                        |.+--.+++++||.+||.. .+.|+|+.|+|+||||+.-
T Consensus       265 ------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 ------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                              2223478999999999999 9999999999999999873

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=331.78  Aligned_cols=259  Identities=28%  Similarity=0.439  Sum_probs=218.5

Q ss_pred             CCCccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        59 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      +.+...+.|.+.+.||+|.|+.|.+|++..+|..||||.+.+..      ....+|+++|+.++|||||+++.+..+   
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t---  126 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET---  126 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee---
Confidence            45556678999999999999999999999999999999886542      234689999999999999999998743   


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                        ...+|+||||+.+ .+.+++.++    .+..+..++.++.|+.+|++|||++ +|||||||++|||++.+. ++||+|
T Consensus       127 --~~~lylV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~m-nikIaD  198 (596)
T KOG0586|consen  127 --EATLYLVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENM-NIKIAD  198 (596)
T ss_pred             --cceeEEEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhccccccc-ceeeec
Confidence              3348999999984 778888775    5566688999999999999999998 999999999999999887 699999


Q ss_pred             cCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       212 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ||++..+..+....+.+|++.|.|||++.+....++++|+||+|+++|-|+.|..||.+.+-.+.-...+.         
T Consensus       199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---------  269 (596)
T KOG0586|consen  199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---------  269 (596)
T ss_pred             cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee---------
Confidence            99999988777778899999999999999888789999999999999999999999998753221111000         


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                              ..+            .++--++.++.++|+++|..+|.+|++.++++.|.|.......
T Consensus       270 --------gk~------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 --------GKY------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             --------eee------------cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                    001            1223478999999999999999999999999999999876544

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.2e-41  Score=314.06  Aligned_cols=264  Identities=26%  Similarity=0.425  Sum_probs=202.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|+..+.||.|++|.||+|.+..+++.+|+|.+....     ....+|+++++.++||||++++++|...   ....+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence            5899999999999999999999999999999886432     3356799999999999999999887442   3345789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+.........+++..+..++.||+.||+|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  156 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV  156 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence            9999985 77777665444456789999999999999999999987 999999999999999877 79999999987543


Q ss_pred             cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCHHHHhccCc
Q 015615          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.....  .... +.............     
T Consensus       157 ~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~-----  228 (287)
T cd06621         157 NSL-AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNPEL-----  228 (287)
T ss_pred             ccc-cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHHHhcCCchhh-----
Confidence            322 1234567889999998654 489999999999999999999999986521  0001 11111110000000     


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                             +.   .+   ......++.+.+||.+||..||++|||+.|+++||||+...
T Consensus       229 -------~~---~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         229 -------KD---EP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             -------cc---CC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                   00   00   00012467899999999999999999999999999996643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=308.58  Aligned_cols=321  Identities=31%  Similarity=0.529  Sum_probs=243.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|.-.+.+|.|.- .|..|.|.-.++.||+|++...      .+...+|..++..++|+||++++.+|.-... ..-..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46888899999998 8888999999999999987432      2344589999999999999999998743221 11223


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|+|||+|..+|.+.+.      ..+.-..+..++.|+++|+.|||+. ||+||||||+||+++.+. .+||.|||+|+.
T Consensus        96 ~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~-~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDC-TLKILDFGLART  167 (369)
T ss_pred             HHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchh-heeeccchhhcc
Confidence            68999999999988876      2366778999999999999999997 999999999999999988 799999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....-..+.++.|.+|.|||++.+.. +.+.+||||+||++.||++|+..|+|.+..++..++...+|.|.+..+..+.+
T Consensus       168 e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  168 EDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             cCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            54443456678899999999998776 99999999999999999999999999999999999999999999987766553


Q ss_pred             Ccccc--cCCCccCCCcccccc-----------cCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCC
Q 015615          298 NYTEF--KFPQIKAHPWHKIFQ-----------KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNG  364 (403)
Q Consensus       298 ~~~~~--~~~~~~~~~~~~~~~-----------~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~  364 (403)
                      ....+  ..++.....+...|+           +.-+..+++|+.+||..||++|.|++++|+||||+-+-.+..  ++.
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~e--v~a  324 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDE--VEA  324 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccc--ccC
Confidence            22111  222222222222221           223456899999999999999999999999999994322211  111


Q ss_pred             CCCCCCCCCChhhcCCCChHHHhhcchHHHHhhhh
Q 015615          365 RFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA  399 (403)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (403)
                       ..|+.. .+-.+....+.+.|+..+=++.+.=.+
T Consensus       325 -p~pe~~-d~~~d~~~~t~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  325 -PPPEIY-DKQLDEREHTIEEWKELIFKEVQRFEE  357 (369)
T ss_pred             -CCCchh-hhhcccccCCHHHHHHHHHHHHHhhcc
Confidence             111111 011223333367777777777665444

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-41  Score=314.86  Aligned_cols=250  Identities=27%  Similarity=0.383  Sum_probs=198.0

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      ||+|+||+||+|.+..+|+.||+|.+...       .....+|+.+++.++||||+++++.+     ......|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            68999999999999999999999988532       12234699999999999999998877     3334578999999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~  224 (403)
                      ++ +|.+.+....  ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            85 7777765432  24689999999999999999999987 999999999999999887 7999999998765443333


Q ss_pred             ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccC
Q 015615          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  304 (403)
Q Consensus       225 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  304 (403)
                      ....++..|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+......                  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence            3456778899999987655 899999999999999999999999775432211111110000                  


Q ss_pred             CCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCCC
Q 015615          305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  357 (403)
Q Consensus       305 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~~  357 (403)
                             ....++..+++.+.++|.+||+.||.+||     ++.++++||||..+.+.
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence                   00012245689999999999999999999     89999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-41  Score=312.50  Aligned_cols=246  Identities=28%  Similarity=0.454  Sum_probs=202.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+...       .....+|+++++.++||||+++++++     .+..+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            489999999999999999999989999999988543       23445799999999999999998877     445568


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++|+||+.+ +|.+.+...    ..+++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            899999985 677666543    5788999999999999999999987 999999999999999887 799999999876


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCHHHHhcc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.  .+.+......            
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence            64443334456788999999986544 89999999999999999999999987664  2222211110            


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH--HHHhcCCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--LEALIHPFF  351 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~--~ell~hp~f  351 (403)
                                      ....++...+.++.++|.+||..||.+||++  .|+++||||
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            0011234568999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.1e-42  Score=315.63  Aligned_cols=251  Identities=25%  Similarity=0.376  Sum_probs=198.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++.+..     ..++++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence            46999999999999999999999999999999885432    234579999999999999999987733     345789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06645          84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNG-HVKLADFGVSAQIT  157 (267)
T ss_pred             EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence            9999985 77776654    35689999999999999999999988 999999999999999877 79999999987653


Q ss_pred             cCC-Ccceeeeccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          220 KGE-PNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ... ......|++.|+|||++.  ....++.++|+|||||++|+|++|..||................-.+         
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~---------  228 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP---------  228 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC---------
Confidence            322 123456899999999874  22347889999999999999999999997655433332221110000         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  350 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~  350 (403)
                              +     .+.  ....++..+.+|+.+||..||++|||++++++|||
T Consensus       229 --------~-----~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         229 --------P-----KLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             --------C-----ccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                    0     000  01235788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.3e-41  Score=310.15  Aligned_cols=249  Identities=28%  Similarity=0.466  Sum_probs=197.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +|++.+.||+|+||.||+|.+..+|..||||.+...         .....+|+.+++.+.||||+++++++..   ....
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence            599999999999999999999999999999987422         1234569999999999999999887632   2234


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .++++|||+++ +|.+.+...    ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~Dfg~~  153 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVG-NVKLGDFGAS  153 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCC-CEEECcCccc
Confidence            57899999985 777776543    4578888999999999999999987 999999999999999877 7999999998


Q ss_pred             eecccCC----CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          216 KVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       216 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......    ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...........+..   .+.   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~---  226 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT---  226 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence            7543211    11234578899999998654 489999999999999999999999987654443332221   110   


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                                           ....+..++..+.++|.+|+. +|++||+++++++|||+.
T Consensus       227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                 001223467889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.2e-41  Score=311.51  Aligned_cols=245  Identities=29%  Similarity=0.482  Sum_probs=198.1

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      ||.|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++.+.     +..+++++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            689999999999998889999999885422       33557999999999999999998763     334578999999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~  224 (403)
                      ++ +|.+.+...    ..++...+..++.||+.||+|||++ +++|+||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            84 777777553    4588899999999999999999997 999999999999999887 7999999999876544333


Q ss_pred             ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCHHHHhccCcCcccc
Q 015615          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  302 (403)
Q Consensus       225 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  302 (403)
                      ....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||....  ..+....+......                
T Consensus       150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------  212 (262)
T cd05572         150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK----------------  212 (262)
T ss_pred             ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC----------------
Confidence            445678899999998654 48999999999999999999999998765  33333322210000                


Q ss_pred             cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                 ..++...++++.++|.+||+.||++|++     +.|+++||||++..+
T Consensus       213 -----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         213 -----------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             -----------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence                       0122345789999999999999999999     999999999998643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=328.37  Aligned_cols=249  Identities=30%  Similarity=0.531  Sum_probs=208.2

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      .+.||+|.||+||-|+++++|+.||||++.+      .....++|+.+|+.+.||.||.+.-.|     +....+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence            4789999999999999999999999999853      235567899999999999999986555     22233789999


Q ss_pred             cccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC--CCceEEeecCCceecccC
Q 015615          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG~a~~~~~~  221 (403)
                      -+.|+.++.+....  .+++++...++++.||+.||.|||.+ ||||+||||+|||+.+.  ...+||||||+|+...+.
T Consensus       644 Kl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  644 KLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            99998888776543  47899999999999999999999987 99999999999999654  347999999999999888


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                      ....+.+|||.|.|||++++.. |+..-|+||+|+|+|--+.|..||....+  +-.+|.+.                 .
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNA-----------------a  780 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNA-----------------A  780 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccc--hhHHhhcc-----------------c
Confidence            7778899999999999997654 99999999999999999999999975432  11222211                 1


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      |.+|   ..||.     .+++++.|||..+|+..-++|.|++..|.|||+++.
T Consensus       781 FMyP---p~PW~-----eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  781 FMYP---PNPWS-----EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             cccC---CCchh-----hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            2222   23443     479999999999999999999999999999999863

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.6e-41  Score=314.26  Aligned_cols=248  Identities=26%  Similarity=0.381  Sum_probs=190.1

Q ss_pred             EeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHH---HcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMR---LLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .||+|+||.||+|.+..+|+.+|+|.+....       ....+|..+++   ...||||+.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            4899999999999999999999999875431       12223443333   3479999998887732     3347899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+++ +|...+..    ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999995 66666554    35689999999999999999999997 999999999999999887 799999999875533


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      .. .....+|+.|+|||.+.+...++.++|+||+||++|+|++|..||......... .+......              
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~--------------  213 (279)
T cd05633         150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT--------------  213 (279)
T ss_pred             cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhc--------------
Confidence            22 233468999999999865455789999999999999999999999764322111 11110000              


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  357 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~~  357 (403)
                                 ....++..++.++.++|++||..||++|+     |+.++++||||+++...
T Consensus       214 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         214 -----------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             -----------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence                       00012345789999999999999999999     69999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4e-41  Score=313.60  Aligned_cols=240  Identities=18%  Similarity=0.231  Sum_probs=192.9

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      ..||+|++|.||+|.+  +|+.||||.+....       ....+|+.++++++||||+++++++.... .+..++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5789999999999997  78999999886432       33458999999999999999999875422 22345789999


Q ss_pred             cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      |+++ +|.+.+...    ..++......++.|++.||.|||+..+++||||||+|||++.++ .+||+|||+++..... 
T Consensus       103 y~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        103 YCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP-  176 (283)
T ss_pred             eCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc-
Confidence            9995 677777643    56788889999999999999999744899999999999999887 7999999998765322 


Q ss_pred             CcceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          223 PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       223 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                       .....+++.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....+......+              
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  241 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--------------  241 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence             2345678999999998642 358999999999999999999999999877665555443321110              


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                   .++...++++.+|+.+||+.||++|||+.++++
T Consensus       242 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 -------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                         012246889999999999999999999999985

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5e-41  Score=307.91  Aligned_cols=248  Identities=28%  Similarity=0.459  Sum_probs=202.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...      .....+|+.+++.++||||+++.+++     ....+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            489999999999999999999999999999987532      12456799999999999999998877     3445688


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+.+ +|.+.+....  ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999985 7777665422  24578889999999999999999987 999999999999999877 7999999998765


Q ss_pred             ccCCCc-ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...... ....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+....  .+         
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~---------  219 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YP---------  219 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--CC---------
Confidence            433221 2345788899999986654 7889999999999999999999998776655554443210  00         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                       ..+..++.++.++|.+||+.+|++||++.++++||||
T Consensus       220 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         220 -----------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -----------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                             0123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=309.35  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=201.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||.|+||.||+|.+..+++.+|+|.+...    .....+|+.+++.++||||+++++++.     +...+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEEE
Confidence            4699999999999999999999889999999988643    234567999999999999999998773     3345889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|||+++ +|.+.+...   ...+++..+..++.|++.||+|||++ |++|+||+|+||+++.++ .+||+|||++....
T Consensus        78 ~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999996 666655442   25688999999999999999999987 999999999999999877 79999999987653


Q ss_pred             cCC-CcceeeecccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          220 KGE-PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ... ......++..|+|||.+.+.  ..++.++|+|||||++|+|++|.+||.+.+.......+....-.+.        
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  224 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP--------  224 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc--------
Confidence            322 22334678889999998644  2478899999999999999999999988765554443322100000        


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  350 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~  350 (403)
                               .       .......+.++.+|+++||..||..|||+.+++.|+|
T Consensus       225 ---------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 ---------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ---------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                     0       0011235788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.6e-41  Score=306.36  Aligned_cols=248  Identities=33%  Similarity=0.495  Sum_probs=204.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||.|+||.||.+++..++..+++|.+...      .....+|+.+++.++|+||+++++++..     ...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            589999999999999999999999999999987532      1334579999999999999999998843     34588


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++|||+++ +|.+.+....  ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            99999984 7887776532  35688999999999999999999987 999999999999999877 7999999998765


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+...  ...         
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------  219 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT---------  219 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence            3332 223456789999999986544 789999999999999999999999887665555544321  000         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                       .....++.++.+++.+||..||++|||+.++++|||+
T Consensus       220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                             0113468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-41  Score=318.17  Aligned_cols=254  Identities=30%  Similarity=0.441  Sum_probs=202.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .|.....||.|+||.||++.+..++..||||.+....    ....+|+.+++.++|+|++++++.+.     ...+.++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence            4555678999999999999998899999999875422    33457999999999999999998873     33457899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+++ +|.+.+..     ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||++.....
T Consensus        98 ~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~  170 (292)
T cd06658          98 MEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSK  170 (292)
T ss_pred             EeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEccCcchhhccc
Confidence            999986 55555432     4588899999999999999999998 999999999999999877 799999999865432


Q ss_pred             CC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       221 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      .. ......+++.|+|||.+.+. .++.++|+||+|+++|||++|..||.+.+....+..+........           
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  238 (292)
T cd06658         171 EVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-----------  238 (292)
T ss_pred             ccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-----------
Confidence            22 12345678999999998654 488999999999999999999999987765554433322110000           


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                                     .....++..+.+++.+||..||.+|||++++++||||.....|.
T Consensus       239 ---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         239 ---------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             ---------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence                           01124688999999999999999999999999999999877664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5e-41  Score=316.11  Aligned_cols=253  Identities=19%  Similarity=0.263  Sum_probs=191.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEcc----------------CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeec
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLE----------------TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  123 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~  123 (403)
                      .+|++.+.||+|+||.||+|.+..                ++..||+|.+....     ....+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            479999999999999999998532                34579999886432     235579999999999999999


Q ss_pred             ceeeeecCCCCceEEEEEEecccc-hHHHHHHhhccc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 015615          124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKM---------------SQRMPLIYVKLYFYQICRALAYIHNTIG  187 (403)
Q Consensus       124 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~  187 (403)
                      ++++..     ....++||||+.+ +|.+.+......               ...++...+..++.||+.||.|||+. |
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~  158 (304)
T cd05096          85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-N  158 (304)
T ss_pred             EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-C
Confidence            998743     2347899999984 787777543211               12467778899999999999999998 9


Q ss_pred             ccccCCCCCceEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-
Q 015615          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  263 (403)
Q Consensus       188 ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-  263 (403)
                      |+||||||+|||++.++ .+||+|||+++........   ....++..|+|||++.+.. ++.++|||||||++|+|++ 
T Consensus       159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHc
Confidence            99999999999999877 7999999999765333211   1233467899999986544 8999999999999999987 


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH
Q 015615          264 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  342 (403)
Q Consensus       264 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~  342 (403)
                       +..||.+.+..+.+..+..........                     .....++..+..+.+|+.+||..||++|||+
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence             567888766555444333221100000                     0000123468899999999999999999999


Q ss_pred             HHHh
Q 015615          343 LEAL  346 (403)
Q Consensus       343 ~ell  346 (403)
                      .++.
T Consensus       296 ~~i~  299 (304)
T cd05096         296 SDIH  299 (304)
T ss_pred             HHHH
Confidence            9995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=328.35  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=221.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +..++..||-|+||.|-++........+|+|.+++.       ......|-.+|.....|.||++|..|     .+..|+
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv  495 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV  495 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence            566777899999999999987655556899987543       23445689999999999999999988     888899


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ||.||-|- |.+...|+.+    +.+....+++|+..+++|++|||++ |||+|||||+|.+++.+| -+||.|||+|+.
T Consensus       496 YmLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~G-y~KLVDFGFAKk  569 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRG-YLKLVDFGFAKK  569 (732)
T ss_pred             hhhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCC-ceEEeehhhHHH
Confidence            99999987 4777777764    6788889999999999999999998 999999999999999888 799999999999


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...+....+++|||.|.|||++.+.. .+.++|.||||+++|||++|.+||.+.++...+..|++.+...          
T Consensus       570 i~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------  638 (732)
T KOG0614|consen  570 IGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------  638 (732)
T ss_pred             hccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------
Confidence            99999999999999999999998765 7999999999999999999999999999999999998854221          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  357 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~~  357 (403)
                                       .|+..++..+.+|++++...+|.+|..     +.|+-+|.||.++++.
T Consensus       639 -----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  639 -----------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             -----------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence                             144568999999999999999999976     8999999999987654

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.4e-41  Score=309.65  Aligned_cols=252  Identities=32%  Similarity=0.539  Sum_probs=198.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--------------hhhHHHHHHHHHcCCCCeeecceeeeecC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (403)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.+....              ....+|+.+++.++|||++++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            5889999999999999999998899999999874211              13456899999999999999988763   


Q ss_pred             CCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                        .....++||||+.+ +|.+.+...    ..++...+..++.||+.||.|||+. +++||||+|+||+++.++ .++|+
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCC-eEEEe
Confidence              33457899999985 677776543    5688889999999999999999997 999999999999999877 79999


Q ss_pred             ecCCceecccCCC---cceeeecccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015615          211 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       211 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      |||++........   .....++..|+|||.+.... .++.++|+||||+++|+|++|..||...........+..... 
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  229 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-  229 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-
Confidence            9999875432211   22345788899999986543 478999999999999999999999976554433322211000 


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                            ...+.......++.++.+++.+||..||++|||++++++||||
T Consensus       230 ----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         230 ----------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ----------------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                  0000111223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.2e-41  Score=314.51  Aligned_cols=253  Identities=30%  Similarity=0.502  Sum_probs=201.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++.+     ....++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            5899999999999999999999999999999885432       2334789999999999999998877     334468


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++ +|.+.+...    ..+++..+..++.|++.||+|||+. |++||||||+||+++.++ .+||+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            899999986 677777543    5688999999999999999999987 999999999999999877 799999998864


Q ss_pred             cccCC----------------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 015615          218 LVKGE----------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (403)
Q Consensus       218 ~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  281 (403)
                      .....                ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21100                00123467789999998654 48999999999999999999999998776554444333


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC---HHHHhcCCCCccCCC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRD  356 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s---~~ell~hp~f~~~~~  356 (403)
                      .....                 .+.         ....++.++.++|++||+.||++||+   +.++|+||||...+.
T Consensus       230 ~~~~~-----------------~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         230 SDDIE-----------------WPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             hcccC-----------------CCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            21000                 000         01246889999999999999999998   799999999987543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.5e-41  Score=325.96  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=192.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccC-----CcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|.+.+.||+|+||.||+|.+...     +..||||.+....     ....+|+.+++.+ +|+||+++++++.    
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~----  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT----  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence            34799999999999999999986544     3579999986432     2345799999999 8999999999873    


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcc-----------------------------------------------------
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYK-----------------------------------------------------  158 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~-----------------------------------------------------  158 (403)
                       ....+++|||||+ ++|.+.+.....                                                     
T Consensus       113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence             3345789999998 478777754221                                                     


Q ss_pred             -------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc-
Q 015615          159 -------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-  224 (403)
Q Consensus       159 -------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~-  224 (403)
                                   ...++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence                         113477888999999999999999997 999999999999999776 7999999998765333211 


Q ss_pred             --ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          225 --ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       225 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                        ....+++.|||||++.+. .++.++|||||||++|+|++ |+.||........+.........+              
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~--------------  334 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM--------------  334 (374)
T ss_pred             eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc--------------
Confidence              112245679999998654 48999999999999999997 999998765444333333210000              


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                   ..+..+++++.+++.+||+.||++|||+.++++
T Consensus       335 -------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 -------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             -------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         011236889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.6e-41  Score=307.06  Aligned_cols=250  Identities=34%  Similarity=0.544  Sum_probs=204.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|++.+.||+|++|.||+|.+..+|+.|++|.+...     .....+|+..+..++|+|++++++++.     .....++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEEE
Confidence            588999999999999999999999999999988654     234567999999999999999998873     3355889


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ||||++ ++|.+.+...    ..+++..+..++.|++.||+|||+ . +++||||+|+||+++.++ .++|+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~  150 (264)
T cd06623          77 VLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKG-EVKIADFGISKVL  150 (264)
T ss_pred             EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCC-CEEEccCccceec
Confidence            999999 5777777653    668999999999999999999998 7 999999999999999887 7999999998876


Q ss_pred             ccCCCcc-eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--cHHH-HHHHHHHhCCCCHHHHhc
Q 015615          219 VKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES--GVDQ-LVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       219 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~-~~~i~~~~~~~~~~~~~~  294 (403)
                      ....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||....  .... ...+..   ...      
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~------  220 (264)
T cd06623         151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP------  220 (264)
T ss_pred             ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC------
Confidence            4433332 45678899999998655 58899999999999999999999997764  2221 111111   000      


Q ss_pred             cCcCcccccCCCccCCCcccccccC-CChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                +         .+... ++..+.++|.+||..+|++|||+.++++||||+..+
T Consensus       221 ----------~---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 ----------P---------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             ----------C---------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                      0         01123 688999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.7e-41  Score=316.22  Aligned_cols=251  Identities=29%  Similarity=0.468  Sum_probs=202.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..|.+.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++.+++..     ...
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence            35999999999999999999998899999999885321       234579999999999999999998743     234


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .++||||+.+++.+.+...   ...+++..+..++.|++.||.|||+. ||+||||+|+||+++.++ .+||+|||++..
T Consensus        90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPG-TVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCC-CEEEeecCccee
Confidence            7899999999887776543   24688999999999999999999987 999999999999999887 799999999875


Q ss_pred             cccCCCcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....   ....+++.|+|||++.+  ...++.++||||||+++|+|++|.+||.+.+.......+...  .+        
T Consensus       165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~--------  231 (307)
T cd06607         165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS--------  231 (307)
T ss_pred             cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC--------
Confidence            4322   23467889999998742  344788999999999999999999999876654443332210  00        


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                               +..        .....+..+.++|.+||..||++||++.+++.||||....
T Consensus       232 ---------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         232 ---------PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             ---------CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                     000        0123577899999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-41  Score=312.01  Aligned_cols=254  Identities=29%  Similarity=0.526  Sum_probs=200.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+....     ....+|+++++.++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            5788889999999999999999999999999885432     234579999999999999999988733     355889


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||++ ++|.+.+....   ..+++..+..++.|++.||+|||+ . |++|+||||+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~  151 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRG-QIKLCDFGVSGQL  151 (265)
T ss_pred             EEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCC-CEEEeecccchhh
Confidence            999999 57777776532   678899999999999999999998 6 999999999999999877 7999999998765


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHH-HhCCCCHHHHhccC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIK-VLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~-~~~~~~~~~~~~~~  296 (403)
                      ...... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+. .+......+ ....+.        
T Consensus       152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  221 (265)
T cd06605         152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--------  221 (265)
T ss_pred             HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--------
Confidence            332222 26678899999998665 589999999999999999999999976421 111111111 110000        


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                              +.        .....++.++.++|.+||..||++|||+.+++.||||+...
T Consensus       222 --------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         222 --------PR--------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             --------CC--------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence                    00        00012688999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-40  Score=305.77  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=201.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|.+.+.||.|+||.||+|.+..+|..||+|.+...      .....+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            488999999999999999999999999999988532      23445799999999999999999877     3344588


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +|+||+++ +|.+.+....  ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++..+||+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999985 7777765432  23578899999999999999999987 99999999999999987656899999998765


Q ss_pred             ccCCCc-ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...... ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            433221 2345788899999986544 8899999999999999999999998765544443322210             


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                            .+         ...+.++.++.+++.+||..+|++|||+.++++||||
T Consensus       219 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------FA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------CC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  00         0123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-40  Score=306.81  Aligned_cols=247  Identities=28%  Similarity=0.485  Sum_probs=192.5

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      ...||+|+||.||+|.+..++..||+|.+...    .....+|+.+++.++|+||+++++++.     ...+.++|+||+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~   87 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFMEQV   87 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEecC
Confidence            35799999999999999989999999987543    234568999999999999999998773     334688999999


Q ss_pred             cc-hHHHHHHhhcccCCCC--CHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          146 PE-TVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l--~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      ++ +|.+.+....   ..+  +...+..++.||+.||+|||+. ||+||||||+||+++.+...++|+|||++.......
T Consensus        88 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          88 PGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             CCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            85 7777776532   234  7778889999999999999987 999999999999998744489999999987653322


Q ss_pred             C-cceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          223 P-NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       223 ~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      . .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|.+||.................               
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  228 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK---------------  228 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc---------------
Confidence            2 2234578899999998543 2378899999999999999999999976433221110000000               


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                 ....++..+++++.+|+++||..+|++|||+.+++.||||
T Consensus       229 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 -----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             -----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                       0001234578899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=313.82  Aligned_cols=253  Identities=29%  Similarity=0.445  Sum_probs=211.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhh-------hHHHHHHHHHc-CCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|....+||+|+||+|.+|..+.+.+.+|||+++++...       ...|-.+|... +-|.++++..||-+     -.
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT-----mD  423 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT-----MD  423 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-----hh
Confidence            4688999999999999999999999999999988765322       22466666655 46788888887733     23


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|+||||+.| +|--.+.+    -+++.+..+..|+.+|+-||-+||++ |||+||||.+|||+|.+|| +||+|||++
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGH-iKi~DFGmc  497 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMC  497 (683)
T ss_pred             heeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCc-eEeeecccc
Confidence            38899999996 55444444    36788889999999999999999998 9999999999999999995 999999999


Q ss_pred             eecc-cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          216 KVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       216 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +... .+....+++|||.|+|||++.-.+ |+.++|+||+|++||||+.|.+||.+.++.+.++.|+...          
T Consensus       498 KEni~~~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----------  566 (683)
T KOG0696|consen  498 KENIFDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----------  566 (683)
T ss_pred             cccccCCcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc----------
Confidence            8643 334455789999999999997655 9999999999999999999999999999999999888731          


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDPN  358 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~~~  358 (403)
                                         ..+++.+|.++.++++..|.+.|.+|..     -.++-.||||+.+.+..
T Consensus       567 -------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  567 -------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             -------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence                               1245779999999999999999999965     36788999999987753

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-40  Score=309.89  Aligned_cols=247  Identities=27%  Similarity=0.392  Sum_probs=190.6

Q ss_pred             EeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHH---HHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNREL---QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .||+|+||.||+|.+..+++.||+|.+....       .....|.   ..++...||||+++++++     ......++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            3899999999999999999999999875421       1122233   344456899999998877     334458899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+.+ +|...+..    ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999985 56655543    35689999999999999999999997 999999999999999887 799999999875533


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      .. .....|+..|+|||++.+...++.++|+||+||++|+|++|+.||.+........ +.......             
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-------------  214 (278)
T cd05606         150 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM-------------  214 (278)
T ss_pred             cC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhcc-------------
Confidence            22 2345689999999998755558899999999999999999999998753221111 00000000             


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                                  ...++...|.++.+++.+||..||.+|+     ++.++++||||+...+
T Consensus       215 ------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         215 ------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence                        0012234689999999999999999999     9999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.2e-41  Score=324.03  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=192.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEE-----ccCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||+|+||.||+|.+     ..++..||||++....     ....+|+.+++.+ +||||+++++++.    
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~----  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT----  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence            34799999999999999999974     3457789999885422     2345799999999 8999999999873    


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcc-----------------------------------------------------
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYK-----------------------------------------------------  158 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~-----------------------------------------------------  158 (403)
                       +....++|||||+ |+|.+.+.....                                                     
T Consensus       110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence             3344789999998 478777754221                                                     


Q ss_pred             ------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          159 ------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       159 ------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                                        ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGR-ITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence                              012467888999999999999999987 999999999999999776 799999999976533


Q ss_pred             CCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          221 GEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       221 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ....   ....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+........+.......+         
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------  336 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM---------  336 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC---------
Confidence            2211   1123456799999996654 8999999999999999998 899998765444433332210000         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                        ..+...+.++.+|+.+||+.||++|||+.++++.
T Consensus       337 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         337 ------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                              0112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-40  Score=307.31  Aligned_cols=247  Identities=26%  Similarity=0.379  Sum_probs=191.3

Q ss_pred             ceEEEeEe--eeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           66 SYMAERVV--GHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        66 ~y~~~~~l--g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      .|.+.+.+  |+|+||.||++.+..++..+|+|.+..... ...|+.....+ +||||++++++|..     ...+++||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEEE
Confidence            46666655  999999999999999999999998864321 11233333323 79999999988743     33588999


Q ss_pred             eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||++ ++|.+.+...    ..+++..+..++.|++.||.|||+. |++||||||+||+++.++..++|+|||++......
T Consensus        89 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         89 DYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            9998 4788777653    3789999999999999999999997 99999999999999987757999999998765322


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                         ....++..|+|||++.+.. ++.++|+||+|+++|+|++|..||........ ..........+             
T Consensus       164 ---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  226 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-------------  226 (267)
T ss_pred             ---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc-------------
Confidence               2346788999999996654 89999999999999999999999986543221 11111110000             


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-HHHHhcCCCCcc
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-ALEALIHPFFDE  353 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-~~ell~hp~f~~  353 (403)
                                   ....+.+++.+.+||.+||+.||.+|++ .+++|+||||+.
T Consensus       227 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        227 -------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             -------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                         0012357899999999999999999996 599999999963

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=306.24  Aligned_cols=246  Identities=34%  Similarity=0.524  Sum_probs=193.0

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccchh-------hhHHHHHH-HHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||.|+||.||+|.+..+|+.||+|.+.....       ....|..+ ....+|+|++++++++.     ....+++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            468999999999999999999999998854321       11234333 34458999999998873     334588999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+++ +|.+++...    ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++ .+||+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99985 777766542    5688999999999999999999997 999999999999999877 799999999875432 


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                        .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+....            ..   
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~---  211 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR------------IN---  211 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc------------cC---
Confidence              22345788899999987654 8999999999999999999999998776655444332210            00   


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC---HHHHhcCCCCccCCC
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRD  356 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s---~~ell~hp~f~~~~~  356 (403)
                                +.......+++++.+++.+||..||++||+   ++|++.||||+.+++
T Consensus       212 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         212 ----------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ----------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence                      011112347899999999999999999995   579999999988754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=325.31  Aligned_cols=244  Identities=32%  Similarity=0.470  Sum_probs=201.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ....|.+...+|.|+|+.|-.+.+..+++..++|++.+......+|+.++... +||||+++.+.+     .+..+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence            35679999999999999999999999999999999987766777788666555 799999999988     667779999


Q ss_pred             Eecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec-CCCCceEEeecCCceecc
Q 015615          142 LEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       142 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~-~~~~~vkl~DfG~a~~~~  219 (403)
                      ||++.|. +++-+..     .+.....+..|++||+.|+.|||++ |+|||||||+|||++ ..+ .++|+|||.++...
T Consensus       395 ~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  395 MELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELE  467 (612)
T ss_pred             ehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCC-cEEEEEechhhhCc
Confidence            9999974 4444333     2233367788999999999999998 999999999999994 666 69999999998654


Q ss_pred             cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      ..  ..+.+.|..|.|||++. ...|++++||||||++||+|++|+.||......   .++.+.++.+.           
T Consensus       468 ~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~-----------  530 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK-----------  530 (612)
T ss_pred             hh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-----------
Confidence            33  33456688899999997 455999999999999999999999999887655   33444333332           


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                      +...+|..+++||+.||+.||.+|+++.+++.||||
T Consensus       531 ----------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 ----------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ----------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                            224689999999999999999999999999999999

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.9e-40  Score=304.04  Aligned_cols=245  Identities=28%  Similarity=0.467  Sum_probs=198.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +|.+.+.||.|+||.||++.+..++..+|+|.+...     .....+|+.+++.++|+||+++++++     .+..++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            488999999999999999999999999999987432     23345789999999999999999887     33446889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|||+++ ++.+.+...  ....+++..+..++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||++....
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999985 677766542  235578999999999999999999988 999999999999999877 79999999987653


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+......            
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------  218 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK------------  218 (255)
T ss_pred             ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC------------
Confidence            3222 2345678899999998654 4899999999999999999999999876655444433221000            


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                      .++..++..+.+|+.+||+.||++|||+.+++.-
T Consensus       219 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 ----------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                            0123467899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.8e-41  Score=310.24  Aligned_cols=249  Identities=26%  Similarity=0.412  Sum_probs=201.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .|...+.||.|+||.||+|.+..++..||||.+....     ....+|+.+++.+.|+||+++++++.     +..+.++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            5888899999999999999998899999999875432     23457999999999999999999873     3345899


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+..     .++++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999986 67666643     4578888999999999999999987 999999999999999877 79999999987654


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .... .....++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||...........+..  +.+           
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~-----------  218 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNP-----------  218 (277)
T ss_pred             CCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCC-----------
Confidence            3322 22345688899999986544 79999999999999999999999987654433322111  000           


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                     ..+...++..+.+++.+||+.+|++||++.++++||||....
T Consensus       219 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         219 ---------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ---------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                           011234678899999999999999999999999999997754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.2e-41  Score=317.84  Aligned_cols=280  Identities=32%  Similarity=0.522  Sum_probs=225.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhh---HHHHHHHHHcC------CCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLD------HPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|.+....|+|-||+|..|.|...|..||||++....-..   .+|+++|++|+      .-|+++++..|     ...
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk  506 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK  506 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence            47999999999999999999999999999999997765433   47999999995      35788988887     555


Q ss_pred             eEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       136 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .++|||+|-+.-+|.++|+... .+-.|....++.|+.|++.||..|.. +||+|.||||+|||++.....+||||||.|
T Consensus       507 nHLClVFE~LslNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  507 NHLCLVFEPLSLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             ceeEEEehhhhchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccc
Confidence            6799999999999999998754 35668888999999999999999986 599999999999999988878999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ......+ .+.+..+..|.|||++.+-+ |+...|+||+||+||||.||+..|+|.+..+++...+.+-|.-+..+++..
T Consensus       585 ~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             ccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            8765443 34566678899999999876 999999999999999999999999999999999999999888887766532


Q ss_pred             C-------cCccc--ccCCCccC-------------CCcccccc--cCCC-------hHHHHHHHHhhccCCCCCCCHHH
Q 015615          296 N-------PNYTE--FKFPQIKA-------------HPWHKIFQ--KRMP-------PEAVDLVSRLLQYSPNLRSTALE  344 (403)
Q Consensus       296 ~-------~~~~~--~~~~~~~~-------------~~~~~~~~--~~~s-------~~~~~ll~~~L~~dP~~R~s~~e  344 (403)
                      .       .++..  .....+..             ..+...+-  ..++       ..+++||.+||..||++|.|+.+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence            2       11111  11111111             01111110  0122       45899999999999999999999


Q ss_pred             HhcCCCCcc
Q 015615          345 ALIHPFFDE  353 (403)
Q Consensus       345 ll~hp~f~~  353 (403)
                      +|+||||++
T Consensus       743 AL~HpFi~~  751 (752)
T KOG0670|consen  743 ALKHPFITE  751 (752)
T ss_pred             HhcCCcccC
Confidence            999999975

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3e-40  Score=302.20  Aligned_cols=250  Identities=32%  Similarity=0.529  Sum_probs=204.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|.+.+.||.|+||.||+|.+..++..||+|.+...      .....+|+++++.++|||++++.+.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            488999999999999999999889999999998543      2334579999999999999999888733     35688


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +|+||+++ +|.+.+.........+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 78887776544457789999999999999999999998 999999999999999877 7999999998765


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .... ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+..+.........             
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  219 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------  219 (258)
T ss_pred             ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence            4432 222356788999999986554 8899999999999999999999998766444333322210             


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                            .+         .++...+..+.+++.+||..+|++|||+.++|+||||
T Consensus       220 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ------YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ------CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                  00         0122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.9e-41  Score=313.44  Aligned_cols=254  Identities=28%  Similarity=0.448  Sum_probs=201.7

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      |.....||.|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++|||++++++++..     ....++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence            44556799999999999999889999999987532    2344578999999999999999998733     34578999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+++ +|...+..     ..+++..+..++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++......
T Consensus        98 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~  170 (297)
T cd06659          98 EFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKD  170 (297)
T ss_pred             ecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCC-cEEEeechhHhhcccc
Confidence            99996 55554432     4588999999999999999999988 999999999999999887 7999999998654332


Q ss_pred             C-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      . ......++..|+|||++.+.. ++.++|+|||||++|+|++|+.||...+..+.+..+...   +..           
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~-----------  235 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP-----------  235 (297)
T ss_pred             cccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC-----------
Confidence            2 123456889999999996544 899999999999999999999999876655444332210   000           


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                                .+  .....++..+.++|.+||+.+|++||++.++++||||.+...+..
T Consensus       236 ----------~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         236 ----------KL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             ----------Cc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence                      00  011346889999999999999999999999999999998766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.2e-40  Score=310.60  Aligned_cols=259  Identities=25%  Similarity=0.405  Sum_probs=199.7

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.++... .||||+++++++.     ...
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~   87 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDS   87 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCC
Confidence            3457999999999999999999998889999999986432     1223466555555 5999999999873     344


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ..+++|||+++.+..++...   ...+++..+..++.|++.||+|||+..||+||||+|+||+++.++ .+||+|||++.
T Consensus        88 ~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~  163 (296)
T cd06618          88 DVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG  163 (296)
T ss_pred             eEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence            58899999988777666543   247889999999999999999999733999999999999999877 79999999987


Q ss_pred             ecccCCCcceeeecccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHH
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  292 (403)
                      ............+++.|+|||.+.+.   ..++.++|+||||+++|+|++|+.||...... +.+..+...   ..    
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~----  236 (296)
T cd06618         164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EP----  236 (296)
T ss_pred             hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CC----
Confidence            65444333344577889999998643   23788999999999999999999999764322 222222110   00    


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                          +        ..   +    ....++.++.+|+.+||..||++||+++++++||||+....
T Consensus       237 ----~--------~~---~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         237 ----P--------SL---P----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             ----C--------CC---C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence                0        00   0    01136789999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=309.31  Aligned_cols=252  Identities=28%  Similarity=0.486  Sum_probs=200.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCceE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+...     .....+|+.+++.+.   |||++++++++.     +..+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            378889999999999999999999999999987532     233557889999986   999999998773     3345


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .++||||+.+ +|.+.+..     ..+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            7899999986 66666543     3688999999999999999999987 999999999999999877 79999999987


Q ss_pred             ecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....... .....++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.........+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------  217 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------  217 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence            7644332 233467889999999866555789999999999999999999999775433222111000            


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                             ..+.+        .....+.++.+++.+||..||++||++.++++||||++...
T Consensus       218 -------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         218 -------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             -------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence                   00000        01126789999999999999999999999999999988653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.3e-41  Score=314.11  Aligned_cols=250  Identities=26%  Similarity=0.407  Sum_probs=199.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .|...+.||+|+||.||+|.+..++..||+|.+....     ....+|+.+++.++||||+++++++.     .....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence            4777788999999999999998899999999875332     23567999999999999999999873     3345789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+.     ...+++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06642          80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCC-CEEEcccccccccc
Confidence            9999995 6666553     24688889999999999999999987 999999999999999877 79999999987654


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...  .            
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------  217 (277)
T cd06642         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--S------------  217 (277)
T ss_pred             CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--C------------
Confidence            3221 1234578889999998654 4889999999999999999999999765443322211110  0            


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                           .         ..+...++.++.+++.+||..+|++|||+.++++||||.....
T Consensus       218 -----~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         218 -----P---------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             -----C---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence                 0         0012346789999999999999999999999999999987653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-40  Score=306.40  Aligned_cols=244  Identities=21%  Similarity=0.261  Sum_probs=191.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|++.+.||+|+||.||+|.+.   ..+..||+|.+....     ....+|+..++.++||||+++++++.     ...
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence            46999999999999999999865   346789999886432     23457999999999999999998873     233


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..++||||+++ +|.+++...   ...+++..+..++.||+.||+|||++ |++||||||+|||++.++ .+|++|||.+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~-~~~l~dfg~~  154 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDL-VCKISGFRRL  154 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCC-cEEECCCccc
Confidence            47899999996 566666543   24688999999999999999999987 999999999999999887 7999999987


Q ss_pred             eecccCCCcc--eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          216 KVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       216 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ..........  ...++..|+|||.+.+. .++.++|||||||++||+++ |..||.+.+..+.+..+......+     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-----  228 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP-----  228 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC-----
Confidence            6432221111  22345689999998654 48999999999999999875 999998876655444432211000     


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                             .+..++..+.+++.+||+.+|++|||++++++
T Consensus       229 -----------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         229 -----------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -----------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                   12346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.8e-41  Score=320.41  Aligned_cols=277  Identities=21%  Similarity=0.327  Sum_probs=196.3

Q ss_pred             EeeeC--CcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           72 VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        72 ~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      .||+|  +||+||+|.+..+|+.||+|.+....      ....+|+.+++.++||||++++++|.     ...+.++|||
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~e   79 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVISP   79 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEEe
Confidence            45666  99999999999999999999875322      33457888999999999999999873     3345789999


Q ss_pred             cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      |+.+ ++.+++....  ...+++..+..++.|++.||+|||+. ||+||||||+|||++.++ .++++||+.+.......
T Consensus        80 ~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          80 FMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             cccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccC
Confidence            9995 7777766543  24588999999999999999999987 999999999999999877 79999998543321111


Q ss_pred             Cc--------ceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH---
Q 015615          223 PN--------ISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---  290 (403)
Q Consensus       223 ~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~---  290 (403)
                      ..        ....++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.................+..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence            10        012235669999998654 347899999999999999999999998876555444333211110000   


Q ss_pred             ------HHhccCcCcc----cccC-----CCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          291 ------EIKCMNPNYT----EFKF-----PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       291 ------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                            .+......+.    +...     .......+........++.+.+|+++||+.||++|||+.++|+||||+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                  0000000000    0000     000000011111234678899999999999999999999999999999876


Q ss_pred             CC
Q 015615          356 DP  357 (403)
Q Consensus       356 ~~  357 (403)
                      ..
T Consensus       316 ~~  317 (328)
T cd08226         316 EQ  317 (328)
T ss_pred             Hh
Confidence            54

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-40  Score=311.64  Aligned_cols=255  Identities=28%  Similarity=0.442  Sum_probs=202.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ...+|.+.+.||+|+||.||+|.+..++..||+|.+...    .....+|+.+++.++|||++++++.+..     ....
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~   91 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDEL   91 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcE
Confidence            346899999999999999999999889999999987532    2334578999999999999999998743     3347


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++|+||+++ +|.+.+..     ..++...+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++..
T Consensus        92 ~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~  164 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQ  164 (293)
T ss_pred             EEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCC-CEEEccCcceec
Confidence            899999985 77666653     3577888999999999999999988 999999999999999877 799999998865


Q ss_pred             cccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          218 LVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       218 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ...... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+....+..+.. .+.+         
T Consensus       165 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~---------  233 (293)
T cd06647         165 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP---------  233 (293)
T ss_pred             ccccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC---------
Confidence            433222 2234678889999998654 478999999999999999999999987654333222111 0000         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                    .+  ..+..++..+.+++.+||..+|++||++.+++.||||+..+.
T Consensus       234 --------------~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         234 --------------EL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             --------------CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence                          00  012346788999999999999999999999999999988653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-40  Score=309.65  Aligned_cols=259  Identities=29%  Similarity=0.423  Sum_probs=199.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|++.+.||+|+||+||+|.+..+|..||+|.+....     ....+|+++++.++||||+++++++.     ...+++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            46899999999999999999999999999999875432     34457999999999999999998873     334688


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+..    .+.++...+..++.|++.||.|||+..+++||||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~  154 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGEL  154 (284)
T ss_pred             EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccch
Confidence            99999996 56555543    356889999999999999999999733899999999999999877 7999999998654


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCCCHHHHhc
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ----LVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~  294 (403)
                      .... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||......+.    ...+.....    ..+..
T Consensus       155 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~  228 (284)
T cd06620         155 INSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ----QIVQE  228 (284)
T ss_pred             hhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH----HHhhc
Confidence            3222 2235678999999998654 588999999999999999999999986543211    111110000    00000


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                              ..+.        .....++.++.+|+.+||+.||++|||+.++++|+||.+..
T Consensus       229 --------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         229 --------PPPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             --------cCCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                    0000        00112678899999999999999999999999999997743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.4e-40  Score=311.07  Aligned_cols=249  Identities=29%  Similarity=0.474  Sum_probs=201.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|...+.||+|+||.||+|.+..+|..||+|.+....       ....+|+.+++.++|||++++++++..     ....
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   96 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTA   96 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence            3677788999999999999999999999999885321       234578999999999999999998743     3457


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||+.+++.+.+...   ...+++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .+||+|||++...
T Consensus        97 ~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~  171 (313)
T cd06633          97 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASKS  171 (313)
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCC-CEEEeecCCCccc
Confidence            899999999887777543   35688899999999999999999987 999999999999999877 7999999998643


Q ss_pred             ccCCCcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .   ......++..|+|||.+..  ...++.++|||||||++|+|++|.+||...+.......+... ..+         
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~---------  238 (313)
T cd06633         172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP---------  238 (313)
T ss_pred             C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCC---------
Confidence            2   2234567889999999842  234788999999999999999999999887655555443321 000         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                               .        .....++..+.+|+.+||+.+|.+||++.++++||||+..
T Consensus       239 ---------~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         239 ---------T--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ---------C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                     0        0112457789999999999999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-40  Score=304.66  Aligned_cols=244  Identities=33%  Similarity=0.570  Sum_probs=196.8

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      ||.|+||.||+|.+..+|+.+++|.+....       ....+|+.+++.++||||+++++++     ......|++|||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999998889999999885432       2345789999999999999998876     3445588999999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC--
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--  222 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~--  222 (403)
                      .+ +|.+.+...    ..+++..+..++.||+.||+|||+. |++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            85 777777653    3689999999999999999999987 999999999999999887 79999999987543321  


Q ss_pred             -------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          223 -------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       223 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                             ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||......+....+...  ..        
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------  218 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KI--------  218 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc--------
Confidence                   112345678899999986654 789999999999999999999999877655544433220  00        


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH---HHHhcCCCCccCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEALIHPFFDELR  355 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~---~ell~hp~f~~~~  355 (403)
                             ..+.          ...++..+.+|+.+||+.+|.+|||+   .++|+||||+++.
T Consensus       219 -------~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         219 -------EWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             -------CCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence                   0000          01248899999999999999999999   9999999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.2e-40  Score=302.32  Aligned_cols=250  Identities=31%  Similarity=0.536  Sum_probs=197.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|.+.+.||+|+||.||+|.+..++..||+|.+....      ....+|+.+++.++|+||+++++.+     .+...++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            5889999999999999999998899999999985432      3445799999999999999998876     3334578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +|+||+++ +|.+.+..    ...+++..+..++.|++.||+|||+. ||+|+||+|+||+++.++ .+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999985 67776654    24578888999999999999999987 999999999999999877 7999999998765


Q ss_pred             ccCCCcc-----eeeecccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          219 VKGEPNI-----SYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       219 ~~~~~~~-----~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......     ...+++.|+|||++.+..  .++.++||||||+++|+|++|..||............... +.++   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---  225 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---  225 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence            4332211     245678899999986543  2788999999999999999999999765433222211111 1000   


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                 ..+          ....+++.+.+|+.+||+.||++|||+.+++.|||+
T Consensus       226 -----------~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -----------PIP----------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------CCC----------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                       000          012358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.6e-40  Score=306.12  Aligned_cols=257  Identities=23%  Similarity=0.306  Sum_probs=197.7

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ...+|++.+.||+|+||.||+|.++.     .+..||+|.+....     ....+|+.+++.++||||+++++++.    
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            34579999999999999999997642     35589999875332     22346889999999999999998763    


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhccc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  205 (403)
                       .....++||||++ ++|.+.+......      ...++...+..++.|++.||.|||++ +|+||||||+||+++.++ 
T Consensus        80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~-  156 (288)
T cd05061          80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDF-  156 (288)
T ss_pred             -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCC-
Confidence             2234789999998 5888888653221      13346677888999999999999988 999999999999999877 


Q ss_pred             ceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015615          206 QLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (403)
Q Consensus       206 ~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  281 (403)
                      .++|+|||+++........   ....++..|+|||.+.+.. ++.++|+|||||++|||++ |.+||.+....+....+.
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            7999999998754322211   1223466799999986544 8999999999999999998 789998766554433322


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc------CCCCccCC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI------HPFFDELR  355 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~------hp~f~~~~  355 (403)
                      .. +.+                           .++...++.+.+++.+||+.||++|||+.++++      ||||+++.
T Consensus       236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         236 DG-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             cC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            11 000                           012345789999999999999999999999986      99998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-40  Score=301.52  Aligned_cols=248  Identities=27%  Similarity=0.474  Sum_probs=198.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +|++.+.||+|+||.||+|.+..+|..||+|.+...         .....+|+.+++.++|+||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEK   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCC
Confidence            699999999999999999999999999999987421         1234579999999999999999987633   2233


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .++++|||+++ +|.+.+...    ..+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~  153 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  153 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECccccc
Confidence            57799999985 677776542    4578888999999999999999988 999999999999999877 7999999998


Q ss_pred             eecccC----CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          216 KVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       216 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      +.....    .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........++.   ..+..  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~--  227 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTK--  227 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCC--
Confidence            764321    111234578899999998664 47899999999999999999999998765444433322   11110  


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                            ..++..++..+.+++.+||. +|..||++.++++|||.
T Consensus       228 ----------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         228 ----------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                  11334578999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.9e-40  Score=305.87  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=200.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      -|.+.+.||+|+||.||+|.+..++..||||.+....     ....+|+.+++.++||||+++++++.     +..+.++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence            3778899999999999999998899999999875322     34457999999999999999999873     3345789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+..     ..++...+..++.|++.|+.+||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCC-CEEEeecccceecc
Confidence            9999986 66666542     4578899999999999999999987 999999999999999877 79999999987653


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+... ..            
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------  218 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------  218 (277)
T ss_pred             cchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC------------
Confidence            3221 1234578889999998654 4788999999999999999999999876544333322110 00            


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                     ..+...++.++.+++.+||+.+|.+||++.++++||||....
T Consensus       219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         219 ---------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence                           012234688999999999999999999999999999998853

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=352.31  Aligned_cols=256  Identities=29%  Similarity=0.473  Sum_probs=205.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      +.+|.-...||.|.||.||-|.+..+|+..|+|.+.-.      .....+|..++..++|||+|++|++-....     .
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----k 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----K 1308 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----H
Confidence            34677788999999999999999999999999987432      234458999999999999999998764322     2


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ++|.||||.+ +|.+++.+    ++..++...+.|..|++.|++|||++ |||||||||+||+++.+| .+|++|||.|.
T Consensus      1309 v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNG-LIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCC-cEEeeccccee
Confidence            6789999995 66666655    35577788888999999999999998 999999999999999888 89999999998


Q ss_pred             ecccCCC-----cceeeecccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          217 VLVKGEP-----NISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       217 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      ...+...     .....||+.|||||++.+..  ....+.||||||||+.||+||+.||...+..=++.-......    
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh---- 1458 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH---- 1458 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC----
Confidence            7755431     13578999999999997543  356789999999999999999999987654322221111111    


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                    -|+         ++.++|++.+|||.+||+.||++|+++.++++|.|-+.-.+.
T Consensus      1459 --------------~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1459 --------------KPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             --------------CCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence                          111         335589999999999999999999999999999987765443

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.5e-40  Score=302.47  Aligned_cols=245  Identities=21%  Similarity=0.325  Sum_probs=195.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ..|.+.+.||+|+||.||+|.+..++..||+|.+..+.   ....+|+.+++.++|+||+++++++.     ....++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence            35899999999999999999999999999999886543   23457999999999999999998773     33347899


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||++ ++|.+.+....  ...++...+..++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            99997 47777775432  34588888999999999999999987 999999999999999877 799999999876543


Q ss_pred             CCCcc--eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .....  ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....            
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------  223 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------  223 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence            32111  12235679999998654 48899999999999999998 9999987665443333322100            


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                      ...+..++.++.+++.+||..||++|||+.++++
T Consensus       224 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         224 ----------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                            0122457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4e-40  Score=338.81  Aligned_cols=250  Identities=24%  Similarity=0.377  Sum_probs=192.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++..+       .....+|+.+++.++||||+++++++.     +...
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            4799999999999999999999999999999998643       123457999999999999999998773     3345


Q ss_pred             EEEEEecccc-hHHHHHHhhccc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEE
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~-------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  209 (403)
                      .++||||++| +|.+.+......       ....+...+..++.||+.||+|||++ ||+||||||+||+++.++ .+||
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCC-CEEE
Confidence            7899999985 777777643211       23355667888999999999999998 999999999999999887 7999


Q ss_pred             eecCCceecccCC-------------------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015615          210 CDFGSAKVLVKGE-------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (403)
Q Consensus       210 ~DfG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  270 (403)
                      +|||++.......                   ......||+.|+|||++.+.. ++.++|||||||++|||+||..||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999997651110                   011246899999999987654 89999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .........  .....|..                   ..     ....+++.+.+++.+||..||++|++..+.+.+
T Consensus       234 ~~~~ki~~~--~~i~~P~~-------------------~~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        234 KKGRKISYR--DVILSPIE-------------------VA-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             cchhhhhhh--hhccChhh-------------------cc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            543322111  10000000                   00     013478899999999999999999887665543

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.2e-40  Score=305.49  Aligned_cols=254  Identities=30%  Similarity=0.477  Sum_probs=201.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .|...+.||+|++|.||+|.+..+++.+++|.+....    ....+|+.+++.++|||++++++++..     ..+.+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            3555678999999999999998899999999875322    234578999999999999999987732     3347899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      +||+.+ +|.+.+..     .+++...+..++.|++.||+|||++ |++||||+|+||+++.++ .++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence            999985 77666654     4578889999999999999999998 999999999999999877 799999998765433


Q ss_pred             CCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          221 GEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       221 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      ... .....+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||...+.......+... ..+.           
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~-----------  234 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK-----------  234 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC-----------
Confidence            221 22346788999999986544 899999999999999999999999876654444433221 0000           


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                             .       .....++..+.+|+.+||..||++|||+.++++||||+..+++.
T Consensus       235 -------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         235 -------L-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             -------C-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence                   0       01123678999999999999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.7e-40  Score=307.64  Aligned_cols=248  Identities=22%  Similarity=0.298  Sum_probs=196.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCC-----cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ....+|+.+++.++||||+++++++.     +
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            46899999999999999999976555     679999885432     23457999999999999999998773     3


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhccc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~  201 (403)
                      ....+++|||++ ++|.+.+......            ...++...+..++.|++.||.|||++ |++||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEc
Confidence            334789999998 4788877654221            14578888999999999999999998 999999999999999


Q ss_pred             CCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015615          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (403)
Q Consensus       202 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  277 (403)
                      .++ .+||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+..
T Consensus       159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            877 799999999876533221   1233557889999998654 48999999999999999998 99999887765544


Q ss_pred             HHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ..+.+....                            ..+..++.++.+|+.+||+.||.+||++.+++++
T Consensus       237 ~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRSRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            443321000                            0123578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=319.58  Aligned_cols=246  Identities=19%  Similarity=0.282  Sum_probs=193.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .....+...||+|.||+||+|++-.   .||||++..+      -+.+++|+.++++-+|.||+-+.+++     .... 
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~-  461 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPP-  461 (678)
T ss_pred             HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCc-
Confidence            3456778999999999999999833   4999998543      24567899999999999999999987     3333 


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +.||+.+|+| +|+..+...   ...|.....+.|++||+.|+.|||.+ +|||||||..|||+..++ .|||+|||++.
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~-kVkIgDFGLat  536 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDL-KVKIGDFGLAT  536 (678)
T ss_pred             eeeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCC-cEEEeccccee
Confidence            3799999998 677777544   36688889999999999999999988 999999999999999876 89999999985


Q ss_pred             ec---ccCCCcceeeecccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VL---VKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~---~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .-   ..........|...|||||+++..  ..|++++|||||||++|||+||..||...+..+++..+-.....|....
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~  616 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK  616 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence            42   122222344567889999999532  3489999999999999999999999996655554443333222222211


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                              ...+.++++++|+..|+.+++++||+..++|.
T Consensus       617 ------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  617 ------------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ------------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                    22356789999999999999999999999886

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.2e-40  Score=302.57  Aligned_cols=250  Identities=30%  Similarity=0.461  Sum_probs=196.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+|++.+.||+|+||.||+|++..+++.||||.+...       .....+|+.+++.++||||+++++++..     ...
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence            3699999999999999999999999999999976431       1234579999999999999999988743     235


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+++|||+++ +|.+.+.........+++..+..++.||+.||.|||++ |++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence            7899999995 77777765444445688999999999999999999988 999999999999999877 79999999987


Q ss_pred             ecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhc
Q 015615          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       217 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ....... .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||..... ...+.......+.++      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  227 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------  227 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence            6543221 12346788899999986544 78999999999999999999999865432 122222211111111      


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                          ......+..+.+++.+||..+|++||++.++++.
T Consensus       228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                                0112367889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.6e-40  Score=306.82  Aligned_cols=256  Identities=27%  Similarity=0.462  Sum_probs=200.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccch--------hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (403)
                      +|++.+.||.|+||.||+|.+.   .+|..||+|.+....        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4889999999999999999874   478999999885421        3345799999999 599999998877     3


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      ....+++||||+++ +|.+.+...    ..+++..+..++.|++.||.|||+. |++||||+|+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCC-CEEEeeC
Confidence            34467899999995 777776542    5688899999999999999999987 999999999999999887 7999999


Q ss_pred             CCceecccCC--CcceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          213 GSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       213 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      |++.......  ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.......  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            9987653322  12245678899999998643 236789999999999999999999997543322222222211000  


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  357 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~~  357 (403)
                            .                 ..++..+++.+.+++.+||..||++|+     ++++++.||||+.+.+.
T Consensus       228 ------~-----------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         228 ------E-----------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             ------C-----------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence                  0                 002245788999999999999999997     89999999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=300.99  Aligned_cols=285  Identities=35%  Similarity=0.589  Sum_probs=223.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC-ceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD-ELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-~~~  137 (403)
                      .+.+-.+.||-|+||.||.+.|..+|+.||+|++..-      .....+|+++|..++|.|++...+.. .....+ -..
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDIL-QPph~dfFqE  131 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDIL-QPANPSFFQE  131 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhc-CCCCchHHHH
Confidence            3455567899999999999999999999999998542      23445899999999999999987754 211111 001


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|+++|.|..+|...+-.    .+.++.+.++-+++||++||.|||+. +|.||||||.|.|+++|. .+||||||+++.
T Consensus       132 iYV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNC-vLKICDFGLARv  205 (449)
T KOG0664|consen  132 LYVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNC-ILKICDFGLART  205 (449)
T ss_pred             HHHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCc-eEEecccccccc
Confidence            567888887777766654    57788889999999999999999997 999999999999999998 799999999987


Q ss_pred             cccCCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          218 LVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       218 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....+..  +..+.|.+|+|||++.+...|+.+.||||+|||+.||+..+..|...++.+++..|...+|.|..+.++..
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            5433222  23456899999999999999999999999999999999999999999999999999999999999987643


Q ss_pred             CcCcccccCCCccCCC-ccccc----ccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHP-WHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~-~~~~~----~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                      -.+...-........+ +...+    +..-..+..+++.++|.+||++|.+.++++.|++..+.+-
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence            2221111111111111 11111    1123457889999999999999999999999999988654

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.6e-40  Score=311.59  Aligned_cols=280  Identities=22%  Similarity=0.327  Sum_probs=196.3

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |.+++.+|.|+  .||.+++..+++.||||++...      .....+|+.+++.++|+||+++++++..     ....++
T Consensus         4 ~~i~~~~~~~~--~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (314)
T cd08216           4 TLIGKCFEDLM--IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYV   76 (314)
T ss_pred             hhhhHhhcCCc--eEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEE
Confidence            34444455554  4555566669999999998543      1345689999999999999999998733     334789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|||+++ ++.+++....  ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||.+....
T Consensus        77 ~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~  152 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDG-KVVLSGLRYSVSMI  152 (314)
T ss_pred             EEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCC-ceEEecCccceeec
Confidence            9999994 6777776543  34588999999999999999999998 999999999999999877 79999999887553


Q ss_pred             cCCC--------cceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          220 KGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       220 ~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ....        .....++..|+|||++.+. ..++.++|+||+||++|+|++|..||..........+...  +.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~  230 (314)
T cd08216         153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCL  230 (314)
T ss_pred             cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccc
Confidence            2211        1223457789999998653 3478999999999999999999999987655443322221  111100


Q ss_pred             H----HhccCcCcccc---cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          291 E----IKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       291 ~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                      .    ...........   .................++.++.+|+.+||+.||++|||+.++|+||||+.++.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~  306 (314)
T cd08216         231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNT  306 (314)
T ss_pred             cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccch
Confidence            0    00000000000   000000011111222345678999999999999999999999999999998875543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=299.12  Aligned_cols=262  Identities=24%  Similarity=0.354  Sum_probs=207.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHH-HHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQT-MRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +.+-...||.|+||+|++..++.+|+..|||+++...     ..+..|.+. ++.-+.||||++|+..+...+     .|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cW  139 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CW  139 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----ee
Confidence            3444567999999999999999999999999996543     223345554 344478999999998865433     78


Q ss_pred             EEEecccchHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      |.||+|+-++..+-+..+. ....+++..+..+....+.||.||....+|||||+||+|||++..| .|||||||++..+
T Consensus       140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQL  218 (361)
T ss_pred             eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhH
Confidence            9999999888776654433 3567999999999999999999999888999999999999999988 7999999999887


Q ss_pred             ccCCCcceeeecccccccccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCHHHHhccC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  296 (403)
                      .++-..+...|...|||||.+..... |+.++|+||||++|||+.||+.||.+.++  .+.++.... |.|+.-.     
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~-----  291 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILL-----  291 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeec-----
Confidence            76666666788889999999965544 89999999999999999999999988654  344443332 2222110     


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                      ...                -.-..+..+..||..||.+|-+.||...+++++||++....
T Consensus       292 ~~~----------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  292 FDK----------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             Ccc----------------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            000                01236889999999999999999999999999999987543

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.8e-40  Score=303.43  Aligned_cols=250  Identities=22%  Similarity=0.291  Sum_probs=192.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ...+|++.+.||+|+||.||+|.+.     .++..||||.+....     ....+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            3457999999999999999999864     235679999875422     2245789999999999999998876     


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhccc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  205 (403)
                      ......++||||+++ +|.+.+......      ...++...+..++.|++.||.|||+. |++||||||+||+++.++ 
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~-  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCC-
Confidence            333457899999984 787777653221      12356778888999999999999987 999999999999999887 


Q ss_pred             ceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015615          206 QLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (403)
Q Consensus       206 ~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  281 (403)
                      .++|+|||++.........   ....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM  235 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            7999999998754322211   1223467899999986544 8999999999999999999 789998776554443332


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .. +.+                           .++...+..+.+++.+||+.||++|||+.+++++
T Consensus       236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         236 EG-GLL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             cC-CcC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            21 000                           0123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.2e-40  Score=309.43  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=201.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|...+.||+|+||.||+|.+..+|..||+|.+....       ....+|+.+++.++|||++++++++..     ....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence            3888899999999999999999999999999885321       234579999999999999999998743     3347


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||+.+++.+.+...   ...+++..+..++.|++.||.|||++ ||+||||+|+||+++.++ .+||+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence            899999999887776543   35688899999999999999999987 999999999999999877 7999999998654


Q ss_pred             ccCCCcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ..   .....+++.|+|||.+..  ...++.++|+|||||++|+|++|.+||...+.......+......+         
T Consensus       176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  243 (317)
T cd06635         176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------  243 (317)
T ss_pred             CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence            32   234467889999999742  2347889999999999999999999998776555554443321100         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                        ......++.+.+|+.+||+.+|.+||++.++++|+|+...
T Consensus       244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                              0012357889999999999999999999999999998663

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.9e-40  Score=307.12  Aligned_cols=254  Identities=29%  Similarity=0.449  Sum_probs=201.0

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      |.....||+|+||.||+|.+..+|+.||||++...    .....+|+.+++.++|+|++++++.+..     ..+.++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence            44446799999999999999999999999987432    2234579999999999999999988733     34578999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+++ +|.+.+..     ..+++..+..++.|++.||+|||+. |++||||+|+||+++.++ .++|+|||++......
T Consensus        97 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~  169 (292)
T cd06657          97 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE  169 (292)
T ss_pred             ecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEcccccceecccc
Confidence            99986 55554432     4578889999999999999999998 999999999999999887 7999999988755332


Q ss_pred             C-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 E-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      . ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+....+....+.....  .         .  
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--~---------~--  235 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--P---------K--  235 (292)
T ss_pred             cccccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--c---------c--
Confidence            2 12235678899999988654 478999999999999999999999987665544433322110  0         0  


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                                 +.  ....+++.+.+++.+||..||.+||++.++++||||.....|+.
T Consensus       236 -----------~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~  281 (292)
T cd06657         236 -----------LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSC  281 (292)
T ss_pred             -----------cC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCcc
Confidence                       00  01246889999999999999999999999999999999876553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.2e-39  Score=298.40  Aligned_cols=249  Identities=28%  Similarity=0.462  Sum_probs=202.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+...      .....+|+.+++.++|+||+++.+++..     ....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            488999999999999999999999999999987542      1233468999999999999999888743     35578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+.........+++..+..++.|++.||+|||+. |++|+||+|+||+++.++ .+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999975 78777766554456789999999999999999999987 999999999999999876 7999999998766


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+....              
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--------------  217 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            444 22335678899999998654 47889999999999999999999998776544333222110              


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                           ++.         .....+.++.+++.+||..+|++|||+.++++||++
T Consensus       218 -----~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         218 -----YPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -----CCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                 000         112467899999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.4e-40  Score=309.66  Aligned_cols=249  Identities=22%  Similarity=0.312  Sum_probs=191.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcE--EEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|.+.+.||+|+||.||+|.+..++..  +|+|.+...     .....+|+.++.++ +|+||+++++++     ...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence            34799999999999999999998877754  577766432     12345799999999 899999999887     333


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~  202 (403)
                      .+.++||||++ ++|.+.+.....            ....+++..++.++.||+.||+|||++ |++||||||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~  159 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  159 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecC
Confidence            45789999998 578887765421            123578999999999999999999987 9999999999999998


Q ss_pred             CCCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015615          203 HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (403)
Q Consensus       203 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  281 (403)
                      ++ .+||+|||++.............++..|+|||.+.+. .++.++|||||||++|+|+| |.+||.+.+..+....+.
T Consensus       160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  237 (303)
T cd05088         160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  237 (303)
T ss_pred             CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence            77 7999999998643211111122335679999998654 48899999999999999998 999998766544333221


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ...                            ....+..+++++.+|+.+||+.+|++||++++++.+
T Consensus       238 ~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 QGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCC----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            100                            000112367899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-40  Score=314.88  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=192.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||.|+||.||+|.+..     +++.||+|++....     ....+|+.++.++ +|+||+++++++...  
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence            3479999999999999999997543     45789999885421     2334699999999 899999999877432  


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcc-----------------------------------------------------
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYK-----------------------------------------------------  158 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~-----------------------------------------------------  158 (403)
                        ...++++|||+++ +|.+.+.....                                                     
T Consensus        84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence              2347799999995 77777654221                                                     


Q ss_pred             ----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCC---cceeeecc
Q 015615          159 ----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSR  231 (403)
Q Consensus       159 ----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~  231 (403)
                          ....++...+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..+.....   .....++.
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCc
Confidence                013678888999999999999999987 999999999999999877 799999999976533221   11234467


Q ss_pred             cccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCC
Q 015615          232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  310 (403)
Q Consensus       232 ~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (403)
                      .|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+.........+                       
T Consensus       240 ~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------  295 (337)
T cd05054         240 KWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-----------------------  295 (337)
T ss_pred             cccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-----------------------
Confidence            899999987654 8999999999999999998 999998754433333222210000                       


Q ss_pred             CcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          311 PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       311 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                          ..+...++++.+++.+||+.+|++||++.++++|
T Consensus       296 ----~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         296 ----RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                0123467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.5e-40  Score=307.58  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=191.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCc--EEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|++.+.||+|+||.||+|.+..++.  .+++|.+...     .....+|+.++.++ +||||+++++++.     ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence            368999999999999999999877765  4688877532     13455799999999 7999999998773     334


Q ss_pred             EEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~  203 (403)
                      .++++|||++ ++|.+.+.....            ....+++..+..++.|++.||+|||++ ||+||||||+|||++.+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~  155 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCC
Confidence            5789999998 578888765321            123588889999999999999999997 99999999999999987


Q ss_pred             CCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 015615          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (403)
Q Consensus       204 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  282 (403)
                      + .+||+|||++..............+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+..
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 L-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             C-eEEECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            7 79999999986432211111122345699999986544 8999999999999999997 9999988766554443322


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ...                            ...+..++..+.+|+.+||+.||.+|||++++++.
T Consensus       234 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            100                            00123478899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-39  Score=294.67  Aligned_cols=248  Identities=29%  Similarity=0.501  Sum_probs=201.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .|.+.+.||+|++|.||+|.+..+++.+++|++....    ....+|+..++.++|+|++++++++..     ....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence            4888999999999999999998899999999986543    455689999999999999999998733     2447899


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      +||++ ++|.+.+...   ...++...+..++.|++.||.+||+. |++||||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence            99999 5777766543   25689999999999999999999987 999999999999999877 799999999877654


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      ........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......... ...+.            
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~------------  216 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPG------------  216 (253)
T ss_pred             cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCC------------
Confidence            43234567788999999986554 78999999999999999999999987654443333222 00000            


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  350 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~  350 (403)
                            .   +    ....++..+.++|.+||..||++|||+.++++|||
T Consensus       217 ------~---~----~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 ------L---R----NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ------c---C----cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                  0   0    01124789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.9e-40  Score=309.04  Aligned_cols=252  Identities=28%  Similarity=0.460  Sum_probs=201.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .|...+.||+|+||.||+|++..++..+|+|.+...       .....+|+.+++.++|+|++++.+++..     ....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence            488888999999999999999999999999987532       1223469999999999999999998743     3347


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||+.+++.+.+...   ...+++..+..++.|++.||.|||++ +++||||+|+||+++.++ .++|+|||++...
T Consensus        91 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence            899999998887766543   34588899999999999999999987 999999999999999877 7999999998765


Q ss_pred             ccCCCcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ...   ....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+.... .+.        
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~--------  233 (308)
T cd06634         166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPA--------  233 (308)
T ss_pred             cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CCC--------
Confidence            322   23467889999999742  2347889999999999999999999997765444443332210 000        


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                        ......+..+.+||++||..+|++||+++++++|||+.....+
T Consensus       234 ------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~  276 (308)
T cd06634         234 ------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (308)
T ss_pred             ------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence                              0112467889999999999999999999999999999885433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.4e-40  Score=310.36  Aligned_cols=244  Identities=23%  Similarity=0.378  Sum_probs=191.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcE----EEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|++.+.||+|+||.||+|.+..+|..    ||+|.+...     .....+|+.+++.++||||+++++++...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            4699999999999999999998766654    899987532     23445789999999999999999887431     


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                       ..+++++|+. |+|.+.+...   ...++...+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~-~~kl~DfG~  155 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCC-cEEEccccc
Confidence             2468999988 5787777653   24578888999999999999999998 999999999999999877 799999999


Q ss_pred             ceecccCCCcce---eeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          215 AKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       215 a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ++..........   ..++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+. ..+......+   
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~---  230 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL---  230 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC---
Confidence            987644332221   2235679999998654 48999999999999999998 9999987654432 2222211000   


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                    +          .+...+.++.+++.+||..||.+|||+.+++.+
T Consensus       231 --------------~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         231 --------------P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             --------------C----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                          0          112357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.1e-40  Score=305.89  Aligned_cols=247  Identities=22%  Similarity=0.329  Sum_probs=195.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      .+|.+.+.||+|+||.||+|.+..     ++..||||.+...     .....+|+++++.++|+||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-----   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence            468899999999999999998743     3678999988643     2345679999999999999999998743     


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhc----------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHY----------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~  203 (403)
                      ....++||||+++ +|.+.+....          .....+++..+..++.|++.||+|||++ |++||||||+||+++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~  158 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCC
Confidence            2457899999984 7777776542          1234578888999999999999999988 99999999999999988


Q ss_pred             CCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 015615          204 THQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  279 (403)
Q Consensus       204 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  279 (403)
                      + .+||+|||++........   .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....
T Consensus       159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             C-eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            7 799999999875432221   12334567899999987654 8999999999999999998 9999987766554444


Q ss_pred             HHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      +...  ...                          ..+..++..+.+++.+||+.||++||++.|+++
T Consensus       237 ~~~~--~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         237 ITQG--RLL--------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHcC--CcC--------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3321  000                          012346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.4e-39  Score=296.21  Aligned_cols=250  Identities=34%  Similarity=0.523  Sum_probs=201.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|.+.+.||+|++|.||+|.+..++..|++|.+....      ....+|+..+++++||||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            4888999999999999999998899999999885433      34567999999999999999988774321   24578


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +++||++ ++|.+.+...    ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999996 5777776653    3788999999999999999999997 999999999999999877 7999999998876


Q ss_pred             ccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .....   .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||........  .......          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc----------
Confidence            55443   33456788999999986544 89999999999999999999999987652211  1111100          


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                    ......++...+..+.+|+.+||..||++||++.++++||||
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                          000001223468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=301.31  Aligned_cols=251  Identities=21%  Similarity=0.294  Sum_probs=193.9

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccC---CcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCce
Q 015615           67 YMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (403)
                      |.+.+.||+|+||.||+|.+..+   +..||+|.+..+.      ....+|+..++.++||||+++++.+..... .+..
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999997643   4789999886432      234578999999999999999987654332 3334


Q ss_pred             EEEEEEecccc-hHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      +.+++|||+.+ +|...+.....  ....+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCC-eEEECCcc
Confidence            57899999984 77777654321  234688999999999999999999997 999999999999999877 79999999


Q ss_pred             CceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          214 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       214 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +++........   ....++..|+|||.+.+. .++.++|||||||++|||++ |.+||.+....+.+..+....  .  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~--  233 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--R--  233 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C--
Confidence            99865433221   112345679999998544 48999999999999999999 899998766554443332210  0  


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                              ...+...+.++.+++.+||+.||++|||+.+++++
T Consensus       234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    00123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.4e-39  Score=335.39  Aligned_cols=141  Identities=26%  Similarity=0.440  Sum_probs=122.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++||||++++.++     ....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            47999999999999999999999999999999986432       4456799999999999999998776     33345


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +||||||+.+ +|.+++...    ..+++..++.++.||+.||.|||++ +||||||||+|||++.++ .+||+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence            8899999974 777777542    4678889999999999999999987 999999999999999887 79999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.4e-40  Score=300.59  Aligned_cols=249  Identities=25%  Similarity=0.473  Sum_probs=196.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEecc---------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +|.+.+.||+|+||.||+|.+..++..+++|.+..         ......+|+.+++.++||||+++++++.     +..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence            58999999999999999999987777777766532         1122346889999999999999998773     233


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..++||||+++ +|.+.+.........+++..+..++.|++.||.|||+. |++|+||+|+||+++. + .++|+|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~-~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-N-LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-C-CEeecccCce
Confidence            47899999985 77777765444456789999999999999999999987 9999999999999975 3 5999999998


Q ss_pred             eecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          216 KVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       216 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ........ .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.........+...  .+       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~-------  222 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PT-------  222 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CC-------
Confidence            76543322 2244578889999998654 4788999999999999999999999766544333332210  00       


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                +         .++..++.++.++|.+||..||++||++.++++||||
T Consensus       223 ----------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 ----------P---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ----------C---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                      0         0123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.7e-40  Score=302.99  Aligned_cols=245  Identities=33%  Similarity=0.584  Sum_probs=200.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  137 (403)
                      +|.+.+.||+|+||.||+|.+..+|..||+|.+...       .....+|+.+++.+. ||||+++++++     .+...
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            599999999999999999999999999999988542       233457889999998 99999998877     34445


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .++||||+. ++|.+.+...    ..++...+..++.|++.||.+||+. |++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            889999995 5787777653    4789999999999999999999987 999999999999999877 79999999987


Q ss_pred             ecccCCC---------------------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 015615          217 VLVKGEP---------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (403)
Q Consensus       217 ~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  275 (403)
                      .......                     .....++..|+|||++.+. .++.++|+||||++++++++|..||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            6533221                     1223567889999998654 48899999999999999999999998776544


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH----HHHhcCCCC
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFF  351 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~----~ell~hp~f  351 (403)
                      .+..+....                             ..++..+++.+.+||.+||..||++|||+    +++++||||
T Consensus       230 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         230 TFQKILKLE-----------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHhcC-----------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            443332210                             01223468899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=295.01  Aligned_cols=246  Identities=35%  Similarity=0.585  Sum_probs=201.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+....      ....+|+++++.++|+|++++++++.     +..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            4889999999999999999998899999999985443      23457999999999999999988773     234578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++|||+++ +|.+.+...    ..+++..+..++.|++.||.+||+. ||+||||+|+||+++.++ .++|+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999986 677666543    5689999999999999999999987 999999999999999877 7999999999876


Q ss_pred             ccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+............             
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  215 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-------------  215 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-------------
Confidence            44332 12346788999999986554 7899999999999999999999998765444333322100             


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                            .         ..++..++..+.+++.+||..+|++|||+.+++.||||
T Consensus       216 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 ------H---------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ------C---------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                  0         01234578899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9.7e-40  Score=302.09  Aligned_cols=251  Identities=20%  Similarity=0.279  Sum_probs=191.4

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCc--EEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      |.+.+.||+|+||.||+|.+..++.  .||+|.+...      .....+|+.+++.++|+||+++++.++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999999877765  6899987532      2334568999999999999999987644322 12234


Q ss_pred             EEEEEeccc-chHHHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          138 LNLVLEYVP-ETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      .+++|||+. ++|.+.+....  .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCC-CEEECCCCc
Confidence            678999998 57777664322  1234578999999999999999999997 999999999999999877 799999999


Q ss_pred             ceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          215 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       215 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ++........   ....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+... ..+   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~---  233 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NRL---  233 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCC---
Confidence            9865433211   122346789999998654 48999999999999999999 89999876654433332221 000   


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                              .....++..+.++|.+||+.||++|||+.+++++
T Consensus       234 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 ------------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    0123467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=294.96  Aligned_cols=259  Identities=25%  Similarity=0.432  Sum_probs=207.7

Q ss_pred             CCCccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHc-CCCCeeecceeeeec
Q 015615           59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFST  130 (403)
Q Consensus        59 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  130 (403)
                      .+.....+|.+.++||+|+|++|.+++.+.+.+.+|+|++++.       -...+.|-.+.... +||.+|.+..||   
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf---  320 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF---  320 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh---
Confidence            3334445799999999999999999999999999999988643       12334566666555 699999999988   


Q ss_pred             CCCCceEEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEE
Q 015615          131 TEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  209 (403)
                        +.+..+++|.||++|+ |--.+.    ....+|++.+++|..+|+.||.|||++ |||+||||.+|+|+|..|| +||
T Consensus       321 --qtesrlffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaegh-ikl  392 (593)
T KOG0695|consen  321 --QTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGH-IKL  392 (593)
T ss_pred             --cccceEEEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCc-eee
Confidence              4555688999999974 322222    346799999999999999999999998 9999999999999999994 999


Q ss_pred             eecCCceec-ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CCcHHHHHHHH
Q 015615          210 CDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-------ESGVDQLVEII  281 (403)
Q Consensus       210 ~DfG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-------~~~~~~~~~i~  281 (403)
                      +|+|.++.. ..+....+++|||.|+|||++.+.. |+..+|+|+||++++||+.|+.||.-       .+..+.+.+++
T Consensus       393 tdygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi  471 (593)
T KOG0695|consen  393 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI  471 (593)
T ss_pred             cccchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence            999999754 4566677899999999999997765 99999999999999999999999952       23333333332


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC------CHHHHhcCCCCccCC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS------TALEALIHPFFDELR  355 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~------s~~ell~hp~f~~~~  355 (403)
                      -..                            +..++..+|-.+..+++..|.+||.+|.      ...++..|+||+.+.
T Consensus       472 lek----------------------------qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  472 LEK----------------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             hhh----------------------------cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            100                            1123456788899999999999999995      378999999999876


Q ss_pred             CC
Q 015615          356 DP  357 (403)
Q Consensus       356 ~~  357 (403)
                      +.
T Consensus       524 wd  525 (593)
T KOG0695|consen  524 WD  525 (593)
T ss_pred             HH
Confidence            53

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-39  Score=298.05  Aligned_cols=238  Identities=22%  Similarity=0.317  Sum_probs=185.7

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      +.||+|+||.||+|.+..+|+.||+|.+...     .....+|+.+++.++||||+++++++.     .....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence            3689999999999999999999999987532     234567999999999999999998873     334578999999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~  224 (403)
                      .+ +|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++.........
T Consensus        76 ~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            85 677766542   34578899999999999999999988 999999999999999877 7999999998754322111


Q ss_pred             c---eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          225 I---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       225 ~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      .   ....+..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||...........+......              
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------  215 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------  215 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC--------------
Confidence            1   112245699999986554 8999999999999999998 88999766544332222211000              


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                    .++...+..+.+|+.+||+.||++|||+.++++
T Consensus       216 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         216 --------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             --------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.6e-39  Score=314.62  Aligned_cols=249  Identities=23%  Similarity=0.346  Sum_probs=191.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccC-----CcEEEEEEeccch-----hhhHHHHHHHHHcC-CCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  132 (403)
                      ..+|+++++||+|+||.||+|.+...     +..||||++....     ....+|+++++.+. ||||+++++++     
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-----  110 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-----  110 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence            45799999999999999999987432     3579999885432     33457999999996 99999999987     


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcc-----------------------------------------------------
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYK-----------------------------------------------------  158 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~-----------------------------------------------------  158 (403)
                      .+...+|||||||+ |+|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            33445889999998 478777754321                                                     


Q ss_pred             ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceE
Q 015615          159 ---------------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (403)
Q Consensus       159 ---------------------------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIl  199 (403)
                                                             ....++...+..++.||+.||.|||+. +|+||||||+|||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEE
Confidence                                                   013477888899999999999999987 9999999999999


Q ss_pred             ecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015615          200 VNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (403)
Q Consensus       200 l~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  275 (403)
                      ++.++ .+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.......
T Consensus       270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            99877 799999999976533221   12234567899999986644 8999999999999999997 999998764433


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .+.........+                           ..+..++.++.+++.+||+.||++|||+.++.+
T Consensus       348 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYNKIKSGYRM---------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333222210000                           012346889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-39  Score=297.04  Aligned_cols=243  Identities=21%  Similarity=0.310  Sum_probs=192.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+...   .....+|+.+++.++||||+++++++.     .....++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence            35899999999999999999874 4567999987543   234567999999999999999998773     33347899


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            99998 4777766543   23578889999999999999999987 999999999999999877 799999999875432


Q ss_pred             CCCcc--eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .....  ...++..|+|||.+.+. .++.++|+||||+++|+|++ |++||...+..+.+..+......           
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-----------  220 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL-----------  220 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence            22111  22345679999998654 48999999999999999999 99999887766555554331100           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       ..+...+..+.+++.+||+.||++|||++++++
T Consensus       221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             011235778999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-39  Score=303.36  Aligned_cols=247  Identities=23%  Similarity=0.330  Sum_probs=193.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|.+.+.||.|+||.||++.+.     .++..+|+|.+....    ....+|+.+++.++||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            46999999999999999999863     345679999885432    23567999999999999999998873     33


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcc---------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYK---------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~---------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  205 (403)
                      .+.++||||++ ++|.+++.....         ....+++..+..++.|++.||+|||++ |++||||||+||+++.++ 
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~-  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL-  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCC-
Confidence            45789999998 577777764421         123489999999999999999999987 999999999999999887 


Q ss_pred             ceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015615          206 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (403)
Q Consensus       206 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  281 (403)
                      .+||+|||++........   .....++..|+|||++.+. .++.++|+|||||++|+|++ |.+||......+....+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            799999999875532221   1122346789999998654 48999999999999999998 999998776555444443


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .....                            ......+.++.+|+.+||+.||.+|||+.+++.
T Consensus       237 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGRVL----------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCcC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            21000                            011346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.4e-39  Score=297.15  Aligned_cols=244  Identities=19%  Similarity=0.295  Sum_probs=192.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.+....   ....+|+.+++.++||||+++++++.     .....+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence            46999999999999999999864 34569999886432   34567999999999999999998873     22347899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+.+ +|.+.+...   ...+++..+..++.||+.||+|||+. |++|+||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05113          78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence            999985 677776543   23688999999999999999999987 999999999999999877 799999999876533


Q ss_pred             CCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+......           
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-----------  220 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence            3211  1223456799999986544 8999999999999999998 99999877655544444321100           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                       ......+..+.+++.+||..||.+|||+.+++.+
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                             0112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-39  Score=297.40  Aligned_cols=245  Identities=24%  Similarity=0.332  Sum_probs=193.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..+|++.+.||+|+||.||+|.+ .++..||+|.+....   ....+|+.+++.++|+||+++++++     .+....++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence            35799999999999999999996 456779999875432   3455799999999999999998876     23344789


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +|||++ ++|.+.+....  ...++...+..++.|++.||+|||+. +++||||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESL-MCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCC-cEEECCCccceecC
Confidence            999997 57887776532  35678888899999999999999987 999999999999999877 79999999997654


Q ss_pred             cCCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          220 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       220 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .....  ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------  223 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            32211  122346679999998654 48899999999999999998 99999876655544433221100          


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                              +          ....++.++.+++.+||..+|++|||++++.+
T Consensus       224 --------~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         224 --------P----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             --------C----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                    0          11346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.9e-40  Score=301.20  Aligned_cols=250  Identities=31%  Similarity=0.487  Sum_probs=195.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+|++.+.||+|+||.||+|.+..+|..+|||.+...       .....+|+.+++.++||||+++++++..     ..+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence            3688999999999999999999999999999987432       1234579999999999999999998743     335


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+++|||+.+ +|.+.+.........+++..+..++.||+.||.|||++ |++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence            7899999985 77777765444456789999999999999999999988 999999999999999877 79999999987


Q ss_pred             ecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.....  ....+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~---------  222 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQ---------  222 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhhc---------
Confidence            6533322 22346788999999986544 7899999999999999999999997643211  111111000         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                            ...+.        ......+..+.+++.+||..||++|||+.++++
T Consensus       223 ------~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         223 ------CDYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ------CCCCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                  00000        011246889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.3e-39  Score=300.65  Aligned_cols=250  Identities=21%  Similarity=0.295  Sum_probs=194.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ..+|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+.+++.++|+||+++++++..    
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE----   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence            3569999999999999999999976     77889999875332     234578999999999999999987743    


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--Cce
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQL  207 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~v  207 (403)
                       ....++||||+. ++|.+++......   ...+++..+..++.||+.||+|||++ +++||||||+||+++.++  ..+
T Consensus        81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcce
Confidence             223679999997 4788877654321   23588899999999999999999998 999999999999998653  259


Q ss_pred             EEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 015615          208 KLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  283 (403)
Q Consensus       208 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~  283 (403)
                      ||+|||+++........   .....+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999998765322111   1122346799999996554 8999999999999999997 99999877654433322211


Q ss_pred             hCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                       ..+                           .++..++..+.+++.+||+.||++|||+.++++|
T Consensus       238 -~~~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 -GRL---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -CcC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             000                           0123568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.1e-39  Score=296.20  Aligned_cols=250  Identities=33%  Similarity=0.525  Sum_probs=196.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ++|++.+.||.|+||.||+|.+..+|+.||+|.+...       .....+|+.+++.++|+|++++++++..     ...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            4699999999999999999999989999999987421       2345579999999999999999998743     345


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .++||||+++ +|...+.........++...+..++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999985 88887766544456689999999999999999999987 999999999999999887 79999999987


Q ss_pred             ecccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ...... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||......  ..........         
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~---------  222 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEK---------  222 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhc---------
Confidence            653322 12345678899999998654 4899999999999999999999999654311  1111110000         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                            ..++.        .....++..+.++|.+||..+|++|||+.++++
T Consensus       223 ------~~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         223 ------CDYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ------CCCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                  00000        011246789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-39  Score=299.55  Aligned_cols=248  Identities=23%  Similarity=0.299  Sum_probs=194.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccC-----CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ..+|.+.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            34799999999999999999998643     3789999875432     23457899999999999999999873     


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhccc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCc
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  206 (403)
                      ...+.++||||++ ++|.+.+......      ...+++..+..++.|++.||.|||+. +++||||||+||+++.++ .
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~-~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDL-T  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCC-C
Confidence            3345789999998 5888887654321      23467888999999999999999987 999999999999999887 7


Q ss_pred             eEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 015615          207 LKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (403)
Q Consensus       207 vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  282 (403)
                      +||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            99999999876533221   1223457789999998654 48999999999999999998 9999987665444333321


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                       ...+                           .++...+.++.+++.+||+.+|++|||+.++++
T Consensus       237 -~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 -GGHL---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -CCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             0000                           012345889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-40  Score=315.32  Aligned_cols=255  Identities=28%  Similarity=0.461  Sum_probs=203.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      -|..++.||-|+||+|.++.-..+...||+|.+++.+       ...+.|..||..-+.+-||++|..|     .+..++
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL  704 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL  704 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence            4888999999999999999988899999999886543       2335699999999999999998777     566678


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+||+|++| ++-.+|-+    .+-|++..+++|+.++.+|+++.|.. |+|||||||+|||||.+|| +||+|||++.-
T Consensus       705 YFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGH-IKLTDFGLCTG  778 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGH-IKLTDFGLCTG  778 (1034)
T ss_pred             EEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCc-eeeeecccccc
Confidence            999999996 56665554    36799999999999999999999986 9999999999999999995 99999999853


Q ss_pred             c---------ccCCC----------------------------------cceeeecccccccccccCCCCCCCchhHHHH
Q 015615          218 L---------VKGEP----------------------------------NISYICSRYYRAPELIFGATEYTAAIDIWSA  254 (403)
Q Consensus       218 ~---------~~~~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  254 (403)
                      +         .++..                                  .-..+||+.|+|||++... .|+..+|+||.
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~  857 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSV  857 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHh
Confidence            2         11100                                  0135689999999999754 48999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhcc
Q 015615          255 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  334 (403)
Q Consensus       255 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~  334 (403)
                      |+|||||+.|++||......+...++.+....                         +.-....++|+++.+||.++.+ 
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~-------------------------l~~~~~~~ls~e~~~li~kLc~-  911 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQYKVINWRNF-------------------------LHIPYQGNLSKEALDLIQKLCC-  911 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcceeeeeehhhc-------------------------cccccccccCHHHHHHHHHHhc-
Confidence            99999999999999887765554444332100                         0001235789999999988654 


Q ss_pred             CCCCCCC---HHHHhcCCCCccCCCCC
Q 015615          335 SPNLRST---ALEALIHPFFDELRDPN  358 (403)
Q Consensus       335 dP~~R~s---~~ell~hp~f~~~~~~~  358 (403)
                      +++.|..   ++++..||||+.+....
T Consensus       912 sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  912 SADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             ChhhhhcccchhhhhcCccccccchHh
Confidence            7788864   67799999999987654

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.9e-39  Score=302.55  Aligned_cols=255  Identities=31%  Similarity=0.479  Sum_probs=206.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ...|++.+.||+|++|.||+|.+..++..|++|.+....   ....+|++.++.++|+|++++++++...     .+.++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   92 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV   92 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence            346899999999999999999998889999999986543   3456799999999999999999987442     45889


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ++||++ ++|.+.+....   ..++...+..++.|++.||+|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  167 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDG-SVKLADFGFAAQLT  167 (286)
T ss_pred             EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCC-CEEECccchhhhhc
Confidence            999999 58888877642   3788999999999999999999987 999999999999999877 79999999876543


Q ss_pred             cCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+... +.+..         
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~---------  236 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPPL---------  236 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCC---------
Confidence            2221 1234567889999998654 4899999999999999999999999876655444333221 00000         


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                      .....++.++.+||.+||+.+|.+|||+.++++||||+...
T Consensus       237 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         237 ----------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             ----------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                            00123678999999999999999999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.3e-39  Score=325.17  Aligned_cols=281  Identities=22%  Similarity=0.288  Sum_probs=183.0

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccC----CcEEEEEEeccchhhhHHHHHHHHH---cCCCCeeecceeeeecCC-CC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLET----GEAVAIKKVLQDKRYKNRELQTMRL---LDHPNVVSLKHCFFSTTE-KD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vaiK~~~~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~-~~  134 (403)
                      ...+|.+.+.||+|+||.||+|.+..+    +..||+|++.....   .|......   ..+.++..+...+..... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            446899999999999999999999888    89999998754322   22222222   233333333332222111 33


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcc----------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYK----------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~----------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~N  197 (403)
                      ...+++||||+++ +|.+++.....                .........+..++.||+.||+|||++ +|+||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHHH
Confidence            4457899999985 67777654210                001122345678999999999999998 99999999999


Q ss_pred             eEecCCCCceEEeecCCceecccCC--CcceeeecccccccccccCCC---------------------CCCCchhHHHH
Q 015615          198 LLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTAAIDIWSA  254 (403)
Q Consensus       198 Ill~~~~~~vkl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Diwsl  254 (403)
                      ||++.+...+||+|||+|+....+.  ......+|+.|+|||.+....                     .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9998654479999999997653322  223567899999999763221                     13456799999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhcc
Q 015615          255 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  334 (403)
Q Consensus       255 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~  334 (403)
                      ||++|||+++..++  .+....+..+....+... ..|.......   ..+...  .....+ ...+..+.+||++||++
T Consensus       366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~-~~~~~~~~~~---~~~~~~--~~~~~~-d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDL-VAWRKLVEPR---ASPDLR--RGFEVL-DLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcH-HHHHHhhccc---cchhhh--hhhhhc-cccchHHHHHHHHHccC
Confidence            99999999976554  333344444444333322 1221111000   000000  000000 12345677999999999


Q ss_pred             CCCCCCCHHHHhcCCCCccCCC
Q 015615          335 SPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       335 dP~~R~s~~ell~hp~f~~~~~  356 (403)
                      ||++|||+.++|+||||++...
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCCc
Confidence            9999999999999999988544

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-39  Score=300.65  Aligned_cols=248  Identities=20%  Similarity=0.303  Sum_probs=192.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEc----cCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|++.+.||+|+||.||+|.+.    .++..||+|.+....     ....+|+.+++.++||||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            46899999999999999999853    456789999886321     345679999999999999999987632     3


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYK-------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~-------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~  201 (403)
                      ...|+||||+++ +|.+.+.....             ....+++..+..++.|++.||+|||++ |++||||||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEc
Confidence            347899999984 77777753221             123477888899999999999999998 999999999999999


Q ss_pred             CCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015615          202 PHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (403)
Q Consensus       202 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  277 (403)
                      .++ .+||+|||+++.......   .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.......
T Consensus       159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            877 799999999976533221   12234466799999986544 8999999999999999998 99999876654433


Q ss_pred             HHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ..+.... .+                           ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       237 ~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKRQ-LL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCC-cC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            3332210 00                           0123468899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-39  Score=303.88  Aligned_cols=248  Identities=21%  Similarity=0.273  Sum_probs=193.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccC-----CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      .+|++.+.||+|+||.||+|.+..+     +..||||.+....     ....+|+.++..++||||+++++.+.     .
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence            3588899999999999999987543     5789999986432     23457899999999999999998773     2


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~  201 (403)
                      ....++++||+.+ +|.+.+....            .....++...+..++.|++.||+|||++ ||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~  158 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVF  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEec
Confidence            3347899999984 6777764321            1123578888999999999999999988 999999999999999


Q ss_pred             CCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015615          202 PHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (403)
Q Consensus       202 ~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  277 (403)
                      .++ .+||+|||+++........   ....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+..
T Consensus       159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            777 7999999998765332211   1234467899999986554 8999999999999999998 88999887665554


Q ss_pred             HHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ..+......                            .++...+.++.+|+.+||+.+|.+||++.+++..
T Consensus       237 ~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         237 EMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            444331100                            0124578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-39  Score=295.29  Aligned_cols=242  Identities=26%  Similarity=0.382  Sum_probs=195.5

Q ss_pred             eEeeeCCcEEEEEEEEccC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|.+...   +..||+|.+....     ....+|+..++.++|+|++++++++..     ...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4689999999999999766   8899999886532     345579999999999999999987733     44578999


Q ss_pred             eccc-chHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          143 EYVP-ETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ||++ ++|.+.+......     ...+++..+..++.|++.||+|||++ |++||||||+||+++.++ .+||+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCC-cEEEccccccc
Confidence            9996 6888887764221     36789999999999999999999997 999999999999999887 79999999998


Q ss_pred             ecccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          217 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       217 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ......   ......+++.|+|||.+... .++.++|||||||++|+|++ |..||......+....+....        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------  224 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------  224 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence            764432   12334568889999998655 48999999999999999999 699998876555444333210        


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                          ....+..+|+++.+++.+||+.||++|||+.+++++
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                001223568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=296.48  Aligned_cols=244  Identities=21%  Similarity=0.319  Sum_probs=192.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+...   .....+|+.+++.++||||+++++++     ....+.++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence            35889999999999999999875 5668999988543   23455799999999999999998876     333457899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+++ +|.+.+...   ...+++..+..++.|++.||+|||+. |++||||||+||+++.++ .+||+|||+++...+
T Consensus        78 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~  152 (256)
T cd05059          78 TEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLD  152 (256)
T ss_pred             EecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCC-cEEECCcccceeccc
Confidence            999985 777777643   23688999999999999999999998 999999999999999887 799999999876543


Q ss_pred             CCCcc--eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .....  ...++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||...+..+....+......           
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-----------  220 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC-----------
Confidence            22111  11234579999998654 48999999999999999999 89999876655444433221000           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                       ..+...+.++.+++.+||..+|++|||+.++++.
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         221 -----------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                             0123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.5e-39  Score=296.38  Aligned_cols=243  Identities=25%  Similarity=0.330  Sum_probs=191.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|+||.||+|.+..+ ..||+|.+....   ....+|+.+++.++||||+++++.+.    .  .+.++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS----E--EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC----C--CCcEEE
Confidence            4699999999999999999998655 459999886432   34567999999999999999987641    1  225799


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+++ +|.+.+....  ...+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~  154 (262)
T cd05071          79 TEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIED  154 (262)
T ss_pred             EEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence            999985 7877776432  34578888999999999999999987 999999999999999877 799999999976543


Q ss_pred             CCCcc--eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .....  ...++..|+|||...+. .++.++|+|||||++|+|+| |.+||.+....+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------  222 (262)
T ss_pred             cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-----------
Confidence            32211  23356679999988654 48999999999999999999 88999877655444333221000           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       .....++..+.+++.+|++.||++||++.++++
T Consensus       223 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 -----------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                             012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-39  Score=294.72  Aligned_cols=244  Identities=23%  Similarity=0.305  Sum_probs=193.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|++|.||+|.+. ++..||+|.+....   ....+|+.+++.++||||+++++++.     .....+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeeee
Confidence            46999999999999999999964 45789999986532   34567999999999999999988763     23347899


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+. ++|.+.+....  ...++...+..++.|++.||.+||+. ||+||||||+||+++.++ .+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENN-ICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence            99996 67887776532  34688999999999999999999987 999999999999999887 799999999987643


Q ss_pred             CCCcc--eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .....  ....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+.......+......           
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  223 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-----------  223 (261)
T ss_pred             CcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            22111  11223579999998654 48999999999999999999 99999887655544433321100           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       ......+..+.+++.+||+.||++||++.++++
T Consensus       224 -----------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 -----------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                             011346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.3e-39  Score=301.17  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=194.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccC-----CcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||+|+||.||+|.+...     ...+|+|.+....     ....+|+.+++.+ +|+||+++++++.    
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----   86 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT----   86 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence            35799999999999999999997643     3789999886432     2345799999999 8999999998773    


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceE
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIl  199 (403)
                       ....++++|||+. ++|...+....            .....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus        87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil  164 (293)
T cd05053          87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVL  164 (293)
T ss_pred             -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeEE
Confidence             3334789999998 47777776432            2345688899999999999999999987 9999999999999


Q ss_pred             ecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015615          200 VNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (403)
Q Consensus       200 l~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  275 (403)
                      ++.++ .+||+|||+++........   ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+
T Consensus       165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99877 7999999999865432211   112345679999998654 48999999999999999997 999998776554


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ....+.....                            ...+...+.++.+|+.+||..||++|||+.+++++
T Consensus       243 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            4433322100                            00123467899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.3e-39  Score=293.39  Aligned_cols=242  Identities=22%  Similarity=0.315  Sum_probs=191.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      .+|.+.+.||+|+||.||+|..  .|..||+|.+..+.  ....+|+.+++.++|+|+++++++++..    ....+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence            4699999999999999999986  58889999886543  3456799999999999999998876432    23468999


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+++ +|.+.+....  ...+++..+..++.|++.||+|||++ |++||||||+||+++.++ .+||+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            99984 7887776532  23478888999999999999999987 999999999999999877 7999999998764332


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      .  ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.+..                
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  216 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------  216 (256)
T ss_pred             C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2  223445679999998654 48999999999999999997 999998765444333332210                


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                  .......+++.+.+++.+||+.||++|||+.++++
T Consensus       217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        00112356899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.9e-39  Score=300.14  Aligned_cols=256  Identities=29%  Similarity=0.461  Sum_probs=196.5

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccch--------hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (403)
                      +|++.+.||+|+||.||+|.+.   .++..||||.+....        ....+|+.++..+ +||||+++++++     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            3889999999999999999864   467899999885321        2345789999999 599999998877     3


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      ....+++||||+.+ +|.+.+..    ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEG-HVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEEEC
Confidence            33457899999985 67666653    25688889999999999999999987 999999999999999887 7999999


Q ss_pred             CCceecccCCC--cceeeecccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          213 GSAKVLVKGEP--NISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       213 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      |++........  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+....   
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---  226 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK---  226 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence            99876533322  12345788999999985432 3678999999999999999999999654322111121111000   


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC---HHHHhcCCCCccCCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRDP  357 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s---~~ell~hp~f~~~~~~  357 (403)
                           ..                 ...+..++..+.+++.+||+.||++|||   +.++|+||||+.+.++
T Consensus       227 -----~~-----------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         227 -----SK-----------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             -----cC-----------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                 00                 0012346889999999999999999998   5678999999998654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-39  Score=292.68  Aligned_cols=238  Identities=35%  Similarity=0.577  Sum_probs=194.8

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      ||.|+||.||+|.+..+++.+|+|.+....       ....+|+.+++.++|+|++++++.+     .+..+.++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            689999999999998889999999885432       2455789999999999999998876     4455688999999


Q ss_pred             c-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC-CC
Q 015615          146 P-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EP  223 (403)
Q Consensus       146 ~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~-~~  223 (403)
                      + ++|.+.+...    ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus        76 ~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            5 6777777653    4688999999999999999999987 999999999999999887 7999999998765443 22


Q ss_pred             cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccccc
Q 015615          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  303 (403)
Q Consensus       224 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                      .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+..  ..               . 
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~---------------~-  210 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DP---------------L-  210 (250)
T ss_pred             ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CC---------------C-
Confidence            33456788899999986544 78899999999999999999999977665333333222  00               0 


Q ss_pred             CCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH---HHHhcCCCC
Q 015615          304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEALIHPFF  351 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~---~ell~hp~f  351 (403)
                                 .++..++..+.+++++||..||++||++   +++++||||
T Consensus       211 -----------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         211 -----------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                       1223468899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.8e-39  Score=300.22  Aligned_cols=247  Identities=23%  Similarity=0.323  Sum_probs=193.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+....    ....+|+.+++.++|+||+++++++.     +.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            46999999999999999999864     345679999875432    34568999999999999999998773     33


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~  202 (403)
                      .+.++||||++ ++|.+.+.....            ....+++..++.++.||+.||+|||++ ||+||||||+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEcc
Confidence            45789999998 578887765321            123478899999999999999999988 9999999999999998


Q ss_pred             CCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015615          203 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (403)
Q Consensus       203 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  278 (403)
                      ++ .++|+|||++........   .....++..|+|||.+.+. .++.++|||||||++|+|+| |..||...+..+...
T Consensus       159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 799999999875533221   1233457789999998654 48999999999999999999 999998766554433


Q ss_pred             HHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .+...  ..                 +         ......+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~--~~-----------------~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQG--RV-----------------L---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCC--CC-----------------C---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            32210  00                 0         011346789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=296.29  Aligned_cols=245  Identities=23%  Similarity=0.320  Sum_probs=192.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|++.+.||+|+||.||+|.+..+   ...||||.+....     ....+|+.+++.++||||+++++.+.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            4699999999999999999998644   4579999875432     23456999999999999999988763     333


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..+++|||+.+ +|.+.+...   ...++...+..++.|++.||+|||++ +|+||||||+||+++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-CEEECccchh
Confidence            47899999985 777776543   24688999999999999999999987 999999999999999877 7999999999


Q ss_pred             eecccCCCcc---eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          216 KVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       216 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ..........   ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+......+    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----  228 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP----  228 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence            8764222111   12335679999998654 48999999999999999998 999997766554443332210000    


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                              .+...+..+.+|+.+||+.+|++||++.+++++
T Consensus       229 ------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 ------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                    113468899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7e-39  Score=297.71  Aligned_cols=243  Identities=21%  Similarity=0.310  Sum_probs=190.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCc----EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|++.+.||+|+||.||+|.+..+|.    .||+|.+...     .....+|+.+++.+.||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------   80 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------   80 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence            469999999999999999999877776    4899987532     2234578899999999999999887632      


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...+++++|++ |+|.+.+...   ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~-~~kL~dfG~  155 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPN-HVKITDFGL  155 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCC-cEEECCCCc
Confidence            12568999998 5777777543   34689999999999999999999998 999999999999998777 799999999


Q ss_pred             ceecccCCCcc---eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          215 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       215 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ++.........   ...+++.|+|||.+.+. .++.++|||||||++|||++ |.+||.......... .......++  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~--  231 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLP--  231 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC--
Confidence            98664332211   12345679999998654 48999999999999999998 999997665433322 222111000  


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                               .+...+.++.+++.+||..||++||++.+++.
T Consensus       232 -------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 -------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             -------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     11346789999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=298.24  Aligned_cols=252  Identities=18%  Similarity=0.225  Sum_probs=184.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccC---CcEEEEEEeccchhhhH---------------HHHHHHHHcCCCCeeeccee
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKN---------------RELQTMRLLDHPNVVSLKHC  126 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~h~niv~~~~~  126 (403)
                      .+|.+.+.||+|+||.||+|.+..+   +..+|+|..........               .+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4799999999999999999998777   66778876432221111               12234455689999999886


Q ss_pred             eeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCc
Q 015615          127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (403)
Q Consensus       127 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  206 (403)
                      ..... ....+.+++++++..++.+.+...    ...++..++.++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~-~  164 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNN-R  164 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-c
Confidence            54322 223456789998877766665542    3356778899999999999999987 999999999999999877 7


Q ss_pred             eEEeecCCceecccCC--------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015615          207 LKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (403)
Q Consensus       207 vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  278 (403)
                      ++|+|||+|+......        ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999997653221        11234689999999998655 48999999999999999999999998774322222


Q ss_pred             HHHH--HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          279 EIIK--VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       279 ~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ...+  .........                       ...+..++.+.++++.|+..+|++||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKCDFIKRLHEGK-----------------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHHHHHHHhhhhh-----------------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1111  000000000                       001245789999999999999999999999874

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.1e-39  Score=300.88  Aligned_cols=248  Identities=23%  Similarity=0.345  Sum_probs=193.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (403)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||+|.+....     ....+|+.+++++ +||||+++++++.   
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---  109 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT---  109 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe---
Confidence            3457999999999999999999852     345689999876432     2345799999999 7999999998773   


Q ss_pred             CCCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                        .....+++|||+. ++|.+.+....  ...+++..+..++.|++.||+|||++ +|+|+||||+|||++.++ .++|+
T Consensus       110 --~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l~  183 (302)
T cd05055         110 --IGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGK-IVKIC  183 (302)
T ss_pred             --cCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCC-eEEEC
Confidence              2334789999998 57777775432  23388999999999999999999998 999999999999999776 79999


Q ss_pred             ecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 015615          211 DFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       211 DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      |||++.........   ....++..|+|||.+.+.. ++.++||||+||++|+|++ |..||.+....+.+.........
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~  262 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR  262 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc
Confidence            99998765333211   1234567899999986654 8999999999999999998 99999877655444333221000


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                                 ...+...++++.+|+.+||..+|++|||+.++++
T Consensus       263 ---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 ---------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                       0011346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-39  Score=297.60  Aligned_cols=245  Identities=22%  Similarity=0.329  Sum_probs=196.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..+|.+.+.||.|+||.||+|.+.. +..+|+|.+....    ....+|+.+++.++|+||+++++++.     +....+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            3469999999999999999999877 8899999886443    34567999999999999999988763     333478


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+....  ...++...+..++.||+.||.|||++ ||+|+||||+||+++.++ .+||+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence            99999985 8888776532  35688889999999999999999988 999999999999999887 7999999998765


Q ss_pred             ccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+..+.+..+......+         
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------  224 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP---------  224 (261)
T ss_pred             CCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC---------
Confidence            33221 1123346679999998654 48899999999999999998 899998877655555443211100         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                         .+...+..+.+++.+||+.||++|||+.++++
T Consensus       225 -------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         225 -------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                               12346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7e-39  Score=300.11  Aligned_cols=254  Identities=19%  Similarity=0.253  Sum_probs=194.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCC----------------cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeec
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETG----------------EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  123 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~  123 (403)
                      .+|++.+.||+|+||.||+|.+...+                ..||+|.+....     ....+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            47999999999999999999876543                568999886432     234579999999999999999


Q ss_pred             ceeeeecCCCCceEEEEEEecccc-hHHHHHHhhcc-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 015615          124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK-------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (403)
Q Consensus       124 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp  195 (403)
                      ++++..     ....+++|||+.+ +|.+++.....       ....+++..+..++.|++.||+|||++ ||+||||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp  158 (296)
T cd05051          85 LGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccch
Confidence            987732     2457899999984 78777765431       122588999999999999999999987 999999999


Q ss_pred             CceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 015615          196 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPG  270 (403)
Q Consensus       196 ~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~  270 (403)
                      +||+++.++ .++|+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999886 799999999876533221   1233456789999998654 48999999999999999998  7788877


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .+..+.+.............                     .........+.++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDDGRQ---------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhcccccccc---------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            66555444433221110000                     000012346789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-38  Score=292.71  Aligned_cols=243  Identities=24%  Similarity=0.318  Sum_probs=191.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|.+.+.||+|+||.||+|.+..+ ..+|+|.+....   ....+|+.+++.++|+|++++++++.    .  ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~--~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS----E--EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc----C--CCcEEE
Confidence            4699999999999999999987554 469999875432   34457999999999999999987651    1  235799


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+.+ +|.+.+....  ...++...+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 7888776532  34578888999999999999999987 999999999999999877 799999999976533


Q ss_pred             CCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+....+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-----------  222 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            2211  122346679999988654 48999999999999999999 99999887665544433221000           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       ..+...+..+.+++++||..||++||+++++++
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 -----------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             -----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.7e-39  Score=301.02  Aligned_cols=249  Identities=21%  Similarity=0.324  Sum_probs=191.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc-------CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeec
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  130 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~  130 (403)
                      ..+|.+.+.||+|+||.||+|++..       ++..+|+|.+..+.     ....+|+.+++.+ +||||+++++++.  
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence            3579999999999999999998643       23579999886432     2344689999999 7999999998873  


Q ss_pred             CCCCceEEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 015615          131 TEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~N  197 (403)
                         .....++||||++ ++|.+++.....            ....++...+..++.|++.||+|||++ |++||||||+|
T Consensus        95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~N  170 (307)
T cd05098          95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARN  170 (307)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHh
Confidence               3335789999998 488888865432            123578888999999999999999987 99999999999


Q ss_pred             eEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 015615          198 LLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (403)
Q Consensus       198 Ill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  273 (403)
                      |+++.++ .+||+|||++.........   ....+++.|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.+.
T Consensus       171 ill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         171 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             eEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            9999887 7999999998765332211   1122346799999986544 8999999999999999998 8899977654


Q ss_pred             HHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .+....+... ..                           ...+...+.++.+|+.+||..+|++|||+.+++++
T Consensus       249 ~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         249 EELFKLLKEG-HR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHcC-CC---------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3333322110 00                           00123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.1e-40  Score=332.79  Aligned_cols=257  Identities=30%  Similarity=0.449  Sum_probs=193.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeec---------
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFST---------  130 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~---------  130 (403)
                      .+|+..+.||+||||.||+++++-+|..||||++....     ....+|+..|.+|+|||||++|..++..         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            46788899999999999999999999999999996542     3345899999999999999998765111         


Q ss_pred             ---------------------------------------------C----------------------------------
Q 015615          131 ---------------------------------------------T----------------------------------  131 (403)
Q Consensus       131 ---------------------------------------------~----------------------------------  131 (403)
                                                                   .                                  
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                         0                                  


Q ss_pred             ------------------CC--------CceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015615          132 ------------------EK--------DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT  185 (403)
Q Consensus       132 ------------------~~--------~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~  185 (403)
                                        ..        ...++||-||||+.++++.+-.......  ....++.+++||++||+|+|++
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC
Confidence                              00        0156899999999876666554432211  3567899999999999999998


Q ss_pred             CCccccCCCCCceEecCCCCceEEeecCCceecc-------------------cCCCcceeeecccccccccccCCC--C
Q 015615          186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-------------------KGEPNISYICSRYYRAPELIFGAT--E  244 (403)
Q Consensus       186 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~  244 (403)
                       |||||||||.||++++++ .|||+|||+|....                   +....++.+||.-|+|||++.+..  .
T Consensus       717 -giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  717 -GIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             -ceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence             999999999999999888 69999999997621                   001234578999999999997665  6


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHH
Q 015615          245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA  324 (403)
Q Consensus       245 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  324 (403)
                      |+.|+|+||||+|++||+.   ||...  ++ ...+++.+..+.                  ++..   .-|...--+.-
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~Ts--ME-Ra~iL~~LR~g~------------------iP~~---~~f~~~~~~~e  847 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTS--ME-RASILTNLRKGS------------------IPEP---ADFFDPEHPEE  847 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCch--HH-HHHHHHhcccCC------------------CCCC---cccccccchHH
Confidence            9999999999999999984   46432  22 223333222111                  1000   11112223456


Q ss_pred             HHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          325 VDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       325 ~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                      ..+|+.||+.||.+||||.|+|++.||.
T Consensus       848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  848 ASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            7899999999999999999999999987

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=309.80  Aligned_cols=262  Identities=27%  Similarity=0.367  Sum_probs=192.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+.+|.-...||+|+||.||+|.. .+|..||||++....    ..+.+|+.++.+++|||+|+++++|.....    ..
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~  147 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR  147 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence            345688888999999999999995 455899999886432    347789999999999999999999954332    36


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCCceEEeecCCc
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      +||+|||+ |+|.+.|......  .+++.....|+.+++.||+|||+...  ||||||||+|||+|.+. +.||+|||+|
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa  224 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLA  224 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCc
Confidence            79999999 6888887654321  78999999999999999999998654  99999999999999888 7999999999


Q ss_pred             eeccc-CCCccee-eecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHH-HHhCCCCHH
Q 015615          216 KVLVK-GEPNISY-ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES--GVDQLVEII-KVLGTPTRE  290 (403)
Q Consensus       216 ~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~-~~~~~~~~~  290 (403)
                      +.... ....... .||..|+|||.+.. ...+.++||||||++|.||+||+.+.....  ....+.... ..+...   
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---  300 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---  300 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---
Confidence            76543 3222233 79999999999965 348999999999999999999998876532  111122211 111111   


Q ss_pred             HHhccCcCcccccCCCccCCCccccccc-CCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                             .+.++--+.+....    +.. ..-..+..+..+|++.+|.+||++.++++
T Consensus       301 -------~~~eiiD~~l~~~~----~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 -------KLREIVDPRLKEGE----YPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             -------chhheeCCCccCCC----CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                   11111111111000    000 01123667779999999999999999754

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-38  Score=293.17  Aligned_cols=242  Identities=24%  Similarity=0.320  Sum_probs=191.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.+...   .....+|+.+++.++|+|++++++++.    .  ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----E--EPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----C--CCcEEE
Confidence            46999999999999999999865 5667999988643   234568999999999999999987651    1  125799


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+++ +|.+.+...  ....+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence            999985 777777543  234588999999999999999999998 999999999999999877 799999999976543


Q ss_pred             CCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.+..+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-----------  222 (260)
T ss_pred             cccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence            2211  122345679999998654 48899999999999999999 89999887655544443321000           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                                       ..+...+..+.+|+.+||..||++|||++++.
T Consensus       223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         223 -----------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             -----------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                             01234688999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.6e-39  Score=306.84  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=190.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEE-----ccCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (403)
                      .+|++.+.||+|+||.||+|.+     ..+++.||||.+....     ....+|+.++..+ +||||+++++++...   
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---   83 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---   83 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence            4799999999999999999985     3467899999986432     2345799999999 689999999876432   


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcc------------------------------------------------------
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYK------------------------------------------------------  158 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------------------------------------------------  158 (403)
                       ...++++||||++ +|.+.+.....                                                      
T Consensus        84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence             2346799999994 77777754211                                                      


Q ss_pred             ---------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc---ce
Q 015615          159 ---------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---IS  226 (403)
Q Consensus       159 ---------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~  226 (403)
                               ....++...+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.........   ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence                     012367778889999999999999998 999999999999999877 7999999998764322211   12


Q ss_pred             eeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCC
Q 015615          227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  305 (403)
Q Consensus       227 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  305 (403)
                      ..+++.|+|||.+.+. .++.++||||||+++|+|++ |..||........+.........+                  
T Consensus       241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------  301 (343)
T cd05103         241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------  301 (343)
T ss_pred             CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC------------------
Confidence            2345679999998654 48999999999999999997 999998754433332222110000                  


Q ss_pred             CccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       306 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                               ..+...++++.+++.+||+.||++|||+.++++|
T Consensus       302 ---------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         302 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                     0112357889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1e-38  Score=292.97  Aligned_cols=235  Identities=24%  Similarity=0.330  Sum_probs=184.1

Q ss_pred             EeeeCCcEEEEEEEE--ccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           72 VVGHGSFGVVFQAKC--LETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      .||+|+||.||+|.+  ..++..+|+|++....      ....+|+.+++.++||||+++++.+.     +. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence            589999999999965  4567899999875332      23457899999999999999988651     11 2578999


Q ss_pred             cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      |+++ +|.+.+..    ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9995 67777654    24688999999999999999999988 999999999999999877 79999999997654332


Q ss_pred             Cc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          223 PN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       223 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ..    ....+++.|+|||.+... .++.++|+|||||++|||++ |.+||.+.+..+....+.+.. .+          
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~----------  217 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RM----------  217 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CC----------
Confidence            21    112235689999998544 48899999999999999998 999998776554444332210 00          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       ..+..+++++.++|.+||+.||++||+++++..
T Consensus       218 -----------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         218 -----------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                             012357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.9e-39  Score=298.75  Aligned_cols=246  Identities=22%  Similarity=0.345  Sum_probs=188.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....     ....+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            47888999999999999998753     23578899875432     23457999999999999999998763     23


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYK--------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlk  194 (403)
                      ...+++|||+. ++|.+++.....                    ....++...+..++.|++.||.|||+. +|+|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-Ceehhhhh
Confidence            34678999999 577777654221                    123578888999999999999999987 99999999


Q ss_pred             CCceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 015615          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (403)
Q Consensus       195 p~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~  270 (403)
                      |+|||++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999877 799999999875432221   1122346689999998654 48999999999999999998 9999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ....+....+.....                            ...+..++.++.+|+.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTGYR----------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCCCC----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            654433322211000                            0012346889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-38  Score=289.94  Aligned_cols=241  Identities=24%  Similarity=0.363  Sum_probs=192.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh---hhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||.|+||.||+|.+  .|+.||+|.+.....   ...+|+.+++.++|+||+++++++..     ....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence            4689999999999999999986  588999999876543   45579999999999999999988743     3347899


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||++ ++|.+.+....  ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .+||+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCC-CEEEccccccccccc
Confidence            99998 48887776532  23688999999999999999999988 999999999999999877 799999999986532


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      ...  ....+..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+...               +
T Consensus       155 ~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------~  216 (256)
T cd05039         155 GQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------------Y  216 (256)
T ss_pred             ccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---------------C
Confidence            221  23345679999998654 48899999999999999997 99999876544332222110               0


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                   ....+...++.+.++|.+||..+|++|||+.++++
T Consensus       217 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 -------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         00012346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-38  Score=299.35  Aligned_cols=249  Identities=21%  Similarity=0.319  Sum_probs=192.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEcc-------CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeee
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~  129 (403)
                      ...+|.+.+.||+|+||.||+|.+..       ....+|+|.+....     ....+|+.+++.+ +||||+++++++. 
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-   88 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-   88 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence            34589999999999999999998632       34579999876432     2345799999999 6999999998773 


Q ss_pred             cCCCCceEEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 015615          130 TTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (403)
Q Consensus       130 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~  196 (403)
                          +..+++++|||++ ++|.+++.....            ....++...+..++.||+.||.|||++ |++||||||+
T Consensus        89 ----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~  163 (314)
T cd05099          89 ----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAAR  163 (314)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-Ceeeccccce
Confidence                3345789999998 478888865421            124578888999999999999999987 9999999999


Q ss_pred             ceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015615          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  272 (403)
                      |||++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+..
T Consensus       164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         164 NVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999877 799999999976532211   1112234579999998654 48999999999999999999 899998766


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ..+.+..+....  .                          ...+..++.++.+++.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~--~--------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         242 VEELFKLLREGH--R--------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHHHcCC--C--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            544443332210  0                          0012346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-38  Score=298.20  Aligned_cols=250  Identities=21%  Similarity=0.328  Sum_probs=193.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc-------cCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeee
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~  129 (403)
                      ...+|.+.+.||+|+||.||+|++.       ..+..||+|.+....     ....+|+.+++.+ +||||+++++++. 
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-   91 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-   91 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence            3457999999999999999999753       234579999875421     3355799999999 8999999998773 


Q ss_pred             cCCCCceEEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 015615          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (403)
Q Consensus       130 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~  196 (403)
                          .....+++|||+.+ +|.+++.....            ....++...+..++.||+.||.|||++ |++||||||+
T Consensus        92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~  166 (304)
T cd05101          92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAAR  166 (304)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-Ceeecccccc
Confidence                33457899999984 78888765422            123577888899999999999999998 9999999999


Q ss_pred             ceEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015615          197 NLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  272 (403)
                      ||+++.++ .+||+|||+++........   ....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+
T Consensus       167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999877 7999999999865432211   122346779999998664 48999999999999999998 889998766


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ..+....+.... .                           ...+...+.++.+|+.+||..+|++|||+.++++.
T Consensus       245 ~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKEGH-R---------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            544443332110 0                           00123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=290.32  Aligned_cols=245  Identities=25%  Similarity=0.342  Sum_probs=194.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..+|++.+.||+|+||.||+|.+. ++..||||.+...   .....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence            357999999999999999999975 5678999988643   234568999999999999999988762     2334789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+....  ...++...+..++.|++.||.|||++ |++|+||||+||+++.++ .+||+|||++....
T Consensus        79 v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENL-VCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCC-CEEECccccceecc
Confidence            9999985 7777776532  34688999999999999999999988 999999999999999887 79999999987654


Q ss_pred             cCCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          220 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       220 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .....  ....++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.||.+.+....+..+......+         
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---------  224 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP---------  224 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence            32111  122345679999998654 48999999999999999998 999998876655555443311100         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                         .+...+.++.+++.+||..||++||+++++++
T Consensus       225 -------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         225 -------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                               11335789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.5e-38  Score=293.70  Aligned_cols=249  Identities=21%  Similarity=0.388  Sum_probs=195.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEcc-CCcEEEEEEeccch--------------hhhHHHHHHHHH-cCCCCeeecceeeee
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK--------------RYKNRELQTMRL-LDHPNVVSLKHCFFS  129 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~--------------~~~~~E~~~l~~-l~h~niv~~~~~~~~  129 (403)
                      .|.+.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++.. ++||||+++++.+. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            37888999999999999999877 68899999874211              112357776654 79999999998873 


Q ss_pred             cCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceE
Q 015615          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (403)
Q Consensus       130 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  208 (403)
                          ...+.+++|||+++ +|.+.+.........+++..++.++.|++.||.|||+..+++|+||+|+||+++.++ .+|
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence                34468899999985 777777554444567899999999999999999999633899999999999999887 799


Q ss_pred             EeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       209 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      |+|||.+.............++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||...+.......+......+ 
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  232 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-  232 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence            99999998765443334556788999999997644 8999999999999999999999997765544433332211100 


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                                ......++.+.+++.+||+.||++||++.++..+
T Consensus       233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                      0112467899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.6e-39  Score=294.43  Aligned_cols=242  Identities=26%  Similarity=0.398  Sum_probs=187.5

Q ss_pred             EEEeEeeeCCcEEEEEEEEc----cCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           68 MAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        68 ~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+.+.||.|.||.||+|...    ..+..|+||.+...     .....+|++.++.++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46789999999999999987    34678999998542     2345679999999999999999998862221     6


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||++ ++|.+.+...  ....++...+..++.||+.||+|||++ +++|+||+++||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--ccccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccc
Confidence            79999998 6898888775  235689999999999999999999998 999999999999999887 899999999987


Q ss_pred             cccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          218 LVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       218 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      .......   ........|+|||.+.... ++.++||||||+++|||++ |+.||.+.+..+....+.+...        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence            6222211   2234567899999986654 8999999999999999999 7899988866665555432110        


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                          ...+..++..+.+++.+||..||++|||+.++++
T Consensus       224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                0022357889999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4e-39  Score=292.34  Aligned_cols=228  Identities=27%  Similarity=0.329  Sum_probs=181.1

Q ss_pred             CCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecccc-hHHHHHH
Q 015615           76 GSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIK  154 (403)
Q Consensus        76 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~  154 (403)
                      |.+|.||+|++..+|+.||+|.+..... ..+|...+....||||+++++++.     +....++||||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            8899999999999999999999866543 334556666678999999998773     33457899999995 7777776


Q ss_pred             hhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCcceeeeccccc
Q 015615          155 HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR  234 (403)
Q Consensus       155 ~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~  234 (403)
                      ..    ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .++++|||.+......  .....++..|+
T Consensus        78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 KF----LNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             Hh----cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            53    4588999999999999999999987 999999999999999887 7999999987654332  22344567799


Q ss_pred             ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCccc
Q 015615          235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  314 (403)
Q Consensus       235 aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (403)
                      |||.+.+. .++.++|+||+|+++|+|++|+.||.......      .               ....            .
T Consensus       150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~---------------~~~~------------~  195 (237)
T cd05576         150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSGI------N---------------THTT------------L  195 (237)
T ss_pred             CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c---------------cccc------------c
Confidence            99998544 47899999999999999999998875321100      0               0000            0


Q ss_pred             ccccCCChHHHHHHHHhhccCCCCCCCH-----HHHhcCCCC
Q 015615          315 IFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFF  351 (403)
Q Consensus       315 ~~~~~~s~~~~~ll~~~L~~dP~~R~s~-----~ell~hp~f  351 (403)
                      .++..+++.+.+||.+||+.||++|+++     +++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1224478899999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-38  Score=293.48  Aligned_cols=244  Identities=26%  Similarity=0.371  Sum_probs=191.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+...     .....+|+.+++.++||||+++++++.     +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            469999999999999999999865543   7999987542     234467999999999999999988773     334


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      +.++||||+++ +|.+.+...   ...++...+..++.|++.||+|||+. |++||||||+|||++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~-~~~l~dfg~~  153 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence            57899999985 677776543   24678889999999999999999987 999999999999999877 7999999998


Q ss_pred             eecccCCCcc----eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          216 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       216 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ..........    ...++..|+|||.+.+. .++.++|+|||||++|++++ |..||.+....+....+.+....+   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---  229 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP---  229 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCC---
Confidence            7654332211    11224579999999654 48999999999999999886 999998776554444333211000   


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                               ....+++.+.+++.+||+.+|.+||++.++++
T Consensus       230 -------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         230 -------------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                     11246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.4e-38  Score=292.18  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=191.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|+..+.||+|+||.||+|.+..++.   .+|+|.+...     .....+|+.+++.++|||++++.+++.     +..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence            368899999999999999999876654   7999987543     223457899999999999999988773     333


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..++||||+++ +|.+.+...   ...++...+..++.|++.||+|||+. |++||||||+||+++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNL-ECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCC-cEEECCCccc
Confidence            47899999995 666666542   35688889999999999999999987 999999999999999877 7999999998


Q ss_pred             eecccCCCcc----eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          216 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       216 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ..........    ....+..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+......|   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---  230 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---  230 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence            7654322211    11224569999998654 48999999999999999997 999998776655444443211100   


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                               .....+.++.+++.+||..||++||++.++++
T Consensus       231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                     11246789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.9e-38  Score=291.66  Aligned_cols=243  Identities=23%  Similarity=0.328  Sum_probs=192.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.++||+|+||.||+|.+ .+++.||+|.+....   ....+|+.+++.++|+||+++++.+.    .  ...+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~--~~~~~v   78 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT----Q--EPIYII   78 (260)
T ss_pred             HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc----c--CCcEEE
Confidence            4699999999999999999986 467889999886533   34567999999999999999987641    1  236799


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+. ++|.+.+....  ...++...+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETL-CCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence            99998 47777765432  34688889999999999999999987 999999999999999877 799999999876542


Q ss_pred             CCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  ....++..|+|||++... .++.++||||||+++|+|++ |++||.+.+..+....+......+          
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------  223 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------  223 (260)
T ss_pred             CCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----------
Confidence            2211  123346679999998654 47899999999999999999 999998876555444332211000          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                        .+...+.++.+++.+||..+|++|||++++++
T Consensus       224 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         224 ------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                              11346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=298.87  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=191.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccC--------------CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLET--------------GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKH  125 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~  125 (403)
                      .+|++.+.||+|+||.||+|.+..+              ...||+|.+....     ....+|+++++.++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4799999999999999999987543              2358999886431     23457999999999999999999


Q ss_pred             eeeecCCCCceEEEEEEecccc-hHHHHHHhhcc--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 015615          126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK--------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (403)
Q Consensus       126 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~  196 (403)
                      ++.     .....++||||+.+ +|.+.+.....        ....++...+..++.|++.||+|||++ |++||||||+
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~  158 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATR  158 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChh
Confidence            873     33347899999985 77777754321        112367888899999999999999998 9999999999


Q ss_pred             ceEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 015615          197 NLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPGE  271 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~  271 (403)
                      ||+++.++ .+||+|||++.........   ....++..|+|||++.+.. ++.++|+|||||++|+|++  |..||...
T Consensus       159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999877 7999999998765332211   1223466899999986554 8999999999999999998  67888877


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       272 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      +..+....+.+.......       ..     +         ...++..++.+.+|+.+||..||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-------~~-----~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         237 SDEQVIENTGEFFRNQGR-------QI-----Y---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ChHHHHHHHHHhhhhccc-------cc-----c---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            665555444332100000       00     0         0012346889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=294.87  Aligned_cols=240  Identities=23%  Similarity=0.338  Sum_probs=184.1

Q ss_pred             EeeeCCcEEEEEEEEccCCc--EEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           72 VVGHGSFGVVFQAKCLETGE--AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      .||+|+||.||+|.+..++.  .+|+|.+...     .....+|+.++.++ +||||+++++++.     ...+.+++||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEEE
Confidence            58999999999999987775  4688877532     12445799999999 7999999999873     3344789999


Q ss_pred             ccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          144 YVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       144 ~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                      |++ ++|.+.+.....            ....++...+..++.|++.||+|||+. |++||||||+||+++.++ .+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~-~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENY-VAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCC-eEEEC
Confidence            998 578888765321            123478889999999999999999987 999999999999999887 79999


Q ss_pred             ecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       211 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      |||++..............+..|+|||++... .++.++|+|||||++|+|++ |..||.+.+..+....+....     
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----  228 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-----  228 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-----
Confidence            99998633211111122235679999998654 48999999999999999997 999998765444333321100     


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                   ..          ..+..++.++.+|+.+||..||.+|||+.++++
T Consensus       229 -------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 -------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                         00          011246789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-38  Score=296.04  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=192.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|++.+.||+|+||.||+|...     .++..+|+|.+...    .....+|+++++.++|+||+++++++.     +.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence            46888999999999999999753     35678999987543    234567999999999999999988763     23


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~  203 (403)
                      ...+++|||++ ++|.+++.....           ....+++..+..++.||+.||+|||+. |++||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCC
Confidence            34789999998 477777765421           113478889999999999999999987 99999999999999987


Q ss_pred             CCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 015615          204 THQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVE  279 (403)
Q Consensus       204 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  279 (403)
                      + .+||+|||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||......+....
T Consensus       159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            7 799999999875532221   11223467899999986544 8999999999999999998 9999987665554443


Q ss_pred             HHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      +.....  .                          ..+..+++.+.+|+.+||+.||++||++.++++
T Consensus       237 ~~~~~~--~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         237 ITQGRE--L--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHcCcc--C--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            332100  0                          012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-38  Score=308.14  Aligned_cols=251  Identities=22%  Similarity=0.327  Sum_probs=193.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccch-----hhhHHHHHHHHHcC-CCCeeecceeeeecC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTT  131 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  131 (403)
                      ...+|.+.+.||+|+||.||+|++.     .++..||+|++....     ....+|+.++.++. ||||+++++++..  
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence            3456889999999999999999863     345789999986432     23457999999997 9999999988733  


Q ss_pred             CCCceEEEEEEeccc-chHHHHHHhhcc----------------------------------------------------
Q 015615          132 EKDELYLNLVLEYVP-ETVHRVIKHHYK----------------------------------------------------  158 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~----------------------------------------------------  158 (403)
                         ...+++||||+. |+|.+.+.....                                                    
T Consensus       113 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         113 ---GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             ---CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence               234789999999 588887764321                                                    


Q ss_pred             ------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 015615          159 ------------------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (403)
Q Consensus       159 ------------------------------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~  196 (403)
                                                                ....++...+..++.||+.||.|||+. +|+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~  268 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAAR  268 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcc
Confidence                                                      012356677888999999999999987 9999999999


Q ss_pred             ceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015615          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  272 (403)
                      |||++.++ .+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||....
T Consensus       269 NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         269 NVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             eEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999876 799999999976532221   12345678899999996544 8999999999999999998 899998765


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ..+...........+                           ..+..++.++.+|+.+||..+|.+||++.++++.
T Consensus       347 ~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         347 MNEQFYNAIKRGYRM---------------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             chHHHHHHHHcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            544443332210000                           0123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-38  Score=295.86  Aligned_cols=257  Identities=26%  Similarity=0.374  Sum_probs=188.6

Q ss_pred             ce-EEEeEeeeCCcEEEEEEEE----ccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           66 SY-MAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        66 ~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      +| .+.+.||+|+||+||++..    ..++..||+|.+...     .....+|+++++.++||||+++++++..   ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence            45 8899999999999988653    356889999988643     2334579999999999999999887643   223


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      .+++++|||+++ +|.+.+..     ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~  153 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDR-LVKIGDFGL  153 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCC-cEEEeeccc
Confidence            457899999985 67666643     3589999999999999999999998 999999999999999877 799999999


Q ss_pred             ceecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCH
Q 015615          215 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPTR  289 (403)
Q Consensus       215 a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~~~  289 (403)
                      +.........    ....++..|+|||.+.+. .++.++||||||+++|+|+||..||......  +...... .+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~  230 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV  230 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch
Confidence            8765433221    122346679999998654 4899999999999999999999998654321  1111110 000000


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ..+...            .........+...+..+.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         231 VRLIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000            0000000123457889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-38  Score=292.39  Aligned_cols=244  Identities=24%  Similarity=0.356  Sum_probs=191.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..|++.+.||+|+||.||+|.+..++.   .||||.+...     ......|+.+++.++||||+++++++     .+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            358999999999999999999877664   6999987543     22445799999999999999998876     2334


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..++||||+++ +|.+++...   ...++...+..++.|++.||+|||++ |++|+||||+||+++.++ .+||+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~-~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCC-cEEECCCccc
Confidence            47899999985 676666543   34688899999999999999999997 999999999999999877 7999999998


Q ss_pred             eecccCCCcce---ee---ecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          216 KVLVKGEPNIS---YI---CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       216 ~~~~~~~~~~~---~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      ...........   ..   .+..|+|||.+.+. .++.++|||||||++|||++ |..||...+..+....+......+ 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~-  231 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP-  231 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC-
Confidence            76533222111   11   13469999998654 48999999999999999886 999998776554444332210000 


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                                 .+..++..+.+++.+||..+|++||++.+++.
T Consensus       232 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         232 ---------------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ---------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                       11346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.2e-38  Score=294.50  Aligned_cols=244  Identities=20%  Similarity=0.313  Sum_probs=187.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCc----EEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|++.+.||+|+||.||+|.+..+|.    .+++|.+....     .....|+..++.++||||+++++++.     + 
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~-   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G-   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C-
Confidence            468999999999999999999877776    47777764321     22345677888999999999988752     1 


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...++++||++ ++|.+.+...   ...+++..+..++.||+.||+|||++ +++||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEEcCCcc
Confidence            12568999998 5888877643   35688999999999999999999997 999999999999999877 799999999


Q ss_pred             ceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          215 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       215 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ++........   ....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+...... ..+......+.  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~--  231 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLA--  231 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCC--
Confidence            9865433221   1234567899999986544 8999999999999999998 9999987654332 22222110000  


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                               .+...+.++.+++.+|+..||++|||+.++++.
T Consensus       232 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         232 -------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                     012246788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-38  Score=300.90  Aligned_cols=249  Identities=21%  Similarity=0.324  Sum_probs=192.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccC-------CcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeec
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  130 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~  130 (403)
                      ..+|++.+.||+|+||.||+|.+...       +..||+|.+....     ....+|+.+++++ +||||+++++++.  
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence            34799999999999999999986432       2368999875422     2345799999999 7999999998873  


Q ss_pred             CCCCceEEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 015615          131 TEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~N  197 (403)
                         ....++++|||+++ +|.+.+.....            ....++...+..++.|++.||.|||++ |++||||||+|
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~N  164 (334)
T cd05100          89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARN  164 (334)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-Ceeccccccce
Confidence               33457899999985 78888765321            123477788889999999999999997 99999999999


Q ss_pred             eEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 015615          198 LLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (403)
Q Consensus       198 Ill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  273 (403)
                      ||++.++ .+||+|||+++........   ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus       165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         165 VLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             EEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999877 7999999998765432211   112234679999999654 48999999999999999998 8899987765


Q ss_pred             HHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .+....+......                            ..+...+.++.+|+.+||..+|++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         243 EELFKLLKEGHRM----------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            5444333221000                            0123467899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3e-38  Score=289.68  Aligned_cols=239  Identities=25%  Similarity=0.338  Sum_probs=189.2

Q ss_pred             eEeeeCCcEEEEEEEEcc-CCc--EEEEEEeccchh-----hhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLE-TGE--AVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~-~~~--~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|++|.||+|.+.. ++.  .||||.+.....     ...+|+.+++.++||||+++++.+..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            368999999999999865 333  699998865433     44579999999999999999887732      4578999


Q ss_pred             eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||++ ++|.+.+.....  ..+++..+..++.|++.||+|||++ |++|+||||+||+++.++ .+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9997 578887766432  4688999999999999999999988 999999999999999887 7999999998766432


Q ss_pred             CCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          222 EPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       222 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ...    ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.......         
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------  220 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL---------  220 (257)
T ss_pred             ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---------
Confidence            211    123456789999998654 48999999999999999998 999998776655544443210000         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                        ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       221 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         221 ------------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ------------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                              011246789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-38  Score=289.07  Aligned_cols=236  Identities=26%  Similarity=0.363  Sum_probs=185.1

Q ss_pred             eEeeeCCcEEEEEEEEccCC---cEEEEEEeccchh-----hhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|.+..++   ..+|+|.+.....     ...+|+.+++.++|+||+++++++.     . ...++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----G-EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----C-CceEEEE
Confidence            46899999999999876554   7899998864432     3457899999999999999988652     1 1357999


Q ss_pred             eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+. ++|.+.+...    ..+++..+..++.|++.||+|||+. +++||||||+|||++.++ .+||+|||+++.....
T Consensus        75 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            9998 4788777653    3688999999999999999999987 999999999999999887 7999999998765433


Q ss_pred             CCcc----eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          222 EPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       222 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ....    ...++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+.... .          
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~----------  216 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-R----------  216 (257)
T ss_pred             CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-c----------
Confidence            3211    11224579999998654 48999999999999999998 999998776544333332210 0          


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       ...+..++..+.+++.+||..||++||++.++++
T Consensus       217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             0012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-38  Score=289.53  Aligned_cols=236  Identities=22%  Similarity=0.287  Sum_probs=183.5

Q ss_pred             EeeeCCcEEEEEEEEc--cCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEec
Q 015615           72 VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      .||+|+||.||+|.+.  ..+..||+|.+....     ....+|+.+++.++||||+++++++.     . ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            3899999999999875  445679999885432     23457999999999999999988751     1 236799999


Q ss_pred             ccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCC
Q 015615          145 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (403)
Q Consensus       145 ~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~  223 (403)
                      +++ +|.+.+...   ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            985 677666532   35689999999999999999999987 999999999999999877 799999999875533322


Q ss_pred             cc----eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          224 NI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       224 ~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ..    ...+++.|+|||.+.... ++.++|||||||++|+|++ |..||.+....+....+.+.. .+           
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~-----------  217 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RL-----------  217 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CC-----------
Confidence            11    112256799999986544 8999999999999999996 999998876554433332210 00           


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                      .++...++++.+++.+||..||++||++.++.+
T Consensus       218 ----------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         218 ----------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            022346889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.8e-38  Score=293.42  Aligned_cols=260  Identities=25%  Similarity=0.383  Sum_probs=189.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEE----ccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|++.+.||+|+||.||+|..    ..++..||+|.+....    ....+|+++++.++||||+++++++...   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            3699999999999999999973    4578899999985432    2456799999999999999998876442   233


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+++||||++ ++|.+.+...   ...++...+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESEN-RVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCC-eEEECCCccc
Confidence            4789999997 5787777543   24578889999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCcc----eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHH
Q 015615          216 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-TPTRE  290 (403)
Q Consensus       216 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~  290 (403)
                      ..........    ...++..|+|||.+.+. .++.++|+|||||++|||++|..++..... .....+..... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  233 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchH
Confidence            8654332211    11234469999998654 489999999999999999998877644321 11100000000 00000


Q ss_pred             HHhc-cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          291 EIKC-MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       291 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .+.. ....             ........++.++.+|+.+||..+|++|||+.++++
T Consensus       234 ~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         234 HLIELLKNN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHHHHhcC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0000 0000             000012457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.6e-38  Score=296.50  Aligned_cols=254  Identities=20%  Similarity=0.273  Sum_probs=190.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEcc----------------CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeec
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLE----------------TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  123 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~  123 (403)
                      .+|++.+.||+|+||.||+|.+..                ++..||+|.+....     ....+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            369999999999999999986532                34579999886432     245579999999999999999


Q ss_pred             ceeeeecCCCCceEEEEEEeccc-chHHHHHHhhccc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 015615          124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (403)
Q Consensus       124 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp  195 (403)
                      ++++..     ....+++|||+. ++|.+++......       ...+++..+..++.|++.||+|||+. |++||||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp  158 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCh
Confidence            987733     234789999998 4787777654321       12467788999999999999999988 999999999


Q ss_pred             CceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 015615          196 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPG  270 (403)
Q Consensus       196 ~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~  270 (403)
                      +|||++.++ .++|+|||++........   .....+++.|+|||...+.. ++.++|+|||||++|||++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999877 799999999876533221   11223356799999876554 8999999999999999998  7789977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .+..+............           ......+          .+...++.+.+|+.+||+.||++|||+.++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFRDQ-----------GRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHhhc-----------cccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66554443322211000           0000000          11346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=313.66  Aligned_cols=264  Identities=28%  Similarity=0.425  Sum_probs=217.2

Q ss_pred             CccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCce
Q 015615           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (403)
                      +...+.|++.+.||.|.+|.||+++++++|+..|+|+...+   ....+.|.++|+.. .|||++.+|++|+........
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            34456799999999999999999999999999999987543   34556788888887 599999999999877666777


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|||||||++ +.-++++...  +.++.+..+..|++.++.||.+||.+ .++|||||-.|||++.++ .|||+|||++
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~-~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENA-EVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccC-cEEEeeeeee
Confidence            89999999995 6677776655  78899999999999999999999987 999999999999999988 7999999998


Q ss_pred             eecccCC-CcceeeecccccccccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          216 KVLVKGE-PNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       216 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ..+.... ...+..|||+|||||++....    .|+..+|+||||++..||.-|.+|+-+.-+...+..|..   -|++.
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPk  247 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPK  247 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCcc
Confidence            7664432 334678999999999995443    377899999999999999999999988766555543322   12211


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      .                       .-++.-+.++.+||..||.+|-.+||+..++|+|||+++.
T Consensus       248 L-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  248 L-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             c-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            1                       0112346789999999999999999999999999999853

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.2e-38  Score=294.67  Aligned_cols=248  Identities=23%  Similarity=0.300  Sum_probs=192.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ..+|++.+.||.|+||.||+|.+..     ++..||+|.+...     .....+|+.+++.++||||+++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            3579999999999999999998743     6788999987543     233557999999999999999988763     


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcc------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYK------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK  194 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlk  194 (403)
                      +....+++|||+++ +|.+.+.....                  ....+++..+..++.|++.||.|||++ +++|||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~  157 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLA  157 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-Ceeccccc
Confidence            23347899999995 78877764321                  112467888899999999999999988 99999999


Q ss_pred             CCceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 015615          195 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG  270 (403)
Q Consensus       195 p~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~  270 (403)
                      |+||+++.++ .++|+|||++........   ......+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus       158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999887 799999999875432211   1122345679999998654 48999999999999999997 8889987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .+..+....+....  .                 .         ..+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~--~-----------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         236 MAHEEVIYYVRDGN--V-----------------L---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCHHHHHHHHhcCC--C-----------------C---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            66554443332210  0                 0         012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.2e-38  Score=286.95  Aligned_cols=244  Identities=20%  Similarity=0.339  Sum_probs=191.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||.|+||.||+|.+. ++..+|+|.+...   .....+|+++++.++|||++++++++     ......++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence            36899999999999999999874 4778999987643   23456799999999999999998876     333457899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+.+ +|.+.+...   ...+++..+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence            999985 666665432   24578888999999999999999987 999999999999999777 799999999876533


Q ss_pred             CCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+.+...            
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------  219 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC------------
Confidence            2211  122345679999998654 48899999999999999998 9999987665544444322100            


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                      ...+...+..+.+|+.+||+.+|++|||+.+++++
T Consensus       220 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 ----------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                            00112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.9e-38  Score=292.77  Aligned_cols=249  Identities=18%  Similarity=0.247  Sum_probs=193.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE----TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|.+.+.||+|+||.||+|.+..    ++..|++|.+...     .....+|+.+++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            3479999999999999999999865    3578999987543     23345799999999999999999876432    


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEE
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKM----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  209 (403)
                      ....+++++|++ ++|.+.+......    ...++...+..++.|++.||+|||++ +++||||||+||+++.++ .+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCC-cEEE
Confidence            223678999998 5777777654322    14688999999999999999999987 999999999999999877 7999


Q ss_pred             eecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015615          210 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  285 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  285 (403)
                      +|||+++.+......   ....++..|+|||++.+.. ++.++|||||||++|++++ |++||...+..+....+.... 
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-  236 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-  236 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence            999999765332211   1223466799999986544 8999999999999999999 999998765544332222100 


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       ..+          ....+++++.+++.+||..||++|||+.++++
T Consensus       237 -----------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 -----------------RLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             -----------------CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                             000          11235789999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.3e-39  Score=320.48  Aligned_cols=245  Identities=23%  Similarity=0.330  Sum_probs=201.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      +-+..+.||+|+||+||+|+...     ....||||.++..     ...++||++++..++|||||++++++..     .
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----~  561 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----G  561 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----C
Confidence            45667889999999999998642     3467999988654     3567899999999999999999999843     2


Q ss_pred             eEEEEEEeccc-chHHHHHHhhccc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKM----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~----------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~  204 (403)
                      .-+|||+|||. |+|.++|+.+...          ..+++..+...++.||+.|+.||-++ .+|||||-..|+||..+.
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccce
Confidence            33789999999 7999999865532          22378889999999999999999988 999999999999999877


Q ss_pred             CceEEeecCCceecccCCCcc---eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 015615          205 HQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (403)
Q Consensus       205 ~~vkl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i  280 (403)
                       .|||+|||+++.....+...   ...-...|||||.++.+. ++++|||||+||+|||+++ |+-||.+..+.+.++.+
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence             79999999998654333221   223366799999998654 9999999999999999998 99999999988888777


Q ss_pred             HHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                      .+..-.                            .-+++.|.++.+|+..||+.+|.+||+..|+=
T Consensus       719 ~~g~lL----------------------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  719 RAGQLL----------------------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HcCCcc----------------------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            652100                            02356899999999999999999999999873

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.2e-38  Score=290.58  Aligned_cols=249  Identities=22%  Similarity=0.289  Sum_probs=193.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      .+|++.+.||.|+||.||+|+++.     +...|++|.+....     ....+|+.++++++|+||+++++.+     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            469999999999999999999754     34679999875432     2356799999999999999998876     33


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceE
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  208 (403)
                      ..+.++||||++ ++|.+++......     ...++...+..++.|++.||+|||+. +|+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCC-cEE
Confidence            445789999998 5787777654311     12689999999999999999999987 999999999999999887 799


Q ss_pred             EeecCCceecccCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015615          209 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  285 (403)
Q Consensus       209 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  285 (403)
                      |+|||++.......  ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.........+...  
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--  234 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--  234 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence            99999986442221  112335577899999986544 7899999999999999998 88999776554433332210  


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .          .             .|  .....++..+.+++.+||+.||++|||+.+++.+
T Consensus       235 ~----------~-------------~~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 K----------L-------------EL--PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             C----------c-------------CC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            0          0             00  0123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-38  Score=291.41  Aligned_cols=243  Identities=25%  Similarity=0.349  Sum_probs=191.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCc----EEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|++.+.||+|+||.||+|.++.+|.    .+|+|......     ....+|+.+++.++||||+++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            479999999999999999999876665    58999875432     234579999999999999999988743      


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...++||||++ ++|.+.+...   ...+++..+..++.||+.||+|||+. |++||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kL~dfg~  155 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCC-eEEECCCcc
Confidence            23679999998 5787777653   24588999999999999999999997 999999999999999877 799999999


Q ss_pred             ceecccCCCcce---eeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          215 AKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       215 a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ++..........   ..++..|+|||.+... .++.++|+|||||++||+++ |..||.+....+....+.+.. ..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~---  230 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL---  230 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC---
Confidence            976543322221   1225679999998544 48899999999999999998 999998876544433332210 00   


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                              ..+...+.++.+++.+||..||.+|||+.++++
T Consensus       231 ------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         231 ------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                    011235788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.4e-38  Score=287.13  Aligned_cols=242  Identities=27%  Similarity=0.393  Sum_probs=192.6

Q ss_pred             EEEeEeeeCCcEEEEEEEEccCC----cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           68 MAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        68 ~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ++.+.||.|+||.||+|.+..++    ..||+|.+....     .....|+..++.++|+||+++++.+..     ....
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCee
Confidence            46788999999999999998766    899999986433     245579999999999999999987733     2457


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++|||+++ +|.+.+....  ...+++..+..++.|++.||++||+. |++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~  152 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENL-VVKISDFGLSRD  152 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCC-eEEEcccCCcee
Confidence            899999985 7777776532  12289999999999999999999987 999999999999999887 799999999976


Q ss_pred             cccCCCcc--eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          218 LVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       218 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ........  ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||...+..+....+......        
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------  223 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--------  223 (258)
T ss_pred             cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------
Confidence            64432211  1236788999999854 458999999999999999998 88999876655554443321000        


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                          ......+.++.+++.+||..||++|||+.++++
T Consensus       224 --------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      224 --------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             --------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                                011336889999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.2e-39  Score=294.27  Aligned_cols=236  Identities=19%  Similarity=0.268  Sum_probs=180.7

Q ss_pred             eEeeeCCcEEEEEEEEccCCc-------EEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGE-------AVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~-------~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +.||+|+||.||+|.+...+.       .||+|.+....    ....+|+.+++.++||||+++++.+...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            368999999999999865544       48888775432    2345688999999999999999987432     2367


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCc-------eEEee
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-------LKLCD  211 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~-------vkl~D  211 (403)
                      +||||+++ +|..++...   ...+++..+..++.||+.||+|||+. ||+||||||+||+++.++..       ++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999985 677776543   23578888999999999999999987 99999999999999876532       79999


Q ss_pred             cCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       212 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ||++.....   .....+++.|+|||++.+...++.++|||||||++|+|++|. +||...+...... ....  .    
T Consensus       152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~--~----  221 (258)
T cd05078         152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED--R----  221 (258)
T ss_pred             cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc--c----
Confidence            999865432   223467888999999976555789999999999999999984 6665544333221 1110  0    


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                            .                 .++...+.++.+|+.+||+.||++|||++++++.
T Consensus       222 ------~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         222 ------H-----------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ------c-----------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                  0                 0122356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.9e-38  Score=289.40  Aligned_cols=245  Identities=21%  Similarity=0.297  Sum_probs=182.1

Q ss_pred             EeeeCCcEEEEEEEEcc--CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEec
Q 015615           72 VVGHGSFGVVFQAKCLE--TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      .||+|+||.||+|....  ....+|+|.+....     ....+|+..++.++|+||+++++.+.     .....++||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEEe
Confidence            58999999999997532  34578899765331     23457899999999999999998773     33447899999


Q ss_pred             ccc-hHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          145 VPE-TVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       145 ~~~-~l~~~l~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      +++ +|.+.+...... ....++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCC-cEEEeccccccccccch
Confidence            984 788877654322 23356778889999999999999998 999999999999999887 79999999986532221


Q ss_pred             C---cceeeecccccccccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          223 P---NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       223 ~---~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      .   .....+++.|+|||++..      ...++.++|||||||++|+|++ |..||......+.+..+........    
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----  230 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL----  230 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC----
Confidence            1   112334667999998742      2346889999999999999999 8899987766555544433211100    


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                  +       .......++..+.+++..|+ .||++|||++++++
T Consensus       231 ------------~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         231 ------------P-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ------------C-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                        0       00122356888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-38  Score=286.12  Aligned_cols=237  Identities=24%  Similarity=0.362  Sum_probs=185.6

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      +.||.|+||.||+|.+.. ++.||+|.+....     ....+|+.+++.++|+||+++++++.     +..+.++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence            368999999999999877 9999999875432     34557999999999999999988773     333478999999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~  224 (403)
                      .+ +|.+.+...   ...++...+..++.|++.||+|||++ +++||||||+||+++.++ .+||+|||++.........
T Consensus        75 ~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            75 677776543   24578888999999999999999988 999999999999999877 7999999998754322111


Q ss_pred             c---eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          225 I---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       225 ~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      .   ....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+......              
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------  214 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------  214 (251)
T ss_pred             eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC--------------
Confidence            1   12235569999998654 48999999999999999999 88999876654433332211000              


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                    ..+..++.++.+++.+||+.+|++|||+.++++
T Consensus       215 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         215 --------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             --------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                          012346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.5e-38  Score=289.79  Aligned_cols=236  Identities=18%  Similarity=0.208  Sum_probs=176.8

Q ss_pred             eEeeeCCcEEEEEEEEcc------------CCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           71 RVVGHGSFGVVFQAKCLE------------TGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~------------~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      +.||+|+||.||+|....            ....|++|.+....    ....+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            368999999999998532            23358899875432    234568889999999999999988743     


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC------ce
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------QL  207 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~------~v  207 (403)
                      ....++||||+++ +|..++...   ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.      .+
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCcee
Confidence            2336799999996 454444332   35688999999999999999999998 9999999999999976542      28


Q ss_pred             EEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCC
Q 015615          208 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       208 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      |++|||++......   ....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+.. .....   
T Consensus       152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---  224 (262)
T cd05077         152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---  224 (262)
T ss_pred             EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---
Confidence            99999998654222   23456788999998865556899999999999999998 588888765432211 11100   


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                 .+     .          .....+.++.+|+.+||+.||.+||++.+++++
T Consensus       225 -----------~~-----~----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 -----------QC-----M----------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -----------Cc-----c----------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                       00     0          011245789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5e-38  Score=291.40  Aligned_cols=235  Identities=18%  Similarity=0.227  Sum_probs=178.0

Q ss_pred             EeeeCCcEEEEEEEEccC------------------------CcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeec
Q 015615           72 VVGHGSFGVVFQAKCLET------------------------GEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSL  123 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~  123 (403)
                      .||+|+||.||+|....+                        ...||+|.+....    ....+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999975321                        2358899875432    234468889999999999999


Q ss_pred             ceeeeecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC
Q 015615          124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (403)
Q Consensus       124 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~  202 (403)
                      ++++..     ..+.++||||+++ +|...+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEec
Confidence            998743     2347899999996 555555432   35688999999999999999999987 9999999999999975


Q ss_pred             CC------CceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCcHH
Q 015615          203 HT------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD  275 (403)
Q Consensus       203 ~~------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~  275 (403)
                      .+      ..+|++|||++......   ....++..|+|||.+.+...++.++|||||||++|||+ +|..||.+....+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            43      13899999987643222   22356788999999866556899999999999999995 6999998765433


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ... .....            .                 .++...++++.++|.+||+.+|++|||+.+++++
T Consensus       230 ~~~-~~~~~------------~-----------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KER-FYEKK------------H-----------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHH-HHHhc------------c-----------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            221 11100            0                 0112346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=313.69  Aligned_cols=206  Identities=28%  Similarity=0.413  Sum_probs=171.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  138 (403)
                      ..|...+.||+|+||.||+++++.+|+.||||.++..     ....-+|+++|++++|+|||+++++--.... --...-
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3578889999999999999999999999999988652     2334479999999999999999775321110 001224


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC---CCceEEeecCC
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH---THQLKLCDFGS  214 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~---~~~vkl~DfG~  214 (403)
                      .+|||||.| +|...|.. .....++++..+..++..+..||.|||++ |||||||||.||++-..   .+..||+|||.
T Consensus        93 vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             eEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            589999995 67766654 33456799999999999999999999998 99999999999998422   23689999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  272 (403)
                      |+.+.++....+.+||+.|.+||++.....|+..+|.|||||++|+++||..||....
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9999888888899999999999999755679999999999999999999999996543

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.7e-38  Score=286.27  Aligned_cols=240  Identities=23%  Similarity=0.337  Sum_probs=190.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      .+|++.+.||+|+||.||++..  +++.||+|.+..+  .....+|+.+++.++|||++++++++..    +  ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~--~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH----N--GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC----C--CcEEEE
Confidence            4699999999999999999874  7889999988643  2345679999999999999999887632    1  157999


Q ss_pred             eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+. ++|.+.+....  ...++...+..++.|++.||.|||+. |++||||||+||+++.++ .+||+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            9998 48888876532  34578888999999999999999987 999999999999999877 7999999998764322


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      .  .....+..|+|||.+.+. .++.++|+|||||++|+|++ |++||...+..+....+.+.. .              
T Consensus       154 ~--~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~--------------  215 (254)
T cd05083         154 V--DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-R--------------  215 (254)
T ss_pred             C--CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-C--------------
Confidence            1  223345679999998654 48999999999999999997 999998776544333222110 0              


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                   ......++..+.+++.+||..+|++||++++++.
T Consensus       216 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 -------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         0011346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-37  Score=285.39  Aligned_cols=243  Identities=24%  Similarity=0.339  Sum_probs=190.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|.+.+.||+|+||.||+|.+. .+..+|+|.+....   ....+|+.+++.++|+||+++++++..      ...+++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v   78 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII   78 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence            47999999999999999999864 55679999886533   345579999999999999999887632      236799


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||++ ++|.+.+....  ...++...+..++.|++.||.|||+. |++|+||||+||+++.++ .+||+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  154 (260)
T cd05073          79 TEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVIED  154 (260)
T ss_pred             EEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCCcceeeccC
Confidence            99998 58888776532  34577888899999999999999987 999999999999999877 799999999876533


Q ss_pred             CCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  ....++..|+|||.+... .++.++|+|||||++|++++ |++||.+.+..+....+......           
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  222 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-----------  222 (260)
T ss_pred             CCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----------
Confidence            2211  122345679999998654 48899999999999999999 99999877655444333221000           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       ......+.++.+++.+||..||++||++.++++
T Consensus       223 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         223 -----------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             -----------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                             011346889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.5e-38  Score=288.85  Aligned_cols=246  Identities=20%  Similarity=0.241  Sum_probs=181.5

Q ss_pred             eEeeeCCcEEEEEEEEc--cCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           71 RVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      +.||+|+||.||+|.+.  .++..+|+|.+....     ....+|+.+++.++||||+++++++.     +....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            35899999999999864  345679999875432     23456999999999999999988773     3334789999


Q ss_pred             ccc-chHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          144 YVP-ETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       144 ~~~-~~l~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      |++ ++|.+.+..... .....+...+..++.|++.||+|||+. +++||||||+||+++.++ .+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            998 577777765332 123456677888999999999999987 999999999999999877 7999999998654322


Q ss_pred             CC---cceeeecccccccccccCCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          222 EP---NISYICSRYYRAPELIFGAT------EYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       222 ~~---~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ..   .....+++.|+|||++.+..      .++.++|+||||+++|+|++ |..||......+...........     
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----  228 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----  228 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence            21   11234577899999985321      25789999999999999996 99999876654433322111000     


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                            .     .+       ...+....+..+.+++.+|+ .+|++|||+++++.
T Consensus       229 ------~-----~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 ------K-----LP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ------C-----CC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                  0     00       00011235778999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-37  Score=284.41  Aligned_cols=238  Identities=23%  Similarity=0.365  Sum_probs=185.0

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      +.||+|+||.||+|.. .++..+|+|.+....     ....+|+.+++.++||||+++++.+.     .....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence            3689999999999986 468899999875432     23457999999999999999998773     233478999999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN  224 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~  224 (403)
                      ++ +|.+.+...   ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++.........
T Consensus        75 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            85 676666432   24578889999999999999999987 999999999999999877 7999999998754332211


Q ss_pred             c--eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          225 I--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       225 ~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                      .  ...++..|+|||++.+. .++.++||||||+++|++++ |..||.+.........+.....                
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------  212 (250)
T ss_pred             cCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence            1  12335679999998654 48899999999999999998 9999987765444333322100                


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                  ..++..++..+.+++.+||..+|++||++.++++.
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         213 ------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence                        00123468899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.3e-37  Score=287.74  Aligned_cols=244  Identities=27%  Similarity=0.382  Sum_probs=191.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|.+.+.||.|+||.||+|.+...   ...||||......     ....+|+.+++.++||||+++++++..     . 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~-   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N-   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C-
Confidence            4689999999999999999987544   3468999875432     244579999999999999999887621     1 


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..++||||++ ++|.+.+...   ...++...+..++.|++.||+|||+. |++||||||+||+++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~  154 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPD-CVKLGDFGLS  154 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCC-CeEEccCcee
Confidence            2568999998 4787777653   24588999999999999999999987 999999999999999877 7999999998


Q ss_pred             eecccCCCcc--eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          216 KVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       216 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ..........  ...++..|+|||.+... .++.++|||||||++|+|++ |..||.+....+....+.+....      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------  227 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------  227 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------
Confidence            7654332111  12234579999998554 48999999999999999996 99999887765554443221000      


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                            ..+..++..+.+++.+|+..+|++|||+.+++..
T Consensus       228 ----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         228 ----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  0124568899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.4e-38  Score=292.07  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=188.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEE----ccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .|++.+.||+|+||.||+|++    ..++..||+|.+....     ....+|+.+++.++|||++++++++..   .+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence            478999999999999999984    4568899999885332     345679999999999999999887633   2234


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      +.++||||+++ +|.+.+...   ...++...+..++.|++.||+|||++ |++||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~-~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCC-CEEECCCccc
Confidence            47899999985 777776543   23578889999999999999999998 999999999999999877 7999999998


Q ss_pred             eecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH--
Q 015615          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR--  289 (403)
Q Consensus       216 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--  289 (403)
                      .........    ....++..|+|||++.+. .++.++|||||||++|+|+++..|+.....  ...   +..+....  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~---~~~~~~~~~~  230 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LFL---KMIGPTHGQM  230 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hhh---hhcccccccc
Confidence            765433221    123456679999998654 488999999999999999998766533211  110   10010000  


Q ss_pred             --H-HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          290 --E-EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       290 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                        . ........            .. ...+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       231 ~~~~~~~~~~~~------------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 TVTRLVRVLEEG------------KR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cHHHHHHHHHcC------------cc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence              0 00000000            00 00123578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-37  Score=286.03  Aligned_cols=240  Identities=23%  Similarity=0.350  Sum_probs=180.3

Q ss_pred             eEeeeCCcEEEEEEEEcc---CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||.||+|.+..   .+..||||.+...     .....+|+.+++.++||||+++++++...    ....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            368999999999998753   3457999987432     12344688999999999999998865432    22367899


Q ss_pred             eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ||+. ++|.+++...   ....+...+..++.|++.||+|||+. +++||||||+|||++.++ .+||+|||+++.....
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            9998 5777777543   23456777888999999999999987 999999999999999887 7999999998754321


Q ss_pred             CC-----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          222 EP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       222 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ..     .....++..|+|||.+.+. .++.++|||||||++|||++ |.+||...+..+....+...  .+.       
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~~-------  221 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RRL-------  221 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCC-------
Confidence            11     1123346789999998654 48999999999999999999 56777765544433222110  000       


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                         ..+..++..+.+++.+||..+|++||++.++++.
T Consensus       222 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         222 -------------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             -------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                               0112357899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-37  Score=292.91  Aligned_cols=244  Identities=22%  Similarity=0.329  Sum_probs=189.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCc----EEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|++.+.||+|+||.||+|.+..+|.    .||+|.+....     ....+|+.+++.++||||+++++.+...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            468899999999999999999877776    47888775432     1345789999999999999999877421     


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                       ..++++||++ +++.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~-~~kL~Dfg~  155 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPN-HVKITDFGL  155 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCC-ceEEccccc
Confidence             1458999998 5777776543   24578889999999999999999998 999999999999998777 799999999


Q ss_pred             ceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          215 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       215 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      +.........   ....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+ ...+......++  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~--  231 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLP--  231 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCC--
Confidence            9865433221   123346789999998654 48999999999999999997 899997765333 222222111000  


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                               .+...+..+.+++.+|+..||++||+++++++.
T Consensus       232 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         232 -------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     112357789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-37  Score=287.71  Aligned_cols=242  Identities=21%  Similarity=0.318  Sum_probs=186.2

Q ss_pred             eEeeeCCcEEEEEEEEccCC------cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           71 RVVGHGSFGVVFQAKCLETG------EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +.||+|+||.||+|++...+      ..+|||.+...     .....+|+.+++.++||||+++++++.     .....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence            36899999999999976443      68999987532     234457999999999999999998773     233478


Q ss_pred             EEEeccc-chHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC----CceEEee
Q 015615          140 LVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCD  211 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~----~~vkl~D  211 (403)
                      +||||++ ++|.+.+.....   ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999998 478888765432   124478888999999999999999987 999999999999998654    2699999


Q ss_pred             cCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          212 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       212 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      ||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+... ..+
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~  232 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRL  232 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Ccc
Confidence            999875533221   11234467899999986554 8999999999999999998 99999876655443332210 000


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                                 ..+..+|..+.++|.+||..+|.+||++.++++
T Consensus       233 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         233 ---------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ---------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                       012346889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.8e-37  Score=283.82  Aligned_cols=245  Identities=19%  Similarity=0.264  Sum_probs=181.2

Q ss_pred             EeeeCCcEEEEEEEEccC--CcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEec
Q 015615           72 VVGHGSFGVVFQAKCLET--GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~--~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      .||+|+||.||+|.....  ...+++|.+...     .....+|+.+++.++||||+++++.+.     +....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            589999999999975433  235667766432     234557888999999999999999873     33457899999


Q ss_pred             ccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC-
Q 015615          145 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-  222 (403)
Q Consensus       145 ~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~-  222 (403)
                      +++ +|.+.+..........+...+..++.||+.||+|||+. +++||||||+|||++.++ .+||+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence            994 78888765433334567778889999999999999987 999999999999999887 79999999975432111 


Q ss_pred             --CcceeeecccccccccccCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          223 --PNISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       223 --~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                        ......++..|+|||++...      ..++.++|||||||++|||++ |..||...+..+.+..+.+......     
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~-----  229 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL-----  229 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc-----
Confidence              11234578889999987421      235789999999999999997 5788877766555554433211000     


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                        +...+...+++.+.+++..|+ .+|++||+++++++
T Consensus       230 ------------------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         230 ------------------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ------------------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                              001112346788999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.7e-37  Score=285.85  Aligned_cols=251  Identities=21%  Similarity=0.321  Sum_probs=189.4

Q ss_pred             eEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc-e
Q 015615           67 YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE-L  136 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-~  136 (403)
                      |.+.+.||+|+||.||+|.+.   .++..||||.+..+.      ....+|+.+++.++||||+++++.+......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999864   357899999886432      234578999999999999999987754332222 2


Q ss_pred             EEEEEEeccc-chHHHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ..+++++|+. +++...+....  .....++...+..++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCC-CEEECccc
Confidence            3468899988 46666654322  1123578888999999999999999987 999999999999999877 79999999


Q ss_pred             CceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          214 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       214 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +++....+..   .....+++.|++||.+... .++.++|||||||++|+|++ |.+||.+.+..+....+... ...  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~--  234 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRL--  234 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcC--
Confidence            9886533221   1122345679999998654 47899999999999999999 89999876554433322211 000  


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                               ......+..+.+++.+||..+|++|||+.+++.+
T Consensus       235 -------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         235 -------------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     0112467899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-37  Score=283.32  Aligned_cols=234  Identities=21%  Similarity=0.219  Sum_probs=180.0

Q ss_pred             eEeeeCCcEEEEEEEEccCC----------cEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           71 RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~----------~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ....+|+.+++.++||||+++++++..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            36899999999999997766          358888765432   345678999999999999999987744      12


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC------ceEEe
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------QLKLC  210 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~------~vkl~  210 (403)
                      .++||||+++ +|.+.+....   ..++...+..++.||+.||+|||++ ||+||||||+|||++.++.      .+||+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeC
Confidence            5799999995 6766665532   2688889999999999999999987 9999999999999986652      49999


Q ss_pred             ecCCceecccCCCcceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       211 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      |||++.....   .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+.......    . 
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~-  222 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q-  222 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C-
Confidence            9999876533   2234456789999998655 358999999999999999999 5788876543221111110    0 


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                               .                ..+......+.+++.+||..+|.+|||+.++++
T Consensus       223 ---------~----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 ---------H----------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ---------C----------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                     0                000112378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-38  Score=300.20  Aligned_cols=244  Identities=24%  Similarity=0.343  Sum_probs=193.2

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCc---E-EEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGE---A-VAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---~-vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      +-.+.+.||+|+||.||+|..+..+.   . ||+|....+       ....-+|.++++.++|||||++||+.....   
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~---  234 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE---  234 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC---
Confidence            34456899999999999999865432   3 899987642       123347999999999999999999774322   


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                        -+++|||+|.| +|.++|+...   ..++..+...++.+.+.||+|||++ ++|||||-.+|+|++.++ .+||+|||
T Consensus       235 --Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~-~vKISDFG  307 (474)
T KOG0194|consen  235 --PLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKG-VVKISDFG  307 (474)
T ss_pred             --ccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCC-eEEeCccc
Confidence              27899999995 8888888752   3689999999999999999999998 999999999999999876 68999999


Q ss_pred             CceecccCCCcc-eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          214 SAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       214 ~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      +++......... ..-....|+|||.+... .|+.++||||+||++||+++ |..||.+....+....+......     
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r-----  381 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR-----  381 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc-----
Confidence            987542111111 11235679999999765 59999999999999999998 88999999888777777442111     


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                            ...+...+.++..++.+|+..||++|||+.++.+
T Consensus       382 ----------------------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  382 ----------------------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                                  1122356788999999999999999999998863

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=294.30  Aligned_cols=264  Identities=26%  Similarity=0.408  Sum_probs=204.1

Q ss_pred             CCCccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----------hhhHHHHHHHHHcCCCCeeecceee
Q 015615           59 GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCF  127 (403)
Q Consensus        59 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~~  127 (403)
                      ..+....+|.+.++||+|||+.||+|.|....+.||+|+-....           ...-+|..+-+.|+||.||++|++|
T Consensus       457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf  536 (775)
T KOG1151|consen  457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF  536 (775)
T ss_pred             cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence            34445568999999999999999999999999999999753221           1223799999999999999999987


Q ss_pred             eecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc-CCccccCCCCCceEecCC--
Q 015615          128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-IGVCHRDIKPQNLLVNPH--  203 (403)
Q Consensus       128 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~~ivH~Dlkp~NIll~~~--  203 (403)
                      --    +...+|-|+|||+| +|.-+|+.+    .-+++..++.|+.||+.||.||.+. ..|||=||||.|||+-..  
T Consensus       537 sl----DtdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  537 SL----DTDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             ee----ccccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc
Confidence            33    22337889999998 555555553    6688999999999999999999973 269999999999999532  


Q ss_pred             CCceEEeecCCceecccCCCc--------ceeeecccccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015615          204 THQLKLCDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFG---ATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (403)
Q Consensus       204 ~~~vkl~DfG~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~  272 (403)
                      .+.+||+|||+++.+......        ....||.+|.+||.+.-   .+..+.++||||+|+|+|.++.|+.||....
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            247999999999988544322        23568999999999843   3457899999999999999999999997653


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                      ....+.+.-..+             ...+..+|.          .+.+++++++||++||++--+.|..+.++..||+|.
T Consensus       689 sQQdILqeNTIl-------------kAtEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  689 SQQDILQENTIL-------------KATEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             hHHHHHhhhchh-------------cceeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence            332222111111             011222222          245899999999999999999999999999999997


Q ss_pred             c
Q 015615          353 E  353 (403)
Q Consensus       353 ~  353 (403)
                      -
T Consensus       746 P  746 (775)
T KOG1151|consen  746 P  746 (775)
T ss_pred             c
Confidence            5

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=262.19  Aligned_cols=216  Identities=23%  Similarity=0.399  Sum_probs=178.5

Q ss_pred             CccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHH-cCCCCeeecceeeeecCCCC
Q 015615           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~  134 (403)
                      ....+....+..||+|+||.|-+.++..+|...|+|.+....     ....+|+.+..+ ...|++|.+|+.++...   
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg---  118 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG---  118 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc---
Confidence            334445666778999999999999999999999999985432     222345555433 36899999999875433   


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                        -++|.||.|..++..+-++..+.++.+++..+-+++..++.||.|||+++.+||||+||+|||+|.+| +||+||||.
T Consensus       119 --dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGI  195 (282)
T KOG0984|consen  119 --DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGI  195 (282)
T ss_pred             --cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEccccc
Confidence              38899999999999998888888999999999999999999999999999999999999999999998 899999999


Q ss_pred             ceecccCCCcceeeecccccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHH
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFG---ATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIK  282 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~  282 (403)
                      +..+.++-..+-..|...|||||.+..   ...|+.++||||||+++.||.+++.||... ++.+++.++.+
T Consensus       196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            988876665555678888999999843   235899999999999999999999999874 45555555543

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=315.70  Aligned_cols=246  Identities=20%  Similarity=0.339  Sum_probs=198.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCC-----cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .-...+.||+|+||.||.|......     ..||||.+.+.     ...+.+|..+|+.++|||||+++++++....   
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~---  769 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP---  769 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC---
Confidence            4677889999999999999976433     24999988653     3445689999999999999999999976322   


Q ss_pred             eEEEEEEeccc-chHHHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                        .+|++|||. |+|..+|++....   ...++...+..++.||+.|+.||+++ ++|||||...|+|++... .|||+|
T Consensus       770 --~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r-~VKIaD  845 (1025)
T KOG1095|consen  770 --PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERR-VVKIAD  845 (1025)
T ss_pred             --cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccC-cEEEcc
Confidence              579999999 5899999875322   34588899999999999999999998 999999999999999886 899999


Q ss_pred             cCCceecccCCCcc---eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          212 FGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       212 fG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      ||+|+.+...+...   ...-...|||||.+.. ..++.|+|||||||++||++| |..||.+.++.+.+.-.......+
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~  924 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD  924 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence            99999543332211   1122457999999975 459999999999999999998 999999998877776555432110


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                                  .+...+..+.+++..||+.+|++||+...+++
T Consensus       925 ----------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 ----------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ----------------------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                        12457889999999999999999999999986

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-36  Score=282.54  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=189.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEc----cCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..|.+.+.||+|+||.||+|...    .++..||||.+....     ....+|+.+++.++|+||+++++++..   .+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            35788899999999999999864    347899999986543     245689999999999999999887633   224


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      .+.+++|||+++ +|.+.+...   ...++...+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESED-LVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEccccc
Confidence            457899999984 787777653   23588889999999999999999987 999999999999999887 799999999


Q ss_pred             ceecccCCCcc----eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-HhCCCCH
Q 015615          215 AKVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK-VLGTPTR  289 (403)
Q Consensus       215 a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-~~~~~~~  289 (403)
                      +..........    ...++..|+|||.+.+. .++.++|+|||||++|+|++|..||.........  +.. ..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~  232 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIV  232 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccH
Confidence            98764322211    12335569999998655 4889999999999999999999998654321100  000 0000000


Q ss_pred             HHHhc-cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          290 EEIKC-MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       290 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ..+.. .....   ..          ..+...+.++.+|+.+||..+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~---~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         233 TRLLELLKEGE---RL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHcCC---cC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00000 00000   00          011245788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.8e-36  Score=294.84  Aligned_cols=273  Identities=21%  Similarity=0.271  Sum_probs=182.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc----------------cCCcEEEEEEeccchh------------------hhHHH
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL----------------ETGEAVAIKKVLQDKR------------------YKNRE  108 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~E  108 (403)
                      ...+|++.++||+|+||.||+|.+.                ..++.||||++.....                  ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                2456799999854321                  11236


Q ss_pred             HHHHHHcCCCCe-----eecceeeeecCC---CCceEEEEEEecccc-hHHHHHHhhcc--------------------c
Q 015615          109 LQTMRLLDHPNV-----VSLKHCFFSTTE---KDELYLNLVLEYVPE-TVHRVIKHHYK--------------------M  159 (403)
Q Consensus       109 ~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------------~  159 (403)
                      +.++.+++|.++     ++++++|.....   ......++||||+++ +|.+.+.....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777776654     555555533211   112346899999995 77777653211                    1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCcce--eeecccccccc
Q 015615          160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YICSRYYRAPE  237 (403)
Q Consensus       160 ~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~--~~gt~~y~aPE  237 (403)
                      ...++...++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||++.....+.....  ..+|+.|+|||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            12345677889999999999999987 999999999999999887 799999999976543322222  23478999999


Q ss_pred             cccCCCC---------------------CCCchhHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          238 LIFGATE---------------------YTAAIDIWSAGCVLAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       238 ~~~~~~~---------------------~~~~~DiwslG~il~elltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .+.....                     ...+.|+||+||++|+|++|.. ||.+.......   .+.... ....|...
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~~-~~~~~r~~  456 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYDN-DLNRWRMY  456 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhccc-hHHHHHhh
Confidence            9753211                     1234799999999999999875 77543211110   110000 00011100


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCC---CCCCCHHHHhcCCCCcc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP---NLRSTALEALIHPFFDE  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP---~~R~s~~ell~hp~f~~  353 (403)
                      ..            ..+.-......++.++||+++||..+|   .+|+|++|+|+||||..
T Consensus       457 ~~------------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        457 KG------------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cc------------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            00            000001124568999999999999876   68999999999999953

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=292.02  Aligned_cols=240  Identities=30%  Similarity=0.484  Sum_probs=192.8

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccC--C--cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLET--G--EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~--~--~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ....++||.|.||.||+|.....  |  -.||||..+.+     .+.+..|..+|+.++||||+++++++....      
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P------  464 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------  464 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc------
Confidence            44567899999999999987432  3  35889987653     344557999999999999999999884321      


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .|||||.++ |.|..+|..+   ...++......|+.||+.||+|||+. ++|||||-..|||+.+.. .|||+|||+++
T Consensus       465 ~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~-CVKLaDFGLSR  539 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQ-CVKLADFGLSR  539 (974)
T ss_pred             eeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcc-eeeecccchhh
Confidence            689999999 7888888765   46789999999999999999999998 999999999999999887 89999999999


Q ss_pred             ecccCCCcceeee--cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          217 VLVKGEPNISYIC--SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       217 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      .+.+........|  ..-|||||.+ +-..++.++|||.||+.+||++. |..||.+-.+.+.+..+.+.-..|      
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------  612 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------  612 (974)
T ss_pred             hccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC------
Confidence            7755443333333  4459999998 44569999999999999999886 999999876655544443321111      


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                                            .+++.|+.+..|+.+||.+||.+||...++.
T Consensus       613 ----------------------~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  613 ----------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ----------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                                  2467899999999999999999999987653

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=3e-37  Score=283.21  Aligned_cols=281  Identities=30%  Similarity=0.493  Sum_probs=214.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEcc---CCcEEEEEEecc--chhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQ--DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  136 (403)
                      ....|.+.++||.|.|+.||+|.+..   .++.||+|.+..  ......+|+++|..+. +.||+++.+++     ....
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCC
Confidence            34569999999999999999999987   788999998853  3456778999999984 89999999887     5555


Q ss_pred             EEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..++||||++.. ..++.       ..++...++.|++.++.||.++|.+ |||||||||+|+|.+....+-.|+|||+|
T Consensus       109 ~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhH
Confidence            688999999963 33333       3366888999999999999999988 99999999999999988778899999998


Q ss_pred             eecc-----------------c--CC--------------------------CcceeeecccccccccccCCCCCCCchh
Q 015615          216 KVLV-----------------K--GE--------------------------PNISYICSRYYRAPELIFGATEYTAAID  250 (403)
Q Consensus       216 ~~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~D  250 (403)
                      ....                 .  +.                          ......||++|+|||+++..+..++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            6210                 0  00                          0012458999999999998888899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHHHHhccCcC--ccc-cc----------CCCc-----cC--
Q 015615          251 IWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEIKCMNPN--YTE-FK----------FPQI-----KA--  309 (403)
Q Consensus       251 iwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~-~~----------~~~~-----~~--  309 (403)
                      |||.|+|+..+++++.||.. .++.+.+.++...+|.........+...  ++. -.          +...     ..  
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            99999999999999988754 5666777777777666544332222221  110 00          0000     00  


Q ss_pred             --CCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          310 --HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       310 --~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                        ..+........+..+.||+.+||+.||.+|.|++++|+||||.+...
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence              01222333445679999999999999999999999999999997544

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=303.70  Aligned_cols=249  Identities=31%  Similarity=0.468  Sum_probs=190.7

Q ss_pred             eEEEeEeeeCCcEE-EEEEEEccCCcEEEEEEeccch-hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           67 YMAERVVGHGSFGV-VFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        67 y~~~~~lg~G~~g~-Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      |.-.+.+|.|+.|+ ||+|..  .|+.||||++.... ....+|+..|+.- +|||||++|..     +.+..++||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence            44556799999885 799987  78999999986654 4667999999888 59999997654     367788999999


Q ss_pred             cccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC---CC-CceEEeecCCceecc
Q 015615          144 YVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HT-HQLKLCDFGSAKVLV  219 (403)
Q Consensus       144 ~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~---~~-~~vkl~DfG~a~~~~  219 (403)
                      .|..+|.+++...............+.++.|++.||++||+- +||||||||.||||+.   ++ .+++|+|||+++.+.
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            999999999987421111122244677889999999999985 9999999999999976   23 479999999999886


Q ss_pred             cCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          220 KGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       220 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      .+...    ....||-+|+|||++.... -+.++|||||||++|+.++| .+||.+.-  +.-..|....          
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~----------  729 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGN----------  729 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCc----------
Confidence            55432    3457899999999997665 57799999999999999996 89997542  2222222210          


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                          +   ..-         .+.+....++.|||.+|+.+||..||+|.++|+||||=
T Consensus       730 ----~---~L~---------~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  730 ----Y---TLV---------HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             ----c---cee---------eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                0   000         01111222899999999999999999999999999994

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.4e-35  Score=265.00  Aligned_cols=238  Identities=39%  Similarity=0.635  Sum_probs=191.0

Q ss_pred             CcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecccc-hHH
Q 015615           77 SFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVH  150 (403)
Q Consensus        77 ~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  150 (403)
                      +||.||+|.+..+|+.+|+|++...     .....+|+..++.++|+|++++.+++..     ....++++||+++ +|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            5899999999888999999998543     3456689999999999999999988743     2457899999997 787


Q ss_pred             HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCcceeeec
Q 015615          151 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS  230 (403)
Q Consensus       151 ~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt  230 (403)
                      ..+...    ..++...+..++.+++.++.+||+. +++|+||+|+||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKKR----GRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            776543    2378889999999999999999987 999999999999999887 7999999999876554444456678


Q ss_pred             ccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCC
Q 015615          231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  310 (403)
Q Consensus       231 ~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (403)
                      ..|++||.+.+. .++.++|+||||+++|+|++|..||.....................                     
T Consensus       150 ~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------  207 (244)
T smart00220      150 PEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP---------------------  207 (244)
T ss_pred             cCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------
Confidence            899999998644 4788999999999999999999999874433333332221000000                     


Q ss_pred             CcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          311 PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       311 ~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                          .....++.++.+++.+||..||++||++.++++||||
T Consensus       208 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      208 ----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ----cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                0001167899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=284.32  Aligned_cols=250  Identities=21%  Similarity=0.294  Sum_probs=199.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ...+.++||+|.||.|.+|.- ..+..||+|.++.+.     ..+.+|+++|.+|+||||+.++++|.....     +|+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----icm  612 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LCM  612 (807)
T ss_pred             heehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hHH
Confidence            577889999999999999984 457999999986542     456689999999999999999999854332     789


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      |+|||+ |+|.+++..+....  +.-.....++.||+.|++||.+- ++|||||.+.|+|++.+. .+||+|||.++.+.
T Consensus       613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEF-TIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcc-cEEecCcccccccc
Confidence            999999 78999988764322  33334566999999999999975 999999999999999988 79999999998765


Q ss_pred             cCCCcc---eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          220 KGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       220 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      .++...   ..+-...|||+|.+...+ ++.++|+|++|+++||+++  ...||....+.+.....-..+..+.......
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence            554332   234467899999997654 9999999999999999875  7789988877776666555443333321111


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                           -++-.+..+.+++.+|+..|-++|||.+++-.
T Consensus       768 ---------------------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  768 ---------------------RPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             ---------------------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                                 12346889999999999999999999999854

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=296.71  Aligned_cols=244  Identities=25%  Similarity=0.375  Sum_probs=206.4

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCC---cEEEEEEecc-----chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .-.|.++||.|.||.||+|+.+..|   ..||||.++.     ....+..|+.||-+++||||+++.++.     ....-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence            3578899999999999999988766   4699999864     345566799999999999999999876     23333


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +.||+|||+ |+|..+|+.+   .+.++..++..+++.|+.|+.||-+. |+|||||...|||+|++- .+|++|||+++
T Consensus       705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnL-vCKVsDFGLSR  779 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNL-VCKVSDFGLSR  779 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeeccce-EEEecccccee
Confidence            789999999 6888888876   36688889999999999999999987 999999999999999998 89999999999


Q ss_pred             ecccCC-Ccceeee---cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGE-PNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~-~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .+.++. ...+..|   ...|.|||.+.- ..++.++||||+|++|||.++ |..||.+.++.+.+..|.+....|++  
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP--  856 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP--  856 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence            875543 2222222   457999999954 459999999999999999886 99999999999999998886665543  


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                                .+.|..+.+|+..||++|-..||..++++.+
T Consensus       857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                                      3578999999999999999999999998864

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=290.87  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=203.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccC-C--cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLET-G--EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      +..+.++||+|.||.|++|.+... |  -.||||.+..+.     ..+.+|+.+|.+|+|+|++++|++.....      
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp------  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP------  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch------
Confidence            456678999999999999998653 3  368999986543     45678999999999999999999875421      


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +.||||+++ |+|++-|..  .....|....+..|+.||+.|++||.++ ++|||||-..|+|+-+.. .|||||||+.+
T Consensus       185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllaspr-tVKI~DFGLmR  260 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPR-TVKICDFGLMR  260 (1039)
T ss_pred             hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccc-eeeeeccccee
Confidence            568999999 688888876  3356788899999999999999999988 999999999999998766 79999999999


Q ss_pred             ecccCCCcceeee----cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGEPNISYIC----SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .+..++.......    ...|.|||.+... .++.++|||++||++|||+| |..||.+....+++..|-+.-..+    
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp----  335 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP----  335 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC----
Confidence            8877666543222    3459999999654 49999999999999999998 889999998888777665321110    


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                              -++..|.++.++++.||..+|.+|||..++.+.-+..+
T Consensus       336 ------------------------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  336 ------------------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             ------------------------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence                                    12457899999999999999999999998865544443

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=282.38  Aligned_cols=241  Identities=21%  Similarity=0.354  Sum_probs=196.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +....++||.|.||.||.|.++.-.-.||||.++.+.   ..+.+|..+|+.++|||+|+++++|.     .+.-+|||+
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPFYIiT  342 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPFYIIT  342 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCeEEEE
Confidence            4566789999999999999999989999999987664   45568999999999999999999983     333478999


Q ss_pred             eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      |||. |+|+++|+....  ..++...+..++.||..|+.||..+ ++|||||-..|+|+..+. .||++|||+++.+..+
T Consensus       343 EfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD  418 (1157)
T ss_pred             ecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccc-eEEeeccchhhhhcCC
Confidence            9988 899999987643  4466777888899999999999987 999999999999999765 8999999999987443


Q ss_pred             CCcceeee---cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          222 EPNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       222 ~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      . .+.-.|   ..-|.|||.+-- ..++.++|||+||++|||+.| |..||++.+-.+.+..+.+..             
T Consensus       419 T-YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-------------  483 (1157)
T KOG4278|consen  419 T-YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-------------  483 (1157)
T ss_pred             c-eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-------------
Confidence            2 222222   456999999853 448999999999999999998 999999987555544443321             


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHH
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  345 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~el  345 (403)
                           ++.          -+..+++...+|++.||++.|..||+.+|+
T Consensus       484 -----RM~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  484 -----RMD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             -----ccc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                 111          124689999999999999999999998886

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.6e-34  Score=311.99  Aligned_cols=251  Identities=22%  Similarity=0.321  Sum_probs=181.9

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      .|...+.||+|+||.||+|.+..+|..||||++........+|++.+++++|||||++++++...     ...++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            45667789999999999999988999999999876555556789999999999999999988432     3368999999


Q ss_pred             c-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHH---hcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          146 P-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH---NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       146 ~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      + ++|.+.+.       .+++..+..++.|++.||+|||   +. +|+||||||+||+++.++ ..++. ||....... 
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence            8 47777764       2678888999999999999999   55 999999999999999776 56665 665543221 


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHh-CCCCHHHHhccCcCc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVL-GTPTREEIKCMNPNY  299 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~~~~~~  299 (403)
                        .....+|+.|+|||++.+. .++.++|||||||++|||+||+.||..... ........... .......        
T Consensus       835 --~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------  903 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM--------  903 (968)
T ss_pred             --CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh--------
Confidence              1233678999999998654 489999999999999999999999854221 11111111100 0000000        


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                        +.-+.+...   .........++.+++.+|++.||++|||+.++++.
T Consensus       904 --~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        904 --WIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             --eeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence              000000000   00011123467889999999999999999999865

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=256.26  Aligned_cols=256  Identities=23%  Similarity=0.282  Sum_probs=183.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-hhhHHHHH--HHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQ--TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~--~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +..+.+.||+|.||.||+|++  .|+.||||++.... +.-.+|.+  .-..|+|+||+.+++.-.. ....-..++||+
T Consensus       212 qI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~-~~gs~TQLwLvT  288 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNK-DNGSWTQLWLVT  288 (513)
T ss_pred             eeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhcccc-CCCceEEEEEee
Confidence            588999999999999999998  78999999986433 33334444  4556799999998765422 224456799999


Q ss_pred             eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CccccCCCCCceEecCCCCceEEeecCC
Q 015615          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-------~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      +|-+ |+|.++|..     ..++......++..++.||++||...       .|.|||||..|||+..++ .+-|+|+|+
T Consensus       289 dYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGL  362 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGL  362 (513)
T ss_pred             ecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeecee
Confidence            9999 799999976     56888889999999999999999532       599999999999999988 799999999


Q ss_pred             ceecccCC-----CcceeeecccccccccccCCCCC-----CCchhHHHHHHHHHHHHh-----C-----CCCCCCCCcH
Q 015615          215 AKVLVKGE-----PNISYICSRYYRAPELIFGATEY-----TAAIDIWSAGCVLAELLL-----G-----QPLFPGESGV  274 (403)
Q Consensus       215 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~ellt-----g-----~~pf~~~~~~  274 (403)
                      |.......     .....+||..|||||++......     -..+||||||+|+||++.     |     .+||.+..+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            97764432     23467899999999999644321     135899999999999985     2     3777653221


Q ss_pred             HHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       275 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                 .|..++++.   ......+.......|.+.   ..-..+-.+++.||..||.-|.|+-.+.+
T Consensus       443 -----------DPs~eeMrk---VVCv~~~RP~ipnrW~s~---~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  443 -----------DPSFEEMRK---VVCVQKLRPNIPNRWKSD---PALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             -----------CCCHHHHhc---ceeecccCCCCCcccccC---HHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence                       111111110   000001111111222211   11134567899999999999999877653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=267.56  Aligned_cols=198  Identities=29%  Similarity=0.441  Sum_probs=172.7

Q ss_pred             CccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhh------------HHHHHHHHHcC---CCCeeecce
Q 015615           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK------------NRELQTMRLLD---HPNVVSLKH  125 (403)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------~~E~~~l~~l~---h~niv~~~~  125 (403)
                      +.+..+|...+.||.|+||.|++|.++.+...|+||.+.+.+-..            -.|+++|..++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            345567999999999999999999999999999999886654222            25999999997   999999999


Q ss_pred             eeeecCCCCceEEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC
Q 015615          126 CFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (403)
Q Consensus       126 ~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~  203 (403)
                      +|     ++..|+||+||--+.  +|.+++..    ...+.+..+..|++|++.|+++||++ ||||||||-+|+.++++
T Consensus       637 fF-----Eddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  637 FF-----EDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSN  706 (772)
T ss_pred             ee-----ecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecC
Confidence            88     777789999998773  67777765    36789999999999999999999998 99999999999999999


Q ss_pred             CCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015615          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (403)
Q Consensus       204 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  270 (403)
                      | -+||+|||.|.... ..+...++||..|.|||++.+.+..+..-|||+||++||.++...-||..
T Consensus       707 g-~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  707 G-FVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             C-eEEEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            8 79999999987553 44566789999999999998888788999999999999999998888753

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=259.44  Aligned_cols=265  Identities=25%  Similarity=0.309  Sum_probs=184.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-hhhhHHHHHHHH--HcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMR--LLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~--~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      ...+.+++|+|.||.||+|..  +++.||||++... .+....|-++.+  .++|+||++++..--... .+..-++||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEe
Confidence            456778899999999999986  6799999999643 444555655554  568999999876532222 2244578999


Q ss_pred             eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CccccCCCCCceEecCCCCceEEeecC
Q 015615          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--------GVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--------~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      +|.+ |+|.++|+.     ..++.....+++..+++||+|||+..        .|+|||||..||||..|. ...|+|||
T Consensus       288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFG  361 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFG  361 (534)
T ss_pred             eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccc
Confidence            9998 799999986     45888899999999999999999632        599999999999999888 79999999


Q ss_pred             CceecccCCCc---ceeeecccccccccccCCCCCC-----CchhHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHh
Q 015615          214 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYT-----AAIDIWSAGCVLAELLLGQPLFP-GESGVDQLVEIIKVL  284 (403)
Q Consensus       214 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~  284 (403)
                      +|..+..+...   ...+||..|||||++.+...+.     .+.||||+|.|||||++.-..+. +..+.-++.--.+..
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99887554433   3478999999999997665444     46899999999999998643332 211111111111122


Q ss_pred             CCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHH
Q 015615          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  345 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~el  345 (403)
                      ..|..+++...-..  +...|.++ ..|...   ....-+++.+..|+..||+-|.|+.=+
T Consensus       442 ~hPt~e~mq~~VV~--kK~RP~~p-~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  442 NHPTLEEMQELVVR--KKQRPKIP-DAWRKH---AGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCCCHHHHHHHHHh--hccCCCCh-hhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            23333332211000  00011110 011111   124568899999999999999997543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=276.59  Aligned_cols=255  Identities=27%  Similarity=0.394  Sum_probs=204.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|.+...+|+|.||.||+|+|+.+++..|+|.++..    -....+|+-+++..+||||+.+++.|.....     +++
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cEE
Confidence            4799999999999999999999999999999998643    3445689999999999999999999855433     889


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      +||||+++.++.+   +...+++++.++...+++.+.||.|||+. |=+|||||-.||+++..+ .+|+.|||.+..+..
T Consensus        90 cMEycgggslQdi---y~~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~g-DvklaDfgvsaqita  164 (829)
T KOG0576|consen   90 CMEYCGGGSLQDI---YHVTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEG-DVKLADFGVSAQITA  164 (829)
T ss_pred             EEEecCCCcccce---eeecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccC-ceeecccCchhhhhh
Confidence            9999997544433   33468899999999999999999999998 999999999999999888 799999998765432


Q ss_pred             C-CCcceeeeccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 G-EPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      . ....++.||++|||||+.-  ....|...+|+|++|+...|+---.+|..+.-....+....+-.-.|+         
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp---------  235 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP---------  235 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC---------
Confidence            2 2234688999999999862  234589999999999999999888888766655555544443221111         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                              .....       ..-++.+-+|++.+|..+|++|||++.+|.|||...
T Consensus       236 --------~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  236 --------TLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             --------cccCC-------ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                    11100       123667899999999999999999999999999864

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-31  Score=273.09  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=190.1

Q ss_pred             eEEEeEeeeCCcEEEEEEEEcc-------CCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 015615           67 YMAERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (403)
                      ..+.+.||+|.||.|++|.-..       ....||||..+..     ...+..|+++|+.+ .|+||+.+.+++..    
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~----  373 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ----  373 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence            4566799999999999997431       1457999987543     34556799999998 59999999998843    


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhc---c-------cCC--CCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHY---K-------MSQ--RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~---~-------~~~--~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll  200 (403)
                       ...+++|+||+. |+|..++++..   .       ...  .++......++.||+.|++||++. ++|||||-..|||+
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLI  451 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEe
Confidence             444789999999 78999998765   1       111  388899999999999999999987 99999999999999


Q ss_pred             cCCCCceEEeecCCceecccCCCcce--ee--ecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015615          201 NPHTHQLKLCDFGSAKVLVKGEPNIS--YI--CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (403)
Q Consensus       201 ~~~~~~vkl~DfG~a~~~~~~~~~~~--~~--gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  275 (403)
                      ..+. .+||+|||+|+..........  ..  -...|||||.+.. ..|+.++||||+|++|||++| |..||++-....
T Consensus       452 ~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  452 TKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             cCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            9876 899999999986533332221  11  2345999999976 569999999999999999998 889999855333


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .+.+..+...+..                           .+...+.++.++++.|+..+|++||+..++.+
T Consensus       530 ~l~~~l~~G~r~~---------------------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  530 ELLEFLKEGNRME---------------------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            3333222111100                           12356899999999999999999999998763

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.3e-32  Score=266.51  Aligned_cols=241  Identities=26%  Similarity=0.369  Sum_probs=192.5

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCc----EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+..++||+|+||+||+|.+...|+    +||||++...     .....+|+-+|..++|||++++++++....      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            4456789999999999999876665    5788877543     334557999999999999999999884322      


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +-||++|++ |.|+++++.+.   .++-......|..||+.|+.|||++ ++|||||-..|||+.+-. .+||.|||+++
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~-hvkitdfgla~  846 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPN-HVKITDFGLAK  846 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCC-eEEEEecchhh
Confidence            568999999 68999988763   6788888999999999999999998 999999999999999877 59999999999


Q ss_pred             ecccCCCcceeee---cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          217 VLVKGEPNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       217 ~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      .+..........+   .+-|||-|.+... .|+.++||||+||++||++| |..|+.+....++-..+.+    +.+   
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----geR---  918 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----GER---  918 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----ccc---
Confidence            8765554443332   4569999998654 59999999999999999998 9999998765443332222    110   


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                               ..            -++..+.++..++.+||..|+..||++.++-.
T Consensus       919 ---------Ls------------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  919 ---------LS------------QPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ---------CC------------CCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                     00            12457889999999999999999999988753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.2e-29  Score=223.69  Aligned_cols=207  Identities=36%  Similarity=0.609  Sum_probs=174.3

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEeccc-
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-  146 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-  146 (403)
                      ||+|++|.||++.+..+|+.+++|.+....     ....+|+..++.++|++++++++++..     ....+++||+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            689999999999998889999999987654     357789999999999999999887732     245789999999 


Q ss_pred             chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC-CCCceEEeecCCceecccCC-Cc
Q 015615          147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PN  224 (403)
Q Consensus       147 ~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~DfG~a~~~~~~~-~~  224 (403)
                      ++|.+.+....   ..++...+..++.+++.++++||+. |++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            57777766431   4678889999999999999999988 9999999999999997 55 79999999987654332 12


Q ss_pred             ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccC
Q 015615          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  304 (403)
Q Consensus       225 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  304 (403)
                      ....+...|++||.+.....++.+.|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3345678899999986543578999999999999999                                           


Q ss_pred             CCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 015615          305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  349 (403)
Q Consensus       305 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp  349 (403)
                                       ..+.+++.+|+..||++||++.++++|+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1567899999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9e-32  Score=233.75  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=185.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+.|.|.+.||+|.||.+-+|+++.+...+++|.+...   ...+.+|..---.| -|.||+.-|++-+.    ...+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----TSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhh----cCceEE
Confidence            35799999999999999999999999999999988654   34455666654445 48999998776543    333677


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe-cCCCCceEEeecCCcee
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll-~~~~~~vkl~DfG~a~~  217 (403)
                      ++|||++ |+|...+.     ..++.+...+.++.|+++|+.|||++ ++||||||.+|||| +.|.-+|||||||+...
T Consensus        99 F~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             EeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccc
Confidence            8999999 66655443     25678888999999999999999998 99999999999998 55555899999999865


Q ss_pred             cccCCCcceeeecccccccccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHH
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  292 (403)
                      ....-.  ..-.+..|.+||.+....    ...+.+|+|.||+++|.++||.+||+..... .-+...++..+....   
T Consensus       173 ~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---  247 (378)
T KOG1345|consen  173 VGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---  247 (378)
T ss_pred             cCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---
Confidence            321111  112255689999874322    2577899999999999999999999853222 123333332221111   


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCC---CCHHHHhcCCCCc
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFFD  352 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R---~s~~ell~hp~f~  352 (403)
                                ..|        ..| ..+++.+..+.++-|..+|++|   .++....+.-|..
T Consensus       248 ----------~~P--------~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  248 ----------ALP--------KKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             ----------cCc--------hhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence                      001        112 3478999999999999999999   5555555555643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=3.2e-31  Score=279.61  Aligned_cols=207  Identities=19%  Similarity=0.226  Sum_probs=146.2

Q ss_pred             HcCC-CCeeecceeeeecCC--CCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 015615          114 LLDH-PNVVSLKHCFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (403)
Q Consensus       114 ~l~h-~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH  190 (403)
                      .++| +||+.+++.|-....  .....++.+|||++++|.+.+...   ...+++..++.++.||+.||+|||++ ||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ-GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            3445 577777776522211  122346688999999999888642   35689999999999999999999987 9999


Q ss_pred             cCCCCCceEecCCC------------------CceEEeecCCceecccCC-----------------Ccceeeecccccc
Q 015615          191 RDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNISYICSRYYRA  235 (403)
Q Consensus       191 ~Dlkp~NIll~~~~------------------~~vkl~DfG~a~~~~~~~-----------------~~~~~~gt~~y~a  235 (403)
                      |||||+||||+..+                  ..+|++|||+++......                 ......||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999995422                  246677777765321100                 0012357889999


Q ss_pred             cccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccc
Q 015615          236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  315 (403)
Q Consensus       236 PE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (403)
                      ||++.+.. ++.++|||||||+||||++|.+|+....  ..+..+.... .|+ .                         
T Consensus       184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~-------------------------  233 (793)
T PLN00181        184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-Q-------------------------  233 (793)
T ss_pred             hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-h-------------------------
Confidence            99987655 8999999999999999999988875321  1111111110 000 0                         


Q ss_pred             cccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          316 FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       316 ~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      . ....+...+++.+||..||.+||++.++++||||.+..
T Consensus       234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            0 01135667899999999999999999999999998753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=5.2e-29  Score=222.99  Aligned_cols=198  Identities=34%  Similarity=0.575  Sum_probs=164.2

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+...     .....+|+..++.++|+|++++++.+..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            56788999999999999999888999999998653     3455679999999999999999887632     2347899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      +||+++ +|.+.+....   ..++...+..++.+++.++.+||++ +++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~  150 (225)
T smart00221       76 MEYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDG-LVKLADFGLARFIHR  150 (225)
T ss_pred             EeccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeCceeeEecC
Confidence            999997 7877776532   1178889999999999999999988 999999999999999876 799999999887654


Q ss_pred             CC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCcH
Q 015615          221 GE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGV  274 (403)
Q Consensus       221 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~  274 (403)
                      ..  ......++..|++||.+.+...++.++|+||||+++++|++|+.||.. .+..
T Consensus       151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            42  233456788899999984334477899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.3e-28  Score=212.72  Aligned_cols=167  Identities=22%  Similarity=0.202  Sum_probs=125.1

Q ss_pred             chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCcce
Q 015615          147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS  226 (403)
Q Consensus       147 ~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~  226 (403)
                      |+|.+.+..+   ...+++..++.++.||+.||+|||++ +      ||+|||++.++ .+|+  ||++......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            4677777653   35699999999999999999999987 6      99999999877 6888  9998865332    2


Q ss_pred             eeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhccCcCcccccCC
Q 015615          227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFP  305 (403)
Q Consensus       227 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  305 (403)
                      ..||+.|||||++.+.. ++.++|||||||++|||+||+.||....... .+..+..........               
T Consensus        64 ~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  127 (176)
T smart00750       64 SRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---------------  127 (176)
T ss_pred             CCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence            36789999999997654 8999999999999999999999997654322 222222211000000               


Q ss_pred             CccCCCcccccccCCCh--HHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          306 QIKAHPWHKIFQKRMPP--EAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       306 ~~~~~~~~~~~~~~~s~--~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                         ..+    ....++.  ++.+++.+||..||.+||++.++++|+|+..
T Consensus       128 ---~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 ---DRS----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ---ccc----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence               000    0011233  6999999999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=7.1e-28  Score=219.06  Aligned_cols=248  Identities=19%  Similarity=0.249  Sum_probs=189.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCC-----cEEEEEEeccchhh-----hHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETG-----EAVAIKKVLQDKRY-----KNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~-----~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      .+++...++-+|.||.||.|.+++..     +.|.+|.++.....     ...|-..+..+.|||+.++.++......  
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~--  361 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA--  361 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC--
Confidence            35777888999999999999776433     34566665543322     2357777777899999999888765322  


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEE
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYK----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  209 (403)
                        ..+.++.+++ |+|..++.....    ..+.++..++..++.|++.|++|||++ ||||.||...|.+||..- +|||
T Consensus       362 --~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~L-qVkl  437 (563)
T KOG1024|consen  362 --TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQL-QVKL  437 (563)
T ss_pred             --cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-Ccccchhhhhcceehhhe-eEEe
Confidence              3457888888 788888874332    234466778888999999999999998 999999999999999776 8999


Q ss_pred             eecCCceecccCCCcc---eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 015615          210 CDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG  285 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~  285 (403)
                      +|=.+++.+-.++.+.   .......||+||.+.+. .|+.++|+||||++||||+| |+.||..-++.+...-+.+.. 
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-  515 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-  515 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-
Confidence            9999998764443321   11224569999999765 49999999999999999998 999999888777665544321 


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       +..          -+-+.|.++..++--||..+|++||+.+++..
T Consensus       516 -----------------Rla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 -----------------RLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -----------------eec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                             110          12368999999999999999999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=8.1e-28  Score=242.09  Aligned_cols=260  Identities=24%  Similarity=0.363  Sum_probs=189.6

Q ss_pred             EEEeEeeeCCcEEEEEEEEccCCcEEEEEEec----cchh------hhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        68 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~----~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .....+|.|++|.|+.+......+.++.|.+.    ....      ....|..+-..+.|||++.....+.....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            35678999999989888877767766666543    1110      02235556677899999877665533221     


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ..-+||||+.+|...+...    ..+....+..++.|++.|+.|||+. ||.|||+||+|++++.++ .+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g-~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENG-ILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCC-ceEEeecCccee
Confidence            2224999999777777653    4677888999999999999999998 999999999999999888 899999999876


Q ss_pred             cccCCC-----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          218 LVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       218 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ......     ....+|+..|+|||++.+...-....||||.|+++..|.+|+.||......+....-..          
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~----------  539 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN----------  539 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------
Confidence            533322     23567889999999998776556789999999999999999999976543322110000          


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                       ...       ...+...+  ..+...++...+.+|.+||+.||.+|.|++++++.+||+++..+.
T Consensus       540 -~~~-------~~~~~~~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~  595 (601)
T KOG0590|consen  540 -YSD-------QRNIFEGP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH  595 (601)
T ss_pred             -ccc-------ccccccCh--HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence             000       00000000  012245788899999999999999999999999999999987653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-25  Score=200.75  Aligned_cols=208  Identities=24%  Similarity=0.346  Sum_probs=170.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEecc--chhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ..|+++++||+|.||.++.|.+.-+++.||||.-..  +...+..|....+.|. .+.|..+|.+  .   ....+-.||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYF--G---qeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYF--G---QEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeee--c---cccchhhhh
Confidence            479999999999999999999999999999997643  3345567888888885 5777776432  2   344556699


Q ss_pred             EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC----CCCceEEeecCCcee
Q 015615          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----HTHQLKLCDFGSAKV  217 (403)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~----~~~~vkl~DfG~a~~  217 (403)
                      ||+++.+|.+++...   +.+|+..++..++.|++.-++|+|++ .+|+|||||+|+||..    +.+.|.|+|||+|+.
T Consensus       103 idLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  103 IDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            999999999988876   57899999999999999999999998 9999999999999953    334799999999998


Q ss_pred             cccCCC--------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHH
Q 015615          218 LVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIK  282 (403)
Q Consensus       218 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~  282 (403)
                      +.+...        ..+..||..||+-...++.. .+.+.|+-|||-++...+-|..||.+..   ..+.+++|-.
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe  253 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE  253 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence            755432        23567999999999888765 7999999999999999999999999854   3344444433

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.5e-26  Score=195.28  Aligned_cols=205  Identities=25%  Similarity=0.335  Sum_probs=164.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--hhhHHHHHHHHHcCCC-CeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .++|.+.++||+|+||.+|+|....+|+.||||.-+...  .....|..+.+.|++- -|..++.+.     .+..|-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----ccccccee
Confidence            357999999999999999999999999999999875543  3455789999998763 344443333     34455679


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC--CCCceEEeecCCceec
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVL  218 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG~a~~~  218 (403)
                      ||+.++.+|.+++.-.   ...++..++..++-|++.-++|+|.+ ++|||||||+|+|+.-  ..+.+.++|||+|+.+
T Consensus        89 VMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   89 VMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            9999999998887654   46789999999999999999999988 9999999999999853  3447999999999887


Q ss_pred             ccCCC--------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015615          219 VKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (403)
Q Consensus       219 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  278 (403)
                      .+...        .....||..|.+-....+.. .+.+.|+-|+|.+|..+..|..||++.......+
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q  231 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ  231 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence            44322        23567899999887765543 6889999999999999999999999965444333

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-25  Score=208.87  Aligned_cols=251  Identities=21%  Similarity=0.208  Sum_probs=188.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCC-cEEEEEEeccch----hhhHHHHHHHHHcCC----CCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDK----RYKNRELQTMRLLDH----PNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~----~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~  136 (403)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|......    .....|+.++..+..    .++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987764 678999765431    146679999998873    56777655442    2455


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC----CceEEeec
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCDF  212 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~----~~vkl~Df  212 (403)
                      +-+|||+.++.+|.++.....  .+.++..++..++.|++.+|.+||+. |++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999988776543  57899999999999999999999987 999999999999997543    46999999


Q ss_pred             CCce--ecccCC--------C-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 015615          213 GSAK--VLVKGE--------P-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (403)
Q Consensus       213 G~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  281 (403)
                      |+++  ......        . .....||..|.++.+..+.. .+.+.|+||++.++.+++.|..||.+........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  431111        1 12345999999999987654 8999999999999999999999997765433333322


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      +........       .                 +....+.++.++...+-..+...+|....+...
T Consensus       251 ~~~~~~~~~-------~-----------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLLTD-------R-----------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhccc-------c-----------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            211000000       0                 112345678888888888899999987776544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=8.6e-26  Score=213.95  Aligned_cols=157  Identities=20%  Similarity=0.307  Sum_probs=119.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc-CCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ...|.+.+.||+|+||+||+|.+.. +++.||||++...         ...+.+|+++|+.++|+|++..+..+      
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------   90 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------   90 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence            4579999999999999999999876 6788899986422         23457899999999999998532211      


Q ss_pred             CceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC-CCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI-KPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dl-kp~NIll~~~~~~vkl~Df  212 (403)
                      +  ..|+||||++|..+..+.       ...   ...++.|++.||.|||++ ||+|||| ||+|||++.++ .+||+||
T Consensus        91 ~--~~~LVmE~~~G~~L~~~~-------~~~---~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~-~ikLiDF  156 (365)
T PRK09188         91 G--KDGLVRGWTEGVPLHLAR-------PHG---DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDG-EAAVIDF  156 (365)
T ss_pred             C--CcEEEEEccCCCCHHHhC-------ccc---hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCC-CEEEEEC
Confidence            1  257999999974333211       111   145788999999999998 9999999 99999998776 7999999


Q ss_pred             CCceecccCCCc---------ceeeeccccccccccc
Q 015615          213 GSAKVLVKGEPN---------ISYICSRYYRAPELIF  240 (403)
Q Consensus       213 G~a~~~~~~~~~---------~~~~gt~~y~aPE~~~  240 (403)
                      |+|+........         ....+++.|+|||.+.
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            999865432211         2345678899999884

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=8.7e-24  Score=198.78  Aligned_cols=260  Identities=34%  Similarity=0.492  Sum_probs=194.8

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCC-CeeecceeeeecCCCCceEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHP-NVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  138 (403)
                      |.+.+.||.|+||.||++.+.   ..+++|.+...       .....+|+.++..+.|+ +++++++.+.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            788899999999999999986   78899987543       23355789999999988 7999988872     22226


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++++++.+ .+.+.+...... ..++......++.|++.++.|+|+. +++|||+||+||+++..+..++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            799999996 555444432111 3688889999999999999999988 9999999999999998764599999999875


Q ss_pred             cccCC-------CcceeeecccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhC
Q 015615          218 LVKGE-------PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLG  285 (403)
Q Consensus       218 ~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~  285 (403)
                      .....       ......+|..|+|||.+.+.  ..++...|+||+|++++++++|..||.....   ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            54332       23566889999999999763  4588999999999999999999999877664   333333333222


Q ss_pred             CC-CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          286 TP-TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       286 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                      .+ ....              .      ...........+.+++.+++..+|..|.+..+...++|......
T Consensus       232 ~~~~~~~--------------~------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         232 TPSLASP--------------L------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             Ccccccc--------------c------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            21 0000              0      00000112357899999999999999999999998877665433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=1.1e-25  Score=227.07  Aligned_cols=225  Identities=28%  Similarity=0.461  Sum_probs=168.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      ...+|..++.+-.|+||.||.++|+.+.+.+|+| +.++.-..++   ++.....|.+|                     
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfvv---------------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFVV---------------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCccee---------------------
Confidence            3457999999999999999999999999999994 5544433322   33333333333                     


Q ss_pred             ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                          |+-...++.    .+.++..        ++.+++|||+. ||+|||+||+|.+|+.-| .+|++|||+++......
T Consensus       136 ----gDc~tllk~----~g~lPvd--------mvla~Eylh~y-givhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLLKN----IGPLPVD--------MVLAVEYLHSY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhccc----CCCCcch--------hhHHhHhhccC-CeecCCCCCCcceeeecc-cccccchhhhhhhhhhc
Confidence                222222222    2445543        37789999986 999999999999999888 59999999986532111


Q ss_pred             Cc----------------ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015615          223 PN----------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       223 ~~----------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      ..                ...+|||.|+|||++.... |+..+|+|++|+|+||.+-|..||.+.+..+.+...+.....
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence            10                1347899999999997655 999999999999999999999999999888877666542111


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC---CHHHHhcCCCCccCCCC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS---TALEALIHPFFDELRDP  357 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~---s~~ell~hp~f~~~~~~  357 (403)
                      -+                         +. ...++++++++|.++|+.+|..|.   .+.++.+|+||+.+.+.
T Consensus       277 wp-------------------------E~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 WP-------------------------EE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cc-------------------------cc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            11                         11 234789999999999999999994   57778899999998765

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8e-26  Score=218.08  Aligned_cols=234  Identities=29%  Similarity=0.442  Sum_probs=186.6

Q ss_pred             eeeCCcEEEEEEEE---ccCCcEEEEEEeccc------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEEEE
Q 015615           73 VGHGSFGVVFQAKC---LETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        73 lg~G~~g~Vy~~~~---~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +|.|.||.|++++-   ...|..+|+|...+.      ......|..++...+ ||.+|++..+|     +....+++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHhh
Confidence            79999999998752   245778899876432      123345888888887 99999998777     3334478899


Q ss_pred             ecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      ++..+ .+...+    .....+.+...+.+...++.+++++|+. +|+|||+|++||+++.+| .+++.|||+++.....
T Consensus        77 d~~rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~G-hi~~tdfglske~v~~  150 (612)
T KOG0603|consen   77 DFLRGGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhcccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccC-ccccCCchhhhHhHhh
Confidence            99986 433333    3346678888999999999999999986 999999999999999999 4999999999877555


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCHHHHhccCcCcc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~  300 (403)
                      ...   +||..|||||++.   .....+|+||+|++++||+||..||.+    +....|.+. ++               
T Consensus       151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~---------------  205 (612)
T KOG0603|consen  151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE---------------  205 (612)
T ss_pred             hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC---------------
Confidence            443   8999999999985   267889999999999999999999987    444445441 11               


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  357 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~~  357 (403)
                                     ++..++..+++++..++..+|..|.-     +.++++|+||+.+.+.
T Consensus       206 ---------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  206 ---------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ---------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                           22457889999999999999999975     5789999999998765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=7.7e-24  Score=192.57  Aligned_cols=237  Identities=25%  Similarity=0.338  Sum_probs=143.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhh-------hHHHHHHHHHcC----------CCC------eee
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-------KNRELQTMRLLD----------HPN------VVS  122 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l~----------h~n------iv~  122 (403)
                      .+...+.||.|+++.||.+.|..+|+.+|+|.+......       .++|.-....+.          |-.      +++
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            577889999999999999999999999999987433211       112221111111          111      111


Q ss_pred             cce--eeeecCC-CCce---EEEEEEecccchHHHHHHhhcccCCC---CCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 015615          123 LKH--CFFSTTE-KDEL---YLNLVLEYVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHRDI  193 (403)
Q Consensus       123 ~~~--~~~~~~~-~~~~---~~~lv~e~~~~~l~~~l~~~~~~~~~---l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dl  193 (403)
                      +-+  .+..... ....   ..+++|+-+.++|.+++.........   +.......+..|++..+++||+. |+||+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEeccc
Confidence            110  0111111 1111   24678998888887776543222222   22223344558999999999998 9999999


Q ss_pred             CCCceEecCCCCceEEeecCCceecccCCCcceeeecccccccccccCC-------CCCCCchhHHHHHHHHHHHHhCCC
Q 015615          194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAELLLGQP  266 (403)
Q Consensus       194 kp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~~  266 (403)
                      +|+|++++.+| .+.|+||+.........  .....+..|.|||.....       ..++.+.|.|+||+++|.|++|..
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999988 79999998776543221  113445779999986432       237889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCC
Q 015615          267 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR  339 (403)
Q Consensus       267 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R  339 (403)
                      ||.........           ..                    .|.. .. ++|..+++||+.+|++||.+|
T Consensus       249 Pf~~~~~~~~~-----------~~--------------------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADP-----------EW--------------------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTS-----------GG--------------------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccc-----------cc--------------------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            99754321000           00                    1111 22 689999999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.6e-24  Score=194.40  Aligned_cols=209  Identities=23%  Similarity=0.360  Sum_probs=146.9

Q ss_pred             CCCCeeecceeeeecC----------------------CCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHH
Q 015615          116 DHPNVVSLKHCFFSTT----------------------EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY  173 (403)
Q Consensus       116 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~  173 (403)
                      +|||||++...|.+..                      -.....+|+||...+.+|.+++-.     +..+....+.++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            6999999988774321                      123346899999999998888764     3456667888999


Q ss_pred             HHHHHHHHHHhcCCccccCCCCCceEecC--CC-CceEEeecCCceecccC-------CCcceeeecccccccccccCCC
Q 015615          174 QICRALAYIHNTIGVCHRDIKPQNLLVNP--HT-HQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPELIFGAT  243 (403)
Q Consensus       174 qi~~~L~~LH~~~~ivH~Dlkp~NIll~~--~~-~~vkl~DfG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~  243 (403)
                      |+++|+.|||.+ ||.|||+|.+|||+.-  |+ ..+.|+|||.+-.-...       ......-|.-.-||||+....+
T Consensus       349 QlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999998 9999999999999832  22 35789999987543221       1122345677799999985433


Q ss_pred             CC-----CCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCccccccc
Q 015615          244 EY-----TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK  318 (403)
Q Consensus       244 ~~-----~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (403)
                      ..     -.++|.|+.|.+.||+++..-||.+..... + +                ...|.+-..|.         ++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L-~----------------~r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-L-D----------------TRTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-e-c----------------hhhhhhhhCCC---------Ccc
Confidence            21     237999999999999999999998743210 0 0                00122222222         235


Q ss_pred             CCChHHHHHHHHhhccCCCCCCCH---HHHhc------CCCCccCCCC
Q 015615          319 RMPPEAVDLVSRLLQYSPNLRSTA---LEALI------HPFFDELRDP  357 (403)
Q Consensus       319 ~~s~~~~~ll~~~L~~dP~~R~s~---~ell~------hp~f~~~~~~  357 (403)
                      .+++.+++|+..+|+.||++|+++   +.+|+      |.|++...++
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~~  528 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMMEK  528 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhccc
Confidence            689999999999999999999995   34443      4555554443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=1.8e-24  Score=218.75  Aligned_cols=241  Identities=30%  Similarity=0.428  Sum_probs=171.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhH---HHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKN---RELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .|...+.||++.|=+|.+|++. .|. |+||++.+..     +...   +|++ ...++|||++.+....     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            5778889999999999999973 344 9999885432     1111   3444 5667899999975543     22333


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .|||-+|+..+|.+-+..+    .-+...+.+.|+.|++.||..+|.. ||+|||||.+||||++-+ -+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWN-W~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWN-WLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeec-hhhhhcccccCC
Confidence            5789999988888877643    4467778889999999999999987 999999999999999877 599999987654


Q ss_pred             cc--cCCCc-ce-eee----cccccccccccCC----------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015615          218 LV--KGEPN-IS-YIC----SRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (403)
Q Consensus       218 ~~--~~~~~-~~-~~g----t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  278 (403)
                      ..  ++++. .+ +.-    -.+|+|||.+...          +..+++.||||+||+++||++ |++||.-    .++.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence            31  11111 11 122    3469999998531          125778999999999999998 7899952    2222


Q ss_pred             HHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ...... ....+..                       +.+--+..++.||..|++.||++|.+|++.|+.
T Consensus       246 aYr~~~-~~~~e~~-----------------------Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQL-----------------------LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhccC-ccCHHHH-----------------------HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            222211 1111111                       111125578999999999999999999999875

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=7.7e-23  Score=178.36  Aligned_cols=134  Identities=16%  Similarity=0.235  Sum_probs=101.9

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh------------------------------hhHHHHHHHHHcCCCC
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN  119 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~n  119 (403)
                      ...||+|+||.||+|.+. +|+.||||+++....                              ...+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            457999999999999986 899999999854311                              1124899999998877


Q ss_pred             eeecceeeeecCCCCceEEEEEEecccchH-HHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCccccCCCCCc
Q 015615          120 VVSLKHCFFSTTEKDELYLNLVLEYVPETV-HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGVCHRDIKPQN  197 (403)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~L-H~~~~ivH~Dlkp~N  197 (403)
                      +.......  .   ..  .+|||||++++. ......    ...++...+..++.|++.+|.++ |+. ||+||||||+|
T Consensus        81 v~~p~~~~--~---~~--~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~N  148 (190)
T cd05147          81 IPCPEPIL--L---KS--HVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYN  148 (190)
T ss_pred             CCCCcEEE--e---cC--CEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHH
Confidence            64332211  1   11  269999999743 222221    25688889999999999999999 676 99999999999


Q ss_pred             eEecCCCCceEEeecCCceec
Q 015615          198 LLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       198 Ill~~~~~~vkl~DfG~a~~~  218 (403)
                      ||++. + .++|+|||+|...
T Consensus       149 Ili~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEEC-C-cEEEEEccccccC
Confidence            99984 4 6999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=2e-22  Score=178.03  Aligned_cols=170  Identities=12%  Similarity=0.154  Sum_probs=124.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhh---------hHHHHHHHHHcCCCCeeecceeeeec
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRY---------KNRELQTMRLLDHPNVVSLKHCFFST  130 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~---------~~~E~~~l~~l~h~niv~~~~~~~~~  130 (403)
                      ..+|++.++||.|+||.||++.+  ++..+|||.+...    ...         .++|+..+.++.|++|..+.+.+...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            35799999999999999999765  4668999998532    111         46788899999999999998876543


Q ss_pred             CCC---CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCc
Q 015615          131 TEK---DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (403)
Q Consensus       131 ~~~---~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  206 (403)
                      ...   .....+|+|||++| +|.+..        .+++    ....+++.+|..||+. |++|||+||+||++++++  
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g--  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG--  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC--
Confidence            211   12346799999997 554431        1222    2355999999999998 999999999999998766  


Q ss_pred             eEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHH
Q 015615          207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  262 (403)
Q Consensus       207 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  262 (403)
                      ++|+|||.+......... .          ..... ..++.++|+||||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~-d----------~~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-D----------RIDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-H----------HHHHH-hHhcccccccceeEeehHHH
Confidence            999999987654221111 0          02222 23678999999999877554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=9.5e-22  Score=171.97  Aligned_cols=134  Identities=16%  Similarity=0.249  Sum_probs=103.9

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------------------------hhhHHHHHHHHHcCCCC
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------------------RYKNRELQTMRLLDHPN  119 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~~l~h~n  119 (403)
                      .+.||+|+||.||+|.+. +|+.||||++....                              ....+|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999986 89999999886431                              11246888999999988


Q ss_pred             eeecceeeeecCCCCceEEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCCc
Q 015615          120 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQN  197 (403)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~~ivH~Dlkp~N  197 (403)
                      +........  .   .  .+|||||++|. +......    ...++...+..++.|++.++.+||+ . ||+||||||+|
T Consensus        81 i~~p~~~~~--~---~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~N  148 (190)
T cd05145          81 VPVPEPILL--K---K--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYN  148 (190)
T ss_pred             CCCceEEEe--c---C--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhh
Confidence            754433221  1   1  36899999974 3222111    2456778899999999999999998 7 99999999999


Q ss_pred             eEecCCCCceEEeecCCceec
Q 015615          198 LLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       198 Ill~~~~~~vkl~DfG~a~~~  218 (403)
                      ||++ ++ .++|+|||++...
T Consensus       149 Ill~-~~-~~~liDFG~a~~~  167 (190)
T cd05145         149 ILYH-DG-KPYIIDVSQAVEL  167 (190)
T ss_pred             EEEE-CC-CEEEEEcccceec
Confidence            9998 55 7999999999765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.3e-21  Score=169.38  Aligned_cols=181  Identities=17%  Similarity=0.127  Sum_probs=131.1

Q ss_pred             EEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh--------hhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEE
Q 015615           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------YKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        68 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+...|++|+||+||++..  .+..++.+.+.....        ...+|+++|++|. |+++++++++.     .    .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----E
Confidence            3567899999999998875  677888776654332        4568999999996 47788876531     1    5


Q ss_pred             EEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC-CCCceEecCCCCceEEeecCCce
Q 015615          139 NLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI-KPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       139 ~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dl-kp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +++|+|+.|. |.+.+.          .. ...++.|++.+|.++|++ ||+|||| ||+|||++.++ .++|+|||+|.
T Consensus        74 ~lvmeyI~G~~L~~~~~----------~~-~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~  140 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPP----------RG-DLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDG-SPAVIDFQLAV  140 (218)
T ss_pred             EEEEeeecCccHHhhhh----------hh-hHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCC-CEEEEECCCce
Confidence            7899999974 332211          01 134678999999999998 9999999 79999999877 79999999998


Q ss_pred             ecccCCCc--------------ceeeecccccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 015615          217 VLVKGEPN--------------ISYICSRYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGES  272 (403)
Q Consensus       217 ~~~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~  272 (403)
                      ........              .-...++.|+.|+...--...+ ...++++.|+-+|.++|+..++.+.+
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            54332211              0112477788887642222233 56788899999999999998876543

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=6.5e-20  Score=161.56  Aligned_cols=134  Identities=18%  Similarity=0.242  Sum_probs=101.6

Q ss_pred             EEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHc-----CCCCeeecceeeeecCCCCceE-E
Q 015615           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLL-----DHPNVVSLKHCFFSTTEKDELY-L  138 (403)
Q Consensus        69 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~-~  138 (403)
                      -.+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     +||||+++++++.+..  +..+ +
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEE
Confidence            346899999999995  7777666 69987543    34567899999999     6799999999875432  2234 3


Q ss_pred             EEEEeccc---chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH-HHHHhcCCccccCCCCCceEecCC---CCceEEee
Q 015615          139 NLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL-AYIHNTIGVCHRDIKPQNLLVNPH---THQLKLCD  211 (403)
Q Consensus       139 ~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L-~~LH~~~~ivH~Dlkp~NIll~~~---~~~vkl~D  211 (403)
                      .+||||++   ++|.+.+.+     ..+++.  ..++.|++.++ +|||++ +||||||||+|||++..   ...++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            47899954   588888854     235554  35678888888 999998 99999999999999742   22699999


Q ss_pred             cCCc
Q 015615          212 FGSA  215 (403)
Q Consensus       212 fG~a  215 (403)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3.3e-20  Score=191.03  Aligned_cols=191  Identities=25%  Similarity=0.404  Sum_probs=143.7

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhh-HHHHHHHHHcC---CCCeeecceeeeecCCCCceEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMRLLD---HPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ....|.|.+.||.|+||+||+|.+.. |+.||||+-+...... .-=.+++.+|+   -+.|..+..++..   .+.  -
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~---~~~--S  769 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVF---QNA--S  769 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHcc---CCc--c
Confidence            34579999999999999999999866 9999999765432110 00123344444   2233344333322   222  3


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec------CCCCceEEee
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN------PHTHQLKLCD  211 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~------~~~~~vkl~D  211 (403)
                      ++|+||.+ |+|++++.    ..+..++..+..++.|++.-+..||.. +|||+||||+|+||.      .+..-++|+|
T Consensus       770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            47999999 78888886    356788888999999999999999987 999999999999993      2222599999


Q ss_pred             cCCceec---ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 015615          212 FGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  265 (403)
Q Consensus       212 fG~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~  265 (403)
                      ||.+--+   .++........|-.+-.+|+..|.+ ++.+.|.|.|+.+++-|++|+
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence            9987543   3343444567788899999997765 999999999999999999997

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.7e-20  Score=163.86  Aligned_cols=238  Identities=17%  Similarity=0.239  Sum_probs=174.3

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEec------cchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      +..+..+|.....|..|+|++.  |..++.|++.      .-.+.+..|.-.|+.+.||||+.+++.+     .....+.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence            4555667899999999999984  4455666542      2245566788899999999999999988     4445588


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc-CCCCCceEecCCCCceEEe--ecCCc
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR-DIKPQNLLVNPHTHQLKLC--DFGSA  215 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~-Dlkp~NIll~~~~~~vkl~--DfG~a  215 (403)
                      ++..||+ |+|...+....  +-.....++..++.++++|++|||+--.++-| -|....+++|.+- ..+|+  |--++
T Consensus       264 ~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfs  340 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFS  340 (448)
T ss_pred             EeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceee
Confidence            9999999 78888876532  23355667889999999999999985355554 5888899998765 44443  32222


Q ss_pred             eecccCCCcceeeecccccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      -      ........|.||+||.+...+.  --.++|+|||++++|||.|...||.+..+.+.-.++.-       +   
T Consensus       341 f------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------e---  404 (448)
T KOG0195|consen  341 F------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------E---  404 (448)
T ss_pred             e------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------c---
Confidence            1      1122344788999999976543  23579999999999999999999998877665443321       0   


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                                       -+...+++.++.....|++-|+.-||.+||..+.+.
T Consensus       405 -----------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  405 -----------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -----------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                             011124567899999999999999999999987654

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=1.6e-19  Score=162.73  Aligned_cols=138  Identities=14%  Similarity=0.161  Sum_probs=103.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEE-EccCCcEEEEEEeccch----------------------------hhhHHHHHHHHHcC
Q 015615           66 SYMAERVVGHGSFGVVFQAK-CLETGEAVAIKKVLQDK----------------------------RYKNRELQTMRLLD  116 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~E~~~l~~l~  116 (403)
                      -|.+.+.||+|+||.||+|. +..+|+.||||.+....                            ....+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 66789999999885321                            11347999999997


Q ss_pred             CCCeeecceeeeecCCCCceEEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC-ccccCCC
Q 015615          117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VCHRDIK  194 (403)
Q Consensus       117 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~-ivH~Dlk  194 (403)
                      +.. +.+...+.. . .    .++||||+++. +......    ...+....+..++.||+.++.+||++ | |+|||||
T Consensus       109 ~~~-i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dik  176 (237)
T smart00090      109 EAG-VPVPKPIAW-R-R----NVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLS  176 (237)
T ss_pred             hcC-CCCCeeeEe-c-C----ceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCC
Confidence            632 222222211 1 1    36999999984 3332211    23455566788999999999999998 9 9999999


Q ss_pred             CCceEecCCCCceEEeecCCcee
Q 015615          195 PQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       195 p~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+||+++ ++ .++|+|||.+..
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhc
Confidence            9999998 55 799999998864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.9e-20  Score=176.58  Aligned_cols=180  Identities=29%  Similarity=0.481  Sum_probs=131.5

Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ..|+||.|++|.. +|.+++.+. ......+......++.|++.|+.|   + +.+|+|+||.||++..+. .+||.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~-q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDD-QLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccch-hhhhhhhh
Confidence            4468999999995 666666543 344556777889999999999999   6 999999999999998777 79999999


Q ss_pred             CceecccCC-------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015615          214 SAKVLVKGE-------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       214 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      +........       ..+...||..||+||.+.+.. |+.++||||||++|+|++.-   |..............    
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~---f~T~~er~~t~~d~r----  473 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQ---FSTQFERIATLTDIR----  473 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHH---hccHHHHHHhhhhhh----
Confidence            987665544       345678999999999997665 99999999999999999972   211111111111110    


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                            ...|...+..+ -+.-..|+..||...|.+||++.+.--|+|.
T Consensus       474 ----------------------~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  474 ----------------------DGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ----------------------cCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                                  01111111111 2455789999999999999988887777765

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=2e-17  Score=147.18  Aligned_cols=129  Identities=19%  Similarity=0.334  Sum_probs=100.5

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +.||+|++|.||+|.+  .|..+++|+.....            ....+|+.++..+.|+++.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5789999999999987  77889999764321            22446899999999998776655443221     25


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++|||++| +|.+.+...    .   . ....++.+++.+|.+||+. |++|||++|+|||++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            689999986 666665432    1   1 6778899999999999987 999999999999998 45 799999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=9e-18  Score=147.90  Aligned_cols=132  Identities=17%  Similarity=0.172  Sum_probs=98.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--------------------------hhhHHHHHHHHHcCCCC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPN  119 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~~l~h~n  119 (403)
                      .|.+.+.||+|+||.||+|.+ .+|+.||||++....                          ....+|..++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            388889999999999999986 479999999864321                          11346788888887774


Q ss_pred             --eeecceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 015615          120 --VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (403)
Q Consensus       120 --iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~N  197 (403)
                        +...++    .     ...++||||++|.....+..         ......++.+++.++.++|+. ||+||||||+|
T Consensus        95 i~v~~~~~----~-----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~N  155 (198)
T cd05144          95 FPVPKPID----W-----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEFN  155 (198)
T ss_pred             CCCCceee----c-----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHC-CCCcCCCCccc
Confidence              333221    1     12478999999743222211         023557888999999999987 99999999999


Q ss_pred             eEecCCCCceEEeecCCceec
Q 015615          198 LLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       198 Ill~~~~~~vkl~DfG~a~~~  218 (403)
                      |+++.++ .++|+|||.+...
T Consensus       156 ill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             EEEcCCC-cEEEEECCccccC
Confidence            9999876 7999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=6.4e-18  Score=163.43  Aligned_cols=205  Identities=26%  Similarity=0.401  Sum_probs=146.9

Q ss_pred             HHHcCCCCeeecceeeeecCCCCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 015615          112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (403)
Q Consensus       112 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH  190 (403)
                      |+.+.|.|+.++++.++..     ...++|.+||. |+|.+.+...   ...++......++++|+.||+|||+.....|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            3568999999999988654     33779999999 7888888763   3556677788889999999999998633399


Q ss_pred             cCCCCCceEecCCCCceEEeecCCceecccC---CCcceeeecccccccccccCCC--C----CCCchhHHHHHHHHHHH
Q 015615          191 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGAT--E----YTAAIDIWSAGCVLAEL  261 (403)
Q Consensus       191 ~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--~----~~~~~DiwslG~il~el  261 (403)
                      +.+++.|.++|..- .+||+|||+.......   .......-..-|.|||.+....  .    .+.+.|+||+|++++|+
T Consensus        73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            99999999999876 8999999998765321   0111111234599999986531  1    46679999999999999


Q ss_pred             HhCCCCCCCCCcH----HHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCC
Q 015615          262 LLGQPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  337 (403)
Q Consensus       262 ltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~  337 (403)
                      ++...||......    +....+.+....+..               |.+.      .. ....+++..++.+|+..+|.
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~r---------------P~i~------~~-~e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPFR---------------PSIE------LL-NELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHhcCCCCcC---------------cchh------hh-hhcchHHHHHHHHhcccChh
Confidence            9999999874322    222222220111111               1110      01 13456899999999999999


Q ss_pred             CCCCHHHHhc
Q 015615          338 LRSTALEALI  347 (403)
Q Consensus       338 ~R~s~~ell~  347 (403)
                      +||+++.+-.
T Consensus       210 ~rPs~~~i~~  219 (484)
T KOG1023|consen  210 KRPSIEQIRS  219 (484)
T ss_pred             hCccHHHHHh
Confidence            9999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=4.6e-17  Score=143.41  Aligned_cols=125  Identities=21%  Similarity=0.360  Sum_probs=93.7

Q ss_pred             EeeeCCcEEEEEEEEccCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .||+|+||.||+|..  +|..|++|......            ....+|+.++..+.|+++......+...   +  ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~---~--~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP---D--NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC---C--CCE
Confidence            379999999999984  67889999854321            2234699999999888754443333221   1  246


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +||||++| ++.+.+....           ..++.|++.+|.+||+. |++|||++|.||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            89999986 5655543210           06788999999999987 999999999999998 55 799999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=7.3e-19  Score=177.43  Aligned_cols=258  Identities=25%  Similarity=0.329  Sum_probs=189.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc-CCcEEEEEEeccch------hhhHHHHHHHHHcC-CCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  135 (403)
                      ...|.+.+.||+|+|+.|-.+.... ....+|.|.+....      .....|..+-+.+. |.|++.+++..     .+.
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence            3468889999999999998887633 34556777654322      22234777777777 99999998876     455


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHH-hcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      .+.+++++|..| .+...+.  .......+...+..++.|+..++.|+| .. ++.|+|+||+|.+++..+..+++.|||
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             cccccccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCch
Confidence            557899999775 4433331  111124566678899999999999999 76 999999999999999776359999999


Q ss_pred             Cceeccc-CCCc---ceeee-cccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          214 SAKVLVK-GEPN---ISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       214 ~a~~~~~-~~~~---~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      +|..... ....   ...+| ++.|+|||...+.....+..|+||+|+++.-+++|..|+..........          
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----------  240 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----------  240 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc----------
Confidence            9987655 2222   23567 9999999999775567889999999999999999999987654322110          


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                 .  .+.... .......+..++....+++.+++..+|..|.+.+++..+||+..
T Consensus       241 -----------~--~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 -----------S--SWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -----------e--eecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                       0  000000 11112233567899999999999999999999999999999988

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=1.3e-16  Score=161.26  Aligned_cols=130  Identities=19%  Similarity=0.308  Sum_probs=97.8

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      .|...+.||+|+||.||+|.+.  +..+++|+....            .....+|+++++.++|++++....++...   
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~---  408 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP---  408 (535)
T ss_pred             ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC---
Confidence            4567889999999999999874  334444432111            12345799999999999988765444321   


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                        ...++||||+++ +|.+.+.            ....++.|++.+|.+||+. |++||||||+|||++ ++ .++|+||
T Consensus       409 --~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl~-~~-~~~liDF  471 (535)
T PRK09605        409 --EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIVR-DD-RLYLIDF  471 (535)
T ss_pred             --CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEEE-CC-cEEEEeC
Confidence              125689999986 6665553            2456889999999999987 999999999999994 44 6999999


Q ss_pred             CCcee
Q 015615          213 GSAKV  217 (403)
Q Consensus       213 G~a~~  217 (403)
                      |+++.
T Consensus       472 Gla~~  476 (535)
T PRK09605        472 GLGKY  476 (535)
T ss_pred             ccccc
Confidence            99875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.4e-16  Score=138.79  Aligned_cols=130  Identities=20%  Similarity=0.236  Sum_probs=89.9

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhh----------------------------HHHHHHHHHcCCCC--
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK----------------------------NRELQTMRLLDHPN--  119 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~E~~~l~~l~h~n--  119 (403)
                      .+.||+|+||.||+|.+. +|+.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999976 79999999876432110                            23444444443332  


Q ss_pred             eeecceeeeecCCCCceEEEEEEecccch-HH-HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCC
Q 015615          120 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQ  196 (403)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~~ivH~Dlkp~  196 (403)
                      +.+.+.+    .     ..++||||++++ +. ..+....     .. ..+..++.+++.++.++|. . ||+||||||+
T Consensus        81 ~~~~~~~----~-----~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~  144 (187)
T cd05119          81 VPKPIDL----N-----RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA-GLVHGDLSEY  144 (187)
T ss_pred             CCceEec----C-----CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc-CcCcCCCChh
Confidence            2222211    1     147999999972 11 1121111     01 4577889999999999998 6 9999999999


Q ss_pred             ceEecCCCCceEEeecCCceec
Q 015615          197 NLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ||+++ ++ .++|+|||.+...
T Consensus       145 Nili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         145 NILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             hEEEE-CC-cEEEEECcccccc
Confidence            99999 55 7999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=2.6e-15  Score=135.69  Aligned_cols=133  Identities=17%  Similarity=0.271  Sum_probs=96.2

Q ss_pred             eEee-eCCcEEEEEEEEccCCcEEEEEEeccc-----------------hhhhHHHHHHHHHcCCCCe--eecceeeeec
Q 015615           71 RVVG-HGSFGVVFQAKCLETGEAVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNV--VSLKHCFFST  130 (403)
Q Consensus        71 ~~lg-~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~  130 (403)
                      ..|| .||.|+||.+..  .+..++||.+...                 .....+|+.++..+.|+++  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 888999999876  4788999977421                 1223569999999998775  4444432221


Q ss_pred             CCCCceEEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceE
Q 015615          131 TEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  208 (403)
                      . ......++|||+++|  +|.+.+..     ..+++.    .+.||+.+|.+||+. ||+||||||+|||++.++ .++
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~-~v~  182 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA-GVYHADLNAHNILLDPDG-KFW  182 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCC-CEE
Confidence            1 111123599999996  56666542     344544    356899999999998 999999999999999876 799


Q ss_pred             EeecCCcee
Q 015615          209 LCDFGSAKV  217 (403)
Q Consensus       209 l~DfG~a~~  217 (403)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=1.7e-15  Score=146.80  Aligned_cols=249  Identities=26%  Similarity=0.278  Sum_probs=187.5

Q ss_pred             cceEEEeEeee--CCcEEEEEEEE--ccCCcEEEEEEec------cchhhhHHHHHHHHHcC-CCCeeecceeeeecCCC
Q 015615           65 ISYMAERVVGH--GSFGVVFQAKC--LETGEAVAIKKVL------QDKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        65 ~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~vaiK~~~------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  133 (403)
                      ..+.+.+.+|.  |.+|.||.+.+  ..++..+|+|.-.      .......+|+...+.++ |+|.++.+..+     .
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e  188 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E  188 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence            35777889999  99999999998  8899999999732      12333446776666664 89999865555     5


Q ss_pred             CceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHH----HHHHHHhcCCccccCCCCCceEecCCCCceEE
Q 015615          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (403)
Q Consensus       134 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~----~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  209 (403)
                      +...+++-+|+|+.++.......   ..-++...++..+.+...    ||.++|+. +++|-|+||+||++..+...+++
T Consensus       189 ~~~~lfiqtE~~~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  189 GSGILFIQTELCGESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cCCcceeeeccccchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeec
Confidence            55668899999997766655432   234778888999999999    99999998 99999999999999988337999


Q ss_pred             eecCCceecccCCCcce------eeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHH
Q 015615          210 CDFGSAKVLVKGEPNIS------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE--SGVDQLVEII  281 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~  281 (403)
                      +|||+...+..+.....      ..+...|++||.+.+  .++...|+|++|.++.+..+|..++...  +...++....
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            99999987765542221      145667999999843  4799999999999999999987665433  2111111100


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                                    ....+-...+.++...+..|+..+|..|++++.+++|+++...
T Consensus       343 ------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 ------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                                          1111223456777779999999999999999999999998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=1.3e-15  Score=127.23  Aligned_cols=131  Identities=19%  Similarity=0.230  Sum_probs=100.1

Q ss_pred             EEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--hhhHHHHHHHHHcCC--CCeeecceeeeecCCCCceEEEEEEec
Q 015615           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        69 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      +.+.||.|.++.||++.+.  +..+++|......  ....+|+..++.++|  .++.+++..+.     .....+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence            3567999999999999973  4789999886554  356789999999976  47777765442     22346899999


Q ss_pred             ccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc--CCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          145 VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT--IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       145 ~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +.+.....+          +......++.+++.+|++||..  .+++|+|++|+||+++..+ .++++|||.+..
T Consensus        75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            986422111          3345567788999999999974  2699999999999999755 799999998863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.49  E-value=1.2e-14  Score=148.19  Aligned_cols=257  Identities=25%  Similarity=0.291  Sum_probs=183.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+.+.+-+-+|.++.++.+.-..+|...++|......       +....+-.++-...+|.++.....+     .-..-
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP  878 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSP  878 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCC
Confidence            45777788999999999999877777666666543222       2222333333334556666643322     12223


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+++++|+.+ ++...+..    .+..+..-++.++..+..++++||+. .+.|+|++|.|+++..++ ..+++|||...
T Consensus       879 ~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~  952 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDG-HRPLTDFGTLS  952 (1205)
T ss_pred             cchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccC-CcccCcccccc
Confidence            6789999975 55544443    24566666788888999999999976 799999999999999888 58999998432


Q ss_pred             eccc------C--------------------------CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhC
Q 015615          217 VLVK------G--------------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  264 (403)
Q Consensus       217 ~~~~------~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg  264 (403)
                      ....      .                          .......+|+.|.+||.+.+.. ....+|+|++|++++|.++|
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcC
Confidence            2100      0                          0012345799999999997765 78889999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHH-
Q 015615          265 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-  343 (403)
Q Consensus       265 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~-  343 (403)
                      .+||......+.+..+.....                         +|.. -....+.++++++.++|..+|.+|..+. 
T Consensus      1032 ~pp~na~tpq~~f~ni~~~~~-------------------------~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRDI-------------------------PWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred             CCCCCCcchhhhhhccccCCC-------------------------CCCC-CccccChhhhhhhhhhhccCchhccCccc
Confidence            999998887777665554211                         1111 1234688999999999999999999877 


Q ss_pred             --HHhcCCCCccCCCCCC
Q 015615          344 --EALIHPFFDELRDPNT  359 (403)
Q Consensus       344 --ell~hp~f~~~~~~~~  359 (403)
                        ++-.||||+...+.+.
T Consensus      1086 ~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1086 AAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred             ccccccCCccCCCCcccc
Confidence              8889999999877654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=8.3e-14  Score=125.39  Aligned_cols=241  Identities=19%  Similarity=0.218  Sum_probs=157.9

Q ss_pred             EEEEEEEccCCcEEEEEEec----cc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEeccc-chHH
Q 015615           80 VVFQAKCLETGEAVAIKKVL----QD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVH  150 (403)
Q Consensus        80 ~Vy~~~~~~~~~~vaiK~~~----~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  150 (403)
                      .||++.+...|..|+--.+.    ++    ....+.-...|-.+.|.|+|++..++.+....+.....++.|||. |++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            35666666666655433221    11    111112244566678999999888765544445566778999999 6888


Q ss_pred             HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc-CCccccCCCCCceEecCCCCceEEeecCCceecc-----cCCCc
Q 015615          151 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-----KGEPN  224 (403)
Q Consensus       151 ~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~-----~~~~~  224 (403)
                      ++|++.......+.....++|+.||+.||.|||+. .-|+|+++..+.|++..++ -+|+.--.-.....     .....
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek  239 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEK  239 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhh
Confidence            89988777777888999999999999999999974 2599999999999999777 67765321111100     00011


Q ss_pred             ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHhccCcCccccc
Q 015615          225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  303 (403)
Q Consensus       225 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                      ....+-++|.+||.=.. ...+.++|||++|....+|..+..--... .....-..+...                    
T Consensus       240 ~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~--------------------  298 (458)
T KOG1266|consen  240 SVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV--------------------  298 (458)
T ss_pred             hccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh--------------------
Confidence            12345678999996422 23677899999999999999887432221 111111111110                    


Q ss_pred             CCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                  ...--...-++++++||+-.|..||++.+++.||.+-++
T Consensus       299 ------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  299 ------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             ------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence                        000011233578999999999999999999999987664

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.45  E-value=1.9e-12  Score=127.09  Aligned_cols=180  Identities=23%  Similarity=0.315  Sum_probs=128.0

Q ss_pred             ceEEEeEeeeCCcEEEE-EEEEccCCcEEEEEEeccchh----hhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVF-QAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy-~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .|.+ ...+-++.+ +| .|..+.++.+|.|..+.....    ...+.++.|+.++||||+++++++     .....+||
T Consensus        14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl   86 (690)
T KOG1243|consen   14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL   86 (690)
T ss_pred             Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence            3665 344444444 44 466677899999988754433    345778899999999999999887     44446899


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |+|.+.. |...++..       ....+..-++||+.||.|||+.++++|++|.-+-|+++..| ..||++|.++.....
T Consensus        87 vTErV~P-l~~~lk~l-------~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~  157 (690)
T KOG1243|consen   87 VTERVRP-LETVLKEL-------GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASG  157 (690)
T ss_pred             Eeecccc-HHHHHHHh-------HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEecccc
Confidence            9999863 22334332       24556777899999999999777999999999999999988 799999998765422


Q ss_pred             CCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhC
Q 015615          221 GEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  264 (403)
Q Consensus       221 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg  264 (403)
                      ... .....---.|..|+.+...   .-..|.|-|||++++++.|
T Consensus       158 ~~~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  158 FNAPAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CCcccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            221 1111112236677655321   2457999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=5.5e-13  Score=132.50  Aligned_cols=142  Identities=20%  Similarity=0.274  Sum_probs=90.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh------------------------------------------
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------------------------------  103 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------------------------------  103 (403)
                      .|.. +.||+|++|+||+|+.+.+|+.||||+.+....                                          
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 789999999999999887799999998854310                                          


Q ss_pred             --hhHHHHHHHHHc----CCCCeeecceeeeecCCCCceEEEEEEecccc-hHHHH--HHhhcccCCCCCHHHHHHHHHH
Q 015615          104 --YKNRELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRV--IKHHYKMSQRMPLIYVKLYFYQ  174 (403)
Q Consensus       104 --~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~--l~~~~~~~~~l~~~~~~~~~~q  174 (403)
                        ...+|...+.++    .+.+.+.+..+|.....    ..+|||||+.| .+.+.  +.........+.+..+..++.|
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence              011233333333    23444444444432221    24699999997 55442  2211101112445555556666


Q ss_pred             HHHHHHHHHhcCCccccCCCCCceEecCCC---CceEEeecCCceeccc
Q 015615          175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLCDFGSAKVLVK  220 (403)
Q Consensus       175 i~~~L~~LH~~~~ivH~Dlkp~NIll~~~~---~~vkl~DfG~a~~~~~  220 (403)
                      ++       .. |++|+|+||.||+++.++   ++++++|||++..+..
T Consensus       276 if-------~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF-------RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            55       35 999999999999998765   2699999999876633

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=1.5e-12  Score=127.68  Aligned_cols=137  Identities=20%  Similarity=0.274  Sum_probs=89.2

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-h-------------------------------------------hh
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-R-------------------------------------------YK  105 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~-------------------------------------------~~  105 (403)
                      .+.||+|++|+||+|+. .+|+.||||+..... .                                           ..
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            35799999999999986 579999999874321 0                                           01


Q ss_pred             HHHHHHHHHc----CCCCeeecceeeeecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHH-HH
Q 015615          106 NRELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR-AL  179 (403)
Q Consensus       106 ~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~-~L  179 (403)
                      .+|...+.++    +|.+-+.+..++.....    ..+|||||++| ++.+......   ....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHH
Confidence            1244444444    23333444344422221    14699999997 5544433211   1122   2334455554 46


Q ss_pred             HHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       180 ~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ..+|.. |++|+|+||.||+++.++ .++++|||++..+.
T Consensus       271 ~ql~~~-g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLRD-GFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHhC-CceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            788987 999999999999998877 79999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=1.4e-12  Score=111.56  Aligned_cols=125  Identities=15%  Similarity=0.221  Sum_probs=88.8

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEeccc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP  146 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~  146 (403)
                      .+.|+.|.++.||++..  .+..|++|......   ....+|+.+++.+.+.+++...-.+ .   ...  .++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~-~---~~~--~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF-D---PET--GVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE-e---CCC--CeEEEEecC
Confidence            35689999999999986  47889999875543   3456899999998765544322212 1   111  258999999


Q ss_pred             chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCc-----cccCCCCCceEecCCCCceEEeecCCce
Q 015615          147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV-----CHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       147 ~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~i-----vH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      |......        ..   ....++.+++.+|+.||+. ++     +|+|++|.||+++ ++ .++++|||.+.
T Consensus        75 G~~l~~~--------~~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DF---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cc---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            7421110        00   1134567999999999986 74     9999999999998 44 69999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.35  E-value=6.5e-12  Score=108.90  Aligned_cols=131  Identities=18%  Similarity=0.235  Sum_probs=91.1

Q ss_pred             eEeeeCCcEEEEEEEEcc------CCcEEEEEEecc--------------chh------------h----hHHHHHHHHH
Q 015615           71 RVVGHGSFGVVFQAKCLE------TGEAVAIKKVLQ--------------DKR------------Y----KNRELQTMRL  114 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~--------------~~~------------~----~~~E~~~l~~  114 (403)
                      ..||.|--+.||.|....      .+..+|||+++-              +.+            .    .++|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998643      357899997621              000            1    1268888888


Q ss_pred             cCC--CCeeecceeeeecCCCCceEEEEEEecccch-HH-HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCcc
Q 015615          115 LDH--PNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGVC  189 (403)
Q Consensus       115 l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~L-H~~~~iv  189 (403)
                      +..  -++...+.+.     .    .+|||||++++ +. ..++.     ..++...+..+..+++.+|..| |+. |||
T Consensus        83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~-glV  147 (197)
T cd05146          83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC-NLV  147 (197)
T ss_pred             HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC-Cee
Confidence            853  3444443321     1    36899999863 21 12221     2344556677789999999999 776 999


Q ss_pred             ccCCCCCceEecCCCCceEEeecCCceec
Q 015615          190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       190 H~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      |+||++.||+++. + .+.|+|||.+...
T Consensus       148 HGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         148 HADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             cCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            9999999999974 4 6999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.32  E-value=1.4e-10  Score=110.92  Aligned_cols=216  Identities=19%  Similarity=0.241  Sum_probs=153.1

Q ss_pred             CcEEEEEEEEccCCcEEEEEEeccchh----hhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecccc--hHH
Q 015615           77 SFGVVFQAKCLETGEAVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVH  150 (403)
Q Consensus        77 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~  150 (403)
                      .-.+.|+|....+|..|++|++.-++.    ..-.-++.++++.|+|+|++.++|.... -+...+++|++|.++  +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence            345789999999999999999833221    1124688999999999999999987433 355568899999884  565


Q ss_pred             HHHHhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          151 RVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       151 ~~l~~~~~-----------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +.-.....           .+...++..++.|+.|+..||.++|+. |+.-+-|.|.+|+++.+. +++|+..|......
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKM-RIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcc-eEEEecccceeeec
Confidence            54432221           234578899999999999999999998 999999999999999776 79999888765543


Q ss_pred             cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      .+.           .  |.+.    --.+-|.=.||.+++.|.||..--...+......  .+                 
T Consensus       445 ~d~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--~~-----------------  488 (655)
T KOG3741|consen  445 EDP-----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--LT-----------------  488 (655)
T ss_pred             CCC-----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHH--HH-----------------
Confidence            322           0  1121    2346799999999999999963211111111110  11                 


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                     .+...+|.++++++.-+...++++ -++.+++.
T Consensus       489 ---------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp  520 (655)
T KOG3741|consen  489 ---------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLP  520 (655)
T ss_pred             ---------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHH
Confidence                           011346788888888888888876 56666664

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=9e-13  Score=129.81  Aligned_cols=161  Identities=22%  Similarity=0.347  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCc--------ce--eeecccccccccccCCC
Q 015615          174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--------IS--YICSRYYRAPELIFGAT  243 (403)
Q Consensus       174 qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~--------~~--~~gt~~y~aPE~~~~~~  243 (403)
                      +.+.|+.|+|.+.++||++|.|++|.++.++ ..||+.|+++.........        ..  ..-...|.|||++.+ .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3448999999988999999999999999887 7999999987654331110        01  112446999999976 4


Q ss_pred             CCCCchhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCCh
Q 015615          244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP  322 (403)
Q Consensus       244 ~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  322 (403)
                      ..+.++|+||+||++|.+. .|+..+................+..                         ......++++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCcH
Confidence            4789999999999999999 5666665443322221111110000                         0112256899


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCC
Q 015615          323 EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL  361 (403)
Q Consensus       323 ~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~  361 (403)
                      ++++=|.+++..++..||++..++..|||++..-..-+.
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aLrf  278 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKALRF  278 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCchhhhhhh
Confidence            999999999999999999999999999999865554443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=4.5e-11  Score=99.92  Aligned_cols=139  Identities=19%  Similarity=0.279  Sum_probs=96.9

Q ss_pred             EEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        69 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ....+-+|+-+.|+++.+  .|+.+.||.-...            .....+|+..|.++.---|..-.-+|.+..   . 
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~---~-   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY---G-   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC---C-
Confidence            456788999999999986  7888888853211            223346888888775322222111122221   1 


Q ss_pred             EEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCce--EEeec
Q 015615          137 YLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDF  212 (403)
Q Consensus       137 ~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~v--kl~Df  212 (403)
                       -+|+|||++|  ++.+++.....  ..........++.+|-+.+.-||.. +|||+||..+||++.+++..+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEee
Confidence             3589999998  67777765542  2222223367888999999999998 999999999999998877655  89999


Q ss_pred             CCcee
Q 015615          213 GSAKV  217 (403)
Q Consensus       213 G~a~~  217 (403)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=1.1e-12  Score=127.42  Aligned_cols=248  Identities=21%  Similarity=0.194  Sum_probs=169.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEc-cCCcEEEEEEeccch------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDK------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|.....||.|.|+.|+.+.-. .++..|++|...+..      .....|+.+...+ .|.+++.++..+.....   
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~---  340 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ---  340 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---
Confidence            456888899999999999987754 678889999765432      2223466665555 58899988776643222   


Q ss_pred             eEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       136 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                        .|+--|||.+....+-..   ....+.+...+.+..|++.++.++|+. .++|+|+||+||++..++...++.|||..
T Consensus       341 --~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 --GYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             --ccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccccc
Confidence              458889997532222111   123455666788899999999999987 99999999999999876457899999987


Q ss_pred             eecccCCCcceeeeccccc-ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          216 KVLVKGEPNISYICSRYYR-APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ..+.-  ........-.++ .+|++.....+..+.|++|||..+.+.++|.+.-...+..   ..+...           
T Consensus       415 t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~-----------  478 (524)
T KOG0601|consen  415 TRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSG-----------  478 (524)
T ss_pred             cccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecc-----------
Confidence            54211  111222233444 3666666666889999999999999999997543322111   111100           


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                              ..+.          .+..+.++..+.+.++..++..|+.+.++..|.=|...
T Consensus       479 --------~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  479 --------DTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             --------cccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                    0000          02234678889999999999999999999988766543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=3.6e-10  Score=94.96  Aligned_cols=123  Identities=15%  Similarity=0.336  Sum_probs=83.9

Q ss_pred             EeeeCCcEEEEEEEEccCCcEEEEEEeccc------------hhhhHHHHHHHHHcCCC--CeeecceeeeecCCCCceE
Q 015615           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQD------------KRYKNRELQTMRLLDHP--NVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~  137 (403)
                      .+++|+-+.+|.+..  -|..+++|.-..+            .....+|..++..+.--  +...++++.     .+.  
T Consensus         3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-----~~~--   73 (204)
T COG3642           3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-----PDN--   73 (204)
T ss_pred             hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCC--
Confidence            578899999999865  4555677743211            12234688888877532  233333321     222  


Q ss_pred             EEEEEecccchHHH-HHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~~l~~-~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ..|+|||++|.+.. .+...           ...++..+-..+.-||.. ||||+||.++||++..+  .+.++|||++.
T Consensus        74 ~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~--~i~~IDfGLg~  139 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGG--RIYFIDFGLGE  139 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCC--cEEEEECCccc
Confidence            34899999986544 55432           134566777788899988 99999999999999854  49999999986


Q ss_pred             e
Q 015615          217 V  217 (403)
Q Consensus       217 ~  217 (403)
                      .
T Consensus       140 ~  140 (204)
T COG3642         140 F  140 (204)
T ss_pred             c
Confidence            4

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=3.4e-09  Score=99.21  Aligned_cols=259  Identities=16%  Similarity=0.213  Sum_probs=154.0

Q ss_pred             EEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-hhhHHHHHHHHHc-CCCCeeecce----eeeecCCCCceEEEEEE
Q 015615           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKH----CFFSTTEKDELYLNLVL  142 (403)
Q Consensus        69 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~----~~~~~~~~~~~~~~lv~  142 (403)
                      .++.||+|+-+.+|-.-.  -+. .+.|++.... ....+-+..|... .||-+-.-..    ..+. . .....+.+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G-~-~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHG-G-RRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecch--hhc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhC-C-CccceeEEec
Confidence            356799999999995432  222 3446654322 2222233333333 4554322010    0111 1 1222267889


Q ss_pred             ecccc--hHHHHHHh--hcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          143 EYVPE--TVHRVIKH--HYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       143 e~~~~--~l~~~l~~--~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +.+++  .+..+..-  +...........+...++.++.+.+-||.+ |.+-+|+.++|+|+.+++ .|.|.|=..-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDS-KVVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCc-eEEEEcccceeec
Confidence            98885  33333321  111233466778889999999999999998 999999999999999777 7999886654444


Q ss_pred             ccCCCcceeeeccccccccccc----CCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCC--HHH
Q 015615          219 VKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPT--REE  291 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~--~~~  291 (403)
                      .++......+|.+.|.+||.-.    ..-..+...|.|.||+++++++.| ++||.+-..         ....|.  +..
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~ap~p~E~~  238 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDAPNPLETD  238 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCCCCcchhh
Confidence            4455555667889999999753    112256789999999999999986 999987421         111111  112


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhcc--CCCCCCCHHH
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY--SPNLRSTALE  344 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~--dP~~R~s~~e  344 (403)
                      +..-.-.|.....+.....+.. .-..-+++++..|..+|+..  ++.-|||++.
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~-~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRS-IPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             hhcceeeechhccCCCCCCCCC-CChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            2211111111111111111111 11134789999999999964  3568999764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=6.8e-10  Score=95.95  Aligned_cols=121  Identities=22%  Similarity=0.304  Sum_probs=75.0

Q ss_pred             EEEEEEEccCCcEEEEEEeccch------------------------------hhhHHHHHHHHHcCCC--Ceeecceee
Q 015615           80 VVFQAKCLETGEAVAIKKVLQDK------------------------------RYKNRELQTMRLLDHP--NVVSLKHCF  127 (403)
Q Consensus        80 ~Vy~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~~l~h~--niv~~~~~~  127 (403)
                      .||.|.. .+|..+|||..+...                              ....+|...|.++..-  ++.+.+.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899986 568899999873210                              1224699999999765  445544321


Q ss_pred             eecCCCCceEEEEEEeccc--chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHH-HHhcCCccccCCCCCceEecCCC
Q 015615          128 FSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY-IHNTIGVCHRDIKPQNLLVNPHT  204 (403)
Q Consensus       128 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~-LH~~~~ivH~Dlkp~NIll~~~~  204 (403)
                           .    .+|||||++  |.....+....     ++......++.+++..+.. +|+. ||||+||.+.||+++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-
Confidence                 2    258999999  63223333211     1122355667788886665 5665 99999999999999865 


Q ss_pred             CceEEeecCCceec
Q 015615          205 HQLKLCDFGSAKVL  218 (403)
Q Consensus       205 ~~vkl~DfG~a~~~  218 (403)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             5999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.02  E-value=2.3e-09  Score=95.68  Aligned_cols=139  Identities=16%  Similarity=0.178  Sum_probs=90.7

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCC--eeecceeeeecCCCCceEEEEEEe
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      +.|+.|.++.||++... +|+.+++|.....     .....+|..+++.+.+.+  +.+++.....  .......++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~--~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCED--PSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCC--CCccCCceEEEE
Confidence            56899999999999863 3688999987543     235678999999997633  4444433211  111123579999


Q ss_pred             cccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 015615          144 YVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--------------------------------------  184 (403)
Q Consensus       144 ~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~--------------------------------------  184 (403)
                      |++|. +...+.     ...++......++.+++.+|..||+                                      
T Consensus        81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99874 222111     0234444555556666666666653                                      


Q ss_pred             -----------------cCCccccCCCCCceEecCC-CCceEEeecCCcee
Q 015615          185 -----------------TIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  217 (403)
Q Consensus       185 -----------------~~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~  217 (403)
                                       ...++|+|++|.||+++.+ +..+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             1257999999999999873 22588999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.02  E-value=1.5e-08  Score=92.85  Aligned_cols=132  Identities=12%  Similarity=0.108  Sum_probs=86.6

Q ss_pred             EEEEEEEccCCcEEEEEEeccch---------------hhhHHHHHHHHHcCCCCeeec--ceeeeecCCCCceEEEEEE
Q 015615           80 VVFQAKCLETGEAVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSL--KHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        80 ~Vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~niv~~--~~~~~~~~~~~~~~~~lv~  142 (403)
                      .|+++..  .|+.|.||......               ....+|...+.++..-.|...  ..+...........-++||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555543  56778888653211               124578888877743332222  2222111111122356899


Q ss_pred             ecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC------CCceEEeecCC
Q 015615          143 EYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH------THQLKLCDFGS  214 (403)
Q Consensus       143 e~~~~--~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~------~~~vkl~DfG~  214 (403)
                      |++++  +|.+++....  ....+......++.+++..+.-||.. ||+|+|++++|||++.+      ...+.|+||+.
T Consensus       115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            99997  5777765332  23445667778999999999999998 99999999999999752      34799999998


Q ss_pred             ce
Q 015615          215 AK  216 (403)
Q Consensus       215 a~  216 (403)
                      +.
T Consensus       192 ~~  193 (268)
T PRK15123        192 AQ  193 (268)
T ss_pred             cc
Confidence            75

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.84  E-value=1.7e-08  Score=90.04  Aligned_cols=130  Identities=19%  Similarity=0.191  Sum_probs=88.9

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--------------------------hhhhHHHHHHHHHcCCC--
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------------------------KRYKNRELQTMRLLDHP--  118 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~E~~~l~~l~h~--  118 (403)
                      +.++..||-|--|.||.|.+. .|.++|||.-+..                          ....++|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            667889999999999999974 7899999954211                          11224789999988654  


Q ss_pred             CeeecceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCce
Q 015615          119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  198 (403)
Q Consensus       119 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NI  198 (403)
                      .+.+.++.         ...++||||++|-.+.-+        ++.......++..|+.-+..+-.. ||||+|+.+-||
T Consensus       172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~~-GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIAW---------NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYRR-GIVHGDLSEFNI  233 (304)
T ss_pred             CCCCcccc---------ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHHc-CccccCCchheE
Confidence            55554331         125689999998422111        112223344455555555555545 999999999999


Q ss_pred             EecCCCCceEEeecCCce
Q 015615          199 LVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       199 ll~~~~~~vkl~DfG~a~  216 (403)
                      +++.+| .+.++||--+.
T Consensus       234 lV~~dg-~~~vIDwPQ~v  250 (304)
T COG0478         234 LVTEDG-DIVVIDWPQAV  250 (304)
T ss_pred             EEecCC-CEEEEeCcccc
Confidence            999988 69999996553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.71  E-value=3.2e-07  Score=81.07  Aligned_cols=107  Identities=18%  Similarity=0.316  Sum_probs=74.0

Q ss_pred             hHHHHHHHHHcCCCCe--eecceeeeecCCCCceEEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHH
Q 015615          105 KNRELQTMRLLDHPNV--VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA  180 (403)
Q Consensus       105 ~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~  180 (403)
                      ..+|...+..+..-.|  .+.+.+...... ....-++|+|++++  +|.+.+....    ..+......++.+++..++
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHHH
Confidence            4568887777643222  222222222111 12345789999986  5677666532    2555567788999999999


Q ss_pred             HHHhcCCccccCCCCCceEecCCC--CceEEeecCCcee
Q 015615          181 YIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  217 (403)
Q Consensus       181 ~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~a~~  217 (403)
                      -||+. ||+|+|+++.|||++.++  ..+.++||+-++.
T Consensus       133 ~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99998 999999999999998764  3589999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.68  E-value=5.3e-07  Score=78.89  Aligned_cols=135  Identities=16%  Similarity=0.198  Sum_probs=84.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhh-------------HHHHHHHHHcCCC---Ceeecceeee
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMRLLDHP---NVVSLKHCFF  128 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------------~~E~~~l~~l~h~---niv~~~~~~~  128 (403)
                      .+|.+.+++-......|.+..-  +|..+++|..+......             .+++..+..+...   ....++-+..
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            4688889999888887777653  78899999775433222             2344444444322   2222211111


Q ss_pred             ecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCce
Q 015615          129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  207 (403)
Q Consensus       129 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~v  207 (403)
                      -....-....+|+|||++| .+.+..        .+++    .+...+..++.-||+. |++|+|..|.|++++.++  +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~~--i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNNG--I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc-CCccCCCCcCcEEEECCc--E
Confidence            1111222335689999998 333221        1222    2334677889999987 999999999999998544  9


Q ss_pred             EEeecCCce
Q 015615          208 KLCDFGSAK  216 (403)
Q Consensus       208 kl~DfG~a~  216 (403)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=8.3e-07  Score=77.41  Aligned_cols=138  Identities=12%  Similarity=0.109  Sum_probs=95.1

Q ss_pred             eeCCcEEEEEEEEccCCcEEEEEEecc----------chhhhHHHHHHHHHcCCCC--eeecceeeeecCCCCceEEEEE
Q 015615           74 GHGSFGVVFQAKCLETGEAVAIKKVLQ----------DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        74 g~G~~g~Vy~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      |.||.+.|+....  .|..+-+|.-..          ....+.+|...|..+..-+  +.+.. ++-.........-+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            6688888988764  455788886531          2234568999988885332  33332 1111112233445789


Q ss_pred             Eecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC-ceEEeecCCcee
Q 015615          142 LEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  217 (403)
Q Consensus       142 ~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-~vkl~DfG~a~~  217 (403)
                      +|-+++  +|.+.+....  ..+.+......++.+++..++-||+. |+.|+|+-+.||+++.++. .++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998884  7777764421  23456666778899999999999998 9999999999999985551 499999986653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.67  E-value=3e-09  Score=104.34  Aligned_cols=242  Identities=18%  Similarity=0.174  Sum_probs=161.6

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCC-eeecceeeeecCCCCceEEEEEEecc
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      |...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++.+     ..+.+.+++|+++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhhh
Confidence            445567899999999999986666555 6766544 44456899999999999 44443333     5667889999999


Q ss_pred             cch--HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCC
Q 015615          146 PET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (403)
Q Consensus       146 ~~~--l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~  223 (403)
                      +++  ......   ...-.+.+-....+.+.-+++++++|+. -=+|+|    ||+..+ + ..|..||+....+.....
T Consensus       317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~-~-~~~~~~~~v~~~L~~~~~  386 (829)
T KOG0576|consen  317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSE-E-EVKLLDFAVPPQLTRTMK  386 (829)
T ss_pred             cCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----cccccc-c-ccccccccCCcccCcccc
Confidence            854  111100   0011223334455566778899999975 558888    888875 3 589999999877766655


Q ss_pred             cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccccc
Q 015615          224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  303 (403)
Q Consensus       224 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                      ..+..+|+.++|||+..... +....|.|++|.--.+|.-|-+|-.....  ...    ..+..+              .
T Consensus       387 ~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~----~~g~~p--------------~  445 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLP----MIGNGP--------------N  445 (829)
T ss_pred             cccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc--ccC----CCCCCC--------------C
Confidence            66778999999999986655 88899999999877778778777644110  000    000000              0


Q ss_pred             CCCccC-CCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          304 FPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       304 ~~~~~~-~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                      .+.+.. ..|...+       -.++...|+..-|..|+....++.|.+|..
T Consensus       446 s~~L~~~~aw~~~~-------~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  446 SPMLTDKSAWSPVF-------HRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             ccccchhhhcCccc-------ccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            000000 1222221       125777899999999999999999988875

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=7.2e-08  Score=95.59  Aligned_cols=133  Identities=22%  Similarity=0.308  Sum_probs=83.8

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccchh--------------------------------------------hhH
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR--------------------------------------------YKN  106 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------------------------------------------~~~  106 (403)
                      +.|+.++-|+||+|+. .+|+.||||+.+..-+                                            ...
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            5789999999999996 5599999998743210                                            001


Q ss_pred             HHHHHHHHc----CCCCeeecceeeeecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHH-----HHHHHHHHHH
Q 015615          107 RELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLI-----YVKLYFYQIC  176 (403)
Q Consensus       107 ~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~-----~~~~~~~qi~  176 (403)
                      +|...+.++    +...-+.+-.+|++...+    -.|+|||++| .+.+......   ..++..     .+..++.|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~~q~~  282 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHHHHHH
Confidence            355555444    233334444445432222    3589999998 4544422211   233322     2333333332


Q ss_pred             HHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       177 ~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                             .. |+.|.|.+|.||+++.++ ++.+.|||+...+..
T Consensus       283 -------~d-gffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 -------RD-GFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP  317 (517)
T ss_pred             -------hc-CccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence                   24 999999999999999987 799999999876533

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.64  E-value=4.5e-07  Score=80.20  Aligned_cols=132  Identities=16%  Similarity=0.208  Sum_probs=88.5

Q ss_pred             EeeeCCcEEEEEEEEccCCcEEEEEEeccchh----------------------------hhHHHHHHHHHcC--CCCee
Q 015615           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR----------------------------YKNRELQTMRLLD--HPNVV  121 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------------------------~~~~E~~~l~~l~--h~niv  121 (403)
                      .|.+|--+.||+|.. .++..+|+|++.....                            ...+|...|+++.  +-.+.
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            677888889999984 5688999998743211                            1135777887774  33333


Q ss_pred             ecceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec
Q 015615          122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (403)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~  201 (403)
                      +-+.+.     .    -.|||||++...   ...-.-..-++....+..+..+++..+.-|-...++||+||+.-|||+.
T Consensus       134 ~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         134 EPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             Cceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence            333322     1    358999998530   0000001122333357777888999998888745999999999999999


Q ss_pred             CCCCceEEeecCCceec
Q 015615          202 PHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       202 ~~~~~vkl~DfG~a~~~  218 (403)
                       ++ .+.|+|||.|...
T Consensus       202 -~~-~p~iID~~QaV~~  216 (268)
T COG1718         202 -DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             -CC-eEEEEECcccccc
Confidence             44 6999999988654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.55  E-value=3.5e-07  Score=95.67  Aligned_cols=204  Identities=21%  Similarity=0.305  Sum_probs=135.2

Q ss_pred             HHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 015615          106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN  184 (403)
Q Consensus       106 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~  184 (403)
                      +-|+..+..+.|+|++.++.+-+.....+ ..+.+..++|.. ++...+.+    -...+...++.+..++++||.++|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            45777888899999999876554332222 112234456664 44444443    3668888999999999999999998


Q ss_pred             cCCccccCCCCC---ceEecCCCCceEEe--ecCCceecccCCCcceeeecccccccccccCCC-CCCCchhHHHHHHHH
Q 015615          185 TIGVCHRDIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVL  258 (403)
Q Consensus       185 ~~~ivH~Dlkp~---NIll~~~~~~vkl~--DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il  258 (403)
                      . ...|.-|..+   +.-.+.++ .+.++  ||+.++.............+..+.+||...... ......|+|++|...
T Consensus       305 ~-~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  305 L-SLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             h-ccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            6 6666655544   34445555 46666  998887765555444455566688888774332 123347999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC
Q 015615          259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  338 (403)
Q Consensus       259 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~  338 (403)
                      ..+..|..+-.....   ....                                   ..........+++.+|+.-++++
T Consensus       383 ~~~~~~~~i~~~~~~---~~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~~~~  424 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV---PVSL-----------------------------------LDVLSTSELLDALPKCLDEDSEE  424 (1351)
T ss_pred             hhhhhcCcccccccc---hhhh-----------------------------------hccccchhhhhhhhhhcchhhhh
Confidence            999987643221100   0000                                   00111226788999999999999


Q ss_pred             CCCHHHHhcCCCCccC
Q 015615          339 RSTALEALIHPFFDEL  354 (403)
Q Consensus       339 R~s~~ell~hp~f~~~  354 (403)
                      |+++.+++.|||.+.-
T Consensus       425 Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  425 RLSALELLTHPFLRFP  440 (1351)
T ss_pred             ccchhhhhhchhcccc
Confidence            9999999999998753

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.35  E-value=5.9e-06  Score=74.08  Aligned_cols=74  Identities=19%  Similarity=0.199  Sum_probs=48.8

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCC--eeecceeeeecCCCCceEEEEEEecc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      .+.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....  +.+++...  .........+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            4679999999999998633  58999987654  345567888888885332  33443322  1122233467899999


Q ss_pred             cc
Q 015615          146 PE  147 (403)
Q Consensus       146 ~~  147 (403)
                      +|
T Consensus        78 ~g   79 (239)
T PF01636_consen   78 PG   79 (239)
T ss_dssp             SS
T ss_pred             cc
Confidence            86

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=1.5e-05  Score=79.18  Aligned_cols=136  Identities=22%  Similarity=0.302  Sum_probs=81.9

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhh-----------------------------------------hHHH
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY-----------------------------------------KNRE  108 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----------------------------------------~~~E  108 (403)
                      .+.||.-+.|+||+|+.+ +|+.||||+-+..-+.                                         +.+|
T Consensus       166 ~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            357999999999999964 5999999975332100                                         0123


Q ss_pred             HHHHH----HcCCCC---eeecceeeeecCCCCceEEEEEEecccc-hH--HHHHHhhcccCCCCCHHHHHHHHHHHHHH
Q 015615          109 LQTMR----LLDHPN---VVSLKHCFFSTTEKDELYLNLVLEYVPE-TV--HRVIKHHYKMSQRMPLIYVKLYFYQICRA  178 (403)
Q Consensus       109 ~~~l~----~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l--~~~l~~~~~~~~~l~~~~~~~~~~qi~~~  178 (403)
                      .+...    .+.|-+   -|.+-.+|++-...    -.|+||||+| .+  .+.+..     ..++...+...+.++..-
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~----RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~  315 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTK----RVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLE  315 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCcc----eEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHH
Confidence            33332    234555   23333334332221    4699999997 22  233433     334444443333333222


Q ss_pred             HHHHHhcCCccccCCCCCceEecC---CCCceEEeecCCceec
Q 015615          179 LAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  218 (403)
Q Consensus       179 L~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~DfG~a~~~  218 (403)
                      +-+  .. |++|+|=+|.||++++   .+.++.+-|||+....
T Consensus       316 qIf--~~-GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  316 QIF--KT-GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHH--hc-CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            222  24 9999999999999984   2458999999998754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.20  E-value=1.7e-05  Score=71.11  Aligned_cols=69  Identities=17%  Similarity=0.143  Sum_probs=44.1

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCe--eecceeeeecCCCCceEEEEEEeccc
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNV--VSLKHCFFSTTEKDELYLNLVLEYVP  146 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~  146 (403)
                      ..||.|..+.||+.    .|..+++|.....  .....+|.++++.+..-.+  .+.+.+.     .+....++|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            46899999999974    2456788987542  2345789999988753322  2332222     12222568999998


Q ss_pred             ch
Q 015615          147 ET  148 (403)
Q Consensus       147 ~~  148 (403)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            83

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.11  E-value=1.5e-05  Score=66.90  Aligned_cols=126  Identities=22%  Similarity=0.368  Sum_probs=83.5

Q ss_pred             EEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        68 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      ++.+.||+|.+|.||+|.+  .|..+|+|+-+.+  ...++.|+++|..++-.++-+-.-.+ .   .    .++.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhhh
Confidence            4567899999999999997  6778999976544  45667899999999876665432111 1   1    23579999


Q ss_pred             cc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC-C-CceEecCCCCceEEeecCCcee
Q 015615          146 PE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK-P-QNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       146 ~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlk-p-~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .| .|......       ...    .-...+++. +|.=+..||-|+.|. | .||+++ ++ .+.|+||..|+.
T Consensus        95 ~G~~L~~~~~~-------~~r----k~l~~vlE~-a~~LD~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~  155 (201)
T COG2112          95 DGRPLGKLEIG-------GDR----KHLLRVLEK-AYKLDRLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATF  155 (201)
T ss_pred             cCcchhhhhhc-------ccH----HHHHHHHHH-HHHHHHhccchhhhcCCceeEEec-CC-cEEEEEccchhh
Confidence            98 54433221       011    222345555 333344599999997 4 455655 44 699999998863

>PLN02876 acyl-CoA dehydrogenase

Probab=97.99  E-value=8.6e-05  Score=79.24  Aligned_cols=77  Identities=19%  Similarity=0.210  Sum_probs=49.2

Q ss_pred             EeEeeeCCcEEEEEEEEccCC--cEEEEEEecc-----chhhhHHHHHHHHHcC-CCCe--eecceeeeecCCCCceEEE
Q 015615           70 ERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQ-----DKRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~--~~vaiK~~~~-----~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~  139 (403)
                      .+.++.|.++.+|+......+  ..+++|+...     ......+|..+++.+. |.++  .+++..+..  .......|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d--~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD--ASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC--CCcCCCce
Confidence            456899999999998764332  4678887543     2235678999999995 6664  444333211  11112356


Q ss_pred             EEEecccch
Q 015615          140 LVLEYVPET  148 (403)
Q Consensus       140 lv~e~~~~~  148 (403)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            899999874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.97  E-value=8.4e-05  Score=64.47  Aligned_cols=126  Identities=26%  Similarity=0.354  Sum_probs=85.9

Q ss_pred             cceEEEeEeeeCCc-EEEEEEEEccCCcEEEEEEecc---c----------h------------hhhHHHHHHHHHc---
Q 015615           65 ISYMAERVVGHGSF-GVVFQAKCLETGEAVAIKKVLQ---D----------K------------RYKNRELQTMRLL---  115 (403)
Q Consensus        65 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~vaiK~~~~---~----------~------------~~~~~E~~~l~~l---  115 (403)
                      .+++..+.||.|.- |.||+++.  .|+.||||.+..   .          .            ..+..|.....+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            46889999999999 99999986  788999998321   0          0            1123466665555   


Q ss_pred             CCCCe--eecceeeeecCC-------------CCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHH
Q 015615          116 DHPNV--VSLKHCFFSTTE-------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA  180 (403)
Q Consensus       116 ~h~ni--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~  180 (403)
                      .+.+.  |+++++..-..+             .......||.||+...-            .+..    .=+.+|.+-+.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHH
Confidence            45555  888887643310             11223467888876531            1222    22457888899


Q ss_pred             HHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       181 ~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|.. ||+-+|+++.|..   +   =||+|||.+
T Consensus       179 ~~~k~-gI~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL-GIVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             HHHHC-CeeeccCcccccc---C---CEEEecccC
Confidence            99976 9999999999975   2   379999865

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.87  E-value=0.00014  Score=66.08  Aligned_cols=69  Identities=19%  Similarity=0.151  Sum_probs=40.8

Q ss_pred             eeeCCc-EEEEEEEEccCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEEEEecccch
Q 015615           73 VGHGSF-GVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPET  148 (403)
Q Consensus        73 lg~G~~-g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~  148 (403)
                      |-.|.. +.||++..  .+..+.+|..... .....+|+++++.+. +--+.+++.+. .  ..  ...++||++++|.
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-~--~~--~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYG-S--DD--GRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEE-e--cC--CccEEEEEeeCCc
Confidence            334444 78999874  3467888876432 134567999988885 22233333322 1  11  2356899999873

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.79  E-value=0.00015  Score=67.91  Aligned_cols=137  Identities=16%  Similarity=0.231  Sum_probs=93.8

Q ss_pred             EEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------h-----------------------hhhHHHHHHHHHcCC
Q 015615           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------K-----------------------RYKNRELQTMRLLDH  117 (403)
Q Consensus        68 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~-----------------------~~~~~E~~~l~~l~h  117 (403)
                      .+..+|..|--+.||.|. ..+|..+|||+++-.       .                       -..++|+..|+++..
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            345678889999999998 477888999986321       0                       122468888998865


Q ss_pred             CCeeecceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 015615          118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (403)
Q Consensus       118 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~N  197 (403)
                      .-|..---..+.       ...|||++++..-   +....-..-.++...+..+-.|++.-+.-|-..+++||.||.--|
T Consensus       226 aGIP~PePIlLk-------~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCPEPILLK-------NHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCCCceeee-------cceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            443322111111       1358999998420   111111134466667888888888888888877899999999999


Q ss_pred             eEecCCCCceEEeecCCcee
Q 015615          198 LLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       198 Ill~~~~~~vkl~DfG~a~~  217 (403)
                      +|+- +| .+.|+|.+-+..
T Consensus       296 ~Lyh-dG-~lyiIDVSQSVE  313 (520)
T KOG2270|consen  296 LLYH-DG-KLYIIDVSQSVE  313 (520)
T ss_pred             heEE-CC-EEEEEEcccccc
Confidence            9997 35 699999987754

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.77  E-value=3e-05  Score=75.23  Aligned_cols=170  Identities=21%  Similarity=0.270  Sum_probs=111.0

Q ss_pred             HHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 015615          107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI  186 (403)
Q Consensus       107 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  186 (403)
                      -....++.+.|+|...+.++.-...   . ...+|||++..++.+.+..+.     +..       .+++     -  + 
T Consensus        31 gr~~~lktl~~~~l~~yl~~~r~~~---~-r~IVV~e~~~~Sled~~~~~~-----l~~-------~s~~-----~--~-   86 (725)
T KOG1093|consen   31 GRFQYLKSLQHDNLCQYLDFSRGKH---E-RVIVVMEHYTMSLEDILKTGN-----LKD-------ESLL-----A--H-   86 (725)
T ss_pred             hhhHHHHhhcCccceeeEeeecCcc---c-eEEEEehhhccchHHHHHhcc-----cch-------hhhc-----c--c-
Confidence            4577888999999999876542222   1 266899999999988876542     100       0111     1  2 


Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  266 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~  266 (403)
                      ++.|-     |        .++.+| -++              |. |  |-.      ..+|+||||+|.++.++..|..
T Consensus        87 ~~~~~-----~--------~~~~td-~~~--------------t~-~--~~~------~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   87 GVLHL-----N--------IIYITD-HFL--------------TK-Y--PSP------IGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             cccee-----h--------hhhccc-ccc--------------cc-C--CCC------CCcchhhhhHHHHHHHHHHhhH
Confidence            33221     1        344444 010              00 1  111      2259999999999999999998


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          267 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       267 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                      .+......+....+.+..-.+.......+..                 .+...++....+++.+|+-..|..||...++.
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-----------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAMEH-----------------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHHHH-----------------HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            8888777777777766544443322211110                 12334678889999999999999999999999


Q ss_pred             cCCCCccC
Q 015615          347 IHPFFDEL  354 (403)
Q Consensus       347 ~hp~f~~~  354 (403)
                      +++-|.++
T Consensus       193 k~~i~~ev  200 (725)
T KOG1093|consen  193 KRCSFTEV  200 (725)
T ss_pred             cCccHHHH
Confidence            99999886

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.76  E-value=0.00039  Score=62.59  Aligned_cols=69  Identities=20%  Similarity=0.314  Sum_probs=43.6

Q ss_pred             EeEeeeCCcEEEEEEEEcc-CCcEEEEEEeccch---hhhHHHHHHHHHcCCCCe-eecceeeeecCCCCceEEEEEEec
Q 015615           70 ERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      .+.|..|-...+|++.... .+..|++|......   ...++|+.+++.+....+ .+++..+     .+    .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence            3567888899999987532 35789999765432   223478989988854333 3332211     11    369999


Q ss_pred             ccc
Q 015615          145 VPE  147 (403)
Q Consensus       145 ~~~  147 (403)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.70  E-value=0.00034  Score=63.13  Aligned_cols=29  Identities=34%  Similarity=0.441  Sum_probs=24.0

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCce
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +++|+|+.|.||+++.++ ..-|+||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            589999999999998543 45699999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.65  E-value=0.00058  Score=59.63  Aligned_cols=123  Identities=20%  Similarity=0.312  Sum_probs=80.0

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccch--------------------hhhHHHHHHHHHcC------CCCeeecc
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------------------RYKNRELQTMRLLD------HPNVVSLK  124 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~------h~niv~~~  124 (403)
                      ..||+|+.=.||.  |. .....+||+.....                    ....+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            4789999999994  33 34457888875544                    34456777766665      78888888


Q ss_pred             eeeeecCCCCceEEEEEEeccc---c----hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 015615          125 HCFFSTTEKDELYLNLVLEYVP---E----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (403)
Q Consensus       125 ~~~~~~~~~~~~~~~lv~e~~~---~----~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~N  197 (403)
                      +...+..     -+.+|+|.+.   |    +|.+++.+     ..++. .+..   .+-.-..||-++ +|+.+||+|.|
T Consensus        84 G~veT~~-----G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~---~L~~f~~~l~~~-~Iv~~dl~~~N  148 (199)
T PF10707_consen   84 GFVETNL-----GLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQ---ALDEFKRYLLDH-HIVIRDLNPHN  148 (199)
T ss_pred             EEEecCC-----ceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHH---HHHHHHHHHHHc-CCeecCCCccc
Confidence            8653322     2567888753   2    45555532     44555 2333   333445667766 99999999999


Q ss_pred             eEecCCC--C-ceEEee
Q 015615          198 LLVNPHT--H-QLKLCD  211 (403)
Q Consensus       198 Ill~~~~--~-~vkl~D  211 (403)
                      |++....  . .+.|+|
T Consensus       149 Iv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEEecCCCceEEEEEe
Confidence            9995432  2 567777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.64  E-value=0.00028  Score=64.56  Aligned_cols=132  Identities=19%  Similarity=0.237  Sum_probs=72.3

Q ss_pred             eeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeee-cceeeeecCCCCceEEEEEEecccc
Q 015615           73 VGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS-LKHCFFSTTEKDELYLNLVLEYVPE  147 (403)
Q Consensus        73 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~lv~e~~~~  147 (403)
                      +..|-.+.+|+..  .++..+++|......    ....+|..+++.+....+++ ++...     .    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4567788899886  356788898754332    13467999999886433322 22111     1    1479999886


Q ss_pred             hHH---------------HHHHhhccc---CCCCCHH-HHHHHHHHH---------HHHHHHHHh-------cCCccccC
Q 015615          148 TVH---------------RVIKHHYKM---SQRMPLI-YVKLYFYQI---------CRALAYIHN-------TIGVCHRD  192 (403)
Q Consensus       148 ~l~---------------~~l~~~~~~---~~~l~~~-~~~~~~~qi---------~~~L~~LH~-------~~~ivH~D  192 (403)
                      ...               +.+.+....   ..+++.. .+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            321               111111111   1111211 112222111         111111211       12589999


Q ss_pred             CCCCceEecCCCCceEEeecCCcee
Q 015615          193 IKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       193 lkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +.|.||+++.++  +.|+||..|..
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccCc
Confidence            999999998765  78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.64  E-value=3.9e-05  Score=82.80  Aligned_cols=216  Identities=17%  Similarity=0.020  Sum_probs=138.9

Q ss_pred             HHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015615          107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT  185 (403)
Q Consensus       107 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~  185 (403)
                      .|...++...|+++...+.-..   .......+.+++|+. |.+...+.+.......+....+-....+.+.+..-+|+.
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~---ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIP---PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCC---CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            3555666778999887654331   122233567999988 577777766554444444444444444446666666654


Q ss_pred             CC----ccccCCCCCceEecCCCCceEEeecCCceeccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHH
Q 015615          186 IG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  260 (403)
Q Consensus       186 ~~----ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e  260 (403)
                      -+    .+|++||+-|.+|..+. ++|+.++|+.+.... ........+++.|+.|++.. ...++.++|+|..|+.+|.
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHH
Confidence            23    68999999999999877 799999999983222 22233557788999999874 3457888999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC
Q 015615          261 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  340 (403)
Q Consensus       261 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~  340 (403)
                      ...|..+|..     .++.+.++.           -.+-..++            .+.-.|.++-.....+|-+.-..||
T Consensus      1433 rs~~n~~fi~-----flq~~Lkgi-----------idn~tf~s------------Ie~l~pgdaNve~~~~Ll~K~~~rp 1484 (2724)
T KOG1826|consen 1433 RSDGNAYFIF-----FLQPALKGI-----------IDNHTFFS------------IEKLKPGDANVEALHRLLWKYMERP 1484 (2724)
T ss_pred             HhcccHHHHH-----HHHHHHcCc-----------cccccccc------------ccccCCCcccHHHHHHHHHHhhhcc
Confidence            9999887742     222222210           00001111            1112345555566666667777899


Q ss_pred             CHHHHhcCCCCccCC
Q 015615          341 TALEALIHPFFDELR  355 (403)
Q Consensus       341 s~~ell~hp~f~~~~  355 (403)
                      .-...+.-+.|.-..
T Consensus      1485 ~q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1485 GQYISLSRDHFAVGL 1499 (2724)
T ss_pred             hhhhhcccccccccc
Confidence            999888887776543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.51  E-value=0.0019  Score=62.59  Aligned_cols=71  Identities=21%  Similarity=0.322  Sum_probs=46.0

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEecc-----------chhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~  135 (403)
                      .+.||.|.+..||++.+...++.|+||.-..           .......|.+.|+.+.   ..++.+++.+-     .+.
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~  105 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL  105 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC
Confidence            3578999999999999854336899997421           1223345777777763   34555655431     111


Q ss_pred             eEEEEEEecccc
Q 015615          136 LYLNLVLEYVPE  147 (403)
Q Consensus       136 ~~~~lv~e~~~~  147 (403)
                        .++||||+++
T Consensus       106 --~~lVME~L~~  115 (401)
T PRK09550        106 --AVTVMEDLSD  115 (401)
T ss_pred             --CEEEEecCCC
Confidence              4589999874

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.43  E-value=0.0015  Score=61.54  Aligned_cols=144  Identities=14%  Similarity=0.044  Sum_probs=75.8

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCC--eeecceeeeec-CCCCceEEEEEEec
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFST-TEKDELYLNLVLEY  144 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~  144 (403)
                      .+.++.|....+|++.. . +..+++|.....  ......|..++..|....  +.+++...-.. ........+++++|
T Consensus        27 i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            45677777789998864 3 346888977542  334556777887774322  23332211000 00112345789999


Q ss_pred             ccchH------------HHHHHhhcccCCCC--------CHHH-----HH----------HHHHHHHHHHHHHHh-----
Q 015615          145 VPETV------------HRVIKHHYKMSQRM--------PLIY-----VK----------LYFYQICRALAYIHN-----  184 (403)
Q Consensus       145 ~~~~l------------~~~l~~~~~~~~~l--------~~~~-----~~----------~~~~qi~~~L~~LH~-----  184 (403)
                      ++|..            ...+.........+        ....     ..          .....+...++++..     
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            87621            11111110000000        0000     00          001122334444432     


Q ss_pred             -cCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          185 -TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       185 -~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                       ..++||+|+.+.||+++.++ .+.|+||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence             24899999999999998776 56899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.41  E-value=0.00012  Score=67.46  Aligned_cols=128  Identities=17%  Similarity=0.223  Sum_probs=84.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEecc----------ch----------------hhhHHHHHHHHHcC-CC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----------DK----------------RYKNRELQTMRLLD-HP  118 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~----------~~----------------~~~~~E~~~l~~l~-h~  118 (403)
                      -|.+++.||-|.-+.||.+-+ ..|.+.++|.-+.          ..                -...+|...|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            377889999999999999986 5688899985311          11                11125888888874 43


Q ss_pred             Ceee-cceeeeecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 015615          119 NVVS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (403)
Q Consensus       119 niv~-~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~  196 (403)
                      .-|+ .++         ....|+|||++.| .|.+. .+      -.+   +..+...+..-+.-|-.+ |+||+|+.-=
T Consensus       172 fpVPkpiD---------~~RH~Vvmelv~g~Pl~~v-~~------v~d---~~~ly~~lm~~Iv~la~~-GlIHgDFNEF  231 (465)
T KOG2268|consen  172 FPVPKPID---------HNRHCVVMELVDGYPLRQV-RH------VED---PPTLYDDLMGLIVRLANH-GLIHGDFNEF  231 (465)
T ss_pred             CCCCCccc---------ccceeeHHHhhcccceeee-ee------cCC---hHHHHHHHHHHHHHHHHc-Cceecccchh
Confidence            3332 222         1225789999887 33222 11      111   223344555556667777 9999999999


Q ss_pred             ceEecCCCCceEEeecCCc
Q 015615          197 NLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a  215 (403)
                      ||+++.++ .++++||--.
T Consensus       232 Nimv~dd~-~i~vIDFPQm  249 (465)
T KOG2268|consen  232 NIMVKDDD-KIVVIDFPQM  249 (465)
T ss_pred             eeEEecCC-CEEEeechHh
Confidence            99999777 6999999643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.40  E-value=0.00043  Score=60.05  Aligned_cols=100  Identities=22%  Similarity=0.183  Sum_probs=73.8

Q ss_pred             HHHHHHHHHcCC-CCeeecceeeeecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHH
Q 015615          106 NRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH  183 (403)
Q Consensus       106 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH  183 (403)
                      ..|.-+++.+++ +++.+++|++     .    ..++.||.+. ++... ..........++.....++.+++..+.+++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            358888888876 6899998887     2    2468999884 33211 000001133577788999999999999999


Q ss_pred             h---cCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          184 N---TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       184 ~---~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .   . .+...|++|+|+-++.++ ++|++|...+..
T Consensus        77 ~~~~~-~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~  111 (188)
T PF12260_consen   77 HGPLG-FFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV  111 (188)
T ss_pred             cCCCC-cEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence            6   3 477889999999999777 799999987644

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=97.35  E-value=0.004  Score=58.90  Aligned_cols=29  Identities=31%  Similarity=0.327  Sum_probs=24.7

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCce
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ++||+|+.|.||+++.+. ..-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            899999999999998544 45799999874

>PRK10593 hypothetical protein; Provisional

Probab=97.35  E-value=0.0032  Score=58.94  Aligned_cols=74  Identities=7%  Similarity=-0.002  Sum_probs=48.5

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEecc--chhhhHHHHHHHHHcCC---CCeeecceeeeecCCCCceEEEEEEec
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLDH---PNVVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      .+.||.|..+.||+...  ++..+.+|..+.  ......+|...|+.+..   ..+.++++++....  ....-+||||+
T Consensus        19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEec
Confidence            45799999999999864  233577777544  23577889999998853   24555554432211  11225689999


Q ss_pred             ccc
Q 015615          145 VPE  147 (403)
Q Consensus       145 ~~~  147 (403)
                      ++|
T Consensus        95 i~G   97 (297)
T PRK10593         95 LRG   97 (297)
T ss_pred             cCC
Confidence            885

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.34  E-value=0.0018  Score=60.54  Aligned_cols=144  Identities=13%  Similarity=0.013  Sum_probs=76.0

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEecc-chhhhHHHHHHHHHcCCCC--eeecceeeeec-CCCCceEEEEEEecc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQTMRLLDHPN--VVSLKHCFFST-TEKDELYLNLVLEYV  145 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~~  145 (403)
                      .+.|..|....+|+...  .+..+++|.... .......|+.++..+.+..  +.+++...-.. ........+++++++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45677788889998864  345789998763 2344557888888885332  33332210000 000112356899999


Q ss_pred             cchH------------HHHHHhhcccCCCC--------CHHHHH------------HHHHHHHHHHHHHHh------cCC
Q 015615          146 PETV------------HRVIKHHYKMSQRM--------PLIYVK------------LYFYQICRALAYIHN------TIG  187 (403)
Q Consensus       146 ~~~l------------~~~l~~~~~~~~~l--------~~~~~~------------~~~~qi~~~L~~LH~------~~~  187 (403)
                      +|..            .+.+.........+        ......            .....+..++.++.+      ..+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            7621            11111111000000        000000            011112233344332      137


Q ss_pred             ccccCCCCCceEecCCCCceEEeecCCce
Q 015615          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       188 ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +||+|+.|.||+++.++ .+.|+||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            99999999999999755 56899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.99  E-value=0.0084  Score=57.01  Aligned_cols=69  Identities=23%  Similarity=0.236  Sum_probs=42.2

Q ss_pred             EeeeCCcEEEEEEEEccCCcEEEEEEeccc-----------hhhhHHHHHHHHHcC--CC-CeeecceeeeecCCCCceE
Q 015615           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------KRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~~~  137 (403)
                      .||.|....||++.+...++.|+||.-...           .....-|...|+...  -| ++.++|.+      ... .
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~------D~e-~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF------DTE-M   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE------ccc-c
Confidence            479999999999997544468999964211           122235777776653  23 44455432      111 1


Q ss_pred             EEEEEecccc
Q 015615          138 LNLVLEYVPE  147 (403)
Q Consensus       138 ~~lv~e~~~~  147 (403)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            3489999863

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.98  E-value=0.012  Score=55.24  Aligned_cols=31  Identities=35%  Similarity=0.580  Sum_probs=26.0

Q ss_pred             CCccccCCCCCceEecCC---CCceEEeecCCce
Q 015615          186 IGVCHRDIKPQNLLVNPH---THQLKLCDFGSAK  216 (403)
Q Consensus       186 ~~ivH~Dlkp~NIll~~~---~~~vkl~DfG~a~  216 (403)
                      ..++|+|+.|.||+++.+   .+.+.++||..|.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            368999999999999874   2369999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.85  E-value=0.016  Score=54.40  Aligned_cols=29  Identities=28%  Similarity=0.582  Sum_probs=24.9

Q ss_pred             CCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       186 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            37999999999999986 4 58999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.81  E-value=0.011  Score=56.85  Aligned_cols=71  Identities=17%  Similarity=0.200  Sum_probs=44.6

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEecc----------chhhhHHHHHHHHHcC--CC-CeeecceeeeecCCCCce
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----------DKRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~~  136 (403)
                      .+.||.|.-..||++.+...++.|+||.-..          ......-|.+.|+...  .| ++.++|.+      ....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------D~e~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------DSVM  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------CcHH
Confidence            5678999999999999744466799996421          1122334777777663  23 45555432      1111


Q ss_pred             EEEEEEecccc
Q 015615          137 YLNLVLEYVPE  147 (403)
Q Consensus       137 ~~~lv~e~~~~  147 (403)
                       ..+|||+++.
T Consensus       108 -~~~vMEdL~~  117 (409)
T PRK12396        108 -NCCVMEDLSD  117 (409)
T ss_pred             -hhHHHHhCcc
Confidence             3579999863

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.69  E-value=0.0081  Score=55.54  Aligned_cols=31  Identities=29%  Similarity=0.517  Sum_probs=25.2

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .++|+|++|.|||++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999986453356999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.67  E-value=0.019  Score=54.87  Aligned_cols=31  Identities=26%  Similarity=0.645  Sum_probs=26.2

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .++|+|+++.|||++.+...+.++||..|..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999986434799999998753

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.62  E-value=0.022  Score=54.18  Aligned_cols=30  Identities=27%  Similarity=0.435  Sum_probs=25.6

Q ss_pred             ccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       188 ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++|+|+.+.|||++.+++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975544799999998753

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.46  E-value=0.043  Score=51.63  Aligned_cols=30  Identities=13%  Similarity=0.186  Sum_probs=26.4

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||+|+.+.|||++.++ .+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            799999999999998776 689999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.33  E-value=0.012  Score=55.47  Aligned_cols=76  Identities=17%  Similarity=0.296  Sum_probs=59.3

Q ss_pred             CCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      .+..|.|++|++-.+.+...        ..-..+++..++.+.+.-++-+..+...-|||+.-.||||+ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            45678899999987764321        11234567788888888888888777899999999999999 66 7999999


Q ss_pred             CCceec
Q 015615          213 GSAKVL  218 (403)
Q Consensus       213 G~a~~~  218 (403)
                      -+++..
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999843

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.16  E-value=0.071  Score=50.03  Aligned_cols=30  Identities=27%  Similarity=0.513  Sum_probs=26.7

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .++|+|+.+.|++++.++ .+=+.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            489999999999999887 599999999864

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.01  E-value=0.14  Score=49.80  Aligned_cols=69  Identities=19%  Similarity=0.247  Sum_probs=43.9

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEecc-----------chhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~  135 (403)
                      .+.||.|....||+..+  .+..++||.-..           .......|...|+.+.   ..++.+++.+.     .+.
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~  109 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM  109 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence            56789999999999886  345699996531           1222234666666553   24566665543     222


Q ss_pred             eEEEEEEecccc
Q 015615          136 LYLNLVLEYVPE  147 (403)
Q Consensus       136 ~~~~lv~e~~~~  147 (403)
                        -+++||++++
T Consensus       110 --~vlvME~L~~  119 (418)
T PLN02756        110 --ALIGMRYLEP  119 (418)
T ss_pred             --CEEEEeecCC
Confidence              3578999965

>PTZ00384 choline kinase; Provisional

Probab=95.98  E-value=0.12  Score=50.00  Aligned_cols=29  Identities=28%  Similarity=0.378  Sum_probs=24.3

Q ss_pred             CCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       186 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ...+|.|+-+.||+.+.+  .+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence            368999999999998644  49999998774

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.66  E-value=0.079  Score=49.19  Aligned_cols=71  Identities=15%  Similarity=0.172  Sum_probs=42.2

Q ss_pred             EEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-hhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCceEEEEEEec
Q 015615           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        69 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      -.+.++.|....+|+..  .+++.+.||.-... ...+..|..-|+.|.   --.+.+++.+...   .+.  -++||||
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~---~~~--~fLlle~   93 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY---DDD--AFLLLEF   93 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE----SSC--CEEEEE-
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee---cCC--ceEEEEe
Confidence            34678999999999887  57888999976533 346678999998884   2234444443311   122  2689999


Q ss_pred             cc
Q 015615          145 VP  146 (403)
Q Consensus       145 ~~  146 (403)
                      ++
T Consensus        94 l~   95 (288)
T PF03881_consen   94 LE   95 (288)
T ss_dssp             --
T ss_pred             ec
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=95.47  E-value=0.06  Score=52.67  Aligned_cols=30  Identities=17%  Similarity=0.302  Sum_probs=23.9

Q ss_pred             ccccCCCCCceEecCCCC----ceEEeecCCcee
Q 015615          188 VCHRDIKPQNLLVNPHTH----QLKLCDFGSAKV  217 (403)
Q Consensus       188 ivH~Dlkp~NIll~~~~~----~vkl~DfG~a~~  217 (403)
                      ++|+||..+|||.+.++.    -..|+||-.+..
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~  303 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR  303 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence            799999999999987553    356889876654

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.85  E-value=0.49  Score=44.88  Aligned_cols=27  Identities=26%  Similarity=0.351  Sum_probs=23.1

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCce
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ++||+|+.+.|||++ +  .+.|+||+-+.
T Consensus       197 ~liHgD~h~~NvL~~-d--~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D--GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C--CcEEEeCCCCC
Confidence            799999999999995 3  37899999764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.55  E-value=0.098  Score=50.24  Aligned_cols=61  Identities=28%  Similarity=0.272  Sum_probs=39.1

Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~  203 (403)
                      ..|+-+|..| ++..+++.     ...++...+.++.-...|+-.+----+++|.|+.|.||++..+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            3466677776 66777664     3345555555555555555443322289999999999999543

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.71  E-value=0.069  Score=47.12  Aligned_cols=30  Identities=40%  Similarity=0.717  Sum_probs=19.9

Q ss_pred             CccccCCCCCceEe-cCCCCceEEeecCCcee
Q 015615          187 GVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       187 ~ivH~Dlkp~NIll-~~~~~~vkl~DfG~a~~  217 (403)
                      -++|+|+.|.|||+ +.++ .++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDG-EVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence            68999999999999 4444 799999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=93.59  E-value=0.082  Score=49.21  Aligned_cols=131  Identities=18%  Similarity=0.259  Sum_probs=86.2

Q ss_pred             EEeEeeeCCcEEEEEEEE-------cc---CCcEEEEEEeccc--------------hh----------------hhHHH
Q 015615           69 AERVVGHGSFGVVFQAKC-------LE---TGEAVAIKKVLQD--------------KR----------------YKNRE  108 (403)
Q Consensus        69 ~~~~lg~G~~g~Vy~~~~-------~~---~~~~vaiK~~~~~--------------~~----------------~~~~E  108 (403)
                      |..+|..|.-+.|+.|.-       ..   ....+|||+++..              -+                ..++|
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            445788888888888732       00   2346889866210              00                11357


Q ss_pred             HHHHHHcC-----CCCeeecceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHH
Q 015615          109 LQTMRLLD-----HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH  183 (403)
Q Consensus       109 ~~~l~~l~-----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH  183 (403)
                      ...|.+++     .|.+|.+..            ..+||.|++..   .+..-.-..-.++....+..-.|+...+..|-
T Consensus       336 mhNL~RMq~~GlpcP~vV~lkk------------hvLVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY  400 (531)
T KOG2269|consen  336 MHNLSRMQKHGLPCPQVVKLKK------------HVLVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRLY  400 (531)
T ss_pred             HHHHHHHHhcCCCCCceeeeec------------ceEEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHHH
Confidence            77776663     577777633            34899998742   01111112345777777777788988888876


Q ss_pred             hcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       184 ~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ..+-+||.||.--|+|...+  .|.++|..-+.
T Consensus       401 ~Ec~LVHADlSEyN~Lw~~g--Kvw~IDVsQsv  431 (531)
T KOG2269|consen  401 KECLLVHADLSEYNLLWTPG--KVWVIDVSQSV  431 (531)
T ss_pred             HhhheeecchhhhhheecCC--ceEEEechhcc
Confidence            66689999999999999864  69999987654

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.55  E-value=0.059  Score=46.43  Aligned_cols=29  Identities=28%  Similarity=0.350  Sum_probs=24.6

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      -.+|+|+.|.||+++.++  ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            469999999999998654  89999998753

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.80  E-value=0.18  Score=46.38  Aligned_cols=46  Identities=30%  Similarity=0.478  Sum_probs=33.3

Q ss_pred             HHHHHHHHHHHHHhc-CCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          171 YFYQICRALAYIHNT-IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       171 ~~~qi~~~L~~LH~~-~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .+..+-.++.-.|.. .-++|+|+.|+|++.++.+ .++|+||..|..
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            344444555555532 2489999999999999756 699999988754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	403
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-142
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-142
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-142
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-142
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-142
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-141
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-141
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-141
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-140
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-140
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-140
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-140
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-139
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-139
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-139
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-138
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-138
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-138
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-138
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-137
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-135
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-133
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-95
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-90
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-45
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-45
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-45
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-44
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-44
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-44
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-44
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-44
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-44
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-44
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-44
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-44
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-44
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-43
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-43
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-43
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-43
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-43
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-43
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-43
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-43
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-43
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-43
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-43
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-43
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-43
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-43
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-43
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-43
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-43
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-43
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-43
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-43
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-43
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-43
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-43
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-43
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-43
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-43
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-43
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-43
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-43
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-43
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-43
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-43
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-43
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-43
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-43
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-43
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-42
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-42
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-42
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-42
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-42
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-42
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-42
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-42
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-42
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-42
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-42
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-42
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-42
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-42
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-42
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-42
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-42
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-42
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-42
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-42
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-41
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-40
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-40
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-40
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-40
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-40
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-40
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-40
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-39
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-39
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-39
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-39
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-39
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-39
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-39
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-39
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-39
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-39
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-39
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-39
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-39
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-39
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-39
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-39
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-39
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-39
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-39
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-39
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-39
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-39
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-39
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-39
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-39
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-39
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-39
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-39
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-39
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-39
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-39
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-39
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-39
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-39
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-39
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-39
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-39
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-38
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-38
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-38
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-38
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-38
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-38
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-38
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-38
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-38
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-38
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-38
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-38
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-38
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-38
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-38
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-38
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-38
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-38
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-38
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-38
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-38
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-38
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-38
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-38
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-37
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-37
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-37
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-36
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-36
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-35
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-35
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-34
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-34
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-33
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-33
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-33
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-33
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-33
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-33
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-32
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-32
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-32
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-32
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-32
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-32
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-32
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-32
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-32
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-32
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-32
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-32
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-32
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-32
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-32
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-32
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-32
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-32
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-32
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-32
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-32
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-32
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-32
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-31
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-31
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-31
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-31
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-31
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-31
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-31
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-31
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		4e-31
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-31
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-31
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-31
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-31
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-31
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-30
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-30
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-29
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-29
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-29
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-29
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-29
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-29
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		6e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-29
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		6e-29
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		6e-29
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		6e-29
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-29
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-29
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-29
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-29
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-29
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		7e-29
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		8e-29
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-29
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-28
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-28
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-27
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-27
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-27
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-27
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-27
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-27
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-27
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-26
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-26
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-26
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-26
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-26
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-25
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-25
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-25
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-24
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-24
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-24
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-23
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-22
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-21
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-21
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-21
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-21
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-21
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-21
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-21
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-21
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		8e-21
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-21
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-20
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-20
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-20
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-20
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-20
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-20
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-20
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-20
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-20
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-20
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-20
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-20
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-20
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-20
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-20
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-20
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-20
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-20
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-20
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-20
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-20
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-20
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-20
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-20
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-20
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-20
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-20
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-20
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-20
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-19
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-19
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-19
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-18
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-17
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-17
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-17
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-17
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-17
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-17
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-17
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-17
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		9e-17
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-16
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-16
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-16
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-16
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-16
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-16
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-16
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-16
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-16
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-16
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-16
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-16
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-16
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-16
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-16
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-16
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-16
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-16
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-16
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-16
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-16
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-16
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-16
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-16
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-16
3soa_A	444	Full-Length Human Camkii Length = 444		8e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-15
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-15
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-14
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-14
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-14
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-14
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-14
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-14
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-13
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-13
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-13
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-12
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		6e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-12
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		7e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-08
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-08
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-07
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-06
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		7e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		8e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  502 bits (1292), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 244/381 (64%), Positives = 295/381 (77%), Gaps = 14/381 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 14  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 62
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 63  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 122
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 123 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 181
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 182 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 241
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 242 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 301
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL 378
           R PPEA+ L SRLL+Y+P  R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL
Sbjct: 302 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 361
Query: 379 KGVPVDMLVKLIPEHARKQCA 399
              P  +   LIP HAR Q A
Sbjct: 362 SSNP-PLATILIPPHARIQAA 381

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  501 bits (1291), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 244/381 (64%), Positives = 295/381 (77%), Gaps = 14/381 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 20  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL 378
           R PPEA+ L SRLL+Y+P  R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 367
Query: 379 KGVPVDMLVKLIPEHARKQCA 399
              P  +   LIP HAR Q A
Sbjct: 368 SSNP-PLATILIPPHARIQAA 387

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  501 bits (1291), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 244/381 (64%), Positives = 295/381 (77%), Gaps = 14/381 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 22  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 70
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 71  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 130
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 131 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 189
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 190 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 249
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 250 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 309
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL 378
           R PPEA+ L SRLL+Y+P  R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL
Sbjct: 310 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 369
Query: 379 KGVPVDMLVKLIPEHARKQCA 399
              P  +   LIP HAR Q A
Sbjct: 370 SSNP-PLATILIPPHARIQAA 389

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  501 bits (1291), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 244/381 (64%), Positives = 295/381 (77%), Gaps = 14/381 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 24  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 72
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 73  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 132
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 133 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 191
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 192 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 251
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 252 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 311
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL 378
           R PPEA+ L SRLL+Y+P  R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL
Sbjct: 312 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 371
Query: 379 KGVPVDMLVKLIPEHARKQCA 399
              P  +   LIP HAR Q A
Sbjct: 372 SSNP-PLATILIPPHARIQAA 391

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  501 bits (1290), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 244/381 (64%), Positives = 295/381 (77%), Gaps = 14/381 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 65  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 113
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 114 VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 173
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 174 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 232
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 233 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 292
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 293 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 352
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL 378
           R PPEA+ L SRLL+Y+P  R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL
Sbjct: 353 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 412
Query: 379 KGVPVDMLVKLIPEHARKQCA 399
              P  +   LIP HAR Q A
Sbjct: 413 SSNP-PLATILIPPHARIQAA 432

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  499 bits (1284), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 243/381 (63%), Positives = 294/381 (77%), Gaps = 14/381 (3%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFG 79
           P     MK+  DK+         G++   ++ T   G+     Q +SY   +V+G+GSFG
Sbjct: 20  PSAFGSMKVSRDKD---------GSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFG 68
Query: 80  VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYL 138
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 198
           NLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 199 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
           L++P T  LKLCDFGSAK LV+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVL
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 259 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 318
           AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ 
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL 378
           R PPEA+ L SRLL+Y+P  R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 367
Query: 379 KGVPVDMLVKLIPEHARKQCA 399
              P  +   LIP HAR Q A
Sbjct: 368 SSNP-PLATILIPPHARIQAA 387

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  498 bits (1282), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 241/353 (68%), Positives = 286/353 (81%), Gaps = 6/353 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 8   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 67
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 128 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 186
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           YICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 187 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 246
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 247 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 399
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 307 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 358

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  498 bits (1282), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 240/361 (66%), Positives = 290/361 (80%), Gaps = 5/361 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 339 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 398
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 365
Query: 399 A 399
           A
Sbjct: 366 A 366

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  496 bits (1276), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/361 (66%), Positives = 289/361 (80%), Gaps = 5/361 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 339 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 398
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 364
Query: 399 A 399
           A
Sbjct: 365 A 365

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  495 bits (1275), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/361 (66%), Positives = 289/361 (80%), Gaps = 5/361 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 339 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 398
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 371
Query: 399 A 399
           A
Sbjct: 372 A 372

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  495 bits (1275), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/361 (66%), Positives = 289/361 (80%), Gaps = 5/361 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 339 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 398
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 360
Query: 399 A 399
           A
Sbjct: 361 A 361

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/361 (66%), Positives = 289/361 (80%), Gaps = 5/361 (1%)
Query: 40  DGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL 99
           D +G++   ++ T   G+     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 100 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYK 158
           QDKR+KNRELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
             Q +P+IYVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 339 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 398
           R T LEA  H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 364
Query: 399 A 399
           A
Sbjct: 365 A 365

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  492 bits (1266), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 239/349 (68%), Positives = 284/349 (81%), Gaps = 6/349 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           YICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  490 bits (1262), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 239/351 (68%), Positives = 284/351 (80%), Gaps = 6/351 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
            ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQ 397
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQ 351

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  489 bits (1260), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 238/349 (68%), Positives = 283/349 (81%), Gaps = 6/349 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 7   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 66
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 127 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 185
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
            ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 245
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 246 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 306 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 353

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  489 bits (1259), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 238/349 (68%), Positives = 283/349 (81%), Gaps = 6/349 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 4   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 63
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 124 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 182
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
            ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 242
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 243 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 303 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 350

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  489 bits (1259), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 238/349 (68%), Positives = 283/349 (81%), Gaps = 6/349 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
            ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  486 bits (1252), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 237/349 (67%), Positives = 282/349 (80%), Gaps = 6/349 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           YICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  486 bits (1251), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 237/349 (67%), Positives = 282/349 (80%), Gaps = 6/349 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR 62
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK D +YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
            ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  486 bits (1250), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 237/351 (67%), Positives = 282/351 (80%), Gaps = 6/351 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           YICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQ 397
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQ 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  479 bits (1234), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 234/349 (67%), Positives = 279/349 (79%), Gaps = 6/349 (1%)
Query: 51  VTTIGGKNGQPK---QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR 107
           VTT+    GQ     Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQ K +KNR
Sbjct: 3   VTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR 62
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
           ELQ MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVP TV+RV +H+ +  Q +P+I
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           YVKLY YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S
Sbjct: 123 YVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
            ICSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGT
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
           PTRE+I+ MNPNYTEF FPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA 
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
            H FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  472 bits (1214), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 227/356 (63%), Positives = 285/356 (80%), Gaps = 5/356 (1%)
Query: 49  IIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE 108
           I V    GK G+ ++ I+Y   +V+G+GSFGVVFQAK +E+ E VAIKKVLQDKR+KNRE
Sbjct: 25  IKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
           LQ MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV+R  +H+ K+ Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +KLY YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPN+S 
Sbjct: 143 IKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           ICSRYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
           +RE+IK MNPNY E KFPQI+ HP+ K+F+ R PP+A+DL+SRLL+Y+P+ R TA+EAL 
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 348 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 403
           HPFFDELR    R+PNGR LPPLFN+   EL   P D++ +L+P+HA  +    G+
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEELSVRP-DLISRLVPQHAEAELLSRGI 376

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  344 bits (882), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 165/369 (44%), Positives = 245/369 (66%), Gaps = 43/369 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH N++ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 127 FFSTTEKD---------------------------------ELYLNLVLEYVPETVHRVI 153
           F++T +++                                   YLN+++EYVP+T+H+V+
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 154 KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 213
           K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNLLVN   + LKLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
           SAK L+  EP+++ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+PLF GE+ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 333
           +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+DL+ ++L+
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 334 YSPNLRSTALEALIHPFFDELRDP-------NTRLPNG--RFLPPLFNFKPHELKGVPVD 384
           Y P+LR    EA+ HPFFD LR+        N+  P+G  + +P LFNF P+EL  +P +
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 385 MLVKLIPEH 393
           +L +++P++
Sbjct: 368 VLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  327 bits (837), Expect = 9e-90,   Method: Compositional matrix adjust.
 Identities = 162/339 (47%), Positives = 228/339 (67%), Gaps = 10/339 (2%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---LLDHP 118
           K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R++NRELQ M+   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 119 NVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           N+V L+  F++  E+D  ++YLN+V+EYVP+T+HR  +++Y+     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 177 RALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L   EPN++YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 296 NPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
           NP++T+      K  PW  +F     +   EA DL+S LLQY P  R    EAL HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 353 ELRDPNTRLPNGRFLP-PLFNFKPHELKGVPVDMLVKLI 390
           EL DP T+LPN + LP  LF F P+E++ +      KL+
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 112/345 (32%), Positives = 189/345 (54%), Gaps = 29/345 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 120
            +  + ++G G++GVV  A    TGE VAIKK+    +        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----------YIC 229
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +   + S           Y+ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 288
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 289 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 346 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
           L HP+     DPN   P G  +PP F    H  + +    L KLI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 112/345 (32%), Positives = 190/345 (55%), Gaps = 29/345 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 120
            +  + ++G G++GVV  A    TGE VAIKK+    +        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------ISYIC 229
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +      EP       + ++ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 288
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 289 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 346 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
           L HP+     DPN   P G  +PP F    H  + +    L KLI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 104/305 (34%), Positives = 176/305 (57%), Gaps = 22/305 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y   + +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H NV+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            ++    ++T +    + +V + +   +++++K     SQ++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFLYQILRGLKY 159
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 237
           IH+   V HRD+KP NLL+N  T  LK+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 296 --NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
               NY +   P      W K+F K    +A+DL+ R+L ++PN R T  EAL HP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 354 LRDPN 358
             DP 
Sbjct: 336 YYDPT 340

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 114/319 (35%), Positives = 176/319 (55%), Gaps = 36/319 (11%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------REL 109
           G  G P+   ++     +G G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIY 167
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +K Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 228 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 285 GTPTREEIKCMN--PNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNL 338
           GTP       +   P+Y    FP+     W  + F K +PP   +   L+S++L Y PN 
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 281
Query: 339 RSTALEALIHPFFDELRDP 357
           R +A  AL HPFF ++  P
Sbjct: 282 RISAKAALAHPFFQDVTKP 300

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 111/345 (32%), Positives = 188/345 (54%), Gaps = 29/345 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 120
            +  + ++G G++GVV  A    TGE VAIKK+    +        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +++ +     + ++   + ++ E +   +HRVI      +Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----------YIC 229
            +H +  V HRD+KP NLL+N +   LK+CDFG A+++ +   + S            + 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-T 288
           +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 289 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
             +++C+ +P   E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 346 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
           L HP+     DPN   P G  +PP F    H  + +    L KLI
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 114/319 (35%), Positives = 176/319 (55%), Gaps = 36/319 (11%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------REL 109
           G  G P+   ++     +G G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIY 167
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           +K Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 228 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 285 GTPTREEIKCMN--PNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNL 338
           GTP       +   P+Y    FP+     W  + F K +PP   +   L+S++L Y PN 
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 281
Query: 339 RSTALEALIHPFFDELRDP 357
           R +A  AL HPFF ++  P
Sbjct: 282 RISAKAALAHPFFQDVTKP 300

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/303 (35%), Positives = 169/303 (55%), Gaps = 26/303 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     VG G++GVV++AK  + G  VA+K++  D   +       RE+  ++ L HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           VSL     S     E  L LV E++ + + +V+  +    Q      +K+Y YQ+ R +A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQ---IKIYLYQLLRGVA 133
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           + H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+
Sbjct: 134 HCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 296
           ++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +  
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
            P + +  F   +  PW  I       E +DL+S +L + PN R +A +A+ HP+F +L 
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL- 307
Query: 356 DPN 358
           DP 
Sbjct: 308 DPQ 310

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/303 (35%), Positives = 168/303 (55%), Gaps = 26/303 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     VG G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           VSL     S     E  L LV E++ + + +V+  +    Q      +K+Y YQ+ R +A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQ---IKIYLYQLLRGVA 133
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           + H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+
Sbjct: 134 HCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 296
           ++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +  
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249
Query: 297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
            P + +  F   +  PW  I       E +DL+S +L + PN R +A +A+ HP+F +L 
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL- 307
Query: 356 DPN 358
           DP 
Sbjct: 308 DPQ 310

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 110/300 (36%), Positives = 170/300 (56%), Gaps = 32/300 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E+V + + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEHVDQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 112/302 (37%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E VH+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 356 DP 357
            P
Sbjct: 291 KP 292

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 167/302 (55%), Gaps = 22/302 (7%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
            +G+G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 126 CFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+ R L Y+H+
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 239
              V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 177 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +    
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 294
Query: 300 TEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
                   P  +  PW  ++      +A+ L+ R+L++ P+ R +A  AL HPF  +  D
Sbjct: 295 VRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353
Query: 357 PN 358
           P+
Sbjct: 354 PD 355

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 356 DP 357
            P
Sbjct: 292 KP 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 356 DP 357
            P
Sbjct: 293 KP 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 356 DP 357
            P
Sbjct: 293 KP 294

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 167/302 (55%), Gaps = 22/302 (7%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
            +G+G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 126 CFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+ R L Y+H+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELI 239
              V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +R+YRAPEL+
Sbjct: 178 A-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +    
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 295
Query: 300 TEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
                   P  +  PW  ++      +A+ L+ R+L++ P+ R +A  AL HPF  +  D
Sbjct: 296 VRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 354
Query: 357 PN 358
           P+
Sbjct: 355 PD 356

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 356 DP 357
            P
Sbjct: 294 KP 295

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 356 DP 357
            P
Sbjct: 291 KP 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 356 DP 357
            P
Sbjct: 291 KP 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 356 DP 357
            P
Sbjct: 292 KP 293

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 356 DP 357
            P
Sbjct: 292 KP 293

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 356 DP 357
            P
Sbjct: 292 KP 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ--RMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 356 DP 357
            P
Sbjct: 295 KP 296

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 356 DP 357
            P
Sbjct: 291 KP 292

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 126 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 181
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 242 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295
Query: 356 DP 357
            P
Sbjct: 296 KP 297

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 356 DP 357
            P
Sbjct: 292 KP 293

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 356 DP 357
            P
Sbjct: 292 KP 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 356 DP 357
            P
Sbjct: 295 KP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 356 DP 357
            P
Sbjct: 294 KP 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 356 DP 357
            P
Sbjct: 291 KP 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 126 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 181
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 242 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295
Query: 356 DP 357
            P
Sbjct: 296 KP 297

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 356 DP 357
            P
Sbjct: 293 KP 294

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 241 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294
Query: 356 DP 357
            P
Sbjct: 295 KP 296

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 317 LEQYYDPS 324

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + L++ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 356 DP 357
            P
Sbjct: 292 KP 293

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 239 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 356 DP 357
            P
Sbjct: 293 KP 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 240 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293
Query: 356 DP 357
            P
Sbjct: 294 KP 295

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 170/302 (56%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 356 DP 357
            P
Sbjct: 292 KP 293

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 101/308 (32%), Positives = 173/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + LV   +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKY 159
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 160 IHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 214
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 275 IINLKARNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPY 332
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 333 LEQYYDPS 340

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 110/298 (36%), Positives = 168/298 (56%), Gaps = 36/298 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF +
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 168/300 (56%), Gaps = 32/300 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   +   +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 73  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 124
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 125 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 241
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 242 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 99/302 (32%), Positives = 173/302 (57%), Gaps = 28/302 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----N 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 357 PN 358
           P+
Sbjct: 319 PS 320

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 169/300 (56%), Gaps = 32/300 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 72  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 123
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 241 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 169/302 (55%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 238 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 356 DP 357
            P
Sbjct: 292 KP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 110/302 (36%), Positives = 169/302 (55%), Gaps = 36/302 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVKLYFYQICRALAYIHN 184
             +   +++LYL      V E +H+ +K     S    +PL  +K Y +Q+ + LA+ H+
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 241
              V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 H-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 299
              Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 300 TEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
               FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++ 
Sbjct: 237 KP-SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 356 DP 357
            P
Sbjct: 291 KP 292

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 169/300 (56%), Gaps = 32/300 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   + + +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 168/300 (56%), Gaps = 32/300 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +   +++LYL  V E++   +   +         +PLI  K Y +Q+ + LA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSYLFQLLQGLAFCHSH- 125
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 301
            Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 302 FKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
             FP+     W  + F K +PP   +   L+S++L Y PN R +A  AL HPFF ++  P
Sbjct: 243 -SFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 317 LEQYYDPS 324

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 147
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 148 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 202
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 262
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 263 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 320
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 321 LEQYYDPS 328

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 139
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 140 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 194
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 255 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 313 LEQYYDPS 320

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 141
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 142 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 196
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 257 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 314
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 315 LEQYYDPS 322

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/339 (30%), Positives = 179/339 (52%), Gaps = 57/339 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTM-RLLDHPN 119
           Y   + +G G++G+V+++    TGE VA+KK+        D +   RE+  +  L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V+L +   +  ++D   + LV +Y+   +H VI+     +  +  ++ +   YQ+ + +
Sbjct: 71  IVNLLNVLRADNDRD---VYLVFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIKVI 122
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------------------- 220
            Y+H+  G+ HRD+KP N+L+N   H +K+ DFG ++  V                    
Sbjct: 123 KYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 221 --GEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
              +P ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG S ++QL
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH-------------PWHKIFQKRMPP-- 322
             II V+  P+ E+++ +   + +     +K                W  +  K  P   
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 323 ---EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
              EA+DL+ +LLQ++PN R +A +AL HPF     +PN
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 139
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 140 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 194
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 255 IINLKARNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPY 312
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 313 LEQYYDPS 320

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 159
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 160 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 214
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 275 IINLKARNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPY 332
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 333 LEQYYDPS 340

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 144
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 145 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 199
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 259
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 260 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 317
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 318 LEQYYDPS 325

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 145
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 146 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 200
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 260
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 261 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 318
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 319 LEQYYDPS 326

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 136
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 137 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 191
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 251
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 252 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 309
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 310 LEQYYDPS 317

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 317 LEQYYDPS 324

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 137
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 138 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 192
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 252
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 253 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 310
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 311 LEQYYDPS 318

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 171/307 (55%), Gaps = 26/307 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 141
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 142 IHSA-NVLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 196
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 295 ---MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
              +         P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ 
Sbjct: 257 GINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 352 DELRDPN 358
            +  DP+
Sbjct: 316 AQYYDPS 322

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 165/304 (54%), Gaps = 23/304 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 119
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 120 VVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+ L   F   +     Y   LV+ ++   + +++   +   +      ++   YQ+ + 
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEK------IQYLVYQMLKG 156
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 237
           L YIH+  GV HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 157 LKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 211
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N 
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271
Query: 298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
              +      PQ     + ++F  R  P+A DL+ ++L+   + R TA +AL HPFF+  
Sbjct: 272 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330
Query: 355 RDPN 358
           RDP 
Sbjct: 331 RDPE 334

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 99/308 (32%), Positives = 174/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAI+K+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 317 LEQYYDPS 324

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 173/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 141
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 142 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 196
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 257 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 314
Query: 351 FDELRDPN 358
             +  DP+
Sbjct: 315 LAQYYDPS 322

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 173/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K      Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQILRGLKY 143
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 198
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 259 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 317 LEQYYDPS 324

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 173/308 (56%), Gaps = 28/308 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 137
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYR 234
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YR
Sbjct: 138 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYR 192
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNC 252
Query: 295 M----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+
Sbjct: 253 IINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 310
Query: 351 FDELRDPN 358
            ++  DP+
Sbjct: 311 LEQYYDPS 318

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 108/301 (35%), Positives = 160/301 (53%), Gaps = 31/301 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 123
           +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F   +      ++LV +++   +  +IK +   S  +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 240
               + HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QHW-ILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPN 298
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 299 YTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
           Y  FK FP I   P H IF      + +DL+  L  ++P  R TA +AL   +F     P
Sbjct: 246 YVTFKSFPGI---PLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301
Query: 358 N 358
Sbjct: 302 T 302

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 98/305 (32%), Positives = 172/305 (56%), Gaps = 22/305 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 143
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 237
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE
Sbjct: 144 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 296 --NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
               NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++
Sbjct: 262 LKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 354 LRDPN 358
             DP+
Sbjct: 320 YYDPS 324

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 98/305 (32%), Positives = 172/305 (56%), Gaps = 22/305 (7%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + +V + +   +++++K     +Q +   ++  + YQI R L Y
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKY 144
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 237
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+YRAPE
Sbjct: 145 IHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 262
Query: 296 --NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
               NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++
Sbjct: 263 LKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 354 LRDPN 358
             DP+
Sbjct: 321 YYDPS 325

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 103/304 (33%), Positives = 165/304 (54%), Gaps = 23/304 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 119
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 120 VVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+ L   F   +     Y   LV+ ++   + +++   +   +   L+Y      Q+ + 
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY------QMLKG 138
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 237
           L YIH+  GV HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 139 LKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 193
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ +N 
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
              +      PQ     + ++F  R  P+A DL+ ++L+   + R TA +AL HPFF+  
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 355 RDPN 358
           RDP 
Sbjct: 313 RDPE 316

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  167 bits (424), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 99/302 (32%), Positives = 171/302 (56%), Gaps = 28/302 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 357 PN 358
           P+
Sbjct: 319 PS 320

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 160/298 (53%), Gaps = 20/298 (6%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 125 HCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F  +T+ +D   + LV   +   ++ ++K     SQ +   +V+   YQ+ R L YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----SQALSDEHVQFLVYQLLRGLKYIH 148
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 302
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 303 --KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
               P +       IF +   P A+DL+ R+L    + R +A EAL H +F +  DP 
Sbjct: 265 IQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 98/302 (32%), Positives = 170/302 (56%), Gaps = 28/302 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            + T +    + +V + +   +++++K     +Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 240
           V HRD+KP NLL+N  T  LK+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMN 296
            +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
            NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++  D
Sbjct: 261 RNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 357 PN 358
           P+
Sbjct: 319 PS 320

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/310 (33%), Positives = 164/310 (52%), Gaps = 21/310 (6%)
Query: 52  TTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYK 105
             +G +N   +    Y    +VG GS+G+V + +  +TG  VAIKK L+       K+  
Sbjct: 12  VDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA 71
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
            RE++ ++ L H N+V+L        +K   YL  V E+V    H ++         +  
Sbjct: 72  MREIKLLKQLRHENLVNLLEV---CKKKKRWYL--VFEFVD---HTILDDLELFPNGLDY 123
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPN 224
             V+ Y +QI   + + H+   + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE  
Sbjct: 124 QVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY 181
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              + +R+YRAPEL+ G  +Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  L
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL 241
Query: 285 GT--PTREEIKCMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           G   P  +E+   NP +   + P+IK   P  + + K +    +DL  + L   P+ R  
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPF 300
Query: 342 ALEALIHPFF 351
             E L H FF
Sbjct: 301 CAELLHHDFF 310

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/296 (34%), Positives = 162/296 (54%), Gaps = 34/296 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNP 297
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA +AL H +F E
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 162/296 (54%), Gaps = 34/296 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNP 297
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA +AL H +F E
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 100/296 (33%), Positives = 162/296 (54%), Gaps = 34/296 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             +        L LV E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNP 297
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA +AL H +F E
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 164/297 (55%), Gaps = 27/297 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 126
           +G GS+GVVF+ +  +TG+ VAIKK L+       K+   RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNT 185
           F     + +  L+LV EY   TV     H     QR +P   VK   +Q  +A+ + H  
Sbjct: 71  F-----RRKRRLHLVFEYCDHTV----LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
               HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G 
Sbjct: 122 -NCIHRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGD 177
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYT 300
           T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  ++
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 301 EFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
             K P  +   P    F     P A+ L+   L   P  R T  + L HP+F+ +R+
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYP-ALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 159/298 (53%), Gaps = 20/298 (6%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 125 HCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F  +T+ +D   + LV   +   ++ ++K      Q +   +V+   YQ+ R L YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 148
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 149 SA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 302
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 303 --KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
               P +       IF +   P A+DL+ R+L    + R +A EAL H +F +  DP 
Sbjct: 265 IQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 321

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 160/298 (53%), Gaps = 24/298 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  +  +++G  +A+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 126 CFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F   T  +E   + LV   +   ++ ++K      Q++   +V+   YQI R L YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 300
           Y   +DIWS GC++AELL G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
               PQ+    +  +F     P AVDL+ ++L    + R TA EAL HP+F +  DP+
Sbjct: 289 N-SLPQMPKRNFADVFIG-ANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPD 344

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 20/298 (6%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 124
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 125 HCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             F  +T+ +D   + LV   +   ++ ++K      Q +   +V+   YQ+ R L YIH
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKYIH 140
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +  G+ HRD+KP N+ VN    +L++ DFG A+     E    Y+ +R+YRAPE++    
Sbjct: 141 SA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 196
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 302
            Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 303 --KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
               P +       IF +   P A+DL+ R+L    + R +A EAL H +F +  DP 
Sbjct: 257 IQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE 313

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 164/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++  A
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNA 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/308 (32%), Positives = 166/308 (53%), Gaps = 23/308 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           +Y+    +G G++  V++ K   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V+L       TEK    L LV EY+ + + + +         + +  VKL+ +Q+ R LA
Sbjct: 63  VTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNIINMHNVKLFLFQLLRGLA 114
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
           N  +  + +P+ +A         R+  +  DL+++LLQ+    R +A +A+ HPFF  L 
Sbjct: 231 NEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 356 DPNTRLPN 363
           +   +LP+
Sbjct: 290 ERIHKLPD 297

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 103/295 (34%), Positives = 154/295 (52%), Gaps = 22/295 (7%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 126
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 127 FFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
           F      D+     LV+ ++   + +++KH      R     ++   YQ+ + L YIH  
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR-----IQFLVYQMLKGLRYIH-A 146
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
            G+ HRD+KP NL VN    +LK+ DFG A+           + +R+YRAPE+I     Y
Sbjct: 147 AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--ADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 301
           T  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ +      NY +
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
              P+++   +  I      P AV+L+ ++L      R TA EAL HP+F+ L D
Sbjct: 264 -GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 164/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 264 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 164/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K     SQ++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----SQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN  + +LK+ DFG  +     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 164/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 217
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 278 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 108 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 160
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 161 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 216
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 276
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 277 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 99  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 151
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 152 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 267
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 268 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 264 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 254 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 100 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 152
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 153 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 208
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 268
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 269 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 264 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 270 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 217
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 278 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 270 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 100 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 152
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 153 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 208
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 268
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 269 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 101 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 153
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 154 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 209
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 269
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 270 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 112 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 164
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 165 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 220
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 280
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 281 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 108 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 160
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 161 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 216
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 276
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 277 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 112 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 164
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 165 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNW 220
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 280
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 281 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 87  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 139
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 140 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 195
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 255
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 256 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 94  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 146
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 147 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 202
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 262
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 263 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 88  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 140
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 141 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 196
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 256
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 257 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 96  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 149 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 204
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 265 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 91  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 143
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 144 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 259
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 260 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 86  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 138
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 139 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 194
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 254
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 255 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 254 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 86  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 138
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 139 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 194
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 254
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 255 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 95  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 147
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 148 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 203
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 263
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 264 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    ++ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 254 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 105/301 (34%), Positives = 158/301 (52%), Gaps = 34/301 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +     L LV E+  + +    K+    +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 303 KFPQIKAHPWHKIFQK------RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
           K P  K +P +           ++     DL+  LL+ +P  R +A EAL HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 357 P 357
           P
Sbjct: 292 P 292

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 105/301 (34%), Positives = 157/301 (52%), Gaps = 34/301 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
             S  +     L LV E+  + +    K+    +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LKL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 303 KFPQIKAHPWHKIFQK------RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
           K P  K +P +           ++     DL+  LL+ +P  R +A EAL HP+F +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
Query: 357 P 357
           P
Sbjct: 292 P 292

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K       ++   +V+   YQI R L YI
Sbjct: 85  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CAKLTDDHVQFLIYQILRGLKYI 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +R+YRAPE++   
Sbjct: 138 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNW 193
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 254 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 163/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D+G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 109 VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 161
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++   
Sbjct: 162 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNW 217
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 277
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 278 YIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DF  A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+  FG A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ DFG A+     +     + +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 162/300 (54%), Gaps = 28/300 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 126 CFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            F    S  E +++YL  V   +   ++ ++K      Q++   +V+   YQI R L YI
Sbjct: 89  VFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYI 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   + HRD+KP NL VN    +LK+ D G A+     +    Y+ +R+YRAPE++   
Sbjct: 142 HSA-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNW 197
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----N 298
             Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++     N
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 257
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +    Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP+
Sbjct: 258 YIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 104/315 (33%), Positives = 167/315 (53%), Gaps = 48/315 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVV- 121
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++ +R LDH N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 122 ----------SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 169
                      L     S TE + +Y+  V EY+   +  V+       ++ PL+  + +
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVL-------EQGPLLEEHAR 123
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 227
           L+ YQ+ R L YIH+   V HRD+KP NL +N     LK+ DFG A+++   +P+ S+  
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKG 179
Query: 228 -----ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL---VE 279
                + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G   ++Q+   +E
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSP 336
            I V+    R+E+  + P Y      +      HK   + +P    EAVD + ++L +SP
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEP-----HKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 337 NLRSTALEALIHPFF 351
             R TA EAL HP+ 
Sbjct: 295 MDRLTAEEALSHPYM 309

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  149 bits (375), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 98/300 (32%), Positives = 161/300 (53%), Gaps = 32/300 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 127
           +G+G++  V++     TG  VA+K+V  D          RE+  M+ L H N+V L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +  +     L LV E++   + + +         + + L  VK + +Q+ + LA+ H  
Sbjct: 73  HTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP+++ G+
Sbjct: 128 -KILHRDLKPQNLLINKRG-QLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP     + + P+ T+ 
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN----ESLWPSVTKL 239
Query: 303 -KF-PQIKAHPWHKIFQKRMP-------PEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
            K+ P I+  P   + Q   P          +D +  LLQ +P++R +A +AL HP+F E
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/312 (31%), Positives = 157/312 (50%), Gaps = 30/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------------LQDKRYKNRELQTMRL 114
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 115 LDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 169
           L+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 290 EEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
           E++   +     +Y       + A  W  +      P A+DL++++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 346 LIHPFFDELRDP 357
           L HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/312 (31%), Positives = 157/312 (50%), Gaps = 30/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------------LQDKRYKNRELQTMRL 114
           Y  +R +  GS+G V  A     G  VAIK+V            L D     R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 115 LDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVK 169
           L+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 290 EEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
           E++   +     +Y       + A  W  +      P A+DL++++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 346 LIHPFFDELRDP 357
           L HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 107/328 (32%), Positives = 167/328 (50%), Gaps = 23/328 (7%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 113
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 114 -------LLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMP 164
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    K+ +  +P
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD---KVPEPGVP 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
              +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++       
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
            S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+
Sbjct: 177 TSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
           G P  E+    +       F    A P  K F   +     DL+ + L ++P  R +A  
Sbjct: 236 GLPGEEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 345 ALIHPFFDELRDPNTRLPNGRFLPPLFN 372
           AL HP+F +L      L +   LPP  N
Sbjct: 294 ALSHPYFQDLERCKENLDS--HLPPSQN 319

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 102/310 (32%), Positives = 161/310 (51%), Gaps = 21/310 (6%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 113
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 114 -------LLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMP 164
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    K+ +  +P
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD---KVPEPGVP 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
              +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++       
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
            S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+
Sbjct: 177 TSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
           G P  E+    +       F    A P  K F   +     DL+ + L ++P  R +A  
Sbjct: 236 GLPGEEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 345 ALIHPFFDEL 354
           AL HP+F +L
Sbjct: 294 ALSHPYFQDL 303

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 37/316 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 LEALIHPFFDELRDPN 358
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 101/307 (32%), Positives = 159/307 (51%), Gaps = 21/307 (6%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKNRELQTMR-- 113
           K+G  +    Y     +G G++G VF+A+ L+ G   VA+K+V      +   L T+R  
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 114 -------LLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMP 164
                    +HPNVV L   C  S T++ E  L LV E+V + +   +    K+ +  +P
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD---KVPEPGVP 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
              +K   +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++       
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
            S + + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+
Sbjct: 177 TSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
           G P  E+    +       F    A P  K F   +     DL+ + L ++P  R +A  
Sbjct: 236 GLPGEEDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 345 ALIHPFF 351
           AL HP+F
Sbjct: 294 ALSHPYF 300

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 97/316 (30%), Positives = 162/316 (51%), Gaps = 37/316 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 LEALIHPFFDELRDPN 358
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 101/311 (32%), Positives = 159/311 (51%), Gaps = 29/311 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y A +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 198 LGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 298 -NYTEF--KFPQIKAH--------PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
            NY E   K+P IK          P      K    +A DL+S++L   P+ R +  EAL
Sbjct: 257 RNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 316
Query: 347 IHPFFDELRDP 357
            HP+     DP
Sbjct: 317 RHPYITVWYDP 327

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 XGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 254 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 343 LEALIHPFFDELRDP 357
            +AL HP+ +   DP
Sbjct: 313 DDALQHPYINVWYDP 327

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYL-----LYQMLXGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 160/315 (50%), Gaps = 37/315 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           +SL + F      +E   + LV+E +   + +VI+    H +MS            YQ+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS---------YLLYQML 129
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 130 XGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 188 EVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P   NY E + P+     + K+F   + P           +A DL+S++L   P  R + 
Sbjct: 247 PTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 343 LEALIHPFFDELRDP 357
            +AL HP+ +   DP
Sbjct: 306 DDALQHPYINVWYDP 320

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 98/318 (30%), Positives = 163/318 (51%), Gaps = 41/318 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQ 174
           + L + F    S  E  ++Y+  V+E +   + +VI+    H +MS            YQ
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS---------YLLYQ 134
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           +   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYR
Sbjct: 135 MLVGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE+I G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K 
Sbjct: 193 APEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKK 251
Query: 295 MNP---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRS 340
           + P    Y E + P+   + + K+F   + P           +A DL+S++L    + R 
Sbjct: 252 LQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310
Query: 341 TALEALIHPFFDELRDPN 358
           +  EAL HP+ +   DP+
Sbjct: 311 SVDEALQHPYINVWYDPS 328

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 161/313 (51%), Gaps = 31/313 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 346 LIHPFFDELRDPN 358
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 155/294 (52%), Gaps = 28/294 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G V++A    T E VAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                      L+L+ EY    + + +  +  +S R+    +K + YQ+   + + H+  
Sbjct: 102 IHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRV----IKSFLYQLINGVNFCHSR- 151
Query: 187 GVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
              HRD+KPQNLL++      T  LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P 297
            G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +   P
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           ++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A  AL HP+F
Sbjct: 270 DWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 161/313 (51%), Gaps = 31/313 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 346 LIHPFFDELRDPN 358
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 91/299 (30%), Positives = 152/299 (50%), Gaps = 25/299 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMR-LLDHPNVVSL 123
            Y   R +G G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 244 EYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMN 296
            Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ ++
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LD 266
Query: 297 PNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 267 PRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/316 (30%), Positives = 161/316 (50%), Gaps = 37/316 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAP
Sbjct: 137 VGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 343 LEALIHPFFDELRDPN 358
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 161/313 (51%), Gaps = 31/313 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 346 LIHPFFDELRDPN 358
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 140
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 258 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 317 LQHPYINVWYDP 328

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 177
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 295 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 354 LQHPYINVWYDP 365

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 177
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 295 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 354 LQHPYINVWYDP 365

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 316 LQHPYINVWYDP 327

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 138
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 139 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 196
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 197 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 255
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 256 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 314
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 315 LQHPYINVWYDP 326

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 140
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 258 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 317 LQHPYINVWYDP 328

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 133
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 251 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 310 LQHPYINVWYDP 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 133
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 251 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 310 LQHPYINVWYDP 321

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 160/312 (51%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 346 LIHPFFDELRDP 357
           L HP+ +   DP
Sbjct: 309 LQHPYINVWYDP 320

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 96/316 (30%), Positives = 161/316 (50%), Gaps = 37/316 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 138
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+        + ++ +RYYRAP
Sbjct: 139 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAP 196
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 197 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 255
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 256 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 314
Query: 343 LEALIHPFFDELRDPN 358
            EAL HP+ +   DP+
Sbjct: 315 DEALQHPYINVWYDPS 330

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 97/312 (31%), Positives = 159/312 (50%), Gaps = 31/312 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI H     +RM  +      YQ+   +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLCGI 137
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 138 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 196 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P      + ++F   + P           +A DL+S++L   P+ R +  EA
Sbjct: 255 RNYVENR-PAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 346 LIHPFFDELRDP 357
           L HP+     DP
Sbjct: 314 LRHPYITVWYDP 325

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 160/313 (51%), Gaps = 31/313 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 140
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 258 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 346 LIHPFFDELRDPN 358
           L HP+ +   DP+
Sbjct: 317 LQHPYINVWYDPS 329

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 96/313 (30%), Positives = 160/313 (51%), Gaps = 31/313 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 346 LIHPFFDELRDPN 358
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 154/313 (49%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L+  
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 47  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 106
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 107 PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 157
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 158 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 216
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 270
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 271 AYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 330
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 331 LEAMTHPYFQQVR 343

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 158/307 (51%), Gaps = 31/307 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F      +E   + LV+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+     + K+F   + P           +A DL+S++L   P  R +  +A
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 346 LIHPFFD 352
           L HP+ +
Sbjct: 316 LQHPYIN 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 86
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 250
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 311 LEAMTHPYFQQVR 323

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 86
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 250
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 311 LEAMTHPYFQQVR 323

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 28  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 87
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 88  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 138
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 139 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 197
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 251
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 252 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 311
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 312 LEAMTHPYFQQVR 324

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 95/313 (30%), Positives = 153/313 (48%), Gaps = 33/313 (10%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--MRLLDH 117
           Q  +   Y   R VG G +  VF+   +   E   IK +   K+ K +        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLK 136
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           L+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LN 249
Query: 297 PNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 342
               +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 343 LEALIHPFFDELR 355
           LEA+ HP+F ++R
Sbjct: 310 LEAMTHPYFQQVR 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 160/313 (51%), Gaps = 31/313 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 144
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 145 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 203 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 261
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 262 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 346 LIHPFFDELRDPN 358
           L HP+ +   DP+
Sbjct: 321 LQHPYINVWYDPS 333

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 160/313 (51%), Gaps = 31/313 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 133
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 251 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 346 LIHPFFDELRDPN 358
           L HP+ +   DP+
Sbjct: 310 LQHPYINVWYDPS 322

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 96/316 (30%), Positives = 159/316 (50%), Gaps = 37/316 (11%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIYVKLYFYQIC 176
           + L + F      +E   + +V+E +   + +VI+    H +MS            YQ+ 
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS---------YLLYQML 136
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             + ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAP
Sbjct: 137 CGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAP 194
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 195 EVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 297 P---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTA 342
           P    Y E + P+   + + K+F   + P           +A DL+S++L    + R + 
Sbjct: 254 PTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISV 312
Query: 343 LEALIHPFFDELRDPN 358
            EAL HP+ +   DP+
Sbjct: 313 DEALQHPYINVWYDPS 328

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 92/301 (30%), Positives = 152/301 (50%), Gaps = 29/301 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E VA+K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N+L++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 351 F 351
           F
Sbjct: 324 F 324

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 106/355 (29%), Positives = 171/355 (48%), Gaps = 77/355 (21%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 119
           +Y+ + ++G GS+G V+ A    T + VAIKKV      L D +   RE+  +  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 120 VVSLKHCFF--STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L          + DELY+  VLE     + ++ K    +++     ++K   Y +  
Sbjct: 87  IIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLL 140
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNI----------- 225
              +IH + G+ HRD+KP N L+N     +K+CDFG A+ +  + + NI           
Sbjct: 141 GENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 226 -----------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQ-------- 265
                      S++ +R+YRAPELI     YT +IDIWS GC+ AELL + Q        
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 266 --PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMN-PNYTEFKFP 305
             PLFPG                 +S  DQL  I  ++GTPT +++K +N P   ++   
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY--- 315
Query: 306 QIKAHPWHK---IFQK--RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
            IK  P  K   + QK   +  + ++L+  +L+++PN R T  +AL HP+  ++R
Sbjct: 316 -IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 109/367 (29%), Positives = 161/367 (43%), Gaps = 95/367 (25%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNV 120
           Y    ++G GS+G V +A        VAIKK+L+      D +   RE+  +  L+H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 121 VSLKHCFF-STTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V +         EK DELY+  VLE       ++ +    +++    +++K   Y +   
Sbjct: 115 VKVLDIVIPKDVEKFDELYV--VLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVG 168
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------------ 226
           + Y+H + G+ HRD+KP N LVN     +K+CDFG A+ +   E   S            
Sbjct: 169 VKYVH-SAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 227 ----------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL------- 263
                           ++ +R+YRAPELI     YT AID+WS GC+ AELL        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 264 ----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNY 299
                 PLFPG S                      DQL  I  +LGTP+ E+I+ +    
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE- 345
Query: 300 TEFKFPQIKAHPWHKIFQKR-----------MPPEAVDLVSRLLQYSPNLRSTALEALIH 348
                    A  + +IF KR              +A+ L+ R+L ++PN R T  E L H
Sbjct: 346 --------DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397
Query: 349 PFFDELR 355
           PFF E+R
Sbjct: 398 PFFKEVR 404

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 94/313 (30%), Positives = 159/313 (50%), Gaps = 31/313 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP    +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
            NY E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 257 RNYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 346 LIHPFFDELRDPN 358
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 96/333 (28%), Positives = 167/333 (50%), Gaps = 53/333 (15%)
Query: 61  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 117
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 118 -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 231
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 292 IKCMNPNYTEFKFPQIKAHPWH------------------KIFQKRMPPEA--------- 324
            K ++ +     F   K +P +                  +  + R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 325 ------VDLVSRLLQYSPNLRSTALEALIHPFF 351
                 +D + + L++ P +R T  +AL HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 96/333 (28%), Positives = 167/333 (50%), Gaps = 53/333 (15%)
Query: 61  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 117
           P   ++Y  E  +V+G GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 118 -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 231
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 292 IKCMNPNYTEFKFPQIKAHPWH------------------KIFQKRMPPEA--------- 324
            K ++ +     F   K +P +                  +  + R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 325 ------VDLVSRLLQYSPNLRSTALEALIHPFF 351
                 +D + + L++ P +R T  +AL HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/313 (29%), Positives = 159/313 (50%), Gaps = 31/313 (9%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 121 VSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L + F      +E   + +V+E +   + +VI+      +RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL-----LYQMLCGI 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V      LK+ DFG A+           + +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 297
            G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 298 -NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSPNLRSTALEA 345
             Y E + P+   + + K+F   + P           +A DL+S++L    + R +  EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 346 LIHPFFDELRDPN 358
           L HP+ +   DP+
Sbjct: 316 LQHPYINVWYDPS 328

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLRQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 100
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 101 TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 151
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 152 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 210
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 211 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 269
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 270 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328
Query: 351 F 351
           F
Sbjct: 329 F 329

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 110 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 162
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 280
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 281 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 109 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 161
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 279
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 280 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 103/360 (28%), Positives = 161/360 (44%), Gaps = 78/360 (21%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPN 119
           +Y  + ++G GS+G V+ A      + VAIKKV      L D +   RE+  +  L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 120 VVSLKHCFF--STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L          + DELY+  VLE     + ++ K    ++++    +VK   Y +  
Sbjct: 89  IIRLHDLIIPEDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLL 142
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI------------ 225
              +IH + G+ HRD+KP N L+N     +K+CDFG A+  +  + +I            
Sbjct: 143 GEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKDIHIVNDLEEKEEN 199
Query: 226 ---------------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ----- 265
                          S++ +R+YRAPELI     YT +IDIWS GC+ AELL        
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 266 ------PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPN---- 298
                 PLFPG                 +S  DQL  I  V+GTP  E++KC+       
Sbjct: 260 NPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIK 319
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
           Y +  FP        K +   +  E +DL+  +L+++   R T  +AL HP+  ++R  N
Sbjct: 320 YIKL-FPTRDGIDLSKKYSS-ISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKEN 377

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 110 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 162
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 312
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 280
Query: 313 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 281 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 90/301 (29%), Positives = 151/301 (50%), Gaps = 29/301 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 121
            Y   R +G G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L         +      LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 242 ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKC 294
              Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 295 MNPNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           ++P + +    +     W    H   Q  + PEA+D + +LL+Y    R TA EA+ HP+
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 351 F 351
           F
Sbjct: 324 F 324

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 24/225 (10%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 112 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 164
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 165 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 310
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 225 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 280
Query: 311 PWHKIFQKR----MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            W           + PEA+DL+ +LL+Y    R TA EA+ HP+F
Sbjct: 281 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 24/225 (10%)
Query: 140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 199
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 117 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 169
Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 259
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 170 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 260 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 310
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 230 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 285
Query: 311 PWHKIFQKR----MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            W           + PEA+DL+ +LL+Y    R TA EA+ HP+F
Sbjct: 286 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 164/333 (49%), Gaps = 53/333 (15%)
Query: 61  PKQTISYMAE--RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDH- 117
           P   ++Y  E  +V+G G FG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 118 -----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
                 N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ + 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKFA 206
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICSR 231
           + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +     I SR
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSR 263
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           +YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P +  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ-- 320
Query: 292 IKCMNPNYTEFKFPQIKAHPWH------------------KIFQKRMPPEA--------- 324
            K ++ +     F   K +P +                  +  + R PPE+         
Sbjct: 321 -KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 325 ------VDLVSRLLQYSPNLRSTALEALIHPFF 351
                 +D + + L++ P +R T  +AL HP+ 
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 138/288 (47%), Gaps = 16/288 (5%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVSL 123
           +G G++G V++A+   +G  VA+K V      +   + T+R           +HPNVV L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                ++    E+ + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
               + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE++  +T
Sbjct: 130 ANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQST 187
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +     
Sbjct: 188 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRGA 245
Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 246 FPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 104/351 (29%), Positives = 160/351 (45%), Gaps = 61/351 (17%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 117 HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 139
Query: 168 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWH----KIFQKRMPPEAV---------------- 325
            P    I    P   +F F ++    W+    K  ++   P                   
Sbjct: 257 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 314
Query: 326 -----------------DLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 359
                            DL+ R+L Y P  R     AL H FF +  D  T
Sbjct: 315 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGT 365

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 138/288 (47%), Gaps = 16/288 (5%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVSL 123
           +G G++G V++A+   +G  VA+K V      +   + T+R           +HPNVV L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                ++    E+ + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
               + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE++  +T
Sbjct: 130 ANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQST 187
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +     
Sbjct: 188 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRGA 245
Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 246 FPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 138/288 (47%), Gaps = 16/288 (5%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVSL 123
           +G G++G V++A+   +G  VA+K V      +   + T+R           +HPNVV L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                ++    E+ + LV E+V + +   +         +P   +K    Q  R L ++H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
               + HRD+KP+N+LV      +KL DFG A++          + + +YRAPE++  +T
Sbjct: 130 ANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQST 187
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    + +     
Sbjct: 188 -YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRGA 245
Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 246 FPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 42/284 (14%)
Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQ 161
           RE+  +R L HPNV+SL+  F S  ++    + L+ +Y    +  +IK H      K   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 162 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL 218
           ++P   VK   YQI   + Y+H    V HRD+KP N+LV    P   ++K+ D G A++ 
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 219 ---VKGEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF------ 268
              +K   ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F      
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 269 ---PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFK-FPQ--------IKAHPWH 313
                    DQL  I  V+G P     E+IK M  + T  K F +        IK    H
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 314 KIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
           K+   +   +A  L+ +LL   P  R T+ +A+  P+F  L DP
Sbjct: 303 KV---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 141/295 (47%), Gaps = 27/295 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------------RELQTMRLLD--- 116
           +G G++G V++A+   +G  VA+K V    R  N             RE+  +R L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           HPNVV L     ++    E+ + LV E+V + +   +         +P   +K    Q  
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIKDLMRQFL 130
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           R L ++H    + HRD+KP+N+LV      +KL DFG A++          + + +YRAP
Sbjct: 131 RGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +
Sbjct: 189 EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RD 246
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            +     FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 103/348 (29%), Positives = 159/348 (45%), Gaps = 61/348 (17%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 117 HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 158
Query: 168 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWH----KIFQKRMPPEAV---------------- 325
            P    I    P   +F F ++    W+    K  ++   P                   
Sbjct: 276 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 326 -----------------DLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
                            DL+ R+L Y P  R     AL H FF +  D
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 103/348 (29%), Positives = 159/348 (45%), Gaps = 61/348 (17%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           KNG+ K    Y  + ++G GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 117 HPN---------VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
             N         +V LK  F         +L LV E +   ++ ++++     + + L  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRN--TNFRGVSLNL 158
Query: 168 VKLYFYQICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             I SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWH----KIFQKRMPPEAV---------------- 325
            P    I    P   +F F ++    W+    K  ++   P                   
Sbjct: 276 IPP-AHILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGG 333
Query: 326 -----------------DLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
                            DL+ R+L Y P  R     AL H FF +  D
Sbjct: 334 RRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 148/304 (48%), Gaps = 38/304 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 127 FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    + 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE----VW 254
Query: 297 PNYTEF----KFPQIKAHPWHKIFQKRMP-----PEAVDLVSRLLQYSPNLRSTALEALI 347
           PN   +    K   +K     +  + R+      P A+DL+ +LL   P  R  + +AL 
Sbjct: 255 PNVDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 348 HPFF 351
           H FF
Sbjct: 313 HDFF 316

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 148/304 (48%), Gaps = 38/304 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 127 FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKASIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    + 
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE----VW 254
Query: 297 PNYTEF----KFPQIKAHPWHKIFQKRMP-----PEAVDLVSRLLQYSPNLRSTALEALI 347
           PN   +    K   +K     +  + R+      P A+DL+ +LL   P  R  + +AL 
Sbjct: 255 PNVDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 312
Query: 348 HPFF 351
           H FF
Sbjct: 313 HDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 148/299 (49%), Gaps = 28/299 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 127 FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 140
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMP----PEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  + +AL H FF
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 148/299 (49%), Gaps = 28/299 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 127 FFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
             +        K  +YL  V ++    +  ++ +   +  +  L  +K     +   L Y
Sbjct: 85  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYY 139
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 236
           IH    + HRD+K  N+L+      LKL DFG A+        +PN   + + + +YR P
Sbjct: 140 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           EL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    ++
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMP----PEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  + +AL H FF
Sbjct: 258 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 112 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 161
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 162 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 221 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 265
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL H +
Sbjct: 266 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 111 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 160
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 161 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 219
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 220 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 264
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL H +
Sbjct: 265 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL H +
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 102/358 (28%), Positives = 162/358 (45%), Gaps = 51/358 (14%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 119 N--------VVSLKHCF-----FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MP 164
           N         +   H       F+    + +++ +V E + E +  +IK   K   R +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIP 129
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 219
           LIYVK    Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------ 273
             E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 274 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FQKRM 320
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 321 PPEAVDLVSRLLQYSPNLRSTALEALIHPFF------DELRDPNTRL-PNGRFLPPLF 371
             E  D +S +LQ  P  R+ A   + HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 102/358 (28%), Positives = 162/358 (45%), Gaps = 51/358 (14%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 119 N--------VVSLKHCF-----FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MP 164
           N         +   H       F+    + +++ +V E + E +  +IK   K   R +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIP 129
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLV 219
           LIYVK    Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A    
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------ 273
             E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G      
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 274 VDQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FQKRM 320
            D + +II++LG            T T    + +  N ++ KF  ++     K  F K  
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 321 PPEAVDLVSRLLQYSPNLRSTALEALIHPFF------DELRDPNTRL-PNGRFLPPLF 371
             E  D +S +LQ  P  R+ A   + HP+       +E+R P+  L  +G  +P  F
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 94  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 143
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 144 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 203 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 247
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL H +
Sbjct: 248 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 131/295 (44%), Gaps = 49/295 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-------KVLQDKRYKNRELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +  L   F     +D+ Y  LV E     E    +I       +R   +       Q+  
Sbjct: 88  IXKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLS 137
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y H    + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIA 196
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
              YT F+ PQ     W     K++   A DL+ + L Y P+ R +A +AL H +
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHP 118
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           NV+     F    E     LN+VLE      + R+IKH  K  + +P   V  YF Q+C 
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAP 236
           AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + + YY +P
Sbjct: 148 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 138/294 (46%), Gaps = 44/294 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   F   T+   +YL + L    E   RV+ K  ++ S    ++        +  A+AY
Sbjct: 71  LYETFEDNTD---IYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAY 121
Query: 182 IHNTIGVCHRDIKPQNLL--VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            H  + V HRD+KP+N L   +     LKL DFG A     G+   + + + YY +P+++
Sbjct: 122 CHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G   Y    D WSAG ++  LL G P F   +  + +++I +  GT             
Sbjct: 181 EGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT------------- 223
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
             F FP+     W  +      P+A  L+ RLL  SP  R T+L+AL H +F++
Sbjct: 224 --FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 138/294 (46%), Gaps = 44/294 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   F   T+   +YL + L    E   RV+ K  ++ S    ++        +  A+AY
Sbjct: 88  LYETFEDNTD---IYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAY 138
Query: 182 IHNTIGVCHRDIKPQNLL--VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            H  + V HRD+KP+N L   +     LKL DFG A     G+   + + + YY +P+++
Sbjct: 139 CHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 197
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G   Y    D WSAG ++  LL G P F   +  + +++I +  GT             
Sbjct: 198 EGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT------------- 240
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
             F FP+     W  +      P+A  L+ RLL  SP  R T+L+AL H +F++
Sbjct: 241 --FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 137/308 (44%), Gaps = 49/308 (15%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 124
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y    D+WSAG +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
             PQ     W  I       +A DL+ ++L + P+LR TA + L HP+   ++  ++  P
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 363 NGRFLPPL 370
               LP L
Sbjct: 289 TISDLPSL 296

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 127
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 230
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 184
Query: 231 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 234
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 235 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 280
Query: 348 HPFFDE 353
           HP+  +
Sbjct: 281 HPWLQD 286

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 230
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 231 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 348 HPFFDE 353
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 230
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 231 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 348 HPFFDE 353
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 230
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 231 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 348 HPFFDE 353
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 120
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 230
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 177
Query: 231 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 227
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 228 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 273
Query: 348 HPFFDE 353
           HP+  +
Sbjct: 274 HPWLQD 279

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 148/327 (45%), Gaps = 54/327 (16%)
Query: 72  VVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
            +G G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 129 STTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                +      ++ +V E +  + +  IK +  +  R+   +++   YQIC+++ ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 185 TIGVCHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEP 223
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           + + + +R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 284 LG---------TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV------DLV 328
           LG         T  R+       ++ E            K  ++ M  + V      DL+
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 329 SRLLQYSPNLRSTALEALIHPFFDELR 355
            ++L+Y P  R T  EAL HPFFD L+
Sbjct: 310 QKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 150
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 207
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 250
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 251 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 294
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 295 FESVTWEN 302

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 95/302 (31%), Positives = 143/302 (47%), Gaps = 46/302 (15%)
Query: 58  NGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTMR 113
           +G  +  +S  +  E  +G G+  +V++ K   T +  A+K  K   DK+    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLY 171
            L HPN++ LK  F + TE     ++LVLE V   E   R+++  Y  S+R     VK  
Sbjct: 104 RLSHPNIIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGY-YSERDAADAVK-- 155
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQ-LKLCDFGSAKVLVKGEPNISYIC 229
             QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K+ V+ +  +  +C
Sbjct: 156 --QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC 211
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
               Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ +          
Sbjct: 212 GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------F 260
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
           R  + C      E+ F      PW       +   A DLV +L+   P  R T  +AL H
Sbjct: 261 RRILNC------EYYF----ISPWW----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306
Query: 349 PF 350
           P+
Sbjct: 307 PW 308

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 146/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             CF    + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 103 YFCF---QDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 154
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 155 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 211
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 212 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 254
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 255 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 298
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 299 FESVTWEN 306

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 129/288 (44%), Gaps = 46/288 (15%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 124
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y    D+WSAG +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
             PQ     W  I       +A DL+ ++L + P+LR TA + L HP+
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 129/288 (44%), Gaps = 46/288 (15%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 124
           ++G GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
             F    +    Y+   L    E    +IK   + S+      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK----QVFSGITYMHK 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y    D+WSAG +L  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
             PQ     W  I       +A DL+ ++L + P+LR TA + L HP+
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 146
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 203
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 204 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 246
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 247 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 290
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 291 FESVTWEN 298

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 92/308 (29%), Positives = 148/308 (48%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L   Y       ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGL--SYAKNGC--LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSASKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 147/327 (44%), Gaps = 54/327 (16%)
Query: 72  VVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
            +G G+FG V +  C++    G  VA+K V    RY       +++L+H N       F 
Sbjct: 21  TLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 129 STTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                +      ++ +V E +  + +  IK +  +  R+   +++   YQIC+++ ++H+
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLHS 136
Query: 185 TIGVCHRDIKPQNLL---------------------VNPHTHQLKLCDFGSAKVLVKGEP 223
              + H D+KP+N+L                     +NP    +K+ DFGSA      E 
Sbjct: 137 N-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEH 190
Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           + + +  R+YRAPE+I  A  ++   D+WS GC+L E  LG  +FP     + L  + ++
Sbjct: 191 HSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 284 LG---------TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV------DLV 328
           LG         T  R+       ++ E            K  ++ M  + V      DL+
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 329 SRLLQYSPNLRSTALEALIHPFFDELR 355
            ++L+Y P  R T  EAL HPFFD L+
Sbjct: 310 QKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 148/308 (48%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL- 204
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 292 FESVTWEN 299

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 260
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 230
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 317
Query: 231 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 367
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 368 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 413
Query: 348 HPFFDE 353
           HP+  +
Sbjct: 414 HPWLQD 419

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSAXKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 69  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 119
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 120 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 74  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 124
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 125 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 65  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 115
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 116 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 147/306 (48%), Gaps = 56/306 (18%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------------NRELQTMR 113
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLYFY
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 246
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYICS 230
           Q+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 303
Query: 231 R-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
              Y APE++   G   Y  A+D WS G +L   L G P F        L          
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 353
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
            +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EAL 
Sbjct: 354 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 399
Query: 348 HPFFDE 353
           HP+  +
Sbjct: 400 HPWLQD 405

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNR---ELQTMRLLDHP 118
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           +++ L     S   KDE+ +  V+EY    +   I    KMS++      + +F QI  A
Sbjct: 75  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 125
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           + Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S  Y APE+
Sbjct: 126 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           I G       +D+WS G +L  +L  +  F  ES
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 292 FESVTWEN 299

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 150
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 151 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 207
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 208 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 250
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 251 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 294
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 295 FESVTWEN 302

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 292 FESVTWEN 299

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 149
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 150 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 206
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 207 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 250 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 293
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 294 FESVTWEN 301

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+   +   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F  +T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-KVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  D    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 73  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 124
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 125 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 181
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 182 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 224
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 350
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 225 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 268
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 269 FESVTWEN 276

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 74  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 125
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 126 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 182
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 183 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 225
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 350
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 226 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 270 FESVTWEN 277

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 75  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 126
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 127 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 183
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 184 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 226
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 350
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 227 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 270
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 271 FESVTWEN 278

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 146
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 147 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 203
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 204 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 246
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 247 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 290
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 291 FESVTWEN 298

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 76  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 127
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 128 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 184
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 185 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 227
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA------LIHPF 350
               E+ FP+       K F     P+A DLV +LL      R    E         HPF
Sbjct: 228 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 271
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 272 FESVTWEN 279

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 91/308 (29%), Positives = 147/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 80  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 131
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 132 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 188
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 189 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 231
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 232 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 275
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 276 FESVTWEN 283

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 137/305 (44%), Gaps = 49/305 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 129 STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
               +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L ++H   
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 274
Query: 187 GVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--AT 243
              H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            YT   D+WS G +   LL G   F GE+  + L              +K  + N  +  
Sbjct: 335 YYT---DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSA 379
Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP--NTRL 361
           F  I               +  D + +LL   PN R T  +AL HP+      P  ++++
Sbjct: 380 FSGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
Query: 362 PNGRF 366
           P+ R+
Sbjct: 427 PSSRY 431

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 127
           V+G G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H+   
Sbjct: 89  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 142
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-GATEY 245
           + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
             A DIWS GC + E+  G+P F                        +   P    FK  
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 239
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
             K HP      + M  EA   + +  +  P+ R+ A + L+  F 
Sbjct: 240 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 127
           V+G G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
                 +  ++ + +E VP      +        +     +  Y  QI   L Y+H+   
Sbjct: 75  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-Q 128
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-GATEY 245
           + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I  G   Y
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
             A DIWS GC + E+  G+P F                        +   P    FK  
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAMFKVG 225
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
             K HP      + M  EA   + +  +  P+ R+ A + L+  F 
Sbjct: 226 MFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 142 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 198
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 199 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 240
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 241 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 137/305 (44%), Gaps = 49/305 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 129 STTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
               +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L ++H   
Sbjct: 118 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 168
Query: 187 GVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--AT 243
              H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G    
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            YT   D+WS G +   LL G   F GE+  + L              +K  + N  +  
Sbjct: 229 YYT---DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSA 273
Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP--NTRL 361
           F  I               +  D + +LL   PN R T  +AL HP+      P  ++++
Sbjct: 274 FSGISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 320
Query: 362 PNGRF 366
           P+ R+
Sbjct: 321 PSSRY 325

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 138/313 (44%), Gaps = 46/313 (14%)
Query: 48  HIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKR 103
           H IVT    K G      +     ++G G FG V + +   TG  +A K +    ++DK 
Sbjct: 75  HRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 104 YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQ 161
               E+  M  LDH N++ L   F S  +     + LV+EYV   E   R+I   Y +++
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKND-----IVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 162 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVK 220
              ++++K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+    
Sbjct: 187 LDTILFMK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
            E       +  + APE++      +   D+WS G +   LL G   F G++  + L  I
Sbjct: 242 REKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 340
           +        EE                        FQ  +  EA + +S+LL    + R 
Sbjct: 301 LACRWDLEDEE------------------------FQD-ISEEAKEFISKLLIKEKSWRI 335
Query: 341 TALEALIHPFFDE 353
           +A EAL HP+  +
Sbjct: 336 SASEALKHPWLSD 348

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 90/308 (29%), Positives = 146/308 (47%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF     A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 147
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 148 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 204
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 205 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 247
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP+       K F     P+A DLV +L  L  +  L    +E       HPF
Sbjct: 248 ----EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 292 FESVTWEN 299

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 99/346 (28%), Positives = 146/346 (42%), Gaps = 90/346 (26%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD 116
           Y  +  +G GS+GVV  A   +T    AIK + ++K          R K  E++ M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYV------------------------------- 145
           HPN+  L   +     +DE Y+ LV+E                                 
Sbjct: 87  HPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 146 -PETVHRVIK---HHYKMS----QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN 197
            PE     I    H ++ S    QR  LI       QI  AL Y+HN  G+CHRDIKP+N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLI--SNIMRQIFSALHYLHNQ-GICHRDIKPEN 198
Query: 198 LLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPELIFGATE-YTAAID 250
            L + + + ++KL DFG +K   K      Y  +      Y+ APE++    E Y    D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 251 IWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 310
            WSAG +L  LL+G   FPG +  D + +++        +++   NPNY           
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN---------- 301
Query: 311 PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
                    + P A DL+S LL  + + R  A+ AL HP+  +  D
Sbjct: 302 --------VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 138/298 (46%), Gaps = 46/298 (15%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTMRLLDH 117
           ++T  +M   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H
Sbjct: 8   RKTFIFM--EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N+V+L+  + STT     YL + L    E   R+++      +   L+       Q+  
Sbjct: 66  ENIVTLEDIYESTTH---YYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS 117
Query: 178 ALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSR-YYR 234
           A+ Y+H   G+ HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE +     Y+ A+D WS G +   LL G P F  E+   +L E IK            
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------------ 220
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
               Y EF+ P          F   +   A D +  LL+  PN R T  +AL HP+ D
Sbjct: 221 --EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 227
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 93/322 (28%), Positives = 150/322 (46%), Gaps = 51/322 (15%)
Query: 62  KQTISYMAERV--VGHGSFGVVF--QAKCLETGEAVAIKKVLQDKRYKN----RELQTMR 113
           K  +S M +RV  +G G++G V   + K      A+ I +        N     E+  ++
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLE-YVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           LLDHPN++ L + FF    +D+    LV+E Y    +   I H  K ++    + +K   
Sbjct: 92  LLDHPNIMKL-YDFF----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK--- 143
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICS 230
            Q+   + Y+H    + HRD+KP+NLL+        +K+ DFG + V    +     + +
Sbjct: 144 -QVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201
Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            YY APE++    +Y    D+WS G +L  LL G P F G++  DQ  EI++        
Sbjct: 202 AYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR-------- 247
Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
             K     YT F  P+     W     K +   A DL+ ++LQ+    R +A +AL HP+
Sbjct: 248 --KVEKGKYT-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 351 FDELRDPNTRLPNGRFLPPLFN 372
             E+    ++  +G  LP L N
Sbjct: 295 IKEM---CSKKESGIELPSLAN 313

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 115/228 (50%), Gaps = 17/228 (7%)
Query: 55  GGKN-GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---- 107
           GG++   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 2   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60
Query: 108 -ELQTMRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP 164
            E+Q M+ L+HPNVVS +           ++L L L +EY      R   + ++    + 
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGE 222
              ++     I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFP 269
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 179 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 115/228 (50%), Gaps = 17/228 (7%)
Query: 55  GGKN-GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR---- 107
           GG++   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 3   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 61
Query: 108 -ELQTMRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP 164
            E+Q M+ L+HPNVVS +           ++L L L +EY      R   + ++    + 
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGE 222
              ++     I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE
Sbjct: 121 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 179
Query: 223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFP 269
               ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 180 LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 124 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 181 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 222
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 223 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 182
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 151 HSK-RVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 144/308 (46%), Gaps = 64/308 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +F+  + ++LY  L      E    ++K+  K+         + Y  +I  AL Y+H
Sbjct: 101 ---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH 152
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIF 240
              G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y +PEL+ 
Sbjct: 153 GK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL- 209
Query: 241 GATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMN 296
             TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+             
Sbjct: 210 --TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL------------- 252
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTALEAL----IHPF 350
               E+ FP                P+A DLV +L  L  +  L    +E       HPF
Sbjct: 253 ----EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 296
Query: 351 FDELRDPN 358
           F+ +   N
Sbjct: 297 FESVTWEN 304

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 125 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 X-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 49/298 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 120 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 171
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 244 E--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           E  Y   +D+WS G    EL   +P     + +  L  I                    +
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 267
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 359
            + P +++  W + F+        + V   LQ  P  R T+   L H F    R P  
Sbjct: 268 NESPALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 317

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 183
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 122 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 179 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 220
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 221 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 141/297 (47%), Gaps = 46/297 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVV 121
           ++ +R +G G+FG V   +   +G    IK + +D+          E++ ++ LDHPN++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +   F     +D   + +V+E     E + R++    +  + +   YV     Q+  AL
Sbjct: 84  KIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNAL 137
Query: 180 AYIHNTIGVCHRDIKPQNLL---VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           AY H+   V H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y AP
Sbjct: 138 AYFHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+     + T   DIWSAG V+  LL G   F G S    L E+        +++     
Sbjct: 196 EVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKE 241
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           PNY       ++  P        + P+AVDL+ ++L   P  R +A + L H +F +
Sbjct: 242 PNYA------VECRP--------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 133/295 (45%), Gaps = 64/295 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-------SAKVLVKGEPNISYICSRYYRA 235
           H+   V HRDIKP+NLL+     +LK+ DFG       S +  + G  +        Y  
Sbjct: 126 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLP 175
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V            
Sbjct: 176 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 223 -----EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G 
Sbjct: 128 HSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   K  ++    Y+     ++  AL+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y  PE+I G 
Sbjct: 127 HSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 183
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   +  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++ + R T  E L HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 49/298 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C+       E    LV+EY   +   +++ H K  Q + +  V    +   + LAY+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT---HGALQGLAYLH 132
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 244 E--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
           E  Y   +D+WS G    EL   +P     + +  L  I                    +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQ 228
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 359
            + P +++  W + F+        + V   LQ  P  R T+   L H F    R P  
Sbjct: 229 NESPALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/325 (25%), Positives = 137/325 (42%), Gaps = 59/325 (18%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G G++GVV + + + +G+ +A+K++   +   N + Q   L+D    +    C F+ T 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 133 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
              L+    + + +E +  ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---FGATEY 245
            HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I        Y
Sbjct: 176 IHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
           +   DIWS G  + EL + +  FP +S            GTP ++               
Sbjct: 235 SVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------LK 268
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR 365
           Q+   P  ++   +   E VD  S+ L+ +   R T  E + HPF               
Sbjct: 269 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF--------------- 313
Query: 366 FLPPLFNFKPHELKGVPVDMLVKLI 390
                  F  HE KG  V   VKLI
Sbjct: 314 -------FTLHESKGTDVASFVKLI 331

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P   V++ ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P  TV+R ++   +  ++    Y+     ++  AL+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 HSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++ + R T  E L HP+
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 50/288 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   T      + L+LEY P   V++ ++   K  ++    Y+     ++  AL+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 130 HSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             +   +D+WS G +  E L+G+P F   +  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 136/297 (45%), Gaps = 47/297 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 139
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 140 YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 189
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 245
           GV HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APELI     Y
Sbjct: 190 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 247
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 288
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           ++K    HK+      P     + RLL   P  R+TA E L HPF  +   P + +P
Sbjct: 289 RLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 338

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 137/322 (42%), Gaps = 50/322 (15%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 112
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE   +   + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 352 DELRDPNTRLPNGRF-LPPLFN 372
                P  RLP     +PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 143/312 (45%), Gaps = 51/312 (16%)
Query: 59  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 111
           G P+   SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 20  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 74
Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 75  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 125
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 126 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 183
Query: 232 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 184 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 227
Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 228 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 276
Query: 351 FDELRDPNTRLP 362
             +   P + +P
Sbjct: 277 LAKAGPPASIVP 288

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/312 (28%), Positives = 143/312 (45%), Gaps = 51/312 (16%)
Query: 59  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 111
           G P+   SY+   + +G GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 16  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70
Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 71  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 121
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 122 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 179
Query: 232 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 223
Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 224 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 272
Query: 351 FDELRDPNTRLP 362
             +   P + +P
Sbjct: 273 LAKAGPPASIVP 284

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 136/297 (45%), Gaps = 47/297 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 96
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 97  YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 146
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 245
           GV HRDIK  ++L+  H  ++KL DFG    + K  P    +    Y+ APELI     Y
Sbjct: 147 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 204
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 245
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           ++K    HK+      P     + RLL   P  R+TA E L HPF  +   P + +P
Sbjct: 246 RLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 295

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 137/297 (46%), Gaps = 47/297 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 94
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 95  YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 144
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 245
           GV HRDIK  ++L+  H  ++KL DFG    + K  P    +  + Y+ APELI     Y
Sbjct: 145 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 202
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 243
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           ++K    HK+      P     + RLL   P  R+TA E L HPF  +   P + +P
Sbjct: 244 RLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 293

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 140/326 (42%), Gaps = 61/326 (18%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G G++GVV + + + +G+ +A+K++   +   N + Q   L+D    +    C F+ T 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 133 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
              L+    + + +E +  ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGATE 244
            HRD+KP N+L+N    Q+K+CDFG +  LV     +I   C + Y APE I        
Sbjct: 132 IHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGC-KPYMAPERINPELNQKG 189
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           Y+   DIWS G  + EL + +  FP +S            GTP ++              
Sbjct: 190 YSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------L 223
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNG 364
            Q+   P  ++   +   E VD  S+ L+ +   R T  E + HPF              
Sbjct: 224 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF-------------- 269
Query: 365 RFLPPLFNFKPHELKGVPVDMLVKLI 390
                   F  HE KG  V   VKLI
Sbjct: 270 --------FTLHESKGTDVASFVKLI 287

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 136/322 (42%), Gaps = 50/322 (15%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 112
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 352 DELRDPNTRLPNGRF-LPPLFN 372
                P  RLP     +PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 137/297 (46%), Gaps = 47/297 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A    +G+ VA+KK+  D R + R      E+  MR   H NVV + + 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 216
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +      DEL++  V+E++       I  H +M++      +      + +AL+ +H   
Sbjct: 217 YLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ- 266
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEY 245
           GV HRDIK  ++L+  H  ++KL DFG    + K  P     + + Y+ APELI     Y
Sbjct: 267 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPY 324
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  E               P  + +K +  N      P
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----P 365
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           ++K    HK+      P     + RLL   P  R+TA E L HPF  +   P + +P
Sbjct: 366 RLKN--LHKVS-----PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 415

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y  ++ +G G+F  V  A+ + TG  VA+K +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E  E  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 74  PNIVKL----FEVIET-EKTLYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 123
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 124 VSAVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 136/322 (42%), Gaps = 50/322 (15%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 112
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 21  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 81  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 132
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 133 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 191 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 227
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF
Sbjct: 228 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 280
Query: 352 DELRDPNTRLPNGRF-LPPLFN 372
                P  RLP     +PP F+
Sbjct: 281 TSGYAP-MRLPTSCLTVPPRFS 301

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/322 (27%), Positives = 136/322 (42%), Gaps = 50/322 (15%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTM 112
            P+    YM  R +G G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 231
            Q  + + Y+HN   V HRD+K  NL +N     +K+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE +     ++  +DIWS GC+L  LL+G+P F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
             C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF
Sbjct: 244 TSCLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFF 296
Query: 352 DELRDPNTRLPNGRF-LPPLFN 372
                P  RLP     +PP F+
Sbjct: 297 TSGYAP-MRLPTSCLTVPPRFS 317

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 128/302 (42%), Gaps = 59/302 (19%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----------------E 108
           SY   R +G G++G V   K        AIK + + +  K R                 E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 109 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLI 166
           +  ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I  H K  +     
Sbjct: 97  ISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAAN 150
Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN 224
            +K    QI   + Y+H    + HRDIKP+N+L+        +K+ DFG +    K    
Sbjct: 151 IMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              + + YY APE++    +Y    D+WS G ++  LL G P F G++  D + ++ K  
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-- 261
Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
                         Y +F       + W     K +  EA +L+  +L Y  N R TA E
Sbjct: 262 -----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 345 AL 346
           AL
Sbjct: 299 AL 300

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------- 106
           G K+    +   Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMP 164
           RE+Q ++L  HP+++ L     + T+       +V+EYV   E    + KH      R+ 
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVE 109
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
            +  +  F QI  A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE  
Sbjct: 110 EMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFL 167
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            +   S  Y APE+I G       +DIWS G +L  LL G   F  E
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 110/227 (48%), Gaps = 25/227 (11%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------R 107
           G + QP    +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        R
Sbjct: 4   GSDEQP-HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFR 60
Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
           E++ M++L+HPN+V L    F   E ++  L L++EY    E    ++ H      RM  
Sbjct: 61  EVRIMKILNHPNIVKL----FEVIETEKT-LYLIMEYASGGEVFDYLVAHG-----RMKE 110
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              +  F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    
Sbjct: 111 KEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLD 168
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           ++  S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 169 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H +   +       +  F QI
Sbjct: 66  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGWMKEKE-----ARAKFRQI 115
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 116 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 173
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 23/227 (10%)
Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------- 106
           G K+    +   Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMP 164
           RE+Q ++L  HP+++ L     + T+       +V+EYV   E    + KH      R+ 
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVE 109
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
            +  +  F QI  A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE  
Sbjct: 110 EMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFL 167
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
                S  Y APE+I G       +DIWS G +L  LL G   F  E
Sbjct: 168 RDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 135/314 (42%), Gaps = 51/314 (16%)
Query: 53  TIGGKNGQPKQTISYMAERV---------VGHGSFGVVFQAKCLETGEAVAIK----KVL 99
           ++  +NG+   +    AE +         +G G+F  V  A+   TG+  A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 100 QDKRYK-NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
           + K      E+  +R + H N+V+L+  + S    + LYL + L    E   R+++  + 
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESP---NHLYLVMQLVSGGELFDRIVEKGFY 117
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL--CDFGSAK 216
             +    +       Q+  A+ Y+H  +G+ HRD+KP+NLL      + K+   DFG +K
Sbjct: 118 TEKDASTL-----IRQVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK 171
Query: 217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 276
           +  KG+   +   +  Y APE +     Y+ A+D WS G +   LL G P F  E+    
Sbjct: 172 MEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKL 230
Query: 277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 336
             +I+K                  EF  P      W  I        A D +  L++  P
Sbjct: 231 FEQILKA---------------EYEFDSPY-----WDDI-----SDSAKDFIRNLMEKDP 265
Query: 337 NLRSTALEALIHPF 350
           N R T  +A  HP+
Sbjct: 266 NKRYTCEQAARHPW 279

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 88/337 (26%), Positives = 155/337 (45%), Gaps = 75/337 (22%)
Query: 55  GGKNGQPKQTIS-----------YMAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDK 102
           GGK G+  +  +            ++E+++G+GS G VVFQ      G  VA+K++L D 
Sbjct: 12  GGKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID- 68
Query: 103 RYKNRELQTMRLL----DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
            + +  L  ++LL    DHPNV+      +  +E  + +L + LE     +  +++    
Sbjct: 69  -FCDIALMEIKLLTESDDHPNVIR-----YYCSETTDRFLYIALELCNLNLQDLVESKNV 122
Query: 159 MSQRMPLIYVKLY-----FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-------- 205
             + + L   K Y       QI   +A++H ++ + HRD+KPQN+LV+  +         
Sbjct: 123 SDENLKL--QKEYNPISLLRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTG 179
Query: 206 ----QLKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE--YTAAIDIWSA 254
               ++ + DFG  K L  G+            +  +RAPEL+  +T+   T +IDI+S 
Sbjct: 180 AENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSM 239
Query: 255 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 314
           GCV    +L +   P      +   II+  G  + +E+KC++                  
Sbjct: 240 GCVFY-YILSKGKHPFGDKYSRESNIIR--GIFSLDEMKCLH------------------ 278
Query: 315 IFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
              + +  EA DL+S+++ + P  R TA++ L HP F
Sbjct: 279 --DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 148/313 (47%), Gaps = 64/313 (20%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 91
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY-----FYQICR 177
                +  +E  + +L + LE     +  +++      + + L   K Y       QI  
Sbjct: 92  -----YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 144
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 145 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 226 SYIC-----SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
                    +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 262
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
            II+  G  + +E+KC++                     + +  EA DL+S+++ + P  
Sbjct: 263 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 300
Query: 339 RSTALEALIHPFF 351
           R TA++ L HP F
Sbjct: 301 RPTAMKVLRHPLF 313

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV+EY    E    ++ H      RM     +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G     +  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 132/304 (43%), Gaps = 48/304 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEA-VAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHC 126
           +G G+FGVV   +C+E     V + K +      DK     E+  M  L HP +++L   
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 127 FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           F     +D+  + L+LE++   E   R+    YKMS+   + Y++    Q C  L ++H 
Sbjct: 117 F-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHE 167
Query: 185 TIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
              + H DIKP+N++        +K+ DFG A  L   E       +  + APE++    
Sbjct: 168 H-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DRE 225
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
                 D+W+ G +   LL G   F GE  ++ L            + +K  +  + E  
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDA 273
Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD-ELRDPNTRLP 362
           F  +              PEA D +  LLQ  P  R T  +AL HP+   +  +  +R+P
Sbjct: 274 FSSVS-------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
Query: 363 NGRF 366
           + R+
Sbjct: 321 SSRY 324

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 134/297 (45%), Gaps = 50/297 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKNRELQTMRLLDHPNVV 121
           YM    +G G FG+V   +C+ET       A  +K    D+    +E+  + +  H N++
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L   F S  E     L ++ E++   +   R+    +++++R  + YV    +Q+C AL
Sbjct: 65  HLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
            ++H+   + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +      + A D+WS G ++  LL G   F  E+   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 299 YT--EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           YT  E  F +I               EA+D V RLL      R TA EAL HP+  +
Sbjct: 220 YTFDEEAFKEI-------------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTMRLLDHPN 119
           Y   + +G G++G V   K   TG   AIK + +              E+  ++ LDHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L   F    +K   YL + +    E    +I     + Q+   +   +   Q+    
Sbjct: 66  IMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGT 117
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + YY APE
Sbjct: 118 TYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++    +Y    D+WS G +L  LL G P F G++  DQ     ++L    + +     P
Sbjct: 177 VL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGKFSFDPP 227
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           ++T+                  +  EA  LV  +L Y P+ R +A EAL HP+
Sbjct: 228 DWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 47/299 (15%)
Query: 63  QTISYMAERV--VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-------ELQTMR 113
           Q +S   +RV  +G G++G V   K   TG   AIK + +              E+  ++
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
            LDHPN++ L   F    +K   YL + +    E    +I     + Q+   +   +   
Sbjct: 77  QLDHPNIMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMK 128
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSR 231
           Q+     Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + + 
Sbjct: 129 QVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTA 187
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           YY APE++    +Y    D+WS G +L  LL G P F G++  DQ     ++L    + +
Sbjct: 188 YYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGK 238
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                P++T+                  +  EA  LV  +L Y P+ R +A EAL HP+
Sbjct: 239 FSFDPPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           Y+    +G GSFG V  A   +T + VA+K + +    K+       RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L     + T+     + +V+EY    +   I    +M++       + +F QI  A+
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELFDYIVEKKRMTEDEG----RRFFQQIICAI 121
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            Y H    + HRD+KP+NLL++ + + +K+ DFG + ++  G    +   S  Y APE+I
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
            G       +D+WS G VL  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L L++EY    E    ++ H      RM     +  F QI
Sbjct: 74  PNIVKL----FEVIETEKT-LYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQI 123
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 124 VSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 20/216 (9%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DH 117
            ++  +++G GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           P +  +  C F T E     L  V+EY+       + +H +   +  L     Y  +I  
Sbjct: 78  PFLTHM-FCTFQTKEN----LFFVMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAP 236
            L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y AP
Sbjct: 130 GLQFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           E++ G  +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 188 EILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 70  ERV--VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNV 120
           ER+  +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYI 76
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V     F+S  E     +++ +E++   ++ +V+K     ++R+P   +      + R L
Sbjct: 77  VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGL 127
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           AY+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE +
Sbjct: 128 AYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERL 185
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQ 265
            G T Y+   DIWS G  L EL +G+
Sbjct: 186 QG-THYSVQSDIWSMGLSLVELAVGR 210

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 91/322 (28%), Positives = 143/322 (44%), Gaps = 71/322 (22%)
Query: 59  GQPKQTISYMAERV-VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQT 111
           G P++   Y+A  + +G GS G+V  A    TG+ VA+KK+  D R + R      E+  
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVI 95
Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 171
           MR   H NVV +   + S    DEL++  V+E++       I  H +M++      +   
Sbjct: 96  MRDYHHDNVVDM---YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 146
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
              + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P    +   
Sbjct: 147 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGT 204
Query: 232 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            Y+ APE+I     Y   +DIWS G ++ E++ G+P +                      
Sbjct: 205 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPY---------------------- 241
Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL--VSRLLQ--------YSPNLRS 340
                      F  P ++A    +  +  +PP   DL  VS +L+          P+ R+
Sbjct: 242 -----------FNEPPLQA---MRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRA 287
Query: 341 TALEALIHPFFDELRDPNTRLP 362
           TA E L HPF      P+  +P
Sbjct: 288 TAQELLGHPFLKLAGPPSCIVP 309

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 134/295 (45%), Gaps = 43/295 (14%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH 117
           QP++    + +  +G GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D 
Sbjct: 26  QPEEVFDVLEK--LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS 83
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           P+VV     +F  T+     L +V+EY    +V  +I+   K      +  +        
Sbjct: 84  PHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI---LQSTL 135
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRYYRA 235
           + L Y+H    + HRDIK  N+L+N   H  KL DFG A  L       +  I + ++ A
Sbjct: 136 KGLEYLHFMRKI-HRDIKAGNILLNTEGHA-KLADFGVAGQLTDXMAKRNXVIGTPFWMA 193
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE+I     Y    DIWS G    E+  G+P +   + +  +  I  +   PT       
Sbjct: 194 PEVI-QEIGYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMI---PT------- 239
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           NP  T F+ P++    W   F         D V + L  SP  R+TA + L HPF
Sbjct: 240 NPPPT-FRKPEL----WSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 58/300 (19%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 118
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH---HYKMSQRMPLIYVKLYFY 173
           +++ L     + ++     + +V+EYV   E    + K+     K S+R+        F 
Sbjct: 77  HIIKLYQVISTPSD-----IFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQ 123
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           QI   + Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y
Sbjct: 124 QILSGVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNY 181
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
            APE+I G       +DIWS+G +L  LL G   F  +               PT  +  
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------------VPTLFKKI 228
Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           C    YT    PQ             + P  + L+  +LQ  P  R+T  +   H +F +
Sbjct: 229 CDGIFYT----PQY------------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           +++G GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           +  C F T E     L  V+EY+       + +H +   +  L     Y  +I   L ++
Sbjct: 84  M-FCTFQTKEN----LFFVMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 241
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G
Sbjct: 136 HSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
             +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 194 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 134/281 (47%), Gaps = 40/281 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           R +G GSFG V   +  +T +  A+K     K ++    +N  +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            + F     +DE  + +V++ +   +   +++H + +       VKL+  ++  AL Y+ 
Sbjct: 81  WYSF-----QDEEDMFMVVDLL---LGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-- 241
           N   + HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+     
Sbjct: 133 NQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TREEI- 292
              Y+ A+D WS G    ELL G+  +   S      EI+    T         ++E + 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEMVS 249
Query: 293 ---KCMNPN----YTEF----KFPQIKAHPWHKIFQKRMPP 322
              K + PN    +++      FP +    W  +FQKR+ P
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 125/291 (42%), Gaps = 42/291 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    K L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------E 234
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            EF  P          +   +   A D +  L++  P  R T  +AL HP+
Sbjct: 235 YEFDSP----------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 94/384 (24%), Positives = 162/384 (42%), Gaps = 67/384 (17%)
Query: 13  TVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERV 72
           + GVD   E +    ++  K    +V D    + GH+ V  IG           ++ ER 
Sbjct: 8   SSGVDLGTENLYFQSMQSSKRSSRSVED---DKEGHL-VCRIG----------DWLQERY 53
Query: 73  -----VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 124
                +G G+FG V   +CL+       VA+K +    +Y+      + +L        +
Sbjct: 54  EIVGNLGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKE 111
Query: 125 HCFFSTTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + F      D      ++ +  E + +     +K +    Q  PL +V+   YQ+C AL 
Sbjct: 112 NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALR 169
Query: 181 YIHNTIGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGE 222
           ++H    + H D+KP+N+L          N H            +++ DFGSA      E
Sbjct: 170 FLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHE 226
Query: 223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
            + + + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K
Sbjct: 227 HHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 285
Query: 283 VLG-------TPTREEIK------CMNPNYTEFKFPQIKAHPWHK-IFQKRMPP-EAVDL 327
           +LG         TR++          + N ++ ++ +    P    + Q  +   +  DL
Sbjct: 286 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 345
Query: 328 VSRLLQYSPNLRSTALEALIHPFF 351
           + R+L++ P  R T  EAL+HPFF
Sbjct: 346 MRRMLEFDPAQRITLAEALLHPFF 369

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 147/317 (46%), Gaps = 68/317 (21%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY-----FYQICR 177
                +  +E  + +L + LE     +  +++      + + L   K Y       QI  
Sbjct: 74  -----YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+ + 
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 226 SYIC-----SRYYRAPELIFGAT------EYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
                    +  +RAPEL+  +         T +IDI+S GCV    +L +   P     
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDH 282
Query: 335 SPNLRSTALEALIHPFF 351
            P  R TA++ L HP F
Sbjct: 283 DPLKRPTAMKVLRHPLF 299

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 112/220 (50%), Gaps = 21/220 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 122
           RV+G GSFG V  A+  ETG+  A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  C F T ++    L  V+E+V       +  H + S+R      + Y  +I  AL ++
Sbjct: 89  L-FCCFQTPDR----LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 241
           H+  G+ +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I  
Sbjct: 141 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQ 197
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
              Y  A+D W+ G +L E+L G   F  E+  D L E I
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 132/289 (45%), Gaps = 48/289 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +G G+F VV +   +  G+  A K +       +D +   RE +  RLL HPN+V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 88
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             S +E+   YL   L    E    ++ + +Y  +     I       QI  A+ + H  
Sbjct: 89  --SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ- 139
Query: 186 IGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG 241
           +GV HRD+KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +  
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLR 197
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y   +D+W+ G +L  LL+G P F  E    +L + IK                   
Sbjct: 198 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GA 240
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           + FP  +   W  +      PEA DL++++L  +P+ R TA EAL HP+
Sbjct: 241 YDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 281

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 121
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 287
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 121
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 91  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 141 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 287
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 199 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 142/303 (46%), Gaps = 39/303 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 98
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 99  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 150 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 206
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           Y+   DIWS G  L E+ +G+ P+ P ++   +L+   +V G       +   P     K
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 304 FPQIKAHPWHKIFQ------KRMPP---------EAVDLVSRLLQYSPNLRSTALEALIH 348
           F  + + P   IF+         PP         E  D V++ L  +P  R+   + ++H
Sbjct: 267 F-GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325
Query: 349 PFF 351
            F 
Sbjct: 326 AFI 328

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY+P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG---DMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EY+P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYMPGG---DMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 146/317 (46%), Gaps = 68/317 (21%)
Query: 68  MAERVVGHGSFG-VVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 122
           ++E+++G+GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIR 73
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY-----FYQICR 177
                +  +E  + +L + LE     +  +++      + + L   K Y       QI  
Sbjct: 74  -----YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPISLLRQIAS 126
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGEPNI 225
            +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+   
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 226 SYIC-----SRYYRAPELIFGAT------EYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
                    +  +RAPEL+  +         T +IDI+S GCV    +L +   P     
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKY 244
Query: 275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
            +   II+  G  + +E+KC++                     + +  EA DL+S+++ +
Sbjct: 245 SRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDH 282
Query: 335 SPNLRSTALEALIHPFF 351
            P  R TA++ L HP F
Sbjct: 283 DPLKRPTAMKVLRHPLF 299

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 121
           +V+G GSFG VF  K +   +A  +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 287
           +     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 86  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 134
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++       
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 195 KVADVWSCGVTLYVMLVG 212

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +   T E VA+K + +         RE+   R L HPN+V  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +++EY    E   R+       + R      + +F Q+   ++Y H ++ 
Sbjct: 88  PT-----HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCH-SMQ 136
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           +CHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYD 195
Query: 247 AAI-DIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
             I D+WS G  L  +L+G  P    E   D    I ++L                ++  
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------------VKYSI 241
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           P             R+ PE   L+SR+    P  R +  E   H +F
Sbjct: 242 PD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 134 AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 185 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 241
Query: 245 YTAAIDIWSAGCVLAELLLGQ 265
           Y+   DIWS G  L E+ +G+
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGR 262

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 22/217 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 90
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 91  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 142 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 198
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           Y+   DIWS G  L E+ +G+      SG   + E++
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQ 276
           Y+   DIWS G  L E+ +G+ P+ P ++  D 
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 138/319 (43%), Gaps = 48/319 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 27  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 130 TTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
               D      ++ +  E + +     +K      Q  PL +V+   YQ+C AL ++H  
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN 142
Query: 186 IGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGEPNISY 227
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 143 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 199
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-- 285
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG  
Sbjct: 200 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 286 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHK-IFQKRMPP-EAVDLVSRLL 332
                  TR++          + N ++ ++ +    P    + Q  +   +  DL+ R+L
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318
Query: 333 QYSPNLRSTALEALIHPFF 351
           ++ P  R T  EAL+HPFF
Sbjct: 319 EFDPAQRITLAEALLHPFF 337

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 139/319 (43%), Gaps = 48/319 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 36  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 93
Query: 130 TTEKDEL----YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
               D      ++ +  E + +     +K +    Q  PL +V+   YQ+C AL ++H  
Sbjct: 94  VLMSDWFNFHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN 151
Query: 186 IGVCHRDIKPQNLLV---------NPHTH---------QLKLCDFGSAKVLVKGEPNISY 227
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 152 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 208
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-- 285
           + +R+YR PE+I     +    D+WS GC+L E   G  LF      + LV + K+LG  
Sbjct: 209 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 267
Query: 286 -----TPTREEIK------CMNPNYTEFKFPQIKAHPWHK-IFQKRMPP-EAVDLVSRLL 332
                  TR++          + N ++ ++ +    P    + Q  +   +  DL+ R+L
Sbjct: 268 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 327
Query: 333 QYSPNLRSTALEALIHPFF 351
           ++ P  R T  EAL+HPFF
Sbjct: 328 EFDPAQRITLAEALLHPFF 346

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           PN+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  PNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  
Sbjct: 114 ESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK          
Sbjct: 172 YLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA--------- 220
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                    + FP   +  W  +      PEA DL++++L  +P  R TA EAL HP+ 
Sbjct: 221 -------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 24/219 (10%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCG 201
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 202 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ 265
           Y+   DIWS G  L E+ +G+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 58/310 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            + F      D   + L+LE+ P   +++ ++ H +  ++    +++    ++  AL Y 
Sbjct: 81  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 131
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 132 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
           T +   +D+W AG +  E L+G P F   S  +    I+ V                 + 
Sbjct: 189 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 230
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           KFP              +   + DL+S+LL+Y P  R      + HP+       N+R  
Sbjct: 231 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA----NSR-- 272
Query: 363 NGRFLPPLFN 372
             R LPP++ 
Sbjct: 273 --RVLPPVYQ 280

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 132/326 (40%), Gaps = 61/326 (18%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G G++GVV + + + +G+  A+K++   +   N + Q   L D         C F+ T 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI---RATVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 133 KDELY----LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
              L+    + +  E    ++ +  K      Q +P   +      I +AL ++H+ + V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGATE 244
            HRD+KP N+L+N    Q+K CDFG +  LV     +I   C + Y APE I        
Sbjct: 159 IHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGC-KPYXAPERINPELNQKG 216
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           Y+   DIWS G    EL + +  FP +S            GTP ++              
Sbjct: 217 YSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ-------------L 250
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNG 364
            Q+   P  ++   +   E VD  S+ L+ +   R T  E   HPF              
Sbjct: 251 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPF-------------- 296
Query: 365 RFLPPLFNFKPHELKGVPVDMLVKLI 390
                   F  HE KG  V   VKLI
Sbjct: 297 --------FTLHESKGTDVASFVKLI 314

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ 265
           Y+   DIWS G  L E+ +G+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGR 200

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 58/310 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            + F      D   + L+LE+ P   +++ ++ H +  ++    +++    ++  AL Y 
Sbjct: 80  YNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 130
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y  PE+I G 
Sbjct: 131 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
           T +   +D+W AG +  E L+G P F   S  +    I+ V                 + 
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 229
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           KFP              +   + DL+S+LL+Y P  R      + HP+       N+R  
Sbjct: 230 KFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA----NSR-- 271
Query: 363 NGRFLPPLFN 372
             R LPP++ 
Sbjct: 272 --RVLPPVYQ 279

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 134/298 (44%), Gaps = 58/298 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSL 123
           R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F     +D   + ++++Y+       +    + SQR P    K Y  ++C AL Y+H
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGE---LFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSR-YYRAPELIFG 241
           +   + +RD+KP+N+L++ + H +K+ DFG AK +    P+++Y +C    Y APE++  
Sbjct: 124 SK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV-S 176
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y  +ID WS G ++ E+L G   F   + +    +I+                   E
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-----------------E 219
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-----QYSPNLRSTALEALIHPFFDEL 354
            +FP                 +  DL+SRL+     Q   NL++   +   HP+F E+
Sbjct: 220 LRFPPF------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 127/291 (43%), Gaps = 42/291 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK + ++     +     E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK----------------- 232
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            E++F    +  W  I        A D +  L++  P  R T  +AL HP+
Sbjct: 233 AEYEF---DSPYWDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 48/298 (16%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           PN+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  PNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      +  +  
Sbjct: 114 ESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK          
Sbjct: 172 YLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA--------- 220
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                    + FP  +   W  +      PEA DL++++L  +P  R TA EAL HP+
Sbjct: 221 -------GAYDFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPW 263

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 24/219 (10%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 19  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 79  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 130
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   
Sbjct: 131 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCG 186
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
           +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ 265
           Y+   DIWS G  L E+ +G+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 245 YTAAIDIWSAGCVLAELLLGQ 265
           Y+   DIWS G  L E+ +G+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGR 200

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 42/291 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------E 234
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            EF  P      W  I        A D +  L++  P  R T  +AL HP+
Sbjct: 235 YEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 42/291 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +L   + S      LYL + L    E   R+++  +   +    +      +Q+  A+ Y
Sbjct: 80  ALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVLDAVKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE +
Sbjct: 132 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-V 189
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA---------------E 234
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            EF  P          +   +   A D +  L++  P  R T  +AL HP+
Sbjct: 235 YEFDSP----------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    R +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           +  + ++ P +V L+  F     KD   L +VLEY P      +  H +   R    + +
Sbjct: 94  RIQQAVNFPFLVKLEFSF-----KDNSNLYMVLEYAPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTM 112
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFSEPHARFYA 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR- 231
            QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTM 112
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFSEPHARFYA 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR- 231
            QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +    +   +YL   L    E + ++++  +  S+R          + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKF-FSERE----ASFVLHTIGKTVEYLHSQ 140
Query: 186 IGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
            GV HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 240 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
                Y    DIWS G +L  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
               KF  +    W+ + +      A DLVS++L   P+ R TA + L HP+  +
Sbjct: 244 ----KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 135/303 (44%), Gaps = 48/303 (15%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 122
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           LK  +      D  Y+ +V E +   E + ++++  +   +    +      + I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFTITKTVE 130
Query: 181 YIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE +     Y AA DIWS G +L  +L G   F      D   EI+  +G+        
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSG------- 238
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF---F 351
                   KF  +    W+ +        A DLVS++L   P+ R TA   L HP+   +
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
Query: 352 DEL 354
           D+L
Sbjct: 285 DQL 287

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 115/250 (46%), Gaps = 36/250 (14%)
Query: 53  TIGGKNGQPK-----QTISY-----MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK 102
           ++GG +G+ +     QT+          RV+  G F  V++A+ + +G   A+K++L ++
Sbjct: 6   SLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE 65
Query: 103 RYKNR----ELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY 157
             KNR    E+  M+ L  HPN+V          E+ +      L        ++++   
Sbjct: 66  EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK 125
Query: 158 KMSQRMPLI--YVKLYFYQICRALAYIHNTI-GVCHRDIKPQNLLVNPHTHQLKLCDFGS 214
           KM  R PL    V   FYQ CRA+ ++H     + HRD+K +NLL++ +   +KLCDFGS
Sbjct: 126 KMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGS 184
Query: 215 AKVLVKGEPNISYICSR--------------YYRAPELI--FGATEYTAAIDIWSAGCVL 258
           A   +   P+ S+   R               YR PE+I  +         DIW+ GC+L
Sbjct: 185 ATT-ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243
Query: 259 AELLLGQPLF 268
             L   Q  F
Sbjct: 244 YLLCFRQHPF 253

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 43/292 (14%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +    +   +YL   L    E + ++++  +   +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV-----LHTIGKTVEYLHSQ 140
Query: 186 IGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
            GV HRD+KP N+L      NP    L++CDFG AK L      +   C +  + APE +
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 240 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
                Y    DIWS G +L  +L G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
               KF  +    W+ + +      A DLVS++L   P+ R TA + L HP+
Sbjct: 244 ----KFT-LSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE----LQTM 112
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R+L   N   L    FS  +   LY  +V+EY P      +  H +   R    + + Y 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG---EMFSHLRRIGRFXEPHARFYA 148
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR- 231
            QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 61/300 (20%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIK--------KVLQDKRYKNRELQTMRLLDHPN 119
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +V L + F +  +     L L+LEY+   E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDT-----ACFYLAEISM 132
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAP 236
           AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +  G    ++  +  Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E++   + +  A+D WS G ++ ++L G P F GE+    + +I+K          K   
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---------KLNL 240
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 351
           P Y                    +  EA DL+ +LL+ +   R       A E   HPFF
Sbjct: 241 PPY--------------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K +E++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFXEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDH 117
           +Y   + +G G+F  V  A+ + TG+ VA+K +  DK   N        RE++  ++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           PN+V L    F   E ++  L LV EY    E    ++ H     +       +  F QI
Sbjct: 73  PNIVKL----FEVIETEKT-LYLVXEYASGGEVFDYLVAHGRXKEKE-----ARAKFRQI 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           PEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 132/289 (45%), Gaps = 48/289 (16%)
Query: 73  VGHGSFGVVFQA-KCLETGEAVAI-----KKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +G G+F VV +  K L   E  A+     K   +D +   RE +  RLL HPN+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 77
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             S +E+   YL   L    E    ++ + +Y  +     I       QI  A+ + H  
Sbjct: 78  --SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ- 128
Query: 186 IGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG 241
           +GV HR++KP+NLL+        +KL DFG A + V+GE      +  +  Y +PE +  
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VLR 186
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y   +D+W+ G +L  LL+G P F  E    +L + IK                   
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GA 229
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           + FP  +   W  +      PEA DL++++L  +P+ R TA EAL HP+
Sbjct: 230 YDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 270

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 114 RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 165
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 166 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 220
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 221 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N+L++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNS 172
Query: 225 I----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           +    + I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           +    E     L +++E++       I    ++++      +      + +ALAY+H   
Sbjct: 111 YLVGEE-----LWVLMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLHAQ- 160
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 245
           GV HRDIK  ++L+     ++KL DFG    + K  P    +    Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
              +DIWS G ++ E++ G+P +  +S V  +            + ++   P       P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------P 259
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           ++K    HK+      P   D + R+L   P  R+TA E L HPF  +   P   +P
Sbjct: 260 KLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 139/298 (46%), Gaps = 51/298 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------LLDHPNVVSLK 124
           ++G GSF  V++A+ + TG  VAIK + +   YK   +Q ++        L HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + F     +D  Y+ LVLE      ++R +K+  K          + + +QI   + Y+H
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE---ARHFMHQIITGMLYLH 129
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGA 242
           +  G+ HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE I   
Sbjct: 130 SH-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATR 186
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
           + +    D+WS GC+   LL+G+P F  ++  + L +++                   ++
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------LADY 229
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR 360
           + P              +  EA DL+ +LL+ +P  R +    L HPF    R+ +T+
Sbjct: 230 EMPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS--RNSSTK 273

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 129/300 (43%), Gaps = 61/300 (20%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIK--------KVLQDKRYKNRELQTMRLLDHPN 119
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +V L + F +  +     L L+LEY+   E   ++ +    M           Y  +I  
Sbjct: 83  IVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDT-----ACFYLAEISM 132
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAP 236
           AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +         C    Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E++   + +  A+D WS G ++ ++L G P F GE+    + +I+K          K   
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---------KLNL 240
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 351
           P Y                    +  EA DL+ +LL+ +   R       A E   HPFF
Sbjct: 241 PPY--------------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFSEPHAR 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 138 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 192
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 140/304 (46%), Gaps = 55/304 (18%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIK-----KVLQDKRYKNRELQTMRLLDH----P 118
           +V+G G++G VF  + +   +TG+  A+K      ++Q  +         ++L+H    P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +V+L + F + T+     L+L+L+Y+       +  H    +R     V++Y  +I  A
Sbjct: 120 FLVTLHYAFQTETK-----LHLILDYINGGE---LFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAP 236
           L ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C    Y AP
Sbjct: 172 LEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 237 ELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           +++ G  + +  A+D WS G ++ ELL G   F  +   +   EI       +R  +K  
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSE 282
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPF 350
            P      +PQ             M   A DL+ RLL   P  R       A E   H F
Sbjct: 283 PP------YPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
Query: 351 FDEL 354
           F ++
Sbjct: 325 FQKI 328

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 107/237 (45%), Gaps = 39/237 (16%)
Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---------------- 207
           P+  V+   +Q+C+A+ ++H+   + H D+KP+N+L     ++L                
Sbjct: 135 PIHQVRHMAFQLCQAVKFLHDN-KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKST 193
Query: 208 --KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
             ++ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC++ E  +G 
Sbjct: 194 AVRVVDFGSATF--DHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGF 250
Query: 266 PLFPGESGVDQLVEIIKVLG-TPTREEIKC------------MNPNYTEFKFPQIKAHPW 312
            LF      + L  + ++LG  P+R   K              + N +  ++ +    P 
Sbjct: 251 TLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPL 310
Query: 313 HKIFQKRMPP--EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD--PNTRLPNGR 365
            +          +  DL+  +L+Y P  R T  EAL HPFF  LR   PN    + R
Sbjct: 311 RRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSR 367

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP--NVVSL 123
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L +    ++VS 
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRALAY 181
             C F        +    L ++ + ++     HY +SQ        + FY  +I   L +
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGG-DLHYHLSQHGVFSEADMRFYAAEIILGLEH 306
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++  
Sbjct: 307 MHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 363
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV------------- 283
              Y ++ D +S GC+L +LL G   F       +  +D++   + V             
Sbjct: 364 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 423
Query: 284 ----LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 322
               L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 424 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP--NVVSL 123
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L +    ++VS 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRALAY 181
             C F        +    L ++ + ++     HY +SQ        + FY  +I   L +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG-DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++  
Sbjct: 308 MHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV------------- 283
              Y ++ D +S GC+L +LL G   F       +  +D++   + V             
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 284 ----LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 322
               L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+C FG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 132/315 (41%), Gaps = 50/315 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 363
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 283
Query: 364 GRFLPPLFNFKPHEL 378
              +PP F+  P  L
Sbjct: 284 CLTIPPXFSIAPSSL 298

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K +ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/298 (29%), Positives = 132/298 (44%), Gaps = 48/298 (16%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDH 117
           T  Y     +G G+F VV +   L TG   A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
            N+V L     S +E+   YL   L    E    ++ + +Y  +     I       QI 
Sbjct: 63  SNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QIL 113
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYICSRY 232
            A+ + H  +GV HRD+KP+NLL+        +KL DFG A + V+G+      +  +  
Sbjct: 114 EAVLHCHQ-MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPG 171
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK          
Sbjct: 172 YLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA--------- 220
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                    + FP   +  W  +      PEA +L++++L  +P  R TA EAL HP+
Sbjct: 221 -------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 122
           R +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
            K   +S   ++   L L++E++P    R  ++  K  +R+  I +  Y  QIC+ + Y+
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLPYGSLR--EYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRA 235
             T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ A
Sbjct: 134 -GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYA 188
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE +   ++++ A D+WS G VL EL 
Sbjct: 189 PESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 132/315 (41%), Gaps = 50/315 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 84  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 137 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 363
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 283
Query: 364 GRFLPPLFNFKPHEL 378
              +PP F+  P  L
Sbjct: 284 CLTIPPRFSIAPSSL 298

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + +
Sbjct: 86  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGG---EMFSHLRRIGRFXEPHAR 137
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 138 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 192
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 193 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 85  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 139 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 194
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 195 SL-TESKFSVASDVWSFGVVLYELF 218

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP--NVVSL 123
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L +    ++VS 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRALAY 181
             C F        +    L ++ + ++     HY +SQ        + FY  +I   L +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG-DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++  
Sbjct: 308 MHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV------------- 283
              Y ++ D +S GC+L +LL G   F       +  +D++   + V             
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 284 ----LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 322
               L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 32/284 (11%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP--NVVSL 123
            +   R++G G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L +    ++VS 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY--QICRALAY 181
             C F        +    L ++ + ++     HY +SQ        + FY  +I   L +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG-DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S + +  Y APE++  
Sbjct: 308 MHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQK 364
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF-----PGESGVDQLVEIIKV------------- 283
              Y ++ D +S GC+L +LL G   F       +  +D++   + V             
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 284 ----LGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPP 322
               L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 132/315 (41%), Gaps = 50/315 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 88  GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE   +   +  Y APE +     
Sbjct: 141 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 197
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 231
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 363
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 232 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 287
Query: 364 GRFLPPLFNFKPHEL 378
              +PP F+  P  L
Sbjct: 288 CLTIPPRFSIAPSSL 302

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 162
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 163 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 218
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 219 SL-TESKFSVASDVWSFGVVLYELF 242

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 20/224 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y+  + +G GSFG     K  E G    IK++       +++    RE+  +  + HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  +  F    E   LY+  V++Y    +   R+      + Q   ++    +F QIC A
Sbjct: 86  VQYRESF---EENGSLYI--VMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLA 137
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPE 237
           L ++H+   + HRDIK QN+ +      ++L DFG A+VL    E   + I + YY +PE
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            I     Y    DIW+ GCVL EL   +  F   S  + +++II
Sbjct: 196 -ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 82  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 135
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 136 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 191
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 192 SL-TESKFSVASDVWSFGVVLYELF 215

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 47/284 (16%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLLD-HPNVVSL 123
           + ++ +G GSF +  +    ++ +A A+K +   KR +    +E+  ++L + HPN+V L
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F      D+L+  LV+E +   E   R+ K  +        I  KL       A+++
Sbjct: 72  HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL-----VSAVSH 121
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
           +H+ +GV HRD+KP+NLL       L  K+ DFG A++       +   C + +Y APEL
Sbjct: 122 MHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM 295
           +     Y  + D+WS G +L  +L GQ  F            VEI+K +           
Sbjct: 181 L-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--------- 230
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
                +F F   +   W  + Q     EA DL+  LL   PN R
Sbjct: 231 ----GDFSF---EGEAWKNVSQ-----EAKDLIQGLLTVDPNKR 262

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--REL 109
           P Q  +++ +    + +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           + ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + +
Sbjct: 94  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGG---EMFSHLRRIGRFSEPHAR 145
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLC 200
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 22/201 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 74
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
            F+S  E     +++ +E++   ++ +V+K     + R+P   +      + + L Y+  
Sbjct: 75  AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T 
Sbjct: 126 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-TH 182
Query: 245 YTAAIDIWSAGCVLAELLLGQ 265
           Y+   DIWS G  L E+ +G+
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGR 203

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 131
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 84  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 137
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 138 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 193
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 194 SL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 134
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 190
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 191 SL-TESKFSVASDVWSFGVVLYELF 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 83  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 136
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 137 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 192
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 193 SL-TESKFSVASDVWSFGVVLYELF 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 131
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 149
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 48/303 (15%)
Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 122
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           LK  +      D  Y+ +V E     E + ++++  +   +    +      + I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV-----LFTITKTVE 130
Query: 181 YIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + 
Sbjct: 131 YLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE +     Y AA DIWS G +L   L G   F      D   EI+  +G+        
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG------- 238
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF---F 351
                   KF  +    W+ +        A DLVS+ L   P+ R TA   L HP+   +
Sbjct: 239 --------KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHW 284
Query: 352 DEL 354
           D+L
Sbjct: 285 DQL 287

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 76  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 129
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 130 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 185
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 186 SL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 149
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNVV 121
           +V+G GSFG VF  + +   ++G   A+K +      ++D+     E   +  ++HP VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQICRAL 179
            L + F     + E  L L+L+++     R      ++S+ +      VK Y  ++   L
Sbjct: 94  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 144 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 287
           +     ++ + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 202 V-NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 131
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 77  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYL-G 130
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 131 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 186
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 187 SL-TESKFSVASDVWSFGVVLYELF 210

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 26/220 (11%)
Query: 61  PKQTISYMAE----RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------ 110
           P Q  +++ +    + +G GSFG V   K +ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 111 -TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
             ++ ++ P +V L+  F     KD   L +V+EYV       +  H +   R    + +
Sbjct: 93  RILQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGG---EMFSHLRRIGRFSEPHAR 144
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 230 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 61  -REAQNAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 119 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 172
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 59  GQPKQTISYMAER-----VVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--------RYK 105
           G    T S++++R     ++G G    V  A+ L     VA+K +  D         R++
Sbjct: 18  GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 77
Query: 106 NRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH-HYKMSQRMP 164
            RE Q    L+HP +V++     + T    L   +V+EYV     R I H    M+ +  
Sbjct: 78  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 135
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +       C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +
Sbjct: 136 IEVIA----DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNS 189
Query: 225 IS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           ++     I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 185
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 186 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 239
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 240 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 130 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 180
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 181 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 234
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 235 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 39/236 (16%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y  ++  A
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA 185
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYI 228
           L  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G P+    
Sbjct: 186 LDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 239
Query: 229 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 240 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 28/206 (13%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 125 HCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              +S   ++   L L++EY+P  ++   ++ H   ++R+  I +  Y  QIC+ + Y+ 
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQAH---AERIDHIKLLQYTSQICKGMEYL- 133
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAP 236
            T    HRD+  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ AP
Sbjct: 134 GTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAP 189
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E +   ++++ A D+WS G VL EL 
Sbjct: 190 ESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 23/228 (10%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-------DKRYKNRELQTMRLLDHP 118
            Y   +V+G G+FG V   +   + +  A+K + +       D  +   E   M   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y  ++  A
Sbjct: 136 WVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYTAEVVLA 186
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNI-SYICSRYYRAP 236
           L  IH ++G+ HRD+KP N+L++ H H LKL DFG+  K+   G  +  + + +  Y +P
Sbjct: 187 LDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYISP 244
Query: 237 ELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           E++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 245 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           VCHRD+K +N L++     +LK+C FG +K  V        + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 131/315 (41%), Gaps = 50/315 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 108 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 161 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 217
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 251
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 363
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 252 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 307
Query: 364 GRFLPPLFNFKPHEL 378
              +PP F+  P  L
Sbjct: 308 CLTIPPRFSIAPSSL 322

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 90/315 (28%), Positives = 131/315 (41%), Gaps = 50/315 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 106 GFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 159 -RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 215
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 249
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 363
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 250 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 305
Query: 364 GRFLPPLFNFKPHEL 378
              +PP F+  P  L
Sbjct: 306 CLTIPPRFSIAPSSL 320

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 131/295 (44%), Gaps = 58/295 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 86  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 138 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 196 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMS 254
Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 322
                     L    +E + C+     +  F  I+ HP      W  + QK++ P
Sbjct: 255 VKAASVLKSFLNKDPKERLGCL----PQTGFADIQGHPFFRNVDWDMMEQKQVVP 305

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 121/255 (47%), Gaps = 29/255 (11%)
Query: 42  NGTEAGHIIVTTIGGKNGQPK-QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ 100
           +G + G++   TIGG+  Q +   +  + E  +G G+ G V++ +  +TG  +A+K++  
Sbjct: 6   SGKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM-- 58
Query: 101 DKRYKNRELQTMRLLDHPNVVSLKH-------CFFSTTEKDELYLNLVLEYVPETVHRVI 153
            +R  N+E +  R+L   +VV   H       CF +     ++++   +E +     ++ 
Sbjct: 59  -RRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI--AMELMGTCAEKLK 114
Query: 154 KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 213
           K   +M   +P   +      I +AL Y+    GV HRD+KP N+L++    Q+KLCDFG
Sbjct: 115 K---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFG 170
Query: 214 SAKVLVKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFP 269
            +  LV  +          Y APE I        +Y    D+WS G  L EL  GQ  FP
Sbjct: 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FP 228
Query: 270 GESGVDQLVEIIKVL 284
            ++       + KVL
Sbjct: 229 YKNCKTDFEVLTKVL 243

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 129/295 (43%), Gaps = 58/295 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 71  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 123 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 181 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 239
Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 322
                     L    +E + C    + +  F  I+ HP      W  + QK++ P
Sbjct: 240 VKAASVLKSFLNKDPKERLGC----HPQTGFADIQGHPFFRNVDWDMMEQKQVVP 290

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 129/295 (43%), Gaps = 58/295 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 122
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 75  LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 127 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 185 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 322
                     L    +E + C    + +  F  I+ HP      W  + QK++ P
Sbjct: 244 VKAASVLKSFLNKDPKERLGC----HPQTGFADIQGHPFFRNVDWDMMEQKQVVP 294

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 125
           +G G    V+ A+       VAIK +    R K        RE+     L H N+VS+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                 E+D+ Y  LV+EY+   T+   I+ H  +S    + +      QI   + + H+
Sbjct: 77  --IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QILDGIKHAHD 129
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIF 240
            + + HRDIKPQN+L++ +   LK+ DFG AK L   E +++     + +  Y +PE   
Sbjct: 130 -MRIVHRDIKPQNILIDSNK-TLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAK 185
Query: 241 G-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           G AT+     DI+S G VL E+L+G+P F GE+ V
Sbjct: 186 GEATD--ECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 132/295 (44%), Gaps = 58/295 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVA---IKKVLQDKRYKNRELQTMRLL-----DHPNVVS 122
           RV+G GS+  V   +  +T    A   +KK L +       +QT + +     +HP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I  AL Y+
Sbjct: 118 LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFG 241
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++ G+   ++  +  Y APE++ G
Sbjct: 170 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII------------ 281
             +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I            
Sbjct: 228 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286
Query: 282 --------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRMPP 322
                     L    +E + C    + +  F  I+ HP      W  + QK++ P
Sbjct: 287 VKAASVLKSFLNKDPKERLGC----HPQTGFADIQGHPFFRNVDWDMMEQKQVVP 337

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 95/329 (28%), Positives = 146/329 (44%), Gaps = 53/329 (16%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTM 112
           QP    ++   RV+G G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLY 171
             ++   VVSL + + +   KD L L L L    +       H Y M Q   P      Y
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKF----HIYHMGQAGFPEARAVFY 291
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + + 
Sbjct: 292 AAEICCGLEDLHRER-IVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE++     YT + D W+ GC+L E++ GQ  F       Q  + IK      REE
Sbjct: 350 GYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REE 396
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEAL 346
           ++ +           +K  P  + + +R  P+A  L S+LL   P  R      +A E  
Sbjct: 397 VERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKP 375
            HP F +L     RL  G   PP   FKP
Sbjct: 444 EHPLFKKLN--FKRLGAGMLEPP---FKP 467

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 124
           V+G GSFG V  A    T E  AIK + +D   ++ +++        + LLD P  ++  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T ++    L  V+EYV       + +H +   +        Y  +I   L ++H 
Sbjct: 86  HSCFQTVDR----LYFVMEYVNGGD---LMYHIQQVGKFKEPQAVFYAAEISIGLFFLHK 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I    
Sbjct: 139 R-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-AYQ 195
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 95/329 (28%), Positives = 146/329 (44%), Gaps = 53/329 (16%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTM 112
           QP    ++   RV+G G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLY 171
             ++   VVSL + + +   KD L L L L    +       H Y M Q   P      Y
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKF----HIYHMGQAGFPEARAVFY 291
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + + 
Sbjct: 292 AAEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y APE++     YT + D W+ GC+L E++ GQ  F       Q  + IK      REE
Sbjct: 350 GYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REE 396
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEAL 346
           ++ +           +K  P  + + +R  P+A  L S+LL   P  R      +A E  
Sbjct: 397 VERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443
Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKP 375
            HP F +L     RL  G   PP   FKP
Sbjct: 444 EHPLFKKLN--FKRLGAGMLEPP---FKP 467

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 93/357 (26%), Positives = 149/357 (41%), Gaps = 77/357 (21%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKC-LETG--EAVAIKKVLQDKR--YKNRELQTMRLL 115
           P+ +  +  E  +G G+F  V+ A   L+ G  E +A+K ++          ELQ + + 
Sbjct: 17  PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 116 D-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
               NV+ +K+CF     +   ++ + + Y+       I +     +      V+ Y   
Sbjct: 77  GGQDNVMGVKYCF-----RKNDHVVIAMPYLEHESFLDILNSLSFQE------VREYMLN 125
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----------VLVKGEP- 223
           + +AL  IH   G+ HRD+KP N L N    +  L DFG A+            V+ E  
Sbjct: 126 LFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184
Query: 224 ------NISYIC-SRY-----------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
                 N   IC SR            +RAPE++      T AID+WSAG +   LL G+
Sbjct: 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244
Query: 266 -PLFPGESGVDQLVEIIKVLGTPTREEIK-----------------------CMNPNYTE 301
            P +     +  L +I+ + G  +RE I+                       C      +
Sbjct: 245 YPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMD 302
Query: 302 FKFPQ----IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
              P+    I+ H  +      +P EA DL+ +LL  +P  R TA EAL+HPFF ++
Sbjct: 303 SSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +S   ++   L L++EY+P    R     +K  +R+  I +  Y  QIC+ + Y+  
Sbjct: 79  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYL-G 132
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 237
           T    HR++  +N+LV  + +++K+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 133 TKRYIHRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWYAPE 188
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +   ++++ A D+WS G VL EL 
Sbjct: 189 SL-TESKFSVASDVWSFGVVLYELF 212

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 37/214 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           V+G G FG   +    ETGE + +K+++    + +R   +E++ MR L+HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 128 FSTTEKDELYLNLVLEYVP-ETVHRVIK---HHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                KD+  LN + EY+   T+  +IK     Y  SQR+       +   I   +AY+H
Sbjct: 73  IGVLYKDK-RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS------FAKDIASGMAYLH 125
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEP-------------NISYI 228
            ++ + HRD+   N LV  + + + + DFG A+++V  K +P               + +
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
            + Y+ APE+I G + Y   +D++S G VL E++
Sbjct: 184 GNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 90/351 (25%), Positives = 151/351 (43%), Gaps = 73/351 (20%)
Query: 24  NDMKIRDDKEME---ATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAE----RVVGHG 76
           + +K ++++EM+    +  D +G E   + +        +PK  ++ M E    +++G G
Sbjct: 111 DGLKKQEEEEMDFRSGSPSDNSGAEEMEVSL-------AKPKHRVT-MNEFEYLKLLGKG 162
Query: 77  SFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +FG V   K   TG          E +  K  +     +NR LQ  R   HP + +LK+ 
Sbjct: 163 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYS 219
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           F  T ++    L  V+EY        +  H    +       + Y  +I  AL Y+H+  
Sbjct: 220 F-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 271
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 245
            V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    +Y
Sbjct: 272 NVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDY 329
Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
             A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+            
Sbjct: 330 GRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------------ 370
Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 351
                     F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 371 ----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 130/312 (41%), Gaps = 50/312 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLKH 125
           +G G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            FF    +D  ++ +VLE       R +   +K  + +     + Y  QI     Y+H  
Sbjct: 82  GFF----EDNDFVFVVLELCRR---RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGATE 244
             V HRD+K  NL +N    ++K+ DFG A KV   GE       +  Y APE +     
Sbjct: 135 -RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 191
Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 225
Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP-N 363
            +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF     P  RLP  
Sbjct: 226 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 281
Query: 364 GRFLPPLFNFKP 375
              +PP F+  P
Sbjct: 282 CLTIPPRFSIAP 293

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 71  TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 239
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 180
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 227
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 351
                           F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 228 ----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 50/282 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 67
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 68  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 121 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 217
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 253

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/325 (23%), Positives = 143/325 (44%), Gaps = 41/325 (12%)
Query: 51  VTTIGGKNGQPKQTISYMAERV-----VGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKR 103
           + + G     P+Q   + AE +     +G G++G V +     +G+ +A+K++    D++
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 104 YKNRELQ----TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK- 158
            + + L      MR  D P +V      F   +       + +E +  +  +  K+ Y  
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSV 117
Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
           +   +P   +        +AL ++   + + HRDIKP N+L++  +  +KLCDFG +  L
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQL 176
Query: 219 VKGEPNISYICSRYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPGESGV- 274
           V           R Y APE I  +     Y    D+WS G  L EL  G+  +P  + V 
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 275 DQLVEIIKVLGTP---TREEIKCMNPNYTEF-------------KFPQIKAHPWHKIFQK 318
           DQL +++K  G P   +  E +  +P++  F             K+ ++  HP+  ++++
Sbjct: 237 DQLTQVVK--GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294
Query: 319 RMPPEAVDLVSRLLQYSPNLRSTAL 343
           R   E    V ++L   P   S+ +
Sbjct: 295 R-AVEVACYVCKILDQMPATPSSPM 318

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 73  TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 124
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 239
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 182
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 229
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 351
                           F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 230 ----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 72  TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 123
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 239
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 181
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 228
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 351
                           F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 229 ----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 69
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETG----------EAVAIKKVLQDKRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I  AL 
Sbjct: 211 TALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 239
           Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-V 320
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
               +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+      
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR------ 367
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF 351
                           F + + PEA  L+S LL+  P  R       A E + H FF
Sbjct: 368 ----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G+FGV    +  +  E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 130 TTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
            T     +L +V+EY    E   R+       + R      + +F Q+   ++Y H  + 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYAH-AMQ 135
Query: 188 VCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
           V HRD+K +N L++     +LK+ DFG +K  V      S + +  Y APE++       
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDG 195
Query: 247 AAIDIWSAGCVLAELLLG 264
              D+WS G  L  +L+G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 128 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  + 
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SK 234
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLF 268
            Y  A+D W+ G ++ E+  G P F
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 136/296 (45%), Gaps = 45/296 (15%)
Query: 65  ISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDKRYKNRELQTMR-LLDHPNVVS 122
           +S +  R V H + G  F  K +E T E ++ +++ + +    RE   +R +  HP++++
Sbjct: 106 VSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + S++     ++ LV + + +  +   +     +S++      +     +  A+++
Sbjct: 165 LIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEK----ETRSIMRSLLEAVSF 215
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE       +  Y APE++  
Sbjct: 216 LHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273
Query: 242 ATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           + +     Y   +D+W+ G +L  LL G P F     +  L  I              M 
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------------ME 319
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
             Y +F  P+     W             DL+SRLLQ  P  R TA +AL HPFF+
Sbjct: 320 GQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 128 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 180 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 233
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 108 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 160 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 213
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 139/299 (46%), Gaps = 47/299 (15%)
Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 122
           IS+  + V+GHG+ G +      +  + VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                +  TEKD  +  + +E    T+   ++   K    + L  + L   Q    LA++
Sbjct: 83  -----YFCTEKDRQFQYIAIELCAATLQEYVEQ--KDFAHLGLEPITL-LQQTTSGLAHL 134
Query: 183 HNTIGVCHRDIKPQNLLVN-PHTH---QLKLCDFGSAKVLVKGEPNISYIC----SRYYR 234
           H ++ + HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  + 
Sbjct: 135 H-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 235 APELIFGATEY--TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           APE++    +   T  +DI+SAGCV    ++ +   P    + +   I+  LG  +   +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS---L 247
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            C++P                   +K     A +L+ +++   P  R +A   L HPFF
Sbjct: 248 DCLHP-------------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 94  EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 146 -SLDLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 199
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 200 KGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 48/281 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+    +L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVK--- 69
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 240
             IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               +   +D+WS G VL  +L G+   P +   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           ++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYV---AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SK 213
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLF 268
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 52/283 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVK--- 69
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 238
             IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL
Sbjct: 123 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPEL 178
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     +   +D+WS G VL  +L G+   P +   D   E                   
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------- 217
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 255

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 125/305 (40%), Gaps = 40/305 (13%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYFYQICR 177
           S    + S   KDEL+L + L     +V  +IKH     +    +     +     ++  
Sbjct: 77  SY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICSR 231
            L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ + 
Sbjct: 133 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            + APE++     Y    DIWS G    EL  G    P        V ++ +   P    
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDP---- 244
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                        P ++     K   K+       ++S  LQ  P  R TA E L H FF
Sbjct: 245 -------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
Query: 352 DELRD 356
            + ++
Sbjct: 292 QKAKN 296

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SK 213
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLF 268
            Y  A+D W+ G ++ E+  G P F
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 133/308 (43%), Gaps = 60/308 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   VA+K + + +  K        RE++    L HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F+     D   + L+LEY P  E    + K      QR   I       ++  AL Y
Sbjct: 89  YNYFY-----DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATI-----MEELADALMY 138
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
            H    V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y  PE+I G
Sbjct: 139 CHGK-KVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              +   +D+W  G +  ELL+G P F   S  +    I+KV                 +
Sbjct: 196 RM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-----------------D 237
Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 361
            KFP              +P  A DL+S+LL+++P+ R    +   HP+         R 
Sbjct: 238 LKFPA------------SVPTGAQDLISKLLRHNPSERLPLAQVSAHPW--------VRA 277
Query: 362 PNGRFLPP 369
            + R LPP
Sbjct: 278 NSRRVLPP 285

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 50/282 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G+ G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 239
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                +   +D+WS G VL  +L G+   P +   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           +++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 54/284 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 125/292 (42%), Gaps = 46/292 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   DHP +V L   +
Sbjct: 19  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +   +     L +++E+ P      I          P I V     Q+  AL ++H+   
Sbjct: 78  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK-R 129
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----FGA 242
           + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 130 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
           T Y    DIWS G  L E+   +P                    P  E    +NP     
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLL 224
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           K    K+ P   +   +   E  D +   L  +P  R +A + L HPF   +
Sbjct: 225 KIA--KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 274

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 102 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 154 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 207
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 208 KGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 126/304 (41%), Gaps = 40/304 (13%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYFYQICR 177
           S    + S   KDEL+L + L     +V  +IKH     +    +     +     ++  
Sbjct: 72  SY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICSR 231
            L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +++ + 
Sbjct: 128 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            + APE++     Y    DIWS G    EL  G    P        V ++ +   P   E
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQNDPPSLE 243
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               +    +          + K F+K        ++S  LQ  P  R TA E L H FF
Sbjct: 244 TGVQDKEMLK---------KYGKSFRK--------MISLCLQKDPEKRPTAAELLRHKFF 286
Query: 352 DELR 355
            + +
Sbjct: 287 QKAK 290

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 136/306 (44%), Gaps = 46/306 (15%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTM-RLLDHPNVVS 122
           +   ++G G++  V  A  L+ G+  A+K + +   +      RE++T+ +   + N++ 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   F     +D+    LV E +   ++   I+     ++R     V+     +  AL +
Sbjct: 76  LIEFF-----EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVR----DVAAALDF 126
Query: 182 IHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDF--GSAKVLVKG-----EPNISYIC-SR 231
           +H T G+ HRD+KP+N+L         +K+CDF  GS   L         P ++  C S 
Sbjct: 127 LH-TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 232 YYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVL 284
            Y APE++      AT Y    D+WS G VL  +L G P F G  G D      E+ +V 
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVC 245
Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
                E I+       +++FP      W  I       EA DL+S+LL      R +A +
Sbjct: 246 QNKLFESIQ-----EGKYEFPD---KDWAHI-----SSEAKDLISKLLVRDAKQRLSAAQ 292
Query: 345 ALIHPF 350
            L HP+
Sbjct: 293 VLQHPW 298

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 125/292 (42%), Gaps = 46/292 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++AK  ETG A+A  KV++ K  +       E++ +   DHP +V L   +
Sbjct: 27  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +   +     L +++E+ P      I          P I V     Q+  AL ++H+   
Sbjct: 86  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK-R 137
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----FGA 242
           + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++       
Sbjct: 138 IIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
           T Y    DIWS G  L E+   +P                    P  E    +NP     
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEP--------------------PHHE----LNPMRVLL 232
Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           K    K+ P   +   +   E  D +   L  +P  R +A + L HPF   +
Sbjct: 233 KIA--KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVV--SLKHCF- 127
           +V+G GSFG V  A+  +  E     KVLQ K    ++ +   ++   NV+  ++KH F 
Sbjct: 44  KVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFL 101
Query: 128 ----FSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
               FS    D+LY   VL+Y+   E  + + +    +  R      + Y  +I  AL Y
Sbjct: 102 VGLHFSFQTADKLYF--VLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALGY 154
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIF 240
           +H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE + 
Sbjct: 155 LH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VL 211
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLF 268
               Y   +D W  G VL E+L G P F
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 133/303 (43%), Gaps = 58/303 (19%)
Query: 64  TISYMAERVVGHGSFGVV-----------FQAKCLETGEAVAIKKVLQDKRYKNRELQTM 112
           T  Y     +G G+F VV           + AK + T +  A     +D +   RE +  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKLEREARIC 84
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLY 171
           RLL HPN+V L     S +E+   YL   L    E    ++ + +Y  +     I+    
Sbjct: 85  RLLKHPNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH---- 137
Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISY 227
             QI  ++ +IH    + HRD+KP+NLL+        +KL DFG A + V+GE      +
Sbjct: 138 --QILESVNHIHQH-DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGF 193
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
             +  Y +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK     
Sbjct: 194 AGTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA---- 247
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
                         + FP   +  W  +      PEA +L++++L  +P  R TA +AL 
Sbjct: 248 ------------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITADQALK 287
Query: 348 HPF 350
           HP+
Sbjct: 288 HPW 290

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 32/223 (14%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKN--RELQTMRLLDHPNVV 121
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L+          E  L LV+E+     ++RV+       +R+P   +  +  QI R + 
Sbjct: 70  ALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 181 YIHN--TIGVCHRDIKPQNLLV-------NPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
           Y+H+   + + HRD+K  N+L+       +     LK+ DFG A+   +    +S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAY 178
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
            + APE+I  A+ ++   D+WS G +L ELL G+  F G  G+
Sbjct: 179 AWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGG---EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ ++  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 54/284 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE------------------ 216
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 128/304 (42%), Gaps = 47/304 (15%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM----- 112
           N   K + +Y  +  +G G+F VV +     TG   A K ++  K+   R+ Q +     
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREAR 80
Query: 113 --RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVK 169
             R L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I   
Sbjct: 81  ICRKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-- 135
Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 227
               QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +
Sbjct: 136 ----QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
             +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK     
Sbjct: 191 AGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA---- 244
Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
                         + +P   +  W  +      PEA  L+  +L  +P  R TA +AL 
Sbjct: 245 ------------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALK 284
Query: 348 HPFF 351
            P+ 
Sbjct: 285 VPWI 288

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 54/284 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 124
           + +G G++G V  A    T EAVA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 237
           H  IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APE
Sbjct: 121 HG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           L+     +   +D+WS G VL  +L G+   P +   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
            Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 132/302 (43%), Gaps = 60/302 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 122
           V+G G+F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP------ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           L   + S        L +V E++       E V R     +  S+ +   Y++    QI 
Sbjct: 91  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMR----QIL 140
Query: 177 RALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSR 231
            AL Y H+   + HRD+KP+N+L+    ++  +KL DFG A  L  GE  +     + + 
Sbjct: 141 EALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTP 197
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I       + +
Sbjct: 198 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGK 248
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            K MNP              W  I +      A DLV R+L   P  R T  EAL HP+ 
Sbjct: 249 YK-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWL 290
Query: 352 DE 353
            E
Sbjct: 291 KE 292

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 141/311 (45%), Gaps = 38/311 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLET--GEAVAIKKVLQDKRYKN------RELQTMRLLDHP 118
           Y+   ++G GS+G V +    ET    AV I K  + +R  N      +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           NV+ L    ++  EK ++Y+  V+EY    +  ++       +R P+     YF Q+   
Sbjct: 67  NVIQLVDVLYNE-EKQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFCQLIDG 121
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRA 235
           L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 236 PELIFGATEYTA-AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV--------LGT 286
           PE+  G   ++   +DIWSAG  L  +  G   F G++ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 287 PTREEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 343
           P  + +K M    P    F   QI+ H W   F+K+ PP    +    +  SP+ +    
Sbjct: 239 PLSDLLKGMLEYEPA-KRFSIRQIRQHSW---FRKKHPPAEAPVP---IPPSPDTKDRWR 291
Query: 344 EALIHPFFDEL 354
              + P+ ++L
Sbjct: 292 SMTVVPYLEDL 302

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 52/283 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 125
           + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            F+    +  +   L LEY    E   R+     +    MP    + +F+Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAPEL 238
             IG+ HRDIKP+NLL++   + LK+ DFG A V      N   + ++      Y APEL
Sbjct: 122 G-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPEL 177
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     +   +D+WS G VL  +L G+   P +   D   E                   
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------- 216
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
           Y+++K  +   +PW KI    +      L+ ++L  +P+ R T
Sbjct: 217 YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSARIT 254

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 95/217 (43%), Gaps = 22/217 (10%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
           Y+  + +G G F  V   + L  G   A+K++L    QD+    RE    RL +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 123 L-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L  +C      K E +L L   +   T+   I+        +    +      ICR L  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPF-FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS---AKVLVKGEPNISYI-------CSR 231
           IH   G  HRD+KP N+L+     Q  L D GS   A + V+G      +       C+ 
Sbjct: 150 IHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 232 YYRAPELIFGATEYTAA---IDIWSAGCVLAELLLGQ 265
            YRAPEL F    +       D+WS GCVL  ++ G+
Sbjct: 208 SYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP +I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPAIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 128/318 (40%), Gaps = 76/318 (23%)
Query: 66  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 113
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 114 ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 160
               +  HPN++ LK  +         F   +K EL+     +Y+ E V    K   K+ 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIM 130
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           + +  +   L+              + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 131 RALLEVICALH-------------KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 176
Query: 221 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           GE   S   +  Y APE+I  +       Y   +D+WS G ++  LL G P F     + 
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            L  I              M+ NY +F  P+   +               DLVSR L   
Sbjct: 237 MLRMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQ 271
Query: 336 PNLRSTALEALIHPFFDE 353
           P  R TA EAL HPFF +
Sbjct: 272 PQKRYTAEEALAHPFFQQ 289

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 129
           ++G G FG VF+AK    G+   IK+V  +     RE++ +  LDH N+V    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 130 ----TTEKDELY-----LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
               T+ K+        L + +E+  + T+ + I+   +  +++  +     F QI + +
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGV 135
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y +PE I
Sbjct: 136 DYIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 240 FGATEYTAAIDIWSAGCVLAELL 262
             + +Y   +D+++ G +LAELL
Sbjct: 194 -SSQDYGKEVDLYALGLILAELL 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 234
Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                      E + P+        IF+        D ++R L      R +A E L H 
Sbjct: 235 -----------ELQNPE----KLSAIFR--------DFLNRCLDMDVEKRGSAKELLQHQ 271
Query: 350 FF 351
           F 
Sbjct: 272 FL 273

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 353 ELRDPNTRLPNGRFLPPLFNFKPH 376
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 72
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 73  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 122
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 123 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 228
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 229 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 270
Query: 353 ELRDPNTRLPNGRFLPPLFNFKPH 376
            +   +  +   + LPP   FKP 
Sbjct: 271 SINWQD--VVQKKLLPP---FKPQ 289

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 178
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 234
Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                      E + P+        IF+        D ++R L+     R +A E L H 
Sbjct: 235 -----------ELQNPE----KLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQ 271
Query: 350 FF 351
           F 
Sbjct: 272 FL 273

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 353 ELRDPNTRLPNGRFLPPLFNFKPH 376
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 132/302 (43%), Gaps = 53/302 (17%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 120
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVG 178
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 234
Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                      E + P+        IF+        D ++R L      R +A E L H 
Sbjct: 235 -----------ELQNPE----KLSAIFR--------DFLNRCLDMDVEKRGSAKELLQHQ 271
Query: 350 FF 351
           F 
Sbjct: 272 FL 273

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K ++++        ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F     KD   L +V+EYV       +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGA 242
            ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-S 212
Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLF 268
             Y  A+D W+ G ++ E+  G P F
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 353 ELRDPNTRLPNGRFLPPLFNFKPH 376
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 70
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 71  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 120
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 121 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 179 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 226
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 227 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 268
Query: 353 ELRDPNTRLPNGRFLPPLFNFKPH 376
            +   +  +   + LPP   FKP 
Sbjct: 269 SINWQD--VVQKKLLPP---FKPQ 287

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 353 ELRDPNTRLPNGRFLPPLFNFKPH 376
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 120
           +++G G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 237
           L Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+    
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 223
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                             F + + PEA  L++ LL+  P  R     S A E + H FF 
Sbjct: 224 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
Query: 353 ELRDPNTRLPNGRFLPPLFNFKPH 376
            +   +  +   + LPP   FKP 
Sbjct: 266 SINWQD--VVQKKLLPP---FKPQ 284

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 121
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +       + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVG 179
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 235
Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                      E + P+        IF+        D ++R L+     R +A E + H 
Sbjct: 236 -----------ELQNPE----KLSAIFR--------DFLNRCLEMDVEKRGSAKELIQHQ 272
Query: 350 FF 351
           F 
Sbjct: 273 FL 274

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 129
           ++G G FG VF+AK    G+   I++V  +     RE++ +  LDH N+V    C+    
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 130 ---TTEKDELYLNLVLEYVPETVHRVIKHHYK---------------------MSQRMPL 165
               T  D L  +   +Y PE      +   K                       +++  
Sbjct: 79  YDPETSDDSLESS---DYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
           +     F QI + + YIH+   + HRD+KP N+ +   T Q+K+ DFG    L       
Sbjct: 136 VLALELFEQITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRT 193
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               +  Y +PE I  + +Y   +D+++ G +LAELL
Sbjct: 194 RSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 127/318 (39%), Gaps = 76/318 (23%)
Query: 66  SYMAERVVGHGSFGVVFQA----KCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 113
           +Y  + ++G G   VV +      C E   AV I  V     +   E+Q +R        
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 114 ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 160
               +  HPN++ LK  +         F   +K EL+     +Y+ E V    K   K+ 
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIM 117
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           + +  +   L+              + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 118 RALLEVICALH-------------KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 163
Query: 221 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           GE       +  Y APE+I  +       Y   +D+WS G ++  LL G P F     + 
Sbjct: 164 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 223
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            L  I              M+ NY +F  P+   +               DLVSR L   
Sbjct: 224 MLRMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQ 258
Query: 336 PNLRSTALEALIHPFFDE 353
           P  R TA EAL HPFF +
Sbjct: 259 PQKRYTAEEALAHPFFQQ 276

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-- 185
            +        + LV+EY        + H  +        +   +  Q  + +AY+H+   
Sbjct: 72  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 181
Query: 246 TAAIDIWSAGCVLAELL 262
           +   D++S G +L E++
Sbjct: 182 SEKCDVFSWGIILWEVI 198

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 47/299 (15%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 114
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 62  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 112
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 231
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK         
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA-------- 221
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     + +P  +   W  +      PEA  L+  +L  +P  R TA +AL  P+
Sbjct: 222 --------GAYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 130/318 (40%), Gaps = 76/318 (23%)
Query: 66  SYMAERVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKNRELQTMR-------- 113
           +Y  + ++G G   VV     +  C E   AV I  V     +   E+Q +R        
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 114 ----LLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 160
               +  HPN++ LK  +         F   +K EL+     +Y+ E V         +S
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKV--------TLS 122
Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           ++     ++     IC AL    + + + HRD+KP+N+L++   + +KL DFG +  L  
Sbjct: 123 EKETRKIMRALLEVIC-AL----HKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDP 176
Query: 221 GEPNISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           GE       +  Y APE+I  +       Y   +D+WS G ++  LL G P F     + 
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            L  I              M+ NY +F  P+   +               DLVSR L   
Sbjct: 237 MLRMI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQ 271
Query: 336 PNLRSTALEALIHPFFDE 353
           P  R TA EAL HPFF +
Sbjct: 272 PQKRYTAEEALAHPFFQQ 289

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-- 185
            +        + LV+EY        + H  +        +   +  Q  + +AY+H+   
Sbjct: 71  LNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
             + HRD+KP NLL+      LK+CDFG+A  +     N     S  + APE +F  + Y
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSNY 180
Query: 246 TAAIDIWSAGCVLAELL 262
           +   D++S G +L E++
Sbjct: 181 SEKCDVFSWGIILWEVI 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 47/299 (15%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 114
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 60
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 61  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 111
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 231
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 112 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 170
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK         
Sbjct: 171 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA-------- 220
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     + +P  +   W  +      PEA  L+  +L  +P  R TA +AL  P+
Sbjct: 221 --------GAYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 263

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 127/299 (42%), Gaps = 47/299 (15%)
Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-------RL 114
           K + +Y  +  +G G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I       
Sbjct: 62  LQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------ 112
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSR 231
           QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  + 
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
            Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK         
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA-------- 221
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     + +P  +   W  +      PEA  L+  +L  +P  R TA +AL  P+
Sbjct: 222 --------GAYDYPSPE---WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 134/302 (44%), Gaps = 53/302 (17%)
Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRL 114
           G PK+   Y     +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +PN+V+    +      DEL++  V+EY+       +     M +             
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ--------IAA 121
Query: 175 ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 229
           +CR    AL ++H+   V HR+IK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 122 VCRECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 179
Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 180 TPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP-- 235
Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                      E + P+        IF+        D ++R L+     R +A E + H 
Sbjct: 236 -----------ELQNPE----KLSAIFR--------DFLNRCLEMDVEKRGSAKELIQHQ 272
Query: 350 FF 351
           F 
Sbjct: 273 FL 274

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 125/309 (40%), Gaps = 57/309 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 123
           +V+G G+F  V   K  +TG+  A+K + +    K  E+   R         D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F     +DE YL LV+EY       ++    K  +R+P    + Y  +I  A+  +H
Sbjct: 127 HFAF-----QDENYLYLVMEYY--VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGE-PNISYICSRYYRAPELIFG 241
             +G  HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++  
Sbjct: 180 R-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 242 ATEYTAA------IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
                         D W+ G    E+  GQ  F  +S  +   +I+              
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-------------- 283
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL---RSTALEALIHPFF- 351
                       K H    +  + +P EA D + RLL   P     R  A +   HPFF 
Sbjct: 284 ----------HYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFF 332
Query: 352 ----DELRD 356
               D LRD
Sbjct: 333 GLDWDGLRD 341

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 102/415 (24%), Positives = 162/415 (39%), Gaps = 101/415 (24%)
Query: 20  PEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGK-NGQPKQTISYMAERVVGHGSF 78
           PE+  ++   DD E E    D N    G   +  IG   NG+      Y   R +G G F
Sbjct: 1   PEQEEEILGSDDDEQE----DPNDYCKGGYHLVKIGDLFNGR------YHVIRKLGWGHF 50
Query: 79  GVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHPN---VVSLKHCF 127
             V+ +  ++  + VA+K V   + Y    L  +RLL        + PN   VV L   F
Sbjct: 51  STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110
Query: 128 FSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
              +  +  ++ +V E +   + + +IK +Y   Q +PL  VK    Q+ + L Y+H   
Sbjct: 111 -KISGVNGTHICMVFEVLGHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKC 166
Query: 187 GVCHRDIKPQNLLV---------------------------------------------- 200
            + H DIKP+N+L+                                              
Sbjct: 167 RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE 226
Query: 201 --NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 258
             N    ++K+ D G+A  + K       I +R YR+ E++ G+  Y    DIWS  C+ 
Sbjct: 227 PKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMA 283
Query: 259 AELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ------ 306
            EL  G  LF   SG       D +  II++LG   R+ I  +   Y++  F +      
Sbjct: 284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYSKEFFTKKGDLKH 341
Query: 307 -IKAHPWHKI--------FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
             K  PW           + +       D +  +L+  P  R+TA E L HP+ +
Sbjct: 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/336 (23%), Positives = 144/336 (42%), Gaps = 60/336 (17%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +++  R +G G+FG V   + ++  +  A+K V   K+Y         +L       + +
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 126 CFFSTTEKDELYLN---LVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
                     +Y +   L+ E +  +++ +I +++Y       +  +KLY  +I +AL Y
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNY 152
Query: 182 IHNTIGVCHRDIKPQNLLVN-PHTHQ-----------------------LKLCDFGSAKV 217
           +   + + H D+KP+N+L++ P+  +                       +KL DFG A  
Sbjct: 153 LRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
             K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF     ++ L
Sbjct: 212 --KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 278 VEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ-----------IKAHPWHKIF 316
             +  ++           T T    K +N +  +  +P+            K  P +KI 
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327
Query: 317 QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
           +  +     D +  +LQ  P LR +  E L H F +
Sbjct: 328 KHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 44/249 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 124
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 125 HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             +          T  K +  L + +EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 225
            AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 226 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 282 KVLGTPTRE 290
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 247 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 44/249 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 124
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 125 HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             +          T  K +  L + +EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 225
            AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 226 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 282 KVLGTPTRE 290
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 127
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 128 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 185
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 245
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 246 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 258
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 35  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 94  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 147
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 148 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 205
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 155
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 156 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 213
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           + +  +  I+ C+    ++   F +I+ HPW
Sbjct: 274 VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 140
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 141 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 198
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 259 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +  K C     EK    L LV+EYVP    R     Y     + L  + L+  QIC  +A
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMA 131
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-------YY 233
           Y+H+   + HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++
Sbjct: 132 YLHSQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFW 186
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELL 262
            APE +     Y A+ D+WS G  L ELL
Sbjct: 187 YAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 141
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 142 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 199
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 260 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 229 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 281
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 282 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 327 QSTKVPQTPLHTSRVL 342

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 48  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 107 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 160
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 161 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 218
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 219 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 278
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 279 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 309

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 131 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 189
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 190 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 242
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 243 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 287
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 288 QSTKVPQTPLHTSRVL 303

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 155
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 156 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 213
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 274 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 176 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 234
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 235 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 287
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 288 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 332
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 333 QSTKVPQTPLHTSRVL 348

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 237
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 238 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 283 QSTKVPQTPLHTSRVL 298

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 132 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 190
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 191 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 243
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 244 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 288
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 289 QSTKVPQTPLHTSRVL 304

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 130 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 188
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 189 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 241
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 242 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 286
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 287 QSTKVPQTPLHTSRVL 302

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 127
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 128 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 185
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 186 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 245
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 246 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 237
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 238 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 283 QSTKVPQTPLHTSRVL 298

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 182
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 235
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 236 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 281 QSTKVPQTPLHTSRVL 296

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 140 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 198
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 199 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 251
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 252 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 296
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 297 QSTKVPQTPLHTSRVL 312

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 125 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 183
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 184 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 236
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 237 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 281
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 282 QSTKVPQTPLHTSRVL 297

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV 283
             +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + 
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246
Query: 284 LGTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
           +    +  I+ C+    ++   F +I+ HPW
Sbjct: 247 VSXECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 37  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +  K C     +     L LV+EYVP    R     Y     + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMA 148
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYY 233
           Y+H    + HRD+  +N+L++ +   +K+ DFG AK + +G       E   S +   ++
Sbjct: 149 YLHAQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FW 203
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELL 262
            APE +     Y A+ D+WS G  L ELL
Sbjct: 204 YAPECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +     +   L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 129
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 130 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPE 184
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 185 SL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 89/367 (24%), Positives = 144/367 (39%), Gaps = 90/367 (24%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHP 118
           Y   R +G G F  V+ +  ++  + VA+K V   + Y    L  +RLL        + P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 119 N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQ 174
           N   VV L   F   +  +  ++ +V E +   + + +IK +Y   Q +PL  VK    Q
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSNY---QGLPLPCVKKIIQQ 138
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLV---------------------------------- 200
           + + L Y+H    + H DIKP+N+L+                                  
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 198
Query: 201 --------------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
                         N    ++K+ D G+A  + K       I +R YR+ E++ G+  Y 
Sbjct: 199 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YN 255
Query: 247 AAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCMNPNYT 300
              DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I  +   Y+
Sbjct: 256 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYS 313
Query: 301 EFKFPQ-------IKAHPWHKI--------FQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
           +  F +        K  PW           + +       D +  +L+  P  R+TA E 
Sbjct: 314 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 373
Query: 346 LIHPFFD 352
           L HP+ +
Sbjct: 374 LRHPWLN 380

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +  K C     EK    L LV+EYVP    R     Y     + L  + L+  QIC  +A
Sbjct: 79  IKYKGCCEDQGEKS---LQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMA 131
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-------YY 233
           Y+H    + HR++  +N+L++ +   +K+ DFG AK + +G     Y   R       ++
Sbjct: 132 YLHAQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPVFW 186
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELL 262
            APE +     Y A+ D+WS G  L ELL
Sbjct: 187 YAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL 115
           GK  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 116 DHPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 166
               VV LK                E+ + ++ L+LE  PE V  +      +++R  L 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQ 128
Query: 167 --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K    
Sbjct: 129 EELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVY 186
Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
             +  +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 132
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 133 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 188 SL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 91/365 (24%), Positives = 147/365 (40%), Gaps = 88/365 (24%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL--------DHP 118
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++LL          P
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDP 92
Query: 119 N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLYFYQ 174
           N   VV L    F  +  + +++ +V E +   + + +IK +Y   Q +P+  VK    Q
Sbjct: 93  NKDMVVQLID-DFKISGMNGIHVCMVFEVLGHHLLKWIIKSNY---QGLPVRCVKSIIRQ 148
Query: 175 ICRALAYIHNTIGVCHRDIKPQN------------------------------------- 197
           + + L Y+H+   + H DIKP+N                                     
Sbjct: 149 VLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAP 208
Query: 198 ---LLVNP------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAA 248
              LLVNP         ++K+ D G+A  + K       I +R YR+ E++ GA  Y+  
Sbjct: 209 AADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQYRSIEVLIGAG-YSTP 265
Query: 249 IDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            DIWS  C+  EL  G  LF   SG       D +  II++LG+  R     ++  Y+  
Sbjct: 266 ADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRH--FALSGKYSRE 323
Query: 303 KFPQ-------IKAHPW---HKIFQKRMPP-----EAVDLVSRLLQYSPNLRSTALEALI 347
            F +        K  PW     + +K   P     +  D +  +L+  P  R++A E L 
Sbjct: 324 FFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLR 383
Query: 348 HPFFD 352
           HP+ +
Sbjct: 384 HPWLN 388

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 133
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 134 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 188
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 189 SL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 73  VGHGSFGVV----FQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 124
           +G G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
              +    +    L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 145
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 237
              V HRD+  +N+LV    H +K+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 146 RRCV-HRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 200
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            +     ++   D+WS G VL EL 
Sbjct: 201 SL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 124
           V+G GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T ++    L  V+EYV       + +H +   R    +   Y  +I   L ++ +
Sbjct: 87  HSCFQTMDR----LYFVMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I    
Sbjct: 140 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 196
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 27/200 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 224
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDFG  + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 225 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 340 STALEALIHPFFDELRDPNT 359
            +A + L HP+       NT
Sbjct: 288 LSAAQVLQHPWVQGCAPENT 307

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K      TE     + L++E++P    +  + K+  K++ +  L Y      QIC+ +
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGM 139
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRA 235
            Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ A
Sbjct: 140 DYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 197
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE +  +  Y A+ D+WS G  L ELL
Sbjct: 198 PECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 86/196 (43%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK             + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPY 182
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 235
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 236 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 281 QSTKVPQTPLHTSRVL 296

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 39/295 (13%)
Query: 71  RVVGHGSFGVV----FQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K      TE     + L++E++P    +  + K+  K++ +  L Y      QIC+ +
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGM 127
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRA 235
            Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +    R    ++ A
Sbjct: 128 DYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 185
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE +  +  Y A+ D+WS G  L ELL        +S    +   +K++G PT  ++   
Sbjct: 186 PECLMQSKFYIAS-DVWSFGVTLHELLT-----YCDSDSSPMALFLKMIG-PTHGQMTVT 238
Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
               T  +  ++   P         P E   L+ +  ++ P+ R T+ + LI  F
Sbjct: 239 RLVNTLKEGKRLPCPP-------NCPDEVYQLMRKCWEFQPSNR-TSFQNLIEGF 285

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 52/303 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 72  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 122
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 123 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F GE+  + L  I              +N 
Sbjct: 182 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVNY 228
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
           ++ E  F                   A D + RLL   P  R T  ++L H +   +R  
Sbjct: 229 DFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
Query: 358 NTR 360
           N R
Sbjct: 276 NVR 278

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/328 (23%), Positives = 127/328 (38%), Gaps = 69/328 (21%)
Query: 56  GKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------- 106
           G +G   Q   Y  +  +G GS+GVV  A         A+K + + K  +          
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 107 ---------------------RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV 145
                                +E+  ++ LDHPNVV L        E D LY+  V E V
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-DHLYM--VFELV 120
Query: 146 PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH 205
            +     +     +S+       + YF  + + + Y+H    + HRDIKP NLLV    H
Sbjct: 121 NQGPVMEVPTLKPLSEDQ----ARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGH 175
Query: 206 QLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELL 262
            +K+ DFG +      +  +S  + +  + APE +    +  +  A+D+W+ G  L   +
Sbjct: 176 -IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 263 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP 322
            GQ  F                     E I C++         +IK+       Q  +  
Sbjct: 235 FGQCPF-------------------MDERIMCLHS--------KIKSQALEFPDQPDIAE 267
Query: 323 EAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +  DL++R+L  +P  R    E  +HP+
Sbjct: 268 DLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 142/327 (43%), Gaps = 46/327 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 130
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 153
Query: 131 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +
Sbjct: 154 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 210
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 240
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 211 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+                N+ 
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 313
Query: 301 E-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDELRDP 357
           E F+FP   +H         +  EA DL+ RL+      L    +E    H FF+ L   
Sbjct: 314 ERFQFP---SHV------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWE 364
Query: 358 NTRLPNGRFLPPLFNFKPHELKGVPVD 384
           N R     ++P + +  P +     VD
Sbjct: 365 NIRNLEAPYIPDVSS--PSDTSNFDVD 389

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 138/302 (45%), Gaps = 26/302 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
            +  +  I+ C+    ++   F +I+ HPW +     +P E  ++    L   P+ ++ A
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAAA 289
Query: 343 LE 344
           LE
Sbjct: 290 LE 291

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 86/327 (26%), Positives = 142/327 (43%), Gaps = 46/327 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 130
           +V+G G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 137
Query: 131 TE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +
Sbjct: 138 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 194
Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 240
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           G  +Y    D WS G  + E+L G+  F  ES V+   +I+                N+ 
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHE 297
Query: 301 E-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDELRDP 357
           E F+FP   +H         +  EA DL+ RL+      L    +E    H FF+ L   
Sbjct: 298 ERFQFP---SHV------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWE 348
Query: 358 NTRLPNGRFLPPLFNFKPHELKGVPVD 384
           N R     ++P + +  P +     VD
Sbjct: 349 NIRNLEAPYIPDVSS--PSDTSNFDVD 373

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 19/218 (8%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 124
           V+G GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           H  F T   D LY   V+EYV       + +H +   R    +   Y  +I   L ++ +
Sbjct: 408 HSCFQTM--DRLYF--VMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGAT 243
             G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I    
Sbjct: 461 K-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 517
Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 54/292 (18%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 245 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK----VLGTPTREEIKCMNPN 298
             Y    D+WS G  L E+   +P     + +  L++I K     L  P+R         
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR--------- 265
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                        W   F+        D + + L+ + + R T  + L HPF
Sbjct: 266 -------------WSSNFK--------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 54/292 (18%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 245 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK----VLGTPTREEIKCMNPN 298
             Y    D+WS G  L E+   +P     + +  L++I K     L  P+R         
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR--------- 265
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                        W   F+        D + + L+ + + R T  + L HPF
Sbjct: 266 -------------WSSNFK--------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 60  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 113
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 114 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 171
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 232 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 2   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 61  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 114
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 115 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 172
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 232
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 293
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +  I+ 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRW 237
Query: 294 CMNPNYTEF-KFPQIKAHPW 312
           C+    ++   F +I+ HPW
Sbjct: 238 CLALRPSDRPTFEEIQNHPW 257

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 127/302 (42%), Gaps = 60/302 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 122
           V+G G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 123 LKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKL----YFYQIC 176
           L      T   D + L +V E++   +    ++K           +Y +     Y  QI 
Sbjct: 93  L----LETYSSDGM-LYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHYMRQIL 142
Query: 177 RALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSR 231
            AL Y H+   + HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + 
Sbjct: 143 EALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTP 199
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I       + +
Sbjct: 200 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGK 250
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            K MNP              W  I +      A DLV R+L   P  R T  EAL HP+ 
Sbjct: 251 YK-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWL 292
Query: 352 DE 353
            E
Sbjct: 293 KE 294

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 130/301 (43%), Gaps = 58/301 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 122
           V+G G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 123 LKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHH---YKMSQRMPLIYVKLYFYQICR 177
           L      T   D + L +V E++   +    ++K     +  S+ +   Y++    QI  
Sbjct: 91  L----LETYSSDGM-LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR----QILE 141
Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRY 232
           AL Y H+   + HRD+KP  +L+    ++  +KL  FG A  L  GE  +     + + +
Sbjct: 142 ALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPH 198
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           + APE++     Y   +D+W  G +L  LL G   F G    ++L E I       + + 
Sbjct: 199 FMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGKY 249
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
           K MNP              W  I +      A DLV R+L   P  R T  EAL HP+  
Sbjct: 250 K-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLK 291
Query: 353 E 353
           E
Sbjct: 292 E 292

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/317 (25%), Positives = 142/317 (44%), Gaps = 68/317 (21%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---------QTMRLLDHPNVV 121
           + +G G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 122 SLKHCFF--STTEK-----DELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              + +   +TTEK      ++YL + ++    E +   +     + +R   + + + F 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI-FL 125
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNIS 226
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P  +
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 227 Y------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
           Y      + ++ Y +PE I G + Y+  +DI+S G +L EL     L+P  + ++++  +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMERVRTL 237
Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 340
             V                   KFP         +F ++ P E V +V  +L  SP  R 
Sbjct: 238 TDV----------------RNLKFP--------PLFTQKYPCEYV-MVQDMLSPSPMERP 272
Query: 341 TALEALIHPFFDELRDP 357
            A+  + +  F++L  P
Sbjct: 273 EAINIIENAVFEDLDFP 289

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 24  KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI- 166
              VV LK                E+ + ++ L+LE  PE V  +      +++R  L  
Sbjct: 83  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQE 136
Query: 167 -YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 137 ELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 194
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 254
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
               +  I+ C+    ++   F +I+ HPW
Sbjct: 255 SXECQHLIRWCLALRPSDRPTFEEIQNHPW 284

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTM-RLLDHPNVVSLKH 125
           +GHGS+G VF+ +  E G   A+K+ +      +D+  K  E+ +  ++  HP  V L+ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            +    E   LYL   L         + +H       +P   V  Y      ALA++H+ 
Sbjct: 125 AW---EEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFG--------SAKVLVKGEPNISYICSRYYRAPE 237
            G+ H D+KP N+ + P   + KL DFG         A  + +G+P         Y APE
Sbjct: 177 -GLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPE 226
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 277
           L+ G+  Y  A D++S G  + E+     L  G  G  QL
Sbjct: 227 LLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 83/196 (42%), Gaps = 26/196 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y APE + G  +Y  + D WS G +   LL G P F    G      +    G  TR   
Sbjct: 229 YVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR--- 278
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
             +     EF  P+     W ++ +     E   L+  LL+  P  R T  E   HP+  
Sbjct: 279 --IRXGQYEFPNPE-----WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPWIX 326
Query: 353 E-LRDPNTRLPNGRFL 367
           +  + P T L   R L
Sbjct: 327 QSTKVPQTPLHTSRVL 342

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 293
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +  I+ 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237
Query: 294 CMNPNYTEF-KFPQIKAHPW 312
           C+    ++   F +I+ HPW
Sbjct: 238 CLALRPSDRPTFEEIQNHPW 257

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 67
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 68  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 122
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 123 LEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 180
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 293
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +  +  I+ 
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 240
Query: 294 CMNPNYTEF-KFPQIKAHPW 312
           C+    ++   F +I+ HPW
Sbjct: 241 CLALRPSDRPTFEEIQNHPW 260

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  K C     EK    + LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 73  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------- 231
           +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       
Sbjct: 124 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 178
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 179 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 71  RVVGHGSFGVVFQAKCLE-----TGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 120
           R +G G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  K C     EK    + LV+EYVP    R  + +H   ++Q +      L+  QIC  
Sbjct: 74  VKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 124
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------- 231
           +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G     Y   R       
Sbjct: 125 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 179
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 180 FWYAPECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 137/305 (44%), Gaps = 54/305 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 127
           +VG+G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 128 FSTTE---KDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    D+L+  LV+E+    +V  +IK+       +   ++     +I R L+++H
Sbjct: 91  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH 146
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 240
               V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 147 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 203
Query: 241 ----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
                AT Y    D+WS G    E+  G P       +  L  I +             N
Sbjct: 204 DENPDAT-YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------------N 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
           P       P++K+  W K FQ          +   L  + + R    + + HPF   +RD
Sbjct: 250 P------APRLKSKKWSKKFQS--------FIESCLVKNHSQRPATEQLMKHPF---IRD 292
Query: 357 -PNTR 360
            PN R
Sbjct: 293 QPNER 297

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 118/260 (45%), Gaps = 22/260 (8%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 127 ---------FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYFYQI 175
                         E+ + ++ L+LE  PE V  +      +++R  L     + +F+Q+
Sbjct: 65  SSGFSGVIRLLDWFERPDSFV-LILER-PEPVQDLFDF---ITERGALQEELARSFFWQV 119
Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSP 177
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK- 293
           PE I     +  +  +WS G +L +++ G  P    E  +   V   + +    +  I+ 
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRW 237
Query: 294 CMNPNYTEF-KFPQIKAHPW 312
           C+    ++   F +I+ HPW
Sbjct: 238 CLALRPSDRPTFEEIQNHPW 257

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+     L +++EY+       +     + +      +     +I + L Y+H+   
Sbjct: 95  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQ----IATILREILKGLDYLHSEKK 145
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 246
           + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 247 AAIDIWSAGCVLAELLLGQP 266
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 137/330 (41%), Gaps = 52/330 (15%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 123
           +V+G G+FG V   K     +  A+K + + +  K  E    R         D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            + F     +D+  L LV++Y       ++    K   R+P    + Y  ++  A+  +H
Sbjct: 140 HYAF-----QDDNNLYLVMDYY--VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI-- 239
             +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 193 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 240 --FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
              G   Y    D WS G  + E+L G+  F  ES V+   +I+                
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------------- 294
Query: 298 NYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDEL 354
           N+ E F+FP              +   A DL+ RL+      L    +E    HPFF  +
Sbjct: 295 NHKERFQFPTQVTD---------VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345
Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVD 384
              N R     ++P + +  P +     VD
Sbjct: 346 DWDNIRNCEAPYIPEVSS--PTDTSNFDVD 373

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 27/200 (13%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 224
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDF   + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 225 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 340 STALEALIHPFFDELRDPNT 359
            +A + L HP+       NT
Sbjct: 288 LSAAQVLQHPWVQGCAPENT 307

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 54/292 (18%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVSLKHCF 127
           +G G+FG V++A+  ET   +A  KV+  K  +  E     +  +   DHPN+V L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +      E  L +++E+        +    ++ + +    +++   Q   AL Y+H+   
Sbjct: 104 YY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQTLDALNYLHDN-K 155
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 244
           + HRD+K  N+L       +KL DFG SAK     +    +I + Y+ APE++   T   
Sbjct: 156 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 245 --YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK----VLGTPTREEIKCMNPN 298
             Y    D+WS G  L E+   +P     + +  L++I K     L  P+R         
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR--------- 265
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                        W   F+        D + + L+ + + R T  + L HPF
Sbjct: 266 -------------WSSNFK--------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 125/303 (41%), Gaps = 52/303 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 93  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 143
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 144 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F GE+  + L  I              +N 
Sbjct: 203 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------------SAVNY 249
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
           ++ E  F                   A D + RLL   P  R    ++L H +   +R  
Sbjct: 250 DFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRR 296
Query: 358 NTR 360
           N R
Sbjct: 297 NVR 299

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           VG GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 119
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L Y+H T  + H 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 174
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 233
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +DIWS+ C++  +L G
Sbjct: 234 DAKVDIWSSCCMMLHMLNG 252

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 133/295 (45%), Gaps = 44/295 (14%)
Query: 89  TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-E 147
             + ++IK    D  +KN ELQ +  + +   ++   C    T  DE+Y+  + EY+  +
Sbjct: 77  NNDKISIKSKYDD--FKN-ELQIITDIKNEYCLT---CEGIITNYDEVYI--IYEYMEND 128
Query: 148 TVHRVIKHHYKMSQR----MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH 203
           ++ +  ++ + + +     +P+  +K     +  + +YIHN   +CHRD+KP N+L++ +
Sbjct: 129 SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188
Query: 204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAA-IDIWSAGCVLAELL 262
             ++KL DFG ++ +V  +   S   +  +  PE     + Y  A +DIWS G  L  + 
Sbjct: 189 G-RVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
Query: 263 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR--- 319
                F  +     LVE+   + T   E             +P  + H  + +  K+   
Sbjct: 247 YNVVPFSLKIS---LVELFNNIRTKNIE-------------YPLDRNHFLYPLTNKKSTC 290
Query: 320 ----MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF-----DELRDPNTRLPNGR 365
               +  E +D +   L+ +P  R T+ +AL H +      ++LR+ +  L   R
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 75  LKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 180
Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 122/270 (45%), Gaps = 23/270 (8%)
Query: 57  KNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD 116
           K  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     + 
Sbjct: 1   KEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 59
Query: 117 HPNVVSLKHC---------FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
              VV LK                E+ + ++ L+LE +   + +   I     + + +  
Sbjct: 60  M-EVVLLKKVSSGFSGVIRLLDWFERPDSFV-LILERMEPVQDLFDFITERGALQEEL-- 115
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K     
Sbjct: 116 --ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYT 171
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 284
            +  +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231
Query: 285 GTPTREEIK-CMNPNYTEF-KFPQIKAHPW 312
            +  +  I+ C+    ++   F +I+ HPW
Sbjct: 232 SSECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           VG GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 135
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L Y+H T  + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 190
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 249
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +DIWS+ C++  +L G
Sbjct: 250 DAKVDIWSSCCMMLHMLNG 268

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 114
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 174 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYI 228
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L   E     ++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFV 177
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 90  LKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 139 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 195
Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
              T+     L +++EY+             + +  PL    +     +I + L Y+H+ 
Sbjct: 75  LKDTK-----LWIIMEYLGGG------SALDLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 180
Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y +  DIWS G    EL  G+P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 133
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ ++IK    + +   L Y+     Q    L Y+H T  + H 
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 188
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 247
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +DIWS+ C++  +L G
Sbjct: 248 DAKVDIWSSCCMMLHMLNG 266

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 154
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ +++K    + +   L Y+     Q    L Y+H+   + H 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 209
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++       LCDFG A  L       S +   Y      + APE++ G +  
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-C 268
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +D+WS+ C++  +L G
Sbjct: 269 DAKVDVWSSCCMMLHMLNG 287

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLSSRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 286
           R    + APE IF    Y+   D+WS G +L E+  LG   +PG       V++ +   +
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFCS 313
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
             RE ++   P Y+  +  QI    WH+  ++R  P   +LV +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 159 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 216
Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 286
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 276
Query: 287 PTREEIK-CMNPNYTEF-KFPQIKAHPW 312
             +  I+ C+    ++   F +I+ HPW
Sbjct: 277 ECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLD---------- 116
           Y    ++G G FG VF    L     VAIK +      +NR L    L D          
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-----PRNRVLGWSPLSDSVTCPLEVAL 87
Query: 117 ---------HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
                    HP V+ L   F    E  E ++ LVLE  P     +  +   ++++ PL  
Sbjct: 88  LWKVGAGGGHPGVIRLLDWF----ETQEGFM-LVLER-PLPAQDLFDY---ITEKGPLGE 138
Query: 168 --VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              + +F Q+  A+ + H+  GV HRDIK +N+L++      KL DFGS   L+  EP  
Sbjct: 139 GPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT 196
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
            +  +R Y  PE I     +     +WS G +L +++ G 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 111/249 (44%), Gaps = 44/249 (17%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 124
           V+G G+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLASLNHQYVVRYY 68
Query: 125 HCFFS--------TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
             +          T  K +  L +  EY        + H   ++Q+    Y +L F QI 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE-YWRL-FRQIL 126
Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPNI---- 225
            AL+YIH+  G+ HR++KP N+ ++  +  +K+ DFG AK       +L     N+    
Sbjct: 127 EALSYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 226 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNIL 238
Query: 282 KVLGTPTRE 290
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM 112
            G+  Q  S M+   +G G+FG V+ A   E  + V +K     KVL+D   ++ +L  +
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 113 RL-------LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRM 163
            L       ++H N++ +   F     +++ +  LV+E       +   I  H ++ +  
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-- 129
Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
           PL      F Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+ 
Sbjct: 130 PL--ASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKL 185
Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
             ++  +  Y APE++ G       +++WS G  L  L+  +  F
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 114
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 174 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 228
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFV 177
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRL 114
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 174 QICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYI 228
           Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFV 177
Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 234
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 235 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 614
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 615 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 233
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 234 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 233
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 234 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE 132
           +G GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 135
Query: 133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 191
           ++  ++N+ +E +   ++ +++K    + +   L Y+     Q    L Y+H+   + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSRR-ILHG 190
Query: 192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 245
           D+K  N+L++       LCDFG A  L         +   Y      + APE++ G +  
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-C 249
Query: 246 TAAIDIWSAGCVLAELLLG 264
            A +D+WS+ C++  +L G
Sbjct: 250 DAKVDVWSSCCMMLHMLNG 268

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG V++     T E VAIK +       +     +E+  +   D P +      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNT 185
             +T+     L +++EY+             + +  PL   Y+     +I + L Y+H+ 
Sbjct: 87  LKSTK-----LWIIMEYLGGG------SALDLLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 244
             + HRDIK  N+L++     +KL DFG A  L   +     ++ + ++ APE+I   + 
Sbjct: 136 RKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSA 192
Query: 245 YTAAIDIWSAGCVLAELLLGQP 266
           Y    DIWS G    EL  G+P
Sbjct: 193 YDFKADIWSLGITAIELAKGEP 214

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 234
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 235 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 79  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 130
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 131 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 185
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 186 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 237
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 238 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 275

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 81  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 132
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 133 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 188 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 239
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 240 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 78  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 130 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 184
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 185 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 236
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 237 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 274

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 231
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 137 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 193
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G        + +    +  
Sbjct: 194 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRR 244
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           I+       ++ FP  +   W ++ +     +A  L+  LL+  P  R T  + + HP+ 
Sbjct: 245 IR-----LGQYGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWI 291
Query: 352 DE-LRDPNTRLPNGRFL 367
           ++ +  P T L   R L
Sbjct: 292 NQSMVVPQTPLHTARVL 308

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 104 L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 155
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 156 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 210
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 211 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 262
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 263 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 300

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 231
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 118 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 174
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G        + +    +  
Sbjct: 175 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRR 225
Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           I+       ++ FP  +   W ++ +     +A  L+  LL+  P  R T  + + HP+ 
Sbjct: 226 IR-----LGQYGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWI 272
Query: 352 DE-LRDPNTRLPNGRFL 367
           ++ +  P T L   R L
Sbjct: 273 NQSMVVPQTPLHTARVL 289

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 73  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 124
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 125 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 179
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 180 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 231
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 232 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLETGE---AVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E    +    Y +     L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 234
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 235 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 272

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 127/299 (42%), Gaps = 58/299 (19%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 456 L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAPE 237
            +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E   M 
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPMP 614
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFFDE 353
           PN                      PP    L+++   Y P+ R   T L+A +    +E
Sbjct: 615 PN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 28/226 (12%)
Query: 59  GQPKQTIS---YMAERVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE---- 108
           G P+  I+    +  R++G G FG V++       GE   VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 109 -LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY 167
               M+ LDHP++V L        E++  ++ + L    E  H + ++       + ++ 
Sbjct: 75  EAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLT 126
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           + LY  QIC+A+AY+  +I   HRDI  +N+LV      +KL DFG ++  ++ E     
Sbjct: 127 LVLYSLQICKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKA 183
Query: 228 ICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLF 268
             +R    + +PE I     +T A D+W     + E+L    QP F
Sbjct: 184 SVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L      TT + ++   L++E+ P     TV     + Y + +   LI ++     +  
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVG 123
Query: 178 ALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYR 234
            + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  +S   +  Y 
Sbjct: 124 GMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 235 APELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
            P++   A        +Y A +D+WS G        G  P  P E 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   F + T+     + L+LE V    +   +     +++     ++K    QI   + 
Sbjct: 79  TLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 129
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F GE+  + L              I  +N 
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNY 235
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           ++ E  F                   A D + RLL   P  R    ++L H +
Sbjct: 236 DFDEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-T 185
            F         L++V EY+       + H     +++         Y + + + Y+HN  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELI 239
             + HRD+K  NLLV+   + +K+CDFG +++         ++ S+       + APE++
Sbjct: 158 PPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWMAPEVL 211
Query: 240 FGATEYTAAIDIWSAGCVLAEL-LLGQP 266
                   + D++S G +L EL  L QP
Sbjct: 212 RDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ERV+G G FG V   +    G+   AVAIK +      K R     E   M   DHPNVV
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+             + +V+E++    +   ++ H     +  +I +      I   + 
Sbjct: 108 HLEGVVTRGKP-----VMIVIEFMENGALDAFLRKH---DGQFTVIQLVGMLRGIAAGMR 159
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + A
Sbjct: 160 YLAD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTA 216
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 217 PEAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 71  RVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 122
           R++G G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L        E++  ++ + L    E  H + ++       + ++ + LY  QIC+A+AY+
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYL 129
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 239
             +I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +PE I
Sbjct: 130 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 186
Query: 240 FGATEYTAAIDIWSAGCVLAELLL--GQPLF 268
                +T A D+W     + E+L    QP F
Sbjct: 187 -NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 71  RVVGHGSFGVVFQAKCLE-TGEA--VAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 122
           R++G G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L        E++  ++ + L    E  H + ++       + ++ + LY  QIC+A+AY+
Sbjct: 74  L----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYL 125
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 239
             +I   HRDI  +N+LV      +KL DFG ++  ++ E       +R    + +PE I
Sbjct: 126 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 182
Query: 240 FGATEYTAAIDIWSAGCVLAELLL--GQPLFPGES 272
                +T A D+W     + E+L    QP F  E+
Sbjct: 183 -NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 127/302 (42%), Gaps = 64/302 (21%)
Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 122
           R +G G FG V Q   +       AVAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L         ++ +++ + L  + E   R      K S  + L  + LY YQ+  ALAY+
Sbjct: 76  L----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL--------VKGEPNISYICSRYYR 234
            +   V HRDI  +N+LV+ +   +KL DFG ++ +         KG+  I ++      
Sbjct: 128 ESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKLPIKWM------ 179
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           APE I     +T+A D+W  G  + E+L+ G   F G    D       V+G     E  
Sbjct: 180 APESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERL 231
Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS--TALEALIHPFF 351
            M PN                      PP    L+++   Y P+ R   T L+A +    
Sbjct: 232 PMPPN---------------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 270
Query: 352 DE 353
           +E
Sbjct: 271 EE 272

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 126
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-T 185
            F         L++V EY+       + H     +++         Y + + + Y+HN  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------YRAPELI 239
             + HR++K  NLLV+   + +K+CDFG +++        +++ S+       + APE++
Sbjct: 158 PPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWMAPEVL 211
Query: 240 FGATEYTAAIDIWSAGCVLAEL-LLGQP 266
                   + D++S G +L EL  L QP
Sbjct: 212 RDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ERV+G G FG V   +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   +K   K   +  +I +      I   + 
Sbjct: 87  HLEGVVTKSKP-----VMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMK 138
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + A
Sbjct: 139 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTA 195
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G V+ E++
Sbjct: 196 PEAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 121
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   + + T+     + L+ E V    +   +     +++     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILIGELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 181 YIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
           Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++          D+WS G +   LL G   F G++  + L  +              +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------------SAVNY 234
Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            + +  F    A              A D + RLL   P  R T  ++L HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 57/296 (19%)
Query: 73  VGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKNRE--LQTMRLLDH-------- 117
           +G G+FG V +A         T   VA+K + +   +      +  +++L H        
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 118 -----------PNVVSLKHCFFSTTEKDELYL----NLVLEYVPETVHRVIKHHYKMSQR 162
                      P +V ++ C F        YL    N  + Y PE +++           
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKPEDLYKDF--------- 144
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 46/297 (15%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 120
           +  + +G G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           ++L   + +T+E     + L+LEY    E     +    +M     +I +     QI   
Sbjct: 92  INLHEVYENTSE-----IILILEYAAGGEIFSLCLPELAEMVSENDVIRL---IKQILEG 143
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           + Y+H    + H D+KPQN+L++       +K+ DFG ++ +         + +  Y AP
Sbjct: 144 VYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E I      T A D+W+ G +   LL     F GE   +  + I +V            N
Sbjct: 203 E-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------------N 249
Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
            +Y+E  F  +                A D +  LL  +P  R TA   L H +  +
Sbjct: 250 VDYSEETFSSVSQL-------------ATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 101/226 (44%), Gaps = 28/226 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L      TT + ++   L++E+ P     TV     + Y + +   LI ++     +  
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR----DVVG 123
Query: 178 ALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPNISYICSRYYR 234
            + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  +    +  Y 
Sbjct: 124 GMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYL 182
Query: 235 APELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGES 272
            P++   A        +Y A +D+WS G        G  P  P E 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 50/292 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     ++ + + F  +    A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKV-----LQDKRYKNRELQTM 112
           P + +   ++RV+G G FGVV+  + ++  +     AIK +     +Q      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R L+HPNV++L            + L       P   H  +    +  QR P +   + F
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ R + Y+     V HRD+  +N +++  +  +K+ DFG A+ ++  E   S    R
Sbjct: 130 GLQVARGMEYLAEQKFV-HRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHR 186
Query: 232 YYRAPELIFGATE------YTAAIDIWSAGCVLAELL 262
           + R P + + A E      +T   D+WS G +L ELL
Sbjct: 187 HARLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 30/231 (12%)
Query: 67  YMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDKRYKNREL-----QTMRLLDHPNV 120
           Y  +  + HG  G ++ A      G  V +K ++     + + +     Q +  + HP++
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V + +    T    +    +V+EYV     +  K      Q++P+     Y  +I  AL+
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALS 196
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSRYYRA 235
           Y+H +IG+ + D+KP+N+++     QLKL D G+   +     + G P         ++A
Sbjct: 197 YLH-SIGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINSFGYLYGTPG--------FQA 245
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           PE++   T  T A DI++ G  LA L L  P   G   VD L E   VL T
Sbjct: 246 PEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKT 293

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 98  RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 149
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 150 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 206
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 207 PEAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 108 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 159
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 160 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 216
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 217 PEAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 162 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 218
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 219 PEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 40/222 (18%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYK----------NRELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 174
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 175 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 229
           I   + Y+ N    + HRD++  N+ +        +C    DFG+++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLL 187
Query: 230 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 268
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +       + +V EY+   ++   ++ H     +  +I +      I   + 
Sbjct: 81  RLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 132
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +
Sbjct: 133 YLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTS 189
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
           PE I    ++T+A D+WS G VL E++
Sbjct: 190 PEAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+             + ++ EY+            K   R  +I +      I   + Y
Sbjct: 94  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + +   V HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LSDMSAV-HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G V+ E++
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 127
           +G GSFG VF+     T + VAIK +       +     +E+  +   D   V      +
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              ++     L +++EY+       +       +      +     +I + L Y+H+   
Sbjct: 91  LKGSK-----LWIIMEYLGGGSALDLLRAGPFDE----FQIATMLKEILKGLDYLHSEKK 141
Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 246
           + HRDIK  N+L++     +KL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 142 I-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 198
Query: 247 AAIDIWSAGCVLAELLLGQP 266
           +  DIWS G    EL  G+P
Sbjct: 199 SKADIWSLGITAIELAKGEP 218

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN--GSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 162
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 252
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 253 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 304
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 305 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 360

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 193
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 254
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 255 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 306
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 307 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 362

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 193
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 245
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 246 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 297
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 298 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 353

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 125/286 (43%), Gaps = 39/286 (13%)
Query: 73  VGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKNRE--LQTMRLL----DHPNVV 121
           +G G+FG V +A         T   VA+K + +   +      +  +++L     H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 122 SLKHCFFSTTEKDELYLNLVLE---------YVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +L         K    L +++E         Y+    +  + +       + L ++  Y 
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +R 
Sbjct: 151 FQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 233 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 288
              + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +      
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRL 260
Query: 289 REEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 81  RLEGVV--TKSKPVMIVTEXME--NGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 133
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G VL E++
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+     T  K  + +   +E    ++   ++ H     +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXME--NGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKY 162
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G VL E++
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYK----------NRELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 174
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 175 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 229
           I   + Y+ N    + HRD++  N+ +        +C    DFG ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 230 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 268
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 247
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 299
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 300 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     ++ + + F       A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     ++ + + F  +    A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 239
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 240 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 291
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--------------- 233
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     ++ + + F  +    A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 129/289 (44%), Gaps = 36/289 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+        +  L + +V EY+   ++   ++ H      M L+ +      +   + 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +Y  +       + A
Sbjct: 166 YLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTA 222
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           PE I   T +++A D+WS G V+ E+L  G+  +   +  D +  +         E  + 
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRL 273
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTA 342
             P        Q+    WHK   +R    + V ++  L++   +LR+TA
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+             + ++ EY+            K   R  +I +      I   + Y
Sbjct: 73  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G V+ E++
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 121
           E+V+G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L+             + ++ EY+            K   R  +I +      I   + Y
Sbjct: 79  HLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           + + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I    ++T+A D+WS G V+ E++
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 204
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 256
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 257 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 312

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 193
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 202
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDP 193
Query: 223 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 278
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 245
Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     ++ + + F       A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 121
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      ++      L LV +Y+P    +  V +H   +  ++ L     +  QI + +
Sbjct: 97  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 146
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A 
Sbjct: 147 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 237 ELI-FGATEYTAAIDIWSAGCVLAELL 262
           E I FG  +YT   D+WS G  + EL+
Sbjct: 205 ESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 50/292 (17%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 122
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   + + T+     + L+LE V    +   +     +S+     ++K    QI   + Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 182 IHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +H T  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +          D+WS G +   LL G   F G++  + L  I  V               
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV--------------- 233
Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                     ++ + + F       A D + +LL      R T  EAL HP+
Sbjct: 234 ----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 121
           +V+G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      ++      L LV +Y+P    +  V +H   +  ++ L     +  QI + +
Sbjct: 79  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN----WGVQIAKGM 128
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++    + A 
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 237 ELI-FGATEYTAAIDIWSAGCVLAELL 262
           E I FG  +YT   D+WS G  + EL+
Sbjct: 187 ESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/345 (21%), Positives = 131/345 (37%), Gaps = 56/345 (16%)
Query: 72  VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 123
           V+G G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F +    +EL++             +  H       + + Y+      + +AL YIH
Sbjct: 76  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 184 NTIGVCHRDIKPQNLLVNPH--------THQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-------------- 281
             L      Y A  DI+S G    EL  G   F        L+E +              
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 282 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 249 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTFS----PHFHHFVEQC 301
Query: 332 LQYSPNLRSTALEALIHPFFDEL-RDPNTRLPN-GRFLPPLFNFK 374
           LQ +P+ R +A   L H FF ++ R  +  LP   R + P+ NF+
Sbjct: 302 LQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 346

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L     S T      + LV + +P        H +K +    L+    +  QI + + Y
Sbjct: 104 RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--WCVQIAKGMMY 155
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 238
           +     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E 
Sbjct: 156 LEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 213
Query: 239 IFGATEYTAAIDIWSAGCVLAELL 262
           I    ++T   D+WS G  + EL+
Sbjct: 214 IH-YRKFTHQSDVWSYGVTIWELM 236

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNR--ELQ 110
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 167
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 226
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F                  
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------ 389
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTA 342
             R E K  N    +    Q   +P       +  P + D    LLQ  P      R  +
Sbjct: 390 RARGE-KVENKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 343 LEAL-IHPFFDELRDPNTR-LPNGRFLPPL 370
            + L  HP F   RD + R L  G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 75/345 (21%), Positives = 131/345 (37%), Gaps = 56/345 (16%)
Query: 72  VVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 123
           V+G G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F +    +EL++             +  H       + + Y+      + +AL YIH
Sbjct: 92  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 184 NTIGVCHRDIKPQNLLVNPH--------THQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           + +G  HR +K  ++L++             L +   G  + +V   P  S     +   
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII-------------- 281
             L      Y A  DI+S G    EL  G   F        L+E +              
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 282 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTFS----PHFHHFVEQC 317
Query: 332 LQYSPNLRSTALEALIHPFFDEL-RDPNTRLPN-GRFLPPLFNFK 374
           LQ +P+ R +A   L H FF ++ R  +  LP   R + P+ NF+
Sbjct: 318 LQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNR--ELQ 110
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 167
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 226
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F                  
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------ 389
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTA 342
             R E K  N    +    Q   +P       +  P + D    LLQ  P      R  +
Sbjct: 390 RARGE-KVENKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 343 LEAL-IHPFFDELRDPNTR-LPNGRFLPPL 370
            + L  HP F   RD + R L  G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNR--ELQ 110
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 167
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 226
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F                  
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------ 389
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTA 342
             R E K  N    +    Q   +P       +  P + D    LLQ  P      R  +
Sbjct: 390 RARGE-KVENKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 343 LEAL-IHPFFDELRDPNTR-LPNGRFLPPL 370
            + L  HP F   RD + R L  G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I    K+L +       ++       M  +DHP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L     S T      + LV + +P        H +K +    L+    +  QI + + Y
Sbjct: 81  RLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--WCVQIAKGMMY 132
Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPEL 238
           +     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +    + A E 
Sbjct: 133 LEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 239 IFGATEYTAAIDIWSAGCVLAELL 262
           I    ++T   D+WS G  + EL+
Sbjct: 191 IH-YRKFTHQSDVWSYGVTIWELM 213

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 82/330 (24%), Positives = 133/330 (40%), Gaps = 55/330 (16%)
Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNR--ELQ 110
             QP     ++  RV+G G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--- 167
            +  +    +VSL + F + T+     L LV+  +     R   H Y + +  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 226
              Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           Y  +  + APEL+ G  EY  ++D ++ G  L E++  +  F                  
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------ 389
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTA 342
             R E K  N    +    Q   +P       +  P + D    LLQ  P      R  +
Sbjct: 390 RARGE-KVENKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGS 442
Query: 343 LEAL-IHPFFDELRDPNTR-LPNGRFLPPL 370
            + L  HP F   RD + R L  G   PP 
Sbjct: 443 CDGLRTHPLF---RDISWRQLEAGMLTPPF 469

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 28/222 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 184
            F   + K +L +  V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 72  LFMGYSTKPQLAI--VTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF- 240
              + HRD+K  N+ ++   + +K+ DFG A V  +   +  +     S  + APE+I  
Sbjct: 127 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKK-VLQDKRYK----------NRELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIK--HHYKMSQRMPLIYVKLYFYQ 174
           N+V L     +          +V+E+VP  +  HR++   H  K S ++ L+        
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM------LD 130
Query: 175 ICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLC----DFGSAKVLVKGEPNISYIC 229
           I   + Y+ N    + HRD++  N+ +        +C    DF  ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---SVSGLL 187
Query: 230 SRY-YRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLF 268
             + + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGXLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 87  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 135
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 136 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 194 LESILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 128/289 (44%), Gaps = 36/289 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+        +  L + +V EY+   ++   ++ H      M L+ +      +   + 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRA 235
           Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +       + A
Sbjct: 166 YLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWTA 222
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           PE I   T +++A D+WS G V+ E+L  G+  +   +  D +  +         E  + 
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRL 273
Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTA 342
             P        Q+    WHK   +R    + V ++  L++   +LR+TA
Sbjct: 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+ DFG A+ + K    +    +
Sbjct: 149 YSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 286
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXR 258
Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 333
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 259 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 84  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 133
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 134 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 192 ESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC--- 126
           +G G FG V++    +    VA+K + +D        +E   M+ + HPN+V L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 127 ---FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F+  TE    Y NL L+Y+ E   + +         + L+Y+     QI  A+ Y+ 
Sbjct: 79  EPPFYIITEF-MTYGNL-LDYLRECNRQEV-------SAVVLLYMAT---QISSAMEYLE 126
Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 240
                 HRD+  +N LV    H +K+ DFG ++ L+ G+   ++  +++   + APE + 
Sbjct: 127 KK-NFIHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL- 182
Query: 241 GATEYTAAIDIWSAGCVLAEL-LLGQPLFPG 270
              +++   D+W+ G +L E+   G   +PG
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 184
            F   + K +L +  V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 84  LFMGYSTKPQLAI--VTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 240
              + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 81  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 106 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 154
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 155 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 213 LESILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 91  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 139
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 140 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 198 LESILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 80/196 (40%), Gaps = 47/196 (23%)
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 232
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK    GE          
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE---------- 173
Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
                      +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 174 -----------KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 216
Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 351
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 217 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261
Query: 352 DELRDPNTRLPNGRFL 367
              + P T L   R L
Sbjct: 262 QSTKVPQTPLHTSRVL 277

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   + + R       N+E+      M  +D+P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 115 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 163
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 164 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 222 LESILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +T      + ++ E++   ++   ++ +     +  +I +      I   + 
Sbjct: 98  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMK 149
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 234
           Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 150 YLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 208 APEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 75  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 124 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 182 LESILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 17/195 (8%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 125
           +G GSF  V++    ET   VA  + LQD++    E Q        ++ L HPN+V    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCE-LQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN- 184
            + ST  K +  + LV E       +     +K+ +   +  ++ +  QI + L ++H  
Sbjct: 93  SWESTV-KGKKCIVLVTELXTSGTLKTYLKRFKVXK---IKVLRSWCRQILKGLQFLHTR 148
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
           T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE      +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--EEK 205
Query: 245 YTAAIDIWSAG-CVL 258
           Y  ++D+++ G C L
Sbjct: 206 YDESVDVYAFGXCXL 220

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 85
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVKLYFYQICRALAYIHN 184
             +ST  +    L +V ++   +    + HH   S+ +  +  +     Q  R + Y+H 
Sbjct: 86  MGYSTAPQ----LAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF- 240
              + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S  + APE+I  
Sbjct: 139 K-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
             +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI   
Sbjct: 78  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAEG 126
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 127 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 185 LESILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 114/243 (46%), Gaps = 41/243 (16%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIK-KVLQDKRYKNR------ELQ 110
           P++ + +   +V+G G+FG V  A      +TG ++ +  K+L++K   +       EL+
Sbjct: 43  PRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 111 TM-RLLDHPNVVSLKHCFFSTTEKDELYLNL-------VLEYVPETVHRVIKHH--YKMS 160
            M +L  H N+V+L     + T    +YL         +L Y+     +  +    Y+  
Sbjct: 101 MMTQLGSHENIVNL---LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 161 QRMP-------LIYVKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 211
           +R+        L +  L  + YQ+ + + ++     V HRD+  +N+LV  H   +K+CD
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV-HRDLAARNVLVT-HGKVVKICD 215
Query: 212 FGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPL 267
           FG A+ ++     +    +R    + APE +F    YT   D+WS G +L E+  LG   
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP 274
Query: 268 FPG 270
           +PG
Sbjct: 275 YPG 277

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA-----VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 119
           ++V+G G FG V++   L+T        VAIK +      K R     E   M    H N
Sbjct: 49  QKVIGAGEFGEVYKG-MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L+             + ++ EY+      + K   +      ++ +      I   +
Sbjct: 108 IIRLEGVISKYKP-----MMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYR 234
            Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 161 KYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT 217
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 218 APEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 65  ISYMA-ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLL 115
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           +HPN++ L+     T     + L   +E    ++  R+    + + Q + ++        
Sbjct: 73  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR------G 124
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 231
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               + APE I    ++T+A D WS G V+ E++
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------TMRLLDHPN 119
           ++  + ++G G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI--CR 177
           ++ L+    + TE+  +Y  +    V   +        +   + PL + K     +   R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLRE------RPESQPPLDWPKRQRIALGSAR 142
Query: 178 ALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY--Y 233
            LAY+H+     + HRD+K  N+L++     + + DFG AK++   + ++         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQ------TMRLLDHPN 119
           ++  + ++G G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI--CR 177
           ++ L+    + TE+  +Y  +    V   +        +   + PL + K     +   R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLRE------RPESQPPLDWPKRQRIALGSAR 150
Query: 178 ALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY--Y 233
            LAY+H+     + HRD+K  N+L++     + + DFG AK++   + ++         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 268
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 99/197 (50%), Gaps = 20/197 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 129
           +G G FGVV   K  +    VA+K + +    ++   +E QTM  L HP +V     F+ 
Sbjct: 16  LGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVK----FYG 70
Query: 130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV 188
              K E  + +V EY+    +   ++ H K  +   L+ +    Y +C  +A++ +   +
Sbjct: 71  VCSK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM---CYDVCEGMAFLESHQFI 126
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEY 245
            HRD+  +N LV+     +K+ DFG  + ++  +  +S + +++   + APE +F   +Y
Sbjct: 127 -HRDLAARNCLVDRDL-CVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPE-VFHYFKY 182
Query: 246 TAAIDIWSAGCVLAELL 262
           ++  D+W+ G ++ E+ 
Sbjct: 183 SSKSDVWAFGILMWEVF 199

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 122
           +V+G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 123 --LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
             L  C  ST +       LV + +P     ++ H  +   R+    +  +  QI + ++
Sbjct: 83  RLLGICLTSTVQ-------LVTQLMPYGC--LLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 237
           Y+ + + + HRD+  +N+LV    H +K+ DFG A++L   E        +    + A E
Sbjct: 134 YLED-VRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 238 LIFGATEYTAAIDIWSAGCVLAELL 262
            I     +T   D+WS G  + EL+
Sbjct: 192 SIL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 124
           +G G FGVV++     T   VA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYI 182
              FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELI 239
           H    + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 124
           +G G FGVV++     T   VA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYI 182
              FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELI 239
           H    + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQP 266
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L     ++T      + L+++ +P    +  V +H   +  +    Y+  +  QI + +
Sbjct: 88  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 137
Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAP 236
            Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A 
Sbjct: 138 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I     YT   D+WS G  + EL+
Sbjct: 196 ESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 121
           +V+  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 122 SLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            L   C  ST +     +    +L+YV E       H   +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRA 235
           + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 236 PELIFGATEYTAAIDIWSAGCVLAELL 262
            E I     YT   D+WS G  + EL+
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 126
           +G G FGVV++     T  AV     + D      K+  ++E++ M    H N+V L   
Sbjct: 33  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL--L 90
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY-VKLYFYQ-ICRALAYIHN 184
            FS+   D   L LV  Y+P     ++     +    PL + ++    Q     + ++H 
Sbjct: 91  GFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 145
Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFG 241
              + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G
Sbjct: 146 NHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG 203
Query: 242 ATEYTAAIDIWSAGCVLAELLLGQP 266
             E T   DI+S G VL E++ G P
Sbjct: 204 --EITPKSDIYSFGVVLLEIITGLP 226

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNVVS 122
           M    +G GSFG V++ K      AV I KV+     Q + ++N E+  +R   H N++ 
Sbjct: 39  MLSTRIGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL- 95
Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
               F     KD L   +V ++   +   + KH +    +  +  +     Q  + + Y+
Sbjct: 96  ---LFMGYMTKDNL--AIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISY-ICSRYYRAPELI 239
           H    + HRD+K  N+ ++     +K+ DFG A V  +  G   +     S  + APE+I
Sbjct: 149 HAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
                  ++   D++S G VL EL+ G+  +   +  DQ++ ++
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 103/266 (38%), Gaps = 81/266 (30%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL---------QTMRLLDHPNVV 121
           + +G G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 122 SLKHCFFST------TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------- 168
              + +  T       E DE++L       P +    +       +RM            
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 169 -----KLYFY---QICR-------------------------------ALAYIHNTIGVC 189
                K+Y Y   Q+CR                               A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186
Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNISY------ICSRYYRAP 236
           HRD+KP N+        +K+ DFG    + + E       P  +Y      + ++ Y +P
Sbjct: 187 HRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSP 245
Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL 262
           E I G   Y+  +DI+S G +L ELL
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 45/218 (20%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHCFF 128
           V   G FG V++A+ L   E VA+K   +QDK+    E +   L  + H N++      F
Sbjct: 31  VKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQ-----F 83
Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC-------RALAY 181
              EK    +++ L  +          H K S    L    + + ++C       R LAY
Sbjct: 84  IGAEKRGTSVDVDLWLIT-------AFHEKGSLSDFLKANVVSWNELCHIAETMARGLAY 136
Query: 182 IHNTI---------GVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEP---NISY 227
           +H  I          + HRDIK +N+L+    + L  C  DFG A     G+        
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 228 ICSRYYRAPELIFGATEYTAA----IDIWSAGCVLAEL 261
           + +R Y APE++ GA  +       ID+++ G VL EL
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+V+G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
            L+     +T      + ++ E++   ++   ++ +     +  +I +      I   + 
Sbjct: 72  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMK 123
Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYR 234
           Y+ + +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 124 YLAD-MNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL 262
           APE I    ++T+A D+WS G V+ E++
Sbjct: 182 APEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 95  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 120 VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
           +V+L              ++C +         LN +    P  +       +   +++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
             +  +  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 166 RDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 223
Query: 226 SYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 224 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 70  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 125
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 126 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 128
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 129 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 60/244 (24%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKRYK-----NRELQ 110
           P+  I Y+  R +G G+FG VFQA+       E    VA+K + ++          RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 111 TMRLLDHPNVVSL--------KHC----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYK 158
            M   D+PN+V L          C    + +  + +E   ++    V    H  +    +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 159 MSQRMP--------LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 210
           +S   P        L   +    Q+   +AY+     V HRD+  +N LV      +K+ 
Sbjct: 163 VSSPGPPPLSCAEQLCIAR----QVAAGMAYLSERKFV-HRDLATRNCLVG-ENMVVKIA 216
Query: 211 DFGSAKVLVKGEPNISYICSRYYRA------------PELIFGATEYTAAIDIWSAGCVL 258
           DFG ++ +   +         YY+A            PE IF    YT   D+W+ G VL
Sbjct: 217 DFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVL 266
Query: 259 AELL 262
            E+ 
Sbjct: 267 WEIF 270

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 65  ISYMA-ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLL 115
           +SY+  E V+G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           +HPN++ L+     T     + L   +E    ++  R+    + + Q + ++        
Sbjct: 75  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR------G 126
Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 231
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
               + APE I    ++T+A D WS G V+ E++
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 152 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 88  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 144 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             +ST  +    L +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 70  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 38/212 (17%)
Query: 74  GHGSFGVVFQAKCLETGEAVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLKH 125
           G G FGVV++     T   VA+KK+         + K+  ++E++      H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK--LYFYQICRALAYIH 183
             FS+   D   L LV  Y P            +  R+  +     L ++  C+      
Sbjct: 87  LGFSSDGDD---LCLVYVYXPNG---------SLLDRLSCLDGTPPLSWHXRCKIAQGAA 134
Query: 184 NTIGV------CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYR 234
           N I         HRDIK  N+L++      K+ DFG A+   K    +     + +  Y 
Sbjct: 135 NGINFLHENHHIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYX 193
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
           APE + G  E T   DI+S G VL E++ G P
Sbjct: 194 APEALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 120 VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
           +V+L              ++C +     D L        V ET       +  +S R  L
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYG----DLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
            +      Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 168 HFSS----QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 226 SYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 125
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F   + K +L   +V ++   +   +  H + +  +  +I +     Q  + + Y+H  
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIFGA 242
             + HRD+K  N+ ++     +K+ DFG A  K    G      +  S  + APE+I   
Sbjct: 124 -SIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 243 TE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
           +V+L     + T    + +  + EY     +   + R  +         PL    L  + 
Sbjct: 104 IVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R 
Sbjct: 159 SQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 233 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
              + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 217 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 189 CHRDIKPQNLLVNPHTHQLKLCDFG--SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 246
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 247 AAIDIWSAGCVLAELLLGQPLFPGE 271
              DI++  CVL E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 120 VVSLKHCFFSTTEKDELYLNLVLEY-----VPETVHRVIKHHYKMSQRMPLIYVKLYFY- 173
           +V+L     + T    + +  + EY     +   + R  +         PL    L  + 
Sbjct: 112 IVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 174 -QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
            Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R 
Sbjct: 167 SQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 233 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
              + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 225 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 42/230 (18%)
Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 119
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 120 VVSL--------------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 165
           +V+L              ++C +          + VLE  P          + ++     
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA---------FAIANSTAS 162
Query: 166 IYVKLYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
               L+F  Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     
Sbjct: 163 TRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNY 220
Query: 225 ISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 221 IVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 333
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 334 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 364
             P  R +  E L HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 333
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 334 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 364
             P  R +  E L HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 129
           VG G +G V++   L  GE+VA+K      +   ++  E+    LL H N++        
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDM- 72
Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--- 186
           T+      L L+  Y     H  +    +     P + ++L     C  LA++H  I   
Sbjct: 73  TSRNSSTQLWLITHYHE---HGSLYDFLQRQTLEPHLALRLAVSAAC-GLAHLHVEIFGT 128
Query: 187 ----GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPE 237
                + HRD K +N+LV  +  Q  + D G A +  +G       N   + ++ Y APE
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 238 LI--------FGATEYTAAIDIWSAGCVLAEL 261
           ++        F + ++T   DIW+ G VL E+
Sbjct: 188 VLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 333
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 334 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 364
             P  R +  E L HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 333
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 259
Query: 334 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 364
             P  R +  E L HP+      P  ++  G
Sbjct: 260 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 42/209 (20%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+   P +  ++
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 228
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 229 QISKLHAII-----------DPNH-EIEFPDIPEK------------DLQDVLKCCLKRD 264
Query: 336 PNLRSTALEALIHPFFDELRDPNTRLPNG 364
           P  R +  E L HP+      P  ++  G
Sbjct: 265 PKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 42/209 (20%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 280
Query: 336 PNLRSTALEALIHPFFDELRDPNTRLPNG 364
           P  R +  E L HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 42/209 (20%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+   P +  ++
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 224
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 225 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 260
Query: 336 PNLRSTALEALIHPFFDELRDPNTRLPNG 364
           P  R +  E L HP+      P  ++  G
Sbjct: 261 PKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+K  +Y  +V+E V             +      + VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTF-----LRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 188 VC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY---YRAPE-LIFG 241
            C  HRD+  +N LV    + LK+ DFG ++    G    S    +    + APE L +G
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 242 ATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 272
              Y++  D+WS G +L E   LG   +P  S
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 45  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 103
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 104 KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 156
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 157 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 210
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 211 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 269
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 270 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 309

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 36/286 (12%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 85  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 137
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    +  + 
Sbjct: 138 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSVHNKTG 195
Query: 232 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 285
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 196 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 250
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 251 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 19  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 77
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 78  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 130
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 131 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 184
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 185 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 243
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 244 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 283

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 46  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 104
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 105 KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 157
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 158 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 211
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 212 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 270
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 271 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 310

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 36/286 (12%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 87  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 139
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ ++  E +  +  + 
Sbjct: 140 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMLDKEFDSVHNKTG 197
Query: 232 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 285
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 198 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 252
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 253 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 127
           +G G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T+K  +Y  +V+E V             +      + VK     +  A A +     
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTF-----LRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 188 VC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 244
            C  HRD+  +N LV    + LK+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 245 -----YTAAIDIWSAGCVLAELL-LGQPLFPGES 272
                Y++  D+WS G +L E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 86  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 138
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 139 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 192
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 193 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 251
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 72/307 (23%), Positives = 129/307 (42%), Gaps = 55/307 (17%)
Query: 71  RVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E   M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP---LIYVKLYFYQICR 177
           V L     S  +   + + L+     ++  R ++   + +   P   L  +     +I  
Sbjct: 83  VRLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYR 234
            +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +        +    + 
Sbjct: 142 GMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           APE +     +T + D+WS G VL E+  L +  + G S  +Q+++ +            
Sbjct: 200 APESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV------------ 245
Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL------I 347
            M+  Y +         P         P    DL+    Q++PN+R T LE +      +
Sbjct: 246 -MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDL 290
Query: 348 HPFFDEL 354
           HP F E+
Sbjct: 291 HPSFPEV 297

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 24  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 83  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 135
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 136 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 189
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 248
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 249 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 288

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 84  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 136
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 137 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 190
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 191 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 249
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 250 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 84/209 (40%), Gaps = 42/209 (20%)
Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 225
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +      +   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKD 186
Query: 226 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+   P +  ++
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIIN 244
Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
           Q+ ++  ++           +PN+ E +FP I               +  D++   L+  
Sbjct: 245 QISKLHAII-----------DPNH-EIEFPDIPE------------KDLQDVLKCCLKRD 280
Query: 336 PNLRSTALEALIHPFFDELRDPNTRLPNG 364
           P  R +  E L HP+      P  ++  G
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 232
           Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R  
Sbjct: 166 QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLP 223
Query: 233 --YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
             + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 224 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 127
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 128 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 183
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 184 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 85  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 137
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 138 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 191
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 192 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 250
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 251 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 133
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 134 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 189
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 190 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 22  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 81  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 133
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 134 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 187
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 246
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 247 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 286

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 60  QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL----QTMRLL 115
           +P+    +   R +G GSFG ++    ++T E VAIK  L++ + K+ +L    +  R+L
Sbjct: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRIL 59
Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
                +     F    E D  Y  LV++ +  ++  +       S+++ L  V +   Q+
Sbjct: 60  QGGTGIPNVRWF--GVEGD--YNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
Query: 176 CRALAYIHNTIGVCHRDIKPQNLL--VNPHTHQLKLCDFGSAK 216
              + ++H+     HRDIKP N L  +    +Q+ + DFG AK
Sbjct: 113 INRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 86  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 138
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + Y+ +   V HRD+  +N +++     +K+ DFG A+ +   E    Y    
Sbjct: 139 GLQVAKGMKYLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSVH 192
Query: 232 YYRAPEL--------IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
                +L             ++T   D+WS G +L EL+  G P +P  +  D  V ++ 
Sbjct: 193 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 251
Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                  +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 -------QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MSLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 179
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 180 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 179
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 180 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 127
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +  Y+   + +    
Sbjct: 128 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFA 183
Query: 235 --APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
             APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 184 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 86  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 145 KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 197
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 198 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 232 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 285
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 256 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 310
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 311 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 350

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 32  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 90
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 91  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 143
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 144 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 201
Query: 232 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 285
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 202 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 256
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 257 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 296

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 86  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 138
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 139 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 196
Query: 232 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 285
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 197 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 251
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 87  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 139
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 140 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 197
Query: 232 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 285
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 198 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 252
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 253 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 133
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYR 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +      R     + 
Sbjct: 134 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 192 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 84  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 136
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 137 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 194
Query: 232 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 285
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 195 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 249
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 250 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 125/286 (43%), Gaps = 36/286 (12%)
Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLET-GEAV--AIKKV--LQDKRYKNRELQ---TM 112
           P   I +  E V+G G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           +   HPNV+SL         + E    +VL Y+    H  +++  +     P +   + F
Sbjct: 86  KDFSHPNVLSL----LGICLRSEGSPLVVLPYMK---HGDLRNFIRNETHNPTVKDLIGF 138
Query: 173 -YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
             Q+ + + ++ +   V HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 139 GLQVAKGMKFLASKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTG 196
Query: 232 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 285
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V ++    
Sbjct: 197 AKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---- 251
Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
               +  + + P Y      ++    WH   +  M P   +LVSR+
Sbjct: 252 ----QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 34/229 (14%)
Query: 73  VGHGSFGVVFQAKC-LETGEAVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 122
           +G GSFGVV + +    +G+ V++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH--HYKMSQRMPLIYVKLYFYQICRA 178
           L     +   K      +V E  P    + R+ KH  H+ +        +  Y  Q+   
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGT------LSRYAVQVAEG 123
Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYR 234
           + Y+ +   + HRD+  +NLL+      +K+ DFG  + L + + +      R     + 
Sbjct: 124 MGYLESKRFI-HRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK 282
           APE +   T ++ A D W  G  L E+   GQ  + G +G   L +I K
Sbjct: 182 APESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 231 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 130/316 (41%), Gaps = 73/316 (23%)
Query: 71  RVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E   M+     +V
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP---LIYVKLYFYQICR 177
           V L     S  +   + + L+     ++  R ++   + +   P   L  +     +I  
Sbjct: 84  VRLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            +AY+ N     HR++  +N +V  H   +K+ DFG  + + +         + YYR   
Sbjct: 143 GMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TDYYRKGG 191
Query: 235 ---------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVL 284
                    APE +     +T + D+WS G VL E+  L +  + G S  +Q+++ +   
Sbjct: 192 KGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV--- 246
Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
                     M+  Y +         P         P    DL+    Q++PN+R T LE
Sbjct: 247 ----------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLE 282
Query: 345 AL------IHPFFDEL 354
            +      +HP F E+
Sbjct: 283 IVNLLKDDLHPSFPEV 298

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 70  ERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 169
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 80  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 170 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
           L+F   + R + Y+     + HRD+  +N+LV    +  K+ DFG ++   V VK    +
Sbjct: 135 LHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KTM 190
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 191 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 70  ERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 169
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 90  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 170 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
           L+F   + R + Y+     + HRD+  +N+LV  + +  K+ DFG ++   V VK    +
Sbjct: 145 LHFAADVARGMDYLSQKQFI-HRDLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KTM 200
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 201 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 235

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 41/211 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSL-KHC 126
           ++GHG FG V++   L  G  VA+K+      Q       E++T+    HP++VSL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----RALAYI 182
                E++E+ L  + +Y+       +K H   S    +        +IC    R L Y+
Sbjct: 105 ----DERNEMIL--IYKYMENGN---LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------VLVKGEPNISYICSR 231
           H T  + HRD+K  N+L++ +    K+ DFG +K            +VKG   + YI   
Sbjct: 156 H-TRAIIHRDVKSINILLDEN-FVPKITDFGISKKGTELGQTHLXXVVKG--TLGYIDPE 211
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
           Y+    L       T   D++S G VL E+L
Sbjct: 212 YFIKGRL-------TEKSDVYSFGVVLFEVL 235

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 74/316 (23%), Positives = 130/316 (41%), Gaps = 73/316 (23%)
Query: 71  RVVGHGSFGVVFQ--AKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           R +G GSFG+V++  A+ +  GEA   VA+K V +    + R     E   M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMP---LIYVKLYFYQICR 177
           V L     S  +   + + L+     ++  R ++   + +   P   L  +     +I  
Sbjct: 83  VRLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            +AY+ N     HR++  +N +V  H   +K+ DFG  + + +         + YYR   
Sbjct: 142 GMAYL-NAKKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYE---------TDYYRKGG 190
Query: 235 ---------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVL 284
                    APE +     +T + D+WS G VL E+  L +  + G S  +Q+++ +   
Sbjct: 191 KGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV--- 245
Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
                     M+  Y +         P         P    DL+    Q++PN+R T LE
Sbjct: 246 ----------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLE 281
Query: 345 AL------IHPFFDEL 354
            +      +HP F E+
Sbjct: 282 IVNLLKDDLHPSFPEV 297

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 41/214 (19%)
Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSL-KHC 126
           ++GHG FG V++   L  G  VA+K+      Q       E++T+    HP++VSL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----RALAYI 182
                E++E+ L  + +Y+       +K H   S    +        +IC    R L Y+
Sbjct: 105 ----DERNEMIL--IYKYMENGN---LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155
Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----------VLVKGEPNISYICSR 231
           H T  + HRD+K  N+L++ +    K+ DFG +K            +VKG   + YI   
Sbjct: 156 H-TRAIIHRDVKSINILLDEN-FVPKITDFGISKKGTELDQTHLXXVVKG--TLGYIDPE 211
Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
           Y+    L       T   D++S G VL E+L  +
Sbjct: 212 YFIKGRL-------TEKSDVYSFGVVLFEVLCAR 238

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKN 106
           G    + + T  +     +G G FG VF  KC++   G   AIK+  +      D++   
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 58
Query: 107 RELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMP 164
           RE+    +L  H +VV     +FS   +D+ ++ +  EY    ++   I  +Y++     
Sbjct: 59  REVYAHAVLGQHSHVVR----YFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFK 113
Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVL 218
              +K    Q+ R L YIH ++ + H DIKP N+ +      N  + +    D+ S KV+
Sbjct: 114 EAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 219 VK 220
            K
Sbjct: 173 FK 174

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSL 123
           +G G FG VF  KC++   G   AIK+  +      D++   RE+    +L  H +VV  
Sbjct: 17  IGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 73
Query: 124 KHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              +FS   +D+  L +  EY    ++   I  +Y++        +K    Q+ R L YI
Sbjct: 74  ---YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 183 HNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 220
           H ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 130 H-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 24/164 (14%)
Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSL 123
           +G G FG VF  KC++   G   AIK+  +      D++   RE+    +L  H +VV  
Sbjct: 15  IGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 71
Query: 124 KHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              +FS   +D+ ++ +  EY    ++   I  +Y++        +K    Q+ R L YI
Sbjct: 72  ---YFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 183 HNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 220
           H ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 128 H-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSL 123
           +G G FG VF  KC++   G   AIK+  +      D++   RE+    +L  H +VV  
Sbjct: 17  IGSGEFGSVF--KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 73
Query: 124 KHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              +FS   +D+  L +  EY    ++   I  +Y++        +K    Q+ R L YI
Sbjct: 74  ---YFSAWAEDDHML-IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 183 HNTIGVCHRDIKPQNLLV------NPHTHQLKLCDFGSAKVLVK 220
           H ++ + H DIKP N+ +      N  + +    D+ S KV+ K
Sbjct: 130 H-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 8/152 (5%)
Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           Y   R +G GSFG ++    + +GE VAIK      ++    +++         V +   
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSI 70
Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
            +   E D  Y  +V+E +  ++  +       S++  L  V L   Q+   + YIH+  
Sbjct: 71  KWCGAEGD--YNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK- 124
Query: 187 GVCHRDIKPQNLL--VNPHTHQLKLCDFGSAK 216
              HRD+KP N L  +    + + + DFG AK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 70  ERVVGHGSFGVVFQAKCLETG--EAVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK------------ 169
           +L        E    YL L +EY P           ++ +  P   +             
Sbjct: 87  NL----LGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 170 LYFY-QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK---VLVKGEPNI 225
           L+F   + R + Y+     + HR++  +N+LV  + +  K+ DFG ++   V VK    +
Sbjct: 142 LHFAADVARGMDYLSQKQFI-HRNLAARNILVGEN-YVAKIADFGLSRGQEVYVK--KTM 197
Query: 226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 262
             +  R+     L +    YT   D+WS G +L E++
Sbjct: 198 GRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 232

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	403
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-99
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-98
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-96
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-92
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-92
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-91
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-89
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-89
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-89
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-88
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-88
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-88
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-87
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-87
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-86
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-86
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-79
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-63
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-60
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-60
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-60
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-60
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-59
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-59
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-59
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-58
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-58
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-57
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-57
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-57
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-56
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-56
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-56
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-56
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-56
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-55
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-55
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-54
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-54
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-54
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-54
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-54
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-54
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-53
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-53
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-53
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-53
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-53
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-53
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-53
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-53
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-52
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-52
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-52
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-52
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-52
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-52
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-51
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-51
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-51
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-51
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-51
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-51
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-50
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-50
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-50
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-50
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-50
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-50
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-50
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-49
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-49
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-49
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-49
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-49
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-49
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-49
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-48
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-48
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-46
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-46
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-46
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-46
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-46
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-45
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-45
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-44
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-44
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-44
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-44
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-42
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-42
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-41
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-41
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-41
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-41
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-41
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-40
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-40
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-39
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-39
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-39
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-38
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-38
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-38
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-38
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-38
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-38
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-38
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-37
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-37
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-37
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-36
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-36
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-35
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-35
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-35
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-35
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-35
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-34
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-34
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-34
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-34
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-34
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-33
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-33
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-32
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-32
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-31
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-31
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-31
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-30
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-29
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-27
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  635 bits (1639), Expect = 0.0
 Identities = 244/392 (62%), Positives = 298/392 (76%), Gaps = 14/392 (3%)

Query: 9   ASGNTVGVDRLPEEMNDMKIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYM 68
           +   +    + P     MK+  DK         +G++   ++ T   G+     Q +SY 
Sbjct: 9   SFAESCKPVQQPSAFGSMKVSRDK---------DGSKVTTVVATP--GQGPDRPQEVSYT 57

Query: 69  AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 128
             +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+
Sbjct: 58  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117

Query: 129 STTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKLY YQ+ R+LAYIH + G
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFG 176

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
           +CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT+
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 236

Query: 248 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 307
           +ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQI
Sbjct: 237 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 296

Query: 308 KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFL 367
           KAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H FFDELRDPN +LPNGR  
Sbjct: 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDT 356

Query: 368 PPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 399
           P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 357 PALFNFTTQELSSNP-PLATILIPPHARIQAA 387

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  625 bits (1615), Expect = 0.0
 Identities = 228/374 (60%), Positives = 290/374 (77%), Gaps = 5/374 (1%)

Query: 31  DKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG 90
           +  +    ++        I V    GK G+ ++ I+Y   +V+G+GSFGVVFQAK +E+ 
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 91  EAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETV 149
           E VAIKKVLQDKR+KNRELQ MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV
Sbjct: 66  E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124

Query: 150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
           +R  +H+ K+ Q MP++ +KLY YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKL 183

Query: 210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP 269
            DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

Query: 270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS 329
           GESG+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+ HP+ K+F+ R PP+A+DL+S
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303

Query: 330 RLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKL 389
           RLL+Y+P+ R TA+EAL HPFFDELR    R+PNGR LPPLFN+   EL  V  D++ +L
Sbjct: 304 RLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRL 362

Query: 390 IPEHARKQCAFLGL 403
           +P+HA  +    G+
Sbjct: 363 VPQHAEAELLSRGI 376

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  598 bits (1544), Expect = 0.0
 Identities = 162/358 (45%), Positives = 231/358 (64%), Gaps = 12/358 (3%)

Query: 47  GHIIVTTIGGKNGQP--KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY 104
           G ++         +   K+   +  ER+ G G+FG V   K   TG +VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 105 KNRELQTMRLL---DHPNVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKM 159
           +NRELQ M+ L    HPN+V L+  F++  E+   ++YLN+V+EYVP+T+HR  +++Y+ 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 160 SQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
               P I +K++ +Q+ R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
              EPN++YICSRYYRAPELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYS 335
           EI++VLG P+RE ++ +NP++T+      K  PW  +F     +   EA DL+S LLQY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 336 PNLRSTALEALIHPFFDELRDPNTRLPNGRFLPP-LFNFKPHELKGVPVDMLVKLIPE 392
           P  R    EAL HP+FDEL DP T+LPN + LP  LF F P+E++ +      KL+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  580 bits (1497), Expect = 0.0
 Identities = 167/382 (43%), Positives = 247/382 (64%), Gaps = 43/382 (11%)

Query: 59  GQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHP 118
           G    +  Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 119 NVVSLKHCFFSTTEK---------------------------------DELYLNLVLEYV 145
           N++ L   F++T ++                                    YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 146 PETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH 205
           P+T+H+V+K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDN 179

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 265
            LKLCDFGSAK L+  EP+++YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 266 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV 325
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 326 DLVSRLLQYSPNLRSTALEALIHPFFDELRDP-------NTRLPNG--RFLPPLFNFKPH 376
           DL+ ++L+Y P+LR    EA+ HPFFD LR+        N+  P+G  + +P LFNF P+
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359

Query: 377 ELKGVPVDMLVKLIPEHARKQC 398
           EL  +P ++L +++P++     
Sbjct: 360 ELSIIPGNVLNRILPKNFSPNY 381

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  297 bits (763), Expect = 2e-99
 Identities = 95/315 (30%), Positives = 155/315 (49%), Gaps = 34/315 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQD----KR-YKNRELQTMRLLDHPNV 120
           YM  + +G G  G+VF A   +  + VAIKK+ L D    K     RE++ +R LDH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 121 VSLKHCF-----------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 169
           V +                S TE + +Y+  V EY+   +  V++        +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 226
           L+ YQ+ R L YIH +  V HRD+KP NL +N     LK+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 227 -YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
             + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 286 TPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 343
               E+ + +      +          P  ++    +  EAVD + ++L +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 344 EALIHPFFDELRDPN 358
           EAL HP+      P 
Sbjct: 302 EALSHPYMSIYSFPM 316

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  295 bits (757), Expect = 2e-98
 Identities = 102/296 (34%), Positives = 157/296 (53%), Gaps = 21/296 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G GS+GVVF+ +  +TG+ VAIKK L+ +          RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
           F     K  L+L  V EY   TV   +    +  + +P   VK   +Q  +A+ + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 245
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 303
              +D+W+ GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 304 FPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
            P  +   P    F   +   A+ L+   L   P  R T  + L HP+F+ +R+  
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  294 bits (754), Expect = 1e-97
 Identities = 110/348 (31%), Positives = 181/348 (52%), Gaps = 37/348 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQD-KR-YKNRELQTMRLLDHPN 119
           +  + ++G G++GVV  A    TGE VAIKK+          R    RE++ ++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 120 VVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++++ +     + ++  E+Y+  + E +   +HRVI      +Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLR 123

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----------- 226
           A+  +H    V HRD+KP NLL+N     LK+CDFG A+++ +   + S           
Sbjct: 124 AVKVLH-GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           ++ +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 287 PTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
           P  +       +P   E+    P   A P  K+F + + P+ +DL+ R+L + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

Query: 343 LEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
            EAL HP+     DPN         P  F F  H  + +    L KLI
Sbjct: 301 KEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  292 bits (750), Expect = 8e-97
 Identities = 93/315 (29%), Positives = 154/315 (48%), Gaps = 34/315 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------------RELQT 111
           Y  +R +  GS+G V        G  VAIK+V                       RE++ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 112 MRLLDHPNVVSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IY 167
           +    HPN++ L+  F  F      +LYL  V E +   + +VI       QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           ++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 288 TREEIKCM-NP---NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 343
             E++    +P   +Y       + A  W  +      P A+DL++++L+++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 344 EALIHPFFDELRDPN 358
           +AL HP+F+ L DP 
Sbjct: 313 QALRHPYFESLFDPL 327

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  291 bits (746), Expect = 1e-96
 Identities = 98/295 (33%), Positives = 155/295 (52%), Gaps = 21/295 (7%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           VG GS+G+V + +  +TG  VAIKK L+    K       RE++ ++ L H N+V+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                +K   YL  V E+V  T+   ++        +    V+ Y +QI   + + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 245
            + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 303
             A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 304 FPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
            P+IK   P  + +  ++    +DL  + L   P+ R    E L H FF      
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  290 bits (744), Expect = 6e-96
 Identities = 106/338 (31%), Positives = 182/338 (53%), Gaps = 29/338 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 121
           Y     +G G++G+V  A        VAIKK+         +   RE++ +    H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88

Query: 122 SLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +     + T +   ++Y+  V + +   +++++K     +Q +   ++  + YQI R L
Sbjct: 89  GINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRA 235
            YIH +  V HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRA
Sbjct: 142 KYIH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259

Query: 296 -NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 352
            N     +    P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

Query: 353 ELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
           +  DP+   P        F F   EL  +P + L +LI
Sbjct: 319 QYYDPS-DEPI---AEAPFKF-DMELDDLPKEKLKELI 351

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  288 bits (740), Expect = 8e-96
 Identities = 89/304 (29%), Positives = 148/304 (48%), Gaps = 25/304 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKNRELQTMR-LLDHPNVVSL 123
           Y   R +G G +  VF+A  +   E V +K +  ++ K+ K RE++ +  L   PN+++L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 124 KHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                    +       V E+V  T   ++        Q +    ++ Y Y+I +AL Y 
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 146

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
           H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+   
Sbjct: 147 H-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205

Query: 243 TEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNY 299
             Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +   K      
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 300 TEFK--FPQIKAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
             F     +     W +      Q  + PEA+D + +LL+Y    R TA EA+ HP+F  
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325

Query: 354 LRDP 357
           +   
Sbjct: 326 VVKD 329

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  287 bits (738), Expect = 1e-95
 Identities = 101/329 (30%), Positives = 171/329 (51%), Gaps = 36/329 (10%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLD 116
           +Y+    +G G++  V++ K   T   VA+K++    R ++         RE+  ++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           H N+V+L         +  L L  V EY+ + + + +         + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLL 110

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYY 233
           R LAY H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 290
           R P+++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            I      +  + +P+ +A         R+  +  DL+++LLQ+    R +A +A+ HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 351 FDELRDPNTRLPNGRFLPPLFNFKPHELK 379
           F  L +   +LP+      +F  K  +L+
Sbjct: 285 FLSLGERIHKLPD---TTSIFALKEIQLQ 310

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  284 bits (729), Expect = 7e-94
 Identities = 106/300 (35%), Positives = 154/300 (51%), Gaps = 31/300 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 123
           +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
              F     K  + L  V +++   +  +IK     S  +   ++K Y     + L Y+H
Sbjct: 78  LDAF---GHKSNISL--VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 240
               + HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 297
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
           +Y    F      P H IF      + +DL+  L  ++P  R TA +AL   +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  283 bits (726), Expect = 4e-93
 Identities = 99/305 (32%), Positives = 160/305 (52%), Gaps = 26/305 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + VG G++G V  A    TG  VAIKK+          +   REL+ ++ + H NV
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 121 VSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           + L   F    +  +  + YL  V+ ++   + +++K      +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 236
            L YIH   G+ HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIH-AAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 295
           E+I     YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 296 NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           +     +    P+++   +  I      P AV+L+ ++L      R TA EAL HP+F+ 
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

Query: 354 LRDPN 358
           L D  
Sbjct: 314 LHDTE 318

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  283 bits (725), Expect = 4e-93
 Identities = 105/337 (31%), Positives = 170/337 (50%), Gaps = 32/337 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y++   VG G++G V  A    +GE VAIKK+          +   REL  ++ + H NV
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 121 VSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           + L   F   +      + YL  V+ ++   + +++        +     ++   YQ+ +
Sbjct: 86  IGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 236
            L YIH+  GV HRD+KP NL VN     LK+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYRAP 192

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 295
           E+I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E ++ + 
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252

Query: 296 NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
           +     +    PQ     + ++F  R  P+A DL+ ++L+   + R TA +AL HPFF+ 
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311

Query: 354 LRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
            RDP             F+    E + + VD   + I
Sbjct: 312 FRDPE-EETE---AQQPFDD-SLEHEKLTVDEWKQHI 343

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  279 bits (715), Expect = 3e-92
 Identities = 102/294 (34%), Positives = 165/294 (56%), Gaps = 27/294 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           VG G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 +  L L  V E++ + + +V+         +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            + HRD+KPQNLL+N     LKL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 300
           +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           +  F   +  PW  I       E +DL+S +L + PN R +A +A+ HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  278 bits (714), Expect = 8e-92
 Identities = 89/298 (29%), Positives = 155/298 (52%), Gaps = 30/298 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G V++A    T E VAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                    L+L  + EY    + + +  +  +S R+    +K + YQ+   + + H+  
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDKNPDVSMRV----IKSFLYQLINGVNFCHSR- 151

Query: 187 GVCHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
              HRD+KPQNLL++         LK+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 296
            G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           P++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A  AL HP+F   
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  278 bits (714), Expect = 3e-91
 Identities = 102/307 (33%), Positives = 163/307 (53%), Gaps = 30/307 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y     VG G++G V  A   +TG  VA+KK+ +        KR Y  REL+ ++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 119 NVVSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           NV+ L   F      +   ++YL  V   +   ++ ++K      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYR 234
            R L YIH+   + HRD+KP NL VN    +LK+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 295 M-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           + + +   +     Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

Query: 352 DELRDPN 358
            +  DP+
Sbjct: 316 AQYHDPD 322

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  275 bits (705), Expect = 5e-91
 Identities = 100/294 (34%), Positives = 159/294 (54%), Gaps = 28/294 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 K  L L  V E++ + + +++         +  +  K +  Q+   +AY H+  
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 300
           +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           +  F   +  PW     K +    +DL+S++L+  PN R TA +AL H +F E 
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  273 bits (701), Expect = 3e-89
 Identities = 102/373 (27%), Positives = 182/373 (48%), Gaps = 65/373 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL---QD----KR-YKNRELQTMRLL-DH 117
           Y   + +G G++G+V+++    TGE VA+KK+    Q+    +R +  RE+  +  L  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            N+V+L +   +  ++D +YL  V +Y+   +H VI+     +  +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----------- 226
            + Y+H + G+ HRD+KP N+L+N   H +K+ DFG ++  V      +           
Sbjct: 121 VIKYLH-SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 227 -----------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 276 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMP----------- 321
           QL  II V+  P+ E+++ + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 322 ----PEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHE 377
                EA+DL+ +LLQ++PN R +A +AL HPF     +PN           +     ++
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN----EEPNCDHIITIPIND 354

Query: 378 LKGVPVDMLVKLI 390
                +D    L+
Sbjct: 355 NVKHSIDDYRNLV 367

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  271 bits (695), Expect = 3e-89
 Identities = 93/306 (30%), Positives = 157/306 (51%), Gaps = 36/306 (11%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 123
           +G+G++  V++     TG  VA+K+V    +  +         RE+  M+ L H N+V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH--YKMSQRMPLIYVKLYFYQICRALAY 181
                    +++L L  V E++   + + +         + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 238
            H    + HRD+KPQNLL+N    QLKL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 295
           + G+  Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 296 NPNYTEFKFPQIKAHPWHKIFQK----RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            P Y      Q       ++ Q      +    +D +  LLQ +P++R +A +AL HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 352 DELRDP 357
            E    
Sbjct: 298 AEYYHH 303

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  270 bits (693), Expect = 4e-89
 Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 28/298 (9%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 126
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                   +L L  V E+  + + +        +  +    VK + +Q+ + L + H+  
Sbjct: 70  L---HSDKKLTL--VFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 243
            V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 244 EYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 299
            Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
             +            +   ++     DL+  LL+ +P  R +A EAL HP+F +   P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  274 bits (703), Expect = 2e-88
 Identities = 99/348 (28%), Positives = 168/348 (48%), Gaps = 41/348 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y   + +G G+ G+V  A        VAIKK+ +        KR Y  REL  M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 119 NVVSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           N++SL + F    +  E  ++YL  V+E +   + +VI+        +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQ------MELDHERMSYLLYQM 173

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
              + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 296 NPNYTEF--KFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYSPNLRSTA 342
            P    +    P+     + K+F            K    +A DL+S++L   P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 343 LEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
            +AL HP+ +   DP          P +++ +  + +   ++   +LI
Sbjct: 351 DDALQHPYINVWYDPAEVEA---PPPQIYDKQ-LDEREHTIEEWKELI 394

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  271 bits (694), Expect = 2e-88
 Identities = 95/346 (27%), Positives = 162/346 (46%), Gaps = 37/346 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+          +   REL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 121 VSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           + L + F    S  E  ++Y+  V+E +   + +VI+        +    +    YQ+  
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQ------MELDHERMSYLLYQMLC 138

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +RYYRAPE
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P
Sbjct: 197 VILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255

Query: 298 NYTEF--KFPQIKAHPWHKIFQKRMP-----------PEAVDLVSRLLQYSPNLRSTALE 344
               +    P+   + + K+F   +             +A DL+S++L    + R +  E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315

Query: 345 ALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
           AL HP+ +   DP+          P       + +   ++   +LI
Sbjct: 316 ALQHPYINVWYDPS-EAEAPPPKIPDKQL---DEREHTIEEWKELI 357

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  273 bits (700), Expect = 4e-88
 Identities = 108/396 (27%), Positives = 164/396 (41%), Gaps = 87/396 (21%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KR-YKNRELQTMRLLDHP 118
           Y    ++G GS+G V +A        VAIKK+L+        KR    RE+  +  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 119 NVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           +VV +         +  DELY  +VLE       ++ +        +  +++K   Y + 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLL 166

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------- 226
             + Y+H + G+ HRD+KP N LVN     +K+CDFG A+ +   E   S          
Sbjct: 167 VGVKYVH-SAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 227 ------------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL----- 263
                             ++ +R+YRAPELI     YT AID+WS GC+ AELL      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 264 ------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM-N 296
                   PLFPG S                      DQL  I  +LGTP+ E+I+ +  
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344

Query: 297 PNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
            +   +   FP+ +     + F      +A+ L+ R+L ++PN R T  E L HPFF E+
Sbjct: 345 EDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 390
           R       N            ++   +    L    
Sbjct: 404 RIAE-VETN---ATEKVRLPFNDWMNMDEPQLRYAF 435

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  271 bits (695), Expect = 1e-87
 Identities = 101/388 (26%), Positives = 163/388 (42%), Gaps = 79/388 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQD-KR-YKNRELQTMRLLDHP 118
           Y+ + ++G GS+G V+ A    T + VAIKKV      L D KR    RE+  +  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 119 NVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            ++ L             ELY+  VLE     + ++ K    +++     ++K   Y + 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTE----EHIKTILYNLL 139

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------- 226
               +IH   G+ HRD+KP N L+N     +K+CDFG A+ +   +              
Sbjct: 140 LGENFIH-ESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 227 -------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-------- 265
                        ++ +R+YRAPELI     YT +IDIWS GC+ AELL           
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 266 ---PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 302
              PLFPG S                   DQL  I  ++GTPT +++K +  P   ++  
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
            FP  K     + +   +  + ++L+  +L+++PN R T  +AL HP+  ++R       
Sbjct: 318 LFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK-LEN 375

Query: 363 NGRFLPPLFNFKPHELKGVPVDMLVKLI 390
              F          +   +    L  + 
Sbjct: 376 ---FSTKKIILPFDDWMVLSETQLRYIF 400

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  266 bits (683), Expect = 7e-87
 Identities = 90/325 (27%), Positives = 146/325 (44%), Gaps = 28/325 (8%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK-- 124
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 125 -HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                S   + +  + LV ++     H +      +  +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNISY---ICSRYYRAPEL 238
               + HRD+K  N+L+      LKL DFG A+   L K      Y   + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 295
           + G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E    +   
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259

Query: 296 NPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
              Y + +  + +        +     P A+DL+ +LL   P  R  + +AL H FF   
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS- 317

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELK 379
            DP       + +         E  
Sbjct: 318 -DPMPSDL--KGMLSTHLTSMFEYL 339

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  264 bits (677), Expect = 1e-86
 Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 32/304 (10%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RE---LQTMRLLDHPNV 120
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L     ++    E+ + LV E+V + +   +         +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLD 134

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 237
           ++H    + HRD+KP+N+LV      +KL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 298 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                    FP     P   +    M      L+  +L ++P+ R +A  AL H +  + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

Query: 355 RDPN 358
            + N
Sbjct: 304 -EGN 306

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  262 bits (673), Expect = 9e-86
 Identities = 97/324 (29%), Positives = 153/324 (47%), Gaps = 37/324 (11%)

Query: 73  VGHGSFGVVFQAK-CLETGEAVAIKKVLQDKRYKN-------RE---LQTMRLLDHPNVV 121
           +G G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNVV
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L      +    E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDF 135

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 238
           +H+   V HRD+KPQN+LV   + Q+KL DFG A++       ++    + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVVVTLWYRAPEV 190

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+     P 
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245

Query: 299 YTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
                   F    A P  K     +     DL+ + L ++P  R +A  AL HP+F +L 
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304

Query: 356 DPNTRLPNGRFLPPLFNFKP-HEL 378
                L        L   +   EL
Sbjct: 305 RCKENLD-----SHLPPSQNTSEL 323

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  249 bits (638), Expect = 2e-79
 Identities = 96/343 (27%), Positives = 154/343 (44%), Gaps = 46/343 (13%)

Query: 73  VGHGSFGVVFQAKCLE--TGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 128
           VG G++G V++AK  +    +  A+K++       +  RE+  +R L HPNV+SL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 129 STTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLIYVKLYFYQICRALAYIH 183
           S  ++    + L+ +Y    +  +IK H      K   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 184 NTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNISY------ICSRYYR 234
               V HRD+KP N+LV    P   ++K+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---------GVDQLVEIIKVLG 285
           APEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 286 TPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 336
            P  +         E   +  ++    +       + +  + +   +A  L+ +LL   P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 337 NLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELK 379
             R T+ +A+  P+F E  DP        F      +   E  
Sbjct: 323 IKRITSEQAMQDPYFLE--DPLPTSD--VFAGCQIPYPKREFL 361

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  207 bits (528), Expect = 7e-63
 Identities = 91/330 (27%), Positives = 150/330 (45%), Gaps = 57/330 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL------DH 117
           Y   +V+G GSFG V +A   +  + VA+K V  +KR+      E++ +  L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 118 PNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
            NV+ +   F         + N   +  E +   ++ +IK +    Q   L  V+ + + 
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHS 208

Query: 175 ICRALAYIHNTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           I + L  +H    + H D+KP+N LL       +K+ DFGS+      +   +YI SR+Y
Sbjct: 209 ILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           RAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P+++ + 
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 294 -----------CMNPNYTEFKF---------------PQIKAHPWHKIFQKRMPPEA--- 324
                         P Y                     +++  P  + +   +       
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 325 -VDLVSRLLQYSPNLRSTALEALIHPFFDE 353
            +D + + L++ P +R T  +AL HP+   
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  200 bits (510), Expect = 1e-60
 Identities = 94/339 (27%), Positives = 149/339 (43%), Gaps = 62/339 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL------DH 117
           Y  + ++G GSFG V +A      E VAIK +   K + N    E++ + L+        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 118 PNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
             +V LK  F         + N   LV E +   ++ ++++     + + L   + +  Q
Sbjct: 116 YYIVHLKRHFM--------FRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165

Query: 175 ICRALAYIH-NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           +C AL ++    + + H D+KP+N LL NP    +K+ DFGS+     G+    YI SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF 223

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG P    +
Sbjct: 224 YRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282

Query: 293 K-----------CMNPNYTEFKFPQIKAH---PWHKIFQ-----KRMPPEA--------- 324
                         +  +   K    K     P  +        +   P           
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342

Query: 325 -------VDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
                   DL+ R+L Y P  R     AL H FF +  D
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  197 bits (504), Expect = 1e-60
 Identities = 67/319 (21%), Positives = 118/319 (36%), Gaps = 60/319 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHPN- 119
           Y   + +G G    VFQ    E  +  AIK V      ++   +   E+  +  L   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 120 -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 89  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 235
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 236 PELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           PE I             ++ +   D+WS GC+L  +  G+  F         +  I    
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 252

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
                    ++PN+ E +FP I               +  D++   L+  P  R +  E 
Sbjct: 253 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 290

Query: 346 LIHPFFDELRDPNTRLPNG 364
           L HP+      P  ++  G
Sbjct: 291 LAHPYVQIQTHPVNQMAKG 309

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  197 bits (503), Expect = 2e-60
 Identities = 69/301 (22%), Positives = 108/301 (35%), Gaps = 65/301 (21%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL----DHP 118
           S+     +GHGS+G VF+ +  E G   A+K+     +  + + R+L  +        HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             V L+  +    E   LY  L  E    ++ +  +        +P   V  Y      A
Sbjct: 118 CCVRLEQAWE---EGGILY--LQTELCGPSLQQHCE---AWGASLPEAQVWGYLRDTLLA 169

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           LA++H+  G+ H D+KP N+ + P     KL DFG    L              Y APEL
Sbjct: 170 LAHLHSQ-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     Y  A D++S G  + E+     L  G                            
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHG---------------------------- 257

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPP--------EAVDLVSRLLQYSPNLRSTALEALIHPF 350
                        W ++ Q  +PP        E   ++  +L+  P LR+TA   L  P 
Sbjct: 258 ----------GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307

Query: 351 F 351
            
Sbjct: 308 L 308

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  196 bits (501), Expect = 8e-60
 Identities = 67/319 (21%), Positives = 117/319 (36%), Gaps = 60/319 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN- 119
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 120 -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 235
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 236 PELIFG----------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           PE I             ++ +   D+WS GC+L  +  G+  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
                    ++PN+ E +FP I               +  D++   L+  P  R +  E 
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 346 LIHPFFDELRDPNTRLPNG 364
           L HP+      P  ++  G
Sbjct: 272 LAHPYVQIQTHPVNQMAKG 290

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  197 bits (502), Expect = 1e-59
 Identities = 84/336 (25%), Positives = 143/336 (42%), Gaps = 42/336 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL-----DHP 118
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 119 NVVSLKHC-----FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
           + +   H       F+    + +++ +V E + E +  +IK +    + +PLIYVK    
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISK 138

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNISYI 228
           Q+   L Y+H   G+ H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIK 282
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 283 VLGTPTREEI-------KCMNPNYTEFKFPQIKAHPWHKIFQKRMP------PEAVDLVS 329
           +LG      +          N         ++K  P   +  ++         E  D +S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 330 RLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR 365
            +LQ  P  R+ A   + HP+  +           R
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 351

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  196 bits (501), Expect = 2e-59
 Identities = 67/319 (21%), Positives = 117/319 (36%), Gaps = 60/319 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPN- 119
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 120 -VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            ++ L           + Y+ +V+E     ++  +K      + +     K Y+  +  A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRA 235
           +  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S + +  Y  
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 236 PELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 285
           PE I             ++ +   D+WS GC+L  +  G+  F         +  I    
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 280

Query: 286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 345
                    ++PN+ E +FP I               +  D++   L+  P  R +  E 
Sbjct: 281 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 318

Query: 346 LIHPFFDELRDPNTRLPNG 364
           L HP+      P  ++  G
Sbjct: 319 LAHPYVQIQTHPVNQMAKG 337

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  194 bits (494), Expect = 4e-59
 Identities = 72/330 (21%), Positives = 111/330 (33%), Gaps = 56/330 (16%)

Query: 51  VTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKN 106
           +  I  K+        Y+  + +G G F  V   + L  G   A+K++L    QD+    
Sbjct: 23  MVIIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74

Query: 107 RELQTMRLLDHPNVVSLKHCFF-STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMP 164
           RE    RL +HPN++ L          K E +  L+L +    T+   I+        + 
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--- 221
              +      ICR L  IH   G  HRD+KP N+L+     Q  L D GS          
Sbjct: 133 EDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEG 190

Query: 222 -------EPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
                  +   +  C+  YRAPEL             D+WS GCVL  ++ G+  +    
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 332
                V +  V                 +   PQ            R       L++ ++
Sbjct: 251 QKGDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMM 284

Query: 333 QYSPNLRSTALEALIHPFFDELRDPNTRLP 362
              P+ R      L      +   P     
Sbjct: 285 TVDPHQRPHIPLLLSQLEALQPPAPGQHTT 314

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  194 bits (494), Expect = 1e-58
 Identities = 77/338 (22%), Positives = 141/338 (41%), Gaps = 66/338 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLL-----DHP 118
           ++  R +G G+FG V   + ++  +  A+K V   K+Y      E   ++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 119 NVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           N+V     F        +Y +   L+ E +  +++ +I  +        +  +KLY  +I
Sbjct: 97  NIVKYHGKF--------MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEI 146

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVN------------------------PHTHQLKLCD 211
            +AL Y+   + + H D+KP+N+L++                          +  +KL D
Sbjct: 147 LKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 271
           FG A    K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  G  LF   
Sbjct: 206 FGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 272 SGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQIKAHPWHKIFQKRMPP 322
             ++ L  +  ++    +  +         K +N +  +  +P+  +        K+  P
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 323 EA--------VDLVSRLLQYSPNLRSTALEALIHPFFD 352
                      D +  +LQ  P LR +  E L H F +
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  196 bits (499), Expect = 1e-58
 Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 51/301 (16%)

Query: 65  ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 122
           IS+  + V+GHG+ G +   + +     VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
                   TEKD  +  + +E    T+   + +  +      P+  ++    Q    LA+
Sbjct: 83  YFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 182 IHNTIGVCHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNISY---IC-SRYY 233
           +H+ + + HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 234 RAPELIFGATE--YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 290
            APE++    +   T  +DI+SAGCV   ++  G   F                G   + 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQR 236

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +   +               P            A +L+ +++   P  R +A   L HPF
Sbjct: 237 QANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

Query: 351 F 351
           F
Sbjct: 287 F 287

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  190 bits (486), Expect = 1e-57
 Identities = 82/337 (24%), Positives = 136/337 (40%), Gaps = 60/337 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKN---RELQTMRLL------D 116
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q +  L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 117 HPNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
               V +   F         +     +V E +  + +  IK +        L +++   Y
Sbjct: 76  TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENGF--LPFRLDHIRKMAY 125

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVN------------------PHTHQLKLCDFGSA 215
           QIC+++ ++H+   + H D+KP+N+L                         +K+ DFGSA
Sbjct: 126 QICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
                 E + + + +R+YRAPE+I     ++   D+WS GC+L E  LG  +FP     +
Sbjct: 185 --TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241

Query: 276 QLVEIIKVLGTPTREEI-KCMNPNY-TEFKFPQIKAHPWHKIFQKRMPP----------- 322
            L  + ++LG   +  I K     Y    +    +     +   +   P           
Sbjct: 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301

Query: 323 --EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
                DL+ ++L+Y P  R T  EAL HPFFD L+  
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  191 bits (487), Expect = 1e-57
 Identities = 79/345 (22%), Positives = 131/345 (37%), Gaps = 60/345 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDKRYKN---RELQTMRLL------D 116
           Y     +G G+FG V +      G   VA+K +    +Y+     E+  ++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 117 HPNVVSLKHCFFSTTEKDELYLN---LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
               V +   F         +     +  E + +     +K +    Q  PL +V+   Y
Sbjct: 81  KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHVRHMAY 130

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVN------------------PHTHQLKLCDFGSA 215
           Q+C AL ++H    + H D+KP+N+L                         +++ DFGSA
Sbjct: 131 QLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
                 E + + + +R+YR PE+I     +    D+WS GC+L E   G  LF      +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

Query: 276 QLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKAHPWHKIFQKRMPPEA-- 324
            LV + K+LG      I               + E            K  +  M  ++  
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306

Query: 325 ----VDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR 365
                DL+ R+L++ P  R T  EAL+HPFF  L          R
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSR 351

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  187 bits (477), Expect = 5e-57
 Identities = 73/299 (24%), Positives = 115/299 (38%), Gaps = 45/299 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V          ++    L +V+EY     +  VI    K  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 180 AYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
              H        V HRD+KP N+ ++     +KL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE +     Y    DIWS GC+L EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
                 E KF +I               E  ++++R+L      R +  E L +P   E
Sbjct: 230 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  190 bits (485), Expect = 1e-56
 Identities = 76/314 (24%), Positives = 137/314 (43%), Gaps = 60/314 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMR-LLDHPNVVSLK 124
            ++E+++G+GS G V   +    G  VA+K++L D       E++ +    DHPNV+   
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---VKLYFYQICRALAY 181
                 +E  + +L + LE     +  +++      + + L           QI   +A+
Sbjct: 76  C-----SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVLVKGE----PNI 225
           +H+ + + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     N+
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 226 SYIC-SRYYRAPELIFGATE------YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 277
           +    +  +RAPEL+  +         T +IDI+S GCV   +L  G+  F  +    + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247

Query: 278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 337
             II+                   F   ++K      +       EA DL+S+++ + P 
Sbjct: 248 SNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285

Query: 338 LRSTALEALIHPFF 351
            R TA++ L HP F
Sbjct: 286 KRPTAMKVLRHPLF 299

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  186 bits (474), Expect = 3e-56
 Identities = 55/302 (18%), Positives = 108/302 (35%), Gaps = 23/302 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      TT      L  ++E+ P       + +     +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 180 AYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 237 ELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           ++   A        +Y A +D+WS G        G   F    G  +  E++  + T   
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                                P      + +      +++ +L+          +     
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

Query: 350 FF 351
             
Sbjct: 305 SD 306

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  187 bits (477), Expect = 5e-56
 Identities = 48/333 (14%), Positives = 92/333 (27%), Gaps = 57/333 (17%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQTMRLLDHP 118
                  +  G   VVF  + +E  E  A+K                +        L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 119 NVVSLKHCFFSTTEKDELYLN---------------------LVLEYVP---ETVHRVIK 154
           +    +         D + +                      L++       E +   + 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 155 HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS 214
             Y       ++ + +   Q+ R  A + +  G+ H    P NL + P    L L D  +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LMLGDVSA 240

Query: 215 AKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
              +  G    +      Y   E +      +T A++ W  G  +  +      F   + 
Sbjct: 241 LWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 333
             +       L  P  +                             +P     L+ R L 
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338

Query: 334 YSPNLRSTALEALIHPFFDELRD-PNTRLPNGR 365
           +    R   LEA+  P F +L++  ++ L  G+
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  190 bits (485), Expect = 5e-56
 Identities = 75/317 (23%), Positives = 128/317 (40%), Gaps = 50/317 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 120
           Y   + +G G++G V   +   T    AIK +               E+  ++LLDHPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           + L   F     +D+    LV+E     E    +I    +  ++        +   Q+  
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKF--NEV----DAAVIIKQVLS 147

Query: 178 ALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+N LL +      +K+ DFG + V    +     + + YY A
Sbjct: 148 GVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++    +Y    D+WS G +L  LL G P F G++  DQ  EI+         +++  
Sbjct: 207 PEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEKG 252

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
              +            W  +        A DL+ ++LQ+    R +A +AL HP+  E+ 
Sbjct: 253 KYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299

Query: 356 DPNTRLPNGRFLPPLFN 372
                      L     
Sbjct: 300 SKKESGIELPSLANAIE 316

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  190 bits (484), Expect = 8e-56
 Identities = 78/317 (24%), Positives = 132/317 (41%), Gaps = 50/317 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 120
           Y    ++G GSFG V + K   T +  A+K +       +D     RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           + L         +D     +V E     E    +IK   +  S+            Q+  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEH----DAARIIKQVFS 132

Query: 178 ALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+N LL +      +K+ DFG +    +       I + YY A
Sbjct: 133 GITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WSAG +L  LL G P F G++  +   +I+        + ++  
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVETG 237

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
              +            W  I       +A DL+ ++L + P+LR TA + L HP+  +  
Sbjct: 238 KYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284

Query: 356 DPNTRLPNGRFLPPLFN 372
                + +   L     
Sbjct: 285 SETPTISDLPSLESAMT 301

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  189 bits (483), Expect = 1e-55
 Identities = 81/297 (27%), Positives = 133/297 (44%), Gaps = 51/297 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKN---RELQTMRLLDHPN 119
           Y  +RV+G GSFG V   K   TG+  A+K +    ++ K  K    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQIC 176
           ++ L   F     +D+ Y  LV E     E    +I    +  S+            Q+ 
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRF--SEV----DAARIIRQVL 136

Query: 177 RALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYR 234
             + Y+H    + HRD+KP+N LL +      +++ DFG +      +     I + YY 
Sbjct: 137 SGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++ G   Y    D+WS G +L  LL G P F G +  +   +I+        ++++ 
Sbjct: 196 APEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEK 241

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               +            W K+        A DL+ ++L Y P++R +A +AL H + 
Sbjct: 242 GKYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  183 bits (467), Expect = 3e-55
 Identities = 72/312 (23%), Positives = 118/312 (37%), Gaps = 59/312 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 123
           +    V+G G+FG V +A+        AIKK+   +   +    E+  +  L+H  VV  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 124 KHCF--------FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
              +          T  K +  L + +EY    T++ +I       QR         F Q
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRLFRQ 124

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 231
           I  AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK + +    +         
Sbjct: 125 ILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 232 ------------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
                        Y A E++ G   Y   ID++S G +  E++   P   G       V 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236

Query: 280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           I+K L +                +FP     P    F          ++  L+ + PN R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275

Query: 340 STALEALIHPFF 351
             A   L   + 
Sbjct: 276 PGARTLLNSGWL 287

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  187 bits (477), Expect = 1e-54
 Identities = 79/307 (25%), Positives = 127/307 (41%), Gaps = 61/307 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------------REL 109
           Y   R +G G++G V   K        AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLI 166
             ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I    +   +     
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKF--DEC---- 146

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPN 224
                  QI   + Y+H    + HRDIKP+N LL N ++   +K+ DFG +    K    
Sbjct: 147 DAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205

Query: 225 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              + + YY APE++    +Y    D+WS G ++  LL G P F G++  DQ  +II   
Sbjct: 206 RDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII--- 256

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
                ++++     +          + W  I       EA +L+  +L Y  N R TA E
Sbjct: 257 -----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEE 298

Query: 345 ALIHPFF 351
           AL   + 
Sbjct: 299 ALNSRWI 305

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  182 bits (463), Expect = 1e-54
 Identities = 81/302 (26%), Positives = 122/302 (40%), Gaps = 60/302 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPN 119
           +  E+ +G G F  V++A CL  G  VA+KKV        + +    +E+  ++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V+     F    E +EL   +VLE      + R+IKH  K  + +P   V  YF Q+C A
Sbjct: 94  VIKYYASFI---EDNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEPNISYIC 229
           L ++H+   V HRDIKP N+ +   T  +KL D G  +           + G P      
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPT 288
             YY +PE I     Y    DIWS GC+L E+   Q  F G+   +  L + I+      
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
                       +  +P +               E   LV+  +   P  R         
Sbjct: 252 ------------QCDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 349 PF 350
             
Sbjct: 292 AK 293

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  180 bits (460), Expect = 2e-54
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 42/300 (14%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
            V+G G++G+V+  + L     +AIK++  +D RY      E+   + L H N+V     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHN 184
            +  +  +  ++ + +E VP  ++  +++  +  +      I    Y  QI   L Y+H+
Sbjct: 84  -YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 243
              + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++  +  Y APE+I    
Sbjct: 141 N-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 244 E-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y  A DIWS GC + E+  G+P F       +L E    +                 F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------F 236

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLP 362
           K    K HP      + M  EA   + +  +  P+ R+ A + L+  F           P
Sbjct: 237 KVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  182 bits (463), Expect = 3e-54
 Identities = 76/313 (24%), Positives = 121/313 (38%), Gaps = 47/313 (15%)

Query: 48  HIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQ 100
           H       G      Q++  Y+  + +G GSFG     K  E G    IK++       +
Sbjct: 6   HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 101 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKM 159
           ++    RE+  +  + HPN+V  +  F    E   LY  +V++Y     + + I      
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINAQKG- 119

Query: 160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 219
                   +  +F QIC AL ++H+   + HRDIK QN+ +      ++L DFG A+VL 
Sbjct: 120 -VLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN 176

Query: 220 KGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
                      + YY +PE+      Y    DIW+ GCVL EL   +  F   S +  LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
             I             ++ +Y                       +   LVS+L + +P  
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267

Query: 339 RSTALEALIHPFF 351
           R +    L   F 
Sbjct: 268 RPSVNSILEKGFI 280

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  180 bits (459), Expect = 4e-54
 Identities = 82/332 (24%), Positives = 126/332 (37%), Gaps = 66/332 (19%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN---RELQTMR 113
           P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 172
            L H +VV     F      D +++  VLE     ++  + K      + +     + Y 
Sbjct: 71  SLAHQHVVGFHGFFED---NDFVFV--VLELCRRRSLLELHKRR----KALTEPEARYYL 121

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------P 223
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE        P
Sbjct: 122 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           N        Y APE++     ++  +D+WS GC++  LL+G+P F      +  + I K 
Sbjct: 180 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230

Query: 284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 343
                            E+  P              + P A  L+ ++LQ  P  R T  
Sbjct: 231 -----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 261

Query: 344 EALIHPFFDELRDPNTRLPNGRFLPPLFNFKP 375
           E L   FF     P         +PP F+  P
Sbjct: 262 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 293

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  179 bits (457), Expect = 6e-54
 Identities = 63/297 (21%), Positives = 110/297 (37%), Gaps = 50/297 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 126
           +    ++G G FG VF+AK    G+   IK+V  +     RE++ +  LDH N+V    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 127 FFSTTEKDEL-----------YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           +       E             L + +E+  + T+ + I+   +  +++  +     F Q
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQ 130

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           I + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           +  Y 
Sbjct: 131 ITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE I    +Y   +D+++ G +LAELL                ++              
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                               I       +   L+ +LL   P  R    E L     
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  178 bits (454), Expect = 1e-53
 Identities = 86/306 (28%), Positives = 133/306 (43%), Gaps = 50/306 (16%)

Query: 59  GQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTM 112
           G  K  I+  Y  E  +G GS+G V  A    T    A K      ++D     +E++ M
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVK 169
           + LDHPN++ L   F     +D   + LV+E     E   RV+    +   +        
Sbjct: 61  KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVF--RES----DAA 109

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 227
                +  A+AY H  + V HRD+KP+N L    +    LKL DFG A     G+   + 
Sbjct: 110 RIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168

Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           + + YY +P+++ G   Y    D WSAG ++  LL G P F   +  + +++I +     
Sbjct: 169 VGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG---- 222

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
                         F FP      W  +      P+A  L+ RLL  SP  R T+L+AL 
Sbjct: 223 -------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALE 261

Query: 348 HPFFDE 353
           H +F++
Sbjct: 262 HEWFEK 267

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  178 bits (453), Expect = 2e-53
 Identities = 74/320 (23%), Positives = 138/320 (43%), Gaps = 66/320 (20%)

Query: 59  GQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQ 110
               + I  +    ++G GSF  V++A+ + TG  VAIK + +   YK         E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 169
               L HP+++ L + F      + +Y  LVLE      ++R +K+  K          +
Sbjct: 64  IHCQLKHPSILELYNYFED---SNYVY--LVLEMCHNGEMNRYLKNRVK---PFSENEAR 115

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE------ 222
            + +QI   + Y+H+  G+ HRD+   NLL+  +   +K+ DFG + ++ +  E      
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC 173

Query: 223 --PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
             PN        Y +PE+    + +    D+WS GC+   LL+G+P F  ++  + L ++
Sbjct: 174 GTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224

Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 340
           +                   +++ P      +       +  EA DL+ +LL+ +P  R 
Sbjct: 225 VLA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRL 255

Query: 341 TALEALIHPFFDELRDPNTR 360
           +    L HPF        ++
Sbjct: 256 SLSSVLDHPFMSRNSSTKSK 275

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  177 bits (452), Expect = 3e-53
 Identities = 67/318 (21%), Positives = 120/318 (37%), Gaps = 60/318 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNRELQTMRLLDHPNVV 121
           +   + +G G FGVVF+AK        AIK++        +    RE++ +  L+HP +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 122 SLKHCFF-------STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 173
              + +              ++YL + ++    E +   +       +          F 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFL 125

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 231
           QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 232 -----------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 280
                       Y +PE I G   Y+  +DI+S G +L ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 340
           ++                    KFP +              P    +V  +L  SP  R 
Sbjct: 240 VR------------------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERP 272

Query: 341 TALEALIHPFFDELRDPN 358
            A+  + +  F++L  P 
Sbjct: 273 EAINIIENAVFEDLDFPG 290

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  179 bits (455), Expect = 4e-53
 Identities = 82/332 (24%), Positives = 126/332 (37%), Gaps = 66/332 (19%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN---RELQTMR 113
           P+    Y+  R +G G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 172
            L H +VV     F      D +++  VLE     ++  + K      + +     + Y 
Sbjct: 97  SLAHQHVVGFHGFFED---NDFVFV--VLELCRRRSLLELHKRR----KALTEPEARYYL 147

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE--------P 223
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE        P
Sbjct: 148 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 205

Query: 224 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
           N        Y APE++     ++  +D+WS GC++  LL+G+P F      +  + I K 
Sbjct: 206 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256

Query: 284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 343
                            E+  P              + P A  L+ ++LQ  P  R T  
Sbjct: 257 -----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 287

Query: 344 EALIHPFFDELRDPNTRLPNGRFLPPLFNFKP 375
           E L   FF     P         +PP F+  P
Sbjct: 288 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 319

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  179 bits (455), Expect = 5e-53
 Identities = 87/348 (25%), Positives = 137/348 (39%), Gaps = 84/348 (24%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL---------QDKRYKNRELQTMRLLDH 117
           Y  +  +G GS+GVV  A   +T    AIK +          +D      E++ M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL----- 170
           PN+  L   +     +DE Y+ LV+E       + ++       + +  +  VK      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 171 ------------------------------YFYQICRALAYIHNTIGVCHRDIKPQN-LL 199
                                            QI  AL Y+HN  G+CHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLF 201

Query: 200 VNPHTHQLKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE-YTAAIDIWS 253
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 254 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 313
           AG +L  LL+G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 314 KIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 361
            +      P A DL+S LL  + + R  A+ AL HP+  +  D   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  180 bits (459), Expect = 7e-53
 Identities = 81/306 (26%), Positives = 141/306 (46%), Gaps = 56/306 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------------RELQTMRL 114
           Y+  + +G G+ G V  A   +T + VAI+ + + K                 E++ ++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 172
           L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       KLYF
Sbjct: 197 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEAT----CKLYF 245

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC- 229
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 246 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303

Query: 230 SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  Y APE++       Y  A+D WS G +L   L G P F        L + I   G  
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
                        ++ F       W ++       +A+DLV +LL   P  R T  EAL 
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399

Query: 348 HPFFDE 353
           HP+  +
Sbjct: 400 HPWLQD 405

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  176 bits (449), Expect = 8e-53
 Identities = 79/320 (24%), Positives = 135/320 (42%), Gaps = 52/320 (16%)

Query: 48  HIIVTTIGGKNGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQ 100
           H    + G +N   + TI   ++ +R +G G+FG V   +   +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 101 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYK 158
                  E++ ++ LDHPN++ +   F     +D   + +V+E     E + R++    +
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 159 M---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFG 213
               S+     YV     Q+  ALAY H+   V H+D+KP+N+L    +    +K+ DFG
Sbjct: 118 GKALSEG----YVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFG 172

Query: 214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 273
            A++    E + +   +  Y APE+     + T   DIWSAG V+  LL G   F G S 
Sbjct: 173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230

Query: 274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 333
            +   +                     E  +               + P+AVDL+ ++L 
Sbjct: 231 EEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQMLT 264

Query: 334 YSPNLRSTALEALIHPFFDE 353
             P  R +A + L H +F +
Sbjct: 265 KDPERRPSAAQVLHHEWFKQ 284

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  179 bits (456), Expect = 8e-53
 Identities = 80/316 (25%), Positives = 129/316 (40%), Gaps = 44/316 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG     K        DK     E+  M  L HP +++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   F     +D+  + L+LE++   E   R+    YKMS+   + Y++    Q C  L 
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163

Query: 181 YIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           ++H    + H DIKP+N++        +K+ DFG A  L   E       +  + APE I
Sbjct: 164 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                     D+W+ G +   LL G   F GE  ++ L  + +                 
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF-DELRDPN 358
            +++F       +  +      PEA D +  LLQ  P  R T  +AL HP+   +  +  
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316

Query: 359 TRLPNGRFLPPLFNFK 374
           +R+P+ R+       K
Sbjct: 317 SRIPSSRYNKIRQKIK 332

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  179 bits (455), Expect = 2e-52
 Identities = 61/313 (19%), Positives = 116/313 (37%), Gaps = 32/313 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L      TT      L  ++E+ P       + +     +  +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125

Query: 180 AYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
            ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 237 ELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTP 287
           ++   A        +Y A +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
           +               +      P      + +      +++ +L+          +   
Sbjct: 245 SGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ--- 299

Query: 348 HPFFDELRDPNTR 360
             FF E  D   R
Sbjct: 300 --FFAETSDILHR 310

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  177 bits (450), Expect = 3e-52
 Identities = 63/328 (19%), Positives = 126/328 (38%), Gaps = 52/328 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN----------------REL 109
           R +  G F  +   +  +  +  A+K      + + + +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMP 164
           Q +  + +   ++      +    DE+Y+  + EY+      +            +  +P
Sbjct: 95  QIITDIKNEYCLTC-EGIITN--YDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 165 LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 224
           +  +K     +  + +YIHN   +CHRD+KP N+L++ +   +KL DFG ++ +V  +  
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206

Query: 225 ISYIC-SRYYRAPELIFGATEY-TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 282
           I     +  +  PE     + Y  A +DIWS G  L  +      F  +  + +L   I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 342
                  + I+   P      F     +         +  E +D +   L+ +P  R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

Query: 343 LEALIHPFF-----DELRDPNTRLPNGR 365
            +AL H +      ++LR+ +  L   R
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYKKR 345

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  175 bits (447), Expect = 5e-52
 Identities = 73/290 (25%), Positives = 127/290 (43%), Gaps = 44/290 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVA---IKKVLQDKRYKNRELQTMRLLDHPNVVSL 123
           YM    +G G FG+V +     + +      +K    D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +    L ++ E++   +   R+    +++++R  + YV     Q+C AL +
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117

Query: 182 IHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
           +H+   + H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y APE +
Sbjct: 118 LHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                 + A D+WS G ++  LL G   F  E+  +Q  +II        E I      +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
            E  F +I               EA+D V RLL      R TA EAL HP
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  181 bits (462), Expect = 5e-52
 Identities = 82/317 (25%), Positives = 136/317 (42%), Gaps = 45/317 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG   A K V      DK    +E+QTM +L HP +V+
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   F     +D+  + ++ E++   E   +V   H KMS+   + Y++    Q+C+ L 
Sbjct: 219 LHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 181 YIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           ++H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+ 
Sbjct: 270 HMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G        D+WS G +   LL G   F GE+  +            T   +K  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF--DELRDP 357
            +  F  I               +  D + +LL   PN R T  +AL HP+         
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

Query: 358 NTRLPNGRFLPPLFNFK 374
           ++++P+ R+     + K
Sbjct: 423 DSQIPSSRYTKIRDSIK 439

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  174 bits (443), Expect = 6e-52
 Identities = 79/309 (25%), Positives = 125/309 (40%), Gaps = 66/309 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  ++   +A+K     ++ +        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F      D   + L+LEY P       + K       +        Y  ++  AL+Y
Sbjct: 75  YGYF-----HDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSY 124

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNISYICSRYYR 234
            H+   V HRDIKP+NLL+      LK+ DFG +            G  +        Y 
Sbjct: 125 CHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YL 174

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
            PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V           
Sbjct: 175 PPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------- 222

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                 EF FP      +       +   A DL+SRLL+++P+ R    E L HP+    
Sbjct: 223 ------EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264

Query: 355 RDPNTRLPN 363
               +   N
Sbjct: 265 SSKPSNCQN 273

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  173 bits (442), Expect = 8e-52
 Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 50/298 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y    ++G GSFG V + K   T +  A+K + +            RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           + L         +D     +V E     E    +IK   +  S+            Q+  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEHD----AARIIKQVFS 132

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
            + Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I + YY A
Sbjct: 133 GITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G   Y    D+WSAG +L  LL G P F G++  D L  +               
Sbjct: 192 PEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------- 236

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
                ++ F       W  I       +A DL+ ++L + P+LR TA + L HP+  +
Sbjct: 237 ----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  174 bits (444), Expect = 1e-51
 Identities = 81/304 (26%), Positives = 139/304 (45%), Gaps = 56/304 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKN--------RELQTMRL 114
           Y+  + +G G+ G V  A   +T + VAIK    +       +          E++ ++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 172
           L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       KLYF
Sbjct: 72  LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEA----TCKLYF 120

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC- 229
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 121 YQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 178

Query: 230 SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           +  Y APE++       Y  A+D WS G +L   L G P F        L + I   G  
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 235

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
                        ++ F       W ++       +A+DLV +LL   P  R T  EAL 
Sbjct: 236 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 274

Query: 348 HPFF 351
           HP+ 
Sbjct: 275 HPWL 278

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  173 bits (440), Expect = 2e-51
 Identities = 56/327 (17%), Positives = 100/327 (30%), Gaps = 90/327 (27%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLL----DHPN 119
           +     +G G FG VF+      G   AIK+    L     +   L+ +        H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           VV     +    E D + +    EY    ++   I  +Y++        +K    Q+ R 
Sbjct: 73  VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPH------------------THQLKLCDFGSAKVL-- 218
           L YIH+   + H DIKP N+ ++                        K+ D G    +  
Sbjct: 128 LRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 219 ---VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
               +G+          + A E++     +    DI++    +      +PL        
Sbjct: 187 PQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----- 233

Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP-------EAVDLV 328
                                               WH+I Q R+P        E  +L+
Sbjct: 234 ---------------------------------GDQWHEIRQGRLPRIPQVLSQEFTELL 260

Query: 329 SRLLQYSPNLRSTALEALIHPFFDELR 355
             ++   P  R +A+  + H       
Sbjct: 261 KVMIHPDPERRPSAMALVKHSVLLSAS 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  174 bits (442), Expect = 3e-51
 Identities = 65/315 (20%), Positives = 119/315 (37%), Gaps = 48/315 (15%)

Query: 45  EAGHIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDK 102
             G ++   +   + + ++ +     +  VG GSFG V + K  +TG   A+KKV L+  
Sbjct: 37  NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV- 95

Query: 103 RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQ 161
            ++  EL     L  P +V L         ++  ++N+ +E +   ++ ++IK    + +
Sbjct: 96  -FRVEELVACAGLSSPRIVPLYGA-----VREGPWVNIFMELLEGGSLGQLIKQMGCLPE 149

Query: 162 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 221
                    Y  Q    L Y+H    + H D+K  N+L++    +  LCDFG A  L   
Sbjct: 150 D----RALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 222 EPNISYICSR------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
               S +          + APE++ G     A +DIWS+ C++  +L G   +       
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
             ++I      P                  +I              P     +   L+  
Sbjct: 264 LCLKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKE 297

Query: 336 PNLRSTALEALIHPF 350
           P  R++A+E      
Sbjct: 298 PVHRASAMELRRKVG 312

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  181 bits (459), Expect = 4e-51
 Identities = 79/339 (23%), Positives = 130/339 (38%), Gaps = 26/339 (7%)

Query: 55  GGKNGQPKQTIS---YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----- 106
           GG       T +   +  +  +G G FG V +    +TGE VAIK+  Q+   KN     
Sbjct: 1   GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60

Query: 107 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN-LVLEYVP--ETVHRVIKHHYKMSQRM 163
            E+Q M+ L+HPNVVS +       +     L  L +EY    +    + +        +
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGL 118

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKG 221
               ++     I  AL Y+H    + HRD+KP+N+++ P   +   K+ D G AK L +G
Sbjct: 119 KEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177

Query: 222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
           E    ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    +
Sbjct: 178 ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

Query: 282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH--KIFQKRMPPEAVDLVSRLLQYSPNLR 339
           +     + E I   +      KF  +   P H   I       +    +  +L +    R
Sbjct: 237 R---EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG----KLERWLQCMLMWHQRQR 289

Query: 340 STALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL 378
            T  +      F  L    +                + +
Sbjct: 290 GTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPV 328

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  172 bits (438), Expect = 5e-51
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 50/305 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 122
           ++   V+G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+V+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRAL 179
           L+  +         Y  LV++ V   E   R++ +  Y  +++       L   Q+  A+
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVY--TEKDA----SLVIQQVLSAV 119

Query: 180 AYIHNTIGVCHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 236
            Y+H   G+ HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y AP
Sbjct: 120 KYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAP 176

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E +     Y+ A+D WS G +   LL G P F  E+      +I +              
Sbjct: 177 E-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------- 222

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
                ++F    +  W  I        A D +  LL+  PN R T  +AL HP+ D    
Sbjct: 223 ----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270

Query: 357 PNTRL 361
            +  +
Sbjct: 271 LHRDI 275

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  171 bits (435), Expect = 9e-51
 Identities = 62/297 (20%), Positives = 118/297 (39%), Gaps = 56/297 (18%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 125
            +G GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH- 183
            + ST +  +  + LV E +   T+   +K      + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAP 236
            T  + HRD+K  N+ +   T  +K+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E+     +Y  ++D+++ G  + E+   +  +       Q+                   
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------- 238

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
                ++       P    F K   PE  +++   ++ + + R +  + L H FF E
Sbjct: 239 -----YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  174 bits (442), Expect = 1e-50
 Identities = 82/320 (25%), Positives = 132/320 (41%), Gaps = 37/320 (11%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
            +  +V+G G  G V Q     T E  A+K +LQD     RE++   R    P++V +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             +         L +V+E +   E   R+  +     ++R            I  A+ Y+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER----EASEIMKSIGEAIQYL 177

Query: 183 HNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           H+ I + HRD+KP+NLL  +   +  LKL DFG AK         +   + YY APE + 
Sbjct: 178 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           G  +Y  + D+WS G ++  LL G P F    G+     +           I+       
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MG 282

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD-PNT 359
           +++FP      W ++       E   L+  LL+  P  R T  E + HP+  +    P T
Sbjct: 283 QYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 334

Query: 360 RLPNGRFLPPLFNFKPHELK 379
            L   R L      +  ++K
Sbjct: 335 PLHTSRVL-KEDKERWEDVK 353

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  170 bits (432), Expect = 2e-50
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 66/297 (22%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 123
           R +G G FG V+ A+  +    +A+K     ++ ++       RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +  +Y  L+LE+ P  E    + KH      R        +  ++  AL Y
Sbjct: 80  YNYFHD---RKRIY--LMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHY 129

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GEPNISYICSRYYR 234
            H    V HRDIKP+NLL+      LK+ DFG +            G  +        Y 
Sbjct: 130 CHER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YL 179

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
            PE+I G   +   +D+W AG +  E L+G P F   S  +    I+ V           
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                 + KFP     P+       +   + DL+S+LL+Y P  R      + HP+ 
Sbjct: 228 ------DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  171 bits (436), Expect = 3e-50
 Identities = 80/317 (25%), Positives = 133/317 (41%), Gaps = 47/317 (14%)

Query: 44  TEAGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR 103
           T   H IV  +   + Q      Y  +  +G GS+ V  +     T    A+K + + KR
Sbjct: 3   TVGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 104 YKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKM 159
               E++ + R   HPN+++LK  +      D  Y+ +V E +   E + ++++   +  
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFF-- 113

Query: 160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAK 216
           S+R          + I + + Y+H   GV HRD+KP N+L    + +   +++CDFG AK
Sbjct: 114 SERE----ASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168

Query: 217 VLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
            L      +   C +  + APE +     Y AA DIWS G +L  +L G   F       
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227

Query: 276 QLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
               + ++  G               +F         W+ +        A DLVS++L  
Sbjct: 228 PEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHV 264

Query: 335 SPNLRSTALEALIHPFF 351
            P+ R TA   L HP+ 
Sbjct: 265 DPHQRLTAALVLRHPWI 281

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  171 bits (435), Expect = 3e-50
 Identities = 74/314 (23%), Positives = 130/314 (41%), Gaps = 39/314 (12%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 128
           ++V+G G  G V +     TG+  A+K +L D     +E+    +    P++V +    +
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91

Query: 129 STTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
                 +  L +++E +   E   R+  +     ++R            I  A+ ++H+ 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----AAEIMRDIGTAIQFLHS- 146

Query: 186 IGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 242
             + HRD+KP+NLL  +      LKL DFG AK   +    +   C + YY APE + G 
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGP 203

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            +Y  + D+WS G ++  LL G P F   +G      + +         I+       ++
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-----QY 250

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF-DELRDPNTRL 361
            FP      W ++       +A  L+  LL+  P  R T  + + HP+    +  P T L
Sbjct: 251 GFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302

Query: 362 PNGRFLPPLFNFKP 375
              R L    +   
Sbjct: 303 HTARVLQEDKDHWD 316

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  172 bits (437), Expect = 5e-50
 Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 43/303 (14%)

Query: 54  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNREL 109
           +  K G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 110 QTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIY 167
             M  LDH N++ L   F     + +  + LV+EYV   E   R+I   Y +++   +++
Sbjct: 138 SVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 168 VKLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           +K    QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E    
Sbjct: 193 MK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
              +  + APE +      +   D+WS G +   LL G   F G++  + L  I+     
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--- 303

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
                          +         +  I       EA + +S+LL    + R +A EAL
Sbjct: 304 --------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEAL 341

Query: 347 IHP 349
            HP
Sbjct: 342 KHP 344

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  168 bits (429), Expect = 6e-50
 Identities = 72/311 (23%), Positives = 119/311 (38%), Gaps = 56/311 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F +V + +   TG+  A K          +    +    RE+  +R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           HPN+++L   F     +++  + L+LE V   E    +  K     ++         +  
Sbjct: 67  HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESL--TEDE----ATQFLK 115

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
           QI   + Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G      I  
Sbjct: 116 QILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFG 173

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           +  + APE I          D+WS G +   LL G   F GE+  + L  I  V      
Sbjct: 174 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV------ 226

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                       + F       +           A D + RLL   P  R T  ++L H 
Sbjct: 227 -----------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEHS 267

Query: 350 FFDELRDPNTR 360
           +   +R  N R
Sbjct: 268 WIKAIRRRNVR 278

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  170 bits (433), Expect = 8e-50
 Identities = 82/325 (25%), Positives = 122/325 (37%), Gaps = 56/325 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDH 117
           Y    V+G G F VV +    ETG+  A+K V   K   +         RE     +L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIY----VKLY 171
           P++V L   +       +  L +V E++   +    ++K           +Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 229
             QI  AL Y H+   + HRD+KP   LL +   +  +KL  FG A  L +         
Sbjct: 136 MRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 230 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
            + ++ APE +     Y   +D+W  G +L  LL G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
                       ++K        W  I        A DLV R+L   P  R T  EAL H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 349 PFFDELRDPNTRLPNGRFLPPLFNF 373
           P+  E      ++     +  L  F
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKF 312

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  169 bits (431), Expect = 1e-49
 Identities = 73/310 (23%), Positives = 137/310 (44%), Gaps = 40/310 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTMRLLD-HPNVVSLK 124
            + ++ +G GSF +  +    ++ +A A+K + +       +E+  ++L + HPN+V L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAY 181
             F      D+L+  LV+E +   E   R+  K H+  S+            ++  A+++
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKKKHF--SETE----ASYIMRKLVSAVSH 121

Query: 182 IHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
           +H+ +GV HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE 
Sbjct: 122 MHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE- 179

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     Y  + D+WS G +L  +L GQ  F            ++++     ++IK     
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG--- 231

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD-P 357
             +F F       W  +       EA DL+  LL   PN R        + +  +     
Sbjct: 232 --DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281

Query: 358 NTRLPNGRFL 367
           +  L     L
Sbjct: 282 SNPLMTPDIL 291

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  169 bits (430), Expect = 2e-49
 Identities = 76/342 (22%), Positives = 126/342 (36%), Gaps = 60/342 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMR-LLDHPNVV 121
               RV+  G F  V++A+ + +G   A+K++L    +  R   +E+  M+ L  HPN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 122 SLKHCFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
                     E        +L L+ E     +   +K   +    +    V   FYQ CR
Sbjct: 90  QFCSAASIGKEESDTGQAEFL-LLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCR 147

Query: 178 ALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------------EP 223
           A+ ++H     + HRD+K +NLL++     +KLCDFGSA  +                E 
Sbjct: 148 AVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 224 NISYICSRYYRAPELI--FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
            I+   +  YR PE+I  +         DIW+ GC+L  L   Q  F   +         
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA--------- 257

Query: 282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
                    +++ +N  Y+                          L+  +LQ +P  R +
Sbjct: 258 ---------KLRIVNGKYSIPPHD-------------TQYTVFHSLIRAMLQVNPEERLS 295

Query: 342 ALEALIHPF-FDELRDPNTRLPNGRFLPPLFNFKPHELKGVP 382
             E +         R+ N + P    L     +    L   P
Sbjct: 296 IAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  172 bits (438), Expect = 2e-49
 Identities = 79/319 (24%), Positives = 127/319 (39%), Gaps = 50/319 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G+F VV +   +  G+  A   +   K          RE +  RLL HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           V L          +E +  L+ + V   E    ++   +Y  S+            QI  
Sbjct: 73  VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYY--SEAD----ASHCIQQILE 121

Query: 178 ALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           A+ + H  +GV HR++KP+NLL  +      +KL DFG A  +   +        +  Y 
Sbjct: 122 AVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE +     Y   +D+W+ G +L  LL+G P F  E       +I              
Sbjct: 181 SPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA------------ 227

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                  + FP   +  W  +      PEA DL++++L  +P+ R TA EAL HP+    
Sbjct: 228 -----GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274

Query: 355 RDPNTRLPNGRFLPPLFNF 373
               + +     +  L  F
Sbjct: 275 STVASCMHRQETVDCLKKF 293

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  169 bits (431), Expect = 2e-49
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 49/318 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y  +  +G G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICR 177
           V L         ++E +  LV + V   E    ++    Y  S+            QI  
Sbjct: 91  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEAD----ASHCIQQILE 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
           ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  +  Y +
Sbjct: 140 SIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 198

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE +     Y+  +DIW+ G +L  LL+G P F  E       +I               
Sbjct: 199 PE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------ 245

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
                 + +P   +  W  +      PEA  L+  +L  +P  R TA +AL  P+     
Sbjct: 246 -----AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 292

Query: 356 DPNTRLPNGRFLPPLFNF 373
              + +     +  L  F
Sbjct: 293 RVASAIHRQDTVDCLKKF 310

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  166 bits (424), Expect = 3e-49
 Identities = 77/297 (25%), Positives = 120/297 (40%), Gaps = 51/297 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y  +  +G G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICR 177
           V L         ++E +  LV + V   E    ++ +  Y  S+            QI  
Sbjct: 68  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEAD----ASHCIQQILE 116

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
           ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E        +  Y 
Sbjct: 117 SIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYL 174

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE +     Y+  +DIW+ G +L  LL+G P F  E       +I              
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                  + +P   +  W  +      PEA  L+  +L  +P  R TA +AL  P+ 
Sbjct: 223 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  167 bits (426), Expect = 5e-49
 Identities = 73/325 (22%), Positives = 117/325 (36%), Gaps = 57/325 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           H NV++L   +     ++   + L+LE V   E    +  K     S+         +  
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----ATSFIK 122

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
           QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  
Sbjct: 123 QILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           +  + APE I          D+WS G +   LL G   F G++  + L  I  V      
Sbjct: 181 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV------ 233

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                       + F       +           A D + +LL      R T  EAL HP
Sbjct: 234 -----------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 350 FFDELRDPNTRLPNGRFLPPLFNFK 374
           +     D    +     +  L NF+
Sbjct: 275 WITP-VDNQQAMVRRESVVNLENFR 298

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  168 bits (428), Expect = 6e-49
 Identities = 85/302 (28%), Positives = 133/302 (44%), Gaps = 48/302 (15%)

Query: 58  NGQPKQTIS--YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMR 113
           +G  +  +S  +  E  +G G+  +V++ K   T +  A+K + +    K    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKL 170
            L HPN++ LK  F     +    ++LVLE V   E   R+++  +Y  S+R        
Sbjct: 104 RLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYY--SERD----AAD 152

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYI 228
              QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K++      +  +
Sbjct: 153 AVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTV 210

Query: 229 C-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           C +  Y APE I     Y   +D+WS G +   LL G   F  E G   +   I      
Sbjct: 211 CGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----- 264

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
                 C      E+ F    +  W ++        A DLV +L+   P  R T  +AL 
Sbjct: 265 -----NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQ 305

Query: 348 HP 349
           HP
Sbjct: 306 HP 307

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  167 bits (426), Expect = 6e-49
 Identities = 66/317 (20%), Positives = 119/317 (37%), Gaps = 54/317 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F VV + +   TG   A K          +    +    RE+  ++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           HPNV++L   +     +++  + L+LE V   E    + +    +++         +  Q
Sbjct: 73  HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKES-LTEEE----ATEFLKQ 122

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
           I   + Y+H+ + + H D+KP+N+++   N    ++K+ DFG A  +  G      I  +
Sbjct: 123 ILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGT 180

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
             + APE I          D+WS G +   LL G   F G++  + L  +  V       
Sbjct: 181 PEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV------- 232

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                      ++F       +           A D + RLL   P  R T  ++L HP+
Sbjct: 233 ----------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

Query: 351 FDELRDPNTRLPNGRFL 367
                           +
Sbjct: 275 IKPKDTQQALSRKASAV 291

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  167 bits (425), Expect = 2e-48
 Identities = 74/325 (22%), Positives = 119/325 (36%), Gaps = 57/325 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK----------KVLQDKRYKNRELQTMRLLD 116
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFY 173
           HPN+++L   +     ++   + L+LE V   E    +  K     S+         +  
Sbjct: 74  HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----ATSFIK 122

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
           QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G      I  
Sbjct: 123 QILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           +  + APE I          D+WS G +   LL G   F G++  + L  I  V      
Sbjct: 181 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV------ 233

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                       + F       + +         A D + +LL      R T  EAL HP
Sbjct: 234 -----------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 350 FFDELRDPNTRLPNGRFLPPLFNFK 374
           +     D    +     +  L NFK
Sbjct: 275 WITP-VDTQQAMVRRESVVNLENFK 298

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  164 bits (418), Expect = 4e-48
 Identities = 75/317 (23%), Positives = 128/317 (40%), Gaps = 62/317 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK------------KVLQDKRYK-NRELQTMR 113
           Y  + ++G G   VV +     T +  A+K            + +Q+ R    +E+  +R
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 114 LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVK 169
            +  HPN++ LK  +     +   +  LV + +   E    + +      S++      +
Sbjct: 79  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTL--SEK----ETR 127

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
                +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE  +  +C
Sbjct: 128 KIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LREVC 184

Query: 230 -SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 283
            +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I+  
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244

Query: 284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 343
                             ++F    +  W             DLVSR L   P  R TA 
Sbjct: 245 -----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAE 279

Query: 344 EALIHPFFDELRDPNTR 360
           EAL HPFF +      R
Sbjct: 280 EALAHPFFQQYVVEEVR 296

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  163 bits (413), Expect = 1e-46
 Identities = 51/339 (15%), Positives = 105/339 (30%), Gaps = 84/339 (24%)

Query: 62  KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRL 114
           ++  + +   V+G        +A   ETGE+  +      +R  +        E+  +RL
Sbjct: 70  ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129

Query: 115 L-------------------------DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 149
           L                             ++ ++            +L   ++   +T 
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189

Query: 150 HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
             V+  H    + +          Q+ R LA +H+  G+ H  ++P +++++     + L
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VFL 247

Query: 210 CDFGSAKVLVKGEPNISYICSRYYRAPELI----------FGATEYTAAIDIWSAGCVLA 259
             F      V+    +    SR +  PEL              T  T + D W+ G V+ 
Sbjct: 248 TGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 260 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ-- 317
            +         ++ +                                        IF+  
Sbjct: 305 WIWCADLPITKDAALG-----------------------------------GSEWIFRSC 329

Query: 318 KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
           K +P     L+   L+Y    R   L+A+  P +++LR 
Sbjct: 330 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  161 bits (409), Expect = 2e-46
 Identities = 82/323 (25%), Positives = 130/323 (40%), Gaps = 51/323 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIK----KVLQDKRYKNRELQTM-RLLDHPNVVSLK 124
           E V+G G+   V     L T +  A+K    +    +    RE++ + +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 125 HCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKLYFYQICRALAY 181
             F     ++E    LV E +     +  + K  H+  ++        +    +  AL +
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHF--NEL----EASVVVQDVASALDF 126

Query: 182 IHNTIGVCHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE-------PNISYIC-SR 231
           +HN  G+ HRD+KP+N+L  +P     +K+CDF     +           P +   C S 
Sbjct: 127 LHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 232 YYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
            Y APE++      A+ Y    D+WS G +L  LL G P F G  G D   +  +     
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245

Query: 288 TR---EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
                E I+       +++FP      W  I        A DL+S+LL      R +A +
Sbjct: 246 QNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLSAAQ 292

Query: 345 ALIHPFFDELRDPNTRLPNGRFL 367
            L HP+      P   LP    L
Sbjct: 293 VLQHPWVQG-CAPENTLPTPMVL 314

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  161 bits (410), Expect = 2e-46
 Identities = 75/307 (24%), Positives = 134/307 (43%), Gaps = 61/307 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----------KVLQDKRYK-NRELQTMRL 114
           Y  + V+G G   VV +     TG   A+K           + L++ R    RE   +R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 115 L-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVKL 170
           +  HP++++L   +     +   ++ LV + +   E    + +      S++      + 
Sbjct: 156 VAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVAL--SEK----ETRS 204

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC- 229
               +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +C 
Sbjct: 205 IMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LRELCG 261

Query: 230 SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
           +  Y APE++  + +     Y   +D+W+ G +L  LL G P F     +  L  I++  
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG- 320

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
                           +++F    +  W             DL+SRLLQ  P  R TA +
Sbjct: 321 ----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAEQ 356

Query: 345 ALIHPFF 351
           AL HPFF
Sbjct: 357 ALQHPFF 363

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  160 bits (408), Expect = 3e-46
 Identities = 69/308 (22%), Positives = 117/308 (37%), Gaps = 50/308 (16%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 120
           +  + +G G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICR 177
           ++L   +     ++   + L+LEY    E     + +    +S+      V     QI  
Sbjct: 92  INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----VIRLIKQILE 142

Query: 178 ALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 234
            + Y+H    + H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y 
Sbjct: 143 GVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE I      T A D+W+ G +   LL     F GE   +  + I +V           
Sbjct: 201 APE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV----------- 248

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                    +       +  +        A D +  LL  +P  R TA   L H +  + 
Sbjct: 249 ------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294

Query: 355 RDPNTRLP 362
              N   P
Sbjct: 295 DFENLFHP 302

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  159 bits (405), Expect = 4e-46
 Identities = 77/320 (24%), Positives = 127/320 (39%), Gaps = 62/320 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN---RELQTMRLLDHP 118
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
           NV+ L    ++  ++  +Y  +V+EY      E +  V +       R P+     YF Q
Sbjct: 67  NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK------RFPVCQAHGYFCQ 117

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SR 231
           +   L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLHS-QGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 232 YYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            ++ PE+  G   ++   +DIWSAG  L  +  G   F G++        I  L     E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
            I         +  P                P   DL+  +L+Y P  R +  +   H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266

Query: 351 FDELRDPNTRLPNGRFLPPL 370
           F        + P      P+
Sbjct: 267 F------RKKHPPAEAPVPI 280

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  158 bits (402), Expect = 1e-45
 Identities = 76/320 (23%), Positives = 123/320 (38%), Gaps = 58/320 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 125
            +  +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 126 CFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYVKLYFYQICRALAYI 182
             +         L +V+E +   E   R+  +     ++R            I  A+ Y+
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE----ASEIMKSIGEAIQYL 133

Query: 183 HNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           H+ I + HRD+KP+NLL  +   +  LKL DFG AK                        
Sbjct: 134 HS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE------------------- 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
              +Y  + D+WS G ++  LL G P F    G+     +           I+       
Sbjct: 174 ---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-----MG 217

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD-PNT 359
           +++FP      W ++       E   L+  LL+  P  R T  E + HP+  +    P T
Sbjct: 218 QYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269

Query: 360 RLPNGRFLPPLFNFKPHELK 379
            L   R L      +  ++K
Sbjct: 270 PLHTSRVL-KEDKERWEDVK 288

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  159 bits (404), Expect = 2e-45
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 46/294 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 121
           Y   + +G G+FGV    +   T E VA+K       + +     RE+   R L HPN+V
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K    +      L   +++EY    E   R+         R      + +F Q+   +
Sbjct: 80  RFKEVILT---PTHLA--IIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGV 129

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           +Y H+ + +CHRD+K +N L++     +LK+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 239 IFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +    EY     D+WS G  L  +L+G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
              ++  P             R+ PE   L+SR+    P  R +  E   H +F
Sbjct: 238 ---KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  157 bits (399), Expect = 2e-44
 Identities = 61/388 (15%), Positives = 116/388 (29%), Gaps = 92/388 (23%)

Query: 50  IVTTIGGKNGQPKQTISYMAER--------VVGHGSFGVVFQAKCLETGEAVAIKKVLQD 101
           +V+T     GQP +  S + ER        V+G        +A   ETGE+  +      
Sbjct: 55  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114

Query: 102 KRYKN-------RELQTMRLL-------------------------DHPNVVSLKHCFFS 129
           +R  +        E+  +RLL                             ++ ++     
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174

Query: 130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC 189
                  +L   ++   +T   V+  H    + +          Q+ R LA +H+  G+ 
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLV 233

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY----YRAPELIFGA--- 242
           H  ++P +++++     + L  F        G   +S I   +      A  ++      
Sbjct: 234 HTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHH 290

Query: 243 -TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
            T  T A D W+ G  +  +         ++ +                           
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------ 326

Query: 302 FKFPQIKAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD--- 356
                        IF+  K +P     L+   L+Y    R   L+A+  P +++LR    
Sbjct: 327 -----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375

Query: 357 PNTRLPNGRFLPPLFNFKPHELKGVPVD 384
               L      P      P      P +
Sbjct: 376 AALPLYQTDGEPTREGGAPPSGTSQPDE 403

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  154 bits (391), Expect = 2e-44
 Identities = 80/313 (25%), Positives = 130/313 (41%), Gaps = 56/313 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
                     E +  Y  L LEY    E   R+          MP    + +F+Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 236
            Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 237 ELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           EL+    E+ A  +D+WS G VL  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
                          PW K     +    + L+ ++L  +P+ R T  +     ++    
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY---- 265

Query: 356 DPNTRLPNGRFLP 368
             N  L  G   P
Sbjct: 266 --NKPLKKGAKRP 276

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  153 bits (390), Expect = 5e-44
 Identities = 77/332 (23%), Positives = 124/332 (37%), Gaps = 73/332 (21%)

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--- 106
            G +G   Q   Y  +  +G GS+GVV  A         A+K     K+++   +     
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 107 ----------------------RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY 144
                                 +E+  ++ LDHPNVV L         +D LY+  V E 
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119

Query: 145 VP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP 202
           V     V  V        + +     + YF  + + + Y+H    + HRDIKP NLLV  
Sbjct: 120 VNQGP-VMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG- 171

Query: 203 HTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT-EYT-AAIDIWSAGCVLA 259
               +K+ DFG +      +  +S    +  + APE +      ++  A+D+W+ G  L 
Sbjct: 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 260 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR 319
             + GQ  F  E  +  L   IK                    +FP     P        
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIK----------------SQALEFPD---QPD------- 264

Query: 320 MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
           +  +  DL++R+L  +P  R    E  +HP+ 
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  155 bits (394), Expect = 5e-44
 Identities = 74/330 (22%), Positives = 132/330 (40%), Gaps = 34/330 (10%)

Query: 53  TIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--R 107
           T   K G+ K    +     +G G+ GVVF+     +G  +A K +   ++        R
Sbjct: 22  TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLI 166
           ELQ +   + P +V     F+S  E     +++ +E++   ++ +V     K + R+P  
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQV----LKKAGRIPEQ 131

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
            +      + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189

Query: 227 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
           ++ +R Y +PE + G   Y+   DIWS G  L E+ +G+   P     +  +     +  
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ---------------KRMPPEAVDLVSRL 331
              E                + + P   IF+                    E  D V++ 
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308

Query: 332 LQYSPNLRSTALEALIHPFFDELRDPNTRL 361
           L  +P  R+   + ++H F           
Sbjct: 309 LIKNPAERADLKQLMVHAFIKRSDAEEVDF 338

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  154 bits (391), Expect = 7e-44
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 50/296 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
                     E +  Y  L LEY    E   R+          MP    + +F+Q+   +
Sbjct: 69  KFYGHR---REGNIQY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 236
            Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 237 ELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           EL+    E+ A  +D+WS G VL  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                          PW K     +    + L+ ++L  +P+ R T  +     ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  148 bits (376), Expect = 4e-42
 Identities = 81/307 (26%), Positives = 130/307 (42%), Gaps = 52/307 (16%)

Query: 55  GGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------R 107
           G K+    +   Y+    +G G+FG V   +   TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
           E+Q ++L  HP+++ L     +     + +  +V+EYV   E    + KH      R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVIST---PTDFF--MVMEYVSGGELFDYICKH-----GRVEE 110

Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
           +  +  F QI  A+ Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 226 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              C S  Y APE+I G       +DIWS G +L  LL G   F  E         +  L
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTL 219

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
                ++I+        F  P      +       +      L+  +LQ  P  R+T  +
Sbjct: 220 ----FKKIR-----GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258

Query: 345 ALIHPFF 351
              H +F
Sbjct: 259 IREHEWF 265

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  149 bits (378), Expect = 5e-42
 Identities = 70/321 (21%), Positives = 118/321 (36%), Gaps = 67/321 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-----RELQTMRLLD 116
           Y    ++G G FG V+    +     VAIK     ++       N      E+  ++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 117 H--PNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLY 171
                V+ L   +F     D   L  +LE      +    + +        +     + +
Sbjct: 105 SGFSGVIRLLD-WFER--PDSFVL--ILERPEPVQDLFDFITER-----GALQEELARSF 154

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
           F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS  +L       +    +
Sbjct: 155 FWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGT 211

Query: 231 RYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
           R Y  PE I     Y      +WS G +L +++ G   F  +       EII+       
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                      +  F             +R+  E   L+   L   P+ R T  E   HP
Sbjct: 258 ----------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

Query: 350 FFDELRDPNTRLP-NGRFLPP 369
           +  ++  P      +   L P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSP 316

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  148 bits (376), Expect = 1e-41
 Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 57/308 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHP 118
           Y   + +G G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           N+V L       TEK    L L++EY    E    ++ H      RM     +  F QI 
Sbjct: 75  NIVKLFEVI--ETEKT---LYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIV 124

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
            A+ Y H    + HRD+K +NLL++     +K+ DFG +     G   +   C +  Y A
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181

Query: 236 PELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           PEL  G  +Y    +D+WS G +L  L+ G   F G++ + +L E +             
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------ 227

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                 +++ P      +       M  +  +L+ R L  +P  R T  + +   + +  
Sbjct: 228 ----RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271

Query: 355 RDPNTRLP 362
            + +   P
Sbjct: 272 HEEDELKP 279

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  147 bits (373), Expect = 2e-41
 Identities = 77/308 (25%), Positives = 122/308 (39%), Gaps = 72/308 (23%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           +++G GSF  V  A+ L T    AIK      ++++    Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D+  L   L Y    E     +  + +          + Y  +I  AL Y
Sbjct: 96  YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---------YICSRY 232
           +H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+    
Sbjct: 146 LHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
             +PEL+        + D+W+ GC++ +L+ G P F   +    + + I           
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII---------- 245

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP------NLRSTALEAL 346
                   E+ FP            ++  P+A DLV +LL                    
Sbjct: 246 ------KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287

Query: 347 IHPFFDEL 354
            HPFF+ +
Sbjct: 288 AHPFFESV 295

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  146 bits (370), Expect = 3e-41
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 41/299 (13%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQ-TMRLLDHPNVVSLKH 125
            +G G++GVV + + + +G+ +A+K++   +  +  K    +L  +MR +D P  V+   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
             F   +     + + +E +  ++ +  K      Q +P   +      I +AL ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---A 242
           + V HRD+KP N+L+N    Q+K+CDFG +  LV           + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y+   DIWS G  + EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 361
             PQ+ A  +          E VD  S+ L+ +   R T  E + HPFF       T +
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  145 bits (369), Expect = 9e-41
 Identities = 77/323 (23%), Positives = 122/323 (37%), Gaps = 68/323 (21%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-----RELQTMRLLD 116
           Y    ++G G FG VF    L     VAIK     +VL      +      E+  +  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 117 ----HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV---IKHHYKMSQRMPLIYVK 169
               HP V+ L   +F T  ++   L  VLE  P     +   I     + +       +
Sbjct: 93  AGGGHPGVIRL-LDWFET--QEGFML--VLER-PLPAQDLFDYITEKGPLGEGP----SR 142

Query: 170 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
            +F Q+  A+ + H+  GV HRDIK +N+L++      KL DFGS  +L       +   
Sbjct: 143 CFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD 199

Query: 230 -SRYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
            +R Y  PE I    +Y A    +WS G +L +++ G   F  +       EI++     
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---- 248

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
                        E  FP              + P+   L+ R L   P+ R +  E L+
Sbjct: 249 -------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

Query: 348 HPFFDELRDPNTRLPNGRFLPPL 370
            P+     +     P+     PL
Sbjct: 284 DPWMQTPAEDVPLNPSKGGPAPL 306

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  145 bits (367), Expect = 3e-40
 Identities = 74/294 (25%), Positives = 128/294 (43%), Gaps = 51/294 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 119
           Y+    +G GSFG V  A   +T + VA+K      + +   +    RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           ++ L     +     ++   +V+EY   E    +++      +RM     + +F QI  A
Sbjct: 71  IIKLYDVITT---PTDIV--MVIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICA 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           + Y H    + HRD+KP+NLL++ +   +K+ DFG + ++  G   +   C S  Y APE
Sbjct: 121 IEYCHR-HKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPE 177

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I G       +D+WS G VL  +L+G+  F  E  +  L + +                
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               +  P      +       + P A  L+ R++   P  R T  E    P+F
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  143 bits (363), Expect = 2e-39
 Identities = 37/315 (11%), Positives = 91/315 (28%), Gaps = 64/315 (20%)

Query: 66  SYMAERVVGHGSFGVVFQAKC-----LETGEAVAIK----KVLQDKRYKNRELQTMRLLD 116
                 ++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
               +           ++   L  V E       ++ +  +     + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----------LKLCDFGSA---KVLVKG 221
           +   +  +H+   + H DIKP N ++     +          L L D G +   K+  KG
Sbjct: 181 MLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
               +   +  ++  E++     +   ID +     +  +L G  +     G        
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------- 290

Query: 282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 341
                    + + +                W++ F              +L         
Sbjct: 291 ------GECKPEGLFRRL-------PHLDMWNEFFHV------------MLNIPDCHHLP 325

Query: 342 ALEALIHPFFDELRD 356
           +L+ L        + 
Sbjct: 326 SLDLLRQKLKKVFQQ 340

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  145 bits (367), Expect = 3e-39
 Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 53/307 (17%)

Query: 56  GKNGQPKQTI-SYMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--R 107
            +    +  I  Y+    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 108 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPL 165
           E+Q ++L  HP+++ L     +     +++  +V+EYV   E    + K+      R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVIST---PSDIF--MVMEYVSGGELFDYICKN-----GRLDE 115

Query: 166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 225
              +  F QI   + Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 116 KESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 172

Query: 226 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
              C S  Y APE+I G       +DIWS+G +L  LL G   F  +  V  L + I   
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC-- 229

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
                            F  P      +       + P  + L+  +LQ  P  R+T  +
Sbjct: 230 --------------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKD 263

Query: 345 ALIHPFF 351
              H +F
Sbjct: 264 IREHEWF 270

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  147 bits (373), Expect = 4e-39
 Identities = 77/345 (22%), Positives = 131/345 (37%), Gaps = 71/345 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRE-----------LQTMRLLDHPN 119
           R++G G FG V+  +  +TG+  A+K  L  KR K ++           L  +   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +V + + F +    D+L    +L+ +   +     + +H           ++ Y  +I  
Sbjct: 254 IVCMSYAFHT---PDKLSF--ILDLMNGGD-----LHYHLSQHGVFSEADMRFYAAEIIL 303

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ + + +  Y APE
Sbjct: 304 GLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     Y ++ D +S GC+L +LL G   F      D             + EI     
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF- 351
                                   PE   L+  LLQ   N R       A E    PFF 
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

Query: 352 ----DELRD--------PNTRLPNGRFLPPLFNFKPHELKGVPVD 384
                 +          P     N      + +F   + KG+ + 
Sbjct: 455 SLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLL 499

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  142 bits (359), Expect = 1e-38
 Identities = 79/321 (24%), Positives = 139/321 (43%), Gaps = 61/321 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           R +G GSFG V   +  +T +  A+K     K ++    R   +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +DE  + +V++ +   +     +++H + +       VKL+  ++  AL Y
Sbjct: 81  WYSF-----QDEEDMFMVVDLLLGGD-----LRYHLQQNVHFKEETVKLFICELVMALDY 130

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF- 240
           + N   + HRD+KP N+L++ H H + + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQN-QRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 241 -GATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNP 297
                Y+ A+D WS G    ELL G+  +   S     ++V   +               
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALIHPFFDELRD 356
             T   +P                 E V L+ +LL+ +P+ R S   +    P+     D
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM---ND 277

Query: 357 PN-TRLPNGRFLPPLFNFKPH 376
            N   +   R +P    F P+
Sbjct: 278 INWDAVFQKRLIPG---FIPN 295

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  140 bits (354), Expect = 1e-38
 Identities = 70/358 (19%), Positives = 121/358 (33%), Gaps = 103/358 (28%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G FGVVF+AK        AIK++    R        RE++ +  L+HP +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------------- 168
              + +  T  +        +    E+    +     M      I               
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 169 -------KLY--------------------------------FYQICRALAYIHNTIGVC 189
                   LY                                F QI  A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-KGLM 186

Query: 190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------------VKGEPNISYICSRYYRAP 236
           HRD+KP N+        +K+ DFG    +                  +   + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E I G   Y+  +DI+S G +L ELL     F  +    +++  ++              
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                 KFP         +F ++ P E   +V  +L  SP  R  A + + +  F+ L
Sbjct: 288 ----NLKFP--------LLFTQKYPQEH-MMVQDMLSPSPTERPEATDIIENAIFENL 332

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  139 bits (353), Expect = 2e-38
 Identities = 66/301 (21%), Positives = 113/301 (37%), Gaps = 46/301 (15%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 125
            +G G+ G V++ +  +TG  +A+K++      +  K    +L   ++  D P +V    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
            F + T+     + + +E +     ++ K   +M   +P   +      I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI----FG 241
            GV HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 300
             +Y    D+WS G  L EL  GQ  +       + L ++++    P             
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR 360
               P +  H            +    V   L      R    + L H F          
Sbjct: 248 ----PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

Query: 361 L 361
           +
Sbjct: 297 V 297

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  139 bits (352), Expect = 4e-38
 Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 39/300 (13%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 125
            +G G++G V +     +G+ +A+K++   + +K  K    +L   MR  D P +V    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 126 CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHN 184
             F   +       + +E +  +  +  K+ Y +    +P   +        +AL ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
            + + HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 245 ---YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y    D+WS G  L EL  G+  +P  + V   +  + V G P              
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 361
              PQ+      + F     P  ++ V+  L    + R    E L HPF     +    +
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  139 bits (352), Expect = 4e-38
 Identities = 69/308 (22%), Positives = 120/308 (38%), Gaps = 66/308 (21%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN-------RELQTMRL 114
           Y     +G G+FG V+ A   E  + V +K     KVL+D   ++        E+  +  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 115 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLY 171
           ++H N++ +    F    +      LV+E      +    + +H      R+        
Sbjct: 86  VEHANIIKVLD-IFEN--QGFFQ--LVMEKHGSGLDLFAFIDRH-----PRLDEPLASYI 135

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 230
           F Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 231 RYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 289
             Y APE++ G   Y    +++WS G  L  L+  +  F       +L E ++       
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238

Query: 290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
                          P              +  E + LVS LLQ  P  R+T  + +  P
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

Query: 350 FFDELRDP 357
           +  +  + 
Sbjct: 277 WVTQPVNL 284

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  141 bits (357), Expect = 5e-38
 Identities = 88/370 (23%), Positives = 148/370 (40%), Gaps = 70/370 (18%)

Query: 27  KIRDDKEMEATVVDGNGTEAGHIIVTTIGGKNGQPKQTIS-YMAERVVGHGSFGVVFQAK 85
            ++     E     G+ ++        +     + + T++ +   +++G G+FG V   K
Sbjct: 109 GLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVK 168

Query: 86  CLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNVVSLKHCFFSTTEKDE 135
              TG   A+K      ++           NR LQ  R   HP + +LK+ F +    D 
Sbjct: 169 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYSFQT---HDR 222

Query: 136 LYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI 193
           L    V+EY    E     +  H    +       + Y  +I  AL Y+H+   V +RD+
Sbjct: 223 LCF--VMEYANGGE-----LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275

Query: 194 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIW 252
           K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++    +Y  A+D W
Sbjct: 276 KLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWW 333

Query: 253 SAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 312
             G V+ E++ G+  F  +   ++L E+I                   E +FP       
Sbjct: 334 GLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEEIRFP------- 369

Query: 313 HKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELRDPN-TRLPNGRF 366
                + + PEA  L+S LL+  P  R       A E + H FF          +   + 
Sbjct: 370 -----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---AGIVWQHVYEKKL 421

Query: 367 LPPLFNFKPH 376
            PP   FKP 
Sbjct: 422 SPP---FKPQ 428

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  140 bits (354), Expect = 6e-38
 Identities = 62/320 (19%), Positives = 114/320 (35%), Gaps = 44/320 (13%)

Query: 67  YMAERVVGHG--SFGVVFQAKCLETGEAVAIKKV----LQDKRYKN--RELQTMRLLDHP 118
           Y    V+G G      V  A+   TGE V ++++      ++       EL   +L +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           N+V  +  F +    +EL+  +V  ++   +   +I  H+     M  + +      + +
Sbjct: 87  NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLK 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGEPNISYIC 229
           AL YIH+  G  HR +K  ++L++    ++ L    S         +  V  +     + 
Sbjct: 140 ALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 230 SRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQP----------LF-------PGE 271
              + +PE++      Y A  DI+S G    EL  G            L        P  
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 331
                +      +          ++ + T               + +   P     V + 
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 332 LQYSPNLRSTALEALIHPFF 351
           LQ +P+ R +A   L H FF
Sbjct: 318 LQRNPDARPSASTLLNHSFF 337

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  140 bits (354), Expect = 9e-38
 Identities = 83/337 (24%), Positives = 124/337 (36%), Gaps = 85/337 (25%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKK-----VLQDKR--YKNRELQTMRLLDHPNVVSL 123
           +V+G G+F  V   K  +TG+  A+K      +L+         E   +   D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +DE YL LV+EY    + +        K  +R+P    + Y  +I  A+  
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--------YICSRYY 233
           +H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+     
Sbjct: 178 VHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230

Query: 234 RAPELI------FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
            +PE++       G   Y    D W+ G    E+  GQ  F  +S   +    I      
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALE 344
                  ++        P            + +P EA D + RLL   P  R     A +
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324

Query: 345 ALIHPFF-----DELRDPNTRLPNGRFLPPLFNFKPH 376
              HPFF     D LR           +PP   F P 
Sbjct: 325 FRTHPFFFGLDWDGLR---------DSVPP---FTPD 349

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  141 bits (358), Expect = 2e-37
 Identities = 86/325 (26%), Positives = 139/325 (42%), Gaps = 65/325 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           RV+G G FG V   +   TG+  A K  L+ KR K R        E Q +  ++   VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPET-----VHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           L + + +   KD L L  VL  +        ++ + +  +  ++         Y  +IC 
Sbjct: 249 LAYAYET---KDALCL--VLTLMNGGDLKFHIYHMGQAGFPEAR------AVFYAAEICC 297

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE 237
            L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE
Sbjct: 298 GLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     YT + D W+ GC+L E++ GQ  F       +  E+ ++        +K +  
Sbjct: 356 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------VKEVPE 406

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
            Y+E                    P+A  L S+LL   P  R      +A E   HP F 
Sbjct: 407 EYSER-----------------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF- 448

Query: 353 ELRDPN-TRLPNGRFLPPLFNFKPH 376
             +  N  RL  G   PP   FKP 
Sbjct: 449 --KKLNFKRLGAGMLEPP---FKPD 468

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  141 bits (356), Expect = 3e-37
 Identities = 74/326 (22%), Positives = 125/326 (38%), Gaps = 56/326 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 122
           RV+G G FG VF  +   TG+  A K  L  KR K R        E + +  +    +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L + F +   K +L L  V+  +   +  +  I +  + +          Y  QI   L 
Sbjct: 250 LAYAFET---KTDLCL--VMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 239
           ++H    + +RD+KP+N+L++   + +++ D G A  L  G+        +  + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G  EY  ++D ++ G  L E++  +  F       +  E+         + +      Y
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAVTY 412

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDEL 354
            +                    P + D    LLQ  P  R      +      HP F   
Sbjct: 413 PDK-----------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF--- 452

Query: 355 RDPN-TRLPNGRFLPPLFNFKPHELK 379
           RD +  +L  G  L P F      + 
Sbjct: 453 RDISWRQLEAGM-LTPPFVPDSRTVY 477

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  138 bits (350), Expect = 5e-37
 Identities = 82/361 (22%), Positives = 138/361 (38%), Gaps = 69/361 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           +V+G G+FG V   K     +  A+K     ++L+         E   +   D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +D+  L LV++Y    + +        K   R+P    + Y  ++  A+  
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELI 239
           +H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++
Sbjct: 191 VHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 240 ----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
                G   Y    D WS G  + E+L G+  F  ES + +    I             M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN-LRSTALEAL-IHPFF-- 351
           N     F+FP              +   A DL+ RL+    + L    +E    HPFF  
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344

Query: 352 ---DELRDPNTRLPNGRFLPPL------FNFKPHELKGVPVDMLV-KLIPEHARKQCAFL 401
              D +R  N   P   ++P +       NF   +      + +        +     F+
Sbjct: 345 IDWDNIR--NCEAP---YIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFV 399

Query: 402 G 402
           G
Sbjct: 400 G 400

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  135 bits (341), Expect = 2e-36
 Identities = 82/322 (25%), Positives = 136/322 (42%), Gaps = 64/322 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 123
           +++G G+FG V   +   TG   A+K      ++      +   E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           K+ F  T ++  L    V+EY    E     +  H    +       + Y  +I  AL Y
Sbjct: 71  KYAF-QTHDR--LCF--VMEYANGGE-----LFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIF 240
           +H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++ 
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
              +Y  A+D W  G V+ E++ G+  F  +   ++L E+I                   
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------ME 220

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELR 355
           E +FP            + + PEA  L++ LL+  P  R     S A E + H FF    
Sbjct: 221 EIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---L 265

Query: 356 DPN-TRLPNGRFLPPLFNFKPH 376
             N   +   + LPP   FKP 
Sbjct: 266 SINWQDVVQKKLLPP---FKPQ 284

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  133 bits (337), Expect = 2e-36
 Identities = 81/311 (26%), Positives = 126/311 (40%), Gaps = 46/311 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y  + V+G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR--- 177
           S    F     KDEL+  LV++ +   +V  +IKH     +    +  +     I R   
Sbjct: 77  SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 178 -ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR---- 231
             L Y+H   G  HRD+K  N+L+      +++ DFG SA +   G+   +    R    
Sbjct: 132 EGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187

Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
               + APE++     Y    DIWS G    EL  G   +     +  L+  ++      
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
                  N        P ++     K   K+       ++S  LQ  P  R TA E L H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288

Query: 349 PFFDELRDPNT 359
            FF + ++   
Sbjct: 289 KFFQKAKNKEF 299

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  135 bits (340), Expect = 5e-36
 Identities = 79/364 (21%), Positives = 137/364 (37%), Gaps = 84/364 (23%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK---NRELQTMRLL-----DHP 118
           Y   R +G G F  V+ +  ++  + VA+K V   + Y      E++ ++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 119 N---VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           N   VV L   F  +      ++ +V E +   + + I       Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLV----------------------------------- 200
            + L Y+H    + H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 201 -------------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
                        N    ++K+ D G+A  +   +     I +R YR+ E++ G+  Y  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 248 AIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 294
             DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMP------PEAVDLVSRLLQYSPNLRSTALEALIH 348
                      ++K     ++  ++            D +  +L+  P  R+TA E L H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 349 PFFD 352
           P+ +
Sbjct: 393 PWLN 396

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  132 bits (335), Expect = 1e-35
 Identities = 78/327 (23%), Positives = 132/327 (40%), Gaps = 77/327 (23%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K     KV++ K   +   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +  F     KD   L +V+EYV   E     +  H +   R    + + Y  QI     Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRA 235
           +H+ + + +RD+KP+NLL++   + +++ DFG AK +        G P           A
Sbjct: 157 LHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALA 206

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE+I     Y  A+D W+ G ++ E+  G P F  +    Q+ E I          +   
Sbjct: 207 PEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG- 253

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPF 350
                + +FP                 +  DL+  LLQ        NL++   +   H +
Sbjct: 254 -----KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

Query: 351 FDELRDPN-TRLPNGRFLPPLFNFKPH 376
           F      +   +   +   P   F P 
Sbjct: 297 FATT---DWIAIYQRKVEAP---FIPK 317

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  131 bits (331), Expect = 3e-35
 Identities = 80/335 (23%), Positives = 140/335 (41%), Gaps = 78/335 (23%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           R +G GSFG V   +    G   A+K      V++ K   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
              F     +D   + ++++Y+   E     +    + SQR P    K Y  ++C AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGE-----LFSLLRKSQRFPNPVAKFYAAEVCLALEY 121

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNISYICSRYYRA 235
           +H+   + +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y A
Sbjct: 122 LHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIA 171

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++     Y  +ID WS G ++ E+L G   F   +   +  E I              
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL------------- 216

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPF 350
                E +FP                 +  DL+SRL+         NL++   +   HP+
Sbjct: 217 ---NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

Query: 351 FDELRDPN-TRLPNGRFLPPLFNFKPHELKGVPVD 384
           F E+      +L +     P   ++P  ++    D
Sbjct: 262 FKEV---VWEKLLSRNIETP---YEPP-IQQGQGD 289

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  130 bits (328), Expect = 6e-35
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 18/215 (8%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
           E VVG G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 128 FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--N 184
                     + LV+EY    +++ V+ H  +        +   +  Q  + +AY+H   
Sbjct: 70  --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
              + HRD+KP NLL+      LK+CDFG+A          +   S  + APE+  G + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 279
           Y+   D++S G +L E++  +  F    G    + 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  130 bits (329), Expect = 7e-35
 Identities = 80/324 (24%), Positives = 134/324 (41%), Gaps = 66/324 (20%)

Query: 71  RVVGHGSFGVVFQAK---CLETGEAVAIKKVLQDKRYKNRELQTM---RLL---DHPNVV 121
           +V+G GSFG VF  K     +  +  A+K + +        ++T     +L   +HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L + F  T  K  LYL  +L+++   +     +              VK Y  ++  AL
Sbjct: 90  KLHYAF-QTEGK--LYL--ILDFLRGGD-----LFTRLSKEVMFTEEDVKFYLAELALAL 139

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 238
            ++H+ +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE+
Sbjct: 140 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     +T + D WS G ++ E+L G   F G+    + + +I                 
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDE 353
             +   PQ             + PEA  L+  L + +P  R         E   H FF  
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF-- 285

Query: 354 LRDPN-TRLPNGRFLPPLFNFKPH 376
               +  +L      PP   FKP 
Sbjct: 286 -STIDWNKLYRREIHPP---FKPA 305

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  130 bits (329), Expect = 7e-35
 Identities = 89/328 (27%), Positives = 137/328 (41%), Gaps = 72/328 (21%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQ----DKRYKNRELQTM---RLL---DH 117
           RV+G G +G VFQ + +    TG+  A+K VL+     +  K+    T     +L    H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTA-HTKAERNILEEVKH 80

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
           P +V L + F  T  K  LYL  +LEY+   E     +    +            Y  +I
Sbjct: 81  PFIVDLIYAF-QTGGK--LYL--ILEYLSGGE-----LFMQLEREGIFMEDTACFYLAEI 130

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YR 234
             AL ++H   G+ +RD+KP+N+++N   H +KL DFG  K  +         C    Y 
Sbjct: 131 SMALGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYM 188

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           APE++   + +  A+D WS G ++ ++L G P F GE+   + ++ I             
Sbjct: 189 APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL------------ 234

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHP 349
                 +   P              +  EA DL+ +LL+ +   R       A E   HP
Sbjct: 235 ----KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278

Query: 350 FFDELRDPN-TRLPNGRFLPPLFNFKPH 376
           FF   R  N   L   +  PP   FKP 
Sbjct: 279 FF---RHINWEELLARKVEPP---FKPL 300

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  131 bits (332), Expect = 1e-34
 Identities = 80/330 (24%), Positives = 127/330 (38%), Gaps = 75/330 (22%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 123
           +V+G G+FG V   +   T +  A+K     ++++     +   E   M   + P VV L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 124 KHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            + F     +D+ YL +V+EY+P  + V+ +  +       +P  + + Y  ++  AL  
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDA 183

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--------YICSRYY 233
           IH+ +G  HRD+KP N+L++   H LKL DFG+   + K              YI     
Sbjct: 184 IHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236

Query: 234 RAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            +PE++    G   Y    D WS G  L E+L+G   F  +S    LV            
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS-------- 283

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALI 347
             K MN       FP              +  EA +L+   L     +R   +   E   
Sbjct: 284 --KIMNHK-NSLTFPD---DND-------ISKEAKNLICAFLT-DREVRLGRNGVEEIKR 329

Query: 348 HPFFDELRDPN-TRLPNGRFLPPLFNFKPH 376
           H FF                + P     P 
Sbjct: 330 HLFFKND---QWAWETLRDTVAP---VVPD 353

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  130 bits (328), Expect = 2e-34
 Identities = 86/326 (26%), Positives = 138/326 (42%), Gaps = 70/326 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
           RV+G GSFG V  A+  ETG+  A+K      +LQD   +      R L   R  +HP +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L  C F T ++  L+   V+E+V   +     +  H + S+R      + Y  +I  A
Sbjct: 87  TQLFCC-FQTPDR--LF--FVMEFVNGGD-----LMFHIQKSRRFDEARARFYAAEIISA 136

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 237
           L ++H+  G+ +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE
Sbjct: 137 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++     Y  A+D W+ G +L E+L G   F  E+  D L E I                
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL--------------- 237

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR------STALEALIHPFF 351
              E  +P              +  +A  ++   +  +P +R            L HPFF
Sbjct: 238 -NDEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

Query: 352 DELRDPN-TRLPNGRFLPPLFNFKPH 376
              ++ +  +L + +  PP   F+P 
Sbjct: 285 ---KEIDWAQLNHRQIEPP---FRPR 304

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  130 bits (328), Expect = 2e-34
 Identities = 83/323 (25%), Positives = 128/323 (39%), Gaps = 66/323 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQ-DKRYKNRELQ-TM-------RLLDHPNVV 121
           +V+G GSFG V  A+        A+ KVLQ     K +E +  M       + + HP +V
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAV-KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L    F T +K  LY   VL+Y+   E     + +H +  +       + Y  +I  AL
Sbjct: 103 GLHFS-FQTADK--LY--FVLDYINGGE-----LFYHLQRERCFLEPRARFYAAEIASAL 152

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 238
            Y+H+ + + +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE+
Sbjct: 153 GYLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     Y   +D W  G VL E+L G P F   +   ++ + I                 
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR----STALEALIHPFFDEL 354
               +                +   A  L+  LLQ     R       +E   H FF   
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF--- 297

Query: 355 RDPN-TRLPNGRFLPPLFNFKPH 376
              N   L N +  PP   F P+
Sbjct: 298 SLINWDDLINKKITPP---FNPN 317

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  129 bits (327), Expect = 2e-34
 Identities = 82/325 (25%), Positives = 126/325 (38%), Gaps = 69/325 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
            V+G GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L  C F T ++  LY   V+EYV   +     + +H +   R    +   Y  +I   
Sbjct: 84  TQLHSC-FQTMDR--LY--FVMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAAEIAIG 133

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 237
           L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE
Sbjct: 134 LFFLQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I                
Sbjct: 192 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 234

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                 +P            K M  EAV +   L+   P  R         +   H FF 
Sbjct: 235 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF- 280

Query: 353 ELRDPN-TRLPNGRFLPPLFNFKPH 376
             R  +  +L      PP   +KP 
Sbjct: 281 --RYIDWEKLERKEIQPP---YKPK 300

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  129 bits (326), Expect = 2e-34
 Identities = 85/323 (26%), Positives = 139/323 (43%), Gaps = 69/323 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 118
           +++G GSFG VF A+  +T +  AIK      VL D   +     TM   R+L    +HP
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLAWEHP 78

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +  +   F  T E   L+   V+EY+   +     + +H +   +  L     Y  +I 
Sbjct: 79  FLTHMFCTF-QTKEN--LFF--VMEYLNGGD-----LMYHIQSCHKFDLSRATFYAAEII 128

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-YRA 235
             L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y A
Sbjct: 129 LGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIA 186

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G  +Y  ++D WS G +L E+L+GQ  F G+   ++L   I+             
Sbjct: 187 PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR------------- 231

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-IHPFFDEL 354
                   +P            + +  EA DL+ +L    P  R      +  HP F   
Sbjct: 232 ---MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF--- 273

Query: 355 RDPN-TRLPNGRFLPPLFNFKPH 376
           R+ N   L      PP   F+P 
Sbjct: 274 REINWEELERKEIDPP---FRPK 293

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  127 bits (322), Expect = 1e-33
 Identities = 88/329 (26%), Positives = 143/329 (43%), Gaps = 66/329 (20%)

Query: 71  RVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKNREL--QTM---RLL----DHP 118
           +V+G G++G VF  + +   +TG+  A+K + +    +  +    T    ++L      P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V+L + F  T  K  L+L  +L+Y+   E     +  H    +R     V++Y  +I 
Sbjct: 120 FLVTLHYAF-QTETK--LHL--ILDYINGGE-----LFTHLSQRERFTEHEVQIYVGEIV 169

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRYYR 234
            AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C +  Y 
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 235 APELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
           AP+++ G    +  A+D WS G ++ ELL G   F  +   +   EI           I 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL 279

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 348
                 +E  +PQ             M   A DL+ RLL   P  R       A E   H
Sbjct: 280 -----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322

Query: 349 PFFDELRDPN-TRLPNGRFLPPLFNFKPH 376
            FF   +  N   L   +   P   FKP 
Sbjct: 323 LFF---QKINWDDLAAKKVPAP---FKPV 345

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  127 bits (321), Expect = 1e-33
 Identities = 76/302 (25%), Positives = 131/302 (43%), Gaps = 49/302 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           +   R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +  + C+     +   +  LV+EY   +   +++ H K    +  + +    +   + L
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
               E  Y   +D+WS G    EL   +P     + +  L  I +               
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------NES 270

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
                  P +++  W + F+        + V   LQ  P  R T+   L H F    R P
Sbjct: 271 -------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315

Query: 358 NT 359
             
Sbjct: 316 TV 317

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  126 bits (319), Expect = 3e-33
 Identities = 75/328 (22%), Positives = 135/328 (41%), Gaps = 65/328 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 118
           RV+G GS+  V   +  +T    A+K      V  D+              +     +HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID----WVQTEKHVFEQASNHP 70

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V L  C F T  +  L+   V+EYV   +     +  H +  +++P  + + Y  +I 
Sbjct: 71  FLVGLHSC-FQTESR--LF--FVIEYVNGGD-----LMFHMQRQRKLPEEHARFYSAEIS 120

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 121 LALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G  +Y  ++D W+ G ++ E++ G+  F      D   +        T + +   
Sbjct: 179 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 227

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR------STALEALIHP 349
                   F  I          + +  +A  ++   L   P  R      +   +   HP
Sbjct: 228 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277

Query: 350 FFDELRDPN-TRLPNGRFLPPLFNFKPH 376
           FF   R+ +   +   + +PP   FKP+
Sbjct: 278 FF---RNVDWDMMEQKQVVPP---FKPN 299

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  124 bits (313), Expect = 5e-33
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 32/225 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----------RELQTMRLLDHP 118
           E+ +G G FG+V + + ++    VAIK ++                  RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYVKLYFYQIC 176
           N+V L                +V+E+VP   ++  +    + +   + L  +      I 
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM----LDIA 132

Query: 177 RALAYIHN-TIGVCHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPNISYICSR 231
             + Y+ N    + HRD++  N+ +           K+ DFG ++           + + 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNF 190

Query: 232 YYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 275
            + APE I    E YT   D +S   +L  +L G+  F   S   
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  123 bits (312), Expect = 1e-32
 Identities = 68/302 (22%), Positives = 118/302 (39%), Gaps = 48/302 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +     +G GSFG VF+     T + VAIK +  ++         +E+  +   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
                +   T+     L +++EY+   +   +++        +    +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 239
           Y+H+     HRDIK  N+L++    ++KL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
             +  Y +  DIWS G    EL  G+P       +  L  I K    PT E         
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG-------- 241

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 359
                       + K  +        + V   L   P+ R TA E L H F        +
Sbjct: 242 -----------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

Query: 360 RL 361
            L
Sbjct: 283 YL 284

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  123 bits (310), Expect = 2e-32
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 47/300 (15%)

Query: 58  NGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMR 113
            G PK+   Y     +G G+ G V+ A  + TG+ VAI+++       K     E+  MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 172
              +PN+V+    +      DEL+  +V+EY+   ++  V+         M    +    
Sbjct: 73  ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTET-----CMDEGQIAAVC 122

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSR 231
            +  +AL ++H+   V HRDIK  N+L+      +KL DFG    +   +    + + + 
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP  + 
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN 238

Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                                  IF+        D ++R L+     R +A E L H F 
Sbjct: 239 -----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  127 bits (320), Expect = 4e-32
 Identities = 82/325 (25%), Positives = 126/325 (38%), Gaps = 69/325 (21%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 120
            V+G GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L  CF +    D LY   V+EYV   +     + +H +   R    +   Y  +I   
Sbjct: 405 TQLHSCFQT---MDRLYF--VMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAAEIAIG 454

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE
Sbjct: 455 LFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           +I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I                
Sbjct: 513 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 555

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFD 352
                 +P            K M  EAV +   L+   P  R         +   H FF 
Sbjct: 556 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF- 601

Query: 353 ELRDPN-TRLPNGRFLPPLFNFKPH 376
             R  +  +L      PP   +KP 
Sbjct: 602 --RYIDWEKLERKEIQPP---YKPK 621

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  123 bits (312), Expect = 5e-32
 Identities = 74/328 (22%), Positives = 135/328 (41%), Gaps = 65/328 (19%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 118
           RV+G GS+  V   +  +T    A++      V  D+              +     +HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID----WVQTEKHVFEQASNHP 113

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            +V L  C F T  +  L+   V+EYV   +     +  H +  +++P  + + Y  +I 
Sbjct: 114 FLVGLHSC-FQTESR--LF--FVIEYVNGGD-----LMFHMQRQRKLPEEHARFYSAEIS 163

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 235
            AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 164 LALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++ G  +Y  ++D W+ G ++ E++ G+  F      D   +        T + +   
Sbjct: 222 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 270

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR------STALEALIHP 349
                   F  I          + +  +A  ++   L   P  R      +   +   HP
Sbjct: 271 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320

Query: 350 FFDELRDPN-TRLPNGRFLPPLFNFKPH 376
           FF   R+ +   +   + +PP   FKP+
Sbjct: 321 FF---RNVDWDMMEQKQVVPP---FKPN 342

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (307), Expect = 6e-32
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYK---NRELQTMRLLDHP 118
           Y   R+VG G  G V++A+       VA+K ++      D  ++    RE +T   L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           +VV +        E D     + +  +    +  +++    ++    +  V+    QI  
Sbjct: 95  HVVPI----HDFGEIDGQLY-VDMRLINGVDLAAMLRRQGPLAPPRAVAIVR----QIGS 145

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYY 233
           AL   H   G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            APE    +   T   DI++  CVL E L G P + G+ 
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (304), Expect = 2e-31
 Identities = 72/291 (24%), Positives = 127/291 (43%), Gaps = 45/291 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
             +   +G GS G+V  A+   +G  VA+K +     Q +     E+  MR   H NVV 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           +   +      +EL+  +++E++    +  ++        R+    +      + +ALAY
Sbjct: 107 MYKSYLV---GEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAY 156

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 240
           +H   GV HRDIK  ++L+     ++KL DFG  A++        S + + Y+ APE+I 
Sbjct: 157 LHAQ-GVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
             + Y   +DIWS G ++ E++ G+P +  +S V  +  +      P  +          
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN--------- 263

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                   +H    + +        D + R+L   P  R+TA E L HPF 
Sbjct: 264 --------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  120 bits (304), Expect = 2e-31
 Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 41/297 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 124
           +     +G GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D P+VV   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
             +F  T+     L +V+EY    +V  +I+     ++ +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLH 142

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 242
                 HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I   
Sbjct: 143 FM-RKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
             Y    DIWS G    E+  G+P +     +  +  I      PT  +           
Sbjct: 201 -GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK----------- 247

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 359
                    W   F         D V + L  SP  R+TA + L HPF    +  + 
Sbjct: 248 ------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  120 bits (303), Expect = 2e-31
 Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 30/222 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDH 117
           Y     +G G    V+ A+       VAIK  +           KR++ RE+     L H
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFE-REVHNSSQLSH 70

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
            N+VS+        E+D+ Y  LV+EY+   T+   I+ H  +S    + +      QI 
Sbjct: 71  QNIVSM----IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QIL 121

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRY 232
             + + H+   + HRDIKPQN+L++     LK+ DFG AK L   E +++     + +  
Sbjct: 122 DGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQ 177

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
           Y +PE   G        DI+S G VL E+L+G+P F GE+ V
Sbjct: 178 YFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (315), Expect = 2e-31
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQD-------KRYKNRELQTMRLLDHP 118
           Y  +  + HG  G ++ A      G  V +K  L               E Q +  + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139

Query: 119 NVVSLKHCFFSTTEKDELYLN-LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           ++V +   F   T++    +  +V+EYV  +++ R         Q++P+     Y  +I 
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISYICSR 231
            AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +     + G P        
Sbjct: 193 PALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYLYGTP-------- 241

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 272
            ++APE++      T A DI++ G  LA L L  P   G  
Sbjct: 242 GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (303), Expect = 2e-31
 Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 46/303 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
           +     +G G+FG V++AK  ETG   A K +     ++      E++ +   DHP +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           L   ++   +     L +++E+ P   V  ++    +    +    +++   Q+  AL +
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNF 132

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 240
           +H+   + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++ 
Sbjct: 133 LHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 241 GAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
             T     Y    DIWS G  L E+   +P     + +  L++I K    PT        
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT----- 244

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
                          W   F+        D +   L  +P  R +A + L HPF   +  
Sbjct: 245 ------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVSSITS 284

Query: 357 PNT 359
              
Sbjct: 285 NKA 287

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (303), Expect = 2e-31
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-----QDKRYKNR---ELQTMRLLDHP 118
           Y    ++G G    V  A+ L     VA+K VL     +D  +  R   E Q    L+HP
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHP 72

Query: 119 NVVSLKHCFFSTTEKDELYLN---LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
            +V++    + T E +        +V+EYV   T+  ++     M+ +  +  +      
Sbjct: 73  AIVAV----YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA----D 124

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICS 230
            C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++     I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 231 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 274
             Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 183 AQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  120 bits (303), Expect = 3e-31
 Identities = 70/307 (22%), Positives = 128/307 (41%), Gaps = 42/307 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMR-LLDHPNVVS 122
           +    +VG+G++G V++ + ++TG+  AIK +     ++    +E+  ++    H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 123 LKHCFF-STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
               F        +  L LV+E+    +V  +IK+       +   ++     +I R L+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLS 143

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 239
           ++H    V HRDIK QN+L+     ++KL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLHQH-KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 240 ----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
                    Y    D+WS G    E+  G P       +  L  I +             
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR------------- 248

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
           NP       P++K+  W K FQ          +   L  + + R    + + HPF  +  
Sbjct: 249 NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIRDQP 294

Query: 356 DPNTRLP 362
           +      
Sbjct: 295 NERQVRI 301

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  118 bits (299), Expect = 3e-31
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--------RELQTMRLLDHPNVV 121
           E ++G G FG V++A  +  G+ VA+K    D             +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 122 SLK-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYVKLYFYQICRA 178
           +L+  C     ++  L L  V+E+     ++RV+          +          QI R 
Sbjct: 70  ALRGVC----LKEPNLCL--VMEFARGGPLNRVLSGKRIPPDILVNWAV------QIARG 117

Query: 179 LAYIH--NTIGVCHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLVKGEPNISYIC 229
           + Y+H    + + HRD+K  N+L+             LK+ DFG A+   +    +S   
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAG 176

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
           +  + APE+I  +  ++   D+WS G +L ELL G+  F G
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  117 bits (294), Expect = 5e-30
 Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 46/312 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKN--RELQTMRLLDHPNVVSLKH 125
             V+G G FG   +    ETGE + +K++++  ++  +   +E++ MR L+HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAYIH 183
                 +   L    + EY+   T+  +IK    M  + P    ++ F   I   +AY+H
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWS-QRVSFAKDIASGMAYLH 125

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------------ 231
           + + + HRD+   N LV      + + DFG A+++V  +     + S             
Sbjct: 126 S-MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 232 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
              Y+ APE+I G   Y   +D++S G VL E++      P          +        
Sbjct: 184 GNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF--L 240

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----L 343
                   P      F  I         +KR  P  V L   L     +L         L
Sbjct: 241 DRYC----PPNCPPSFFPITVRCCDLDPEKR--PSFVKLEHWLETLRMHLAGHLPLGPQL 294

Query: 344 EALIHPFFDELR 355
           E L   F++  R
Sbjct: 295 EQLDRGFWETYR 306

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  116 bits (293), Expect = 6e-30
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
           +  +G GSFG V +A+    G  VA+K +++   +        RE+  M+ L HPN+V  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                + T+   L   +V EY+   +++R++ H     +++         Y + + + Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 183 HN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 240
           HN    + HR++K  NLLV+   + +K+CDFG +++      +  S   +  + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
                    D++S G +L EL   Q  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  116 bits (293), Expect = 8e-30
 Identities = 44/216 (20%), Positives = 84/216 (38%), Gaps = 34/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 125
            + +G G +G V+  K    GE VA+K     ++    RE  +    L+ H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 183
               T    +LYL  + +Y    +++  +K         + L Y           L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 184 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 231
             I        + HRD+K +N+LV  +     + D G A   +     +    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 232 YYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 262
            Y  PE++  +      +     D++S G +L E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  115 bits (289), Expect = 2e-29
 Identities = 47/216 (21%), Positives = 87/216 (40%), Gaps = 34/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 125
              VG G +G V++      GE VA+K    +D++   RE  L    +L H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 183
              S     +L+L  +  Y    +++  ++         + +         I   LA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRI------VLSIASGLAHLH 122

Query: 184 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 231
             I        + HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 232 YYRAPELI-----FGATEYTAAIDIWSAGCVLAELL 262
            Y APE++         +    +DIW+ G VL E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  112 bits (282), Expect = 9e-29
 Identities = 28/211 (13%), Positives = 74/211 (35%), Gaps = 22/211 (10%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 123
              +     G +++ +    G  + +K +          R  N E   +R+  HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                        +  L+  ++P  +++ V+  H   +  +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 183 HN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           H     +    +  ++++++      ++                  + +  + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEALQK 182

Query: 242 --ATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
                   + D+WS   +L EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (281), Expect = 5e-28
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 125
           +  +G G FG V++ K    GE VA+K    +++R   RE  +    +L H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 126 CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIH 183
                    +L+L  V +Y    ++   +  +   +   + L             LA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156

Query: 184 NTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS-----R 231
             I        + HRD+K +N+LV  +     + D G A         I    +     +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 232 YYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 262
            Y APE++  +      E     DI++ G V  E+ 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  109 bits (275), Expect = 1e-27
 Identities = 48/224 (21%), Positives = 96/224 (42%), Gaps = 26/224 (11%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 124 KHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F   +   +L +  V ++    +++  +        +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
           H    + HRD+K  N+ ++   + +K+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 H-AKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 281
                  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  109 bits (273), Expect = 4e-27
 Identities = 56/255 (21%), Positives = 104/255 (40%), Gaps = 39/255 (15%)

Query: 64  TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV 120
           ++      V   G FG V++A+     E VA+K    QDK+    E  + ++  + H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 121 VS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVKLYFYQICR 177
           +  +      T+   +L+L  +  +  + ++   +K +    ++   +         + R
Sbjct: 81  LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132

Query: 178 ALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
            LAY+H  I          + HRDIK +N+L+  +     + DFG A      E   S  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAG 188

Query: 229 CSRY------YRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 278
            +        Y APE++ GA     +    ID+++ G VL EL        G      L 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 279 EIIKVLGTPTREEIK 293
              ++   P+ E+++
Sbjct: 249 FEEEIGQHPSLEDMQ 263

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  107 bits (268), Expect = 2e-26
 Identities = 41/228 (17%), Positives = 85/228 (37%), Gaps = 47/228 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
             ++G G FG V+  +       VAI+ +  ++  ++      RE+   R   H NVV  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 124 K-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI---KHHYKMSQRMPLIYVKLYFYQICRA 178
              C         L   ++       T++ V+   K    +++   +        +I + 
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVRDAKIVLDVNKTRQIA------QEIVKG 142

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY------ 232
           + Y+H   G+ H+D+K +N+  +     + + DFG     + G         +       
Sbjct: 143 MGYLH-AKGILHKDLKSKNVFYDNGK--VVITDFGLFS--ISGVLQAGRREDKLRIQNGW 197

Query: 233 --YRAPELIFGATE--------YTAAIDIWSAGCVLAELLLGQPLFPG 270
             + APE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  103 bits (259), Expect = 4e-25
 Identities = 53/253 (20%), Positives = 98/253 (38%), Gaps = 37/253 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHC 126
             ++G G +G V++         VA+K     +++    E    R+  ++H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT 185
               T    +   LV+EY P  ++ + +  H         +      + + R LAY+H  
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130

Query: 186 I--------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY----- 232
           +         + HRD+  +N+LV        + DFG +  L                   
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 233 ----YRAPELIFGA------TEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVD-QLVEI 280
               Y APE++ GA            +D+++ G +  E+ +    LFPGES  + Q+   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 281 IKVLGTPTREEIK 293
            +V   PT E+++
Sbjct: 250 TEVGNHPTFEDMQ 262

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 93.7 bits (233), Expect = 6e-22
 Identities = 37/313 (11%), Positives = 69/313 (22%), Gaps = 76/313 (24%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNR---ELQTMRLLDHPN 119
           Y      G       +QA        VA+  V                    +  +D P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  +              L +V E++   ++  V             +        +  A
Sbjct: 93  VARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAA 141

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
               H   GV      P  + V+     + L                             
Sbjct: 142 ADAAHRA-GVALSIDHPSRVRVSI-DGDVVLAYPA-------------------TMPDA- 179

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
                      DI   G  L  LL+ +   P       L    +        E   ++ +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD 231

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
                                +P +   + +R +Q    +RS +         + ++   
Sbjct: 232 ---------------------IPFQISAVAARSVQGDGGIRSASTLL------NLMQQAT 264

Query: 359 TRLPNGRFLPPLF 371
                   L P+ 
Sbjct: 265 AVADRTEVLGPID 277

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 52/238 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
             L            +   L+ + +P    +  V +H       +   Y+  +  QI + 
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKG 129

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                    A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 44/235 (18%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            R +G G FG V           TGE VA+K +  D   ++     +E+  +R L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +  K C     +     L LV+EYVP      ++  Y     + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLR-DYLPRHSIGLAQLLLFAQQICEGMA 148

Query: 181 YIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR---- 234
           Y+H  + I   HRD+  +N+L++ +   +K+ DFG AK + +G          YYR    
Sbjct: 149 YLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVRED 196

Query: 235 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 280
                   APE +     +  A D+WS G  L ELL          +   +L+ I
Sbjct: 197 GDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            + +G G+FG V   +       TGE VA+KK LQ    ++     RE++ ++ L H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  K             L L++EY+P       + KH  ++     L Y      QIC+ 
Sbjct: 74  VKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT----SQICKG 126

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+     I   HRD+  +N+LV  + +++K+ DFG  KVL + +         +++  
Sbjct: 127 MEYLGTKRYI---HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE--------FFKVK 174

Query: 235 ----------APELIFGATEYTAAIDIWSAGCVLAELL 262
                     APE +   ++++ A D+WS G VL EL 
Sbjct: 175 EPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 44/217 (20%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIK--KVLQDKRYKN--RELQTMRLLDHPNVV 121
            + +G G+FG V   +       TGE VA+K  +   ++  ++  RE++ ++ L H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             K             L L++EY+P       + KH  ++     L Y      QIC+ +
Sbjct: 106 KYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT----SQICKGM 158

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +         YY+   
Sbjct: 159 EYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKE 206

Query: 235 ---------APELIFGATEYTAAIDIWSAGCVLAELL 262
                    APE +   ++++ A D+WS G VL EL 
Sbjct: 207 PGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 49/233 (21%), Positives = 88/233 (37%), Gaps = 40/233 (17%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
            R++G G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 121 VSLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL--YFYQIC 176
             L      S  +       ++L ++    +H  +           L    L  +   I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
             + Y+ ++    HRD+  +N ++      + + DFG ++ +  G+         YYR  
Sbjct: 148 CGMEYL-SSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD---------YYRQG 196

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     A E L      YT   D+W+ G  + E++  GQ  + G    +
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 43/217 (19%)

Query: 70  ERVVGHGSFGVVFQAKCL----ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            R +G G FG V   +       TGE VA+K +  +    +     +E++ +R L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V  K      TE     + L++E++P  ++   +  +     ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGM 139

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     +   HRD+  +N+LV    HQ+K+ DFG  K +   +         YY    
Sbjct: 140 DYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKD 187

Query: 235 ---------APELIFGATEYTAAIDIWSAGCVLAELL 262
                    APE +  +  +  A D+WS G  L ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 46/218 (21%)

Query: 70  ERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
              +G G+FG V   +       TG  VA+K  LQ           RE+Q ++ L    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           V  +   +    +  L   LV+EY+P       + +H  ++     L+Y      QIC+ 
Sbjct: 87  VKYRGVSYGPGRQS-LR--LVMEYLPSGCLRDFLQRHRARLDASRLLLYS----SQICKG 139

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   +         YY   
Sbjct: 140 MEYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVR 187

Query: 235 ----------APELIFGATEYTAAIDIWSAGCVLAELL 262
                     APE +     ++   D+WS G VL EL 
Sbjct: 188 EPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 46/234 (19%), Positives = 87/234 (37%), Gaps = 43/234 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
            +++G G FG V +    +       VA+K +  D   +        E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL--YFYQICR 177
           + L       + +      ++L ++    +H  + +    +    +    L  +   I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + Y+   N +   HRD+  +N ++      + + DFG +K +  G+         YYR 
Sbjct: 159 GMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YYRQ 205

Query: 235 -----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                      A E L      YT+  D+W+ G  + E+   G   +PG    +
Sbjct: 206 GRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 55/224 (24%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT----MRLLDHPNVVSL-K 124
           + ++GHG FG V++   L  G  VA+K+   +      E +T    +    HP++VSL  
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 125 HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMS--QRMPLIYVKLYFYQIC- 176
            C     E++E+ L  + +Y+        ++        MS  QR+          +IC 
Sbjct: 103 FC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EICI 146

Query: 177 ---RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 232
              R L Y+H    + HRD+K  N+L++ +    K+ DFG +K   + +   +++ +   
Sbjct: 147 GAARGLHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELDQ--THLSTVVK 202

Query: 233 ----YRAPELIFGATEY------TAAIDIWSAGCVLAELLLGQP 266
               Y  P       EY      T   D++S G VL E+L  + 
Sbjct: 203 GTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 33/226 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
               T +   Y  ++ E++    +  +  + +   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N I   HR++  +N LV    H +K+ DFG ++++        Y      +      AP
Sbjct: 337 KNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 388

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E +     ++   D+W+ G +L E+   G   +PG       +L+E
Sbjct: 389 ESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 83.8 bits (206), Expect = 4e-18
 Identities = 50/330 (15%), Positives = 90/330 (27%), Gaps = 74/330 (22%)

Query: 73  VGHGSFGVVFQAKCLETGEAVAIKKV-LQDKRYKNRE--------------------LQT 111
           +G G FG VFQ         VAIK + ++     N                      L  
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY---------------------VPETVH 150
                    + L            L L     Y                     V E   
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 151 RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 210
             I      ++   L   K   +Q+  +LA    ++   HRD+   N+L+   + + KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK-KLH 204

Query: 211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 270
              + K                     L     +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 271 ESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIFQ--KRMP 321
           +   D   +I +++           +P       +Y   K  +             K++ 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309

Query: 322 PEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            +  +    +L +     S+A + L     
Sbjct: 310 RKIQEFHRTMLNF-----SSATDLLCQHSL 334

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 47/232 (20%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGEA--VAIKKV---LQDKRYKN---RELQTMRLLDHPN 119
           + ++ +G G+FG V +           VA+K +     D   K+    E   M+ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V +        E +     LV+E         +  + + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+   N +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + +   ++++  D+WS G ++ E    GQ  + G  G +
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 45/228 (19%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 124
              +G G+FG VF  +       VA+K   +      +     E + ++   HPN+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 125 H--CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRALAY 181
              C    T+K  +Y  +V+E V            +       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------- 234
           + +     HRD+  +N LV    + LK+ DFG ++    G          Y         
Sbjct: 229 LES-KCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLRQV 277

Query: 235 -----APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                APE L +G   Y++  D+WS G +L E   LG   +P  S   
Sbjct: 278 PVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 82.0 bits (203), Expect = 9e-18
 Identities = 45/235 (19%), Positives = 78/235 (33%), Gaps = 50/235 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA-------VAIKKVLQDKRYKN----RELQTMRLLDHP 118
              +G G+F  +F+    E G+        V +K + +  R  +         M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 119 NVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQIC 176
           ++V     C       DE    LV E+V       +  + K ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 177 RALAYI--HNTIGVCHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVKGEPNISY 227
            A+ ++  +  I   H ++  +N+L+     +        KL D G +  ++  +     
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----- 175

Query: 228 ICSRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 +       PE I        A D WS G  L E+   G           
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 33/216 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
               T +   Y  ++ E++    +  +  + +   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N I   HRD+  +N LV  + H +K+ DFG ++++        Y      +      AP
Sbjct: 130 KNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAP 181

Query: 237 E-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
           E L +   +++   D+W+ G +L E+   G   +PG
Sbjct: 182 ESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 48/236 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
             L            +   L+ + +P   +   ++ H      +   Y+  +  QI + +
Sbjct: 80  CRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E          Y    
Sbjct: 131 NYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAEG 178

Query: 235 --------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                   A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 179 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 37/215 (17%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
            + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI--H 183
               EK  LY  +V EY+       +  + +   R  L    L  +   +C A+ Y+  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APE 237
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 309 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 356

Query: 238 -LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
            L     +++   D+WS G +L E+   G+  +P 
Sbjct: 357 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
            ++   ++ +Y  +V EY+       +    K      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 299 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 350

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E       +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 351 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 37/220 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 127
            + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI--H 183
               EK  LY  +V EY+       +  + +   R  L    L  +   +C A+ Y+  +
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------APE 237
           N +   HRD+  +N+LV+   +  K+ DFG  K                 +      APE
Sbjct: 137 NFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPE 184

Query: 238 -LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
            L     +++   D+WS G +L E+   G+  +P     D
Sbjct: 185 ALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 35/226 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
            ++   ++ +Y  +V EY+       +    K      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR------AP 236
            N +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      AP
Sbjct: 382 MNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAP 433

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
           E       +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 434 EAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 51/231 (22%), Positives = 94/231 (40%), Gaps = 38/231 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
            +V+G G FG V +   +  GE+    V IK +      ++       +  +  LDH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L            L   LV +Y+P  ++   ++ H      +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGM 128

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+  H  +   HR++  +N+L+     Q+++ DFG A +L   +     +     +   
Sbjct: 129 YYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPI 181

Query: 235 ---APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
              A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 47/232 (20%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L        + + L   LV+E      +H+ +       + +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGM 449

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+   N +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + F   ++++  D+WS G  + E L  GQ  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E+ +G G FG V+ A   +  + VA+K +            E   M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
             +   K+ +Y  ++ E++       +    K  +       KL  +  QI   +A+I  
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 234
            N I   HRD++  N+LV+      K+ DFG A+V+   E         Y          
Sbjct: 303 RNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPI 349

Query: 235 ---APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
              APE + FG   +T   D+WS G +L E++  G+  +PG S  +  + +E
Sbjct: 350 KWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 57/252 (22%), Positives = 93/252 (36%), Gaps = 56/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLDHP 118
            + +G G+FG V +A        +    VA+K +     L ++     EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRMPL 165
           N+V+L       T        ++ EY                 +             + L
Sbjct: 88  NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 166 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
               L    YQ+ + +A++  +    HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDS- 199

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                    Y             APE IF    YT   D+WS G  L EL  LG   +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 271 ESGVDQLVEIIK 282
                +  ++IK
Sbjct: 251 MPVDSKFYKMIK 262

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 47/232 (20%)

Query: 68  MAERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V L        + + L   LV+E      +H+ +    +      +       +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAE---LLHQVSMGM 123

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+   N +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + F   ++++  D+WS G  + E L  GQ  +    G +
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 49/242 (20%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTM 112
           P + +   ++RV+G G FGVV+  + ++  +     AIK    + + +      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 113 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 172
           R L+HPNV++L         +   +  ++L Y+    H  +    +  QR P +   + F
Sbjct: 77  RGLNHPNVLALIGI--MLPPEGLPH--VLLPYMC---HGDLLQFIRSPQRNPTVKDLISF 129

Query: 173 -YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 229
             Q+ R + Y+     +   HRD+  +N +++  +  +K+ DFG A+ ++  E       
Sbjct: 130 GLQVARGMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE------- 178

Query: 230 SRYYR--------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 273
             YY               A E L      +T   D+WS G +L ELL  G P +     
Sbjct: 179 --YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

Query: 274 VD 275
            D
Sbjct: 235 FD 236

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 78.8 bits (195), Expect = 8e-17
 Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 51/229 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 125
            + +G G FG+V     L   + VAIK + +    +     E + M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 126 CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C     E+  +   LV E++         R  +  +       L+        +C  +AY
Sbjct: 72  C----LEQAPIC--LVTEFMEHGCLSDYLRTQRGLFAAET---LLG---MCLDVCEGMAY 119

Query: 182 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
           +     I   HRD+  +N LV  +   +K+ DFG  + ++  +         Y       
Sbjct: 120 LEEACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTK 166

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 +PE   F    Y++  D+WS G ++ E+   G+  +   S  +
Sbjct: 167 FPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 51/229 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 125
            + +G G FGVV   K     + VA+K + +    ++   +E QTM  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 126 CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    +++  +Y  +V EY+         R      + SQ   L+      Y +C  +A+
Sbjct: 72  C----SKEYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQ---LLE---MCYDVCEGMAF 119

Query: 182 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
           +  H  I   HRD+  +N LV+     +K+ DFG  + ++  +         Y       
Sbjct: 120 LESHQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTK 166

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 APE   +   +Y++  D+W+ G ++ E+  LG+  +   +  +
Sbjct: 167 FPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 56/261 (21%), Positives = 102/261 (39%), Gaps = 63/261 (24%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKV----LQDKRYKNRELQT 111
            ++ I     R +G G+FG VF A+C           VA+K +    L  ++   RE + 
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMS 160
           +  L H ++V          + D L   +V EY+                 ++       
Sbjct: 71  LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 161 QRMPLIYVKLYF--YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 216
            +  L   ++     QI   + Y+   + +   HRD+  +N LV  +   +K+ DFG ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSR 181

Query: 217 VLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL- 262
            +   +         YYR             PE +++   ++T   D+WS G +L E+  
Sbjct: 182 DVYSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFT 230

Query: 263 LG-QPLFPGESGVDQLVEIIK 282
            G QP +   S   +++E I 
Sbjct: 231 YGKQP-WFQLS-NTEVIECIT 249

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
              +G G FG V+        + VA+K + Q     +    E   M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL--YFYQICRALAYI-- 182
            ++   ++ +Y  ++ EY+    +  +    K    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-------- 234
            N I   HRD++  N+LV+      K+ DFG A+++   E         Y          
Sbjct: 128 RNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPI 174

Query: 235 ---APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
              APE + +G   +T   D+WS G +L E++  G+  +PG +   V Q +E
Sbjct: 175 KWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 52/243 (21%), Positives = 95/243 (39%), Gaps = 50/243 (20%)

Query: 71  RVVGHGSFGVVFQAKCLETGE-----AVAIKKV-----LQDKRYKNRELQTMRLLDHPNV 120
           R +G GSFG+V++       +      VAIK V     ++++     E   M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVKLYFY 173
           V L       ++       +++E +            R    +  +     L  +     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
           +I   +AY+ N     HRD+  +N +V      +K+ DFG  + + + +         YY
Sbjct: 146 EIADGMAYL-NANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD---------YY 194

Query: 234 R------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 279
           R            +PE L  G   +T   D+WS G VL E+  L +  + G S  +Q++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251

Query: 280 IIK 282
            + 
Sbjct: 252 FVM 254

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 53/249 (21%)

Query: 71  RVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLD-HPN 119
           + +G G+FG V +A         T   VA+K +       + R    EL+ +  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRMPLI 166
           VV+L      T     L   +++E+               E V   +         + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 167 YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
           ++  Y +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ + K      
Sbjct: 149 HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP---- 202

Query: 227 YICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 273
                 Y             APE IF    YT   D+WS G +L E+  LG   +PG   
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 274 VDQLVEIIK 282
            ++    +K
Sbjct: 257 DEEFCRRLK 265

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 77.6 bits (192), Expect = 3e-16
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 54/233 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
            R++G G FG V++            VA+K   +D    N+     E   M+ LDHP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L        E++  +  +++E  P           K+  K+     L+    Y  QIC+
Sbjct: 77  KL----IGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLT---LVL---YSLQICK 124

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
           A+AY+   N +   HRDI  +N+LV      +KL DFG ++ +   +         YY+ 
Sbjct: 125 AMAYLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKA 171

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     +PE + F    +T A D+W     + E+L  G+  F      D
Sbjct: 172 SVTRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 55/236 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 121
             V+G G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIYVKL--YFYQI 175
           SL         +      +VL Y+        KH    ++  ++        L  +  Q+
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + + Y+ +     HRD+  +N +++     +K+ DFG A+ +   E         YY  
Sbjct: 138 AKGMKYLAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSV 186

Query: 235 -------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                        A E L     ++T   D+WS G +L EL+  G P +P  +  D
Sbjct: 187 HNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 56/239 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
            R +G G FG V Q   +       AVAIK          R     E  TMR  DHP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L         ++ ++  +++E        +  +V K    ++    LI    Y YQ+  
Sbjct: 455 KL----IGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLAS---LIL---YAYQLST 502

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
           ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+ 
Sbjct: 503 ALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKA 549

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQLVE 279
                     APE + F    +T+A D+W  G  + E+L  G   F G     V   +E
Sbjct: 550 SKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 56/240 (23%), Positives = 90/240 (37%), Gaps = 54/240 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
              +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           ++ L    +       +   +V E  P    + R+ KH         L  +  Y  Q+  
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAE 132

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + Y+     I   HRD+  +NLL+      +K+ DFG  + L + +         +Y  
Sbjct: 133 GMGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVM 180

Query: 235 -----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 279
                      APE L      ++ A D W  G  L E+   GQ  + G +G      ++
Sbjct: 181 QEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 54/233 (23%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
            R +G G FG V Q   +       AVAIK          R     E  TMR  DHP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
            L         ++ ++  +++E        +  +V K+   ++    LI    Y YQ+  
Sbjct: 80  KL----IGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLAS---LIL---YAYQLST 127

Query: 178 ALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
           ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +             YY+ 
Sbjct: 128 ALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKA 174

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     APE + F    +T+A D+W  G  + E+L  G   F G    D
Sbjct: 175 SKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 43/229 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           ++VVG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 122 SLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L+       T+   +   +V EY+   ++   ++ H      + L+        I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYMENGSLDSFLRKHDAQFTVIQLVG---MLRGIASGM 160

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
            Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL              Y      
Sbjct: 161 KYL-SDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRGGK 211

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                 +PE + +   ++T+A D+WS G VL E++  G+  +   S  D
Sbjct: 212 IPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 49/232 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 121
           E+++G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 122 SLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            L+       T        +V EY+   ++   ++ H      M L+        +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGM 164

Query: 180 AYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR--- 234
            Y+     +   HRD+  +N+LV+ +    K+ DFG ++VL                   
Sbjct: 165 RYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTT 212

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + F    +++A D+WS G V+ E+L  G+  +   +  D
Sbjct: 213 GGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.0 bits (190), Expect = 7e-16
 Identities = 55/249 (22%), Positives = 96/249 (38%), Gaps = 56/249 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKV----LQDKRYKNRELQTMRLLDHPNV 120
           +  +G G+FG VF A+C           VA+K +       ++   RE + + +L H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP----------ETVHRVIKHHYKMSQRMPLIYVKL 170
           V         TE   L   +V EY+                 +    +     PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 171 YF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
                Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ +   +      
Sbjct: 161 LAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD------ 212

Query: 229 CSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGESG 273
              YYR             PE +++   ++T   D+WS G VL E+   G QP +   S 
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265

Query: 274 VDQLVEIIK 282
             + ++ I 
Sbjct: 266 NTEAIDCIT 274

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 76.6 bits (189), Expect = 8e-16
 Identities = 47/223 (21%), Positives = 87/223 (39%), Gaps = 43/223 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 123
           Y   R +G GSFGV+F+   L   + VAIK   +         E +T +LL     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            +       ++ L+  LV++ +  ++  ++       ++  +  V +   Q+   +  IH
Sbjct: 72  YYFG-----QEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 184 NTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YR 234
               + +RDIKP N L+    + + + + + DFG  K          Y          YR
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173

Query: 235 APELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
             + + G   Y  +I            D+ + G V    L G 
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 51/229 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 125
            + +G G FGVV   K     + VAIK + +    ++    E + M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 126 CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           C    T++  ++  ++ EY+         R ++H ++  Q   L+        +C A+ Y
Sbjct: 88  C----TKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQ---LLE---MCKDVCEAMEY 135

Query: 182 I--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR----- 234
           +     +   HRD+  +N LVN     +K+ DFG ++ ++  E         Y       
Sbjct: 136 LESKQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSK 182

Query: 235 ------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                  PE L++   ++++  DIW+ G ++ E+  LG+  +   +  +
Sbjct: 183 FPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 51/222 (22%), Positives = 98/222 (44%), Gaps = 50/222 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 124
           + ++G G FG V++ + L  G  VA+K++ +++          E++ + +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 125 -HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKM--SQRMPLIYVKLYFYQIC 176
             C        E  L  V  Y+        +    +    +   +R           +I 
Sbjct: 94  GFC----MTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQ----------RIA 137

Query: 177 ----RALAYIHNTIGVC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 230
               R LAY+H+       HRD+K  N+L++    +  + DFG AK++   +   +++ +
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTT 193

Query: 231 RY-----YRAPE-LIFG-ATEYTAAIDIWSAGCVLAELLLGQ 265
                  + APE L  G ++E T   D++  G +L EL+ GQ
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 50/233 (21%), Positives = 90/233 (38%), Gaps = 49/233 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA---VAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 121
             V+G G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIYVKL--YFYQI 175
           SL         +      +VL Y+        KH    ++  ++        L  +  Q+
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTVKDLIGFGLQV 201

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR- 234
            + + ++  +    HRD+  +N +++     +K+ DFG A+ +   E +        +  
Sbjct: 202 AKGMKFL-ASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNK 253

Query: 235 ----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                     A E L     ++T   D+WS G +L EL+  G P +P  +  D
Sbjct: 254 TGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 45/223 (20%), Positives = 81/223 (36%), Gaps = 43/223 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIK--KVLQDKRYKNRELQTMRLLDH-PNVVSL 123
           +   + +G G+FG +   K L T E VAIK   +       + E +  + L     +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            +           Y  +VLE +  ++  +        +   L  V +   Q+   + Y+H
Sbjct: 71  YYFG-----PCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 184 NTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YR 234
           +   + +RD+KP+N L+    N     + + DF  AK          YI         YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172

Query: 235 APELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
             + + G   Y  +I            D+ + G +    L G 
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 58/268 (21%), Positives = 100/268 (37%), Gaps = 68/268 (25%)

Query: 61  PKQTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQ 110
           P+  I Y+  R +G G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-------------------ETVHR 151
            M   D+PN+V L            + L  + EY+                         
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 152 VIKHHYKMSQRMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL 209
             +         PL   +      Q+   +AY+ +     HRD+  +N LV  +   +K+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGEN-MVVKI 215

Query: 210 CDFGSAKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGC 256
            DFG ++ +   +         YY+             PE + +    YT   D+W+ G 
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264

Query: 257 VLAELL-LG-QPLFPGESGVDQLVEIIK 282
           VL E+   G QP + G +  ++++  ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 49/232 (21%), Positives = 91/232 (39%), Gaps = 48/232 (20%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 120
           ++V+G G FG V++     +       VAIK +      K R     E   M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 121 VSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF-YQICRA 178
           + L+       ++   +   ++ EY+    +  +    +       +   +     I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 179 LAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-- 234
           + Y+   N +   HRD+  +N+LVN +    K+ DFG ++VL              Y   
Sbjct: 160 MKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-------EATYTTS 208

Query: 235 ---------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
                    APE + +    +T+A D+WS G V+ E++  G+  +   S  +
Sbjct: 209 GGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 41/221 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 123
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           + C       +  Y  +V+E +  ++  +       S++  L  V L   Q+   + YIH
Sbjct: 71  RWCG-----AEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 184 NTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 236
           +     HRD+KP N L+      + + + DFG AK          Y  +R      YR  
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172

Query: 237 ELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
           + + G   Y A+I            D+ S G VL    LG 
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 52/245 (21%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            R +GHG+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYF--Y 173
           +V        + +    +  +++E +      +  R  +   + SQ   L  + L     
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 147

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSR 231
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 148 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197

Query: 232 YYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 277
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254

Query: 278 VEIIK 282
           +E + 
Sbjct: 255 LEFVT 259

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 55/258 (21%), Positives = 100/258 (38%), Gaps = 64/258 (24%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            + +G G FG V +A             VA+K +       + R    E   ++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVK--- 169
           V+ L       ++   L   L++EY             R +   Y  S            
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 170 ----------LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
                     + F +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDV 200

Query: 219 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG- 264
            + +          Y             A E +F    YT   D+WS G +L E++ LG 
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250

Query: 265 QPLFPGESGVDQLVEIIK 282
            P +PG    ++L  ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 54/245 (22%), Positives = 94/245 (38%), Gaps = 52/245 (21%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            R +GHG+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIYVKLYF--Y 173
           +V        + +    +  ++LE +      +  R  +   + SQ   L  + L     
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 188

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYICSR 231
            I     Y+       HRDI  +N L+         K+ DFG A+ + +           
Sbjct: 189 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238

Query: 232 YYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 277
           YYR             PE  + G   +T+  D WS G +L E+  LG   +P +S   ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295

Query: 278 VEIIK 282
           +E + 
Sbjct: 296 LEFVT 300

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 57/251 (22%), Positives = 93/251 (37%), Gaps = 58/251 (23%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
              +G   FG V++         E  +AVAIK +        +     E      L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPLIYV 168
           VV L       T+   L   ++  Y                  V       + +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 169 KLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
                  QI   + Y+ ++  V H+D+  +N+LV      +K+ D G  + +   +    
Sbjct: 129 DFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD---- 182

Query: 227 YICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGE 271
                YY+            APE +++G  +++   DIWS G VL E+   G QP + G 
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCGY 234

Query: 272 SGVDQLVEIIK 282
           S    +VE+I+
Sbjct: 235 S-NQDVVEMIR 244

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 57/258 (22%), Positives = 100/258 (38%), Gaps = 63/258 (24%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLDHP 118
            +V+G G+FG V  A             VA+K +       ++     EL+ M +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP-----------------ETVHRVIKHHYKMSQ 161
           N+V+L       T    +YL  + EY                   + +    +   +  +
Sbjct: 110 NIVNLLGA---CTLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 162 RMPLIYVK--LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
            + ++  +  L F YQ+ + + ++       HRD+  +N+LV      +K+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDI 222

Query: 219 VKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAEL--LLG 264
           +             Y             APE +F    YT   D+WS G +L E+  L  
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272

Query: 265 QPLFPGESGVDQLVEIIK 282
            P +PG        ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 57/249 (22%), Positives = 95/249 (38%), Gaps = 54/249 (21%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKV-----LQDKRYKNRELQTM-RLLDHP 118
            + +G G+FG V +A     G+      VA+K +       +K     EL+ M  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP---------ETVHRVIKHHYKMSQRMPLIYVK 169
           N+V+L       T    +   ++ EY                +                 
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 170 L-YF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 227
           L +F  Q+ + +A++  +    HRD+  +N+L+    H  K+ DFG A+ ++        
Sbjct: 166 LLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS----- 218

Query: 228 ICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG-QPLFPGESG 273
                Y             APE IF    YT   D+WS G +L E+  LG  P +PG   
Sbjct: 219 ----NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILV 272

Query: 274 VDQLVEIIK 282
             +  +++K
Sbjct: 273 NSKFYKLVK 281

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLL-DHPNVVSL 123
           +   R +G GSFG ++    ++T E VAIK      ++     E +  R+L     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +         +  Y  LV++ +  ++  +       S+++ L  V +   Q+   + ++H
Sbjct: 69  RWFG-----VEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 184 NTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 236
           +     HRDIKP N L+      +Q+ + DFG AK          Y  +       YR  
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170

Query: 237 ELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 265
           + + G   Y A++            D+ S G VL   L G 
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 58/252 (23%), Positives = 103/252 (40%), Gaps = 57/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 116
            + +G G+FG V  A+ +            VA+K +      +D      E++ M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPL 165
           H N+++L       T+   LY  +++EY                     ++   +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 166 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
               L    YQ+ R + Y+  +    HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 189 SSKDLVSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID- 245

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                   YY+            APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 271 ESGVDQLVEIIK 282
              V++L +++K
Sbjct: 297 VP-VEELFKLLK 307

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 57/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 116
            + +G G FG V  A+ +       +    VA+K +      +D      E++ M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKMSQRM 163
           H N+++L       T+   LY  +++EY              P  +      +    ++M
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
               +    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 201 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 257

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 271 ESGVDQLVEIIK 282
              V++L +++K
Sbjct: 309 IP-VEELFKLLK 319

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 56/252 (22%), Positives = 105/252 (41%), Gaps = 57/252 (22%)

Query: 70  ERVVGHGSFGVVFQAKCL-------ETGEAVAIKKV-----LQDKRYKNRELQTM-RLLD 116
            + +G G+FG V  A+ +       +    VA+K +      +D      E++ M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-----------TVHRVIKHHYKMSQRMPL 165
           H N+++L       T+   LY  +++EY  +                  +         +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 166 IYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            +  L    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 211

Query: 224 NISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 271 ESGVDQLVEIIK 282
              V++L +++K
Sbjct: 263 IP-VEELFKLLK 273

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 40/250 (16%), Positives = 81/250 (32%), Gaps = 49/250 (19%)

Query: 46  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK 105
            G ++    G +         ++  + +G G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 106 N---RELQTMRLLDHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYVPET 148
                EL+  + +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 149 VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQL 207
           + ++   +    +      V     ++   L YIH      H DIK  NLL+   +  Q+
Sbjct: 138 LQKISGQNGTFKKST----VLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 208 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWSAG 255
            L D+G +        +  Y         +   G  E+  ++            D+   G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247

Query: 256 CVLAELLLGQ 265
             +   L G+
Sbjct: 248 YCMLRWLCGK 257

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 46/218 (21%)

Query: 72  VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK----NRELQT----MRLLDHPNVVSL 123
            +G G FGVV++   +     VA+KK+            ++       M    H N+V L
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 124 K-HCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQIC----R 177
                   ++ D+L L  V  Y+P  ++         +    PL +      +I      
Sbjct: 96  LGFS----SDGDDLCL--VYVYMPNGSLLD---RLSCLDGTPPLSWHMRC--KIAQGAAN 144

Query: 178 ALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSR-- 231
            + ++H      HRDIK  N+L+           K+ DFG A+   K     + + SR  
Sbjct: 145 GINFLHEN-HHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTSRIV 196

Query: 232 --Y-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 266
               Y APE + G  E T   DI+S G VL E++ G P
Sbjct: 197 GTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 60/238 (25%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEA--VAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQRMPLIYVKL 170
           +L         +  LYL   +EY P             +          S    L   +L
Sbjct: 90  NLLGA---CEHRGYLYL--AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 171 -YF-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 226
            +F   + R + Y+     I   HRD+  +N+LV  + +  K+ DFG ++          
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG--------- 191

Query: 227 YICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 270
                 Y             A E L +    YT   D+WS G +L E++ LG   + G
Sbjct: 192 ---QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 38/252 (15%), Positives = 80/252 (31%), Gaps = 50/252 (19%)

Query: 46  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETG--------EAVAIKK 97
            G ++    G +         +  +      + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 98  VLQDKRYKNRELQTMRLLDHPNVVSLK-----------HCFFSTTEKDELYLNLVLEYVP 146
             +D R  N +    R      V   K            C      +D+    LVL  + 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTH 205
            ++   +    K    +    V     ++  AL ++H      H ++  +N+ V+P    
Sbjct: 142 RSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQS 198

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWS 253
           Q+ L  +G A        +++Y             G  E+  ++            D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253

Query: 254 AGCVLAELLLGQ 265
            G  + + L G 
Sbjct: 254 LGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 43/252 (17%), Positives = 77/252 (30%), Gaps = 50/252 (19%)

Query: 46  AGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQA-----KCLETGEAVAIKKVLQ 100
            G II                +     +G G FG ++ A     + + +     +K    
Sbjct: 25  VGEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS 75

Query: 101 DKRYKNRELQTMRLLDHPNVVSLK--------------HCFFSTTEKDELYLNLVLEYVP 146
           D      EL+  +    P  +                        +  + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 147 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTH 205
             + ++ + + K   R     V     +I   L YIH      H DIK  NLL+N  +  
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191

Query: 206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWS 253
           Q+ L D+G A        + +Y             G  E+  +I            D+  
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEI 246

Query: 254 AGCVLAELLLGQ 265
            G  + + L G 
Sbjct: 247 LGYCMIQWLTGH 258

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 25/123 (20%)

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 232
           +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ + K            
Sbjct: 200 FQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP---------D 248

Query: 233 YR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 279
           Y             APE IF    YT   D+WS G +L E+  LG   +PG    ++   
Sbjct: 249 YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307

Query: 280 IIK 282
            +K
Sbjct: 308 RLK 310

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 27/147 (18%), Positives = 52/147 (35%), Gaps = 23/147 (15%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKV-----LQDKRYKNRELQTMRLLD-HP 118
            + +G G+FG V +A         T   VA+K +       + R    EL+ +  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           NVV+L      T     L   +++E+        +  +   S+R   +  K    +  + 
Sbjct: 87  NVVNLLGA--CTKPGGPLM--VIVEFCK---FGNLSTYL-RSKRNEFVPYKTKGARFRQG 138

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTH 205
             Y+         D+K +   +     
Sbjct: 139 KDYVGA----IPVDLKRRLDSITSSQS 161

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 6e-06
 Identities = 52/388 (13%), Positives = 97/388 (25%), Gaps = 130/388 (33%)

Query: 96  KKVLQDKRYK------NRELQTMRLLD-------------------------------HP 118
           K +L  +         +    T+RL                                   
Sbjct: 43  KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM----PLIYVKLY--- 171
              S+    +   ++D LY N    +    V R ++ + K+ Q +    P   V +    
Sbjct: 103 RQPSMMTRMYI-EQRDRLY-NDNQVFAKYNVSR-LQPYLKLRQALLELRPAKNVLIDGVL 159

Query: 172 -------FYQICRALAYIHN--------TIGVCHRD---IKPQNLLVNPHTHQLKLCDFG 213
                     +C +               +  C+     ++    L+    +Q+   ++ 
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL----YQID-PNWT 214

Query: 214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAI----DIWSAGCVLAELLLGQPLFP 269
           S         NI             +  +  Y   +    ++ +A    A        F 
Sbjct: 215 S---RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--------FN 263

Query: 270 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLV 328
                       K+L T TR          T+F       H         + P E   L+
Sbjct: 264 LSC---------KILLT-TR------FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 329 SRLLQYSPN-LRSTALEALIHPFF-----DELRDPNTRLPNGRFLPP----------LFN 372
            + L   P  L    L    +P       + +RD      N + +            L  
Sbjct: 308 LKYLDCRPQDLPREVLT--TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365

Query: 373 FKPHELKGV-------PVDMLVKLIPEH 393
            +P E + +       P       IP  
Sbjct: 366 LEPAEYRKMFDRLSVFPPS--AH-IPTI 390

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.4 bits (96), Expect = 6e-04
 Identities = 24/139 (17%), Positives = 44/139 (31%), Gaps = 30/139 (21%)

Query: 108 ELQTMRLLD---HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-- 162
           +L    L++     + +S+   +     K E    L         HR I  HY + +   
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL---------HRSIVDHYNIPKTFD 460

Query: 163 ---MPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
              +   Y+  YFY     + + H   I    R    + + ++    + K+    +A   
Sbjct: 461 SDDLIPPYLDQYFYSH---IGH-HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516

Query: 219 VKGEPNI--------SYIC 229
                N          YIC
Sbjct: 517 SGSILNTLQQLKFYKPYIC 535

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	403
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.67
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.58
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.28
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.26
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.26
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.21
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.2
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.05
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.61
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.55
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.5
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.43
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.37
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.34
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.3
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.2
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.19
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.16
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.11
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.03
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.68
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.71
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.6
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.97

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-63  Score=458.52  Aligned_cols=250  Identities=29%  Similarity=0.450  Sum_probs=202.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...       .....+|+.+++.++|||||+++++|.     +..
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECC
Confidence            45799999999999999999999999999999998542       234568999999999999999999883     344


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+|||||||+|+|.+.+...    +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        87 ~~~ivmEy~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~-~vkl~DFGla~  160 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHL-NVKIADFGLSN  160 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred             EEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCC-CEEEeecCCCe
Confidence            58999999999999888763    6799999999999999999999998 999999999999999888 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .........+.+||+.|||||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+.+..  +         
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~---------  229 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--Y---------  229 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C---------
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--C---------
Confidence            77665555678999999999999877656789999999999999999999999887766666554421  0         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                        .++..+|+++++||++||+.||++|||++|+|+||||+.
T Consensus       230 ------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 ------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                              123457999999999999999999999999999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-62  Score=476.07  Aligned_cols=319  Identities=34%  Similarity=0.608  Sum_probs=253.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecC-CCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTT-EKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~  137 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....      ....+|+.+|+.++|||||++++++.... ..+...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            47999999999999999999999999999999986432      23457999999999999999999875432 123456


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|||||||+|+|.+.+..    .+.+++..++.|+.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+.
T Consensus       134 ~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCC-CEEEeecceeee
Confidence            899999999998888764    46799999999999999999999998 999999999999999888 799999999986


Q ss_pred             cccC-----CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          218 LVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       218 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ....     ....+.+||+.|||||++.+...++.++||||+||++|||++|++||.+.+..+++..|....+.|+...+
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            5332     22346789999999999987777899999999999999999999999999999999999999999887655


Q ss_pred             hccCcCcc---cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCC
Q 015615          293 KCMNPNYT---EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPP  369 (403)
Q Consensus       293 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~  369 (403)
                      ........   ...++.....+|...+ +.+|+++.|||++||++||++|||++|+|+||||++..+|....    ...+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p----~~~~  362 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP----DCAP  362 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSC----CCSS
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcccc----CCCC
Confidence            43221110   0122333334454443 46899999999999999999999999999999999987765421    1223


Q ss_pred             CCCCChhhcCCCChHHHhhcchHHHH
Q 015615          370 LFNFKPHELKGVPVDMLVKLIPEHAR  395 (403)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (403)
                      .+++. .+....+.+.++..+.++.+
T Consensus       363 ~~~~~-~~~~~~~~~~~k~~i~~ei~  387 (398)
T 4b99_A          363 PFDFA-FDREALTRERIKEAIVAEIE  387 (398)
T ss_dssp             CCCCH-HHHSCCCHHHHHHHHHHHHH
T ss_pred             CCCCc-cchhhcCHHHHHHHHHHHHH
Confidence            33332 34445566777777766554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.9e-63  Score=461.06  Aligned_cols=254  Identities=31%  Similarity=0.530  Sum_probs=219.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|+.++|||||+++++|     .+..
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            35799999999999999999999999999999998542       23456899999999999999999988     3445


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++|||||||+| +|.+.+...    +.+++..++.|+.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g-~vKl~DFGla  179 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTA  179 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCC-CEEEEEcCCc
Confidence            68999999985 898888764    6799999999999999999999998 999999999999999888 7999999999


Q ss_pred             eecccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          216 KVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       216 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      +......   ...+.+||+.|||||++.+.. |+.++|||||||++|+|+||++||.+.+..+.+..+.+..        
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--------  250 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--------  250 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Confidence            8764332   234678999999999997654 8999999999999999999999999988877777776521        


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHH------HhcCCCCccCCCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE------ALIHPFFDELRDPN  358 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~e------ll~hp~f~~~~~~~  358 (403)
                               +            .++..+|+++++||++||+.||++|||++|      +++||||+++.+..
T Consensus       251 ---------~------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          251 ---------Y------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             ---------C------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             ---------C------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence                     0            123468999999999999999999999987      58999999987653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2e-62  Score=462.92  Aligned_cols=254  Identities=29%  Similarity=0.436  Sum_probs=216.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|..     ..++||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3456789999999999999999999843     345899


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      |||||+| +|.+++.+     ..+++..++.|+.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999995 78777754     4699999999999999999999998 999999999999999888 79999999998764


Q ss_pred             cCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ... ...+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+........          
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~----------  290 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL----------  290 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred             CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence            433 34567899999999999655 489999999999999999999999999888777776654211000          


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                      .....+|+++++||.+||+.||++|||++|+|+||||++...+
T Consensus       291 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          291 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             ----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             ----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence                            0123579999999999999999999999999999999986443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-61  Score=445.14  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=208.6

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |++.+.||+|+||+||+|.+..++..||+|++...      ...+.+|+.+++.++|||||+++++|.... .+..++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            47888999999999999999999999999998543      234568999999999999999999875432 34567899


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |||||+ |+|.+.+...    ..+++..++.|+.||+.||+|||++ |  ||||||||+|||++...+.+||+|||+|+.
T Consensus       107 vmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            999999 4888888764    6799999999999999999999987 8  999999999999985333799999999975


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      . ......+.+||+.|||||++.+  .|+.++|||||||++|||+||++||.+.+....+.........|          
T Consensus       182 ~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~----------  248 (290)
T 3fpq_A          182 K-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------  248 (290)
T ss_dssp             C-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred             C-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC----------
Confidence            4 3334456789999999999854  48999999999999999999999998876655554433211111          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                      ..++...++++.+||.+||+.||++|||++|+|+||||++
T Consensus       249 ----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                            0123457899999999999999999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.3e-62  Score=462.10  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=209.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++...      .....+|+.+|+.++|||||+++++|.     +...
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence            35799999999999999999999999999999998543      234568999999999999999999884     3345


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +|||||||+ |+|.+.+....  ...+++..++.|+.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~  173 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIAR  173 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-CEEEcccccce
Confidence            899999998 58988886542  35678999999999999999999998 999999999999999888 79999999998


Q ss_pred             ecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....... ..+.+||+.|||||++.+.. |+.++|||||||++|||+||++||.+.+..+.+..+....-          
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----------  242 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----------  242 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----------
T ss_pred             eecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC----------
Confidence            7643322 23567999999999997654 89999999999999999999999999888887777765210          


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                               +         .++..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       243 ---------~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          243 ---------P---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ---------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ---------C---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                     0         022457999999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.2e-61  Score=464.73  Aligned_cols=254  Identities=29%  Similarity=0.437  Sum_probs=217.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..|++.+.||+|+||.||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|..     ..++||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3456789999999999999999999844     335899


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      |||||+| +|.+++..     ..+++..++.|+.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+...
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence            9999995 78777753     4699999999999999999999998 999999999999999888 79999999998764


Q ss_pred             cC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .. ....+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+.......           
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------  366 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------  366 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred             CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence            43 334567899999999999655 48999999999999999999999999988877777665421100           


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                     ......+|+++++||.+||+.||++|||++|+|+||||++...+
T Consensus       367 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          367 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             ---------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             ---------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence                           00124579999999999999999999999999999999985433

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.8e-61  Score=452.84  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=214.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      ...|.+.++||+|+||.||+|+++.+|+.||||++..+. ...+|+.+++.++|||||+++++|.     +..++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEe
Confidence            346999999999999999999999999999999996543 3457999999999999999999884     3345899999


Q ss_pred             cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      ||+| +|.+++...    +.+++..++.|+.||+.||+|||++ |||||||||+||||+.++..+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9994 898888764    5799999999999999999999998 999999999999999887569999999998764332


Q ss_pred             C------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          223 P------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       223 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .      ....+||+.|||||++.+.. |+.++|||||||++|||+||++||.+.+..+.+..+...  .++.       
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~-------  275 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPPI-------  275 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCGG-------
T ss_pred             cccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCCc-------
Confidence            1      12357999999999997654 899999999999999999999999987766655555441  1100       


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHH-------------hcCCCCccCCCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA-------------LIHPFFDELRDPN  358 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~el-------------l~hp~f~~~~~~~  358 (403)
                                       ..+++.+|+++.+||.+||+.||.+|||+.|+             |+|||+.+.+.|.
T Consensus       276 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          276 -----------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             -----------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             -----------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                             11345689999999999999999999999997             6799999887663

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-61  Score=450.63  Aligned_cols=251  Identities=27%  Similarity=0.426  Sum_probs=209.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|++.+.||+|+||+||+|++.   .+++.||||++...      .....+|+.+|+.++|||||+++++|..     .
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence            57999999999999999999974   46889999998542      2345679999999999999999998843     3


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+|||||||+| +|.+.+...    ..+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGl  172 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGL  172 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence            458999999994 888888764    6799999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      |+..... ....+.+||+.|||||++.+.. |+.++|||||||++|||+||++||.+.+..+.+..+.+..  +      
T Consensus       173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~------  243 (304)
T 3ubd_A          173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--L------  243 (304)
T ss_dssp             EEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------
T ss_pred             ceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--C------
Confidence            9865433 3345678999999999997654 8999999999999999999999999988887777776521  0      


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                           .++..+|+++++||++||+.||++|||     ++|+++||||+++++
T Consensus       244 ---------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          244 ---------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence                                 023458999999999999999999998     589999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.5e-60  Score=461.93  Aligned_cols=334  Identities=70%  Similarity=1.166  Sum_probs=296.2

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceEEEE
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLNL  140 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l  140 (403)
                      ....+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++||||++++++|+.... .+..++++
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            44568999999999999999999999999999999998777777789999999999999999998866433 45677889


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||+++++.+.+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||+++....
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            999999988888876655667899999999999999999999987 9999999999999997765799999999988766


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      +.......||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.++.+.++.|..+.+...++.+.
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666778999999999997765689999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCChhhcCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKG  380 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (403)
                      .+.++.+...+|...+...+++++.+||++||++||.+|||+.|+++||||++++++...++.....|..++|...++..
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS  369 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhcc
Confidence            99999999999999998999999999999999999999999999999999999998887777777778889998887765


Q ss_pred             CChHHHhhcchHHHHhh
Q 015615          381 VPVDMLVKLIPEHARKQ  397 (403)
Q Consensus       381 ~~~~~~~~~~~~~~~~~  397 (403)
                       .......+.|.+.+.+
T Consensus       370 -~~~~~~~~~~~~~~~~  385 (420)
T 1j1b_A          370 -NPPLATILIPPHARIQ  385 (420)
T ss_dssp             -CGGGHHHHSCTTTTCC
T ss_pred             -ChhHHHhhCCHhhhhc
Confidence             4455555666655433

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-60  Score=462.19  Aligned_cols=333  Identities=50%  Similarity=0.982  Sum_probs=287.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCC-----------
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-----------  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----------  132 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++..+.....+|+.+++.++||||++++++|.....           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            457999999999999999999999999999999998877777799999999999999999998866433           


Q ss_pred             ----------------------CCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 015615          133 ----------------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (403)
Q Consensus       133 ----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH  190 (403)
                                            .+..++++||||++++|.+.+.........+++..++.++.||+.||+|||++ ||+|
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-gi~H  164 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICH  164 (383)
T ss_dssp             ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEEC
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-cCcc
Confidence                                  34556889999999999988887666678899999999999999999999987 9999


Q ss_pred             cCCCCCceEecCCCCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015615          191 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (403)
Q Consensus       191 ~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  270 (403)
                      |||||+|||++.+.+.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|++||.+
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998544489999999999876666666778899999999997766689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 015615          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  350 (403)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~  350 (403)
                      .+..+.+..+.+..+.|..+.+...++.+....++......|...++..+++++.+||.+||+.||.+|||+.|+|+|||
T Consensus       245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF  324 (383)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccCCC-------CCCCCCCC--CCCCCCCCCChhhcCCCChHHHhhcchHHHHhh
Q 015615          351 FDELRD-------PNTRLPNG--RFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQ  397 (403)
Q Consensus       351 f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (403)
                      |+++++       +....+++  ...|++++|.+.+++.++.+.+.+++|++....
T Consensus       325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  380 (383)
T 3eb0_A          325 FDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSPN  380 (383)
T ss_dssp             GHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC-----
T ss_pred             HHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhccc
Confidence            998755       33445554  567889999999999889999999999987654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.9e-59  Score=454.49  Aligned_cols=331  Identities=66%  Similarity=1.150  Sum_probs=297.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceEEEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLV  141 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv  141 (403)
                      ...+|++.+.||+|+||.||+|++..++. ||+|++..+.....+|+.+++.++||||++++++|..... .+..++++|
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            44679999999999999999999877665 9999887777777789999999999999999999876554 566778999


Q ss_pred             EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec-CCCCceEEeecCCceeccc
Q 015615          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~-~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+++++.+.+.........+++..++.++.||+.||+|||++ ||+||||||+|||++ .++ .+||+|||+|+....
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA  194 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence            99999988887776666677899999999999999999999998 999999999999999 455 899999999988766


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      +.......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.|..+.+...++.+.
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666788999999999997766689999999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCChhhcCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKG  380 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (403)
                      ...++.....++...+...+++++.+||.+||+.||.+|||+.++++||||++++++....+.....|+++++...++..
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSV  354 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHHT
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhhc
Confidence            88999999999999998899999999999999999999999999999999999999888888888889999999888775


Q ss_pred             CChHHHhhcchHHHHhh
Q 015615          381 VPVDMLVKLIPEHARKQ  397 (403)
Q Consensus       381 ~~~~~~~~~~~~~~~~~  397 (403)
                       ..+.+.+++|.+.+.+
T Consensus       355 -~~~~~~~~~~~~~~~~  370 (394)
T 4e7w_A          355 -RPDLISRLVPQHAEAE  370 (394)
T ss_dssp             -CGGGHHHHSCGGGCSS
T ss_pred             -CHHHHHhhccHhhhhh
Confidence             5589999999887543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.9e-59  Score=444.02  Aligned_cols=280  Identities=28%  Similarity=0.460  Sum_probs=215.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccch--hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDK--RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..++|++.+.||+|+||+||+|+++   .+++.||||.+....  ....+|+++|+.+ +||||++++++|.     +..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KND   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETT
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECC
Confidence            3457999999999999999999875   467899999886543  3456899999998 6999999999883     344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++|||||||++ +|.+.+       ..+++..++.++.||+.||+|||++ |||||||||+|||++.+.+.+||+|||+|
T Consensus        94 ~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            68999999984 777766       3489999999999999999999998 99999999999999987558999999999


Q ss_pred             eecccCC-----------------------------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 015615          216 KVLVKGE-----------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  266 (403)
Q Consensus       216 ~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~  266 (403)
                      +......                             ...+.+||+.|||||++.+...|+.++||||+||++|||+||++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            7653321                             11245799999999999877779999999999999999999999


Q ss_pred             CCC-CCCcHHHHHHHHHHhCCCCHHHHhccCcC-------cc--------------cccCCC----ccCCCcccccccCC
Q 015615          267 LFP-GESGVDQLVEIIKVLGTPTREEIKCMNPN-------YT--------------EFKFPQ----IKAHPWHKIFQKRM  320 (403)
Q Consensus       267 pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~~--------------~~~~~~----~~~~~~~~~~~~~~  320 (403)
                      ||. +.++.+++..|....|.+...........       ..              ....+.    .............+
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            985 45677888889888876544332211100       00              000000    00011111223568


Q ss_pred             ChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          321 PPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       321 s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      |++++|||++||++||++|+|++|+|+||||+++.
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999999999999863

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-58  Score=431.19  Aligned_cols=261  Identities=24%  Similarity=0.420  Sum_probs=194.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC-------
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-------  132 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------  132 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++|||||+++++|.....       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999999999999999985422     334589999999999999999999865442       


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                      ....++|||||||++ +|.+.+..... ....+...++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCC-cEEEcc
Confidence            234568999999985 78888865422 22345667889999999999999998 999999999999999888 799999


Q ss_pred             cCCceecccCCC-------------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015615          212 FGSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (403)
Q Consensus       212 fG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  278 (403)
                      ||+|+.......             ..+.+||+.|||||++.+. .|+.++|||||||++|||++   ||.+..  +...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            999987643321             1245799999999999765 49999999999999999996   776432  2222


Q ss_pred             HHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      .+........+..                         ....++.+.+||++||+.||++|||+.|+|+||||+++..|.
T Consensus       236 ~~~~~~~~~~p~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFPPL-------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCCHH-------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCCCC-------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            2222211111110                         122467889999999999999999999999999999987664


Q ss_pred             C
Q 015615          359 T  359 (403)
Q Consensus       359 ~  359 (403)
                      .
T Consensus       291 ~  291 (299)
T 4g31_A          291 K  291 (299)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-57  Score=456.73  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=211.1

Q ss_pred             CccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHH---HHHHHHHcCCCCeeecceeeeec
Q 015615           61 PKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFST  130 (403)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~niv~~~~~~~~~  130 (403)
                      +....+|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+   ++.+++.++|||||+++++|   
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f---  261 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF---  261 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence            344568999999999999999999999999999999985432       12223   35566677899999999988   


Q ss_pred             CCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEE
Q 015615          131 TEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  209 (403)
                        .+..++|||||||+| +|...+...    +.+++..++.|+.||+.||+|||++ |||||||||+||||+.+| .+||
T Consensus       262 --~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G-~vKL  333 (689)
T 3v5w_A          262 --HTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRI  333 (689)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTS-CEEE
T ss_pred             --EECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCC-CEEe
Confidence              444568999999995 888888764    6799999999999999999999998 999999999999999988 6999


Q ss_pred             eecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCC
Q 015615          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGT  286 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~~~~~~  286 (403)
                      +|||+|+...... ..+.+||+.|||||++.+...|+.++|||||||++|||++|.+||.+.+..+   ....+...   
T Consensus       334 ~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---  409 (689)
T 3v5w_A          334 SDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---  409 (689)
T ss_dssp             CCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---
T ss_pred             cccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---
Confidence            9999998765443 4567999999999999755569999999999999999999999998643222   22222210   


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCCC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  357 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~~  357 (403)
                      +                          ..++..+|+++++||.+||+.||.+|++     ++|+++||||+++.+.
T Consensus       410 ~--------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          410 A--------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             C--------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             C--------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            0                          0133568999999999999999999998     7999999999998653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.1e-56  Score=449.99  Aligned_cols=259  Identities=27%  Similarity=0.423  Sum_probs=221.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||+|+||.||+|+++.+|+.||||++...    .....+|+.+|+.++|||||+++++|     .+..++||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence            5799999999999999999999999999999998543    23456899999999999999999988     34456899


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC-CCceEEeecCCceec
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  218 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~~  218 (403)
                      |||||+| +|.+.+...   ...+++..++.|+.||+.||.|||++ ||+||||||+|||++.+ .+.+||+|||+|+.+
T Consensus       232 v~E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          232 IYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEeecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            9999985 787777542   35799999999999999999999998 99999999999999864 237999999999987


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      .........+||+.|||||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+.......+.         
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------  377 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD---------  377 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS---------
T ss_pred             cCCCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc---------
Confidence            6666666788999999999997654 899999999999999999999999999888877776653211111         


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                                      .....+|+++++||++||+.||.+|||++|+|+||||+...++.
T Consensus       378 ----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          378 ----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             ----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             ----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                            12245899999999999999999999999999999999876654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.6e-55  Score=410.36  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=206.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|.+.+.||+|+||+||+|++.     .++..||||++...    ...+.+|+++|++++|||||++++++..     
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----
Confidence            357999999999999999999875     35789999998643    2345689999999999999999998843     


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHY---------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~  204 (403)
                      ...++||||||+ |+|.+++....         .....+++..+..++.||+.||+|||++ +||||||||+|||++.++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCC
Confidence            233789999999 58999887643         2245799999999999999999999998 999999999999999887


Q ss_pred             CceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 015615          205 HQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  280 (403)
Q Consensus       205 ~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i  280 (403)
                       .+||+|||+|+........   ....||+.|||||++.+.. |+.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus       166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             7999999999865433222   2356899999999997654 9999999999999999998 89999998877766666


Q ss_pred             HHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      .+....                            ..+..+|+++.+|+.+||+.||++|||+.++.  +|++++.
T Consensus       244 ~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~  288 (299)
T 4asz_A          244 TQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLA  288 (299)
T ss_dssp             HHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHH
T ss_pred             HcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHH
Confidence            542100                            02245799999999999999999999999994  6776653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.8e-55  Score=410.69  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=198.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|.+.+.||+|+||+||+|++.     .++..||||++...    ...+.+|+++|++++|||||++++++..     
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence            357999999999999999999864     36889999998643    2345689999999999999999998843     


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~  202 (403)
                      ...+|||||||+ |+|.+++.....           ...++++..+..|+.||+.||+|||++ +||||||||+|||++.
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEET
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECC
Confidence            334789999999 588888876432           234689999999999999999999998 9999999999999998


Q ss_pred             CCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015615          203 HTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLV  278 (403)
Q Consensus       203 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  278 (403)
                      ++ .+||+|||+|+.......   .....||+.|||||++.+.. ++.++|||||||++|||+| |+.||.+.+..+.+.
T Consensus       194 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          194 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TT-EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            87 899999999986543322   23457899999999997654 8999999999999999999 899999988777666


Q ss_pred             HHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .+.+....                            ..+..+|+++.+|+.+||+.||++|||+.|++++
T Consensus       272 ~i~~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            66542110                            0224579999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-54  Score=406.23  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=203.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ..++++.+.||+|+||+||+|...     .+++.||||++...     ...+.+|+.++++++|||||++++++..    
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----  100 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----  100 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----
Confidence            346889999999999999999863     46789999998543     2456789999999999999999998843    


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll  200 (403)
                       ...++||||||+ |+|.++|.....            ....+++..+..++.||+.||+|||++ +||||||||+|||+
T Consensus       101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl  178 (308)
T 4gt4_A          101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLV  178 (308)
T ss_dssp             -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEE
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEE
Confidence             223789999999 589998865432            134689999999999999999999998 99999999999999


Q ss_pred             cCCCCceEEeecCCceecccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 015615          201 NPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQ  276 (403)
Q Consensus       201 ~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~  276 (403)
                      +.++ .+||+|||+|+......   ......||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..+.
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 79999999998654332   223457899999999997654 9999999999999999998 8999999887766


Q ss_pred             HHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      +..+......|                            .+..+|+++.+|+.+||+.||++|||+.+++++
T Consensus       257 ~~~i~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          257 VEMIRNRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            65554321100                            124578999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-54  Score=403.30  Aligned_cols=247  Identities=22%  Similarity=0.315  Sum_probs=195.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..++.+.+.||+|+||+||+|++.   ..||||+++..      ...+.+|+.++++++|||||++++++.    .+.  
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~----~~~--  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT----KDN--  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----SSS--
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----CCe--
Confidence            356889999999999999999863   35999988532      234568999999999999999999762    122  


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ++||||||+ |+|.+.+...   ...+++..+..|+.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~-~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTE-EEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCC-cEEEeeccCce
Confidence            679999999 5888888653   35799999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCC---CcceeeecccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ......   .....+||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+..+......+    
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~----  256 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS----  256 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC----
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC----
Confidence            653322   22356899999999999643  248999999999999999999999999887766665554421111    


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                   |..      ...+..+|+++.+|+.+||+.||++|||+.++++
T Consensus       257 -------------p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          257 -------------PDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             -------------CCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             -------------CCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                         000      1123467899999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.8e-54  Score=410.67  Aligned_cols=301  Identities=49%  Similarity=0.906  Sum_probs=246.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh---hhHHHHHHHHHcCCCCeeecceeeeecCC--CCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTE--KDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~  138 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++..+..   ...+++..++.++||||+++++++.....  ....++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            4579999999999999999999999999999998865433   33456777788899999999998866443  445678


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHH--hcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH--~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ++||||+++++...+.........+++..++.++.|++.||.|||  ++ ||+||||||+|||++...+.+||+|||++.
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            899999999988888776666778999999999999999999999  87 999999999999999733389999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ............||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.+....
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3e3p_A          181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN  260 (360)
T ss_dssp             CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence            77666555667889999999999776668999999999999999999999999999999999999999999999888877


Q ss_pred             cCcccccCCCccCCCccccccc---CCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR  365 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~  365 (403)
                      +.............+|...+..   ..++++.+||.+||+.||.+|||+.++|+||||+++.++....+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~  332 (360)
T 3e3p_A          261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNK  332 (360)
T ss_dssp             TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSC
T ss_pred             cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCC
Confidence            7766666655555566555433   36789999999999999999999999999999999988776554433

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-53  Score=422.05  Aligned_cols=286  Identities=31%  Similarity=0.557  Sum_probs=228.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .+..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            35799999999999999999999999999999998643      2334579999999999999999998854332 2335


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+|+||||+++++.+.+.      ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~-~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCCC-
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCC-CEEEEEEEeee
Confidence            678999999998877663      3488999999999999999999998 999999999999999888 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.|..+.+....
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            77655555667899999999999765 48999999999999999999999999999999999999999999988776544


Q ss_pred             cCcccc--cCCCccCCCcccccccC-----------CChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          297 PNYTEF--KFPQIKAHPWHKIFQKR-----------MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       297 ~~~~~~--~~~~~~~~~~~~~~~~~-----------~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      +....+  ..+......+...++..           .++++++||++||++||++|||++|+|+||||+.+.++.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  366 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPA  366 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHH
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcc
Confidence            322111  11111122222222211           256799999999999999999999999999999876653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-53  Score=420.96  Aligned_cols=321  Identities=32%  Similarity=0.520  Sum_probs=237.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...      .....+|+.+|+.++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            35799999999999999999999999999999998542      234457999999999999999999886554444456


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|+||||++++|.+.+..    ...+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||+|+.
T Consensus       132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~-~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCC-CEeecccccchh
Confidence            889999999998888864    36799999999999999999999998 999999999999999888 799999999986


Q ss_pred             cccCC----------------------------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh------
Q 015615          218 LVKGE----------------------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL------  263 (403)
Q Consensus       218 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt------  263 (403)
                      .....                            .....+||+.|+|||++.....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            53221                            12345789999999987666669999999999999999999      


Q ss_pred             -----CCCCCCCCC--------------------cHHHHHHHHHHhCCCCHHHHhccCcCccc---ccCCCccCCCcccc
Q 015615          264 -----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKI  315 (403)
Q Consensus       264 -----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  315 (403)
                           |+++|.+.+                    ..+++..+.+.+|.|..+.+.........   ..++......+...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 788887754                    35778889999999998877654321100   01222222333333


Q ss_pred             cccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCChhhcCCCChHHHhhcchHHHH
Q 015615          316 FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR  395 (403)
Q Consensus       316 ~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (403)
                      + +.+++++.+||++||.+||++|||++|+|+||||++++++.......  .+....|  .++...+.+.+...+.+|.+
T Consensus       366 ~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~--~~~~~~~--~~~~~~~~~~~~~~~~~e~~  440 (458)
T 3rp9_A          366 F-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNAT--EKVRLPF--NDWMNMDEPQLRYAFVKEIQ  440 (458)
T ss_dssp             S-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCS--SCCCCSS--CTTSCCCHHHHHHHHHHHHT
T ss_pred             C-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCC--CCCCCCc--cccccCCHHHHHHHHHHHHH
Confidence            3 45799999999999999999999999999999999998765432111  1111112  23455667777777777665

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-53  Score=410.25  Aligned_cols=285  Identities=34%  Similarity=0.673  Sum_probs=223.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.+. ||||+++++++...   +...
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~   85 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD   85 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence            4799999999999999999999999999999988432      233457999999997 99999999987542   2334


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|+|||||+++|...+..     ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus        86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAEC-HVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCC-CEEecCCccccc
Confidence            789999999998888865     4688999999999999999999998 999999999999999888 799999999986


Q ss_pred             cccC----------------------CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 015615          218 LVKG----------------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (403)
Q Consensus       218 ~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  275 (403)
                      ....                      ......+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            5321                      112345789999999999776668999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccC------CCccCCCccccc------------ccCCChHHHHHHHHhhccCCC
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKF------PQIKAHPWHKIF------------QKRMPPEAVDLVSRLLQYSPN  337 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~s~~~~~ll~~~L~~dP~  337 (403)
                      ++..+...++.|..+.+......+.....      .......+...+            ...+++++.+||++||+.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            99999999999998877654432211000      000011111111            126789999999999999999


Q ss_pred             CCCCHHHHhcCCCCccCCCCCC
Q 015615          338 LRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       338 ~R~s~~ell~hp~f~~~~~~~~  359 (403)
                      +|||++|+|+||||+.+.++..
T Consensus       319 ~R~t~~e~l~Hp~~~~~~~~~~  340 (388)
T 3oz6_A          319 KRISANDALKHPFVSIFHNPNE  340 (388)
T ss_dssp             GSCCHHHHTTSTTTTTTCCGGG
T ss_pred             cCCCHHHHhCCHHHHHhcCCcc
Confidence            9999999999999999877654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-53  Score=406.21  Aligned_cols=251  Identities=23%  Similarity=0.349  Sum_probs=204.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccC-----CcEEEEEEeccc-----hhhhHHHHHHHHHcCC-CCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQD-----KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||+|+||+||+|.+..+     ++.||||.+...     ...+.+|+.+|..++| ||||+++++|.... 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-
Confidence            35799999999999999999997654     368999998643     2345679999999976 89999999874322 


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhccc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceE
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIl  199 (403)
                         ..++||||||+ |+|.++|......            ...+++..+..++.||+.||+|||++ +||||||||+|||
T Consensus       142 ---~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NIL  217 (353)
T 4ase_A          142 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  217 (353)
T ss_dssp             ---SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCcccee
Confidence               23689999999 5899998764321            34589999999999999999999998 9999999999999


Q ss_pred             ecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015615          200 VNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (403)
Q Consensus       200 l~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  275 (403)
                      ++.++ .+||+|||+|+........   ....||+.|||||++.+.. |+.++|||||||++|||+| |..||.+.+..+
T Consensus       218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99887 7999999999876443322   2457899999999997654 9999999999999999998 999999876555


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .+..+......+.                           .+..+++++.+|+.+||+.||++|||+.++++|
T Consensus       296 ~~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 EFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5554443211110                           224578999999999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-52  Score=411.77  Aligned_cols=322  Identities=30%  Similarity=0.513  Sum_probs=245.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            35799999999999999999999999999999998642      234558999999999999999999875543333345


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|+||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus       105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~-~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCC-CEEEccCCCccc
Confidence            889999999999888865    35699999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCCC-----------------------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-----------
Q 015615          218 LVKGEP-----------------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-----------  263 (403)
Q Consensus       218 ~~~~~~-----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-----------  263 (403)
                      ......                       ....+||+.|+|||++.....++.++|||||||++|||++           
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            643321                       2456789999999997666679999999999999999998           


Q ss_pred             CCCCCCCCC-----------------cHHHHHHHHHHhCCCCHHHHhccCcCcc-cc--cCCCccCCCcccccccCCChH
Q 015615          264 GQPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYT-EF--KFPQIKAHPWHKIFQKRMPPE  323 (403)
Q Consensus       264 g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~  323 (403)
                      |.++|.+.+                 ..+++..+...+|.|..+.+........ .+  ..+.....++...+ +.++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~  337 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDD  337 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHH
Confidence            556666654                 3678889999999999987765432110 00  11111222222222 458999


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCChhhcCCCChHHHhhcchHHHHh
Q 015615          324 AVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK  396 (403)
Q Consensus       324 ~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (403)
                      +.+||++||++||++|||++|+|+||||++++++........  +....|.  +....+.+.+...+.+|+..
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~--~~~~~~~--~~~~~~~~~~~~~~~~e~~~  406 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTK--KIILPFD--DWMVLSETQLRYIFLKEVQS  406 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CC--CCCCSSC--TTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCC--CCCCChh--hcccCCHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999987654321111  1111122  33456677777777777653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.6e-53  Score=392.03  Aligned_cols=281  Identities=34%  Similarity=0.560  Sum_probs=227.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++..     ...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            46999999999999999999999999999999985432      344579999999999999999998743     3457


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||+++++.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence            899999999888777653   36799999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .... ......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            4332 233457899999999997766689999999999999999987766 67777778888888888888776554332


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      ........+............+.+++++.+||++||+.||++|||++|+|+||||+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            11111111222112222223356899999999999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-52  Score=394.61  Aligned_cols=281  Identities=35%  Similarity=0.664  Sum_probs=228.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|++.+.||+|+||.||+|++. +|+.||+|++....      ....+|+.+++.++||||+++++++.     +..
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~   92 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SER   92 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCC
Confidence            3457999999999999999999984 58999999985432      34458999999999999999999873     344


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ++++||||+++++.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        93 ~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~  167 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLAR  167 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCC-CEEEccCcCce
Confidence            58899999999988887653   35689999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ...... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+....+.+....+...
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            764332 2334578999999999977666899999999999999999999999999888899999998888877655432


Q ss_pred             Cc--CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          296 NP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       296 ~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      ..  .+....+......++.. ..+.+++++.+||++||+.||++|||++|+|+||||+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hccchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            21  11111122222233333 2356889999999999999999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.8e-52  Score=392.31  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=217.9

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++.     ..
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~   86 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TE   86 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence            34568999999999999999999999999999999985432      23457999999999999999999873     33


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+++||||++ ++|.+.+...    +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~  160 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADM-NIKIADFGF  160 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCC-CEEEeeccC
Confidence            45889999997 5888887654    5689999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.....+......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....          
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  230 (328)
T 3fe3_A          161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK----------  230 (328)
T ss_dssp             CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            9876655555667899999999999876645689999999999999999999999887766665554421          


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                             +            .++..+++++.+||++||..||.+|||++++++||||+...+.
T Consensus       231 -------~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          231 -------Y------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             -------C------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence                   0            0123478999999999999999999999999999999986554

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-52  Score=390.05  Aligned_cols=285  Identities=29%  Similarity=0.524  Sum_probs=230.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---------hhhHHHHHHHHHcC---CCCeeecceeeeecC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLD---HPNVVSLKHCFFSTT  131 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~---h~niv~~~~~~~~~~  131 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....         ....+|+.+++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            457999999999999999999999999999999985321         24457777777664   999999999987665


Q ss_pred             CCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          132 EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                      .....++++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEEee
Confidence            55566789999999999988887542  23489999999999999999999998 999999999999999887 799999


Q ss_pred             cCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       212 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            99998765555556678899999999997654 89999999999999999999999999999999999999888887665


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      +..... .....++.....+.. ...+.+++++.+||.+||+.||++|||+.++|+||||++..
T Consensus       243 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          243 WPRDVS-LPRGAFPPRGPRPVQ-SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             SCSSCS-SCGGGSCCCCCCCHH-HHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ccchhh-ccccccCCCCCCcHH-HhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            432111 111112222222222 23356899999999999999999999999999999999743

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-51  Score=395.59  Aligned_cols=317  Identities=32%  Similarity=0.613  Sum_probs=249.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|++.+.||+|+||.||+|.+..++..||||++....     ....+|+.+++.++||||+++++++...........+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            47999999999999999999999999999999986422     3445899999999999999999988654434445678


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||++++|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus       107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  179 (364)
T ss_dssp             EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCC-CEEEEeCcceEecC
Confidence            9999999999888864     4689999999999999999999998 999999999999999887 79999999998654


Q ss_pred             cCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          220 KGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       220 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....    .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.|..+.+...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            3322    234578999999999866666899999999999999999999999999999999999999999998876543


Q ss_pred             CcCcc---cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCC
Q 015615          296 NPNYT---EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFN  372 (403)
Q Consensus       296 ~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  372 (403)
                      .....   ....+.....+|... .+.+++++.+||.+||+.||++|||++++|+||||++...+....    .....+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~~  334 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPFK  334 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCCC
T ss_pred             hhhhHHHHHHhcCCccCCCHHHh-CCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcCC
Confidence            21100   011222222233332 356799999999999999999999999999999999986554321    1122222


Q ss_pred             CChhhcCCCChHHHhhcchHHH
Q 015615          373 FKPHELKGVPVDMLVKLIPEHA  394 (403)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~  394 (403)
                      +. .++..++.+.+...+.++.
T Consensus       335 ~~-~~~~~~~~~~~~~~~~~e~  355 (364)
T 3qyz_A          335 FD-MELDDLPKEKLKELIFEET  355 (364)
T ss_dssp             CC------CCHHHHHHHHHHHT
T ss_pred             cc-cccccCCHHHHHHHHHHHH
Confidence            22 4566677777777776654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-51  Score=396.35  Aligned_cols=315  Identities=32%  Similarity=0.561  Sum_probs=239.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .+...
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4799999999999999999999999999999998432      1334579999999999999999998754322 12234


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|+||||++++|.+++..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  177 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  177 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence            689999998888888764     4689999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+..+.|+.+.+.....
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            533  234567899999999998756689999999999999999999999999999999999999999999887655432


Q ss_pred             Cccc---ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015615          298 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFK  374 (403)
Q Consensus       298 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  374 (403)
                      ....   ...+......+...+ ..+++++.+||.+||+.||++|||++++|+||||+++.++......     ..+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~-----~~~~~~  329 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV-----QKYDDS  329 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC-----CCCCCC
T ss_pred             HHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCC-----CCCCCC
Confidence            2100   012333333444333 4679999999999999999999999999999999998776542111     112222


Q ss_pred             hhhcCCCChHHHhhcchHHHH
Q 015615          375 PHELKGVPVDMLVKLIPEHAR  395 (403)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~  395 (403)
                       .+-...+.+.|++.+.++..
T Consensus       330 -~~~~~~~~~~~~~~~~~~~~  349 (367)
T 1cm8_A          330 -FDDVDRTLDEWKRVTYKEVL  349 (367)
T ss_dssp             ------CCHHHHHHHHHHHHH
T ss_pred             -hhhhcCCHHHHHHHHHHHHH
Confidence             12223456677776666554

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-52  Score=396.19  Aligned_cols=288  Identities=33%  Similarity=0.630  Sum_probs=229.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh-----hhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++.....     ...+|+.+++.++||||+++++++..     ...++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            469999999999999999999999999999999864332     23369999999999999999998733     33478


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      +||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            99999999998888764   35689999999999999999999998 999999999999999887 79999999997653


Q ss_pred             cCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc-
Q 015615          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  297 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  297 (403)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.|....+..... 
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            322 223457899999999997766689999999999999999999999999999999999999999888765543221 


Q ss_pred             -CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCC
Q 015615          298 -NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPN  363 (403)
Q Consensus       298 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~  363 (403)
                       .+..+.++......... ..+.+++++.+||.+||+.||++|||++|+|+||||.++.......+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  297 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPD  297 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCT
T ss_pred             hhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCC
Confidence             11122222222222222 234689999999999999999999999999999999998776555444

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.1e-52  Score=385.47  Aligned_cols=277  Identities=35%  Similarity=0.665  Sum_probs=221.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|++.+.||+|+||.||+|++ .+|+.||+|++....      ....+|+.+++.++||||+++++++..     ...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            4699999999999999999998 678999999985432      344589999999999999999998743     2347


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||++++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence            899999999988887653   35689999999999999999999998 999999999999999887 7999999998765


Q ss_pred             ccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC-
Q 015615          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  296 (403)
Q Consensus       219 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  296 (403)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.... 
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            322 222345789999999999766668999999999999999999999999999888898888888877655433211 


Q ss_pred             -cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          297 -PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                       +.+. -.++.....+|.. +...+++++.+||++||+.||++|||++++|+||||++.
T Consensus       231 ~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYD-PNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCC-TTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccc-cccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence             0110 0111112222322 335689999999999999999999999999999999874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1e-51  Score=389.83  Aligned_cols=288  Identities=32%  Similarity=0.573  Sum_probs=217.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||.+....     ....+|+.+++.++||||+++++++     .+...++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence            46999999999999999999999999999999985432     3456899999999999999999987     3344588


Q ss_pred             EEEecccchHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          140 LVLEYVPETVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +||||++++|.+.+.....  ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            9999999999888876532  234589999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       218 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ..... ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            64322 23355789999999999765568999999999999999999999999999999999999888887765443221


Q ss_pred             --cCcccccCCCccCCCc----ccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCC
Q 015615          297 --PNYTEFKFPQIKAHPW----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR  360 (403)
Q Consensus       297 --~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~  360 (403)
                        +.+.. ..+......+    .......++.++.+||.+||+.||++|||++++|+||||++...+...
T Consensus       238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          238 KLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             GCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred             hhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence              11100 0011011111    111234678999999999999999999999999999999998766543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.8e-51  Score=392.33  Aligned_cols=257  Identities=25%  Similarity=0.367  Sum_probs=217.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ....|.+.+.||+|+||.||+|.+..+|+.||+|.+....          ....+|+.+++.++||||++++++|.    
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----   85 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE----   85 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE----
Confidence            3457999999999999999999999999999999985432          34568999999999999999999873    


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC---ceE
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  208 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~vk  208 (403)
                       +...+++||||++ ++|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.   .+|
T Consensus        86 -~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           86 -NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             -eCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEE
Confidence             3445889999997 588877754    35799999999999999999999998 9999999999999987653   699


Q ss_pred             EeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       209 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      |+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+........
T Consensus       160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD  238 (361)
T ss_dssp             ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EEecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            9999999887665555667899999999999654 489999999999999999999999999887777766654321111


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      .                         .+...+|+++++||++||..||.+|||++++|+||||+...
T Consensus       239 ~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          239 E-------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             H-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             c-------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            1                         12245799999999999999999999999999999998653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-51  Score=393.61  Aligned_cols=252  Identities=29%  Similarity=0.481  Sum_probs=210.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|+++.+|+.||||++....       ....+|..+++.+ +||||+++++++     .+.
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence            457999999999999999999999999999999986432       2345789999988 799999999987     334


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+|+|||||.+ +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g-~ikL~DFG~  170 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFGM  170 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCC-CEEEccccc
Confidence            458899999985 787777654    5699999999999999999999998 999999999999999888 799999999


Q ss_pred             ceeccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      |+.... .......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+....         
T Consensus       171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------  240 (353)
T 3txo_A          171 CKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------  240 (353)
T ss_dssp             CBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             eeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------
Confidence            975432 23344668999999999997554 8999999999999999999999999988877777766521         


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH------HHHhcCCCCccCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHPFFDELRD  356 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~------~ell~hp~f~~~~~  356 (403)
                              .            .++..+++++.+||++||+.||.+||++      +++++||||+++.+
T Consensus       241 --------~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          241 --------V------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             --------C------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence                    0            1234578999999999999999999998      89999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-51  Score=396.13  Aligned_cols=316  Identities=32%  Similarity=0.547  Sum_probs=233.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4799999999999999999999999999999998542      2334579999999999999999998754311 12234


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++||||++++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence            689999998888777653     5689999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+..+.|..+.+.....
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            532  234567899999999997756689999999999999999999999999999999999999999998887655432


Q ss_pred             Cccc---ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015615          298 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFK  374 (403)
Q Consensus       298 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  374 (403)
                      ....   ...+..+..++...+ ...++++.+||.+||+.||++|||++++|+||||++..++......     +.+.+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~-----~~~~~~  333 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA-----DPYDQS  333 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCC-----CCCCGG
T ss_pred             HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCC-----CCCCcc
Confidence            2100   012223333344333 4678999999999999999999999999999999998776543211     122221


Q ss_pred             hhhcCCCChHHHhhcchHHHHh
Q 015615          375 PHELKGVPVDMLVKLIPEHARK  396 (403)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~  396 (403)
                       .+......+.|+..+.++...
T Consensus       334 -~~~~~~~~~~~~~~~~~e~~~  354 (367)
T 2fst_X          334 -LESRDLLIDEWKSLTYDEVIS  354 (367)
T ss_dssp             -GSSCCCCHHHHHHHHHHHHHH
T ss_pred             -hhhccCCHHHHHHHHHHHHHH
Confidence             233445677777777766553

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2e-51  Score=396.28  Aligned_cols=319  Identities=29%  Similarity=0.512  Sum_probs=233.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .+...
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            5799999999999999999999999999999998542      1234579999999999999999998754321 22346


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++||||++++|.+.+.      ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~  176 (371)
T 2xrw_A          105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLART  176 (371)
T ss_dssp             EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCCCC---
T ss_pred             eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEEEeecccc
Confidence            78999999999888774      3588999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+....+
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             -------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             cccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            6544444567889999999999765 489999999999999999999999999999999999999888888776654432


Q ss_pred             Ccccc--cCCCccCCCcccccc-----------cCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCC
Q 015615          298 NYTEF--KFPQIKAHPWHKIFQ-----------KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNG  364 (403)
Q Consensus       298 ~~~~~--~~~~~~~~~~~~~~~-----------~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~  364 (403)
                      ....+  ..+......+...++           ...+.++++||++||+.||++|||++++|+||||+...++.....  
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~--  333 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA--  333 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC--
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC--
Confidence            21111  011111111111111           112578999999999999999999999999999998665432211  


Q ss_pred             CCCCCCCCCChhhcCCCChHHHhhcchHHHHh
Q 015615          365 RFLPPLFNFKPHELKGVPVDMLVKLIPEHARK  396 (403)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (403)
                       ..|.... ...+-.....+.|+.++.++...
T Consensus       334 -~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  363 (371)
T 2xrw_A          334 -PPPKIPD-KQLDEREHTIEEWKELIYKEVMD  363 (371)
T ss_dssp             -CCCCCCT-TTTCCCCCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCCC-hhhccccCcHHHHHHHHHHHHHH
Confidence             1111111 11223345677888887777654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.9e-51  Score=390.04  Aligned_cols=284  Identities=30%  Similarity=0.586  Sum_probs=227.0

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ....+|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..     .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence            34568999999999999999999999999999999985432      234579999999999999999998743     3


Q ss_pred             eEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC----CceEEee
Q 015615          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT----HQLKLCD  211 (403)
Q Consensus       136 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~----~~vkl~D  211 (403)
                      ..+++||||++++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++    ..+||+|
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             CEEEEEEecCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECc
Confidence            457899999999998888753    5689999999999999999999998 999999999999995332    2599999


Q ss_pred             cCCceecccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          212 FGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       212 fG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+...
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            9999765332 223345779999999999776668999999999999999999999999999999999999988888765


Q ss_pred             HHhccC--cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          291 EIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       291 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                      .+....  +.+ ...++......+...+...+++++.+||.+||+.||++|||++++|+||||++..+
T Consensus       261 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          261 TWPGVTALPDW-KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TSTTGGGSTTC-CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhh-hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            543221  111 11233334444444555568999999999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.3e-51  Score=386.49  Aligned_cols=252  Identities=26%  Similarity=0.402  Sum_probs=213.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...       .....+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence            35799999999999999999999999999999998643       233457999999999999999999873     334


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|+||||+++ +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG~a  152 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCC-CEEEeeccch
Confidence            58899999985 787777653    5789999999999999999999998 999999999999999888 7999999999


Q ss_pred             eecc-cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          216 KVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       216 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +... .+......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+....          
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  221 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------  221 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Confidence            8643 23334567899999999999654 48999999999999999999999999887766665554310          


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                             .            .++..+++++.+||.+||+.||++||     +++++++||||+.+.+
T Consensus       222 -------~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          222 -------I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -------C------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence                   0            12345799999999999999999999     9999999999998754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-51  Score=388.38  Aligned_cols=285  Identities=34%  Similarity=0.590  Sum_probs=226.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||.+....         ....+|+.+++.++||||+++++++.     +
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----H   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----C
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----e
Confidence            357999999999999999999999999999999985321         23457999999999999999999873     3


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ....++||||+++++...+...   ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             CCceEEEEEcCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence            3347899999999888777543   34678888999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      +....... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            98653322 23456789999999999766668999999999999999999999999999999999999988888776554


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                      ..........+...+..++.. +...++.++.+||++||..||++|||++|+|+||||+....+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~  303 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  303 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence            322111111111222222222 22467899999999999999999999999999999998765543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.5e-50  Score=390.40  Aligned_cols=254  Identities=25%  Similarity=0.447  Sum_probs=208.6

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (403)
                      ....+|++.+.||+|+||.||+|+++.+++.||||++....       ....+|..++..+ +||||++++++|.     
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----  123 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----  123 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----
Confidence            34468999999999999999999999999999999986432       2345788888877 8999999999873     


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      +...+|+|||||++ +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DF  197 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDY  197 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCC-CEEEeec
Confidence            34458899999985 777777653    5799999999999999999999998 999999999999999888 7999999


Q ss_pred             CCceec-ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH--------HHH-HHHHH
Q 015615          213 GSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV--------DQL-VEIIK  282 (403)
Q Consensus       213 G~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~-~~i~~  282 (403)
                      |+|+.. .........+||+.|+|||++.+. .++.++|||||||++|||++|++||......        +.+ ..+..
T Consensus       198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             ceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence            999863 333445567899999999999765 4899999999999999999999999753221        111 11211


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH------HHHhcCCCCccCCC
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHPFFDELRD  356 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~------~ell~hp~f~~~~~  356 (403)
                      .            .                 ..++..+++++.+||++||+.||.+||++      +++++||||+.+.+
T Consensus       277 ~------------~-----------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          277 K------------Q-----------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             C------------C-----------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             c------------c-----------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence            0            0                 01334689999999999999999999985      89999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-50  Score=376.29  Aligned_cols=284  Identities=35%  Similarity=0.613  Sum_probs=220.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            47999999999999999999999999999999885432      234579999999999999999998743     3347


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||++++++..+...   ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            899999997544444332   36689999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc--
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  295 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  295 (403)
                      .... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+.+..+..........  
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            4322 2335578999999999977666899999999999999999999999999998988888888877766543221  


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      ...+.....+............+.+++++.+||++||+.||++|||++++++||||+++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            111122222222111111122246899999999999999999999999999999999987654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.2e-50  Score=394.98  Aligned_cols=280  Identities=31%  Similarity=0.535  Sum_probs=227.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHc------CCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLL------DHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.+      .|+||+++++++..     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----
Confidence            347999999999999999999999999999999997653   3345688888887      57799999988743     


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC-ceEEeecC
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-~vkl~DfG  213 (403)
                      ...+++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++. .+||+|||
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            34588999999999998887643  34589999999999999999999998 9999999999999998762 29999999


Q ss_pred             CceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ++.....  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|+...+.
T Consensus       248 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            9976432  334568899999999997654 8999999999999999999999999999999999999999999987665


Q ss_pred             ccCcCccccc---C---------------------------CCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHH
Q 015615          294 CMNPNYTEFK---F---------------------------PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  343 (403)
Q Consensus       294 ~~~~~~~~~~---~---------------------------~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~  343 (403)
                      ........+.   +                           .......|...+....++++.+||++||++||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence            3321100000   0                           001122344444556689999999999999999999999


Q ss_pred             HHhcCCCCccC
Q 015615          344 EALIHPFFDEL  354 (403)
Q Consensus       344 ell~hp~f~~~  354 (403)
                      |+|+||||++.
T Consensus       405 e~L~Hpw~~~~  415 (429)
T 3kvw_A          405 QALRHPWLRRR  415 (429)
T ss_dssp             HHHTSTTTC--
T ss_pred             HHhCChhhccC
Confidence            99999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7e-50  Score=384.02  Aligned_cols=288  Identities=31%  Similarity=0.587  Sum_probs=228.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---------------hhhHHHHHHHHHcCCCCeeecceeeee
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSLKHCFFS  129 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~niv~~~~~~~~  129 (403)
                      .+|++.+.||+|+||.||+|.+.. |..||||++....               ....+|+.+++.++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            479999999999999999999854 9999999884321               345689999999999999999999877


Q ss_pred             cCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEE
Q 015615          130 TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (403)
Q Consensus       130 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  209 (403)
                      .......++++||||+++++.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl  175 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNN-DITI  175 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEE
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCC-CEEE
Confidence            665666678999999999988888743   35689999999999999999999998 999999999999999887 7999


Q ss_pred             eecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999986555555556788999999999976566899999999999999999999999999999999999999999887


Q ss_pred             HHHhccCcC-c---ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          290 EEIKCMNPN-Y---TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       290 ~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                      ..+...... .   ............|.. ..+..++.+.+||.+||+.||++|||+.++|+||||+++..+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  328 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD  328 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence            765432211 0   001111222222322 23567899999999999999999999999999999999876543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-51  Score=384.73  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=216.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+....   ....+|+.+++.++||||+++++++..     ...+++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEE
Confidence            357999999999999999999999999999999986432   345689999999999999999998833     335889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC--CCCceEEeecCCcee
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKV  217 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG~a~~  217 (403)
                      |||||++ +|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.  ++ .+||+|||++..
T Consensus        79 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCC-CEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCC-CEEEEECCCCeE
Confidence            9999985 787776432   34689999999999999999999998 9999999999999986  44 799999999988


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...+.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+...........      
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------  226 (321)
T 1tki_A          154 LKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------  226 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------
T ss_pred             CCCCCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh------
Confidence            76655555678999999999996644 79999999999999999999999999887777777665432222221      


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                         .+.+|.++.+||.+||..||.+|||+.++|+||||++.
T Consensus       227 -------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          227 -------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             -------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             -------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                               23579999999999999999999999999999999874

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-50  Score=395.65  Aligned_cols=262  Identities=26%  Similarity=0.410  Sum_probs=218.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|+||+||+|++..+++.||||++...       .....+|+.++..++||||++++++|     .+..
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence            35799999999999999999999999999999998542       22356899999999999999999987     3344


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|+|||||. |+|.+.+...   ...+++..++.++.||+.||.|||+. |||||||||+|||++.++ .+||+|||+|
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence            5889999997 5888887653   36799999999999999999999997 999999999999999888 7999999999


Q ss_pred             eecccCCCc--ceeeeccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          216 KVLVKGEPN--ISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       216 ~~~~~~~~~--~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +........  ...+||+.|+|||++.    +...++.++|||||||++|||++|++||.+.+..+.+..+......   
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---  299 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER---  299 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---
Confidence            866443322  2357999999999986    2345899999999999999999999999998888877777642110   


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC--CCCHHHHhcCCCCccCCCCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~s~~ell~hp~f~~~~~~~~  359 (403)
                                  +.+|.         ....+|+++++||++||+.+|++  |++++|+++||||+++.+...
T Consensus       300 ------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          300 ------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             ------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             ------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence                        01111         11347999999999999999988  999999999999999877654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.3e-50  Score=385.38  Aligned_cols=315  Identities=33%  Similarity=0.573  Sum_probs=242.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC-CceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  137 (403)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4799999999999999999999999999999998643      23345799999999999999999988543321 1122


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++||||+.++|.+.+      ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~  193 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH  193 (371)
T ss_dssp             CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred             EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence            4799999999877665      24589999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+.....
T Consensus       194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            532  234467899999999997756689999999999999999999999999999999999999999988776554332


Q ss_pred             Ccccc---cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015615          298 NYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFK  374 (403)
Q Consensus       298 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  374 (403)
                      .....   ..+......+.. ..+.+++++.+||.+||+.||++|||++++|+||||+.+..+............     
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~-----  345 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDD-----  345 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCC-----
T ss_pred             hhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCc-----
Confidence            11100   111111222222 234679999999999999999999999999999999998776543222111111     


Q ss_pred             hhhcCCCChHHHhhcchHHHH
Q 015615          375 PHELKGVPVDMLVKLIPEHAR  395 (403)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~  395 (403)
                      ..+...++.+.++..+.++..
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~  366 (371)
T 4exu_A          346 SLEHEKLTVDEWKQHIYKEIV  366 (371)
T ss_dssp             TTSSCCCCHHHHHHHHHHHHH
T ss_pred             chhhcccchHHHHHHHHHHHH
Confidence            123344667777777776553

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.5e-52  Score=392.68  Aligned_cols=253  Identities=28%  Similarity=0.454  Sum_probs=211.6

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...++|.+.+.||+|+||.||+|.+..+|+.||||++...       .....+|+.+++.++||||+++++++..     
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----
Confidence            3456899999999999999999999999999999998543       2345689999999999999999998733     


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...+++||||++++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~DFG~  154 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNL-NVKIADFGL  154 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTC-CEEECCSSC
T ss_pred             CCEEEEEEECCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCC-CEEEEEecc
Confidence            3457899999999998888764    5699999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+........                
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------  218 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------  218 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------
Confidence            9877666555667899999999999766545789999999999999999999997643211000                


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                 .+..  ....++..+|+++.+||++||+.||.+|||++++++||||+..
T Consensus       219 -----------~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          219 -----------KVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             -----------CCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             -----------HHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                       0000  0011234579999999999999999999999999999999863

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-50  Score=380.07  Aligned_cols=250  Identities=26%  Similarity=0.462  Sum_probs=214.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++...       .....+|+.+++.++||||+++++++.     +..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence            45799999999999999999999999999999998643       233457999999999999999999873     344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|+||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCC-CEEEeecCcc
Confidence            58899999985 888887653    5689999999999999999999988 999999999999999888 7999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      +....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....           
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  219 (318)
T 1fot_A          154 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------  219 (318)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred             eecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            86533  23456899999999999665 48999999999999999999999999888777776665421           


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                            .            .++..+++++.+||++||..||++|+     +++++++||||+++.+
T Consensus       220 ------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          220 ------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             ------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence                  0            12345789999999999999999999     9999999999998754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.5e-50  Score=383.23  Aligned_cols=289  Identities=34%  Similarity=0.622  Sum_probs=228.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||.+....     ....+|+.+++.++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            357999999999999999999999999999999985322     234579999999999999999987654333334567


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||||+.++|.+.+..     ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCC-cEEEEeccccccc
Confidence            89999999998888764     4689999999999999999999998 999999999999999887 7999999999865


Q ss_pred             ccCCC-----------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          219 VKGEP-----------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       219 ~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      .....           .....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            43211           1234679999999998765668999999999999999999999999999888888888887776


Q ss_pred             CHHHHhccCcC--ccc--ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCC
Q 015615          288 TREEIKCMNPN--YTE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTR  360 (403)
Q Consensus       288 ~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~  360 (403)
                      ...........  ...  ...+.....++.. ..+.+++++.+||.+||..||++|||++++++||||+....+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~  318 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDE  318 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSS
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccc
Confidence            53221110000  000  0011111122222 224689999999999999999999999999999999998877654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.7e-51  Score=381.06  Aligned_cols=254  Identities=19%  Similarity=0.233  Sum_probs=187.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh---hhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++.....   ..++|+..+..++|||||++++++.... .....+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            3699999999999999999987  689999999865432   2234666667889999999999886543 233457899


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCccccCCCCCceEecCCCCceEEeecC
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------IGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-------~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ||||+ |+|.+.+..     .++++..+..++.|++.||+|||++       .+||||||||+|||++.++ .+||+|||
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            99999 588888864     4688999999999999999999964       2899999999999999888 79999999


Q ss_pred             CceecccCCCc-----ceeeecccccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCc----------
Q 015615          214 SAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESG----------  273 (403)
Q Consensus       214 ~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~----------  273 (403)
                      +|+........     ...+||+.|||||++.+..     .++.++|||||||++|||+||.+||.....          
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876544322     2357999999999996542     257799999999999999999877643221          


Q ss_pred             ----HHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          274 ----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       274 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                          .+.+......             ..    ..|.++..    ......+..+.+|+.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~-------------~~----~rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          234 SDPSVEEMRKVVCE-------------QK----LRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SSCCHHHHHHHHTT-------------SC----CCCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHHHhc-------------cc----CCCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                1111111100             00    00000000    0001133578899999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-50  Score=379.05  Aligned_cols=257  Identities=24%  Similarity=0.376  Sum_probs=215.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ....|.+.+.||+|+||.||+|.+..+|+.||+|.+...          .....+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   84 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----   84 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            345799999999999999999999999999999988542          234668999999999999999999873    


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC---ceE
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLK  208 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~vk  208 (403)
                       +...+++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.   .+|
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           85 -NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEE
Confidence             3345789999997 488877754    35799999999999999999999998 9999999999999987652   699


Q ss_pred             EeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       209 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      |+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence            9999999877555555567899999999999654 489999999999999999999999998877776666554321111


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      ..                         ....++..+.+||++||+.||++|||++++|+||||+...
T Consensus       238 ~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          238 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            11                         2245789999999999999999999999999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.8e-50  Score=374.99  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=212.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||.+...    .....+|+.+++.++||||+++++++..     ...++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEEE
Confidence            45799999999999999999999999999999998533    3345689999999999999999998844     23478


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+. ++|.+.+..     ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCC-CEEEeeCCCceec
Confidence            9999997 578877764     3589999999999999999999998 999999999999999888 7999999998876


Q ss_pred             ccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+........         
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  236 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------  236 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------
T ss_pred             CCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            44332 34567899999999997654 89999999999999999999999998877666655544211100         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                       ..+..+++.+.+||.+||+.||++|||++++++||||+...
T Consensus       237 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          237 -----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             -----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -----------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence                             01245789999999999999999999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.9e-50  Score=383.68  Aligned_cols=258  Identities=29%  Similarity=0.388  Sum_probs=211.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...|++.+.||+|+||.||+|.+..+|+.||||++...         .....+|+.+++.++||||+++++++..     
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence            45799999999999999999999999999999998532         2445689999999999999999998743     


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEee
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCD  211 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~D  211 (403)
                      ...+|+|||||+ ++|.+.+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++  ..+||+|
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEec
Confidence            345889999998 588777776655556789999999999999999999998 999999999999998654  2499999


Q ss_pred             cCCceecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          212 FGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       212 fG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.. .+....+.+........
T Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~  254 (351)
T 3c0i_A          177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR  254 (351)
T ss_dssp             CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred             CcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence            999987654332 33567899999999997654 8999999999999999999999998753 33334443321111111


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                               ....++.++.+||++||..||++|||+.++|+||||++.
T Consensus       255 -------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          255 -------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             -------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                                     113578999999999999999999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.2e-50  Score=390.79  Aligned_cols=258  Identities=28%  Similarity=0.434  Sum_probs=216.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||++++++|     .+..
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~  142 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR  142 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence            45799999999999999999999999999999998542       23456899999999999999999988     3445


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++|+|||||+ |+|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCC-CEEEecccee
Confidence            6899999997 588877754     4689999999999999999999998 999999999999999888 7999999999


Q ss_pred             eecccCCC--cceeeecccccccccccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          216 KVLVKGEP--NISYICSRYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       216 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      +.......  ..+.+||+.|+|||++.+...   ++.++|||||||++|||++|.+||.+.+..+.+..+......    
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----  291 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS----  291 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc----
Confidence            87644322  235679999999999975432   678999999999999999999999998888777777653110    


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCC--CCCHHHHhcCCCCccCCCCC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~s~~ell~hp~f~~~~~~~  358 (403)
                                 ..+|          ....+|+++++||++||+.+|.+  |++++|+++||||+.+.+.+
T Consensus       292 -----------~~~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          292 -----------LTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW  340 (410)
T ss_dssp             -----------CCCC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred             -----------ccCC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence                       0011          01357999999999999999988  99999999999999986654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.9e-50  Score=382.21  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=215.1

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ....+|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.     +
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~  112 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----D  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----c
Confidence            34568999999999999999999999999999999985432       33457999999999999999998873     3


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+|+||||++ ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       113 ~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DFg  186 (350)
T 1rdq_E          113 NSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFG  186 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCC-CEEEcccc
Confidence            445889999997 5888888764    5689999999999999999999998 999999999999999888 79999999


Q ss_pred             CceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      +++....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....  +      
T Consensus       187 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~------  255 (350)
T 1rdq_E          187 FAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--V------  255 (350)
T ss_dssp             TCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------
T ss_pred             cceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC--C------
Confidence            9987533  23456899999999999765 48999999999999999999999999887777666665420  0      


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                           .++..+++++.+||++||+.||.+||+     ++++++||||+.+.+
T Consensus       256 ---------------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          256 ---------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                                 123457999999999999999999998     999999999998654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.6e-50  Score=382.23  Aligned_cols=290  Identities=29%  Similarity=0.486  Sum_probs=227.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC---C
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE---K  133 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~  133 (403)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++.....   .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4568999999999999999999999999999999884332      234589999999999999999998755321   1


Q ss_pred             CceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       134 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ....+++||||+++++.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-CEEEccch
Confidence            13457899999999888887654   35699999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccC-----CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          214 SAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       214 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      ++......     .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99865422     1223457899999999997766689999999999999999999999999999899999988888776


Q ss_pred             HHHHhccCc--CcccccCCCccCCCccccc-ccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          289 REEIKCMNP--NYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       289 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      ...+.....  .+................+ ....++++.+||.+||+.||++|||++|+|+||||+....+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            654432211  0111111110001111100 01247889999999999999999999999999999875444

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3e-50  Score=388.54  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=211.9

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ....+|++.+.||+|+||.||+|.+..+|+.||||.+....       ....+|+.+++.++||||++++++|.     +
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~   86 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----D   86 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            34568999999999999999999999999999999985432       34557999999999999999998873     3


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+|+||||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG  160 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHG-HVHITDFN  160 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCC-CEEEeccc
Confidence            3458899999975 77777764    35799999999999999999999998 999999999999999888 79999999


Q ss_pred             CceecccCCCcceeeecccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCH
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV--DQLVEIIKVLGTPTR  289 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~  289 (403)
                      ++.............||+.|+|||++.+.  ..++.++|||||||++|+|++|..||......  ..+........    
T Consensus       161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----  236 (384)
T 4fr4_A          161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV----  236 (384)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC----
T ss_pred             eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc----
Confidence            99887666666678899999999998642  34789999999999999999999999764322  22211111100    


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-HHHHhcCCCCccCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-ALEALIHPFFDELRD  356 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-~~ell~hp~f~~~~~  356 (403)
                                              ..++..+++++.+||.+||+.||.+||+ ++++++||||+++.+
T Consensus       237 ------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          237 ------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             ------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                                    0123457899999999999999999998 999999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.1e-50  Score=382.83  Aligned_cols=253  Identities=27%  Similarity=0.475  Sum_probs=213.0

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|.+.+.||+|+||.||+|+++.+|+.||||.+....       ....+|..++..+ +||||+++++++.     +
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----T   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----C
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----e
Confidence            3457999999999999999999999999999999986432       3345788888876 9999999999873     3


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+|+||||+++ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG  163 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFG  163 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCC-CEEEeECh
Confidence            4458899999974 888887653    5689999999999999999999998 999999999999999888 79999999


Q ss_pred             Cceeccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          214 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       214 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      +++.... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....        
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  234 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------  234 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            9976432 22344668999999999997654 8999999999999999999999999888776666654410        


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHH-HHhcCCCCccCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-EALIHPFFDELRD  356 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~-ell~hp~f~~~~~  356 (403)
                          +                 .++..+++++.+||++||+.||++||++. ++++||||+++.+
T Consensus       235 ----~-----------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          235 ----P-----------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             ----C-----------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             ----C-----------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence                0                 12245789999999999999999999998 9999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.8e-50  Score=384.19  Aligned_cols=253  Identities=27%  Similarity=0.411  Sum_probs=213.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....       ....+|..++..+ .||||+++++++     .+.
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence            457999999999999999999999999999999986432       2345688888877 799999999987     334


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+|+||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG~  167 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFGM  167 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCC-cEEEEeCCc
Confidence            468899999985 888887654    5689999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecc-cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..+....         
T Consensus       168 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------  237 (353)
T 2i0e_A          168 CKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------  237 (353)
T ss_dssp             CBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             ccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------
Confidence            98643 233344678999999999996554 8999999999999999999999999888777776665520         


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRDP  357 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~~  357 (403)
                              .            .++..+|+++.+||++||+.||.+||+     ++++++||||+.+.+.
T Consensus       238 --------~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          238 --------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             --------C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence                    0            123457999999999999999999994     7999999999987553

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-49  Score=380.45  Aligned_cols=253  Identities=25%  Similarity=0.454  Sum_probs=207.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.+.||+|+||.||+|+++.+|+.||||++....       ....+|..+++.+ +||||+++++++.     +
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~   81 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----T   81 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----e
Confidence            4568999999999999999999999999999999986432       2345789999887 8999999999873     3


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+|+||||+++ +|...+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        82 ~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DFG  155 (345)
T 3a8x_A           82 ESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDYG  155 (345)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCGG
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEEecc
Confidence            4458899999985 887777653    5689999999999999999999998 999999999999999888 79999999


Q ss_pred             Cceecc-cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc--------HH-HHHHHHHH
Q 015615          214 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--------VD-QLVEIIKV  283 (403)
Q Consensus       214 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~-~~~~i~~~  283 (403)
                      +++... ........+||+.|+|||++.+. .++.++|||||||++|||++|++||.....        .. ....+...
T Consensus       156 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~  234 (345)
T 3a8x_A          156 MCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK  234 (345)
T ss_dssp             GCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC
T ss_pred             ccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC
Confidence            997642 23334566899999999999765 489999999999999999999999975321        11 11111110


Q ss_pred             hCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH------HHHhcCCCCccCCC
Q 015615          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHPFFDELRD  356 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~------~ell~hp~f~~~~~  356 (403)
                                  .                 ..++..+++++.+||++||+.||.+||++      +++++||||+.+.+
T Consensus       235 ------------~-----------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          235 ------------Q-----------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             ------------C-----------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             ------------C-----------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence                        0                 01234579999999999999999999995      89999999998754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.3e-50  Score=384.94  Aligned_cols=255  Identities=29%  Similarity=0.403  Sum_probs=213.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     +..+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            457999999999999999999999999999999985432      34567999999999999999999873     3445


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEeecCC
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  214 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~  214 (403)
                      .++||||+.+ +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++  ..+||+|||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            7899999985 77777654    35689999999999999999999998 999999999999998653  2599999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.......+.     
T Consensus       178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-----  251 (362)
T 2bdw_A          178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-----  251 (362)
T ss_dssp             CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred             ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence            9876655555567899999999999654 4899999999999999999999999988776666665542111110     


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                          .....+++++.+||.+||..||++|||++++|+||||+..
T Consensus       252 --------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          252 --------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             --------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             --------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                                0113578999999999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=387.48  Aligned_cols=261  Identities=28%  Similarity=0.445  Sum_probs=215.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|+++.+|+.||||++.+.       .....+|..++..++||||++++++|     .+..
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  134 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDEN  134 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCC
Confidence            45799999999999999999999999999999998642       23356799999999999999999887     3445


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++|+||||++ ++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g-~vkL~DFGla  209 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCG-HIRLADFGSC  209 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCC-CEEEeechhh
Confidence            6899999997 5888888654   35799999999999999999999997 999999999999999888 6999999999


Q ss_pred             eecccCCC--cceeeecccccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          216 KVLVKGEP--NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       216 ~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      +.......  ....+||+.|+|||++..      ...++.++|||||||++|||++|++||.+.+..+.+..+...... 
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-  288 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-  288 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-
Confidence            87644332  224579999999999862      234899999999999999999999999998887777776642100 


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCC---CCHHHHhcCCCCccCCCCCC
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFFDELRDPNT  359 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R---~s~~ell~hp~f~~~~~~~~  359 (403)
                                    ..++.         +...+|+++++||++||+ +|.+|   ++++++++||||+++.+..-
T Consensus       289 --------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          289 --------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             --------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             --------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                          00010         123579999999999999 99998   59999999999999876643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=391.95  Aligned_cols=256  Identities=29%  Similarity=0.391  Sum_probs=211.7

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++     .+..
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence            3457999999999999999999999999999999985432      3456899999999999999999987     3444


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC--CCceEEeecC
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFG  213 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG  213 (403)
                      ..++|||||.+ +|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+|||++.+  ++.+||+|||
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            57899999985 787777653    5699999999999999999999998 99999999999999842  2379999999


Q ss_pred             CceecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          214 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       214 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.......+.   
T Consensus       159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---  234 (444)
T 3soa_A          159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS---  234 (444)
T ss_dssp             SCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             eeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc---
Confidence            9976644322 2456799999999999654 4899999999999999999999999998877777666553211110   


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                            .....+|+++.+||.+||+.||++|||+.++|+||||+..
T Consensus       235 ----------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          235 ----------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ----------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                                  0123579999999999999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5e-50  Score=391.03  Aligned_cols=290  Identities=31%  Similarity=0.514  Sum_probs=212.4

Q ss_pred             cceEE-EeEeeeCCcEEEEEEEEc--cCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMA-ERVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..|.+ +++||+|+||.||+|++.  .+++.||||++...  .....+|+.+++.++||||+++++++...   ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEE
Confidence            35777 558999999999999965  56889999998654  23456899999999999999999988552   234578


Q ss_pred             EEEecccchHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe----cCCCCceEEe
Q 015615          140 LVLEYVPETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLC  210 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll----~~~~~~vkl~  210 (403)
                      +||||++++|.+.+......     ...+++..++.++.||+.||+|||++ ||+||||||+|||+    +.++ .+||+
T Consensus        97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kl~  174 (405)
T 3rgf_A           97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIA  174 (405)
T ss_dssp             EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTT-CEEEC
T ss_pred             EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCC-cEEEE
Confidence            99999999998888654321     23489999999999999999999998 99999999999999    4445 79999


Q ss_pred             ecCCceecccC----CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---------HHHH
Q 015615          211 DFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---------VDQL  277 (403)
Q Consensus       211 DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~  277 (403)
                      |||+++.....    .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...         .+++
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999865432    1223467899999999997766689999999999999999999999987654         4788


Q ss_pred             HHHHHHhCCCCHHHHhccCcC--c-------ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          278 VEIIKVLGTPTREEIKCMNPN--Y-------TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ..+...++.|....|......  +       ....+.......+........++.+.+||++||++||.+|||++|+|+|
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            889999998887655432110  0       0000000000001111122347899999999999999999999999999


Q ss_pred             CCCccCCCCCC
Q 015615          349 PFFDELRDPNT  359 (403)
Q Consensus       349 p~f~~~~~~~~  359 (403)
                      |||++...+..
T Consensus       335 p~f~~~~~~~~  345 (405)
T 3rgf_A          335 PYFLEDPLPTS  345 (405)
T ss_dssp             GGGTSSSCCCS
T ss_pred             hhhccCCCCcc
Confidence            99998665543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-48  Score=370.07  Aligned_cols=291  Identities=33%  Similarity=0.555  Sum_probs=234.0

Q ss_pred             CccccceEEEeEeeeCCcEEEEEEEEc-cCCcEEEEEEeccch------hhhHHHHHHHHHc---CCCCeeecceeeeec
Q 015615           61 PKQTISYMAERVVGHGSFGVVFQAKCL-ETGEAVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFST  130 (403)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~  130 (403)
                      .....+|++.+.||+|+||.||+|++. .+|+.||||++....      ....+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            344568999999999999999999995 678999999885322      2445788877766   899999999988644


Q ss_pred             CCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          131 TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                      .......+++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~-~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEEC
T ss_pred             ccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCC-CEEEe
Confidence            444566789999999999988887643  24589999999999999999999998 999999999999999887 79999


Q ss_pred             ecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       211 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      |||++.............+|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+.+...
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            999998664444444567899999999997654 8999999999999999999999999999989999999888888766


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      .+...... ....+......+ ...+...++..+.+||.+||..||.+|||+.++++||||+++....
T Consensus       242 ~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          242 DWPRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             GSCTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             cCcccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            55321110 001111111111 1233467899999999999999999999999999999999987654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-49  Score=377.04  Aligned_cols=285  Identities=33%  Similarity=0.591  Sum_probs=227.4

Q ss_pred             CCccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           60 QPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        60 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ......+|++.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++.     
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   94 (331)
T 4aaa_A           20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----   94 (331)
T ss_dssp             CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----
Confidence            3345568999999999999999999999999999999885432      23457999999999999999999873     


Q ss_pred             CceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       134 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      +....++||||++++++..+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg  169 (331)
T 4aaa_A           95 KKKRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFG  169 (331)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             cCCEEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCC-cEEEEeCC
Confidence            33457899999998655554332   35699999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          214 SAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       214 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.......
T Consensus       170 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (331)
T 4aaa_A          170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ  249 (331)
T ss_dssp             TC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             CceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence            99765332 22334578999999999977656899999999999999999999999999999999998888887766543


Q ss_pred             hc--cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          293 KC--MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       293 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      ..  ..+.+.....+............+.+++++.+||.+||+.||++|||++++|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            22  233333444444433333333445689999999999999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.5e-49  Score=366.06  Aligned_cols=257  Identities=29%  Similarity=0.452  Sum_probs=206.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ...+|.+.+.||+|+||.||+|.+..+|..||+|.+....     ....+|+.+++.++||||+++++++.     +...
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCe
Confidence            3457999999999999999999999999999999986543     44568999999999999999999873     3345


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC--CCceEEeecCC
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGS  214 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG~  214 (403)
                      .++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.+  ...+||+|||+
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            7899999985 88888876655567899999999999999999999998 99999999999999532  23799999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.............+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+....          
T Consensus       174 a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------  241 (285)
T 3is5_A          174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE----------  241 (285)
T ss_dssp             CCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             ceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC----------
Confidence            987655555556778999999999843  48999999999999999999999999877555444333210          


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                        +.+.              .....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       242 --~~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          242 --PNYA--------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --CCCC--------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             --cccc--------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence              0000              011236899999999999999999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-50  Score=373.79  Aligned_cols=255  Identities=28%  Similarity=0.432  Sum_probs=204.3

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------------------------hhhHHHHHH
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------------------------RYKNRELQT  111 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~  111 (403)
                      ....+|++.+.||+|+||.||+|++..+|+.||||++....                              ....+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            44568999999999999999999999999999999985432                              335679999


Q ss_pred             HHHcCCCCeeecceeeeecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 015615          112 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH  190 (403)
Q Consensus       112 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH  190 (403)
                      ++.++||||+++++++..   .....+++||||+++ +|.+.     .....+++..++.++.||+.||+|||++ ||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH  160 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIH  160 (298)
T ss_dssp             HHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            999999999999998743   223467899999985 44332     1245799999999999999999999998 9999


Q ss_pred             cCCCCCceEecCCCCceEEeecCCceecccCCC-cceeeecccccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCC
Q 015615          191 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPL  267 (403)
Q Consensus       191 ~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~p  267 (403)
                      |||||+|||++.++ .+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|+|++|..|
T Consensus       161 ~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          161 RDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            99999999999887 799999999987644322 234578999999999865432  37789999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      |.+.+.......+....                 ..++          ....+++++.+||.+||+.||++|||+.++++
T Consensus       240 f~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          240 FMDERIMCLHSKIKSQA-----------------LEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCCSSHHHHHHHHHHCC-----------------CCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccHHHHHHHHhccc-----------------CCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            98876554444333210                 0000          11357899999999999999999999999999


Q ss_pred             CCCCcc
Q 015615          348 HPFFDE  353 (403)
Q Consensus       348 hp~f~~  353 (403)
                      ||||++
T Consensus       293 hp~~~~  298 (298)
T 2zv2_A          293 HPWVTR  298 (298)
T ss_dssp             CHHHHC
T ss_pred             CccccC
Confidence            999963

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.7e-50  Score=383.03  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=197.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++...   .....+|+.+++.++||||+++++++.     +...++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence            345799999999999999999999999999999998653   244568999999999999999999884     334588


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC-ceEEeecCCcee
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  217 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-~vkl~DfG~a~~  217 (403)
                      +||||+. ++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++. .+||+|||+++.
T Consensus        93 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           93 IIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999997 4888777653    5699999999999999999999998 9999999999999986552 499999999975


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........||+.|+|||++.+....+.++|||||||++|+|++|++||.+.........+.......          
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~----------  237 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV----------  237 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT----------
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC----------
Confidence            5444444567899999999999776534455999999999999999999998754433332222211000          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                         .+..+          ....+++++.+||++||+.||++|||+.++++||||...
T Consensus       238 ---~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          238 ---KYSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             ---CCCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             ---CCCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence               00000          112478999999999999999999999999999999764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4e-49  Score=378.47  Aligned_cols=277  Identities=26%  Similarity=0.448  Sum_probs=220.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcC-----CCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----HPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+.     ||||+++++++..     .
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-----~  108 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-----Y  108 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-----T
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-----C
Confidence            357999999999999999999999999999999986432   34457999999997     9999999998844     2


Q ss_pred             eEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC-------------
Q 015615          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-------------  202 (403)
Q Consensus       136 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~-------------  202 (403)
                      .++++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.             
T Consensus       109 ~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          109 DHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             CeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcc
Confidence            3588999999889998887643  24589999999999999999999998 9999999999999975             


Q ss_pred             ------------CCCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 015615          203 ------------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  270 (403)
Q Consensus       203 ------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  270 (403)
                                  ++ .+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+
T Consensus       186 ~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          186 TDGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        44 799999999986433  234567899999999997654 89999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhccCcCc-ccc--------cCCCccCC--------CcccccccCCChHHHHHHHHhhc
Q 015615          271 ESGVDQLVEIIKVLGTPTREEIKCMNPNY-TEF--------KFPQIKAH--------PWHKIFQKRMPPEAVDLVSRLLQ  333 (403)
Q Consensus       271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~--------~~~~~~~~--------~~~~~~~~~~s~~~~~ll~~~L~  333 (403)
                      .+..+.+..+....+.++...+....... ..+        .++.....        .....+....++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            99888888888888877766543322110 000        00100000        00001112245788899999999


Q ss_pred             cCCCCCCCHHHHhcCCCCc
Q 015615          334 YSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       334 ~dP~~R~s~~ell~hp~f~  352 (403)
                      .||++|||++|+|+||||+
T Consensus       342 ~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          342 IDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SSGGGSCCHHHHTTSGGGC
T ss_pred             CChhhCCCHHHHhcCcccC
Confidence            9999999999999999996

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-49  Score=382.55  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=208.1

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh-------hhHHHHHH-HHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.+.||+|+||.||+|+++.+++.||||++.....       ...+|..+ ++.++||||++++++|.     +
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----T  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----C
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----e
Confidence            44689999999999999999999999999999999865431       22234444 46679999999998873     3


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+|+||||+.+ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~ikL~DFG  184 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDFG  184 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEeeCc
Confidence            4468899999985 787777653    5689999999999999999999998 999999999999999888 79999999


Q ss_pred             Cceeccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          214 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       214 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      +++.... .......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+....        
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  255 (373)
T 2r5t_A          185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------  255 (373)
T ss_dssp             BCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC--------
T ss_pred             cccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------
Confidence            9976432 3334567899999999999765 48999999999999999999999999888777776665420        


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH----HHHhcCCCCccCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEALIHPFFDELRD  356 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~----~ell~hp~f~~~~~  356 (403)
                                           ..++..++.++.+||++||+.||.+|+++    +++++||||+.+.+
T Consensus       256 ---------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          256 ---------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             ---------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             ---------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence                                 01234679999999999999999999996    69999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-49  Score=379.81  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=209.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ...+|++.+.||+|+||.||+|.++.+|+.||||.+........+|++++.++ +||||+++++++     .+..++|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence            34579999999999999999999999999999999987776777899999888 799999999987     344568899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC---CceEEeecCCcee
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLCDFGSAKV  217 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~---~~vkl~DfG~a~~  217 (403)
                      ||||.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||+..+.   ..+||+|||++..
T Consensus        95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999985 78877764    35689999999999999999999998 999999999999985432   2499999999987


Q ss_pred             cccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHHhCCCCHHHHh
Q 015615          218 LVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       218 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.   +..+.+..+...  .       
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--~-------  239 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--K-------  239 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--C-------
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--C-------
Confidence            64432 234567899999999996543 789999999999999999999999863   222333333221  0       


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                              +.        +....+..+|+++.+||++||..||++|||++++++||||....
T Consensus       240 --------~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          240 --------FS--------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             --------CC--------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             --------cc--------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence                    00        00112245799999999999999999999999999999997753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.4e-49  Score=376.68  Aligned_cols=315  Identities=33%  Similarity=0.577  Sum_probs=239.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCC-CceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK-DELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  137 (403)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||.+....      ....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            47999999999999999999999999999999985431      2345799999999999999999987443221 1123


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++||||+.++|.+.+      ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            5799999998766554      24589999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+.....
T Consensus       176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            432  233467899999999997656689999999999999999999999999999999999999989888776544332


Q ss_pred             Cccc---ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015615          298 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFK  374 (403)
Q Consensus       298 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  374 (403)
                      ....   ...+......+.. ....+++++.+||.+||+.||++|||++++|+||||+....+......    ...++. 
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~----~~~~~~-  327 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEA----QQPFDD-  327 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCC----SSCCCC-
T ss_pred             HHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccC----CCCCcc-
Confidence            1100   0111111112222 224679999999999999999999999999999999988766433211    111221 


Q ss_pred             hhhcCCCChHHHhhcchHHHH
Q 015615          375 PHELKGVPVDMLVKLIPEHAR  395 (403)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~  395 (403)
                      ..+....+.+.|...+.++..
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~  348 (353)
T 3coi_A          328 SLEHEKLTVDEWKQHIYKEIV  348 (353)
T ss_dssp             TTTTCCCCHHHHHHHHHHHHH
T ss_pred             chhhccCCHHHHHHHHHHHHH
Confidence            123345667777777766654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-48  Score=362.28  Aligned_cols=260  Identities=28%  Similarity=0.402  Sum_probs=215.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     .+...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence            457999999999999999999999999999999985432      3345799999999999999999987     33445


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEeecCC
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  214 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~  214 (403)
                      .++||||+.+ +|.+.+...    ..+++..+..++.|++.||.|||++ ||+||||||+||+++.++  ..+||+|||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            7899999985 777777654    5689999999999999999999998 999999999999997654  2499999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.............||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+.......+.     
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  228 (284)
T 3kk8_A          155 AIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-----  228 (284)
T ss_dssp             CEECCSSCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred             eEEcccCccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc-----
Confidence            98776555555678899999999997654 899999999999999999999999988776666655542111110     


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                                          .....+++++.+||.+||+.||++|||++++++||||+.......
T Consensus       229 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          229 --------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             --------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             --------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence                                011357899999999999999999999999999999998765443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-48  Score=369.85  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=215.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+...          .....+|+.+++.++||||+++++++.     
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence            45799999999999999999999999999999998543          234568999999999999999999873     


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC---ceEE
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKL  209 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~vkl  209 (403)
                      +....++||||++ ++|.+.+..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.   .+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEEE
Confidence            3345789999997 588888764    35689999999999999999999998 9999999999999987663   5999


Q ss_pred             eecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE  239 (321)
T ss_dssp             CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             ccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence            999999877655555566789999999999654 4899999999999999999999999988776666655442211111


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                               .+...++..+.+||.+||..||++|||++++++||||+....
T Consensus       240 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          240 -------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             -------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             -------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence                                     122457899999999999999999999999999999987643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-49  Score=380.86  Aligned_cols=257  Identities=27%  Similarity=0.395  Sum_probs=213.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...|++.+.||+|+||.||+|.+..+|+.||+|.+...    .....+|+.+++.++||||+++++++.     +...++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            45799999999999999999999999999999998643    234568999999999999999999873     344588


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC-CCceEEeecCCcee
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  217 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~  217 (403)
                      +||||+.+ +|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.+ .+.+||+|||++..
T Consensus       125 lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999985 777766432   34689999999999999999999998 99999999999999753 23799999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......          
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~----------  269 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF----------  269 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC----------
T ss_pred             cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence            7655555566899999999999654 48999999999999999999999999887776666554421000          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                     .......+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus       270 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          270 ---------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             ---------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ---------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                           0011235799999999999999999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.9e-49  Score=381.38  Aligned_cols=287  Identities=22%  Similarity=0.355  Sum_probs=209.5

Q ss_pred             ccccceEEEeEeeeC--CcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           62 KQTISYMAERVVGHG--SFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ...++|++.+.||+|  +||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----   97 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----   97 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----
Confidence            345689999999999  99999999999999999999986432      344579999999999999999998843    


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                       ...+++|||||. ++|.+++....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~df  172 (389)
T 3gni_B           98 -DNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGL  172 (389)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCG
T ss_pred             -CCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEccc
Confidence             335889999998 57888776542  35689999999999999999999998 999999999999999888 7999999


Q ss_pred             CCceecccCC--------CcceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 015615          213 GSAKVLVKGE--------PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (403)
Q Consensus       213 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  283 (403)
                      |++.......        ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            9876542221        11234678999999999763 45899999999999999999999999887666555443321


Q ss_pred             hCCCCH-------HHHh-ccC-----cCccc-----ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHH
Q 015615          284 LGTPTR-------EEIK-CMN-----PNYTE-----FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  345 (403)
Q Consensus       284 ~~~~~~-------~~~~-~~~-----~~~~~-----~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~el  345 (403)
                      .-....       .... ...     .....     ...+. ........+...+++++.+||++||+.||++|||++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            100000       0000 000     00000     00000 00001112345689999999999999999999999999


Q ss_pred             hcCCCCccCCCCC
Q 015615          346 LIHPFFDELRDPN  358 (403)
Q Consensus       346 l~hp~f~~~~~~~  358 (403)
                      |+||||+++....
T Consensus       332 l~hp~f~~~~~~~  344 (389)
T 3gni_B          332 LNHSFFKQIKRRA  344 (389)
T ss_dssp             TTSGGGGGC---C
T ss_pred             hcCHHHHHHhhcc
Confidence            9999999986543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.5e-49  Score=372.80  Aligned_cols=282  Identities=30%  Similarity=0.527  Sum_probs=218.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++ ||||+++++++...   ...+.++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEE
Confidence            45799999999999999999999999999999998643 455678999999997 99999999987432   23447899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+.+ +|.+.+       ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||++.....
T Consensus       112 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999995 555544       2378889999999999999999998 9999999999999997776799999999987765


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHHHHhc-cCcC
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEIKC-MNPN  298 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~-~~~~  298 (403)
                      ........+|+.|+|||++.+...++.++|||||||++|+|++|..||.. .+..+.+..+....+.+....... ....
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence            55555678899999999997756689999999999999999999999854 455566666666655433322111 1100


Q ss_pred             cccc---cCCCccCCCccccc----ccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          299 YTEF---KFPQIKAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       299 ~~~~---~~~~~~~~~~~~~~----~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                      ....   .........|...+    ...+++++.+||.+||+.||++|||++++|+||||+++..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            0000   00011111222111    2347999999999999999999999999999999998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-49  Score=399.44  Aligned_cols=257  Identities=28%  Similarity=0.433  Sum_probs=212.9

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ....+|++.+.||+|+||.||+|++..+|+.||||++...       .....+|+.+++.++||||+++++++.     +
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~  255 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----T  255 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----e
Confidence            3456799999999999999999999999999999998543       233457999999999999999998873     3


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+|+||||++ ++|.+.+....  ...+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g-~vKL~DFG  331 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHG-HIRISDLG  331 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCC-CeEEEecc
Confidence            446889999997 57877776432  34589999999999999999999998 999999999999999888 79999999


Q ss_pred             CceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHH
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~  290 (403)
                      +++....+......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+...   ...+.......      
T Consensus       332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------  404 (576)
T 2acx_A          332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------  404 (576)
T ss_dssp             TCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred             cceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence            998776555555678999999999997654 89999999999999999999999987542   22222222110      


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                           .                 ..++..+|+++.+||++||+.||.+||     +++|+++||||+.+.+
T Consensus       405 -----~-----------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          405 -----P-----------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             -----C-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             -----c-----------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence                 0                 012345799999999999999999999     8999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.6e-49  Score=371.59  Aligned_cols=255  Identities=27%  Similarity=0.349  Sum_probs=206.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...     .....+|+.+++.++||||+++++++.     +....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence            45799999999999999999999999999999998533     244568999999999999999999873     34457


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  154 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  154 (323)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCC-CEEEEEeeccce
Confidence            899999985 66655532    35689999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          218 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       218 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      .....   ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.................       
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------  227 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  227 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-------
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-------
Confidence            53322   12346789999999999766545789999999999999999999998765432222211110000       


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                    ..     ....+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       228 --------------~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          228 --------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             --------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             --------------CC-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence                          00     1134789999999999999999999999999999998743

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-48  Score=360.93  Aligned_cols=255  Identities=31%  Similarity=0.460  Sum_probs=215.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++...    .....+|+.+++.++||||+++++++.     +....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            45799999999999999999999999999999998543    345668999999999999999999873     344578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe---cCCCCceEEeecCCc
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA  215 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~DfG~a  215 (403)
                      +||||+++ +|.+.+...    ..+++..+..++.|++.||.|||++ ||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence            99999985 787777653    5689999999999999999999998 99999999999999   5555 7999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .............+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......+...+   
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW---  231 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred             eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence            87766555566789999999999854  3899999999999999999999999988877776666553222222211   


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                            ..+++++.+||.+||+.||.+|||+.++|+||||++...
T Consensus       232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence                                  247899999999999999999999999999999987543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-48  Score=370.85  Aligned_cols=253  Identities=28%  Similarity=0.455  Sum_probs=205.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCCeeecceeeeecC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (403)
                      ...+|++.+.||+|+||.||+|++.   .+|+.||||++...        .....+|+.+++.++||||+++++++..  
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   92 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--   92 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence            3457999999999999999999985   68999999998643        1234579999999999999999988733  


Q ss_pred             CCCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                         ...+|+||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+
T Consensus        93 ---~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~  163 (327)
T 3a62_A           93 ---GGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQG-HVKLT  163 (327)
T ss_dssp             ---SSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTS-CEEEC
T ss_pred             ---CCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCC-cEEEE
Confidence               334789999998 5888777653    5688999999999999999999998 999999999999999887 79999


Q ss_pred             ecCCceecccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          211 DFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       211 DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      |||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+...    
T Consensus       164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----  238 (327)
T 3a62_A          164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL----  238 (327)
T ss_dssp             CCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----
T ss_pred             eCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC----
Confidence            99998754322 223345789999999999654 489999999999999999999999998887776666654210    


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                                               .++..+++++.+||.+||..||.+||     +++++++||||+.+.+
T Consensus       239 -------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          239 -------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             -------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                                     02245789999999999999999999     8999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2e-49  Score=391.55  Aligned_cols=254  Identities=27%  Similarity=0.400  Sum_probs=207.1

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----H  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----T
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----C
Confidence            3467999999999999999999999999999999986431       233468888999999999999998843     3


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCCceEecCCCCceEEeecC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ..+++||||+++ +|...+...    ..+++..++.++.||+.||+|||+ + ||+||||||+|||++.++ .+||+|||
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~-~~kl~DFG  294 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDG-HIKITDFG  294 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSS-CEEECCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCC-CEEEccCC
Confidence            348899999985 777777653    578999999999999999999998 6 999999999999999887 79999999


Q ss_pred             Cceeccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          214 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       214 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      +|+.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....        
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  365 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------  365 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------
Confidence            9975432 2233456799999999999765 48999999999999999999999999887766666554410        


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRDP  357 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~~  357 (403)
                               .            .++..+++++.+||.+||+.||.+||     |++++++||||+++.+.
T Consensus       366 ---------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          366 ---------I------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             ---------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------C------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                     0            12345789999999999999999999     99999999999997543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-49  Score=369.38  Aligned_cols=247  Identities=27%  Similarity=0.389  Sum_probs=197.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+..+..+ +||||+++++++.     +...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            57999999999999999999999999999999875422      1122344444444 8999999999873     3345


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +++||||++++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence            8899999999998887765   35699999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..||.+...   ...+..  +..+         
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~--~~~~---------  270 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ--GYLP---------  270 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT--TCCC---------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc--cCCC---------
Confidence            655554555678999999999865  489999999999999999999777654322   111111  0000         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                      ..+...+++++.+||.+||+.||++|||++++|+||||++
T Consensus       271 ----------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          271 ----------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ----------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                            1123457999999999999999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-49  Score=391.06  Aligned_cols=252  Identities=29%  Similarity=0.440  Sum_probs=214.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~   88 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----P   88 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            4568999999999999999999999999999999985432       345689999999999999999998733     3


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~-~vkL~DFG~  162 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFGL  162 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTC-CEEECCCSS
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCC-CeEEEeccc
Confidence            45889999997 578777653    36799999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....         
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------  233 (476)
T 2y94_A          163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---------  233 (476)
T ss_dssp             CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---------
T ss_pred             hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---------
Confidence            98876655556678999999999997765457899999999999999999999998877666655543110         


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                          ..+..+++++.+||++||+.||.+|||++++++||||+..
T Consensus       234 --------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          234 --------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             --------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                                0123478999999999999999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.8e-49  Score=366.18  Aligned_cols=259  Identities=26%  Similarity=0.402  Sum_probs=198.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++....      ....++...++.++||||+++++++...     .
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----G   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----C
Confidence            3468999999999999999999999999999999986432      1122344457778999999999987432     2


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ..++||||+++++.+.+.........+++..++.++.||+.||+|||++.||+||||||+||+++.++ .+||+|||++.
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISG  158 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC----
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcc
Confidence            37899999999998888776666778999999999999999999999855999999999999999877 79999999998


Q ss_pred             ecccCCCcceeeecccccccccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHH
Q 015615          217 VLVKGEPNISYICSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  292 (403)
                      ............||+.|+|||++   .....++.++|||||||++|+|++|..||..... ...+....... .+.    
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~----  233 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQ----  233 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CCC----
T ss_pred             cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-CCC----
Confidence            76555545556789999999997   2344589999999999999999999999987433 33333332210 000    


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                            .....+++++.+||.+||+.||++|||++++++||||+..
T Consensus       234 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          234 ----------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ----------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ----------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                                  0113578999999999999999999999999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-48  Score=390.42  Aligned_cols=258  Identities=28%  Similarity=0.458  Sum_probs=213.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEecc------chhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++..      ......+|+.+++.++||||+++++++     .+..
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence            44689999999999999999999999999999999843      234456899999999999999999987     3344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEeecC
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFG  213 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG  213 (403)
                      .+++|||||.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++..+  ..+||+|||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            58899999985 787777654    5689999999999999999999998 999999999999996432  269999999


Q ss_pred             CceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+..........   
T Consensus       170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---  244 (486)
T 3mwu_A          170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP---  244 (486)
T ss_dssp             CTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG---
T ss_pred             cCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---
Confidence            9987655555556789999999999965  38999999999999999999999999988777776665531111100   


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                            ....+|+++++||++||+.||.+|||+.++|+||||+.....
T Consensus       245 ----------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          245 ----------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             ----------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             ----------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence                                  123579999999999999999999999999999999986543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-49  Score=396.30  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=213.0

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ....+|.+.+.||+|+||.||+|+++.+|+.||||++....       ....+|+.+++.++||||++++++|.     +
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~  256 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----T  256 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----e
Confidence            34468999999999999999999999999999999985432       33457999999999999999998873     3


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+|+||||++| +|...+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g-~vkL~DFG  334 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDG-NVRISDLG  334 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCC-CEEEeecc
Confidence            4458899999984 78887776544456799999999999999999999998 999999999999999888 79999999


Q ss_pred             CceecccCCCc-ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCC
Q 015615          214 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGTPT  288 (403)
Q Consensus       214 ~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~  288 (403)
                      +++........ ...+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+.    .+....+...  .  
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~--  409 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--A--  409 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--C--
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--c--
Confidence            99876544332 345899999999999765 489999999999999999999999987532    2222222221  0  


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                               ..++..+|+++.+||++||+.||.+||+     ++++++||||+.+.+
T Consensus       410 -------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          410 -------------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             -------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             -------------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                                     0123457999999999999999999996     589999999998754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=373.11  Aligned_cols=256  Identities=29%  Similarity=0.416  Sum_probs=195.7

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ...+|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++||||+++++++.     +....++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEE
Confidence            445799999999999999999999999999999998653  344567999999999999999999873     3345789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC---CCCceEEeecCCce
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAK  216 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~DfG~a~  216 (403)
                      ||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.   ++ .+||+|||++.
T Consensus       126 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDA-PLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTC-CEEECCCC---
T ss_pred             EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCC-CEEEccCcccc
Confidence            9999984 78777654    35689999999999999999999998 9999999999999975   45 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCHHHHhcc
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~  295 (403)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+.. ..+......         
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~---------  269 (349)
T 2w4o_A          200 IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY---------  269 (349)
T ss_dssp             -------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC---------
T ss_pred             ccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc---------
Confidence            76544444556789999999999765 4899999999999999999999999877655433 323221000         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                      +...+...++.++.+||++||+.||++|||+.++|+||||+...
T Consensus       270 ----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          270 ----------------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             ----------------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             ----------------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                            00012245789999999999999999999999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.3e-48  Score=389.72  Aligned_cols=256  Identities=29%  Similarity=0.458  Sum_probs=215.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----------------hhhhHHHHHHHHHcCCCCeeeccee
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNVVSLKHC  126 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~h~niv~~~~~  126 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++...                 .....+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            45799999999999999999999999999999998542                 2335579999999999999999998


Q ss_pred             eeecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC
Q 015615          127 FFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (403)
Q Consensus       127 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  205 (403)
                      +     .+..++++|||||++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus       115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          115 F-----EDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             E-----ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTC
T ss_pred             E-----EcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCC
Confidence            8     344568899999985 787777654    5689999999999999999999998 9999999999999987652


Q ss_pred             --ceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 015615          206 --QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (403)
Q Consensus       206 --~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  283 (403)
                        .+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  262 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG  262 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence              599999999988766555566789999999999853  4899999999999999999999999998887777776653


Q ss_pred             hCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                      ........                         ...+|+++++||++||+.||.+|||++++|+||||+....
T Consensus       263 ~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          263 KYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            22222111                         1457999999999999999999999999999999998643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.3e-49  Score=369.04  Aligned_cols=287  Identities=31%  Similarity=0.510  Sum_probs=219.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecC---------
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT---------  131 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~---------  131 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++....    ....+|+.+++.++||||+++++++....         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            47999999999999999999999999999999885432    34457999999999999999998763221         


Q ss_pred             CCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          132 EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                      ..+....++||||++++|.+.+..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEcc
Confidence            123356789999999998887743     5689999999999999999999998 9999999999999985555899999


Q ss_pred             cCCceecccCC----CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          212 FGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       212 fG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      ||++.......    ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......+
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998653221    12234568899999998765668999999999999999999999999998888888888877666


Q ss_pred             CHHHHhccCcCcccccCC--CccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          288 TREEIKCMNPNYTEFKFP--QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      ..............+...  .....++ ..+.+.++.++.+||.+||+.||++|||++++|+||||+....|.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             chhhhhhhhhcCcccccccccCCCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            655443221111100000  0001111 122356899999999999999999999999999999999876654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.1e-48  Score=370.62  Aligned_cols=253  Identities=27%  Similarity=0.443  Sum_probs=212.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------hhhHHHHHHHHHc-CCCCeeecceeeeecC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (403)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++....            ....+|+.+++.+ +||||+++++++.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            47999999999999999999998899999999885432            2345799999999 7999999999873   


Q ss_pred             CCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                        .....++||||+++ +|.+.+...    ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+
T Consensus       171 --~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          171 --SSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             --BSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEEC
T ss_pred             --eCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEE
Confidence              34458899999986 888877653    5689999999999999999999998 999999999999999887 79999


Q ss_pred             ecCCceecccCCCcceeeecccccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015615          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  285 (403)
Q Consensus       211 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  285 (403)
                      |||++.............||+.|+|||++.+.     ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999877655555667899999999998532     2478899999999999999999999988776666665554322


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                      ......                         ...++..+.+||.+||+.||++|||++++|+||||++
T Consensus       323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            211111                         1346889999999999999999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.7e-48  Score=376.95  Aligned_cols=284  Identities=27%  Similarity=0.425  Sum_probs=222.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcC--------CCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD--------HPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....   ....+|+.+++.++        |+||+++++++.... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            357999999999999999999999999999999997543   34457999999885        788999999875322 


Q ss_pred             CCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--------
Q 015615          133 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--------  204 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--------  204 (403)
                      .+..++++||||+++++.+.+....  ...+++..++.++.||+.||+|||++.||+||||||+|||++.++        
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            2456789999999988888776542  356899999999999999999999844999999999999998664        


Q ss_pred             ----------------------------------------CceEEeecCCceecccCCCcceeeecccccccccccCCCC
Q 015615          205 ----------------------------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE  244 (403)
Q Consensus       205 ----------------------------------------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  244 (403)
                                                              ..+||+|||++......  .....||+.|+|||++.+.. 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-
Confidence                                                    26999999999876432  34567899999999997655 


Q ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhccCcCccccc----CCCccC-CCcc
Q 015615          245 YTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQIKA-HPWH  313 (403)
Q Consensus       245 ~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~  313 (403)
                      ++.++|||||||++|+|++|+.||.+.+      ..+.+..+.+..+.++...+.........+.    ...+.. .+|.
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            8999999999999999999999998754      5567778888888888766543221111110    000000 0000


Q ss_pred             --c------ccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          314 --K------IFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       314 --~------~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                        .      .+....+..+.+||.+||+.||++|||++++|+||||++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence              0      011234567899999999999999999999999999974

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.8e-49  Score=391.71  Aligned_cols=256  Identities=32%  Similarity=0.502  Sum_probs=215.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++...       .....+|+.+++.++||||+++++++     .+.
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   98 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK   98 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            345799999999999999999999999999999998432       34456899999999999999999987     334


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec---CCCCceEEee
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLCD  211 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~---~~~~~vkl~D  211 (403)
                      .++++|||||.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++   .++ .+||+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~-~~kl~D  172 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDA-NIRIID  172 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTC-CEEECC
T ss_pred             CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCC-cEEEEe
Confidence            568899999984 77777764    36799999999999999999999998 999999999999995   344 799999


Q ss_pred             cCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       212 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ||++.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.+.......  
T Consensus       173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  248 (484)
T 3nyv_A          173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL--  248 (484)
T ss_dssp             TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--
T ss_pred             eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence            999987655555556789999999999965  4899999999999999999999999998887777766552111110  


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                             .....+|+++++||++||+.||.+|||+.++|+||||+....
T Consensus       249 -----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          249 -----------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             -----------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             -----------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence                                   011357999999999999999999999999999999998654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.3e-49  Score=378.87  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=205.4

Q ss_pred             EEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEe
Q 015615           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE  143 (403)
Q Consensus        68 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  143 (403)
                      ...+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++.     +...+++|||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E  166 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVME  166 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEe
Confidence            3367899999999999999999999999998653    345568999999999999999999873     3345789999


Q ss_pred             cccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe--cCCCCceEEeecCCceeccc
Q 015615          144 YVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       144 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll--~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |+++ +|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||+  +.++ .+||+|||+++....
T Consensus       167 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          167 YVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKP  241 (373)
T ss_dssp             CCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTT-EEEECCCSSCEECCT
T ss_pred             CCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCC-cEEEEeCCCceecCC
Confidence            9985 777777543   24588999999999999999999998 99999999999999  4444 799999999987765


Q ss_pred             CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          221 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........           
T Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-----------  309 (373)
T 2x4f_A          242 REKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-----------  309 (373)
T ss_dssp             TCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS-----------
T ss_pred             ccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh-----------
Confidence            5555566799999999998654 4899999999999999999999999998887777777653211110           


Q ss_pred             cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                    .....+++++.+||.+||+.||.+|||++++|+||||++..
T Consensus       310 --------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 --------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             --------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             --------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                          01235799999999999999999999999999999999754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-48  Score=388.84  Aligned_cols=254  Identities=29%  Similarity=0.458  Sum_probs=211.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|++.+.||+|+||.||+|++..++..||||++...      .....+|+.+++.++||||+++++++.     +...
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            34799999999999999999999999999999998543      234568999999999999999999883     3445


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEeecCC
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  214 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~  214 (403)
                      +|+|||||.+ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++..+  ..+||+|||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            8899999985 787777654    5689999999999999999999998 999999999999997643  2599999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.........     
T Consensus       186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-----  258 (494)
T 3lij_A          186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS-----  258 (494)
T ss_dssp             CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS-----
T ss_pred             CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence            988766655566789999999999853  4899999999999999999999999998887777666553211111     


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                          .....+|+++.+||++||+.||.+|||+.++|+||||++.
T Consensus       259 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          259 --------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             --------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             --------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                                1124579999999999999999999999999999999875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.9e-48  Score=370.86  Aligned_cols=251  Identities=28%  Similarity=0.453  Sum_probs=210.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     ...
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence            46999999999999999999999999999999985321       234589999999999999999998844     234


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .++||||+.|++.+.+...   ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence            7899999999988887654   36789999999999999999999998 999999999999999887 799999999976


Q ss_pred             cccCCCcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ...   .....||+.|+|||++.+  ...++.++|||||||++|+|++|++||.+.+..+.+..+..... +.       
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~-------  272 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA-------  272 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC-------
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC-------
Confidence            532   234678999999999852  34589999999999999999999999998877666655544210 00       


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                         ......+..+.+||.+||+.||++|||++++++||||....
T Consensus       273 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          273 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence                               01234688999999999999999999999999999998743

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.1e-48  Score=366.56  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=200.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC------
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE------  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  132 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...     .....+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            45799999999999999999999999999999998532     2345689999999999999999998765432      


Q ss_pred             ----------------------------------------------CCceEEEEEEecccc-hHHHHHHhhcccCCCCCH
Q 015615          133 ----------------------------------------------KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPL  165 (403)
Q Consensus       133 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~  165 (403)
                                                                    ....++++|||||++ +|.+.+..... ....+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                          123458899999986 78777765432 234566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC-------------Ccceeeeccc
Q 015615          166 IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------PNISYICSRY  232 (403)
Q Consensus       166 ~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~-------------~~~~~~gt~~  232 (403)
                      ..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            67899999999999999998 999999999999999887 79999999998764432             1233568999


Q ss_pred             ccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCc
Q 015615          233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  312 (403)
Q Consensus       233 y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (403)
                      |+|||++.+. .++.++|||||||++|+|++|..|+..     ....+........+.                      
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPL----------------------  293 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCH----------------------
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCc----------------------
Confidence            9999999765 489999999999999999998766421     111111111111000                      


Q ss_pred             ccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          313 HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       313 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                         .....++++.+||.+||+.||++|||++++++||||+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               012346788999999999999999999999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-48  Score=372.06  Aligned_cols=263  Identities=31%  Similarity=0.461  Sum_probs=209.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|++.+.||+|+||.||+|.+..++..||+|++...         .....+|+.+++.++||||+++++++.     +
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence            35799999999999999999999999999999998543         134567999999999999999999873     3


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhccc------------------------------------CCCCCHHHHHHHHHHHHH
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKM------------------------------------SQRMPLIYVKLYFYQICR  177 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~------------------------------------~~~l~~~~~~~~~~qi~~  177 (403)
                      ..+.++|||||+ ++|.+.+......                                    ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            445889999997 4777776421111                                    122467788899999999


Q ss_pred             HHHHHHhcCCccccCCCCCceEecCCCC-ceEEeecCCceecccCC-----CcceeeecccccccccccCC-CCCCCchh
Q 015615          178 ALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGA-TEYTAAID  250 (403)
Q Consensus       178 ~L~~LH~~~~ivH~Dlkp~NIll~~~~~-~vkl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~D  250 (403)
                      ||+|||++ ||+||||||+|||++.++. .+||+|||++.......     ......||+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999998 9999999999999986542 69999999998653322     12356789999999998642 45899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHH
Q 015615          251 IWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSR  330 (403)
Q Consensus       251 iwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~  330 (403)
                      ||||||++|+|++|+.||.+.+..+....+.........                         .....+++++.+||.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHH
Confidence            999999999999999999998877777666552111110                         0113478999999999


Q ss_pred             hhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          331 LLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       331 ~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      ||+.||.+|||+.++|+||||+++.+.
T Consensus       314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999987543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.6e-48  Score=358.44  Aligned_cols=258  Identities=25%  Similarity=0.397  Sum_probs=210.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.+...          .....+|+.+++.++||||+++++++.     +
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence            4799999999999999999999999999999988543          234568999999999999999999873     3


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC---ceEEe
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKLC  210 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~vkl~  210 (403)
                      ....++||||++ ++|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++.   .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEE
Confidence            345789999997 5888887653    5689999999999999999999998 9999999999999986652   69999


Q ss_pred             ecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       211 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      |||++.............+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+......... 
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  232 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-  232 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence            99999876555444556789999999998654 4899999999999999999999999988766655554432111111 


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                                              .....++..+.+||++||..||++|||+.++++||||+.++...
T Consensus       233 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          233 ------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             ------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             ------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence                                    12245789999999999999999999999999999999875543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-48  Score=367.23  Aligned_cols=255  Identities=27%  Similarity=0.429  Sum_probs=187.2

Q ss_pred             cceEEE---eEeeeCCcEEEEEEEEccCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAE---RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~---~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|.+.   +.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. ||||+++++++.     +....|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEE
Confidence            467775   7899999999999999999999999998654 345568999999997 999999999873     344578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC--ceEEeecCCce
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAK  216 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~DfG~a~  216 (403)
                      +||||+++ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.  .+||+|||++.
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999985 88888765    36799999999999999999999998 9999999999999976542  69999999998


Q ss_pred             ecccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCC
Q 015615          217 VLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-------DQLVEIIKVLGTPT  288 (403)
Q Consensus       217 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~~~  288 (403)
                      ...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..       +.+..+.....   
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~---  233 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF---  233 (325)
T ss_dssp             ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC---
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC---
Confidence            654332 23456789999999999655 4899999999999999999999999875432       11221111000   


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                            .+.......+++++.+||.+||+.||.+|||++++++||||++..
T Consensus       234 ----------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          234 ----------------------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             ----------------------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             ----------------------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence                                  001111235799999999999999999999999999999999754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.6e-48  Score=359.19  Aligned_cols=256  Identities=28%  Similarity=0.430  Sum_probs=212.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|.+...       .....+|+.+++.++||||+++++++.     +.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cC
Confidence            445799999999999999999999999999999998543       233457999999999999999999873     33


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...++||||++ ++|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~  161 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGL  161 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCC-CEEEEeccC
Confidence            45789999998 4777776553    5689999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      +...... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+....+....+....         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------  231 (294)
T 2rku_A          162 ATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------  231 (294)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------
T ss_pred             ceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc---------
Confidence            9875432 223345789999999998654 48999999999999999999999998877655544433210         


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT  359 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~  359 (403)
                              .            .++..+++.+.+||.+||+.||++|||++++++||||++...+..
T Consensus       232 --------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~  277 (294)
T 2rku_A          232 --------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR  277 (294)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred             --------C------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCC
Confidence                    0            022457899999999999999999999999999999998766543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.5e-48  Score=373.20  Aligned_cols=281  Identities=31%  Similarity=0.551  Sum_probs=217.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcC-CC-----CeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-HP-----NVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~  134 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++....   ....+|+.+++.++ |+     +|+++++++..     
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  127 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-----  127 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----
Confidence            458999999999999999999999999999999997543   23446888888885 55     48888887743     


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCCceEecC--CCCceEEee
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNP--HTHQLKLCD  211 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~~ivH~Dlkp~NIll~~--~~~~vkl~D  211 (403)
                      ...+|+||||++++|.+.+....  ...+++..++.++.||+.||.|||+ ..||+||||||+|||++.  ++ .+||+|
T Consensus       128 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred             CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence            23588999999999999887643  2458999999999999999999995 239999999999999953  44 799999


Q ss_pred             cCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       212 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ||++.....  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...
T Consensus       205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceeccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987633  234567899999999997654 89999999999999999999999999999999999999999888765


Q ss_pred             HhccCcC---cccc---------------cCCCccCCCccccccc-----------------CCChHHHHHHHHhhccCC
Q 015615          292 IKCMNPN---YTEF---------------KFPQIKAHPWHKIFQK-----------------RMPPEAVDLVSRLLQYSP  336 (403)
Q Consensus       292 ~~~~~~~---~~~~---------------~~~~~~~~~~~~~~~~-----------------~~s~~~~~ll~~~L~~dP  336 (403)
                      +......   +...               .+.......+...+..                 ..++++.+||++||++||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence            5422110   0000               0000000000000000                 011478999999999999


Q ss_pred             CCCCCHHHHhcCCCCccCC
Q 015615          337 NLRSTALEALIHPFFDELR  355 (403)
Q Consensus       337 ~~R~s~~ell~hp~f~~~~  355 (403)
                      ++|||++|+|+||||++..
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998854

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-47  Score=362.57  Aligned_cols=255  Identities=28%  Similarity=0.438  Sum_probs=209.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...|...+.||+|+||.||+|++..+|+.||||++...    .....+|+.+++.++||||+++++++...     ...+
T Consensus        44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  118 (321)
T 2c30_A           44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELW  118 (321)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence            34588899999999999999999989999999998543    23456899999999999999999987442     3478


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+..     ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus       119 lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~  191 (321)
T 2c30_A          119 VLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQI  191 (321)
T ss_dssp             EEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-cEEEeeeeeeeec
Confidence            99999985 67666542     4689999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... .+.         
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~---------  260 (321)
T 2c30_A          192 SKDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPK---------  260 (321)
T ss_dssp             CSSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCC---------
T ss_pred             ccCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC---------
Confidence            4432 23456789999999999654 48999999999999999999999998877666555443311 000         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                       .               .....+++++.+||.+||+.||++|||++++++||||.....+
T Consensus       261 -~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  304 (321)
T 2c30_A          261 -L---------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP  304 (321)
T ss_dssp             -C---------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred             -c---------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence             0               0113478999999999999999999999999999999875433

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.7e-48  Score=400.66  Aligned_cols=253  Identities=27%  Similarity=0.408  Sum_probs=214.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....       ....+|..++..+ .||||++++++|     .+.
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~~  414 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM  414 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BCS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----EeC
Confidence            457999999999999999999999999999999986432       2345688888877 799999998887     344


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+||||||+++ +|...+...    ..+++..++.|+.||+.||+|||++ |||||||||+|||++.++ .+||+|||+
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g-~ikL~DFGl  488 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFGM  488 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSS-CEEECCCTT
T ss_pred             CEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCC-cEEEeecce
Confidence            568899999985 788777654    5699999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecc-cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      |+... .+.......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+....         
T Consensus       489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---------  558 (674)
T 3pfq_A          489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------  558 (674)
T ss_dssp             CEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---------
T ss_pred             eeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------
Confidence            98643 23344567899999999999655 48999999999999999999999999988877777665410         


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH-----HHHhcCCCCccCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIHPFFDELRDP  357 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~-----~ell~hp~f~~~~~~  357 (403)
                                          ..++..+++++.+||++||+.||++|+++     +++++||||+.+.+.
T Consensus       559 --------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          559 --------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             --------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence                                01334689999999999999999999997     999999999997653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6e-48  Score=375.44  Aligned_cols=261  Identities=27%  Similarity=0.377  Sum_probs=200.1

Q ss_pred             cccceEEE-eEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHH-HHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           63 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        63 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ...+|.+. +.||+|+||+||+|.+..+|+.||||++... ....+|+.++ +..+||||++++++|.... .+..++|+
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l  136 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI  136 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence            34568876 7899999999999999999999999998643 4456788887 4558999999999874322 34567899


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC---CCCceEEeecCCce
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAK  216 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~DfG~a~  216 (403)
                      |||||.+ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.   ++ .+||+|||+++
T Consensus       137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~  212 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK  212 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCc-cEEEEeccccc
Confidence            9999985 8888886532  34689999999999999999999998 9999999999999987   44 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHHHH
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEI  292 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~  292 (403)
                      ...........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.....    ....+...         
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~---------  282 (400)
T 1nxk_A          213 ETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------  282 (400)
T ss_dssp             ECC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT---------
T ss_pred             ccCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC---------
Confidence            76554445567889999999998654 58999999999999999999999998754321    11222110         


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                              .+.++.        .....++.++.+||++||+.||++|||++++++||||....
T Consensus       283 --------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          283 --------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             --------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             --------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence                    000110        01135789999999999999999999999999999998643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.2e-48  Score=356.60  Aligned_cols=253  Identities=30%  Similarity=0.467  Sum_probs=208.9

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ....+|++.+.||+|+||.||+|.+..++..||+|++...       .....+|+.+++.++||||+++++++.     +
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   80 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----D   80 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----c
Confidence            3456899999999999999999999999999999998543       234567999999999999999999873     3


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ....++||||++ ++|.+.+...    ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~l~Dfg  154 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFG  154 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTS-CEEECSCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCC-CEEEEecc
Confidence            345789999998 4787777654    5689999999999999999999987 999999999999999887 79999999


Q ss_pred             CceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ++...... ......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+.....        
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  224 (279)
T 3fdn_A          155 WSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------  224 (279)
T ss_dssp             EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------
T ss_pred             ccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------
Confidence            88654322 23456789999999999654 479999999999999999999999998776666555543110        


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                           .++..++.++.+||.+||+.||.+|||+.++++||||+....
T Consensus       225 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          225 ---------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                                 022347899999999999999999999999999999998544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=368.78  Aligned_cols=246  Identities=25%  Similarity=0.402  Sum_probs=207.0

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeecceeeeec
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFST  130 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~  130 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||.+....            ....+|+.+++.++||||+++++++   
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            3457999999999999999999999999999999986432            2345799999999999999999987   


Q ss_pred             CCCCceEEEEEEeccc-c-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceE
Q 015615          131 TEKDELYLNLVLEYVP-E-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  208 (403)
                        .+...+++||||+. + +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+|
T Consensus        99 --~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~k  170 (335)
T 3dls_A           99 --ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDF-TIK  170 (335)
T ss_dssp             --ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEE
T ss_pred             --eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCC-cEE
Confidence              33445789999986 4 77777764    35699999999999999999999998 999999999999999887 799


Q ss_pred             EeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       209 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      |+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||......      ..      
T Consensus       171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------  238 (335)
T 3dls_A          171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------  238 (335)
T ss_dssp             ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT------
T ss_pred             EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh------
Confidence            999999988766655667789999999999977664588999999999999999999999753210      00      


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                              .               ....+..+++++.+||.+||+.||++|||++++++||||++.
T Consensus       239 --------~---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 --------A---------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             --------T---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             --------h---------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                    0               000123478999999999999999999999999999999874

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-47  Score=356.04  Aligned_cols=259  Identities=26%  Similarity=0.376  Sum_probs=213.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------------hhhHHHHHHHHHcC-CCCeeecceeee
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFF  128 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~niv~~~~~~~  128 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||.+....             ....+|+.+++.+. ||||+++++++ 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-   93 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   93 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence            3457999999999999999999999999999999985321             23457999999995 99999999987 


Q ss_pred             ecCCCCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCce
Q 015615          129 STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL  207 (403)
Q Consensus       129 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~v  207 (403)
                          ......++||||++ ++|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+
T Consensus        94 ----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~  163 (298)
T 1phk_A           94 ----ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-NI  163 (298)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CE
T ss_pred             ----ccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCC-cE
Confidence                33455889999998 5888888653    5689999999999999999999998 999999999999999887 79


Q ss_pred             EEeecCCceecccCCCcceeeeccccccccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015615          208 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK  282 (403)
Q Consensus       208 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~  282 (403)
                      ||+|||++.............+|+.|+|||++.     ....++.++|||||||++|+|++|..||.+.+.......+..
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            999999998776555555667899999999985     234478999999999999999999999988776665555544


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .......                         .....++..+.+||.+||..||.+|||++++++||||++....
T Consensus       244 ~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          244 GNYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             TCCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             CCcccCc-------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            2111000                         0113478999999999999999999999999999999986544

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.4e-48  Score=378.08  Aligned_cols=255  Identities=30%  Similarity=0.461  Sum_probs=197.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++.    
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----  210 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD----  210 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE----
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe----
Confidence            57999999999999999999999999999999986432            13568999999999999999999762    


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEE
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKL  209 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl  209 (403)
                       .. ..++||||+.+ +|.+.+.    ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++  ..+||
T Consensus       211 -~~-~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -AE-DYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SS-EEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -cC-ceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEEE
Confidence             11 25799999985 6655443    246799999999999999999999998 999999999999997543  25999


Q ss_pred             eecCCceecccCCCcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      +|||+++............||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+......+..........
T Consensus       284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~  363 (419)
T 3i6u_A          284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  363 (419)
T ss_dssp             CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred             eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence            99999987655544456789999999999853  3457889999999999999999999998754433332222211110


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      .                        .......+++.+.+||++||+.||++|||++++|+||||++.
T Consensus       364 ~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          364 F------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             C------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             C------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            0                        011124578999999999999999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.7e-47  Score=363.72  Aligned_cols=255  Identities=28%  Similarity=0.431  Sum_probs=213.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|.+...       .....+|+.+++.++||||+++++++.     +.
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence            345799999999999999999999999999999998543       234557999999999999999999873     33


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+++||||+.+ +|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~  187 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGL  187 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCC-CEEEeeccC
Confidence            458899999984 777776653    5689999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      +...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+....         
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  257 (335)
T 2owb_A          188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------  257 (335)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred             ceecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC---------
Confidence            9876432 2234467899999999997654 8999999999999999999999998877665555443310         


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                              +            .++..+++++.+||++||+.||++|||++++++||||+....+.
T Consensus       258 --------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          258 --------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             --------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             --------C------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence                    0            02235789999999999999999999999999999999876554

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.2e-47  Score=353.45  Aligned_cols=254  Identities=23%  Similarity=0.350  Sum_probs=207.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..|++.+.||+|+||.||+|.+..++..||+|.+....      ....+|+.+++.++||||+++++++.... .+..++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            46999999999999999999999999999999985432      33457999999999999999999875433 345678


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCCceEEeecCCc
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ |  |+||||||+|||++.+.+.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            899999975 888888654    5688999999999999999999987 8  9999999999999843348999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ..... .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+................+        
T Consensus       180 ~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  248 (290)
T 1t4h_A          180 TLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------  248 (290)
T ss_dssp             GGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--------
T ss_pred             ccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--------
Confidence            65432 23345678999999998853  48999999999999999999999998866555444332211000        


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                        ..++...++++.+||.+||+.||.+|||++++++||||++
T Consensus       249 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          249 ------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                              1123456889999999999999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-47  Score=360.52  Aligned_cols=259  Identities=26%  Similarity=0.360  Sum_probs=198.2

Q ss_pred             cccceEEE-eEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ....|.+. +.||+|+||.||+|.+..+|+.||||++...    .....+|+.++.++ +||||+++++++..     ..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~   84 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----ED   84 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CC
Confidence            34579985 7899999999999999999999999998543    23456899999885 79999999998743     33


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC--ceEEeecC
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFG  213 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~DfG  213 (403)
                      .+++||||++ ++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.  .+||+|||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            5889999998 5888888664    5689999999999999999999998 9999999999999987652  39999999


Q ss_pred             CceecccCC--------CcceeeecccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-------
Q 015615          214 SAKVLVKGE--------PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-------  274 (403)
Q Consensus       214 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------  274 (403)
                      ++.......        ......||+.|+|||++.+.    ..++.++|||||||++|+|++|..||.+....       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            987543211        11234589999999998541    23788999999999999999999999875421       


Q ss_pred             --------HHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          275 --------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       275 --------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                              .....+.......+                         ......+++++.+||++||+.||++|||++++|
T Consensus       240 ~~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          240 EACPACQNMLFESIQEGKYEFP-------------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             -CCHHHHHHHHHHHHHCCCCCC-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             ccchhHHHHHHHHHhccCcccC-------------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence                    11122211100000                         001135789999999999999999999999999


Q ss_pred             cCCCCccCCC
Q 015615          347 IHPFFDELRD  356 (403)
Q Consensus       347 ~hp~f~~~~~  356 (403)
                      +||||++...
T Consensus       295 ~hp~~~~~~~  304 (316)
T 2ac3_A          295 QHPWVQGCAP  304 (316)
T ss_dssp             HSTTCC----
T ss_pred             cChhhcCCCC
Confidence            9999998643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-47  Score=354.62  Aligned_cols=252  Identities=29%  Similarity=0.431  Sum_probs=202.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|.+.+.||+|+||.||+|.+..+|+.||||.+....       ....+|+.+++.++||||+++++++.     ..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TP   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence            3467999999999999999999999899999999985432       24568999999999999999999873     33


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...++||||+. ++|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~  157 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFGL  157 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred             CeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCC-CEEEeeccc
Confidence            45789999997 4888888654    5689999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.............+|+.|+|||++.+....+.++||||||+++|+|++|..||.+.........+.....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  228 (276)
T 2h6d_A          158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---------  228 (276)
T ss_dssp             GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---------
Confidence            98765544444567899999999997655457899999999999999999999988766555544433100         


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                          .++..++..+.+||.+||+.||++|||++++++||||++.
T Consensus       229 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 --------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             --------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                                0123468899999999999999999999999999999873

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-47  Score=363.70  Aligned_cols=259  Identities=24%  Similarity=0.356  Sum_probs=208.4

Q ss_pred             cceEEE-eEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCce
Q 015615           65 ISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..|.+. +.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.+. ||||+++++++     .+..
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~~  102 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS  102 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeCC
Confidence            468887 8999999999999999999999999988542      234567999999995 69999999987     3344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC---CCCceEEeec
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDF  212 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~Df  212 (403)
                      .+++||||+.+ +|.+.+...  ....+++..++.++.||+.||+|||++ ||+||||||+|||++.   ++ .+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~-~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLG-DIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBC-CEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCC-cEEEeeC
Confidence            57899999985 666555322  236689999999999999999999998 9999999999999987   45 7999999


Q ss_pred             CCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          213 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       213 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      |++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.........   
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---  254 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE---  254 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             ccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc---
Confidence            999877555555567899999999999655 4899999999999999999999999998877776666553211111   


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                                            .....+++.+.+||.+||+.||.+|||++++|+||||+++....
T Consensus       255 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          255 ----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             ----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence                                  11235789999999999999999999999999999999976553

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=355.11  Aligned_cols=253  Identities=28%  Similarity=0.483  Sum_probs=185.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.+.||+|+||.||+|++..+|+.||||.+....       ....+|+.+++.++||||+++++++.     +.
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   83 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS   83 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence            3457999999999999999999999999999999985432       34568999999999999999999873     34


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...++||||+++ +|.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~  158 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNM-NIKIADFGL  158 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEEeecc
Confidence            458899999974 787777643   35689999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          215 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       215 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      +...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+..           
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------  226 (278)
T 3cok_A          159 ATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-----------  226 (278)
T ss_dssp             CEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------
T ss_pred             eeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------
Confidence            9865432 223346789999999998654 479999999999999999999999987543322211100           


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                            ..+            ..+..++.++.+||.+||+.||++|||++++++||||....
T Consensus       227 ------~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          227 ------ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             ------SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             ------ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                  000            12245789999999999999999999999999999998743

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.7e-47  Score=363.98  Aligned_cols=289  Identities=29%  Similarity=0.465  Sum_probs=221.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcC-----------CCCeeecceeee
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCFF  128 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~niv~~~~~~~  128 (403)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++..+.   ....+|+.+++.++           ||||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            4468999999999999999999999999999999987543   34557899888876           899999999875


Q ss_pred             ecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC-----
Q 015615          129 STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-----  203 (403)
Q Consensus       129 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~-----  203 (403)
                      ... .+..++++||||++++|.+.+....  ...+++..+..++.||+.||+|||++.||+||||||+|||++.+     
T Consensus        97 ~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             ccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence            433 3445788999999889998887643  34589999999999999999999984499999999999999532     


Q ss_pred             CCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------cHHHH
Q 015615          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQL  277 (403)
Q Consensus       204 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~  277 (403)
                      ...+||+|||++......  .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+      ..+.+
T Consensus       174 ~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             cceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            226999999999876432  33457899999999997654 8999999999999999999999998654      45677


Q ss_pred             HHHHHHhCCCCHHHHhccCcCcccc-------cCCCccCCCccc------ccccCCChHHHHHHHHhhccCCCCCCCHHH
Q 015615          278 VEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHK------IFQKRMPPEAVDLVSRLLQYSPNLRSTALE  344 (403)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~s~~~~~ll~~~L~~dP~~R~s~~e  344 (403)
                      ..+...++.++...+.........+       ........+...      .++..++.++.+||.+||+.||++|||+++
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            7888888888776543321110000       000000001000      122345678999999999999999999999


Q ss_pred             HhcCCCCccCCCC
Q 015615          345 ALIHPFFDELRDP  357 (403)
Q Consensus       345 ll~hp~f~~~~~~  357 (403)
                      +|+||||++....
T Consensus       331 ll~hp~f~~~~~~  343 (373)
T 1q8y_A          331 LVNHPWLKDTLGM  343 (373)
T ss_dssp             HHTCGGGTTCTTC
T ss_pred             HhhChhhhcccCc
Confidence            9999999986443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.7e-47  Score=353.42  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=203.8

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (403)
                      ....+|++.+.||+|+||.||+|.+..+++.||||.+...      .....+|+..+..+ +||||+++++++..     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----   82 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----   82 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----
Confidence            3456899999999999999999999999999999998642      23345788888888 99999999998743     


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC---------
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---------  204 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~---------  204 (403)
                      ....++||||+++ +|.+.+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCccccccc
Confidence            3357899999975 99999887665567799999999999999999999998 999999999999998432         


Q ss_pred             ---------CceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 015615          205 ---------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (403)
Q Consensus       205 ---------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  275 (403)
                               ..+||+|||++......   ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+.....  
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                     26999999999876432   2346899999999997665577899999999999999999987754422  


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                       ...+...                   ..+         .++..+++++.+||.+||..||++|||+.++++||||++.
T Consensus       237 -~~~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          237 -WHEIRQG-------------------RLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -HHHHHTT-------------------CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -HHHHHcC-------------------CCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence             2222110                   000         1234578999999999999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=357.98  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=211.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|.+..++..||+|.+...        .....+|+.+++.++||||+++++++..   .+.
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            35799999999999999999999999999999998543        2345689999999999999999998753   223


Q ss_pred             eEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       136 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ...++||||+.+++.+.+....  ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~-~~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGG-TLKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             CeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCC-cEEeeccccc
Confidence            3478999999988877776543  45789999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCC---CcceeeecccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          216 KVLVKGE---PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       216 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......   ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+..       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-------  229 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-------  229 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-------
Confidence            8653221   123456899999999986533 24779999999999999999999999877665555443310       


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                                +            .++..+++.+.+||.+||..||.+|||++++++||||++...+.
T Consensus       230 ----------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          230 ----------Y------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             ----------C------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             ----------C------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence                      0            02245789999999999999999999999999999999875543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.1e-47  Score=360.53  Aligned_cols=281  Identities=28%  Similarity=0.484  Sum_probs=219.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEE-ccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCC------eeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKC-LETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPN------VVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~  134 (403)
                      .+|++.+.||+|+||.||+|.+ ..+|+.||||++....   ....+|+.+++.++|++      ++++++++.     .
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-----~   88 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-----H   88 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----E
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----c
Confidence            4799999999999999999998 5688999999986543   34567999999887654      889888773     3


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC-----------
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-----------  203 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~-----------  203 (403)
                      ..++++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+           
T Consensus        89 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           89 HGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCccc
Confidence            33588999999889998887642  24688999999999999999999998 99999999999999863           


Q ss_pred             -------CCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 015615          204 -------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ  276 (403)
Q Consensus       204 -------~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  276 (403)
                             ...+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                   22699999999986432  23456789999999999765 489999999999999999999999999988888


Q ss_pred             HHHHHHHhCCCCHHHHhccCcCcc----cccCCCc---------cCCCccc--ccccCCChHHHHHHHHhhccCCCCCCC
Q 015615          277 LVEIIKVLGTPTREEIKCMNPNYT----EFKFPQI---------KAHPWHK--IFQKRMPPEAVDLVSRLLQYSPNLRST  341 (403)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~--~~~~~~s~~~~~ll~~~L~~dP~~R~s  341 (403)
                      ...+....+..+...+........    ...+...         ...++..  ......++++.+||.+||+.||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            888888888777765543321100    0000000         0000000  001223577999999999999999999


Q ss_pred             HHHHhcCCCCccCCC
Q 015615          342 ALEALIHPFFDELRD  356 (403)
Q Consensus       342 ~~ell~hp~f~~~~~  356 (403)
                      ++|+++||||+.++.
T Consensus       323 ~~ell~hp~f~~~~~  337 (339)
T 1z57_A          323 LREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHTTSGGGGGGGC
T ss_pred             HHHHhcCHHHHHHhc
Confidence            999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.4e-47  Score=370.07  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=198.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcC--CCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|++.+.||+|+||.||+|.+.. ++.||||++....      ....+|+.+++.++  ||||+++++++..     ..
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence            469999999999999999999764 8999999985432      34568999999997  5999999987743     33


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ++++|||+..++|.+++...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++ ++ .+||+|||+++
T Consensus       130 ~~~lv~E~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~-~~kl~DFG~a~  202 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DG-MLKLIDFGIAN  202 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SS-CEEECCCSSSC
T ss_pred             EEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CC-eEEEEecCccc
Confidence            48899998778998888763    4688889999999999999999998 999999999999996 45 79999999998


Q ss_pred             ecccCCC---cceeeecccccccccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHH
Q 015615          217 VLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIK  282 (403)
Q Consensus       217 ~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~  282 (403)
                      .......   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|.+||.+.... ..+..+..
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence            6643322   2345799999999998641          34889999999999999999999999875432 22222221


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .              ..             ...++...+.++.+||.+||..||.+|||+.++|+||||+....+
T Consensus       283 ~--------------~~-------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          283 P--------------NH-------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             T--------------TS-------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             c--------------cc-------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence            0              00             001223357899999999999999999999999999999875444

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4e-47  Score=352.48  Aligned_cols=251  Identities=28%  Similarity=0.458  Sum_probs=210.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|.+.+.||+|+||.||+|.+..++..||||.+...       .....+|+.+++.++||||+++++++.     +.
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   86 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DR   86 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cC
Confidence            446899999999999999999999999999999998543       234568999999999999999999873     33


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...++||||+++ +|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg~  160 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKG-ELKIADFGW  160 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTC-CEEECCCTT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCC-CEEEecccc
Confidence            457899999984 888887654    4689999999999999999999988 999999999999999887 799999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +...... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+....          
T Consensus       161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------  228 (284)
T 2vgo_A          161 SVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD----------  228 (284)
T ss_dssp             CEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC----------
T ss_pred             cccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc----------
Confidence            8765332 23456789999999999765 48999999999999999999999998877665554443210          


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                        .                 .++..++.++.+||.+||..||.+|||++++++||||+...
T Consensus       229 --~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          229 --L-----------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             --C-----------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             --c-----------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence              0                 12245789999999999999999999999999999999754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=365.70  Aligned_cols=275  Identities=20%  Similarity=0.322  Sum_probs=206.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++...   +..+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            357999999999999999999999999999999986432     3445899999999999999999877432   23347


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe----cCCCCceEEeecC
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFG  213 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll----~~~~~~vkl~DfG  213 (403)
                      ++||||++ ++|.+.+.... ....+++..++.++.||+.||+|||++ ||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence            89999998 58888877543 234489999999999999999999998 99999999999998    6555 79999999


Q ss_pred             CceecccCCCcceeeecccccccccccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHH
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG----VDQLVEIIK  282 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~  282 (403)
                      ++.............||+.|+|||++..       ...++.++|||||||++|+|++|..||.....    .+.+..+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            9988766655566789999999999852       34589999999999999999999999975432    333333333


Q ss_pred             HhCCCCHHHHhccC-cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 015615          283 VLGTPTREEIKCMN-PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  349 (403)
Q Consensus       283 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp  349 (403)
                      .  .|. ..+.... .....+.+..  ..+....+...++..+.+||++||+.||++|||++|+|+||
T Consensus       242 ~--~p~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          242 G--KPS-GAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             H--CCT-TCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             C--CCc-ccchhhhcccCCccccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            2  111 1000000 0000000000  00111112234567899999999999999999999999996

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.5e-47  Score=356.46  Aligned_cols=253  Identities=28%  Similarity=0.429  Sum_probs=209.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..+|.+.+.||+|+||.||+|++..+|+.||+|.+...    .....+|+.+++.++||||+++++++.     +....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            35799999999999999999999999999999998643    234568999999999999999999873     334578


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe---cCCCCceEEeecCCc
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA  215 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~DfG~a  215 (403)
                      +||||+++ +|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+||++   +.++ .+||+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~  156 (304)
T 2jam_A           83 LVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENS-KIMITDFGLS  156 (304)
T ss_dssp             EEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred             EEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence            99999984 888877653    5689999999999999999999998 99999999999999   5555 7999999998


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......         
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------  225 (304)
T 2jam_A          157 KMEQNG-IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE---------  225 (304)
T ss_dssp             CCCCCB-TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC---------
T ss_pred             eecCCC-ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            754322 23445689999999999655 4899999999999999999999999988776666555442110         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                      +...+...+++++.+||.+||..||++|||++++++||||++.
T Consensus       226 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          226 ----------------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ----------------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                            0011224578999999999999999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.4e-48  Score=372.92  Aligned_cols=266  Identities=15%  Similarity=0.141  Sum_probs=188.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHc--CCCCeeecceeee------
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLL--DHPNVVSLKHCFF------  128 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l--~h~niv~~~~~~~------  128 (403)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.+  +||||++++..++      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999999999999999986532       2334675545444  6999888654332      


Q ss_pred             -ecCC------------CCceEEEEEEecccchHHHHHHhhcccCCCCCHHHH------HHHHHHHHHHHHHHHhcCCcc
Q 015615          129 -STTE------------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------KLYFYQICRALAYIHNTIGVC  189 (403)
Q Consensus       129 -~~~~------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~------~~~~~qi~~~L~~LH~~~~iv  189 (403)
                       ....            .....+|+|||||+++|.+++.....   .++....      ..++.||+.||+|||++ ||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK-GLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCc
Confidence             1110            01145789999999999999987532   2233333      46669999999999998 999


Q ss_pred             ccCCCCCceEecCCCCceEEeecCCceecccCCCcceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 015615          190 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLF  268 (403)
Q Consensus       190 H~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf  268 (403)
                      ||||||+|||++.++ .+||+|||+++....  ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus       217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999887 799999999986532  22245677999999999641 34899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          269 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       269 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .+.....                    ...+............+.......+++++.+||.+||+.||++|||++++|+|
T Consensus       294 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            8763210                    00011000011111111111224689999999999999999999999999999


Q ss_pred             CCCccCCC
Q 015615          349 PFFDELRD  356 (403)
Q Consensus       349 p~f~~~~~  356 (403)
                      |||+++.+
T Consensus       354 p~f~~~~~  361 (371)
T 3q60_A          354 PEFLQLQN  361 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.5e-47  Score=360.41  Aligned_cols=255  Identities=30%  Similarity=0.482  Sum_probs=203.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||.+....            ....+|+.+++.++||||+++++++..   
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   86 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---   86 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence            57999999999999999999999999999999985432            235689999999999999999987632   


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC--ceEE
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKL  209 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl  209 (403)
                       +.  .++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.  .+||
T Consensus        87 -~~--~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           87 -ED--YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             -SS--EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             -Cc--eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEEE
Confidence             11  6799999985 77776653    36789999999999999999999998 9999999999999986552  4999


Q ss_pred             eecCCceecccCCCcceeeeccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      +|||++.............||+.|+|||++.  +...++.++|||||||++|+|++|..||........+..........
T Consensus       159 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (322)
T 2ycf_A          159 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  238 (322)
T ss_dssp             CCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred             ccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence            9999998764443334557899999999974  23458999999999999999999999998754432222222211110


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      .                        .......++.++.+||.+||..||++|||++++|+||||++.
T Consensus       239 ~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          239 F------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             C------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             c------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            0                        001124578999999999999999999999999999999863

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-47  Score=360.20  Aligned_cols=260  Identities=25%  Similarity=0.382  Sum_probs=207.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            457999999999999999999999999999999986532       23457899999999999999999875433 2334


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      +.|+||||++ ++|.+.+...    ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTS-CEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCC-CEEEeeccCc
Confidence            5689999997 5888887653    5689999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          216 KVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       216 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ........    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+... 
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  241 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA-  241 (311)
T ss_dssp             ------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH-
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc-
Confidence            76543321    2235689999999999765 48999999999999999999999999887766665554422111111 


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                              ....++.++.+||.+||+.||.+||++.+++.|+|++....
T Consensus       242 ------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          242 ------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ------------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                                    12457999999999999999999999999999999986543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-47  Score=361.47  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=199.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCC--CCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|.+ .+++.||||++....      ....+|+.+++.++|  |||+++++++.     ..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence            34799999999999999999997 568999999985432      334679999999987  99999999873     33


Q ss_pred             eEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       136 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .++++|||+.+++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++ ++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~-~~kl~DFG~a  154 (343)
T 3dbq_A           82 QYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DG-MLKLIDFGIA  154 (343)
T ss_dssp             SEEEEEECCCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TT-EEEECCCSSS
T ss_pred             CEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CC-cEEEeecccc
Confidence            468899998888999888763    6789999999999999999999998 999999999999997 45 7999999999


Q ss_pred             eecccCCC---cceeeecccccccccccC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH
Q 015615          216 KVLVKGEP---NISYICSRYYRAPELIFG----------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEII  281 (403)
Q Consensus       216 ~~~~~~~~---~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~  281 (403)
                      ........   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||.+.... ..+..+.
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  234 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  234 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence            86543322   234578999999999853          245889999999999999999999999875432 2222211


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .   ..                        ....++...+.++.+||.+||+.||.+|||+.++|+||||+....+
T Consensus       235 ~---~~------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          235 D---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             C---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             c---CC------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            1   00                        0001223457899999999999999999999999999999875443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.5e-49  Score=381.43  Aligned_cols=255  Identities=17%  Similarity=0.219  Sum_probs=194.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHH---HHHHHcCCCCeeecceeeee----
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNREL---QTMRLLDHPNVVSLKHCFFS----  129 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~---~~l~~l~h~niv~~~~~~~~----  129 (403)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++...       .....+|+   ..++.++||||+++++.+..    
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45799999999999999999999899999999998532       23455788   45555689999999844321    


Q ss_pred             ---cC---------CCCce---EEEEEEecccchHHHHHHhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 015615          130 ---TT---------EKDEL---YLNLVLEYVPETVHRVIKHHYKMSQ---RMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (403)
Q Consensus       130 ---~~---------~~~~~---~~~lv~e~~~~~l~~~l~~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~  191 (403)
                         ..         ..+..   ..|+||||++|+|.+++........   .+++..+..++.||+.||+|||++ ||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence               10         11111   2679999999999999886532211   244577888999999999999998 99999


Q ss_pred             CCCCCceEecCCCCceEEeecCCceecccCCCcceeeecccccccccccCC----------CCCCCchhHHHHHHHHHHH
Q 015615          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAEL  261 (403)
Q Consensus       192 Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~el  261 (403)
                      ||||+|||++.++ .+||+|||+++...  .......| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999887 79999999998632  23344566 999999999765          1489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC
Q 015615          262 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  341 (403)
Q Consensus       262 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s  341 (403)
                      ++|+.||.+.+.......+.                                 .....+++++.+||.+||+.||++|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            99999997643211110000                                 011457899999999999999999999


Q ss_pred             HHHHhcCCCCccCCC
Q 015615          342 ALEALIHPFFDELRD  356 (403)
Q Consensus       342 ~~ell~hp~f~~~~~  356 (403)
                      +.++++||||++++.
T Consensus       354 ~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          354 PLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHHTSHHHHHHHH
T ss_pred             HHHHhhChHHHHHHH
Confidence            999999999998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.3e-47  Score=349.37  Aligned_cols=256  Identities=27%  Similarity=0.351  Sum_probs=205.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||.+....     ....+|+.+++.++||||+++++++..     ....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence            357999999999999999999999999999999985432     345689999999999999999998733     3457


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++ +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~  154 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  154 (276)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCC-CEEEeeCCCccc
Confidence            899999985 66655532    35689999999999999999999998 999999999999999877 799999999976


Q ss_pred             cccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          218 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       218 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      .....   ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+................        
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  226 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------  226 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--------
Confidence            53322   1234568999999999976554578999999999999999999999876543222111110000        


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                         .          ..     ....+++.+.+||.+||..||++|||++++++||||++...
T Consensus       227 ---~----------~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          227 ---Y----------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             ---T----------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ---c----------cC-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence               0          00     11347899999999999999999999999999999987543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.4e-47  Score=360.85  Aligned_cols=280  Identities=27%  Similarity=0.464  Sum_probs=217.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCC-cEEEEEEeccch---hhhHHHHHHHHHcCCCC------eeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETG-EAVAIKKVLQDK---RYKNRELQTMRLLDHPN------VVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~---~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~  134 (403)
                      .+|++.+.||+|+||.||+|.+..++ ..||+|++....   ....+|+.+++.++|++      ++.+++++.     .
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-----~   93 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-----F   93 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-----E
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-----e
Confidence            57999999999999999999998776 789999986532   34557999999997765      777777663     2


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe--------------
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV--------------  200 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll--------------  200 (403)
                      ...+++||||+++++.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||+              
T Consensus        94 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           94 HGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeccccccccccccc
Confidence            33588999999988888776542  24689999999999999999999998 99999999999999              


Q ss_pred             -----cCCCCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 015615          201 -----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD  275 (403)
Q Consensus       201 -----~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  275 (403)
                           +.++ .+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+
T Consensus       171 ~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 3444 799999999986433  234567899999999997654 8999999999999999999999999998888


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccc----cCCCc---------cCCCccc--ccccCCChHHHHHHHHhhccCCCCCC
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQI---------KAHPWHK--IFQKRMPPEAVDLVSRLLQYSPNLRS  340 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~---------~~~~~~~--~~~~~~s~~~~~ll~~~L~~dP~~R~  340 (403)
                      .+..+.+..+.++...+.........+    .++..         ...++..  ......+.++.+||++||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            888888888887776554322110000    00000         0000000  00112345899999999999999999


Q ss_pred             CHHHHhcCCCCccCCC
Q 015615          341 TALEALIHPFFDELRD  356 (403)
Q Consensus       341 s~~ell~hp~f~~~~~  356 (403)
                      |++++|+||||+++..
T Consensus       327 t~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CHHHHTTSGGGGGCCH
T ss_pred             CHHHHhcChhhcCCCh
Confidence            9999999999998753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-47  Score=366.79  Aligned_cols=259  Identities=28%  Similarity=0.455  Sum_probs=204.7

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccc--------hhhhHHHHHHHHHc-CCCCeeecceeeee
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l-~h~niv~~~~~~~~  129 (403)
                      ....+|++.+.||+|+||.||+|++.   .+|+.||||++...        .....+|+.+++.+ .||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            34468999999999999999999984   58999999988532        23345799999999 69999999988733


Q ss_pred             cCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceE
Q 015615          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (403)
Q Consensus       130 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  208 (403)
                           ...+++||||+++ +|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+|
T Consensus       131 -----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~k  199 (355)
T 1vzo_A          131 -----ETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVV  199 (355)
T ss_dssp             -----TTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEE
T ss_pred             -----CceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-cEE
Confidence                 3347899999985 888887654    5689999999999999999999998 999999999999999887 799


Q ss_pred             EeecCCceecccCC--CcceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015615          209 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG  285 (403)
Q Consensus       209 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~  285 (403)
                      |+|||+++......  ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+.... 
T Consensus       200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-  278 (355)
T 1vzo_A          200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-  278 (355)
T ss_dssp             ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-
T ss_pred             EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH-
Confidence            99999998653322  22345789999999999753 347899999999999999999999997643222122221110 


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                             ....+                 .++..++..+.+||.+||..||.+||     |++++++||||+.+.+
T Consensus       279 -------~~~~~-----------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          279 -------LKSEP-----------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             -------HHCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             -------hccCC-----------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                   00000                 12345789999999999999999999     9999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-46  Score=348.12  Aligned_cols=259  Identities=27%  Similarity=0.386  Sum_probs=212.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|.+...      .....+|+.+++.++||||+++++++...   ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence            456899999999999999999999999999999998542      23455799999999999999999977543   234


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ccccCCCCCceEecCCCCceEEe
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-----VCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~-----ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                      .+++||||+++ +|.+.+.........+++..+..++.||+.||.|||+. |     |+||||||+||+++.++ .+||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~-~~kl~  158 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLG  158 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSS-CEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCC-CEEEe
Confidence            57899999985 89988887655556799999999999999999999998 8     99999999999999887 79999


Q ss_pred             ecCCceecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          211 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       211 DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      |||++........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.....    
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----  233 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----  233 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred             cCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----
Confidence            9999876533221 12356899999999997654 89999999999999999999999998776555544443110    


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                     +         .++..++.++.+||.+||..||.+|||++++++|+|+.+-.
T Consensus       234 ---------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          234 ---------------R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             ---------------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ---------------c---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                           0         12235789999999999999999999999999999998743

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.4e-47  Score=350.97  Aligned_cols=256  Identities=28%  Similarity=0.456  Sum_probs=210.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++.     +...
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence            35799999999999999999999999999999998542      234568999999999999999999873     3345


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEeecCC
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGS  214 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~  214 (403)
                      .++||||+. ++|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            789999997 4777777653    4689999999999999999999998 999999999999997643  2699999999


Q ss_pred             ceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          215 AKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       215 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +.............+|+.|+|||++.+  .++.++||||||+++|+|++|..||.+.+..+....+........      
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------  242 (287)
T 2wei_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------  242 (287)
T ss_dssp             GGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred             ceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            886655444445678999999999854  389999999999999999999999998876665555443210000      


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                               .          .....+++++.+||.+||..||++|||++++++||||++...
T Consensus       243 ---------~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          243 ---------L----------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             ---------S----------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             ---------c----------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                     0          011357899999999999999999999999999999998643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-46  Score=350.95  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=205.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+...    .....+|+.+++.++||||+++++++..     ....+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeEE
Confidence            45799999999999999999999999999999988543    2345679999999999999999998743     23478


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        93 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKN  167 (302)
T ss_dssp             EEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTS-CEEECCCHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCC-CEEEEECCCCccc
Confidence            99999985 676666543   35689999999999999999999998 999999999999999887 7999999987543


Q ss_pred             ccC-CCcceeeeccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          219 VKG-EPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       219 ~~~-~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ... .......||+.|+|||++.    ....++.++|||||||++|+|++|..||...+.......+.......      
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  241 (302)
T 2j7t_A          168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT------  241 (302)
T ss_dssp             HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC------
T ss_pred             cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc------
Confidence            211 1223457899999999984    23458899999999999999999999999887666555544321000      


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                          ...+..++.++.+||.+||..||++|||++++++||||+....
T Consensus       242 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          242 --------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             --------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             --------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                                0112356889999999999999999999999999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-46  Score=351.82  Aligned_cols=261  Identities=24%  Similarity=0.396  Sum_probs=206.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHc-CCCCeeecceeeeecCC-CCceE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++...   .....+|+.+++.+ +||||+++++++..... .....
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            446799999999999999999999999999999998543   34566899999999 79999999998865432 11456


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +++||||+++ +|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~  177 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCCTTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCC-CEEEeeCcCce
Confidence            7899999985 8888887542  35689999999999999999999998 999999999999999887 79999999987


Q ss_pred             ecccCC-CcceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ...... ......||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+.......+..... +    
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----  252 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P----  252 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C----
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c----
Confidence            653322 2234578999999999852    23478999999999999999999999988776655544433100 0    


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                            ......++..+.+||.+||..||.+|||++++++||||++.
T Consensus       253 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          253 ----------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ----------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ----------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                                  01123578999999999999999999999999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.9e-47  Score=363.44  Aligned_cols=282  Identities=24%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|++.+.||+|+||.||+|.+..+|..||+|++...     .....+|+.+++.++||||+++++++..     ...+
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence            45799999999999999999999999999999998643     2345689999999999999999998743     3347


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+++ +|.+.+...    ..+++..+..++.|++.||.|||+..||+||||||+|||++.++ .+||+|||++..
T Consensus       107 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  181 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcc
Confidence            899999985 888888654    56899999999999999999999833899999999999999887 799999999875


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHHHHhcc-
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG-TPTREEIKCM-  295 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~-  295 (403)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+..... .+........ 
T Consensus       182 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          182 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             cccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            5332 23346789999999999765 489999999999999999999999988765543322211110 0000000000 


Q ss_pred             -CcCcccccCCC------------ccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          296 -NPNYTEFKFPQ------------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       296 -~~~~~~~~~~~------------~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                       ...+..+....            +............++.++.+||.+||+.||++|||++++|+||||+.....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence             00000000000            000000111123478899999999999999999999999999999986443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6e-46  Score=349.46  Aligned_cols=255  Identities=29%  Similarity=0.441  Sum_probs=206.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||.+....  ....+|+.+++.++||||+++++++..     ...+++|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEE
Confidence            346999999999999999999999999999999986543  455689999999999999999998743     2347899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||+++ +|.+.+...   ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++.....
T Consensus       103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~  177 (314)
T 3com_A          103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTD  177 (314)
T ss_dssp             EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECBT
T ss_pred             eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCC-CEEEeecccchhhhh
Confidence            999985 888877643   46789999999999999999999998 999999999999999887 799999999976644


Q ss_pred             CC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCc
Q 015615          221 GE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  299 (403)
Q Consensus       221 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  299 (403)
                      .. ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....  +         +.+
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------~~~  245 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--P---------PTF  245 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C---------CCC
T ss_pred             hccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--C---------ccc
Confidence            32 22345789999999999654 48999999999999999999999998877655444332210  0         000


Q ss_pred             ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                     ..+..++..+.+||.+||..||.+|||+.++++||||+...
T Consensus       246 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          246 ---------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             ---------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             ---------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                           01234688999999999999999999999999999999854

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.1e-46  Score=356.45  Aligned_cols=266  Identities=24%  Similarity=0.373  Sum_probs=186.7

Q ss_pred             ccccceEEEe-EeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           62 KQTISYMAER-VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        62 ~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ....+|.+.+ .||+|+||.||+|.+..+|+.||||++........+....++.++||||+++++++.... .+..++++
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l  103 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI  103 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence            3456899955 699999999999999999999999999776555555556678889999999999875432 34566889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEeecCCcee
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  217 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~a~~  217 (403)
                      ||||+.+ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..+||+|||++..
T Consensus       104 v~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            9999985 8888887542  35699999999999999999999998 999999999999997643  2599999999986


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+................           
T Consensus       181 ~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  247 (336)
T 3fhr_A          181 TTQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-----------  247 (336)
T ss_dssp             C-----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred             cccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-----------
Confidence            5432 23456789999999998554 4889999999999999999999999776543321111110000           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                        .....+        ......+++++.+||.+||+.||.+|||++++|+||||++.
T Consensus       248 --~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 --GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -----CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             --cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence              000000        01123579999999999999999999999999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.1e-46  Score=348.59  Aligned_cols=255  Identities=27%  Similarity=0.394  Sum_probs=201.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|+||.||+|++..++..||+|.+...       .....+|+.+++.++||||+++++++     .+..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            35799999999999999999999999999999988432       13446799999999999999999987     3344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+++||||+++ +|.+.+...    ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  158 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNK-TLKIFDFGIA  158 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCSSS
T ss_pred             eEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEEeCCCc
Confidence            58899999985 888887654    5689999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          216 KVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       216 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      .......  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+........ ..+..    
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~----  232 (294)
T 4eqm_A          159 KALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD-SVPNV----  232 (294)
T ss_dssp             TTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS-CCCCH----
T ss_pred             cccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-cCCCc----
Confidence            7653322  123456899999999997654 899999999999999999999999988765554433321 11111    


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                         ...+...+|+.+.++|.+||+.||.+||+..+.+.+.|..-+
T Consensus       233 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          233 -------------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             -------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             -------------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence                               111235689999999999999999999966666666654443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.3e-46  Score=347.66  Aligned_cols=249  Identities=27%  Similarity=0.411  Sum_probs=208.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..|.+.+.||+|+||.||+|.+..+++.||||.+...     .....+|+.+++.++||||+++++++..     ...++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence            4699999999999999999999999999999998543     2445689999999999999999998743     23478


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+..     ..+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        97 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQL  169 (303)
T ss_dssp             EEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCC-CEEEeecccceec
Confidence            99999985 77776642     5689999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...  .+          
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~----------  236 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP----------  236 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC----------
T ss_pred             CccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC----------
Confidence            4432 22345789999999999654 4899999999999999999999999887765554443321  00          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                      ..+...++..+.+||.+||..||.+|||+.++++||||...
T Consensus       237 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          237 ----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                            01224578999999999999999999999999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5e-46  Score=349.67  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=195.6

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ....+|++.+.||+|+||.||+|++  +|..||||++....      ....+|+.+++.++||||+++++++.     +.
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~  106 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QP  106 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----ST
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence            3456899999999999999999987  68899999985432      23457999999999999999999873     23


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCCceEEeec
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      ..+++||||+.+ +|.+.+..... ...+++..+..++.||+.||+|||++ |  |+||||||+|||++.++ .+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~-~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY-TVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTC-CEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCC-cEEECCC
Confidence            337899999985 88888765321 12388999999999999999999987 9  99999999999999887 7999999


Q ss_pred             CCceecccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          213 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       213 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      |+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+......     
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-----  257 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-----  257 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-----
Confidence            9997543332 223467899999999997654 899999999999999999999999988766655444321110     


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc--CCCCcc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDE  353 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~--hp~f~~  353 (403)
                                            ..++..+++++.+||.+||+.||.+|||++++++  +++++.
T Consensus       258 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 ----------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                  0123467899999999999999999999999987  444444

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.4e-47  Score=355.80  Aligned_cols=269  Identities=27%  Similarity=0.406  Sum_probs=190.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ...+|++.+.||+|+||.||+|.+..+++.||||.+...     .....+|+.+++.++||||+++++++...     ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DE   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----SC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CC
Confidence            345799999999999999999999889999999987543     23345789999999999999999987432     23


Q ss_pred             EEEEEeccc-chHHHHHHhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYK----MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      .++||||++ ++|.+.+.....    ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~df  165 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDG-SVQIADF  165 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCC-CEEEEec
Confidence            789999997 488887765322    235589999999999999999999998 999999999999999887 7999999


Q ss_pred             CCceecccCC------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015615          213 GSAKVLVKGE------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       213 G~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      |++.......      ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.............  .
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~  243 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN--D  243 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--S
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--C
Confidence            9986543221      1224568999999999865345899999999999999999999999887655544332221  1


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      +..                 .............++.++.+||.+||+.||.+|||+.++++||||+.....
T Consensus       244 ~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          244 PPS-----------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             CCC-----------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             CCc-----------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            000                 000000011224578999999999999999999999999999999986543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-45  Score=343.93  Aligned_cols=259  Identities=24%  Similarity=0.359  Sum_probs=198.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCC--------
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTE--------  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--------  132 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||.+....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            357999999999999999999999999999999986543   334579999999999999999998754321        


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                      .....+++||||+++ +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCC-CEEEee
Confidence            235678999999985 888888753   34577888999999999999999998 999999999999999887 799999


Q ss_pred             cCCceecccC---------------CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 015615          212 FGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ  276 (403)
Q Consensus       212 fG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  276 (403)
                      ||++......               .......||+.|+|||++.+...++.++|||||||++|+|++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765321               112345689999999999766568999999999999999998   5543222221


Q ss_pred             HHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      ........           ..             .+...+....+..+.+||++||+.||.+|||++++++||||+..
T Consensus       237 ~~~~~~~~-----------~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          237 ILKKLRSV-----------SI-------------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHST-----------TC-------------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHhcccc-----------cc-------------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            11111100           00             00111334567889999999999999999999999999999764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=346.34  Aligned_cols=258  Identities=24%  Similarity=0.355  Sum_probs=188.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||.+....      ....++..+++.++||||+++++++..     ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~   97 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT   97 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence            4568999999999999999999999999999999986432      122234556788899999999998743     33


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .+++||||+++.+..+....   ...+++..+..++.||+.||.|||++.||+||||||+||+++.++ .+||+|||++.
T Consensus        98 ~~~lv~e~~~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~  173 (318)
T 2dyl_A           98 DVFIAMELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISG  173 (318)
T ss_dssp             EEEEEECCCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC-
T ss_pred             cEEEEEeccCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCch
Confidence            57899999976665555432   367899999999999999999999822999999999999999887 79999999997


Q ss_pred             ecccCCCcceeeeccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGEPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~  291 (403)
                      ............+|+.|+|||++.    ....++.++|||||||++|+|++|..||..... .+.+..+.... .+    
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~----  248 (318)
T 2dyl_A          174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PP----  248 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CC----
T ss_pred             hccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CC----
Confidence            765544445567899999999985    234478999999999999999999999987443 33333333310 00    


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                            .     .+          ....+++++.+||.+||..||.+|||++++++||||++..
T Consensus       249 ------~-----~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 ------L-----LP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             ------C-----CC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             ------C-----CC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                  0     00          0124789999999999999999999999999999998754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.2e-46  Score=356.36  Aligned_cols=272  Identities=20%  Similarity=0.342  Sum_probs=206.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---------------------hhhHHHHHHHHHcCCCCeee
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------------------RYKNRELQTMRLLDHPNVVS  122 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l~h~niv~  122 (403)
                      ..+|++.+.||+|+||.||+|.+  +|+.||||.+....                     ....+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            45799999999999999999998  89999999985432                     55678999999999999999


Q ss_pred             cceeeeecCCCCceEEEEEEecccc-hHHHHHHhh--c--ccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCC
Q 015615          123 LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH--Y--KMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQ  196 (403)
Q Consensus       123 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~--~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~~ivH~Dlkp~  196 (403)
                      +++++..     ....++||||+++ +|.+++...  .  .....+++..++.++.||+.||.|||+ + ||+||||||+
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~  181 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPS  181 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGG
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChH
Confidence            9998733     3458899999986 766552110  1  114678999999999999999999998 7 9999999999


Q ss_pred             ceEecCCCCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCc-H
Q 015615          197 NLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA-AIDIWSAGCVLAELLLGQPLFPGESG-V  274 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~-~  274 (403)
                      ||+++.++ .+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|..||..... .
T Consensus       182 Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          182 NILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             hEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999887 7999999999875433 3345678999999999976534555 99999999999999999999988766 4


Q ss_pred             HHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       275 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      +....+.... .....       ....+..+ ... .........+++++.+||.+||+.||.+|||++++++||||++.
T Consensus       260 ~~~~~i~~~~-~~~~~-------~~~~~~~~-~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          260 ELFNNIRTKN-IEYPL-------DRNHFLYP-LTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHHTSCC-CCCCC-------SSSSSTTT-TCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHhccC-cCCcc-------chhhhhcc-ccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            4433332210 00000       00000000 000 00011224689999999999999999999999999999999885


Q ss_pred             C
Q 015615          355 R  355 (403)
Q Consensus       355 ~  355 (403)
                      .
T Consensus       330 ~  330 (348)
T 2pml_X          330 N  330 (348)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=343.55  Aligned_cols=255  Identities=25%  Similarity=0.455  Sum_probs=198.7

Q ss_pred             EEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEEec
Q 015615           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        69 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      ....||+|+||.||+|.+..++..||||.+...    .....+|+.+++.++||||+++++++..     ....++||||
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  100 (295)
T 2clq_A           26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFMEQ  100 (295)
T ss_dssp             SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEEC
T ss_pred             CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEEEe
Confidence            344899999999999999999999999988543    2345689999999999999999998743     3357899999


Q ss_pred             cc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCC
Q 015615          145 VP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP  223 (403)
Q Consensus       145 ~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~  223 (403)
                      ++ ++|.+.+.... ....+++..+..++.||+.||.|||++ ||+||||||+||+++.+.+.+||+|||++........
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            97 57888776532 234567888999999999999999998 9999999999999987334899999999986543222


Q ss_pred             -cceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCccc
Q 015615          224 -NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  301 (403)
Q Consensus       224 -~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  301 (403)
                       .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..................         .     
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~-----  244 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV---------H-----  244 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC---------C-----
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc---------c-----
Confidence             2345789999999998643 23789999999999999999999999765443322111111100         0     


Q ss_pred             ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                  ..++..+++++.+||.+||..||++|||++++++||||+....
T Consensus       245 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          245 ------------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             ------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                        0123457899999999999999999999999999999987543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8e-45  Score=339.00  Aligned_cols=250  Identities=19%  Similarity=0.222  Sum_probs=202.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...  .....+|+.+++.+ +|+|++++++++.     .....++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~lv   84 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLV   84 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeEEE
Confidence            4799999999999999999999999999999988543  34567899999999 7999999988763     33457899


Q ss_pred             EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC----ceEEeecCCcee
Q 015615          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH----QLKLCDFGSAKV  217 (403)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~----~vkl~DfG~a~~  217 (403)
                      |||++++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.    .+||+|||++..
T Consensus        85 ~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999988999888754   35689999999999999999999988 9999999999999986652    399999999987


Q ss_pred             cccCCC--------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCC
Q 015615          218 LVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGT  286 (403)
Q Consensus       218 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~  286 (403)
                      ......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+   ..+.+..+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            644322        23456899999999996654 8999999999999999999999998843   33333333332211


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ++...                        +...+++++.+|+.+||+.||++|||++++++.
T Consensus       240 ~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          240 TPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             SCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             ccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11111                        123578999999999999999999999998753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.8e-46  Score=353.11  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=205.2

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----------hhhHHHHHHHHHcC--CCCeeecceeeeec
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFST  130 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~  130 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||.+....          ....+|+.+++.++  |+||+++++++.  
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~--  118 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--  118 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe--
Confidence            3457999999999999999999999999999999985432          23457999999996  599999999873  


Q ss_pred             CCCCceEEEEEEeccc--chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceE
Q 015615          131 TEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLK  208 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vk  208 (403)
                         .....++|||++.  ++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+.+.+|
T Consensus       119 ---~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          119 ---RPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             ---CSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEE
T ss_pred             ---cCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEE
Confidence               3345789999997  6888887763    5689999999999999999999998 9999999999999984444899


Q ss_pred             EeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          209 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       209 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      |+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||....      .+...  .  
T Consensus       191 L~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~--~--  259 (320)
T 3a99_A          191 LIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q--  259 (320)
T ss_dssp             ECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C--
T ss_pred             EeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc--c--
Confidence            9999999876433 33456789999999998766545788999999999999999999996531      11110  0  


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                                               ..+...+++++.+||.+||..||++|||++++++||||++...+
T Consensus       260 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          260 -------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             -------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             -------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence                                     01234579999999999999999999999999999999987543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-45  Score=347.63  Aligned_cols=247  Identities=19%  Similarity=0.209  Sum_probs=199.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|+||.||+|++..+|+.||||.+...  .....+|+.+++.+ +||||+++++++..     ..+.++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEE
Confidence            4799999999999999999999999999999988543  34567899999999 99999999987733     3457899


Q ss_pred             EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCc-----eEEeecCCce
Q 015615          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----LKLCDFGSAK  216 (403)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~-----vkl~DfG~a~  216 (403)
                      |||++++|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .     +||+|||+++
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           84 LELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCE
T ss_pred             EEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCC-CCCCceEEEEEcccce
Confidence            999988898888764   36799999999999999999999998 999999999999998766 4     9999999998


Q ss_pred             ecccCCC--------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhC
Q 015615          217 VLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLG  285 (403)
Q Consensus       217 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~  285 (403)
                      .......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..   +.+..+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            7644322        23567899999999997654 899999999999999999999999885432   23333322111


Q ss_pred             CCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          286 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ..+...                        .....+ ++.+|+.+||..||.+||+++++++
T Consensus       238 ~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111110                        112234 9999999999999999999988865

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-45  Score=349.08  Aligned_cols=263  Identities=25%  Similarity=0.366  Sum_probs=185.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHH-HHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||.+....     ....+|+. +++.++||||+++++++..     ...
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence            457999999999999999999999999999999986432     12223444 6677899999999998743     335


Q ss_pred             EEEEEecccchHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .++||||++++|.+.+..... ....+++..+..++.|++.||.|||++.||+||||||+|||++.++ .+||+|||++.
T Consensus        96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~  174 (327)
T 3aln_A           96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISG  174 (327)
T ss_dssp             EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSC
T ss_pred             eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCce
Confidence            789999999988887765332 2467899999999999999999999844999999999999999887 79999999998


Q ss_pred             ecccCCCcceeeeccccccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          217 VLVKGEPNISYICSRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ............||+.|+|||++.   ....++.++|||||||++|+|++|..||.+.......  +...          
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~----------  242 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--LTQV----------  242 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC----------
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--HHHH----------
Confidence            765544444557899999999983   2334899999999999999999999999865321100  0000          


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                            .....+     .+.......+++++.+||.+||..||++|||+.++++||||....
T Consensus       243 ------~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          243 ------VKGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             ------CCSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ------hcCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                  000000     011112245789999999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=344.28  Aligned_cols=253  Identities=26%  Similarity=0.456  Sum_probs=200.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|.+...    .....+|+.+++.++||||+++++++..     ....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence            45799999999999999999999999999999988542    2345689999999999999999998843     33478


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+.+ +|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  158 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENK-NVVVADFGLARLM  158 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence            99999985 888887653   35689999999999999999999998 999999999999999887 7999999999865


Q ss_pred             ccCCCc---------------ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 015615          219 VKGEPN---------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (403)
Q Consensus       219 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  283 (403)
                      ......               ....||+.|+|||++.+. .++.++|||||||++|+|++|..||..........     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----  232 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----  232 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----
Confidence            333221               145789999999999764 48999999999999999999999987542110000     


Q ss_pred             hCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                       .......                    .....+..+++.+.+|+.+||+.||++|||+.++++  |++.++
T Consensus       233 -~~~~~~~--------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          233 -GLNVRGF--------------------LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             -SBCHHHH--------------------HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             -hhhhhcc--------------------ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence             0000000                    001123567899999999999999999999999986  566553

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=345.90  Aligned_cols=247  Identities=22%  Similarity=0.337  Sum_probs=199.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+   .||||.+...     .....+|+.+++.++||||+++++++     .+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  121 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR  121 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            44689999999999999999999976554   5999998643     23456799999999999999999987     33


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ....++||||+++ +|.+++...   ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg  196 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNL-VCKVSDFG  196 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred             CCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCC-CEEECCCC
Confidence            3447899999975 888887543   35799999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       214 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      ++.........    ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......+ 
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-  274 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-  274 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-
T ss_pred             cccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC-
Confidence            99876433221    1234577899999997554 8999999999999999999 999999887766665554321111 


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                                 .+..+++++.+||.+||..||.+|||+.++++.
T Consensus       275 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          275 ---------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                       123578999999999999999999999999853

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-45  Score=335.73  Aligned_cols=246  Identities=20%  Similarity=0.337  Sum_probs=201.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|++...   .....+|+.+++.++||||+++++++.     +....+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence            3457999999999999999999986 5778999998653   345668999999999999999999873     233378


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+...   ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCC-CEEeccccccccc
Confidence            99999985 788777653   35689999999999999999999998 999999999999999877 7999999999754


Q ss_pred             ccCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....  ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......         
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---------  226 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------  226 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred             cccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------
Confidence            3221  122345677899999996554 8999999999999999999 99999988776665554432100         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                         ..+...++.+.+++.+||+.||++|||+.++++|
T Consensus       227 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          227 -------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                               1123468999999999999999999999999976

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=355.85  Aligned_cols=255  Identities=19%  Similarity=0.236  Sum_probs=203.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEE-----EccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ...+|++.+.||+|+||.||+|.     +..++..||||++...     .....+|+.+++.++||||+++++++..   
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---  145 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---  145 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence            34579999999999999999999     4457789999998532     2334579999999999999999998733   


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--Cc
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQ  206 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~  206 (403)
                        ....++||||+. ++|.+++.....   ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++  ..
T Consensus       146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 --SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCC
T ss_pred             --CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCce
Confidence              233679999997 589888876542   224589999999999999999999998 999999999999998544  25


Q ss_pred             eEEeecCCceecccC---CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 015615          207 LKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (403)
Q Consensus       207 vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  282 (403)
                      +||+|||+++.....   .......+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999754222   2223456789999999997654 8999999999999999998 9999998876665554443


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                      ....                            ..+..++..+.+||.+||+.||.+|||+.++++|.++-
T Consensus       302 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          302 GGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2100                            01245789999999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.3e-45  Score=351.21  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=201.0

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc-------cCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeee
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~  129 (403)
                      ...+|.+.+.||+|+||.||+|++.       .++..||||.+....     ....+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3468999999999999999999974       345679999986432     3456799999999 89999999998732


Q ss_pred             cCCCCceEEEEEEecccc-hHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 015615          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (403)
Q Consensus       130 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~  196 (403)
                           ...+|+||||+.+ +|.+++.....            ....++...+..++.||+.||+|||++ ||+||||||+
T Consensus       159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~  232 (370)
T 2psq_A          159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAAR  232 (370)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGG
T ss_pred             -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-Ceeccccchh
Confidence                 3347899999985 88888876432            124588999999999999999999998 9999999999


Q ss_pred             ceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015615          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  272 (403)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+..
T Consensus       233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999887 799999999986543321   22345678999999997654 8999999999999999999 999998876


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ..+....+.....                            ...+..++.++.+||.+||..||.+|||+.+++++
T Consensus       311 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          311 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5554443322100                            01224578999999999999999999999999864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-45  Score=341.31  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=208.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecC-----------C
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT-----------E  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----------~  132 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+........+|+.+++.++||||+++++++....           .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            35799999999999999999999989999999999877777889999999999999999999774311           1


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                      .....+++||||+++ +|.+++....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  165 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTK-QVKIGD  165 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCC-CEEECc
Confidence            234568899999996 8888887543  35689999999999999999999998 999999999999999877 799999


Q ss_pred             cCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          212 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       212 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||....  .....+..         
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred             chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence            9999877655555566789999999999765 48999999999999999999998874211  11111100         


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                            ..++..++.++.+||.+||..||.+|||+.++++|.+.-.
T Consensus       234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                  0012347889999999999999999999999999976543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.4e-44  Score=347.53  Aligned_cols=257  Identities=16%  Similarity=0.147  Sum_probs=196.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccC-----CcEEEEEEeccchhhhHHHHH---------------HHHHcCCCCeeecc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLET-----GEAVAIKKVLQDKRYKNRELQ---------------TMRLLDHPNVVSLK  124 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~E~~---------------~l~~l~h~niv~~~  124 (403)
                      .+|++.+.||+|+||.||+|.+..+     ++.||||++........+|+.               .++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4799999999999999999998764     588999998665444444444               44556799999999


Q ss_pred             eeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec--C
Q 015615          125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN--P  202 (403)
Q Consensus       125 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~--~  202 (403)
                      +++.... .+..+.+|||||++++|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++  .
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSC
T ss_pred             eeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCC
Confidence            9876533 345678999999977888888763   36799999999999999999999998 999999999999998  6


Q ss_pred             CCCceEEeecCCceecccCCCc--------ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH
Q 015615          203 HTHQLKLCDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  274 (403)
Q Consensus       203 ~~~~vkl~DfG~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  274 (403)
                      ++ .+||+|||+++........        ....||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+....
T Consensus       190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            66 7999999999765432211        2345899999999997654 899999999999999999999999864333


Q ss_pred             HHHHHHHH-HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          275 DQLVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       275 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ........ ..............                   ....++.++.+|+.+||..||.+||++.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCF-------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHS-------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhc-------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            32222222 11111111111000                   01357899999999999999999999999874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.1e-45  Score=344.60  Aligned_cols=261  Identities=20%  Similarity=0.280  Sum_probs=189.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCc---EEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|++.+.||+|+||.||+|.+..++.   .||||.+...      .....+|+.+++.++||||+++++++......+
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4579999999999999999999877765   8999988543      234568999999999999999999875533221


Q ss_pred             -ceEEEEEEecccc-hHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          135 -ELYLNLVLEYVPE-TVHRVIKHHYKM--SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       135 -~~~~~lv~e~~~~-~l~~~l~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                       ....++||||+.+ +|.+.+......  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~-~~kl~  179 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDM-TVCVA  179 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEEC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCC-CEEEe
Confidence             1224799999985 888887654322  23589999999999999999999998 999999999999999887 79999


Q ss_pred             ecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 015615          211 DFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       211 DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      |||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~  258 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL  258 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence            99999765433221   2345678899999997654 8999999999999999999 99999987766655544331100


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-------HHHHhcCCCCccCC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-------ALEALIHPFFDELR  355 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-------~~ell~hp~f~~~~  355 (403)
                                                  ..+..+++++.+||.+||+.||++|||       ++++++|||+....
T Consensus       259 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          259 ----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             ----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             ----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence                                        012457899999999999999999999       77788999998753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-44  Score=339.88  Aligned_cols=254  Identities=25%  Similarity=0.356  Sum_probs=196.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcC--CCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++....      ....+|+.+++.++  ||||+++++++.     ..
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~  100 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD  100 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CS
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cC
Confidence            347999999999999999999985 58999999985321      34467999999997  599999998773     33


Q ss_pred             eEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          136 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       136 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .++++|||+..++|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+|||++. + .+||+|||++
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~  173 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-G-MLKLIDFGIA  173 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred             CEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-C-eEEEeecccc
Confidence            458899998888999888753    5788999999999999999999998 9999999999999974 4 7999999999


Q ss_pred             eecccCCC---cceeeecccccccccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHH
Q 015615          216 KVLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD-QLVEII  281 (403)
Q Consensus       216 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~  281 (403)
                      ........   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|..||....... .+..+.
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            76543322   1245689999999998641          347889999999999999999999998754332 222111


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .   .           .             ....++...+.++.+||.+||..||.+|||++++++||||+....+
T Consensus       254 ~---~-----------~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          254 D---P-----------N-------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             C---T-----------T-------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             h---c-----------c-------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            1   0           0             0001223457899999999999999999999999999999976544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.1e-45  Score=348.57  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=201.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEE-----EccCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (403)
                      ...+|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+.+++.+ +||||+++++++... 
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence            34679999999999999999999     45667899999986532     3356899999999 789999999987432 


Q ss_pred             CCCceEEEEEEecccc-hHHHHHHhhccc---------------------------------------------------
Q 015615          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKM---------------------------------------------------  159 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------------------------------------------  159 (403)
                         ...+++|||||.+ +|.+++......                                                   
T Consensus        99 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           99 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             ---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence               2236799999985 888888764321                                                   


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCC---cc
Q 015615          160 -----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NI  225 (403)
Q Consensus       160 -----------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~  225 (403)
                                 ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++........   ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC-
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhcc
Confidence                       12288999999999999999999998 999999999999999877 799999999986533322   23


Q ss_pred             eeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccC
Q 015615          226 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  304 (403)
Q Consensus       226 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  304 (403)
                      ...+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+.........+                 
T Consensus       254 ~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  315 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----------------  315 (359)
T ss_dssp             -CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred             ccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------
Confidence            456788999999997644 8999999999999999998 999999876555554444321111                 


Q ss_pred             CCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       305 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                ..+..+++++.+++.+||+.||.+|||+.++++|
T Consensus       316 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                      0123478999999999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=360.29  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=190.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      .+|.+.+.||+|+||+||. ....+|+.||||++... .....+|+.+++.+ +||||+++++++     .+..++|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence            3699999999999999764 34568999999998643 34467899999999 799999998877     3344578999


Q ss_pred             ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC---C-CceEEeecCCceec
Q 015615          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH---T-HQLKLCDFGSAKVL  218 (403)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~---~-~~vkl~DfG~a~~~  218 (403)
                      |||+++|.+.+....   ..++...+..++.||+.||.|||++ ||+||||||+|||++.+   + ..+||+|||+|+..
T Consensus        98 E~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCAATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCSEEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCCCCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            999999998887542   2344445678999999999999998 99999999999999532   2 25889999999876


Q ss_pred             ccCC----CcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          219 VKGE----PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       219 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ....    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |.+||......... .+   .+....  
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~---~~~~~~--  247 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL---LGACSL--  247 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH---TTCCCC--
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH---hccCCc--
Confidence            4332    2234678999999999964  2346889999999999999999 99999665432221 11   111000  


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                   ...       ......+..+.+||.+||+.||.+|||++++++||||..+
T Consensus       248 -------------~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          248 -------------DCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             -------------TTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             -------------ccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence                         000       0011235678999999999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.7e-44  Score=331.80  Aligned_cols=246  Identities=20%  Similarity=0.308  Sum_probs=200.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+.+++.++||||+++++++     .+....+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence            3457999999999999999999875 5778999998653   34456899999999999999999987     3333478


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||++ ++|.+.+...   ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred             EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCC-CEEEccCccceec
Confidence            9999997 4788888664   24589999999999999999999998 999999999999999887 7999999999865


Q ss_pred             ccCCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ......  ....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+......         
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------  224 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL---------  224 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred             chhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------
Confidence            433221  2234567899999996544 8999999999999999999 99999888776655544331100         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                         ..+...++.+.+|+.+||+.||++|||+.+++++
T Consensus       225 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 -------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                               0123468899999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=342.43  Aligned_cols=246  Identities=28%  Similarity=0.446  Sum_probs=197.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----------hhhHHHHHHHHHc----CCCCeeecceeeee
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLL----DHPNVVSLKHCFFS  129 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~h~niv~~~~~~~~  129 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||.+....          ....+|+.+++.+    +||||+++++++. 
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~-  108 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE-  108 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe-
Confidence            457999999999999999999999999999999985432          2334699999999    8999999999873 


Q ss_pred             cCCCCceEEEEEEec-cc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec-CCCCc
Q 015615          130 TTEKDELYLNLVLEY-VP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN-PHTHQ  206 (403)
Q Consensus       130 ~~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~-~~~~~  206 (403)
                          .....++|||| +. ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||||+||+++ .++ .
T Consensus       109 ----~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~-~  178 (312)
T 2iwi_A          109 ----TQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRG-C  178 (312)
T ss_dssp             --------CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTT-E
T ss_pred             ----cCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCC-e
Confidence                23346789998 55 5888888763    5689999999999999999999998 999999999999998 555 8


Q ss_pred             eEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015615          207 LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       207 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      +||+|||++...... ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||....      .+...   
T Consensus       179 ~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~---  248 (312)
T 2iwi_A          179 AKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---  248 (312)
T ss_dssp             EEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT---
T ss_pred             EEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh---
Confidence            999999999876443 33456789999999998765544568999999999999999999997531      11110   


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                               .                 ..++..++.++.+||.+||+.||++|||++++++||||+...+
T Consensus       249 ---------~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 ---------E-----------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---------C-----------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---------c-----------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                     0                 0123457899999999999999999999999999999998654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.6e-44  Score=332.93  Aligned_cols=250  Identities=21%  Similarity=0.248  Sum_probs=200.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+.+++.++|++++..+..+..    ...+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEE
Confidence            35799999999999999999999999999999987543  3456789999999999988777665533    23357899


Q ss_pred             EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec---CCCCceEEeecCCceec
Q 015615          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~---~~~~~vkl~DfG~a~~~  218 (403)
                      |||++++|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++   .++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccc
Confidence            999988998888643   35699999999999999999999998 999999999999994   555 7999999999876


Q ss_pred             ccCCC--------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCC
Q 015615          219 VKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTP  287 (403)
Q Consensus       219 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~  287 (403)
                      .....        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+...   .+.+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            54332        23457899999999997654 89999999999999999999999987432   22233332211111


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      +..                        .+...+|+++.+|+.+||+.||++|||++++++
T Consensus       238 ~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 PIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             chH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            111                        112457899999999999999999999999885

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.4e-44  Score=333.19  Aligned_cols=246  Identities=22%  Similarity=0.345  Sum_probs=196.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----------hhhHHHHHHHHHcCCCCeeecceeeeecC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  131 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  131 (403)
                      ...+|++.+.||+|+||.||+|++..+++.||||.+....           ....+|+.+++.++||||+++++++    
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----   92 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM----   92 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee----
Confidence            3457999999999999999999999999999999984321           3456899999999999999999987    


Q ss_pred             CCCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCC---
Q 015615          132 EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTH---  205 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~---  205 (403)
                       .+..  ++||||+. ++|.+.+...   ...+++..+..++.|++.||+|||++ |  |+||||||+|||++.++.   
T Consensus        93 -~~~~--~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           93 -HNPP--RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             -TTTT--EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             -cCCC--eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCCc
Confidence             2222  48999998 5887777543   35789999999999999999999998 9  999999999999987662   


Q ss_pred             -ceEEeecCCceecccCCCcceeeecccccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHH
Q 015615          206 -QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL-VEIIK  282 (403)
Q Consensus       206 -~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~i~~  282 (403)
                       .+||+|||++.....  ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||......... .....
T Consensus       166 ~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  243 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR  243 (287)
T ss_dssp             CCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred             eeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence             299999999975422  3345678999999999842 233688999999999999999999999876543321 11111


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ..+.                          ...++..+++++.+||.+||+.||.+|||++++++
T Consensus       244 ~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          244 EEGL--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HSCC--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCC--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1110                          01123467899999999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.7e-45  Score=357.34  Aligned_cols=258  Identities=28%  Similarity=0.407  Sum_probs=189.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-hhhHHHHHHHHHc-CCCCeeecceeeeecCCCCceEEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      ..|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++     .+..++++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEE
Confidence            357788999999999998754 5689999999986543 3456899999876 899999998876     3345688999


Q ss_pred             ecccchHHHHHHhhcccCCC---CCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC------------Cce
Q 015615          143 EYVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT------------HQL  207 (403)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~---l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~------------~~v  207 (403)
                      |||+++|.+.+.........   .++..+..++.||+.||+|||++ ||+||||||+|||++.++            ..+
T Consensus        89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            99999999988764322211   12334567999999999999998 999999999999997532            379


Q ss_pred             EEeecCCceecccCCC-----cceeeecccccccccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015615          208 KLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (403)
Q Consensus       208 kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  275 (403)
                      ||+|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|+|+| |..||.+....+
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            9999999987644322     124578999999999865      2458999999999999999999 999997654432


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                        ..+.....                 ..+..     .......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       248 --~~i~~~~~-----------------~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 --SNIIRGIF-----------------SLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             --HHHHHTCC-----------------CCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             --HHHhcCCC-----------------Ccccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence              22222100                 00000     00011235688999999999999999999999999999964

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.3e-45  Score=350.80  Aligned_cols=246  Identities=21%  Similarity=0.289  Sum_probs=199.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ...+|.+.+.||+|+||.||+|.+..+++.||||.+....     ....+|+.+++.++||||+++++++..     ...
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence            4468999999999999999999999899999999986431     344579999999999999999998732     233


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +++||||++ ++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~  261 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKN-VLKISDFGMSR  261 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCC-cEEECcCCCce
Confidence            689999998 5888888754   24588999999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          217 VLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       217 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      ........   ....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.... .+     
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~-----  334 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RL-----  334 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CC-----
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC-----
Confidence            64332111   1223577899999997554 8999999999999999998 999999877655444332210 00     


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                            ..+..+++++.+||.+||+.||++|||++++++
T Consensus       335 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          335 ----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                  012357889999999999999999999999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=344.41  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=201.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ...+|++.+.||+|+||.||+|++.     .+++.||||.+...     .....+|+.+++.++||||+++++++..   
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence            3467999999999999999999986     35589999998643     2345689999999999999999998733   


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhccc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKM--------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~  191 (403)
                        ...+++||||+++ +|.+++......                    ...+++..++.++.||+.||.|||++ ||+||
T Consensus       122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~  198 (343)
T 1luf_A          122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHR  198 (343)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence              3347899999985 888888764321                    25689999999999999999999998 99999


Q ss_pred             CCCCCceEecCCCCceEEeecCCceecccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 015615          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  267 (403)
Q Consensus       192 Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p  267 (403)
                      ||||+|||++.++ .+||+|||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..|
T Consensus       199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999877 79999999997653321   123456788999999987654 8999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      |.+.+..+....+.....                   +         .++..+++++.+||++||..||++|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNI-------------------L---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCC-------------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCc-------------------C---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            998776655544433100                   0         022457899999999999999999999999986


Q ss_pred             C
Q 015615          348 H  348 (403)
Q Consensus       348 h  348 (403)
                      +
T Consensus       329 ~  329 (343)
T 1luf_A          329 I  329 (343)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-44  Score=345.13  Aligned_cols=250  Identities=21%  Similarity=0.322  Sum_probs=202.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccC-------CcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeee
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~  129 (403)
                      ...+|.+.+.||+|+||.||+|++..+       +..||||++....     ....+|+.+++.+ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            446899999999999999999997543       3579999986432     3355899999999 99999999998733


Q ss_pred             cCCCCceEEEEEEecccc-hHHHHHHhhccc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 015615          130 TTEKDELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (403)
Q Consensus       130 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~  196 (403)
                           ...+++||||+++ +|.+.+......            ...+++..++.++.||+.||+|||++ ||+||||||+
T Consensus       147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~  220 (382)
T 3tt0_A          147 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAAR  220 (382)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGG
T ss_pred             -----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCcc
Confidence                 2336899999985 898888765421            24589999999999999999999998 9999999999


Q ss_pred             ceEecCCCCceEEeecCCceecccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015615          197 NLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  272 (403)
                      |||++.++ .+||+|||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+
T Consensus       221 NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          221 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999887 79999999998654332   223345688999999997654 8999999999999999999 999999877


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ..+....+......                            ..+..+++++.+||.+||+.||++|||+.+++++
T Consensus       299 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEELFKLLKEGHRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTTCCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            65554443321100                            0124578999999999999999999999999976

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.8e-44  Score=332.71  Aligned_cols=250  Identities=21%  Similarity=0.251  Sum_probs=197.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++|++++..+..+..    ...+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEE
Confidence            35799999999999999999999999999999986433  3456789999999999998887766543    23357899


Q ss_pred             EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe---cCCCCceEEeecCCceec
Q 015615          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~DfG~a~~~  218 (403)
                      |||++++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||+   +.++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCC-eEEEecCccceec
Confidence            999988998888753   35699999999999999999999998 99999999999999   5555 7999999999876


Q ss_pred             ccCCC--------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCC
Q 015615          219 VKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGTP  287 (403)
Q Consensus       219 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~  287 (403)
                      .....        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..   ..+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            44322        22457899999999997654 899999999999999999999999875322   2222222211111


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      +..                        .....+|+++.+||.+||+.||++|||++++++
T Consensus       238 ~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 PIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            111                        122457899999999999999999999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.6e-44  Score=330.14  Aligned_cols=243  Identities=27%  Similarity=0.445  Sum_probs=188.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|.+  +|..||||++...        .....+|+.+++.++||||+++++++.     +.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence            35799999999999999999997  5889999987532        134567999999999999999999873     33


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC---ccccCCCCCceEecCC-------C
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG---VCHRDIKPQNLLVNPH-------T  204 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~---ivH~Dlkp~NIll~~~-------~  204 (403)
                      ...++||||+++ +|.+.+.     ...+++..+..++.|++.||.|||++ |   |+||||||+|||++.+       .
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccC
Confidence            457899999984 6666653     35789999999999999999999997 8   9999999999999852       2


Q ss_pred             CceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015615          205 HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (403)
Q Consensus       205 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  284 (403)
                      +.+||+|||++....... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus       153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  230 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK  230 (271)
T ss_dssp             CCEEECCCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred             cceEEccCCccccccccc-ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence            379999999997654332 33567899999999997654 8999999999999999999999999877655544333210


Q ss_pred             CCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .                           ....+..+++.+.+|+.+||..||.+|||+.+++++
T Consensus       231 ~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 L---------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             C---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C---------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            0                           001224578999999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=358.89  Aligned_cols=273  Identities=21%  Similarity=0.331  Sum_probs=202.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.||||++....     ....+|+.+++.++||||+++++++...   +..+.
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence            357999999999999999999999999999999986432     3445899999999999999999877432   23346


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe----cCCCCceEEeecC
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFG  213 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll----~~~~~~vkl~DfG  213 (403)
                      ++|||||. ++|.+.+.... ....+++..++.++.||+.||+|||++ ||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence            89999997 57887776532 234489999999999999999999998 99999999999998    5555 79999999


Q ss_pred             CceecccCCCcceeeecccccccccccCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHH
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAELLLGQPLFPGES----GVDQLVEIIK  282 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~  282 (403)
                      +++............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||....    ..+.+..+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            99877555555567799999999998541       236789999999999999999999997532    3333333333


Q ss_pred             HhCCCCHHHHhccC-cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          283 VLGTPTREEIKCMN-PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       283 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                        +.|.. .+.... .....+.+..  ..+....+...++..+.+||++||+.||++|||+.++++
T Consensus       242 --~~p~~-~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 --GKPSG-AISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             --SCCTT-CCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             --CCCcc-cchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence              22211 110000 0000000000  000111122345678899999999999999999999854

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=341.34  Aligned_cols=251  Identities=26%  Similarity=0.387  Sum_probs=184.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcC-CCCeeecceeeeecCC---CCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTE---KDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~---~~~~  136 (403)
                      .+|++.+.||+|+||.||+|++..+|+.||||++....    ....+|+.+++.+. ||||+++++++.....   ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            47999999999999999999999999999999884432    33457999999996 9999999998754322   4556


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCCceEEeecCC
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      .+++||||+.++|.+.+.... ....+++..+..++.||+.||+|||++ |  |+||||||+|||++.++ .+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            688999999999988887543 245699999999999999999999987 8  99999999999999887 799999999


Q ss_pred             ceecccCCCc-------------ceeeeccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 015615          215 AKVLVKGEPN-------------ISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE  279 (403)
Q Consensus       215 a~~~~~~~~~-------------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  279 (403)
                      +.........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|..||.+.........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            9765432211             1445899999999983  233478899999999999999999999976433221110


Q ss_pred             HHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 015615          280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  349 (403)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp  349 (403)
                      .   .                  .          .......+..+.+||++||+.||.+|||+.++++|-
T Consensus       265 ~---~------------------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          265 K---Y------------------S----------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ----C------------------C----------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             c---c------------------c----------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            0   0                  0          001134577899999999999999999999999873

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.3e-44  Score=338.46  Aligned_cols=250  Identities=20%  Similarity=0.325  Sum_probs=200.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||||.+....     ....+|+.+++.++||||+++++++..   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ---   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence            3467999999999999999999983     456899999986432     344579999999999999999998732   


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYK--------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~  191 (403)
                        ....++||||++ ++|.+++.....                    ....+++..+..++.||+.||.|||++ ||+||
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~  174 (314)
T 2ivs_A           98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHR  174 (314)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCccc
Confidence              333789999998 588888876432                    123488999999999999999999998 99999


Q ss_pred             CCCCCceEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 015615          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  267 (403)
Q Consensus       192 Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p  267 (403)
                      ||||+|||++.++ .+||+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..|
T Consensus       175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999877 7999999999866433221   2345678899999997654 8999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      |.+.........+.....                            ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            988766544433322100                            0122457899999999999999999999999986


Q ss_pred             C
Q 015615          348 H  348 (403)
Q Consensus       348 h  348 (403)
                      +
T Consensus       305 ~  305 (314)
T 2ivs_A          305 D  305 (314)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.8e-45  Score=343.91  Aligned_cols=268  Identities=21%  Similarity=0.250  Sum_probs=197.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..+|++.+.||+|+||.||+|++  .++.||||++....   ....+|+.+++.++||||+++++++..... ....+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence            35799999999999999999987  48999999986443   233458888999999999999998755432 2445789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CccccCCCCCceEecCCCCceEEe
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---------~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                      ||||+++ +|.+++..     ..+++..+..++.||+.||+|||+..         ||+||||||+|||++.++ .+||+
T Consensus       100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEEC
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEc
Confidence            9999985 88888865     45899999999999999999999632         999999999999999887 79999


Q ss_pred             ecCCceecccCCC---cceeeecccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 015615          211 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (403)
Q Consensus       211 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  283 (403)
                      |||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|+|+||+.||.+.............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999987644332   2235789999999999653    23556889999999999999999999875432221111222


Q ss_pred             hCCCCHHHHhccCcCcccccCCCccCCCccccc-ccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ...+....+......  ....+     .....+ ....++++.+||.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          254 GQHPSLEDMQEVVVH--KKKRP-----VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CSSCCHHHHHHHHTT--SCCCC-----CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCchhhhhhhhhc--ccCCC-----CccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            222333222111000  00000     000001 0123456999999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-44  Score=333.12  Aligned_cols=247  Identities=19%  Similarity=0.281  Sum_probs=199.0

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ....+|++.+.||+|+||.||+|.+. ++..||||++...   .....+|+.+++.++||||+++++++.     +....
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCe
Confidence            34458999999999999999999875 6778999998653   345668999999999999999999873     33347


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+. ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred             EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCC-CEEEcccccccc
Confidence            89999997 5788887653   25689999999999999999999998 999999999999999887 799999999975


Q ss_pred             cccCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          218 LVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       218 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      .....  ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |+.||...+..+....+......        
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------  240 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------  240 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred             ccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence            53221  122344578899999997554 8999999999999999998 99999988776666555432111        


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                          ..+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       241 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 --------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                0123468899999999999999999999999976

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-44  Score=336.12  Aligned_cols=262  Identities=24%  Similarity=0.398  Sum_probs=193.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEE----EccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.+.||+|+||.||+|+    +..+|+.||||++....    ....+|+.+++.++||||+++++++....   
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            34589999999999999999998    56789999999986543    34568999999999999999999875422   


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+++||||++ ++|.+.+....   ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCC-eEEEccCc
Confidence            223679999997 48888887642   4589999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       214 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      ++........    .....+|+.|+|||++.+.. ++.++|||||||++|+|+||..||.....  ...   ...+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~---~~~~~~~~  233 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EFM---RMIGNDKQ  233 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHH---HHHCTTCC
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChH--HHH---hhhcCccc
Confidence            9986543321    12234677899999997654 89999999999999999999999865321  111   11111110


Q ss_pred             HHHh--ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          290 EEIK--CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       290 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ....  ........         ......+..+++++.+||.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          234 GQMIVFHLIELLKN---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             THHHHHHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cchhHHHHHHHHhc---------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0000  00000000         0000123457899999999999999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.1e-44  Score=336.57  Aligned_cols=250  Identities=23%  Similarity=0.332  Sum_probs=201.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEE-----ccCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||+|+||.||+|.+     ..+++.||||.+...     .....+|+.+++.+ +||||+++++++..   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence            45799999999999999999985     457789999998643     23456899999999 99999999998733   


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~N  197 (403)
                        ....++||||+++ +|.+.+.....              ....+++..+..++.||+.||+|||++ ||+||||||+|
T Consensus        99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~N  175 (313)
T 1t46_A           99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARN  175 (313)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGG
T ss_pred             --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccce
Confidence              2336799999985 89888876432              123589999999999999999999998 99999999999


Q ss_pred             eEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 015615          198 LLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (403)
Q Consensus       198 Ill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  273 (403)
                      |+++.++ .+||+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+...
T Consensus       176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999877 7999999999866443321   2345688899999987654 8999999999999999999 9999988765


Q ss_pred             HHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .............+                           ..+..++.++.+||.+||..||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            55554444321110                           1123578999999999999999999999999865

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.1e-44  Score=332.64  Aligned_cols=247  Identities=27%  Similarity=0.374  Sum_probs=189.8

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccC---CcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ....+|++.+.||+|+||.||+|.+..+   +..||+|.+...     .....+|+.+++.++||||+++++++.    .
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~   87 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----E   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----S
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc----c
Confidence            3456899999999999999999998653   457999987542     234557999999999999999998762    1


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      +  ..++||||+.+ +|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        88 ~--~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Df  160 (281)
T 1mp8_A           88 N--PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDF  160 (281)
T ss_dssp             S--SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC-
T ss_pred             C--ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCC-CEEECcc
Confidence            1  25799999985 888887653   34689999999999999999999998 999999999999999877 7999999


Q ss_pred             CCceecccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          213 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       213 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      |++........  .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+......   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---  236 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---  236 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---
Confidence            99986643322  12335578899999996544 8999999999999999997 99999987766555444321100   


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                               .++..+++++.+||.+||..||++|||+.+++++
T Consensus       237 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                     0224578999999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.2e-44  Score=335.42  Aligned_cols=254  Identities=22%  Similarity=0.308  Sum_probs=193.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-hhhHHHHHHHHH--cCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|++.+.||+|+||.||+|++  +|+.||||++.... ....+|.+++..  ++||||+++++++.... .....++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~   82 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLW   82 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeE
Confidence            345799999999999999999987  78999999986543 333457777776  79999999999875533 3455678


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCccccCCCCCceEecCCCCceEEe
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------NTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH--------~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                      +||||+++ +|.+.+.     ...+++..+..++.||+.||+|||        +. ||+||||||+|||++.++ .+||+
T Consensus        83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~-~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNG-QCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTS-CEEEC
T ss_pred             EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCC-CEEEe
Confidence            99999985 8888774     257899999999999999999999        87 999999999999999887 79999


Q ss_pred             ecCCceecccCCCc-----ceeeecccccccccccCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCC
Q 015615          211 DFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLG----------QPLFPG  270 (403)
Q Consensus       211 DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~elltg----------~~pf~~  270 (403)
                      |||++.........     ....||+.|+|||++.+...     ++.++|||||||++|||++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999766443322     23478999999999965532     34789999999999999999          888865


Q ss_pred             CCc----HHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          271 ESG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       271 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                      ...    .............                 .+..    ....+....++++.+|+.+||+.||++|||+.+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-----------------~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  294 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQ-----------------RPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK  294 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCC-----------------CCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCC-----------------CCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence            321    2222221111000                 0000    00111223567899999999999999999999998


Q ss_pred             c
Q 015615          347 I  347 (403)
Q Consensus       347 ~  347 (403)
                      +
T Consensus       295 ~  295 (301)
T 3q4u_A          295 K  295 (301)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5e-44  Score=332.11  Aligned_cols=248  Identities=20%  Similarity=0.312  Sum_probs=203.7

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ....+|++.+.||+|+||.||+|.+..++..||+|.+..+.   ....+|+.+++.++||||+++++++.     +....
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCE
Confidence            34568999999999999999999999999999999986543   34568999999999999999999873     33347


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||+. ++|.+.+....  ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence            89999998 58888886532  35689999999999999999999998 999999999999999877 799999999976


Q ss_pred             cccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          218 LVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       218 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ......  .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |.+||.+.+.......+.....         
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------  230 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------  230 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------
T ss_pred             ccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---------
Confidence            543322  12345678899999997654 8999999999999999999 9999988765554443332100         


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                         ...+..+++++.+||.+||..||.+|||++++++
T Consensus       231 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          231 -------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                               0122457899999999999999999999999975

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-44  Score=341.21  Aligned_cols=251  Identities=21%  Similarity=0.300  Sum_probs=200.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  131 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  131 (403)
                      ...+|.+.+.||+|+||.||+|.+.     .++..||||.+...     .....+|+.+++.+ +||||+++++++..  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence            3457999999999999999999973     45678999998643     23456899999999 89999999998743  


Q ss_pred             CCCceEEEEEEecccc-hHHHHHHhhccc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 015615          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKM-------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~  191 (403)
                         ...+++||||+++ +|.+.+......                   ...+++..+..++.||+.||+|||++ ||+||
T Consensus       121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~  196 (344)
T 1rjb_A          121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHR  196 (344)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEET
T ss_pred             ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence               2337899999985 888888764321                   13478999999999999999999998 99999


Q ss_pred             CCCCCceEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 015615          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  267 (403)
Q Consensus       192 Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p  267 (403)
                      ||||+|||++.++ .+||+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|+| |..|
T Consensus       197 Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          197 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCC
Confidence            9999999999887 7999999999866443322   2345688999999987654 8999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          268 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       268 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      |.+......+..+......+                           ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             STTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            98876555554444321000                           012357899999999999999999999999997


Q ss_pred             C
Q 015615          348 H  348 (403)
Q Consensus       348 h  348 (403)
                      |
T Consensus       328 ~  328 (344)
T 1rjb_A          328 F  328 (344)
T ss_dssp             H
T ss_pred             H
Confidence            6

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-44  Score=341.18  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=200.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEE--EEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAV--AIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v--aiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|++..+|..+  |+|.+...     .....+|+.+++.+ +||||+++++++..     .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----C
Confidence            368999999999999999999998888865  99988542     23456799999999 89999999998733     3


Q ss_pred             eEEEEEEecccc-hHHHHHHhhc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP  202 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~  202 (403)
                      .++++||||+++ +|.+.+....            .....+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  177 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEcC
Confidence            458899999975 8888887543            2235789999999999999999999998 9999999999999998


Q ss_pred             CCCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015615          203 HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (403)
Q Consensus       203 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  281 (403)
                      ++ .+||+|||++.............+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       178 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          178 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CC-eEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            77 79999999987543333333456688999999986544 7999999999999999998 999998877655443332


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ....                            ...+..+++++.+||.+||..||.+|||+++++++
T Consensus       256 ~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          256 QGYR----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GTCC----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCC----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2100                            00123578999999999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7e-44  Score=340.20  Aligned_cols=257  Identities=14%  Similarity=0.131  Sum_probs=192.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEcc---CCcEEEEEEeccchhh---------------hHHHHHHHHHcCCCCeeeccee
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRY---------------KNRELQTMRLLDHPNVVSLKHC  126 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~h~niv~~~~~  126 (403)
                      .+|.+.+.||+|+||.||+|.+..   ++..||||.+......               ..+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            479999999999999999999987   7889999998654322               2356777888899999999998


Q ss_pred             eeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC-C
Q 015615          127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT-H  205 (403)
Q Consensus       127 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~-~  205 (403)
                      +.... .+..++++||||++++|.+++...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .
T Consensus       117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEF-KGRSYRFMVMERLGIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEES-SSCEEEEEEEECEEEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTT
T ss_pred             ccccc-CCCcEEEEEEeccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCC
Confidence            75533 345678999999977888877543    3789999999999999999999998 999999999999998654 2


Q ss_pred             ceEEeecCCceecccCCC--------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CcHHH
Q 015615          206 QLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQ  276 (403)
Q Consensus       206 ~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~  276 (403)
                      .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+. .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            699999999976533211        1345789999999999765 4899999999999999999999999653 22222


Q ss_pred             HHHHHH-HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          277 LVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       277 ~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ...... .....+...... .                   -...+++++.+||.+||..||++|||++++++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~-~-------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKW-A-------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHH-S-------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHhhcccccHHHHhh-c-------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            222222 211111111110 0                   012578999999999999999999999999854

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-43  Score=332.77  Aligned_cols=247  Identities=25%  Similarity=0.319  Sum_probs=190.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence            4467999999999999999999999999999999986432       345579999999999999999998743     3


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+++||||+++ +|.+.+...    ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~-~~kl~Dfg~  180 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADD-FAYLVDFGI  180 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSCCC
T ss_pred             CeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCC-CEEEecCcc
Confidence            357899999985 888888754    5689999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015615          215 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       215 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  292 (403)
                      +.......  ......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.. .+...... ..+.    
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~-~~~~----  253 (309)
T 2h34_A          181 ASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQ-AIPR----  253 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHS-CCCC----
T ss_pred             CccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhcc-CCCC----
Confidence            87654332  12345789999999998654 4899999999999999999999999876543 22222221 0000    


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-CHHHHhc
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-TALEALI  347 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-s~~ell~  347 (403)
                                          .......+|+++.++|.+||..||++|| |++++++
T Consensus       254 --------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          254 --------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             --------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             --------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                                1112356899999999999999999999 7887774

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-43  Score=333.63  Aligned_cols=255  Identities=19%  Similarity=0.272  Sum_probs=194.0

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEcc---CCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ...+|.+.+.||+|+||.||+|.+..   ++..||+|.+....      ....+|+.+++.++||||+++++++......
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            34579999999999999999998765   45689999985431      3355799999999999999999988654443


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhc--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                      +....++||||+.+ +|.+.+....  .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kl~  189 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDM-TVCVA  189 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTS-CEEEC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEEe
Confidence            33456899999985 8888875433  2345699999999999999999999998 999999999999999887 79999


Q ss_pred             ecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 015615          211 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       211 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      |||++........   .....+++.|+|||++.+. .++.++|||||||++|+|++ |.+||.+....+....+..... 
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-  267 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-  267 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-
Confidence            9999976543321   2234567889999999764 48999999999999999999 8999988776555444432110 


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                                 ...+..+++++.+||.+||..||.+|||+.+++++
T Consensus       268 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 ---------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ---------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       01224578999999999999999999999999865

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5e-44  Score=332.25  Aligned_cols=251  Identities=18%  Similarity=0.253  Sum_probs=196.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCC-------cEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETG-------EAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ..+|.+.+.||+|+||.||+|.+..++       ..||+|.+....    ....+|+.+++.++||||+++++++..   
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC---   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence            457999999999999999999998877       479999985432    345679999999999999999998743   


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCc-----
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----  206 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~-----  206 (403)
                        ....++||||+. ++|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++..     
T Consensus        84 --~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           84 --GDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             --TTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             --CCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCCccccccc
Confidence              223679999998 5888888764   23488999999999999999999998 99999999999999877621     


Q ss_pred             --eEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHH
Q 015615          207 --LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKV  283 (403)
Q Consensus       207 --vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~  283 (403)
                        +||+|||++....   ......+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+... .......
T Consensus       158 ~~~kl~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~  233 (289)
T 4fvq_A          158 PFIKLSDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED  233 (289)
T ss_dssp             CEEEECCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT
T ss_pred             ceeeeccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc
Confidence              9999999986442   2234567899999999976456899999999999999999954 5555444333 2222221


Q ss_pred             hCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      ..                             .++...++++.+||.+||+.||++|||+.++++|  ++++-.|.
T Consensus       234 ~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~p~  277 (289)
T 4fvq_A          234 RH-----------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTPD  277 (289)
T ss_dssp             TC-----------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC---
T ss_pred             cC-----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCCC
Confidence            00                             0123457889999999999999999999999987  55554443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.6e-44  Score=336.73  Aligned_cols=259  Identities=22%  Similarity=0.275  Sum_probs=206.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ...+|++.+.||+|+||.||+|.+.     .++..||||.+....     ....+|+.+++.++||||+++++++..   
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   99 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---   99 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence            4467999999999999999999876     457889999986432     234579999999999999999998732   


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhcc------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYK------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH  205 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~  205 (403)
                        ....++||||+++ +|.+.+.....      ....+++..+..++.||+.||+|||++ ||+||||||+||+++.++ 
T Consensus       100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~-  175 (322)
T 1p4o_A          100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-  175 (322)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC-
T ss_pred             --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCC-
Confidence              2336799999985 88888875432      124578899999999999999999998 999999999999999887 


Q ss_pred             ceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015615          206 QLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII  281 (403)
Q Consensus       206 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~  281 (403)
                      .+||+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            799999999976533321   12345688999999987554 8999999999999999999 899998877655554443


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC------CCCccCC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH------PFFDELR  355 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h------p~f~~~~  355 (403)
                      ... .+                           ..+..++..+.+||.+||..||.+|||+.++++|      ++|+++.
T Consensus       255 ~~~-~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          255 EGG-LL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             TTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             cCC-cC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            210 00                           0124578999999999999999999999999876      6776654


Q ss_pred             CC
Q 015615          356 DP  357 (403)
Q Consensus       356 ~~  357 (403)
                      ..
T Consensus       307 ~~  308 (322)
T 1p4o_A          307 FY  308 (322)
T ss_dssp             ST
T ss_pred             cc
Confidence            44

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.1e-44  Score=339.78  Aligned_cols=245  Identities=22%  Similarity=0.308  Sum_probs=194.7

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcE----EEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEA----VAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.    ||+|.+....     ....+|+.+++.++||||+++++++.     +
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~   86 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----G   86 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----B
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence            45799999999999999999999888876    7777664321     33457999999999999999999762     1


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                       ...++||||+. ++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        87 -~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg  160 (325)
T 3kex_A           87 -SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFG  160 (325)
T ss_dssp             -SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSS-CEEECSCS
T ss_pred             -CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCC-eEEECCCC
Confidence             12678999998 5888877653   24678888999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          214 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       214 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +++.......   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......   
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---  236 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL---  236 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC---
T ss_pred             cccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---
Confidence            9987643322   23445678999999997654 8999999999999999999 99999887655544433321000   


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                               ..+..++.++.+||.+||..||.+|||+.++++|
T Consensus       237 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          237 -------------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -------------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -------------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     0123467889999999999999999999999976

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.4e-44  Score=337.69  Aligned_cols=250  Identities=22%  Similarity=0.303  Sum_probs=201.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCc-----EEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|.+.+.||+|+||.||+|.+..++.     .||+|.+...     .....+|+.+++.+ +||||+++++++..   
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---  121 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH---  121 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec---
Confidence            4579999999999999999999876654     7999998643     23456899999999 89999999998733   


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhccc----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKM----------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~----------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~  201 (403)
                        ...+++||||+++ +|.+.+......          ...+++..+..++.||+.||+|||++ ||+||||||+|||++
T Consensus       122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLT  198 (333)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEEE
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEEC
Confidence              2337899999985 898888764321          34689999999999999999999998 999999999999999


Q ss_pred             CCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015615          202 PHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQL  277 (403)
Q Consensus       202 ~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  277 (403)
                      .++ .+||+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|+| |..||.+......+
T Consensus       199 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          199 NGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             GGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             CCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            877 7999999999865443321   2345688899999987654 8999999999999999998 99999887655555


Q ss_pred             HHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          278 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       278 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ..+......+                           ..+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       277 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          277 YKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            5444321110                           0123468899999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.5e-44  Score=336.05  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=200.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...    .....+|+.+++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            4799999999999999999999999999999988532    234568999999999999999999875432 34456789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+.+ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            9999996 89888887655567899999999999999999999998 999999999999999887 79999999987542


Q ss_pred             cCCC----------cceeeecccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Q 015615          220 KGEP----------NISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGT  286 (403)
Q Consensus       220 ~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~  286 (403)
                      ....          .....||+.|+|||++.+..  .++.++|||||||++|+|++|..||...... .........   
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---  262 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---  262 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence            2111          11235689999999986433  2688999999999999999999999531100 000000000   


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                                    ....+          ....+++++.+||.+||+.||.+|||+.+++++  +..+.
T Consensus       263 --------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~  305 (317)
T 2buj_A          263 --------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQ  305 (317)
T ss_dssp             --------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTC
T ss_pred             --------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcC
Confidence                          00000          113578999999999999999999999999986  44443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5e-45  Score=344.53  Aligned_cols=266  Identities=21%  Similarity=0.249  Sum_probs=198.9

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ....+|++.+.||+|+||.||+|.+ .+|+.||||++....    ....+|+.+++.++||||+++++++..     ...
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  109 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNE  109 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TTC
T ss_pred             HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCe
Confidence            3456799999999999999999996 468999999875432    345689999999999999999998732     334


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .++||||+++ +|.+.+.........+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~  187 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENF-VPKITDFGISK  187 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCC-CEEEeeccccc
Confidence            6899999985 77776654433345689999999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          217 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       217 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+........     ...  
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~--  259 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VES--  259 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHH--
T ss_pred             ccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhc--
Confidence            643222   123456899999999987654 899999999999999999999999765432211000000     000  


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .....     ............+....+..+.+++.+||+.||++|||+.++++|
T Consensus       260 ~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          260 HNNGQ-----LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             HTTTC-----CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccc-----HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00000     011111111112223456789999999999999999999999976

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.1e-43  Score=334.15  Aligned_cols=251  Identities=21%  Similarity=0.327  Sum_probs=200.1

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEc-------cCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeee
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCL-------ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  128 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~  128 (403)
                      ....+|++.+.||+|+||.||+|.+.       .++..||||++....     ....+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34468999999999999999999975       457789999986432     3345799999999 8999999999873


Q ss_pred             ecCCCCceEEEEEEecccc-hHHHHHHhhccc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 015615          129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP  195 (403)
Q Consensus       129 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp  195 (403)
                           ....+++||||+++ +|.+++......            ...+++..+..++.||+.||.|||++ ||+||||||
T Consensus       112 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp  185 (334)
T 2pvf_A          112 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAA  185 (334)
T ss_dssp             -----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSG
T ss_pred             -----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCcc
Confidence                 23347899999985 888888764321            23488999999999999999999998 999999999


Q ss_pred             CceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 015615          196 QNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGE  271 (403)
Q Consensus       196 ~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  271 (403)
                      +|||++.++ .+||+|||++........   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.
T Consensus       186 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          186 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            999999887 799999999986644322   22345678899999987654 8999999999999999999 99999887


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          272 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       272 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      +..+....+......                            ..+..++.++.+||.+||..||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          264 PVEELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CHHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            765555444331100                            0124578999999999999999999999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-43  Score=330.83  Aligned_cols=252  Identities=31%  Similarity=0.479  Sum_probs=190.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++...       .....+|+.+++.++||||+++++++..     .
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence            345799999999999999999999999999999998632       2334579999999999999999998754     2


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ...++||||+.+ +|.+.+.........+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~-~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCC-CEEEEeccc
Confidence            347899999986 88888876655567799999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHH
Q 015615          215 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEI  292 (403)
Q Consensus       215 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  292 (403)
                      +........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ...+.........      
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  255 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY------  255 (310)
T ss_dssp             ----------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS------
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC------
Confidence            876543222 2345689999999998654 489999999999999999999999976432 1222211111100      


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                  +.        .....++.++.+||.+||..||.+|||+.+++++
T Consensus       256 ------------~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          256 ------------PP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             ------------CC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                        00        0113578999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.6e-43  Score=346.26  Aligned_cols=244  Identities=22%  Similarity=0.310  Sum_probs=198.1

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ...+|++.+.||+|+||.||+|.+  .|+.||||.+....  ....+|+.+++.++||||+++++++....    ..+++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~i  264 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI  264 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEE
Confidence            446799999999999999999987  47899999986543  44568999999999999999999875422    23789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+++....  ...++...+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus       265 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCC-CEEEeeCCCccccc
Confidence            9999985 8988887642  23478999999999999999999998 999999999999999887 79999999998543


Q ss_pred             cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ..  .....+++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.+...             
T Consensus       341 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------------  404 (450)
T 1k9a_A          341 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------------  404 (450)
T ss_dssp             --------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------------
T ss_pred             cc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            22  2233568899999999765 48999999999999999998 9999988765555444332110             


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                     ...+..+++++.+||.+||..||.+|||+.++++
T Consensus       405 ---------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          405 ---------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                           0122457899999999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.6e-44  Score=337.07  Aligned_cols=245  Identities=23%  Similarity=0.355  Sum_probs=192.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEE----EEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|++.+.||+|+||.||+|++..+|+.+    |+|.+...     .....+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   89 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence            457999999999999999999998877654    77776432     23456899999999999999999987431    


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      .  .++|++|+. ++|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 ~--~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Dfg  162 (327)
T 3poz_A           90 T--VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             S--EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             C--eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCC-CEEEccCc
Confidence            1  567889888 5888887654   35689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          214 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       214 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +++........   ....+|+.|+|||++.+.. ++.++|||||||++|+|+| |..||.+.+..+....+......   
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---  238 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---  238 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---
Confidence            99866443322   2334578899999997654 8999999999999999999 99999887655443333221100   


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                               ..+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       239 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 -------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                     0123468899999999999999999999999876

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.2e-43  Score=326.87  Aligned_cols=248  Identities=25%  Similarity=0.363  Sum_probs=196.7

Q ss_pred             CccccceEEEeEeeeCCcEEEEEEEEcc---CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           61 PKQTISYMAERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        61 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      .....+|.+.+.||+|+||.||+|.+..   ++..||+|.+...     .....+|+.+++.++||||+++++++..   
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   84 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---   84 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---
Confidence            3445689999999999999999999754   3456999998653     2345679999999999999999987621   


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEee
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD  211 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D  211 (403)
                       +.  .++||||+. ++|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        85 -~~--~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  156 (281)
T 3cc6_A           85 -EP--TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPE-CVKLGD  156 (281)
T ss_dssp             -SS--CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETT-EEEECC
T ss_pred             -CC--CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCC-cEEeCc
Confidence             11  468999998 5888888654   35689999999999999999999998 999999999999999877 799999


Q ss_pred             cCCceecccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          212 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       212 fG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      ||++........  .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....+......+ 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~-  234 (281)
T 3cc6_A          157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP-  234 (281)
T ss_dssp             CCGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-
T ss_pred             cCCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-
Confidence            999876543221  22345678899999996544 8999999999999999998 999998776655544443311100 


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                                 .+..+++.+.+||.+||..||++|||+.+++++
T Consensus       235 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          235 ---------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                       123478999999999999999999999999865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-43  Score=333.05  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=200.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEE-----ccCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||+|+||.||+|.+     ..+++.||||.+....     ....+|+.+++.+ +||||+++++++...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            45799999999999999999985     3567899999986532     3345799999999 689999999987432  


Q ss_pred             CCceEEEEEEecccc-hHHHHHHhhccc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceE
Q 015615          133 KDELYLNLVLEYVPE-TVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL  199 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIl  199 (403)
                        ...+++||||+++ +|.+.+......            ...+++..+..++.||+.||.|||++ ||+||||||+||+
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEE
Confidence              2236799999984 888888764321            12388999999999999999999998 9999999999999


Q ss_pred             ecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015615          200 VNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  275 (403)
Q Consensus       200 l~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  275 (403)
                      ++.++ .+||+|||++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99877 7999999999765433222   2356788999999997654 8999999999999999998 999998876544


Q ss_pred             HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       276 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .+.........+                           ..+..+++++.++|.+||..||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            444333321110                           0123478999999999999999999999999976

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-43  Score=324.23  Aligned_cols=245  Identities=20%  Similarity=0.329  Sum_probs=199.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+.+++.++||||+++++++..     ....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEE
Confidence            357999999999999999999985 6788999998654   2456689999999999999999998733     233789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||+++ +|.+.+...   ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  155 (267)
T ss_dssp             EECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             EEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCC-CEEEcccccccccc
Confidence            9999984 888887653   35689999999999999999999998 999999999999999877 79999999987543


Q ss_pred             cCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          220 KGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       220 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ...  ......+|+.|+|||++.+.. ++.++||||||+++|+|++ |.+||.+.+..+....+......          
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~----------  224 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------  224 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------
T ss_pred             cccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC----------
Confidence            211  112345678899999996544 8999999999999999999 89999987766655544331100          


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                        ..+...+..+.+++.+||..||++|||+.+++++
T Consensus       225 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          225 ------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                              0123468899999999999999999999999865

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.2e-44  Score=338.77  Aligned_cols=265  Identities=20%  Similarity=0.285  Sum_probs=199.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ..+|.+.+.||+|+||.||+|.+ .+|+.||||++....     ....+|+.+++.++||||+++++++..     ....
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  102 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTER  102 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----SSCC
T ss_pred             hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-----CCce
Confidence            35799999999999999999985 468999999985432     245689999999999999999998843     2336


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC--CccccCCCCCceEecCCCCceEEeecCCc
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--GVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++||||+.+ +|.+.+.........+++..+..++.|++.||+|||++.  ||+||||||+|||++.++ .+||+|||++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~  181 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA  181 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence            799999985 888888776555567999999999999999999999743  999999999999999887 7999999999


Q ss_pred             eecccCCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHhCCCCH
Q 015615          216 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       216 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~~  289 (403)
                      .........  ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||....    ..........       
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------  253 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK-------  253 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-------
T ss_pred             cccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-------
Confidence            876433322  2345899999999996654 8999999999999999999999995210    0000000000       


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  350 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~  350 (403)
                          .   ..................+....+..+.+|+.+||+.||.+|||+.++++|-.
T Consensus       254 ----~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          254 ----G---LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             ----T---TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ----H---HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                0   00000011111111111122334578999999999999999999999998854

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.3e-44  Score=343.17  Aligned_cols=246  Identities=24%  Similarity=0.351  Sum_probs=188.1

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|.+.+.||+|+||.||+|++.   .++..||||.+...     .....+|+.+++.++||||+++++++..     
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----  117 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----  117 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----
Confidence            3457999999999999999999986   46778999998643     2345679999999999999999998733     


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+++||||++ ++|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg  192 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNL-VCKVSDFG  192 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             CCceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCC-CEEECcCc
Confidence            334789999997 5888888653   35689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       214 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      +++........    ....+|+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+......+ 
T Consensus       193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~-  270 (373)
T 2qol_A          193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP-  270 (373)
T ss_dssp             ---------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-
T ss_pred             cccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            99865433211    1223467899999997554 8999999999999999998 999998877665554443211110 


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                                 .+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       271 ---------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 ---------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                       11346889999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.9e-43  Score=323.63  Aligned_cols=245  Identities=14%  Similarity=0.214  Sum_probs=197.7

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|++.+.||+|+||.||+|++  +|..||||++....      ....+|+.+++.++||||+++++++...   ...
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence            446899999999999999999998  48899999986432      3456799999999999999999987432   123


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCCceEEeecC
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ..++||||+++ +|.+.+....  ...+++..+..++.||+.||+|||++ |  |+||||||+||+++.++ .++|+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~-~~~l~~~~  158 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDM-TARISMAD  158 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred             CeEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCc-ceeEEecc
Confidence            46799999985 8888886532  23589999999999999999999987 9  99999999999999887 79999888


Q ss_pred             CceecccCCCcceeeecccccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ++...    ......+|+.|+|||++.+...  ++.++|||||||++|+|++|..||.+.+..+....+......+    
T Consensus       159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----  230 (271)
T 3kmu_A          159 VKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP----  230 (271)
T ss_dssp             SCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC----
T ss_pred             ceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC----
Confidence            76542    2234567999999999976432  2337999999999999999999999887766655544321111    


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                             .++..+++++.+||.+||+.||++|||++++++
T Consensus       231 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 -----------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   123457999999999999999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.6e-43  Score=328.60  Aligned_cols=260  Identities=23%  Similarity=0.363  Sum_probs=195.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEE----EccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..|++.+.||+|+||.||+|+    +..+++.||||++....     ....+|+.+++.++||||+++++++...   +.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            469999999999999999999    56789999999986432     4456899999999999999999987542   22


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+++||||+++ +|.+.+...   ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~  172 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFGL  172 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCC-CEEECcccc
Confidence            347899999985 888888654   35689999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          215 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       215 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      +........    .....+|..|+|||++.+.. ++.++|||||||++|+|++|..|+....  .   ......+.....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~--~---~~~~~~~~~~~~  246 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM--A---LFLKMIGPTHGQ  246 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH--H---HHHHHHCSCCGG
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh--h---HHhhccCCcccc
Confidence            987644332    12345688899999997654 7899999999999999999998864321  1   111111111100


Q ss_pred             H-HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          291 E-IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       291 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      . ..........         ......+..+++++.+||.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          247 MTVTRLVNTLKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GHHHHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            0 0000000000         0000123467899999999999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.7e-43  Score=326.76  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=187.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..++|++.+.||+|+||.||+|++.   ..||+|.+....      ....+|+.+++.++||||++++++. .   .  .
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~---~--~   92 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T---A--P   92 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C---S--S
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c---C--C
Confidence            3457999999999999999999863   359999885332      3456899999999999999998854 1   1  1


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..++||||+. ++|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  167 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDN-TVKIGDFGLA  167 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTT-EEEECCCC--
T ss_pred             ccEEEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCC-CEEEccceec
Confidence            2579999998 4777776432   35689999999999999999999998 999999999999999887 8999999998


Q ss_pred             eecccC---CCcceeeecccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          216 KVLVKG---EPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       216 ~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      ......   .......||+.|+|||++..  ...++.++|||||||++|+|++|..||.+....+.+.........+.. 
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  246 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-  246 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-
Confidence            754321   12234568999999999852  334788999999999999999999999987777666555543211110 


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                            ...+...+++++.+||.+||..||.+|||+.++++
T Consensus       247 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 ----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                  00122457899999999999999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=329.71  Aligned_cols=244  Identities=28%  Similarity=0.397  Sum_probs=187.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ..+|++.+.||+|+||.||+|++  .++.||||.+....  ....+|+.+++.++||||+++++++.     +.  .++|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence            45799999999999999999987  57899999986543  34568999999999999999988763     22  5789


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh---cCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN---TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |||+++ +|.+.+.... ....++...+..++.|++.||+|||+   + ||+||||||+|||++.++..+||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            999985 8888876532 12347888899999999999999998   6 9999999999999988775589999999975


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||................+..          
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------  222 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----------  222 (307)
T ss_dssp             -----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----------
T ss_pred             cccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----------
Confidence            5322  2345689999999999654 48999999999999999999999998653322111111100000          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                      ..+...++..+.+|+.+||+.||++|||++++++
T Consensus       223 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          223 ----------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ----------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                            0122457899999999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=339.76  Aligned_cols=255  Identities=13%  Similarity=0.125  Sum_probs=196.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEcc--------CCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeec-------------
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLE--------TGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------------  123 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~-------------  123 (403)
                      .+|++.+.||+|+||.||+|++..        .++.||||.+... ....+|+.+++.++||||+++             
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            479999999999999999999987        4889999998654 456789999999999999984             


Q ss_pred             --ceeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec
Q 015615          124 --KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (403)
Q Consensus       124 --~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~  201 (403)
                        ++++..    ...+.++||||+.++|.+++....  ...+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus       121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEE
T ss_pred             chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEc
Confidence              333321    234578999999879999887542  35689999999999999999999998 999999999999999


Q ss_pred             CCC-CceEEeecCCceecccCCC--------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 015615          202 PHT-HQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  272 (403)
Q Consensus       202 ~~~-~~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  272 (403)
                      .++ ..+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            765 2699999999976533221        1234789999999999765 48999999999999999999999998764


Q ss_pred             -cHHHHHHHHHHh-CCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          273 -GVDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       273 -~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                       ..+.+....... ..+.         .+.        ..   ......+++++.+||.+||..||++|||++++++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~---------~~~--------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPG---------PFV--------GP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCC---------CEE--------CT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cCHHHHHHHHHhccCChh---------hhh--------hh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence             333333332211 1100         000        00   00113578999999999999999999999999753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.7e-43  Score=334.93  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=199.5

Q ss_pred             cccceEEEeEeeeCCcEEEEEEE----EccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.+.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++||||+++++++..   .+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   97 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PG   97 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CC
Confidence            34589999999999999999999    56789999999986542    335689999999999999999987754   34


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+++||||++ ++|.+++....   ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg  172 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA-HVKIADFG  172 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCGG
T ss_pred             CceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCC-CEEEcccc
Confidence            456789999996 58888887642   4589999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       214 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      ++........    .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||........ .........+..
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~  250 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-RMMGCERDVPAL  250 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHCC----CCHH
T ss_pred             cceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhh-hhcccccccccH
Confidence            9987643332    12345788899999987654 79999999999999999999999875432110 000000000000


Q ss_pred             HHHh-ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          290 EEIK-CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       290 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .... .....             .....+..+++++.+||.+||+.||++|||+.+++++
T Consensus       251 ~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          251 SRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0000 00000             0001234678999999999999999999999999754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-43  Score=331.63  Aligned_cols=246  Identities=22%  Similarity=0.314  Sum_probs=192.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCC----cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|.+.+.||+|+||.||+|.+..++    ..||||.+...     .....+|+.+++.++||||+++++++.     +
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----c
Confidence            457999999999999999999986553    45999998643     223457999999999999999999873     3


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ....++||||+++ +|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg  192 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDFG  192 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCC-cEEECCCC
Confidence            3347899999985 888887653   35689999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          214 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       214 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      ++........    .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......+ 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~-  270 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-  270 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC-
Confidence            9986543221    11234577899999997554 8999999999999999999 999998877655554443211000 


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                                 .+..++..+.+|+.+||+.||.+||++.+++++
T Consensus       271 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          271 ---------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       123578899999999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-44  Score=354.03  Aligned_cols=253  Identities=19%  Similarity=0.196  Sum_probs=191.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCC-CCeeecce---------e
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDH-PNVVSLKH---------C  126 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h-~niv~~~~---------~  126 (403)
                      ...|...+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.+++.+.| +|...+..         .
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34699999999999999999999999999999988622       2345689999998877 32211111         0


Q ss_pred             ------------eeecCCCCceEEEEEEecccchHHHHHHhh---cccCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 015615          127 ------------FFSTTEKDELYLNLVLEYVPETVHRVIKHH---YKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR  191 (403)
Q Consensus       127 ------------~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~  191 (403)
                                  +..........++++|+++.++|.+++...   ......+++..+..++.||+.||+|||++ ||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence                        000000012236789999998888887533   22234577778888999999999999998 99999


Q ss_pred             CCCCCceEecCCCCceEEeecCCceecccCCCcceeeeccccccccccc---------CCCCCCCchhHHHHHHHHHHHH
Q 015615          192 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTAAIDIWSAGCVLAELL  262 (403)
Q Consensus       192 Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwslG~il~ell  262 (403)
                      ||||+|||++.++ .+||+|||+++.....  .....| +.|+|||++.         ....++.++|||||||++|+|+
T Consensus       236 DiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999888 6999999998765332  334567 9999999983         3334788999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCH
Q 015615          263 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  342 (403)
Q Consensus       263 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~  342 (403)
                      +|+.||.+.+..+....+                       +.          -...+|+++.+||.+||+.||++|||+
T Consensus       312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999765421110000                       00          013578999999999999999999999


Q ss_pred             HHHhcCCCCccC
Q 015615          343 LEALIHPFFDEL  354 (403)
Q Consensus       343 ~ell~hp~f~~~  354 (403)
                      .++++||||+++
T Consensus       359 ~~~l~~~~~~~~  370 (413)
T 3dzo_A          359 LQAMETPEYEQL  370 (413)
T ss_dssp             HHHTTSHHHHHH
T ss_pred             HHHHhCHHHHHH
Confidence            999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-42  Score=324.11  Aligned_cols=243  Identities=22%  Similarity=0.288  Sum_probs=195.5

Q ss_pred             ccceEEEe-EeeeCCcEEEEEEEE--ccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAER-VVGHGSFGVVFQAKC--LETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|.+.+ .||+|+||.||+|.+  ..+++.||||.+...      .....+|+.+++.++||||+++++++ ..   +
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~---~   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA---E   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES---S
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC---C
Confidence            35799998 999999999999954  566889999998643      23456799999999999999999977 21   1


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                        ..++||||+. ++|.+.+..    ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg  162 (291)
T 1xbb_A           91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFG  162 (291)
T ss_dssp             --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCC-cEEEccCC
Confidence              2679999998 588888765    35689999999999999999999998 999999999999999877 79999999


Q ss_pred             CceecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       214 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      ++.........    ....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+.... .+ 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~-  239 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RM-  239 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC-
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC-
Confidence            99876443322    1234568899999996554 7899999999999999999 999999877655444333210 00 


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                                .++..+++++.++|.+||..||.+|||+.++++
T Consensus       240 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          240 --------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      122457899999999999999999999999885

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.9e-43  Score=352.94  Aligned_cols=247  Identities=20%  Similarity=0.310  Sum_probs=201.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|.+.+.||+|+||.||+|.+..++..||||.+..+   ...+.+|+.+++.++||||+++++++..     ...++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence            345799999999999999999999988999999998654   3445689999999999999999998733     23368


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+. ++|.+++....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENH-LVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGG-CEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCC-cEEEeecccceec
Confidence            9999998 58888887532  35688999999999999999999998 999999999999999877 7999999999865


Q ss_pred             ccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .....  .....+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.....          
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------  437 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------  437 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            33221  12234567899999997554 8999999999999999999 9999998765544433322100          


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                        ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       438 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          438 ------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                              0122457899999999999999999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.3e-43  Score=327.40  Aligned_cols=244  Identities=25%  Similarity=0.352  Sum_probs=188.5

Q ss_pred             cccceEEE-eEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHH-HHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           63 QTISYMAE-RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        63 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ...+|.+. +.||+|+||.||+|.+..+|+.||||.+... ....+|+.++ +.++||||+++++++.... .+..++++
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l   92 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI   92 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEE
Confidence            44578887 7899999999999999999999999998654 4456788887 6679999999999874422 34566889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC---CCCceEEeecCCce
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAK  216 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~DfG~a~  216 (403)
                      ||||+++ +|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.   ++ .+||+|||++.
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~  168 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK  168 (299)
T ss_dssp             EECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred             EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCC-cEEEecccccc
Confidence            9999985 8888887642  34699999999999999999999998 9999999999999987   44 79999999986


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ...                      ...++.++|||||||++|+|++|..||.+...........               
T Consensus       169 ~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---------------  211 (299)
T 3m2w_A          169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------------  211 (299)
T ss_dssp             ECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---------------
T ss_pred             ccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---------------
Confidence            431                      1236889999999999999999999997654322110000               


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      ..   ...   ....+.......+++++.+||.+||+.||.+|||++++++||||++..
T Consensus       212 ~~---~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          212 TR---IRM---GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             CS---SCT---TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HH---Hhh---ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            00   000   000111111245799999999999999999999999999999998854

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-43  Score=323.76  Aligned_cols=246  Identities=25%  Similarity=0.315  Sum_probs=198.1

Q ss_pred             ccceEEEe-EeeeCCcEEEEEEEEc--cCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAER-VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|.+.+ .||+|+||.||+|.+.  .++..||||.+...     .....+|+.+++.++||||+++++++ ..   + 
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~---~-   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA---E-   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES---S-
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC---C-
Confidence            34677776 9999999999999864  46788999998653     23455799999999999999999987 21   1 


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                       ..++||||+++ +|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        83 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~  156 (287)
T 1u59_A           83 -ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGL  156 (287)
T ss_dssp             -SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -CcEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCC-CEEECcccc
Confidence             26799999985 787777532   35689999999999999999999998 999999999999999877 799999999


Q ss_pred             ceecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          215 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       215 a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +.........    ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.... .   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~---  231 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-R---  231 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-C---
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-c---
Confidence            9876433221    2234578899999996544 8999999999999999998 999999877666554443210 0   


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  349 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp  349 (403)
                                              ..++..+++++.+||.+||..||++|||+.++++|.
T Consensus       232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                                    012345799999999999999999999999999873

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=331.83  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=190.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEE----EEEEecc-----chhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAV----AIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v----aiK~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|++.+.||+|+||.||+|.+..+++.|    |+|.+..     ......+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            357999999999999999999998888765    6666532     234456899999999999999999987431    


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      .  .++|++|+. ++|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 ~--~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kL~DfG  162 (327)
T 3lzb_A           90 T--VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             S--EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             C--ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence            1  567889888 5888887654   35689999999999999999999998 999999999999999877 79999999


Q ss_pred             CceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          214 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       214 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      ++.........   ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+......   
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---  238 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---  238 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            99865433222   2334577899999997654 8999999999999999999 99999887665544333221100   


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                               ..+..++.++.+||.+||..||.+|||+.++++
T Consensus       239 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          239 -------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     012346889999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.3e-43  Score=335.62  Aligned_cols=256  Identities=19%  Similarity=0.231  Sum_probs=198.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEE-----EccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAK-----CLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  132 (403)
                      ...+|++.+.||+|+||.||+|+     +..++..||||.+...     .....+|+.+++.++||||+++++++..   
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC---
Confidence            34579999999999999999999     5567889999998532     2344579999999999999999998743   


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--Cc
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQ  206 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~  206 (403)
                        ....++||||++ ++|.+++......   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++  ..
T Consensus       105 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 --SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCC
T ss_pred             --CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcce
Confidence              233679999996 5898888765322   24588999999999999999999998 999999999999998432  26


Q ss_pred             eEEeecCCceecccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 015615          207 LKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIK  282 (403)
Q Consensus       207 vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~  282 (403)
                      +||+|||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            9999999987543322   122345688999999987654 8999999999999999998 9999988766554444332


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                      .. .+                           ..+..++..+.+||.+||..||.+|||+.++++|.|+-.
T Consensus       261 ~~-~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          261 GG-RM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-CC---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            10 00                           012457899999999999999999999999999987643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.5e-43  Score=325.52  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=194.0

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCC---cEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.+.||+|+||.||+|.+..++   ..||+|.+....     ....+|+.+++.++||||+++++++...    
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   98 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----   98 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----
Confidence            3457999999999999999999975433   468999886422     3345799999999999999999976432    


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ....++||||+++ +|.+.+...   ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg  173 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKF-TVKVADFG  173 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSCG
T ss_pred             CCceEEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCC-CEEECccc
Confidence            2236799999986 888888643   35688999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCC-----CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          214 SAKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       214 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      ++.......     ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+...... 
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-  251 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-  251 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-
Confidence            997653322     122345678899999996654 8999999999999999999 67788776655544443321100 


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                                 ..+..++..+.+++.+||..||++|||+.++++
T Consensus       252 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          252 ---------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                       012346889999999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.8e-42  Score=343.58  Aligned_cols=250  Identities=21%  Similarity=0.245  Sum_probs=197.9

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ...+|++.+.||+|+||.||+|.+..+|+.||||++...  .....+|+.+++.++|++.+..+..+..    ...+.+|
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~l   80 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVL   80 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEE
Confidence            345799999999999999999999999999999987533  3456789999999998665555444432    2335789


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe---cCCCCceEEeecCCcee
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~DfG~a~~  217 (403)
                      ||||+.++|.+++...   ...+++..++.++.||+.||.|||++ |||||||||+||||   +.++ .+||+|||+++.
T Consensus        81 vme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~  155 (483)
T 3sv0_A           81 VMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKK  155 (483)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred             EEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCC-eEEEEeCCccee
Confidence            9999988999888753   35799999999999999999999998 99999999999999   4555 799999999987


Q ss_pred             cccCCCc--------ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCC
Q 015615          218 LVKGEPN--------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGT  286 (403)
Q Consensus       218 ~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~  286 (403)
                      .......        ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+...   .+.+..+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            6543321        2567899999999997654 89999999999999999999999987543   2333333322111


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                      ....                        .+...++.++.+||.+||..||++||++.+++
T Consensus       235 ~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~  270 (483)
T 3sv0_A          235 TSIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLK  270 (483)
T ss_dssp             SCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             ccHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            1111                        11245789999999999999999999998875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.7e-43  Score=346.02  Aligned_cols=245  Identities=25%  Similarity=0.364  Sum_probs=199.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|.+.+.||+|+||.||+|.+. ++..||||.+...   .....+|+.+++.++||||+++++++.    .+  .++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~----~~--~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT----KE--PIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC----SS--SCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe----CC--ccE
Confidence            3457999999999999999999974 5778999998653   345568999999999999999998762    11  267


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+. ++|.+++....  ...++...+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTC-CEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCC-cEEEeeCCCceEc
Confidence            9999998 58888887542  23578888999999999999999998 999999999999999887 7999999999765


Q ss_pred             ccCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....  ......+|+.|+|||++.... ++.++|||||||++|||+| |+.||.+.+..+....+......+        
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------  405 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP--------  405 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--------
T ss_pred             CCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            3221  112234577899999996554 8999999999999999999 999999888776665554421111        


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                          .+..+++++.+||.+||..||++|||++++++
T Consensus       406 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          406 --------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                12357899999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-42  Score=321.57  Aligned_cols=249  Identities=21%  Similarity=0.315  Sum_probs=194.7

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCc---EEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      .....|.+.+.||+|+||.||+|.+..++.   .||+|.+....     ....+|+.+++.++||||+++++++....  
T Consensus        18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--   95 (298)
T 3pls_A           18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE--   95 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS--
T ss_pred             ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC--
Confidence            344578999999999999999999765544   79999986432     33457999999999999999999874322  


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                        ...++||||+. ++|.+.+...   ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus        96 --~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~-~~kl~Df  168 (298)
T 3pls_A           96 --GLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESF-TVKVADF  168 (298)
T ss_dssp             --SCCEEEECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECCT
T ss_pred             --CCcEEEEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEeCcC
Confidence              22468999986 5888887653   36689999999999999999999998 999999999999999887 7999999


Q ss_pred             CCceecccC-----CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCC
Q 015615          213 GSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGT  286 (403)
Q Consensus       213 G~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~  286 (403)
                      |++......     .......+|+.|+|||.+.+. .++.++|||||||++|+|++| .+||...+..+....+......
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  247 (298)
T 3pls_A          169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL  247 (298)
T ss_dssp             TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC
T ss_pred             CCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC
Confidence            999754322     122334678899999999654 489999999999999999995 5556555544433333221100


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                                  ..+..++..+.+|+.+||..||.+|||+.++++.
T Consensus       248 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          248 ----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                        0123578899999999999999999999999853

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.4e-43  Score=323.18  Aligned_cols=245  Identities=21%  Similarity=0.311  Sum_probs=192.0

Q ss_pred             ccccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch--hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           62 KQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        62 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ....+|++.+.||+|+||.||+|.+  +|+.||||.+....  ....+|+.+++.++||||+++++++...    ...++
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~   91 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY   91 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceE
Confidence            3456899999999999999999987  58899999986543  4456899999999999999999876432    22367


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+++ +|.+.+....  ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~  167 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  167 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC----
T ss_pred             EEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCC-cEEEeeccccccc
Confidence            99999985 8888887542  12378888999999999999999998 999999999999999877 7999999998754


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+....             
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------  231 (278)
T 1byg_A          168 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------  231 (278)
T ss_dssp             ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-------------
T ss_pred             ccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------
Confidence            332  2234678899999999654 48999999999999999998 999998776544433322110             


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                     ....+..+++.+.++|++||..||.+|||+.++++
T Consensus       232 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 ---------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                           00122457899999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-42  Score=343.77  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=197.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|++.+.||+|+||.||+|.+.. +..||||.+...   .....+|+.+++.++||||+++++++..      ..++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            34579999999999999999999854 567999998653   2456789999999999999999987632      1267


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+. ++|.+++....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCC-CEEECCCccceec
Confidence            9999998 48888886432  24588999999999999999999998 999999999999999877 7999999999865


Q ss_pred             ccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .....  .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+....+....+......         
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  400 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------  400 (452)
T ss_dssp             ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             CCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            43221  1233457889999999755 48999999999999999999 99999988776655554331110         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc--CCCCcc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDE  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~--hp~f~~  353 (403)
                                         ..+..+++.+.+||.+||..||++|||++++++  ..++..
T Consensus       401 -------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          401 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                               012457899999999999999999999999986  345444

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-44  Score=367.48  Aligned_cols=283  Identities=25%  Similarity=0.337  Sum_probs=205.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  138 (403)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...     .....+|+.+++.++||||+++++++..... ......
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            5799999999999999999999999999999987543     2345579999999999999999887633111 123446


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC--ceEEeecCCc
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSA  215 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~DfG~a  215 (403)
                      ++|||||+ ++|.+++.... ....+++..++.++.|++.||+|||+. ||+||||||+||+++.++.  .+||+|||++
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            79999997 58888776532 234588889999999999999999998 9999999999999987652  3899999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...........   ...........
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i---~~~~~~~~~~~  247 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---REKSNEHIVVY  247 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC---C------CCSC
T ss_pred             cccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh---hcccchhhhhh
Confidence            877665555567889999999999654 48999999999999999999999998754332211000   00000000000


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      ........+..  ..+....+...+++.+.+||.+||.+||++|||+.++++||||+.+.
T Consensus       248 ~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          248 DDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            00000011111  11111223345678999999999999999999999999999998754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2e-42  Score=319.89  Aligned_cols=245  Identities=22%  Similarity=0.302  Sum_probs=197.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|++.+.||+|+||.||+|.+. ++..||||.+...   .....+|+.+++.++||||+++++++..    +  ..+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~--~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC----C--CcE
Confidence            3467999999999999999999974 5778999998653   3455689999999999999999987621    1  157


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||+. ++|.+.+....  ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLI  159 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence            9999997 58887775432  23688999999999999999999998 999999999999999877 7999999999876


Q ss_pred             ccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .....  .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....          
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------  228 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------  228 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             cCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----------
Confidence            43321  12334677899999996544 8999999999999999999 9999998776655544432100          


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                        ...+..++.++.+|+.+||..||++|||++++++
T Consensus       229 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                              0112457899999999999999999999999886

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-43  Score=337.74  Aligned_cols=248  Identities=20%  Similarity=0.310  Sum_probs=188.1

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ....|.+.+.||+|+||.||+|.+..++   ..||+|.+...     .....+|+.+++.++||||+++++++....   
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~---  163 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---  163 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS---
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC---
Confidence            3457999999999999999999976433   46899987532     234557999999999999999999764322   


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                       ...++||||+.+ +|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       164 -~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DFG  237 (373)
T 3c1x_A          164 -GSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFG  237 (373)
T ss_dssp             -SCCEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             -CCeEEEEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCC-CEEEeecc
Confidence             236799999985 888888643   35688899999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCC-----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          214 SAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       214 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      +++.......     .....+|+.|+|||++.+.. ++.++|||||||++|+|+| |.+||.+.+..+....+.....  
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~--  314 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--  314 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--
Confidence            9976533221     12345678899999997654 8999999999999999999 7888987665444433322100  


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                                ...+..++..+.+++.+||..||++|||+.+++++
T Consensus       315 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      00123578999999999999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5e-43  Score=328.46  Aligned_cols=254  Identities=24%  Similarity=0.298  Sum_probs=193.7

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      |...+.||+|+||.||+|.+  ++..||||++...        .....+|+.+++.++||||+++++++..     ....
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~  105 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDL  105 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCce
Confidence            55668999999999999986  6889999998532        2345689999999999999999998733     2336


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++||||++ ++|.+.+.... ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~  182 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAF-TAKISDFGLARA  182 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence            89999997 58888776532 345689999999999999999999998 999999999999999877 799999999986


Q ss_pred             cccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC--CCHHHH
Q 015615          218 LVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEI  292 (403)
Q Consensus       218 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--~~~~~~  292 (403)
                      ......   .....||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+......+..+......  +....+
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence            543322   123468999999999854  3789999999999999999999999876543333333221111  111110


Q ss_pred             hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                        ....        .      .......+..+.+++.+||..||.+|||+.+++++
T Consensus       261 --~~~~--------~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          261 --IDKK--------M------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             --SCSS--------C------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --cccc--------c------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              0000        0      00112345679999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.6e-43  Score=332.30  Aligned_cols=278  Identities=20%  Similarity=0.285  Sum_probs=192.4

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh-hhHH--HHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR-YKNR--ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~--E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|++.+.||+|+||.||+|++  +++.||||++..... ....  |+..+..++||||+++++.+......+...++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            446899999999999999999986  789999999864432 2223  34444558999999998876655556666788


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CccccCCCCCceEecCCCCceEEe
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--------GVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--------~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                      +||||++ ++|.+++..     ...++..+..++.||+.||+|||+..        ||+||||||+|||++.++ .+||+
T Consensus        89 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~  162 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVIS  162 (336)
T ss_dssp             EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEEC
T ss_pred             EEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEe
Confidence            9999997 588888864     34588889999999999999999632        999999999999999887 79999


Q ss_pred             ecCCceecccCC---------CcceeeecccccccccccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCC-CCcH
Q 015615          211 DFGSAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGV  274 (403)
Q Consensus       211 DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~elltg~~pf~~-~~~~  274 (403)
                      |||++.......         ......||+.|+|||++.+.      ..++.++|||||||++|||++|..||.. ....
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998654321         11234689999999998652      2356789999999999999999765533 2211


Q ss_pred             HHHHHHH-HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc------
Q 015615          275 DQLVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI------  347 (403)
Q Consensus       275 ~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~------  347 (403)
                      +....+. .....+....+......  ....+..+. .+.  .....++++.+||.+||+.||++|||+.++++      
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSR--EKQRPKFPE-AWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTT--SCCCCCCCT-TCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcc--cccCCCCCc-ccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            1100111 11122222221110000  000000000 000  01123557999999999999999999999954      


Q ss_pred             CCCCcc
Q 015615          348 HPFFDE  353 (403)
Q Consensus       348 hp~f~~  353 (403)
                      ++|-+.
T Consensus       318 ~~~~~~  323 (336)
T 3g2f_A          318 MIWERN  323 (336)
T ss_dssp             HCCCC-
T ss_pred             HHHHhc
Confidence            666554

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.6e-42  Score=322.39  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=191.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc-CCc--EEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE-TGE--AVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ..+|++.+.||+|+||.||+|.+.. ++.  .||||.+...       .....+|+.+++.++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            3579999999999999999998643 333  6899987532       23445899999999999999999987431   


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeec
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                       .  .++||||+. ++|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        94 -~--~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Df  165 (291)
T 1u46_A           94 -P--MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDF  165 (291)
T ss_dssp             -S--CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -C--ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCC-CEEEccc
Confidence             1  578999998 5888888764   24588999999999999999999998 999999999999999877 7999999


Q ss_pred             CCceecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          213 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       213 G~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      |++.........    ....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+..+....+......+
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL  244 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence            999876443321    2335677899999996554 7899999999999999999 999999887666555443311000


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                                 .....++.++.++|.+||..||.+|||+.+++++  +++.
T Consensus       245 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~--l~~~  282 (291)
T 1u46_A          245 ---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF--LLEA  282 (291)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             ---------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH--HHHh
Confidence                                       0123578999999999999999999999999963  4443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-42  Score=325.68  Aligned_cols=254  Identities=20%  Similarity=0.304  Sum_probs=186.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-hhhHHHHHHHHH--cCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..+|++.+.||+|+||.||+|++  +|+.||||++.... ....+|.+++..  ++||||+++++++.... .....+++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l  112 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYL  112 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEE
Confidence            35799999999999999999997  48999999985443 223345555554  48999999999875432 22256789


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CccccCCCCCceEecCCCCceEEeec
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-------~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      ||||+.+ +|.+.+..     ..+++..+..++.|++.||.|||++.       ||+||||||+|||++.++ .+||+||
T Consensus       113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            9999985 88888854     46899999999999999999999632       899999999999999887 7999999


Q ss_pred             CCceecccCCCc-----ceeeecccccccccccCCCCCCC------chhHHHHHHHHHHHHhC----------CCCCCCC
Q 015615          213 GSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTA------AIDIWSAGCVLAELLLG----------QPLFPGE  271 (403)
Q Consensus       213 G~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~------~~DiwslG~il~elltg----------~~pf~~~  271 (403)
                      |++.........     ....||+.|+|||++.+.. .+.      ++|||||||++|||+||          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999765433222     2457899999999996554 344      39999999999999999          6676543


Q ss_pred             Cc----HHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          272 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       272 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ..    ............         ..+.+     +       .......+++++.+|+.+||+.||++|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~---------~~~~~-----~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKK---------LRPSF-----P-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSC---------CCCCC-----C-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCchhhhHHHHhhhc---------cCccc-----c-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            21    111111111000         00000     0       00011235678999999999999999999999997


Q ss_pred             C
Q 015615          348 H  348 (403)
Q Consensus       348 h  348 (403)
                      |
T Consensus       325 ~  325 (337)
T 3mdy_A          325 T  325 (337)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=331.76  Aligned_cols=244  Identities=16%  Similarity=0.171  Sum_probs=189.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEE-----EEccCCcEEEEEEeccc-hhhhHHHHHHHHHcC---CCCeeecceeeeecCCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQA-----KCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~-----~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~  134 (403)
                      ..+|.+.+.||+|+||.||+|     .+..+++.||||++... .....+|+.+++.+.   |+||+++++++...    
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~----  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ----  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS----
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC----
Confidence            357999999999999999999     46778999999998654 344567888888887   99999999887432    


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC----------
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP----------  202 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~----------  202 (403)
                       ...++|||||+ ++|.+.+..... ....+++..+..++.||+.||+|||++ |||||||||+|||++.          
T Consensus       140 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          140 -NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             -SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC-----
T ss_pred             -CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCcccccc
Confidence             23689999998 588888876443 246699999999999999999999997 9999999999999987          


Q ss_pred             -CCCceEEeecCCceeccc---CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015615          203 -HTHQLKLCDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  278 (403)
Q Consensus       203 -~~~~vkl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  278 (403)
                       ++ .+||+|||+|+....   ........||+.|+|||++.+.. ++.++|||||||++|||+||+.||.......   
T Consensus       218 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          218 LSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             -CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence             55 799999999976532   22233457899999999997655 8999999999999999999999996432100   


Q ss_pred             HHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       279 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                             ......    + ..  ...+..+.+++.+||..+|.+|++..+.+.+
T Consensus       293 -----------------------~~~~~~----~-~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 -----------------------CKPEGL----F-RR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             -----------------------EEECSC----C-TT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             -----------------------eeechh----c-cc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence                                   000000    0 00  0235678999999999999999765555543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.8e-42  Score=325.41  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=191.5

Q ss_pred             eEEEeEeeeCCcEEEEEEEE----ccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           67 YMAERVVGHGSFGVVFQAKC----LETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      |++.+.||+|+||.||+|..    ..+|+.||||++....     ....+|+.+++.++||||+++++++...   +...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence            59999999999999988753    4578999999986542     3456899999999999999999987542   2345


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +++||||+++ +|.+.+..     ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDR-LVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCC-CEEECCccccc
Confidence            7899999985 88777653     3589999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH-
Q 015615          217 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE-  291 (403)
Q Consensus       217 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~-  291 (403)
                      .......    .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.......     ....+...... 
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~  256 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQMT  256 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccchh
Confidence            7654432    22345688899999997654 7899999999999999999999997532110     00001110000 


Q ss_pred             ---HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          292 ---IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       292 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                         +......            ......+..++.++.+||++||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          257 VLRLTELLER------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhc------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               0000000            0000123457899999999999999999999999984

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.4e-42  Score=346.15  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=201.0

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++...   ...+.+|+.+|+.++||||+++++++..      ..++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            34579999999999999999999854 567999998653   2456789999999999999999987632      1267


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      |||||+.+ +|.+++....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence            99999984 8888886432  24588999999999999999999998 999999999999999877 7999999999765


Q ss_pred             ccCC--CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....  ......++..|+|||++.+. .++.++|||||||++|||++ |+.||.+....+.+..+......         
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  483 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------  483 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            3211  11223457789999998755 48999999999999999999 99999988776655554331100         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC--CCCcc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH--PFFDE  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h--p~f~~  353 (403)
                                         ..+..++.++.+||.+||..||++|||++++++.  .+|..
T Consensus       484 -------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          484 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                               0124578999999999999999999999999863  44443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-41  Score=348.91  Aligned_cols=240  Identities=21%  Similarity=0.298  Sum_probs=191.4

Q ss_pred             eEE-EeEeeeCCcEEEEEEEE--ccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           67 YMA-ERVVGHGSFGVVFQAKC--LETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        67 y~~-~~~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      +.+ .+.||+|+||.||+|.+  ..+++.||||++....      ....+|+.+++.++||||+++++++..    +.  
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~--  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----ES--  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES----SS--
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----CC--
Confidence            444 35899999999999955  4567899999986432      345689999999999999999997621    11  


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .++|||||. ++|.+++..    ...+++..+..++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+++
T Consensus       444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~-~~kL~DFGla~  517 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSK  517 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred             EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence            579999998 478888764    35689999999999999999999998 999999999999999887 79999999998


Q ss_pred             ecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......    .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+......     
T Consensus       518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-----  591 (635)
T 4fl3_A          518 ALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----  591 (635)
T ss_dssp             HTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred             ccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            6543322    12234578899999996544 8999999999999999998 99999988776655554432100     


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                             ..+..+++++.+||.+||..||++|||++++++
T Consensus       592 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 -----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                   122457899999999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=323.44  Aligned_cols=258  Identities=25%  Similarity=0.421  Sum_probs=195.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEE----EccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAK----CLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.+.||+|+||.||+|+    +..+|+.||||++....    ....+|+.+++.++||||+++++++...   +
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---C
Confidence            34579999999999999999998    45689999999986532    3456899999999999999999877432   2


Q ss_pred             ceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+++||||+++ +|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kL~Dfg  190 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDFG  190 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             CCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCC-cEEEecCc
Confidence            2246799999985 888888754   35689999999999999999999998 999999999999999877 79999999


Q ss_pred             CceecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       214 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      ++.........    ....++..|+|||++.+.. ++.++|||||||++|+|+||..||....  ..+.   ...+....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~--~~~~---~~~~~~~~  264 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP--AEFM---RMIGNDKQ  264 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH--HHHH---HHHCTTCC
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH--HHHH---Hhhccccc
Confidence            99876443321    2234677899999997654 7899999999999999999999886421  1111   11111110


Q ss_pred             HH-----H-hccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          290 EE-----I-KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       290 ~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ..     + ......   ..          ...+..++.++.+||.+||..||++|||+.++++
T Consensus       265 ~~~~~~~~~~~~~~~---~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          265 GQMIVFHLIELLKNN---GR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             THHHHHHHHHHHHTT---CC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhhHHHHHHHhhcC---CC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00     0 000000   00          0012457899999999999999999999999985

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.2e-44  Score=339.23  Aligned_cols=247  Identities=17%  Similarity=0.176  Sum_probs=183.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------hhhHHHHHHHHHcC---------CCCeeec
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLD---------HPNVVSL  123 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~---------h~niv~~  123 (403)
                      .+|++.+.||+|+||.||+|++  +|+.||||++....            ....+|+.+++.++         ||||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999998  78999999986542            45568999999886         6666555


Q ss_pred             ceeeeecC-------------------------CCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHH
Q 015615          124 KHCFFSTT-------------------------EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR  177 (403)
Q Consensus       124 ~~~~~~~~-------------------------~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~  177 (403)
                      .+++....                         ..+...+|+|||||.+ ++.+.+.     ...+++..++.++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence            54432110                         0013458899999975 4444442     256899999999999999


Q ss_pred             HHHHHH-hcCCccccCCCCCceEecCCC-------------------CceEEeecCCceecccCCCcceeeecccccccc
Q 015615          178 ALAYIH-NTIGVCHRDIKPQNLLVNPHT-------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPE  237 (403)
Q Consensus       178 ~L~~LH-~~~~ivH~Dlkp~NIll~~~~-------------------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE  237 (403)
                      ||+||| ++ ||+||||||+|||++.++                   ..+||+|||+|+.....    ...||+.|+|||
T Consensus       173 aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE  247 (336)
T 2vuw_A          173 SLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred             HHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence            999999 88 999999999999998764                   26999999999876432    458999999999


Q ss_pred             cccCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccc
Q 015615          238 LIFGATEYTAAIDIWSAGCV-LAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  315 (403)
Q Consensus       238 ~~~~~~~~~~~~DiwslG~i-l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (403)
                      ++.+..  +.++||||++++ .+++++|..||.+..... ....+.......                  .   .. ...
T Consensus       248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~---~~-~~~  303 (336)
T 2vuw_A          248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK------------------T---KC-NTP  303 (336)
T ss_dssp             GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS------------------S---CC-CSH
T ss_pred             hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC------------------c---cc-chh
Confidence            997543  889999998777 778889999985421111 111111110000                  0   00 001


Q ss_pred             cccCCChHHHHHHHHhhccCCCCCCCHHHHh-cCCCCc
Q 015615          316 FQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-IHPFFD  352 (403)
Q Consensus       316 ~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell-~hp~f~  352 (403)
                      ..+.+|+++.+||++||++|     |++|+| +||||+
T Consensus       304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            12346889999999999987     999999 999995

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=346.96  Aligned_cols=242  Identities=25%  Similarity=0.322  Sum_probs=192.3

Q ss_pred             ceEEEe-EeeeCCcEEEEEEEEc--cCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           66 SYMAER-VVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        66 ~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ++.+.+ .||+|+||.||+|.+.  .++..||||++...     .....+|+.+++.++||||+++++++..    +  .
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~--~  409 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----E--A  409 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----S--S
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----C--C
Confidence            455555 8999999999999875  35667999998642     2445689999999999999999998732    1  2


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +++|||||.+ +|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~-~vkL~DFGla~  484 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRH-YAKISDFGLSK  484 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCSTTT
T ss_pred             eEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCC-cEEEeeccCcc
Confidence            7899999985 787777542   45689999999999999999999998 999999999999999877 79999999998


Q ss_pred             ecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ........    ....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.....      
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------  557 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------  557 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC------
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            65332221    122346789999999654 48999999999999999998 9999999887766655443110      


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                            ..++..+++++.+||.+||..||++|||+.++++
T Consensus       558 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          558 ----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                  0122457899999999999999999999999853

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.9e-41  Score=320.32  Aligned_cols=253  Identities=20%  Similarity=0.238  Sum_probs=192.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-hhhHHHHHHHHH--cCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|.+.+.||+|+||.||+|.+  +|+.||||.+.... ....+|.++++.  ++||||+++++++.... .....+++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence            4799999999999999999997  68999999986543 344578888888  78999999999875432 122357899


Q ss_pred             Eecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCccccCCCCCceEecCCCCceEEeec
Q 015615          142 LEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------NTIGVCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       142 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH--------~~~~ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      |||+++ +|.+.+..     ..+++..+..++.|++.||.|||        +. ||+||||||+|||++.++ .+||+||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~-~~kL~Df  191 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNG-TCCIADL  191 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTS-CEEECCC
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCC-CEEEEEC
Confidence            999996 88888864     46899999999999999999999        76 999999999999999887 7999999


Q ss_pred             CCceecccCCC-----cceeeecccccccccccCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 015615          213 GSAKVLVKGEP-----NISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLG----------QPLFPGES  272 (403)
Q Consensus       213 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~elltg----------~~pf~~~~  272 (403)
                      |++........     .....||+.|+|||++.+...     ++.++|||||||++|+|+||          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99987654432     234578999999999965432     23689999999999999999          77886642


Q ss_pred             c----HHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          273 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       273 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .    .+.+.........         .+        ..+    ........+..+.+|+.+||+.||++|||+.++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~~---------~~--------~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKL---------RP--------NIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCC---------CC--------CCC----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHh---------CC--------CCc----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            1    1222211110000         00        000    000112245679999999999999999999999976

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.2e-42  Score=321.82  Aligned_cols=250  Identities=19%  Similarity=0.262  Sum_probs=193.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ...+|++.+.||+|+||.||+|.+..   .||+|.+...      .....+|+.+++.++||||+++++++...     .
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~  102 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----P  102 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----S
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----C
Confidence            34579999999999999999999743   4999988532      23345799999999999999999987432     2


Q ss_pred             EEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+++||||+. ++|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++ ++ .+||+|||++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~  176 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NG-KVVITDFGLF  176 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC----CCEECCCSCC
T ss_pred             ceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CC-CEEEeecCCc
Confidence            3789999998 5777776542   34688999999999999999999998 999999999999998 45 7999999997


Q ss_pred             eeccc------CCCcceeeecccccccccccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 015615          216 KVLVK------GEPNISYICSRYYRAPELIFG--------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  281 (403)
Q Consensus       216 ~~~~~------~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  281 (403)
                      .....      ........||+.|+|||++.+        ...++.++|||||||++|+|++|..||.+.........+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            65421      112233468999999999864        2347889999999999999999999998877655554433


Q ss_pred             HHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          282 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      .... +          .                .....++.++.+++.+||..||.+|||+.++++.  ++.+.
T Consensus       257 ~~~~-~----------~----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~l~  301 (319)
T 2y4i_B          257 TGMK-P----------N----------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLP  301 (319)
T ss_dssp             TTCC-C----------C----------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH--HTTC-
T ss_pred             cCCC-C----------C----------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH--HHHHH
Confidence            2100 0          0                0112478899999999999999999999999964  44443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.6e-41  Score=343.38  Aligned_cols=246  Identities=27%  Similarity=0.376  Sum_probs=197.6

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccC---CcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.+.||+|+||.||+|.+..+   +..||||.+....     ....+|+.+++.++||||+++++++.    .+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----~~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----EN  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence            446799999999999999999998643   4679999875432     34557999999999999999998762    11


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                        .+++||||++ ++|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       464 --~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~-~vkL~DFG  536 (656)
T 2j0j_A          464 --PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDFG  536 (656)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             --ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCC-CEEEEecC
Confidence              2579999998 5888887653   34688999999999999999999998 999999999999999887 79999999


Q ss_pred             CceecccCCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          214 SAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       214 ~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      +++........  ....+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+......    
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----  611 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----  611 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence            99865433221  233457889999999755 48999999999999999997 99999988777666655442110    


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                              .++..+++.+.+||.+||..||.+|||+.++++.
T Consensus       612 ------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          612 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                    0224578999999999999999999999999853

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-41  Score=352.13  Aligned_cols=242  Identities=25%  Similarity=0.352  Sum_probs=194.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc-CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE-TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .++|++.+.||+|+||.||+|.+.. +|+.||||.+....     ....+|+.+++.++||||+++++++......+..+
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999999976 78999999885321     23457999999999999999999887655545556


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      .||||||+++ +|.+.+.      ..+++..+..++.||+.||.|||++ |||||||||+|||++.+  .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC--cEEEEecccch
Confidence            7899999985 6655432      3689999999999999999999998 99999999999999864  69999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+....          +.+.        
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~--------  286 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE--------  286 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT--------
T ss_pred             hcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------cccc--------
Confidence            75433   456789999999998653  488999999999999999999988652110          0000        


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                   .    ......++.+.+||.+||+.||++||+..+.+.|+|+.-+
T Consensus       287 -------------~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          287 -------------D----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------------T----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------------c----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                         0    0001246789999999999999999999999999988643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-39  Score=301.00  Aligned_cols=221  Identities=15%  Similarity=0.064  Sum_probs=173.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.++..++||||+++++++..     ..
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RA  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CC
Confidence            357999999999999999999999999999999986432       345679999999999999999998743     33


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ..|+||||+++ +|.+++..     + .....+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+++|  
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g-~~kl~~~~--  174 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDG-DVVLAYPA--  174 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTS-CEEECSCC--
T ss_pred             cEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCC-CEEEEecc--
Confidence            47899999985 78777642     2 34556888999999999999998 999999999999999887 79988543  


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                                       |++|        ++.++|||||||++|+|+||+.||.+.+..+.+...               
T Consensus       175 -----------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------------  214 (286)
T 3uqc_A          175 -----------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------------  214 (286)
T ss_dssp             -----------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------------
T ss_pred             -----------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------------
Confidence                             3332        688999999999999999999999876432110000               


Q ss_pred             CcCcccccCCCcc-CCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          296 NPNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       296 ~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                              ..... ..+....+...+++++.+||.+||+.||++| |+.++++.
T Consensus       215 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          215 --------ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             --------CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             --------HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence                    00000 0011112335689999999999999999999 99999864

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.2e-33  Score=281.68  Aligned_cols=178  Identities=17%  Similarity=0.092  Sum_probs=124.2

Q ss_pred             EeeeCCcEEEEEEEEccCCcEEEEEEeccc--------------hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCCce
Q 015615           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQD--------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+.|++|.+..++....|+.||+|.+..+              .+.+.+|+++|+++ .|+||+++++++     ++..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            467788888888887788999999998543              13356799999999 699999999987     4555


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|||||||+| +|.+.+...    +++++.   .|+.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCC-CEEEeecccC
Confidence            68999999996 888888753    556654   5789999999999998 999999999999999888 7999999999


Q ss_pred             eecccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 015615          216 KVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  265 (403)
Q Consensus       216 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~  265 (403)
                      +..... ....+.+||+.|||||++.+  .+..++|+||+|+++++|.++.
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence            866433 23446789999999999965  3678899999999988876654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=8.2e-28  Score=241.67  Aligned_cols=179  Identities=17%  Similarity=0.242  Sum_probs=133.4

Q ss_pred             EEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           68 MAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        68 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ...+.||+|+||.||+|.  ..+..+++|+.....            ....+|+++++.++||||+++..++...   +.
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~---~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL---DN  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET---TT
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC---Cc
Confidence            446689999999999995  467889999863321            2246899999999999999654444322   22


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                        .||||||++ ++|.+.+..            +..++.|++.||.|||++ ||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC---eEEEEECcc
Confidence              479999998 688777653            457899999999999998 9999999999999996   699999999


Q ss_pred             ceecccCCC--------cceeeecccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 015615          215 AKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFP  269 (403)
Q Consensus       215 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~  269 (403)
                      |+.......        .....||+.|||||++... ..|+..+|+||..+-..+.+.++.+|.
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            987644322        1256789999999998541 237788999999998888888776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=6.5e-25  Score=202.79  Aligned_cols=138  Identities=16%  Similarity=0.201  Sum_probs=109.4

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----------------------hhhhHHHHHHHHHcCCCCeeecc
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------------------KRYKNRELQTMRLLDHPNVVSLK  124 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------------------~~~~~~E~~~l~~l~h~niv~~~  124 (403)
                      |.+.+.||+|+||.||+|.+ .+|+.||||.+...                      .....+|+.+++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            55669999999999999999 88999999998532                      123568999999999  5 6666


Q ss_pred             eeeeecCCCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC
Q 015615          125 HCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH  203 (403)
Q Consensus       125 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~  203 (403)
                      +++ ..     ...|+||||++| +|.+ +.          ......++.|++.||.|||++ ||+||||||+|||++ +
T Consensus       168 ~~~-~~-----~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          168 KVY-AW-----EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CEE-EE-----ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-T
T ss_pred             eEE-ec-----cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-C
Confidence            654 21     225799999986 6654 21          112457899999999999987 999999999999999 6


Q ss_pred             CCceEEeecCCceecccCCCcceeeeccccccccccc
Q 015615          204 THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF  240 (403)
Q Consensus       204 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~  240 (403)
                      + .+||+|||+|+.            +..++|||.+.
T Consensus       229 ~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          229 E-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             T-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             C-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            6 799999999863            34578999873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.7e-21  Score=177.65  Aligned_cols=135  Identities=17%  Similarity=0.247  Sum_probs=102.6

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcE--EEEEEeccch----------------------------hhhHHHHHHHHHc
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQDK----------------------------RYKNRELQTMRLL  115 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~~~l~~l  115 (403)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            488999999999999999998788999  9999864321                            1356799999999


Q ss_pred             CCCCeeecceeeeecCCCCceEEEEEEecccc------hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHH-hcCCc
Q 015615          116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE------TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGV  188 (403)
Q Consensus       116 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~~i  188 (403)
                      .|+++.... .+.. .     ..+|||||+++      .|.+....       .++..+..++.|++.||.||| +. ||
T Consensus       128 ~~~~i~~p~-~~~~-~-----~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~-gi  192 (258)
T 1zth_A          128 KEAGVSVPQ-PYTY-M-----KNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA-EL  192 (258)
T ss_dssp             HHTTCCCCC-EEEE-E-----TTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS-CE
T ss_pred             HhCCCCCCe-EEEc-C-----CCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC-CE
Confidence            887642221 1111 1     14689999953      45443221       123457789999999999999 87 99


Q ss_pred             cccCCCCCceEecCCCCceEEeecCCceec
Q 015615          189 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       189 vH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +||||||+|||++.   .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999986   5999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=2e-18  Score=164.06  Aligned_cols=133  Identities=14%  Similarity=0.179  Sum_probs=91.1

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh------------------h--------hHHHHHHHHHcCCCC
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR------------------Y--------KNRELQTMRLLDHPN  119 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------------~--------~~~E~~~l~~l~h~n  119 (403)
                      -|.+.+.||.|+||.||+|.+ .+|+.||||+++....                  .        ..+|...|.++.+..
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            399999999999999999997 4799999998742110                  0        123455555553333


Q ss_pred             eeecceeeeecCCCCceEEEEEEecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCce
Q 015615          120 VVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL  198 (403)
Q Consensus       120 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NI  198 (403)
                      +.. ...+ ... .    .+|||||++|. +.++        ...  .....++.||+.+|.+||+. |||||||||.||
T Consensus       175 v~v-p~p~-~~~-~----~~LVME~i~G~~L~~l--------~~~--~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NI  236 (397)
T 4gyi_A          175 FPV-PEPI-AQS-R----HTIVMSLVDALPMRQV--------SSV--PDPASLYADLIALILRLAKH-GLIHGDFNEFNI  236 (397)
T ss_dssp             CSC-CCEE-EEE-T----TEEEEECCSCEEGGGC--------CCC--SCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSE
T ss_pred             CCC-Ceee-ecc-C----ceEEEEecCCccHhhh--------ccc--HHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHE
Confidence            211 1111 000 1    25899999973 3211        111  23456789999999999987 999999999999


Q ss_pred             EecCCCC---------ceEEeecCCcee
Q 015615          199 LVNPHTH---------QLKLCDFGSAKV  217 (403)
Q Consensus       199 ll~~~~~---------~vkl~DfG~a~~  217 (403)
                      |++.++.         .+.|+||+-+..
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EEeCCCCcccccccccceEEEEeCCccc
Confidence            9986541         288999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=5.3e-12  Score=114.64  Aligned_cols=134  Identities=15%  Similarity=0.114  Sum_probs=99.0

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEecc----chhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ----DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .|++...++.|+.+.||++..  .|..+++|....    ......+|+.+++.+. +..+.++++++.     +....|+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence            588888999999999999974  468899998853    3345778999999985 556667766542     2234679


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT----------------------------------  185 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~----------------------------------  185 (403)
                      ||||++| ++.+.+.         +......++.+++.+|+.||+.                                  
T Consensus        88 v~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999998 4443310         1112346778999999999970                                  


Q ss_pred             ------------------------CCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          186 ------------------------IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       186 ------------------------~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                                              ..++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                    2589999999999998543 56799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=1.2e-10  Score=105.18  Aligned_cols=133  Identities=16%  Similarity=0.065  Sum_probs=88.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-hhhhHHHHHHHHHcCCCC--eeecceeeeecCCCCceEEEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      .|.+....+.|..+.||++.. .+|..+++|..... .....+|+.+++.+.+.+  +.+++.+...     ....++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEE
Confidence            356554445666799999964 56778999987543 244578999999986544  3445554321     12367899


Q ss_pred             ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 015615          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI------------------------------------  186 (403)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~------------------------------------  186 (403)
                      ||++|.... .       ....   ...++.+++..|+.||+..                                    
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999973212 1       0111   1245667777777777531                                    


Q ss_pred             ---------------------CccccCCCCCceEecCCCCceEEeecCCce
Q 015615          187 ---------------------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       187 ---------------------~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                                           .++|+|++|.||+++.++ .+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                 299999999999998654 56799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=2.1e-10  Score=109.11  Aligned_cols=139  Identities=16%  Similarity=0.186  Sum_probs=97.2

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEec--cc-----hhhhHHHHHHHHHcCC--CCeeecceeeeecCCCCceEEEE
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVL--QD-----KRYKNRELQTMRLLDH--PNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~--~~-----~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+.|+.|.++.||++..  .+..+++|+..  ..     .....+|..+++.+..  ..+.+++..+...  ......++
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeEE
Confidence            56789999999999885  35678899775  22     3456789999999974  4456665544221  11123568


Q ss_pred             EEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 015615          141 VLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-----------------------------------  185 (403)
Q Consensus       141 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-----------------------------------  185 (403)
                      ||||++|....   .  .....++......++.+++..|+.||+.                                   
T Consensus       119 vme~v~G~~l~---~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          119 IMEFVSGRVLW---D--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EEECCCCBCCC---C--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEEecCCeecC---C--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            99999974210   0  0123466777888899999999999961                                   


Q ss_pred             ----------------------CCccccCCCCCceEecCCCC-ceEEeecCCcee
Q 015615          186 ----------------------IGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  217 (403)
Q Consensus       186 ----------------------~~ivH~Dlkp~NIll~~~~~-~vkl~DfG~a~~  217 (403)
                                            ..++|+|++|.|||++.++. .+.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  36999999999999987653 368999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=2.2e-10  Score=106.40  Aligned_cols=184  Identities=12%  Similarity=0.165  Sum_probs=111.1

Q ss_pred             eEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeec-CCCCceEEEEEEecccc
Q 015615           71 RVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFST-TEKDELYLNLVLEYVPE  147 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~~~~lv~e~~~~  147 (403)
                      +.++.|..+.||++.     ..+++|+....  .....+|..+++.+.+..-+.+-..+... ........|+||++++|
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458999999999863     46899986543  34567899999888432212222222111 11111234689999997


Q ss_pred             -hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 015615          148 -TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-----------------------------------------  185 (403)
Q Consensus       148 -~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-----------------------------------------  185 (403)
                       .+.....      ..++......++.|++..|+.||+.                                         
T Consensus       101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence             3332211      2355666667777777777777751                                         


Q ss_pred             ----------------CCccccCCCCCceEecCC-CCceEEeecCCceecccCCCcceeeecccc---cccccc----cC
Q 015615          186 ----------------IGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYY---RAPELI----FG  241 (403)
Q Consensus       186 ----------------~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y---~aPE~~----~~  241 (403)
                                      ..++|+|++|.||+++.+ +..+.|+||+.+.......   .......+   ..|+..    ..
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHHH
Confidence                            147999999999999874 4368899999986532111   00000001   122211    00


Q ss_pred             CC---------CCCCchhHHHHHHHHHHHHhCCCCC
Q 015615          242 AT---------EYTAAIDIWSAGCVLAELLLGQPLF  268 (403)
Q Consensus       242 ~~---------~~~~~~DiwslG~il~elltg~~pf  268 (403)
                      ..         ....-.+.|+++.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            00         0122368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.58  E-value=9.2e-07  Score=81.90  Aligned_cols=134  Identities=16%  Similarity=0.084  Sum_probs=80.4

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCC---eeecceeeeecCCCCceEEEEEEec
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPN---VVSLKHCFFSTTEKDELYLNLVLEY  144 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~  144 (403)
                      .+.++.|....||+.     |..+++|+-...  .....+|..+|+.+.+..   +.+.+.+. . ..  ....++||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~-~-~~--~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIG-K-RS--DGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEE-E-CT--TSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeec-c-cC--CCceEEEEec
Confidence            345789999999987     567889975432  245668999999997532   22322222 1 11  2234689999


Q ss_pred             ccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 015615          145 VPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN---------------------------------------  184 (403)
Q Consensus       145 ~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---------------------------------------  184 (403)
                      ++| .+.....      ..++......++.++...|+.||+                                       
T Consensus        95 i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           95 VQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             cCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            997 3322110      112222333333333333333332                                       


Q ss_pred             --------------------cCCccccCCCCCceEecC---CCCceEEeecCCceec
Q 015615          185 --------------------TIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVL  218 (403)
Q Consensus       185 --------------------~~~ivH~Dlkp~NIll~~---~~~~vkl~DfG~a~~~  218 (403)
                                          ...++|+|++|.||+++.   ++..+.|+||+.+...
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                124699999999999987   3434589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.26  E-value=1.2e-05  Score=72.60  Aligned_cols=130  Identities=15%  Similarity=0.124  Sum_probs=80.5

Q ss_pred             eeeCCcE-EEEEEEEccCCcEEEEEEeccch-hhhHHHHHHHHHcCC-CCeeecceeeeecCCCCceEEEEEEecccc-h
Q 015615           73 VGHGSFG-VVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPE-T  148 (403)
Q Consensus        73 lg~G~~g-~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~  148 (403)
                      +..|..| .||+......+..+++|.-.... ....+|...|+.+.. --+.+++.++.     +....++|||+++| .
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEeeCCcc
Confidence            4445544 69998876677889999865432 345679999988853 12333333331     12235789999987 4


Q ss_pred             HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 015615          149 VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI------------------------------------------  186 (403)
Q Consensus       149 l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~------------------------------------------  186 (403)
                      +.+......        .....+..++...|+.||+..                                          
T Consensus       107 ~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            443332110        112234445555555555310                                          


Q ss_pred             ---------------CccccCCCCCceEecCCCCceEEeecCCce
Q 015615          187 ---------------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       187 ---------------~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                                     .++|+|+.|.|||++.++ .+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence                           279999999999998654 56799999875

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.26  E-value=4.3e-06  Score=78.25  Aligned_cols=30  Identities=23%  Similarity=0.458  Sum_probs=26.3

Q ss_pred             CCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          186 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       186 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ..+||+|+++.|||++.++ .+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            4899999999999997665 69999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.21  E-value=8.3e-06  Score=78.23  Aligned_cols=71  Identities=17%  Similarity=0.181  Sum_probs=44.1

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----------hhhhHHHHHHHHHcCC--CCe-eecceeeeecCCCCc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------KRYKNRELQTMRLLDH--PNV-VSLKHCFFSTTEKDE  135 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~h--~ni-v~~~~~~~~~~~~~~  135 (403)
                      .+.||.|.++.||++.+..++..++||.....           ......|.++++.+..  +.. .+++.+  .   .+.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence            45789999999999976556788999975421           1223578888888743  333 333321  1   122


Q ss_pred             eEEEEEEecccc
Q 015615          136 LYLNLVLEYVPE  147 (403)
Q Consensus       136 ~~~~lv~e~~~~  147 (403)
                        .++|||++++
T Consensus       110 --~~lvmE~l~g  119 (397)
T 2olc_A          110 --AVTVMEDLSH  119 (397)
T ss_dssp             --TEEEECCCTT
T ss_pred             --cEEEEEeCCC
Confidence              3589999975

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.05  E-value=1.8e-05  Score=74.61  Aligned_cols=77  Identities=10%  Similarity=0.075  Sum_probs=47.7

Q ss_pred             EEeEe-eeCCcEEEEEEEEc--c----CCcEEEEEEeccch-------hhhHHHHHHHHHcCC---CCeeecceeeeecC
Q 015615           69 AERVV-GHGSFGVVFQAKCL--E----TGEAVAIKKVLQDK-------RYKNRELQTMRLLDH---PNVVSLKHCFFSTT  131 (403)
Q Consensus        69 ~~~~l-g~G~~g~Vy~~~~~--~----~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h---~niv~~~~~~~~~~  131 (403)
                      ..+.| +.|..+.+|+....  .    ++..+++|......       ....+|..+++.+..   ..+.+++...... 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~-  102 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG-  102 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS-
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC-
Confidence            34677 88889999988753  0    26678999765432       346789998888742   2344554433111 


Q ss_pred             CCCceEEEEEEecccc
Q 015615          132 EKDELYLNLVLEYVPE  147 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~~  147 (403)
                       ......++||||++|
T Consensus       103 -~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 -DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             -TTTSSCEEEEECCCC
T ss_pred             -CccCCceEEEEecCC
Confidence             101223579999986

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.61  E-value=0.0012  Score=56.88  Aligned_cols=98  Identities=15%  Similarity=0.093  Sum_probs=63.3

Q ss_pred             hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCCCccee
Q 015615          148 TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY  227 (403)
Q Consensus       148 ~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~  227 (403)
                      +|.+.|..+   +.++++++++.++.|.+.+|.-+-.+..-..+=+.|..|++..+| .|.+.+ +.+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            678888776   589999999999999999987762110111233446888998888 576553 1110           


Q ss_pred             eecccccccccccCCCCCCCchhHHHHHHHHHHHHh
Q 015615          228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  263 (403)
Q Consensus       228 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt  263 (403)
                      .....+.|||...  ...+.+.=|||||+++|..+-
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            1122367888763  235788999999999999885

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.55  E-value=0.00036  Score=64.02  Aligned_cols=65  Identities=15%  Similarity=0.094  Sum_probs=40.0

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCe-eecceeeeecCCCCceEEEEEEecc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      .+.|+.|....+|++      ..+++|+.....   ....+|..+++.+....+ .+++...     .+.  -++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            567899999999998      458899775432   223578888877743222 2332221     111  14789999


Q ss_pred             -cc
Q 015615          146 -PE  147 (403)
Q Consensus       146 -~~  147 (403)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             54

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.50  E-value=0.0016  Score=59.14  Aligned_cols=73  Identities=15%  Similarity=0.123  Sum_probs=48.0

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      ..-.+.+|.|..+.||+... .+|+.|++|+....    .....+|...|+.|....-+.+-.++...  .    -++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEEE
Confidence            34567899999999999984 67899999976432    23467899999988532212222222111  1    25799


Q ss_pred             eccc
Q 015615          143 EYVP  146 (403)
Q Consensus       143 e~~~  146 (403)
                      ||+.
T Consensus        90 e~l~   93 (288)
T 3f7w_A           90 EWVD   93 (288)
T ss_dssp             ECCC
T ss_pred             Eeec
Confidence            9986

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.43  E-value=0.00089  Score=64.53  Aligned_cols=76  Identities=12%  Similarity=-0.049  Sum_probs=46.5

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCceecccCCCcceeee--cccccccccccCCCC--CCCchhHHHHHHHHHHHH
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELL  262 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell  262 (403)
                      .++|+|++|.|||++.++  +.|+||+.+..............  ...|.+|+.......  .....++.++...+|+.+
T Consensus       233 ~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             EEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            899999999999998654  99999999875321111111111  234677765531110  112345557777788777


Q ss_pred             hC
Q 015615          263 LG  264 (403)
Q Consensus       263 tg  264 (403)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.37  E-value=0.00067  Score=62.69  Aligned_cols=142  Identities=13%  Similarity=0.040  Sum_probs=73.9

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEecc--chhhhHHHHHHHHHcCCCC--eeecceeeeecCC----CCceEEEEE
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQ--DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTE----KDELYLNLV  141 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~----~~~~~~~lv  141 (403)
                      .+.|+.|....+|++.. .+| .+++|....  .......|+.+++.+....  +.+++..   ...    ......+++
T Consensus        27 ~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEEE
T ss_pred             eeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEEE
Confidence            45678888899999875 233 688998865  3345567888887774222  2222211   000    001235689


Q ss_pred             EecccchH------------HHHHHhhccc----CCC----CCHHHHHH---------------HHHHHHHHHHHHHh--
Q 015615          142 LEYVPETV------------HRVIKHHYKM----SQR----MPLIYVKL---------------YFYQICRALAYIHN--  184 (403)
Q Consensus       142 ~e~~~~~l------------~~~l~~~~~~----~~~----l~~~~~~~---------------~~~qi~~~L~~LH~--  184 (403)
                      |+|++|..            ...+......    ...    .....-..               +...+...++.++.  
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            99987621            1111111000    000    11100000               00113334445542  


Q ss_pred             ----cCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          185 ----TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       185 ----~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                          ..+++|+|+.+.|||++.++ .+.|+||+.+..
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             cccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence                12799999999999998654 457999998753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.34  E-value=0.0028  Score=61.70  Aligned_cols=69  Identities=13%  Similarity=0.213  Sum_probs=44.5

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccchh---hhHHHHHHHHHcCCCCee-ecceeeeecCCCCceEEEEEEecc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVV-SLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      .+.|+.|....+|++.....+..+++|+......   ...+|..+++.|...++. ++++.+     .+    .+||||+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~I  183 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEFM  183 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEECC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEee
Confidence            4578889999999998644357899998743221   225899999999755543 444433     11    2499998


Q ss_pred             cc
Q 015615          146 PE  147 (403)
Q Consensus       146 ~~  147 (403)
                      +|
T Consensus       184 ~G  185 (458)
T 2qg7_A          184 DG  185 (458)
T ss_dssp             CS
T ss_pred             CC
Confidence            75

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.30  E-value=0.0015  Score=63.21  Aligned_cols=69  Identities=17%  Similarity=0.237  Sum_probs=45.6

Q ss_pred             EeEeeeCCcEEEEEEEEcc-------CCcEEEEEEecc-ch-hhhHHHHHHHHHcCCCCe-eecceeeeecCCCCceEEE
Q 015615           70 ERVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQ-DK-RYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~  139 (403)
                      .+.|+.|....||++....       .+..+++|+... .. ....+|..+++.+...++ .++++.+     .+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence            4578889999999998642       257899998844 22 344578888888853333 3444433     22    2


Q ss_pred             EEEecccc
Q 015615          140 LVLEYVPE  147 (403)
Q Consensus       140 lv~e~~~~  147 (403)
                      +|++|++|
T Consensus       149 ~v~e~l~G  156 (429)
T 1nw1_A          149 RLEEYIPS  156 (429)
T ss_dssp             EEECCCCE
T ss_pred             EEEEEeCC
Confidence            68999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.20  E-value=0.002  Score=59.77  Aligned_cols=31  Identities=39%  Similarity=0.543  Sum_probs=26.3

Q ss_pred             CccccCCCCCceEecCC---CCceEEeecCCcee
Q 015615          187 GVCHRDIKPQNLLVNPH---THQLKLCDFGSAKV  217 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~---~~~vkl~DfG~a~~  217 (403)
                      .++|||+.+.|||++.+   ...+.|+||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            79999999999999864   13689999998864

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.19  E-value=0.0014  Score=60.51  Aligned_cols=71  Identities=15%  Similarity=0.061  Sum_probs=49.0

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-hhhhHHHHHHHHHcC---CCCeeecceeeeecCCCCceEEEEEEecc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTEKDELYLNLVLEYV  145 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~  145 (403)
                      .+.|+.|....+|+...  ++..+++|..... .....+|...|+.|.   ...+.+++....     .....++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEec
Confidence            45789999999999874  5678899987543 345678988888874   234555544331     113467899999


Q ss_pred             cc
Q 015615          146 PE  147 (403)
Q Consensus       146 ~~  147 (403)
                      +|
T Consensus       114 ~G  115 (312)
T 3jr1_A          114 NK  115 (312)
T ss_dssp             CC
T ss_pred             cC
Confidence            85

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.16  E-value=0.0014  Score=61.87  Aligned_cols=69  Identities=12%  Similarity=0.129  Sum_probs=40.1

Q ss_pred             EeEeeeCCcEEEEEEEEcc--------CCcEEEEEEeccchh---hhHHHHHHHHHcCCCCe-eecceeeeecCCCCceE
Q 015615           70 ERVVGHGSFGVVFQAKCLE--------TGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELY  137 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~  137 (403)
                      .+.|+.|....+|++....        .+..+++|+......   ....|..+++.+....+ .+++..+     .+   
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT---
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC---
Confidence            3467888888999988643        136788998754322   23578888888753333 3443322     11   


Q ss_pred             EEEEEecccc
Q 015615          138 LNLVLEYVPE  147 (403)
Q Consensus       138 ~~lv~e~~~~  147 (403)
                       ++||+|++|
T Consensus       110 -~~v~e~i~G  118 (369)
T 3c5i_A          110 -GRIEEWLYG  118 (369)
T ss_dssp             -EEEEECCCS
T ss_pred             -cEEEEEecC
Confidence             468999875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.11  E-value=0.0025  Score=60.37  Aligned_cols=138  Identities=17%  Similarity=0.258  Sum_probs=75.8

Q ss_pred             eEeeeCCcEEEEEEEEcc-------CCcEEEEEEecc---chhhhHHHHHHHHHcCCCCe-eecceeeeecCCCCceEEE
Q 015615           71 RVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQ---DKRYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~  139 (403)
                      +.|..|....+|++....       ++..+++|+.-.   ......+|..+++.+..-.+ .+++..+     .+    .
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence            457778888999988632       357899998633   23344579888888753222 3443333     22    2


Q ss_pred             EEEecccch-H--------------HHHHHhhccc----CCCCC--HHHHHHHHHHHHH-------------------HH
Q 015615          140 LVLEYVPET-V--------------HRVIKHHYKM----SQRMP--LIYVKLYFYQICR-------------------AL  179 (403)
Q Consensus       140 lv~e~~~~~-l--------------~~~l~~~~~~----~~~l~--~~~~~~~~~qi~~-------------------~L  179 (403)
                      +||||++|. +              .+.|......    .....  ...+..|..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            799998751 1              1122211111    11111  3445555544322                   12


Q ss_pred             HHHHh-------cCCccccCCCCCceEecCC---CCceEEeecCCcee
Q 015615          180 AYIHN-------TIGVCHRDIKPQNLLVNPH---THQLKLCDFGSAKV  217 (403)
Q Consensus       180 ~~LH~-------~~~ivH~Dlkp~NIll~~~---~~~vkl~DfG~a~~  217 (403)
                      ..|.+       ...++|+|+.+.||+++.+   ...+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33321       1259999999999999876   23699999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.03  E-value=0.0043  Score=57.31  Aligned_cols=72  Identities=14%  Similarity=-0.008  Sum_probs=43.0

Q ss_pred             EeeeCCcEEEEEEEEccCCcEEEEEEecc---chhhhHHHHHHHHHcCCCC--eeecceeeeecCC--CCceEEEEEEec
Q 015615           72 VVGHGSFGVVFQAKCLETGEAVAIKKVLQ---DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTE--KDELYLNLVLEY  144 (403)
Q Consensus        72 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~lv~e~  144 (403)
                      .|+ |....||++.. .+|+.+++|....   .......|..+++.+....  +.+++..  ....  ......+++|++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence            456 77889998764 4566799998863   2345567888888774222  3333321  0000  012245689999


Q ss_pred             ccc
Q 015615          145 VPE  147 (403)
Q Consensus       145 ~~~  147 (403)
                      ++|
T Consensus       109 i~G  111 (328)
T 1zyl_A          109 VGG  111 (328)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            986

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.68  E-value=0.0026  Score=59.38  Aligned_cols=30  Identities=27%  Similarity=0.546  Sum_probs=26.2

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            699999999999998655 699999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.60  E-value=0.082  Score=50.72  Aligned_cols=69  Identities=13%  Similarity=0.174  Sum_probs=43.5

Q ss_pred             EeEeeeCCcEEEEEEEEccC-------CcEEEEEEeccch---hhhHHHHHHHHHcCCCCe-eecceeeeecCCCCceEE
Q 015615           70 ERVVGHGSFGVVFQAKCLET-------GEAVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~  138 (403)
                      .+.|..|....+|++.....       +..+++|+.....   ....+|..+++.+....+ .++++.+     .+    
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~~----  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----PE----  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----CC----
Confidence            34677788889999986421       5789999864322   223578988888853223 3333322     11    


Q ss_pred             EEEEecccc
Q 015615          139 NLVLEYVPE  147 (403)
Q Consensus       139 ~lv~e~~~~  147 (403)
                      ++||+|++|
T Consensus       146 ~~I~efI~G  154 (424)
T 3mes_A          146 GRIEEFIDG  154 (424)
T ss_dssp             EEEEECCCS
T ss_pred             CEEEEEeCC
Confidence            468999876

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=82.97  E-value=0.58  Score=44.36  Aligned_cols=31  Identities=29%  Similarity=0.484  Sum_probs=24.8

Q ss_pred             CccccCCCCCceEecC-----CCCceEEeecCCcee
Q 015615          187 GVCHRDIKPQNLLVNP-----HTHQLKLCDFGSAKV  217 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~-----~~~~vkl~DfG~a~~  217 (403)
                      .++|+|+.+.|||+..     +...+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            3689999999999932     233799999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	403
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-126
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-71
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-70
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-67
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-67
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-67
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-66
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-66
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-65
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-65
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-65
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-63
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-63
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-61
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-60
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-60
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-60
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-59
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-59
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-57
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-56
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-54
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-53
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-52
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-52
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-52
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-50
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-50
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-43
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-43
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  367 bits (942), Expect = e-126
 Identities = 238/347 (68%), Positives = 284/347 (81%), Gaps = 4/347 (1%)

Query: 50  IVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNREL 109
           +V T G    +P Q +SY   +V+G+GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 110 QTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 168
           Q MR LDH N+V L++ F+S+ E KDE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
           KLY YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
           CSRYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
           RE+I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

Query: 349 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 395
            FFDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (594), Expect = 2e-74
 Identities = 106/342 (30%), Positives = 179/342 (52%), Gaps = 25/342 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV--LQDKRYKN---RELQTMRLLDHPNVV 121
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++ +    H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +     + T +    + LV   +   +++++K      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRAPE 237
           IH+   V HRD+KP NLL+N  T  LK+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 295
           ++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 296 -NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                     P     PW+++F      +A+DL+ ++L ++P+ R    +AL HP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 355 RDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK 396
            DP+            F F   EL  +P + L +LI E   +
Sbjct: 302 YDPSDE----PIAEAPFKF-DMELDDLPKEKLKELIFEETAR 338

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 8e-71
 Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 31/305 (10%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +     +G G+ GVVF+     +G  +A K +  + +        RELQ +   + P +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                F       E+ +   +E++       +    K + R+P   +      + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           +     + HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 300
            T Y+   DIWS G  L E+ +G+   P       +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 301 EFKF--------------PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
              +                I   P  K+       E  D V++ L  +P  R+   + +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 347 IHPFF 351
           +H F 
Sbjct: 297 VHAFI 301

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 1e-70
 Identities = 99/304 (32%), Positives = 148/304 (48%), Gaps = 23/304 (7%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---------RELQTMRLLDHPNVV 121
             +G G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L   F     K  + L  V +++   +          S  +   ++K Y     + L Y
Sbjct: 64  GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 240
           +H    + HRD+KP NLL++ +   LKL DFG AK         ++   +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
           GA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT E+   M     
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP--N 358
              F      P H IF      + +DL+  L  ++P  R TA +AL   +F     P   
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

Query: 359 TRLP 362
            +LP
Sbjct: 293 CQLP 296

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-67
 Identities = 103/307 (33%), Positives = 163/307 (53%), Gaps = 21/307 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           +     +G G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L           E  L LV E++ + + + +         +PLI  K Y +Q+ + LA
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLA 116

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           + H+   V HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 298
            G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
             +  FP+     + K+    +  +   L+S++L Y PN R +A  AL HPFF ++  P 
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292

Query: 359 TRLPNGR 365
             +P+ R
Sbjct: 293 --VPHLR 297

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  214 bits (545), Expect = 6e-67
 Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 41/309 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   F     +D+  + ++ E++      + +       +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF-----EDDNEMVMIYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 183 HNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           H      H D+KP+N++     +++LKL DFG    L   +       +  + APE+  G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
                   D+WS G +   LL G   F GE+  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP--NT 359
                             +  +  D + +LL   PN R T  +AL HP+      P  ++
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 360 RLPNGRFLP 368
           ++P+ R+  
Sbjct: 294 QIPSSRYTK 302

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 9e-67
 Identities = 86/309 (27%), Positives = 144/309 (46%), Gaps = 22/309 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 121 VSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           V+L     +      + +  + LV ++     H +      +  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-----SYICSRY 232
            L YIH    + HRD+K  N+L+      LKL DFG A+     + +      + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 293 KCMNPNYTEFKFPQIKAHP---WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 349
             ++      K   +K        ++      P A+DL+ +LL   P  R  + +AL H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 350 FFDELRDPN 358
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-66
 Identities = 98/335 (29%), Positives = 162/335 (48%), Gaps = 24/335 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV------LQDKRYKNRELQTMRLLDHPNV 120
           Y     VG G++G V  A   +TG  VA+KK+      +   +   REL+ ++ + H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + L   F      +E     ++ ++         ++    Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 240
           YIH+   + HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 241 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
               Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 301 EF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
                   Q+    +  +F     P AVDL+ ++L    + R TA +AL H +F +  DP
Sbjct: 252 RNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 358 NTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE 392
           +        +   ++    E + + +D    L  +
Sbjct: 311 DDEP-----VADPYDQ-SFESRDLLIDEWKSLTYD 339

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 5e-66
 Identities = 100/302 (33%), Positives = 157/302 (51%), Gaps = 20/302 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y   + VG G++G V  A    TG  VAIKK+ +  + +       REL+ ++ + H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 121 VSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           + L   F    T  D     LV+ ++   + +++KH     +++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            YIH   G+ HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 300 TEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD 356
            +      P+++   +  I      P AV+L+ ++L      R TA EAL HP+F+ L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 357 PN 358
             
Sbjct: 310 TE 311

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  209 bits (533), Expect = 2e-65
 Identities = 90/300 (30%), Positives = 149/300 (49%), Gaps = 21/300 (7%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-NRELQTM-RLLDHPNVVSLK 124
           Y   R +G G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
                  +       LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H+
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 244
            +G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY++ PEL+     
Sbjct: 148 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 245 YTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           Y  ++D+WS GC+LA ++  + P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 304 FPQI----KAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
           F  I        W +      Q  + PEA+D + +LL+Y    R TA EA+ HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 5e-65
 Identities = 96/299 (32%), Positives = 151/299 (50%), Gaps = 17/299 (5%)

Query: 67  YMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQDKRYKN------RELQTMRLL---D 116
           Y     +G G++G VF+A+ L+  G  VA+K+V      +       RE+  +R L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           HPNVV L      +    E  L LV E+V + +   +    +    +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLL 126

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
           R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
           E++   + Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
                  F    A P  K     +     DL+ + L ++P  R +A  AL HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 6e-65
 Identities = 98/299 (32%), Positives = 151/299 (50%), Gaps = 18/299 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L           +  L LV E+       + K+    +  +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           + H+   V HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           FGA  Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
                +P   A         ++     DL+  LL+ +P  R +A EAL HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  205 bits (523), Expect = 2e-63
 Identities = 80/334 (23%), Positives = 127/334 (38%), Gaps = 44/334 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+FGVV +     TG     K +      DK     E+  M  L HP +++
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           L   F     +D+  + L+LE++   E   R+    YKMS+      V  Y  Q C  L 
Sbjct: 91  LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE----VINYMRQACEGLK 141

Query: 181 YIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           ++H    + H DIKP+N++        +K+ DFG A  L   E       +  + APE++
Sbjct: 142 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                     D+W+ G +   LL G   F GE  ++ L  + +       +         
Sbjct: 201 DR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------- 252

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF-DELRDPN 358
                               + PEA D +  LLQ  P  R T  +AL HP+   +  +  
Sbjct: 253 ------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 294

Query: 359 TRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE 392
           +R+P+ R+       K            +  I  
Sbjct: 295 SRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIAN 328

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 7e-63
 Identities = 77/305 (25%), Positives = 123/305 (40%), Gaps = 32/305 (10%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 128
            +V+G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 129 STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
           +     +  L +V+E +    +   I+   +  Q             I  A+ Y+H+ I 
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-IN 131

Query: 188 VCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 245
           + HRD+KP+NLL         LKL DFG AK         +   + YY APE++    +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
             + D+WS G ++  LL G P F    G+     +   +                +++FP
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFP 237

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF-DELRDPNTRLPNG 364
             +           +  E   L+  LL+  P  R T  E + HP+     + P T L   
Sbjct: 238 NPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289

Query: 365 RFLPP 369
           R L  
Sbjct: 290 RVLKE 294

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  200 bits (509), Expect = 2e-62
 Identities = 95/295 (32%), Positives = 155/295 (52%), Gaps = 20/295 (6%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y     +G G++GVV++A+    GE  A+KK+  +K  +       RE+  ++ L H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           V L           +  L LV E++ + + +++         +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIA 114

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 239
           Y H+   V HRD+KPQNLL+N    +LK+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 298
            G+ +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
             +  F   +  PW     K +    +DL+S++L+  PN R TA +AL H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 9e-62
 Identities = 72/295 (24%), Positives = 117/295 (39%), Gaps = 44/295 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +   + +G G++G V  A    T EAVA+K V   +         +E+   ++L+H NVV
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                             L LEY             +    MP    + +F+Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 238
           +H  IG+ HRDIKP+NLL++   + LK+ DFG A V               +  Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     +   +D+WS G VL  +L G+  +   S   Q     K   T            
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
                      +PW KI         + L+ ++L  +P+ R T  +     ++++
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 1e-61
 Identities = 59/289 (20%), Positives = 119/289 (41%), Gaps = 40/289 (13%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
           +  +G GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
            +  + +T K +  + LV E +       +K + K  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 184 -NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 242
             T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 243 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 302
            +Y  ++D+++ G  + E+   +  +       Q+                         
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------- 224

Query: 303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
               + +      F K   PE  +++   ++ + + R +  + L H FF
Sbjct: 225 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (506), Expect = 2e-61
 Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 49/305 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           +   R +GHGSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
            +  + C+       E    LV+EY   +   +++ H K    +  + +    +   + L
Sbjct: 77  TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 128

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           AY+H+   + HRD+K  N+L++     +KL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 240 FGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
               E  Y   +D+WS G    EL   +P     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
                       +    +          + V   LQ  P  R T+   L H F    R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 358 NTRLP 362
              + 
Sbjct: 277 TVIMD 281

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 3e-61
 Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 48/292 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           +   R +G G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ L   F      D   + L+LEY P      +    +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF-----HDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
           +Y H+   V HRDIKP+NLL+      LK+ DFG +          +   +  Y  PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G   +   +D+WS G +  E L+G+P F   +  +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
            EF FP              +   A DL+SRLL+++P+ R    E L HP+ 
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 5e-61
 Identities = 65/294 (22%), Positives = 116/294 (39%), Gaps = 44/294 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           +     +G G+FG V++A+  ET    A K +     ++      E+  +   DHPN+V 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L   F       E  L +++E+             ++ + +    +++   Q   AL Y+
Sbjct: 74  LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG 241
           H+   + HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 242 AT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
            T     Y    D+WS G  L E+   +P     + +  L++I                 
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 351
                     K+ P       R      D + + L+ + + R T  + L HPF 
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 1e-60
 Identities = 72/296 (24%), Positives = 116/296 (39%), Gaps = 45/296 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVL------QDKRYKNRELQTMRLLDHPNV 120
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           V         T      L +V+EY     +  VI    K  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 180 AYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYR 234
              H        V HRD+KP N+ ++   + +KL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +PE +     Y    DIWS GC+L EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                 E KF +I               E  ++++R+L      R +  E L +P 
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 4e-60
 Identities = 68/292 (23%), Positives = 118/292 (40%), Gaps = 40/292 (13%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV---LQDKRYKNRELQTMRLLDHPNVVSL 123
           YM    +G G FG+V +     + +    K V     D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
              F     +    L ++ E++    +   I      +  +    +  Y +Q+C AL ++
Sbjct: 67  HESF-----ESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFL 118

Query: 183 HNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 241
           H+   + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+   
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
               + A D+WS G ++  LL G   F  E+    +  I+    T   E           
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
                           K +  EA+D V RLL      R TA EAL HP+  +
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 5e-60
 Identities = 93/333 (27%), Positives = 160/333 (48%), Gaps = 32/333 (9%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNV 120
           Y   + +G G+ G+V  A        VAIKK+ +  + +       REL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 121 VSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +SL + F    T ++   + LV+E +   + +VI+      +      +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQMLCGI 132

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            ++H+  G+ HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
            G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 300 TEF--KFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
             +    P+     + K+F            K    +A DL+S++L   P  R +  +AL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELK 379
            HP+ +   DP          P +++ +  E +
Sbjct: 310 QHPYINVWYDPAEVEAP---PPQIYDKQLDERE 339

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 5e-59
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 43/301 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 122
           Y     +G G+ G V+ A  + TG+ VAI+++       K     E+  MR   +PN+V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
               +      DEL++  V+EY+                 M    +     +  +AL ++
Sbjct: 82  YLDSY---LVGDELWV--VMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 241
           H+   V HRDIK  N+L+      +KL DFG    +   +   S +  + Y+ APE++  
Sbjct: 133 HSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 242 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 301
              Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP             E
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP-------------E 235

Query: 302 FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 361
            + P            +++     D ++R L      R +A E L H F    +  ++  
Sbjct: 236 LQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283

Query: 362 P 362
           P
Sbjct: 284 P 284

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  193 bits (491), Expect = 7e-59
 Identities = 93/349 (26%), Positives = 155/349 (44%), Gaps = 49/349 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 123
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 124 KH----------CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 173
                         F+    + +++ +V E + E +  +IK +    + +PLIYVK    
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQISK 132

Query: 174 QICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNISYI 228
           Q+   L Y+H   G+ H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIK 282
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 283 VLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FQKRMPPEAVDLVS 329
           +LG      ++      T F          ++K  P   +      F K    E  D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 330 RLLQYSPNLRSTALEALIHPFF------DELRDPNTRL-PNGRFLPPLF 371
            +LQ  P  R+ A   + HP+       +E+R P+  L  +G  +P  F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  187 bits (477), Expect = 1e-57
 Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 56/307 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------------LQDKRYKNRELQTMR 113
           Y  + ++G G   VV +     T +  A+K +              + +    +E+  +R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 114 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLY 171
            +  HPN++ LK  +     +   +  LV + +    +   +     +S++      +  
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE----TRKI 115

Query: 172 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 231
              +   +  +H    + HRD+KP+N+L++   + +KL DFG +  L  GE       + 
Sbjct: 116 MRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTP 173

Query: 232 YYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 286
            Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I      
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------ 227

Query: 287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
                   M+ NY +F  P+                   DLVSR L   P  R TA EAL
Sbjct: 228 --------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268

Query: 347 IHPFFDE 353
            HPFF +
Sbjct: 269 AHPFFQQ 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (478), Expect = 2e-57
 Identities = 69/304 (22%), Positives = 119/304 (39%), Gaps = 44/304 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           Y    V+G G+F  V  A+   T + VAIK + +            E+  +  + HPN+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           +L   +        LYL  +++ V    +   I      ++R          +Q+  A+ 
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVSGGELFDRIVEKGFYTERD----ASRLIFQVLDAVK 121

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 238
           Y+H+   + HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE+
Sbjct: 122 YLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180

Query: 239 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 298
           +     Y+ A+D WS G +   LL G P F  E+      +I+K                
Sbjct: 181 LAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------- 231

Query: 299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 358
                            +   +   A D +  L++  P  R T  +AL HP+       +
Sbjct: 232 -----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274

Query: 359 TRLP 362
             + 
Sbjct: 275 KNIH 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-56
 Identities = 82/313 (26%), Positives = 132/313 (42%), Gaps = 58/313 (18%)

Query: 60  QPKQTI--SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYK-------NRELQ 110
           QP++     +   +++G GSF  V  A+ L T    AIK + +    K        RE  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 111 TMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 170
            M  LDHP  V L   F    + ++LY    L Y     +  +  + +          + 
Sbjct: 61  VMSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRF 112

Query: 171 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SY 227
           Y  +I  AL Y+H    + HRD+KP+N+L+N   H +++ DFG+AKVL          S+
Sbjct: 113 YTAEIVSALEYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170

Query: 228 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 287
           + +  Y +PEL+        + D+W+ GC++ +L+ G P F   +      +IIK+    
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---- 225

Query: 288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 347
                        E+ FP+            +  P+A DLV +LL      R    E   
Sbjct: 226 -------------EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEG 260

Query: 348 ------HPFFDEL 354
                 HPFF+ +
Sbjct: 261 YGPLKAHPFFESV 273

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-54
 Identities = 81/356 (22%), Positives = 140/356 (39%), Gaps = 62/356 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQT--------MRLLDHP 118
           ++  +++G GSFG VF A+  +T +  AIK + +D    + +++             +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
            +  +   F     + +  L  V+EY+       + +H +   +  L     Y  +I   
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 237
           L ++H+  G+ +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 238 LIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           ++ G  +Y  ++D WS G +L E+L+GQ  F G+   +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALIHPFFDELRD 356
            Y  +                 +  EA DL+ +L    P  R     +   HP F E+  
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN- 262

Query: 357 PNTRLPNGRFLPP----------LFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 402
               L      PP            NF    L   P          ++  Q  F  
Sbjct: 263 -WEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRN 317

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 3e-53
 Identities = 65/318 (20%), Positives = 120/318 (37%), Gaps = 50/318 (15%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD 116
           Y     +G G F VV + +   TG   A K + + +   +          RE+  ++ + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           HPNV++L   +     +++  + L+LE V       +       + +       +  QI 
Sbjct: 72  HPNVITLHEVY-----ENKTDVILILELVA---GGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 177 RALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 233
             + Y+H+   + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  +
Sbjct: 124 NGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 234 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 293
            APE++          D+WS G +   LL G   F G++  + L  +  V      E   
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--- 238

Query: 294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 353
                                 +       A D + RLL   P  R T  ++L HP+   
Sbjct: 239 ----------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

Query: 354 LRDPNTRLPNGRFLPPLF 371
                 +  +  +  P F
Sbjct: 277 K--DTQQALSSAWSHPQF 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-52
 Identities = 68/303 (22%), Positives = 115/303 (37%), Gaps = 56/303 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN----------RELQTMRLLD 116
           Y    ++G G FG V+    +     VAIK V +D+               E+  ++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 117 --HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
                V+ L   F            L+LE       + +         +     + +F+Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 234
           +  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
            PE I     +  +  +WS G +L +++ G   F  +       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
                                F++R+  E   L+   L   P+ R T  E   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 355 RDP 357
             P
Sbjct: 262 LLP 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  176 bits (446), Expect = 1e-52
 Identities = 74/323 (22%), Positives = 136/323 (42%), Gaps = 62/323 (19%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKV-------LQDKRYKNRELQTMRLLDHPN 119
           +   R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           ++ +   F     +D   + ++++Y+       +    + SQR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 239
            Y+H+   + +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 240 FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 299
                Y  +ID WS G ++ E+L G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 300 TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFF--- 351
            E +FP                 +  DL+SRL+    + R     +   +   HP+F   
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

Query: 352 --DELRDPNTRLPNGRFLPPLFN 372
             ++L   N   P   + PP+  
Sbjct: 264 VWEKLLSRNIETP---YEPPIQQ 283

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  176 bits (446), Expect = 4e-52
 Identities = 76/350 (21%), Positives = 130/350 (37%), Gaps = 73/350 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD 116
           +   R++G G FG V+  +  +TG+  A+K + + +            +   L  +   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 175
            P +V + + F      D+L    +L+ +    +H  +  H   S+      ++ Y  +I
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQHGVFSEAD----MRFYAAEI 116

Query: 176 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 235
              L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S   +  Y A
Sbjct: 117 ILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMA 173

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE++     Y ++ D +S GC+L +LL G   F      D+       L           
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------ 227

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPF 350
                                     PE   L+  LLQ   N R       A E    PF
Sbjct: 228 --------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267

Query: 351 F-----DELRDPNTRLPNGRFLPPLF-----------NFKPHELKGVPVD 384
           F       +       P    +PP             +F   + KG+ + 
Sbjct: 268 FRSLDWQMVFLQKYPPP---LIPPRGEVNAADAFDIGSFDEEDTKGIKLL 314

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 43/295 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPN 119
           Y    ++G G    V  A+ L     VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL 179
           +V++ +              +V+EYV       ++        M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 180 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRA 235
            + H   G+ HRD+KP N++++   + +K+ DFG A+ +     ++    + I +  Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 236 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           PE   G     A  D++S GCVL E+L G+P F G+S V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
                                 + +  +   +V + L  +P  R      +    
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 7e-50
 Identities = 71/318 (22%), Positives = 121/318 (38%), Gaps = 56/318 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           +++G G+FG V   +   TG   A+K + ++             E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           K+ F      D L        +       +  H    +       + Y  +I  AL Y+H
Sbjct: 71  KYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           +   V +RDIK +NL+++   H +K+ DFG  K  +     +   C         +    
Sbjct: 123 S-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           +Y  A+D W  G V+ E++ G+  F  +        I+                   E +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPFFDELRDPN 358
           FP            + + PEA  L++ LL+  P  R     S A E + H FF  +    
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269

Query: 359 TRLPNGRFLPPLFNFKPH 376
             +   + LPP   FKP 
Sbjct: 270 QDVVQKKLLPP---FKPQ 284

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 2e-47
 Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 49/291 (16%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 123
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 124 KHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
                         L +V ++    +++  +     +  +  +I +     Q  + + Y+
Sbjct: 70  MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 239
           H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S  + APE+I
Sbjct: 121 HAK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 240 FG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
                  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++                
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
               +  P +             P     L++  L+   + R    + L  
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (402), Expect = 2e-46
 Identities = 54/302 (17%), Positives = 100/302 (33%), Gaps = 45/302 (14%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 124
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     +   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
               +    +  Y  +V+E +  ++          S++  L  V L   Q+   + YIH+
Sbjct: 69  RWCGA----EGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 185 TIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNI--------SYICSRYYR 234
                HRD+KP N L+        +   DFG AK       +         +   +  Y 
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 235 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 294
           +     G  E +   D+ S G VL    LG   + G     +  +  ++        I+ 
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFF 351
           +   Y                     P E    ++       + +   S   +   + F 
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

Query: 352 DE 353
            +
Sbjct: 279 RQ 280

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 9e-44
 Identities = 53/282 (18%), Positives = 101/282 (35%), Gaps = 45/282 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 128
           + +G G FG V        G  VA+K +  D   +    E   M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 129 STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
               +++  L +V EY+ + ++   ++   +    +    +  +   +C A+ Y+     
Sbjct: 71  ----EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN-N 123

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA 247
             HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++ 
Sbjct: 124 FVHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179

Query: 248 AIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 306
             D+WS G +L E+   G+  +P     D +  + K                  +   P 
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----------------KMDAPD 223

Query: 307 IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
                         PP   +++         +R + L+    
Sbjct: 224 ------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (382), Expect = 2e-43
 Identities = 49/267 (18%), Positives = 98/267 (36%), Gaps = 24/267 (8%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 124
           Y   R +G GSFGV+F+   L   + VAIK   +         E +T +LL     +   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 184
           + F      + L+  LV++ +  ++  ++       ++  +  V +   Q+   +  IH 
Sbjct: 67  YYFGQ----EGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 185 TIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNI--------SYICSRY 232
              + +RDIKP N L+      + + + + DFG  K                 +   +  
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           Y +     G  E +   D+ + G V    L G   + G        +  ++        +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKR 319
           + +   + E +F +   +  +  F   
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (383), Expect = 4e-43
 Identities = 63/313 (20%), Positives = 114/313 (36%), Gaps = 57/313 (18%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 123
           + +G GSFG V   K  E+G   A+K + + K  K         E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
           +  F   +    +                +  H +   R    + + Y  QI     Y+H
Sbjct: 107 EFSFKDNSNLYMVM--------EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 243
           + + + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I    
Sbjct: 159 S-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213

Query: 244 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
            Y  A+D W+ G ++ E+  G P F  +  +    +I                       
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEALIHPFFDELRDPN 358
                       F      +  DL+  LLQ        NL++   +   H +F      +
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTD 301

Query: 359 TRLPNGRFLPPLF 371
                 R +   F
Sbjct: 302 WIAIYQRKVEAPF 314

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 8e-43
 Identities = 79/330 (23%), Positives = 138/330 (41%), Gaps = 60/330 (18%)

Query: 67  YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKV--------LQDKRYKNRELQTMRLL 115
           +   +V+G G++G VF  + +   +TG+  A+K +         +   +   E Q +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 116 DH-PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 174
              P +V+L + F     + E  L+L+L+Y+       +  H    +R     V++Y  +
Sbjct: 86  RQSPFLVTLHYAF-----QTETKLHLILDYIN---GGELFTHLSQRERFTEHEVQIYVGE 137

Query: 175 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SR 231
           I  AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y       
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 291
           Y     +  G + +  A+D WS G ++ ELL G   F  +   +   EI +         
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 246

Query: 292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEAL 346
                    + + P          + + M   A DL+ RLL   P  R       A E  
Sbjct: 247 ------RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290

Query: 347 IHPFFDELRDPNTRLPNGRFLPPLFNFKPH 376
            H FF ++   +  L   +   P   FKP 
Sbjct: 291 EHLFFQKINWDD--LAAKKVPAP---FKPV 315

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-41
 Identities = 56/293 (19%), Positives = 101/293 (34%), Gaps = 47/293 (16%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 123
                 +G G FG V+          VA+K + Q     +    E   M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 124 KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH 183
                    ++ +Y  ++ EY+                ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIY--IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126

Query: 184 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFG 241
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 242 ATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 300
              +T   D+WS G +L E++  G+  +PG +  + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 301 EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL--IHPFF 351
                      +  +     P E   L+    +  P  R T       +  FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-40
 Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 47/296 (15%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           E  +G G FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
                 ++ +Y+  V EY+ +          +  + + L  +     QI   +AY+   +
Sbjct: 81  V----SEEPIYI--VTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATE 244
              HRD++  N+LV  +    K+ DFG A+++   E            + APE       
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 245 YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 303
           +T   D+WS G +L EL   G+  +PG    + L ++ +    P   E            
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239

Query: 304 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--LEALIHPFFDELRDP 357
                            P    DL+ +  +  P  R T   L+A +  +F      
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 6e-40
 Identities = 55/302 (18%), Positives = 108/302 (35%), Gaps = 37/302 (12%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS 122
           + + +  +G G FG V++ K    GE VA+K     +    ++  E+    +L H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 123 LKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
                 +        L LV +Y    ++   +  +      + +  +          LA+
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115

Query: 182 IHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----YIC 229
           +H  I        + HRD+K +N+LV        + D G A         I       + 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 230 SRYYRAPELIFGA-----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 284
           ++ Y APE++  +      E     DI++ G V  E+     +  G     QL     V 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233

Query: 285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 344
             P+ EE++ +          +++ +  ++            ++      +   R TAL 
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

Query: 345 AL 346
             
Sbjct: 288 IK 289

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 1e-39
 Identities = 63/309 (20%), Positives = 115/309 (37%), Gaps = 54/309 (17%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVL-----QDKRYKNRELQTMRLLDH 117
               E+V+G G FG V        G+    VAIK +      + +R    E   M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 118 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 177
           PNV+ L+      T+   +   ++ E++            +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 178 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------ 231
            + Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 232 YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 290
            + APE I    ++T+A D+WS G V+ E++  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256

Query: 291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 350
           +                             P     L+    Q   N R    + +    
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287

Query: 351 FDELRDPNT 359
              +R+PN+
Sbjct: 288 DKMIRNPNS 296

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-39
 Identities = 59/299 (19%), Positives = 105/299 (35%), Gaps = 53/299 (17%)

Query: 71  RVVGHGSFGVVFQAKCLET---GEAVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 120
             +G GSFGVV + +         +VA+K +  D   +        RE+  M  LDH N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA 180
           + L     +        + +V E  P     ++    K      L  +  Y  Q+   + 
Sbjct: 74  IRLYGVVLTP------PMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 181 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 237
           Y+ +     HRD+  +NLL+      +K+ DFG  + L + + +     +    +     
Sbjct: 126 YLESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 238 LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
                  ++ A D W  G  L E+   GQ  + G +G   L +I K      R E     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----- 238

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 355
                                   P +  +++ +   + P  R T +   +  F  E +
Sbjct: 239 ----------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-39
 Identities = 49/283 (17%), Positives = 95/283 (33%), Gaps = 43/283 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 127
           + +G G FG+V         + VAIK + +    +     E + M  L HP +V L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
               E+  + L  V E++         +            +      +C  +AY+     
Sbjct: 70  ---LEQAPICL--VFEFMEHGCLS--DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-C 121

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEY 245
           V HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 246 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 305
           ++  D+WS G ++ E+     +        ++VE I                        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216

Query: 306 QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
                 +     +        +++   +  P  R      L  
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-39
 Identities = 64/304 (21%), Positives = 117/304 (38%), Gaps = 53/304 (17%)

Query: 71  RVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
           +V+G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            L     ++T      + L+ + +P     ++ +  +    +   Y+  +  QI + + Y
Sbjct: 75  RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR---YYRAPEL 238
           + +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +    + A E 
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 239 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           I     YT   D+WS G  + EL+  G   + G     ++  I++      +  I     
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPI----- 237

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 357
                                    +   ++ +      + R    E +I  F    RDP
Sbjct: 238 ----------------------CTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274

Query: 358 NTRL 361
              L
Sbjct: 275 QRYL 278

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 4e-39
 Identities = 53/284 (18%), Positives = 106/284 (37%), Gaps = 45/284 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 127
           + +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 128 FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG 187
              T++  ++  ++ EY+         +  +M  R     +      +C A+ Y+ +   
Sbjct: 69  ---TKQRPIF--IITEYMANGCLL--NYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-Q 120

Query: 188 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEY 245
             HRD+  +N LVN     +K+ DFG ++ ++  E   S        +  PE++   +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 246 TAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++  DIW+ G ++ E+  LG+  +   +  +    I + L                    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------------RLYR 222

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
           P +               +   ++        + R T    L +
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 6e-39
 Identities = 55/299 (18%), Positives = 105/299 (35%), Gaps = 56/299 (18%)

Query: 70  ERVVGHGSFGVVFQAKC--LETGEAVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 121
           ++ +G G+FG V +      +  + VA+K +  +            E   M+ LD+P +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
            +        E +   L  V+E         +  + + ++ +    +    +Q+   + Y
Sbjct: 72  RMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICSRYYRAPE 237
           +  +    HRD+  +N+L+    H  K+ DFG +K L   E              + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 238 LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 296
            I    ++++  D+WS G ++ E    GQ  + G  G +    + K              
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 230

Query: 297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEALIHPFFD 352
                                   P E  DL++    Y    R         L + ++D
Sbjct: 231 -------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-38
 Identities = 63/298 (21%), Positives = 107/298 (35%), Gaps = 54/298 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE--AVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVS 122
           +  +G G+FG V Q       +   VAIK + Q     +     RE Q M  LD+P +V 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 123 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 182
           L        + + L L  V+E          K      + +P+  V    +Q+   + Y+
Sbjct: 74  LIGVC----QAEALML--VMEMAGGGPLH--KFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 183 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 238
                  HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + APE 
Sbjct: 126 EEK-NFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 239 IFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 297
           I    ++++  D+WS G  + E L  GQ  +    G + +  I +        E      
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237

Query: 298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFFD 352
                                  PPE   L+S    Y    R    T  + +   ++ 
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-38
 Identities = 59/314 (18%), Positives = 108/314 (34%), Gaps = 70/314 (22%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQDKRYKN-----RELQTM-RLLDHP 118
            +V+G G+FG V  A      +      VA+K + +            EL+ M +L  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------------- 158
           N+V+L       T    +Y  L+ EY     +   ++   +                   
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 159 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 218
               +    +  + YQ+ + + ++       HRD+  +N+LV      +K+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214

Query: 219 VKGEPNISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 274
           +     +    +R    + APE +F    YT   D+WS G +L E+  LG   +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 275 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 334
               ++I+               N  +   P                 E   ++     +
Sbjct: 274 ANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSCWAF 306

Query: 335 SPNLRSTALEALIH 348
               R +       
Sbjct: 307 DSRKRPSFPNLTSF 320

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (345), Expect = 4e-38
 Identities = 54/290 (18%), Positives = 110/290 (37%), Gaps = 43/290 (14%)

Query: 70  ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 126
           +  +G G +G V++    +    VA+K + +D        +E   M+ + HPN+V L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 127 FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI 186
               T +   Y+    E++               Q +  + +     QI  A+ Y+    
Sbjct: 82  C---TREPPFYIIT--EFMTYGNLLDY-LRECNRQEVSAVVLLYMATQISSAMEYLEK-K 134

Query: 187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--YYRAPELIFGATE 244
              HRD+  +N LV  + H +K+ DFG ++++                + APE +    +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 245 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 304
           ++   D+W+ G +L E+            + Q+ E+++                    + 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDYRMER 237

Query: 305 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 354
           P            +  P +  +L+    Q++P+ R +  E  IH  F+ +
Sbjct: 238 P------------EGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 7e-37
 Identities = 53/304 (17%), Positives = 108/304 (35%), Gaps = 57/304 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLE---TGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 121
             V+G G FG V+    L+        A+K + +            E   M+   HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY 181
           SL         + E    +VL Y+     R        +    +  +  +  Q+ + + +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 182 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 236
           + +     HRD+  +N +++     +K+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           E +    ++T   D+WS G +L EL+  G P +P  +  D  V +++             
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALIHP 349
                              +  +  P    +++ +       +R +       + A+   
Sbjct: 250 ---------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

Query: 350 FFDE 353
           F  E
Sbjct: 295 FIGE 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 4e-36
 Identities = 69/293 (23%), Positives = 104/293 (35%), Gaps = 50/293 (17%)

Query: 67  YMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHP 118
               R +G G FG V Q   +       AVAIK               +E  TMR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRA 178
           ++V L           E  + +++E       R           + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 179 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAP 236
           LAY+ +     HRDI  +N+LV+ +   +KL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 237 ELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 295
           E I     +T+A D+W  G  + E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
                                    PP    L+++   Y P+ R    E    
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 5e-36
 Identities = 61/307 (19%), Positives = 109/307 (35%), Gaps = 65/307 (21%)

Query: 70  ERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDKRYKN-----RELQTM-RLLDHP 118
            + +G G+FG V +A        +    VA+K +              EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 119 NVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM--------------SQRM 163
           N+V+L       T      +  + EY     +   ++                      +
Sbjct: 88  NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 164 PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 223
            L  +  + YQ+ + +A++ +     HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200

Query: 224 NISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 279
            +    +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 280 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 339
           +IK                             +  +  +  P E  D++       P  R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 340 STALEAL 346
            T  + +
Sbjct: 293 PTFKQIV 299

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-35
 Identities = 57/300 (19%), Positives = 107/300 (35%), Gaps = 56/300 (18%)

Query: 70  ERVVGHGSFGVVFQAKCLETGE--AVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 121
           + V+G G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 122 SLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYV 168
           +L             YL L +EY P   +   ++    +            +  +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 169 KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 228
             +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 229 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 288
               + A E +   + YT   D+WS G +L E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 348
                         + P                 E  DL+ +  +  P  R +  + L+ 
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 52/294 (17%), Positives = 96/294 (32%), Gaps = 50/294 (17%)

Query: 66  SYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQDKRYKN-----RELQTMRLLD 116
               ++V+G G FG V++     +       VAIK +      K       E   M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
           H N++ L+             + ++ EY+        K   +      ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC----SRY 232
             + Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 233 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 292
           + APE I      +A+ D+WS G V+ E++        E    ++++ I           
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 293 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 346
                              +        P     L+ +  Q     R    + +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (317), Expect = 5e-34
 Identities = 58/311 (18%), Positives = 99/311 (31%), Gaps = 71/311 (22%)

Query: 71  RVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 120
           R +G G+FG VFQA+       E    VA+K + ++          RE   M   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 121 VSLKHCFFSTTEKDELYLNLVLEYVP---------------------ETVHRVIKHHYKM 159
           V              + L  + EY+                        +    +     
Sbjct: 79  V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 160 SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 219
              +          Q+   +AY+       HRD+  +N LV  +   +K+ DFG ++ + 
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191

Query: 220 KGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 275
             +      +      +  PE IF    YT   D+W+ G VL E+   G   + G +  +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 276 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 335
            +  +                          I A P      +  P E  +L+       
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282

Query: 336 PNLRSTALEAL 346
           P  R +     
Sbjct: 283 PADRPSFCSIH 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-33
 Identities = 58/310 (18%), Positives = 114/310 (36%), Gaps = 66/310 (21%)

Query: 67  YMAERVVGHGSFGVVFQAKCLETGEA-------VAIKKVLQDKRYKN-----RELQTM-R 113
            +  + +G G+FG V  A+ +   +        VA+K +  D   K+      E++ M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 114 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS------------ 160
           +  H N+++L           +  L +++EY  +  +   ++                  
Sbjct: 75  IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 161 QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 220
           +++    +    YQ+ R + Y+ +     HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 221 GEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQ 276
            +      +      + APE +F    YT   D+WS G +L E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 336
           L +++K                      P                 E   ++       P
Sbjct: 246 LFKLLK---------------EGHRMDKP------------SNCTNELYMMMRDCWHAVP 278

Query: 337 NLRSTALEAL 346
           + R T  + +
Sbjct: 279 SQRPTFKQLV 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 4e-32
 Identities = 57/310 (18%), Positives = 106/310 (34%), Gaps = 62/310 (20%)

Query: 67  YMAERVVGHGSFGVVFQAKC-----LETGEAVAIKKVLQD------KRYKNRELQTMRLL 115
               + +G G+FG V +A         T   VA+K + +       +   +     + + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 116 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-------------SQR 162
            H NVV+L              L +++E+             +                 
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 163 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 222
           + L ++  Y +Q+ + + ++ +     HRD+  +N+L++     +K+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 223 PNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLV 278
             +          + APE IF    YT   D+WS G +L E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 279 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 338
             +K                 T  + P                PE    +       P+ 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 339 RSTALEALIH 348
           R T  E + H
Sbjct: 281 RPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 7e-31
 Identities = 54/312 (17%), Positives = 110/312 (35%), Gaps = 63/312 (20%)

Query: 70  ERVVGHGSFGVVFQAKC-----LETGEAVAIKKV-----LQDKRYKNRELQTMRLLDHPN 119
            R +G GSFG+V++         E    VAIK V     ++++     E   M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 120 VVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLI------YVKLYF 172
           VV         ++       +++E +    +   ++         P++       +    
Sbjct: 85  VV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 173 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--- 229
            +I   +AY++      HRD+  +N +V      +K+ DFG  + + + +          
Sbjct: 140 GEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 230 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 288
              + +PE +     +T   D+WS G VL E+  L +  + G S    L  +++      
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250

Query: 289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------ 342
                                           P    +L+    QY+P +R +       
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

Query: 343 LEALIHPFFDEL 354
           ++  + P F E+
Sbjct: 289 IKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.7 bits (206), Expect = 1e-19
 Identities = 30/204 (14%), Positives = 56/204 (27%), Gaps = 32/204 (15%)

Query: 71  RVVGHGSFGVVFQAKCLETGEAVAIKKV--------------LQDKRYKNRELQTMRLLD 116
           +++G G    VF     E      +K                     + +         +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 117 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 176
              +  L+               +++E              K   R+ +         I 
Sbjct: 65  FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 177 RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 236
             +A  ++   + H D+   N+LV      + + DF  +  +  GE     I  R  R  
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRNI 168

Query: 237 ELIFGATEYTAAIDIWSAGCVLAE 260
              F    Y    DI SA   + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	403
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.17
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.92
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.82
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.98
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.87
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-65  Score=483.56  Aligned_cols=330  Identities=70%  Similarity=1.176  Sum_probs=292.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceEEEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELYLNLVL  142 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~  142 (403)
                      ..+|+..++||+|+||+||+|++..+|+.||||++..+.....+|+.+|+.++||||++++++|..... .+..+++|||
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            447999999999999999999999999999999998877777899999999999999999999866543 4667889999


Q ss_pred             ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccCC
Q 015615          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE  222 (403)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~  222 (403)
                      |||++++...+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||++.......
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            9999988877776666677899999999999999999999998 999999999999999877679999999998876666


Q ss_pred             CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccc
Q 015615          223 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  302 (403)
Q Consensus       223 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  302 (403)
                      ...+..||+.|+|||.+.+...++.++||||+||++|||++|++||.+.+..+.+..+.+.++.+..+.+....+.+...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            66778899999999998777779999999999999999999999999999999999999999999999999888888888


Q ss_pred             cCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCChhhcCCCC
Q 015615          303 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVP  382 (403)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (403)
                      .++.....++.....+.+++++.+||.+||++||++|||+.|+|+||||+++.++..++++....+.++++...++..- 
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-  336 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN-  336 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTC-
T ss_pred             cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCC-
Confidence            8888888888888888899999999999999999999999999999999999999888888888888889998888864 


Q ss_pred             hHHHhhcchHHHH
Q 015615          383 VDMLVKLIPEHAR  395 (403)
Q Consensus       383 ~~~~~~~~~~~~~  395 (403)
                      ...-...+|.+++
T Consensus       337 ~~~~~~~~p~~~r  349 (350)
T d1q5ka_         337 PPLATILIPPHAR  349 (350)
T ss_dssp             GGGHHHHSCTTTT
T ss_pred             ccccccCCCcccc
Confidence            4556666666553

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-60  Score=432.82  Aligned_cols=248  Identities=31%  Similarity=0.502  Sum_probs=212.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++...       .....+|+.+++.++|||||++++++.     +..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECC
Confidence            35799999999999999999999999999999998532       234568999999999999999999883     344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|+|||||++ +|.+.+...    ..+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCC-CEeeccccee
Confidence            58899999994 888887654    5799999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ...... ......||+.|||||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.+..           
T Consensus       154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----------  220 (263)
T d2j4za1         154 VHAPSS-RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------  220 (263)
T ss_dssp             SCCCCC-CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred             eecCCC-cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            765433 345668999999999997654 8999999999999999999999999887766665554310           


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                            +            .++..+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus       221 ------~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         221 ------F------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ------C------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                  0            123457999999999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-60  Score=436.73  Aligned_cols=253  Identities=27%  Similarity=0.347  Sum_probs=208.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...     .....+|+.+++.++|||||++++++..     ...+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            35799999999999999999999999999999998543     2345689999999999999999998843     3458


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |||||||++ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus        79 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~  152 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  152 (271)
T ss_dssp             EEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCC-CEEEccchhhee
Confidence            899999985 77666543    46799999999999999999999998 999999999999999887 799999999987


Q ss_pred             cccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          218 LVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       218 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      .....   .....+||+.|||||++.+...++.++|||||||++|+|+||++||...................       
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------  225 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  225 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence            64332   23456799999999999776655788999999999999999999998765433333222210000       


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                         ......+|+++.+||++||+.||++|||++|+|+||||++
T Consensus       226 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 -------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                               0012357999999999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=438.14  Aligned_cols=278  Identities=35%  Similarity=0.610  Sum_probs=226.5

Q ss_pred             EEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           69 AERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        69 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+++.++|||||++++++.     +..++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence            4678999999999999999999999999985332         23558999999999999999999883     334478


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||||.+++...+..   ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        77 ivmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCC-ccccccCccccccC
Confidence            9999999876655543   246688899999999999999999998 999999999999999887 79999999997654


Q ss_pred             cCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ... .....+||+.|+|||++.....++.++|||||||++|||+||.+||.+.+..+.+..+.+..+.|..+.+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            433 2345678999999999976666899999999999999999999999999999999999999998887765433322


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .....+...+..++...+ +.+++++.+||++||+.||++|||++|+|+||||++...|
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            222222233333333332 4679999999999999999999999999999999976544

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=434.45  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=212.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+.+++.++|||||+++++|..     ..++||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            3699999999999999999999999999999998543    2345689999999999999999998843     335889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      |||||++ +|.+++..     ..+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+...
T Consensus        95 vmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCC-cEeeccchhheeec
Confidence            9999995 67665543     4699999999999999999999998 999999999999999887 79999999998764


Q ss_pred             cCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ... ......||+.|+|||++.+. .++.++|||||||++|+|+||.+||.+.+..+.+..+..... +..         
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~---------  236 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PEL---------  236 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCC---------
T ss_pred             cccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCC---------
Confidence            433 34456799999999999765 489999999999999999999999999887777766654311 100         


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                      ..+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       237 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         237 ----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ----------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ----------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                            122457999999999999999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-59  Score=431.44  Aligned_cols=257  Identities=24%  Similarity=0.378  Sum_probs=218.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----------hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...          .....+|+.+|+.++|||||+++++|     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            35799999999999999999999999999999998532          23456899999999999999999988     3


Q ss_pred             CceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC---ceEE
Q 015615          134 DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH---QLKL  209 (403)
Q Consensus       134 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~---~vkl  209 (403)
                      +..++|||||||++ +|.+.+...    ..+++..++.++.||+.||+|||++ |||||||||+|||++.++.   .+||
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             ECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEe
Confidence            44568899999984 888888764    5799999999999999999999998 9999999999999987653   4999


Q ss_pred             eecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      +|||+|.....+.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.......+.
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  237 (293)
T ss_dssp             CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             cchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            999999887666666677899999999999764 4899999999999999999999999998877777666543211111


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                                               .+.+.+|+++++||++||+.||++|||++|+|+||||+....
T Consensus       238 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         238 -------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             -------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence                                     123468999999999999999999999999999999997643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-59  Score=431.55  Aligned_cols=252  Identities=31%  Similarity=0.530  Sum_probs=212.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...       .....+|+++++.++||||++++++|     .+...
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            4799999999999999999999999999999998532       23456899999999999999999988     33455


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +|+|||||++ +|.+.+...    +.+++..++.++.|++.||+|||++ |||||||||+|||++.++ .+||+|||+|+
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~-~vkl~DFG~a~  156 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTAK  156 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCc-eEEecccccce
Confidence            8899999995 787777654    6799999999999999999999998 999999999999999888 79999999998


Q ss_pred             ecccCC---CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          217 VLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       217 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      ......   ...+..||+.|||||++.+.. ++.++|||||||++|+|+||++||.+.+..+.+..+.+..         
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~---------  226 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE---------  226 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC---------
T ss_pred             ecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC---------
Confidence            764332   223567999999999997654 8999999999999999999999999988777666655310         


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHH------HhcCCCCccCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE------ALIHPFFDELRDP  357 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~e------ll~hp~f~~~~~~  357 (403)
                              +            .++..+|+++++||++||+.||++|||++|      +++||||+++.+.
T Consensus       227 --------~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         227 --------Y------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  276 (288)
T ss_dssp             --------C------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             --------C------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence                    0            123458999999999999999999999987      5889999998654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-58  Score=423.55  Aligned_cols=251  Identities=23%  Similarity=0.351  Sum_probs=207.2

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      |++.+.||+|+||+||+|++..+++.||+|.+....      ....+|+++|+.++|||||+++++|.... .+..++||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            478889999999999999999999999999985432      34568999999999999999999875433 34566889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |||||++ +|.+.+...    ..+++..++.++.||+.||+|||++ +  |+||||||+|||++.+.+.+||+|||+|+.
T Consensus        90 vmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999985 888887654    5789999999999999999999987 7  999999999999975333799999999975


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .. ........||+.|||||++.+  .++.++|||||||++|||++|+.||.+......+....... .++         
T Consensus       165 ~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~-~~~---------  231 (270)
T d1t4ha_         165 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKP---------  231 (270)
T ss_dssp             CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCC---------
T ss_pred             cc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC-CCC---------
Confidence            43 333456789999999999854  48999999999999999999999998776655544333211 110         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                                      ..++...++++.+||.+||+.||++|||++|+|+||||+
T Consensus       232 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                            113345789999999999999999999999999999996

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-59  Score=429.14  Aligned_cols=253  Identities=27%  Similarity=0.405  Sum_probs=204.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||.+....      ....+|+++++.++|||||++++++...   ....+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence            57999999999999999999999999999999985432      3355799999999999999999987542   22347


Q ss_pred             EEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ccccCCCCCceEecCCCCceEEeec
Q 015615          139 NLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-----VCHRDIKPQNLLVNPHTHQLKLCDF  212 (403)
Q Consensus       139 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~-----ivH~Dlkp~NIll~~~~~~vkl~Df  212 (403)
                      |||||||+ |+|.+++.........+++..++.++.||+.||+|||++ |     ||||||||+|||++.++ .+||+||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~-~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF  158 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTS-CEEECCH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCC-cEEEeec
Confidence            89999998 589998887666678899999999999999999999986 5     99999999999999887 7999999


Q ss_pred             CCceecccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          213 GSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       213 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      |+|+....... .....||+.|||||++.+. .++.++|||||||++|||+||++||.+.+..+....+....       
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-------  230 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-------  230 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------
Confidence            99987644332 3456889999999999654 48999999999999999999999999887776666654421       


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  351 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f  351 (403)
                                  ++         .++..+|+++.+||++||+.||.+|||++|+|+|||+
T Consensus       231 ------------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 ------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             ------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ------------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                        00         1234579999999999999999999999999999995

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-58  Score=429.11  Aligned_cols=288  Identities=33%  Similarity=0.561  Sum_probs=235.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccC-CcEEEEEEeccc------hhhhHHHHHHHHHc---CCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLET-GEAVAIKKVLQD------KRYKNRELQTMRLL---DHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~------~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~  133 (403)
                      ..+|++.+.||+|+||+||+|++..+ ++.||||++...      .....+|+.+++.+   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            45899999999999999999999765 677999998532      22345788877766   799999999998766556


Q ss_pred             CceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          134 DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       134 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+++++||||.+++.......  ....+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~-~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCC-Ceeecchh
Confidence            67788999999998766554432  246789999999999999999999998 999999999999999888 79999999


Q ss_pred             CceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      +++............||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+.+..+.+....+.
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            998765555556778999999999997654 8999999999999999999999999999999999999999988876654


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                      ...... ...+......+. ..+...+++++.+||++||++||++|||++|+|+||||++++.+.
T Consensus       241 ~~~~~~-~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k  303 (305)
T d1blxa_         241 RDVALP-RQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  303 (305)
T ss_dssp             TTCSSC-GGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccccch-hhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence            321111 111111111222 224467899999999999999999999999999999999987653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=431.08  Aligned_cols=283  Identities=35%  Similarity=0.644  Sum_probs=231.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...      .....+|+++++.++|||||+++++|..     ...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            4799999999999999999999999999999998543      2345689999999999999999999843     3458


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      |+||||+.+++...+....  ...+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccC-cceeccCCcceec
Confidence            9999999988777665432  46799999999999999999999998 999999999999999887 7999999999866


Q ss_pred             ccC-CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ... .......||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            433 3334568899999999987777678999999999999999999999999999999999998888877654432211


Q ss_pred             Cc-ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          298 NY-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       298 ~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .. .....+......+.. ..+.+|+++.+||++||+.||++|||++|+|+||||+++..|
T Consensus       233 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            00 001112222222222 224688999999999999999999999999999999998766

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-59  Score=429.12  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=211.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++...    .....+|+++|+.++|||||++++++..     ...++|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence            4699999999999999999999999999999998542    2455689999999999999999998843     335889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      |||||++ +|.+.+.+.   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCC-CEEEEechhhhccC
Confidence            9999985 777766543   35799999999999999999999998 999999999999999888 79999999997653


Q ss_pred             cCC-CcceeeecccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          220 KGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       220 ~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      ... ......||+.|||||++..    ...|+.++|||||||++|+|+||++||.+.+..+.+..+.+..  ++      
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~------  233 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PP------  233 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CC------
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC------
Confidence            321 2235679999999999842    3347899999999999999999999999988777776665521  00      


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                 .       ...+..+|+++.+||++||+.||++|||++|+|+||||+.
T Consensus       234 -----------~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 -----------T-------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             -----------C-------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             -----------C-------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                       0       0012457999999999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-58  Score=439.23  Aligned_cols=259  Identities=26%  Similarity=0.408  Sum_probs=220.2

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .+|++.+.||+|+||.||+|+++.+|+.||||++....    ....+|+.+|+.++|||||+++++|..     ...+||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            47999999999999999999999999999999986432    345689999999999999999998843     345889


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC-CCceEEeecCCceec
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVL  218 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~~  218 (403)
                      |||||++ +|.+.+...   ...+++..++.++.||+.||.|||++ |||||||||+|||++.+ .+.+||+|||+|+..
T Consensus       101 vmE~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999985 787777532   35699999999999999999999998 99999999999999643 237999999999987


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ..........||+.|||||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+......++.         
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------  246 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD---------  246 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC---------
T ss_pred             ccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---------
Confidence            6666666788999999999997654 899999999999999999999999998888877777653221111         


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  358 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~  358 (403)
                                      .....+|+++++||++||+.||++|||++|+|+||||+....+.
T Consensus       247 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         247 ----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             ----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred             ----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence                            12245799999999999999999999999999999999876543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-59  Score=435.19  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=199.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++|||||++++++     .+..++|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            46999999999999999999999999999999985432     2345799999999999999999988     3445688


Q ss_pred             EEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC---CCCceEEeecCCc
Q 015615          140 LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSA  215 (403)
Q Consensus       140 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~DfG~a  215 (403)
                      ||||||+ ++|.+.+..    ...+++..++.++.||+.||+|||++ |||||||||+|||+..   ++ .+||+|||+|
T Consensus        84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a  157 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDS-KIMISDFGLS  157 (307)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred             EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCc-eEEEecccee
Confidence            9999998 588888865    36799999999999999999999998 9999999999999953   44 7999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      +.........+.+||+.|||||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+.+....+        
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--------  228 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF--------  228 (307)
T ss_dssp             ---------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC--------
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC--------
Confidence            8776555556678999999999997654 8999999999999999999999999888777666665421111        


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                       .....+.+|+++.+||++||+.||++|||++|+|+||||++
T Consensus       229 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         229 -----------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             -----------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             -----------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                             01123468999999999999999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-58  Score=430.67  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=215.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+|++.+.||+|+||.||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||++++++|     .+..+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence            4799999999999999999999999999999998643       23346799999999999999999988     44556


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +|+|||||++ +|...+...    ..+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g-~vkl~DFG~a~  153 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLCK  153 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTCB
T ss_pred             cccceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCC-CEEEeeccccc
Confidence            8999999995 777777654    6789999999999999999999998 999999999999999888 79999999998


Q ss_pred             eccc-CCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          217 VLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       217 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .... .......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+....           
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-----------  221 (337)
T d1o6la_         154 EGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-----------  221 (337)
T ss_dssp             CSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             ccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-----------
Confidence            6543 33445678999999999997654 8999999999999999999999999988777666555420           


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                            .            .++..+|+++++||++||++||.+|++     ++++++||||+++.+
T Consensus       222 ------~------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         222 ------I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             ------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------C------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                  0            133568999999999999999999994     999999999998643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-58  Score=438.07  Aligned_cols=256  Identities=27%  Similarity=0.396  Sum_probs=217.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+.|++.+.||+|+||.||+|++..+|+.||||++...    .....+|+.+|+.++|||||+++++|.     +...+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence            35699999999999999999999999999999998643    234567999999999999999999883     445588


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecC-CCCceEEeecCCcee
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKV  217 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~DfG~a~~  217 (403)
                      ||||||+| +|.+.+...   ..++++..++.++.||+.||+|||++ |||||||||+|||++. +.+.+||+|||+|..
T Consensus       103 ivmE~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         103 LILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeeccccee
Confidence            99999995 776655432   45799999999999999999999988 9999999999999973 223799999999998


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........||+.|||||++.+.. ++.++|||||||++|+|+||++||.+.+..+.+..+......++         
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------  248 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------  248 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred             cCCCCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            87666666788999999999997654 89999999999999999999999999888887777765321111         


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                      ......+|+++.+||++||+.||.+|||++|+|+||||++.
T Consensus       249 ----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 ----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             ----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                            11224589999999999999999999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-58  Score=428.81  Aligned_cols=250  Identities=28%  Similarity=0.437  Sum_probs=209.8

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..|++.+.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.++|||||++++++..     ..+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence            35999999999999999999999999999999985432       234579999999999999999998843     335


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|||||||.+++...+...   ...+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||+|..
T Consensus        90 ~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCC-CEEEeecccccc
Confidence            8899999997655444332   36799999999999999999999998 999999999999999887 799999999986


Q ss_pred             cccCCCcceeeecccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ...   .....||+.|||||++.+.  ..|+.++|||||||++|||++|.+||.+.+..+.+..+......+        
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------  233 (309)
T d1u5ra_         165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------  233 (309)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred             cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence            532   3456899999999998642  348999999999999999999999999888777776665421100        


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                                         ..+..+|+++.+||.+||+.||++|||++++|+||||..-
T Consensus       234 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         234 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             -------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence                               0123578999999999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=435.89  Aligned_cols=280  Identities=25%  Similarity=0.427  Sum_probs=208.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++..+     .....+|+.+|+.++|||||+++++|.     +...+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            45799999999999999999999999999999998543     234568999999999999999999884     33458


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      |+|||||++ +|.+++.+.    ..+++..++.++.||+.||.|||++.||+||||||+|||++.++ .+||+|||+|+.
T Consensus        80 ~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  154 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccc
Confidence            899999995 888887654    56999999999999999999999632899999999999999888 799999999986


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhccC
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .... ...+.+||+.|||||++.+.. |+.++||||+||++|||++|+.||.+.+..+. ...+....+.+.........
T Consensus       155 ~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         155 LIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             cCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            6433 234678999999999998754 99999999999999999999999988654332 22222222221111000000


Q ss_pred             cC--cccc---cCCC---------ccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCC
Q 015615          297 PN--YTEF---KFPQ---------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  355 (403)
Q Consensus       297 ~~--~~~~---~~~~---------~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~  355 (403)
                      ..  ....   ..+.         ....+........+|.++++||++||+.||.+|||++|+|+||||++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            00  0000   0000         0000111111234688999999999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-57  Score=425.54  Aligned_cols=249  Identities=27%  Similarity=0.461  Sum_probs=213.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...       .....+|+.+++.++|||||++++++.     +..+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence            4699999999999999999999999999999998542       234568999999999999999999883     4456


Q ss_pred             EEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +|+|||||.| ++...+..    ...+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+
T Consensus        79 ~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g-~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             eeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCC-CEEEecCccce
Confidence            8999999996 55555554    36688999999999999999999998 999999999999999888 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ....  ...+.+||+.|||||++.+.. ++.++|||||||++|+|+||+.||.+.+..+....+.....           
T Consensus       153 ~~~~--~~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----------  218 (316)
T d1fota_         153 YVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----------  218 (316)
T ss_dssp             ECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----------
T ss_pred             Eecc--ccccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------
Confidence            7643  334678999999999997654 89999999999999999999999999888777776655210           


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                                        .++..+|+++.++|++||+.||.+|+     |++++++||||+++.+
T Consensus       219 ------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         219 ------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence                              12345799999999999999999996     9999999999999754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-57  Score=427.20  Aligned_cols=316  Identities=32%  Similarity=0.557  Sum_probs=239.5

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  136 (403)
                      ..+|++.+.||+|+||+||+|.++.+|+.||||++....      ....+|+.+|+.++|||||+++++|..... ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357999999999999999999999999999999986431      234579999999999999999998855332 2334


Q ss_pred             EEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          137 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       137 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      ++|+|||||+.++...+..     .++++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||+|+
T Consensus        97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhccccc-cccccccccee
Confidence            5789999998777776653     5799999999999999999999998 999999999999999888 79999999998


Q ss_pred             ecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          217 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ....  ......||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+....
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         170 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            7533  33457899999999999877768999999999999999999999999999999999999999999887665433


Q ss_pred             cCccc---ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCC
Q 015615          297 PNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNF  373 (403)
Q Consensus       297 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~  373 (403)
                      .....   ...+......+... ...+++++.+||++||+.||++|||++|+|+||||+++.++......     +.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~-----~~~~~  321 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV-----QKYDD  321 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC-----CCCCC
T ss_pred             chhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccC-----CCCCC
Confidence            22110   11222333333333 25689999999999999999999999999999999998765432111     11111


Q ss_pred             ChhhcCCCChHHHhhcchHHHH
Q 015615          374 KPHELKGVPVDMLVKLIPEHAR  395 (403)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~  395 (403)
                      .-.+.. -+.+.+++.+-+|+.
T Consensus       322 ~~~~~~-~~~~e~k~~~~~e~~  342 (346)
T d1cm8a_         322 SFDDVD-RTLDEWKRVTYKEVL  342 (346)
T ss_dssp             C------CCHHHHHHHHHHHHH
T ss_pred             chhhhh-cCHHHHHHHHHHHhh
Confidence            112222 356777776666554

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.5e-57  Score=414.95  Aligned_cols=254  Identities=26%  Similarity=0.393  Sum_probs=216.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------------hhhHHHHHHHHHcC-CCCeeecceeeeec
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFFST  130 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~niv~~~~~~~~~  130 (403)
                      .+|++.+.||+|+||+||+|++..+|+.||||++....             ....+|+.+++.++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            57999999999999999999999999999999985431             13457999999997 99999999988   


Q ss_pred             CCCCceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEE
Q 015615          131 TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL  209 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl  209 (403)
                        .+..++|||||||+ ++|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEE
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCC-CeEE
Confidence              34456899999998 4898888754    5799999999999999999999987 999999999999999887 7999


Q ss_pred             eecCCceecccCCCcceeeecccccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015615          210 CDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL  284 (403)
Q Consensus       210 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  284 (403)
                      +|||+++....+.......||+.|+|||.+.+     ...++.++||||+||++|+|++|++||.+.+..+....+....
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999998766655666789999999999852     3347889999999999999999999999988777776666531


Q ss_pred             CCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          285 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      ..++.                         ....++|+++++||++||+.||++|||++|+|+||||++.
T Consensus       232 ~~~~~-------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         232 YQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCCCC-------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            11100                         0123589999999999999999999999999999999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.6e-57  Score=426.18  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=214.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++....       ....+|+.+|+.++|||||++++++     .+..
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence            468999999999999999999999999999999985321       2345899999999999999999988     3344


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+++||||+.+ ++...+...    ..+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g-~ikL~DFG~a  188 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFGFA  188 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCC-CEEeeeceee
Confidence            58899999985 777777654    5799999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          216 KVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      +.....  .....||+.|||||++.+.. ++.++|||||||++|+|+||++||.+.+....+..+.....          
T Consensus       189 ~~~~~~--~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------  255 (350)
T d1rdqe_         189 KRVKGR--TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------  255 (350)
T ss_dssp             EECSSC--BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred             eecccc--cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC----------
Confidence            876432  34578999999999997654 89999999999999999999999999887777776655210          


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                                         .++..+|+++.+||++||+.||.+|+     |++++++||||+.+.+
T Consensus       256 -------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         256 -------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             -------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                               12345899999999999999999995     9999999999998754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.5e-57  Score=416.60  Aligned_cols=277  Identities=34%  Similarity=0.630  Sum_probs=223.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...      .....+|+.+|+.++||||++++++|..     ....
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCce
Confidence            47999999999999999999985 7899999998543      2345689999999999999999998843     3347


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +++|||+.+++...+...   ...+++..++.++.||+.||+|||+. |||||||||+|||++.++ .+||+|||.|...
T Consensus        76 ~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            899999998877666543   47799999999999999999999998 999999999999999888 7999999999765


Q ss_pred             ccCCC-cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          219 VKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       219 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ..... .....+++.|+|||.+.+...++.++|||||||++|||++|++||.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            43322 33456899999999998777789999999999999999999999999999999999999888887665432211


Q ss_pred             Ccc-cccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          298 NYT-EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       298 ~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                      ... ..........++. .+...+++++.|||++||++||++|||++|+|+||||++
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcchh-hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            100 0111111122222 234568999999999999999999999999999999985

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-57  Score=424.49  Aligned_cols=255  Identities=26%  Similarity=0.409  Sum_probs=218.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .++|++.+.||+|+||+||+|.++.+|+.||||.+....   ....+|+++|+.++|||||+++++|.     +..++||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence            457999999999999999999999999999999996543   34568999999999999999999884     3345899


Q ss_pred             EEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC-CceEEeecCCceec
Q 015615          141 VLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT-HQLKLCDFGSAKVL  218 (403)
Q Consensus       141 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~-~~vkl~DfG~a~~~  218 (403)
                      |||||+| +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ ..+||+|||+++..
T Consensus        79 vmE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          79 IFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999995 788777543   34699999999999999999999998 999999999999997543 37999999999887


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ..........+|+.|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.+.....+..        
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------  225 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--------  225 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH--------
T ss_pred             ccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh--------
Confidence            6655566778899999999986654 8999999999999999999999999998888887777643222222        


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                                       ..+.+|+++++||.+||..||.+|||++|+|+||||++
T Consensus       226 -----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         226 -----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -----------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                             22457999999999999999999999999999999976

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.9e-57  Score=430.40  Aligned_cols=254  Identities=26%  Similarity=0.380  Sum_probs=207.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHH---HHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      .+|++.+.||+|+||.||+|++..+|+.||||++....       ....+   |+.+++.++|||||+++++|.     +
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence            47999999999999999999999999999999985321       12223   456666778999999999883     3


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ...+|+|||||+ ++|.+.+...    ..+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g-~iKl~DFG  152 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLG  152 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCC-cEEEeeec
Confidence            345889999999 5888888764    5688999999999999999999998 999999999999999888 79999999


Q ss_pred             CceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015615          214 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  293 (403)
Q Consensus       214 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  293 (403)
                      +|+..... ......||+.|||||++.+...++.++|||||||++|+|+||++||.+.+..+...........+      
T Consensus       153 la~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~------  225 (364)
T d1omwa3         153 LACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------  225 (364)
T ss_dssp             TCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC------
T ss_pred             eeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC------
Confidence            99876543 33456899999999999766668999999999999999999999998765433222111111100      


Q ss_pred             ccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCC-----HHHHhcCCCCccCCC
Q 015615          294 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHPFFDELRD  356 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s-----~~ell~hp~f~~~~~  356 (403)
                                          ..++..+|+++++||.+||+.||++|||     ++++++||||+++.+
T Consensus       226 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         226 --------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             --------------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                                0123468999999999999999999999     799999999998753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-57  Score=421.86  Aligned_cols=250  Identities=28%  Similarity=0.500  Sum_probs=210.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHH-HHcCCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTM-RLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++..+.       ....+|..++ +.++|||||++++++     .+..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            46999999999999999999999999999999986432       2234566655 468999999999988     3345


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      ++|||||||++ +|.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCC-ceeccccchh
Confidence            58999999995 888887654    5689999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhc
Q 015615          216 KVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  294 (403)
Q Consensus       216 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  294 (403)
                      +...... ......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+.+..+....+...  .+       
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------  220 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------  220 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence            8654333 334468999999999997654 899999999999999999999999998877766666441  11       


Q ss_pred             cCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHH-HHhcCCCCccCC
Q 015615          295 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-EALIHPFFDELR  355 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~-ell~hp~f~~~~  355 (403)
                                          .+++.+|+++.+||++||+.||.+|||+. ++++||||+++.
T Consensus       221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                                12345799999999999999999999995 899999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=419.47  Aligned_cols=316  Identities=33%  Similarity=0.622  Sum_probs=240.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      .+|++.+.||+|+||+||+|.+..+|+.||||++....     ....+|+.+|+.++||||+++++++.........+++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            46999999999999999999999999999999986432     2345799999999999999999998665544455577


Q ss_pred             EEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          140 LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       140 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ++|++++++|.+++..     .++++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|....
T Consensus        88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCC-CEEEcccCceeecc
Confidence            8888887899988864     4699999999999999999999998 999999999999999887 79999999998653


Q ss_pred             cCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          220 KGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       220 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      ....    .....||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+...........+........
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            3322    234678999999999866666899999999999999999999999999988888888888888877654322


Q ss_pred             CcC-c--ccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCC
Q 015615          296 NPN-Y--TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFN  372 (403)
Q Consensus       296 ~~~-~--~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~  372 (403)
                      ... .  .....+.....++...+ +.+|+++++||.+||+.||.+|||++|+|+||||++...+...    ...++.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~----~~~~~~~~  315 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE----PIAEAPFK  315 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGS----CCCSSCC-
T ss_pred             hhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccC----ccccCccC
Confidence            110 0  01122223333343333 4689999999999999999999999999999999987666432    12233333


Q ss_pred             CChhhcCCCChHHHhhcchHH
Q 015615          373 FKPHELKGVPVDMLVKLIPEH  393 (403)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~  393 (403)
                      +. .+....+.+-++.++.+|
T Consensus       316 ~~-~~~~~~~~~~l~~l~~~e  335 (345)
T d1pmea_         316 FD-MELDDLPKEKLKELIFEE  335 (345)
T ss_dssp             --------CCHHHHHHHHHHH
T ss_pred             CC-hhhhhCCHHHHHHHHHHH
Confidence            43 444455666666554443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=411.66  Aligned_cols=246  Identities=27%  Similarity=0.418  Sum_probs=205.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----------hhhHHHHHHHHHcC--CCCeeecceeeeecCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTE  132 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~  132 (403)
                      .+|++.+.||+|+||.||+|++..+|+.||||++....          ....+|+.+++.++  |||||+++++|.    
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~----   79 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE----   79 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence            47999999999999999999999999999999985432          22458999999997  899999999883    


Q ss_pred             CCceEEEEEEecccc--hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          133 KDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       133 ~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                       +...+++||||+.+  ++.+.+...    ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+++.+||+
T Consensus        80 -~~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          80 -RPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             -CSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEEC
T ss_pred             -eCCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEEC
Confidence             33457899999973  566666553    6799999999999999999999998 999999999999998765589999


Q ss_pred             ecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          211 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       211 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      |||+|+.... ....+..||+.|+|||++.+...++.++|||||||++|+|+||+.||.+.+      .+.+.       
T Consensus       154 DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-------  219 (273)
T d1xwsa_         154 DFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-------  219 (273)
T ss_dssp             CCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred             ccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence            9999986533 334567899999999999766656788999999999999999999997532      11110       


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                           .                 ..++..+|+++++||++||+.||++|||++|+|+||||+++..
T Consensus       220 -----~-----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         220 -----Q-----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             -----C-----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             -----c-----------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence                 0                 0133568999999999999999999999999999999998643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-55  Score=415.91  Aligned_cols=281  Identities=30%  Similarity=0.518  Sum_probs=222.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++ ||||++++++|...   ...++++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence            5799999999999999999999999999999998654 345678999999995 99999999987432   334478999


Q ss_pred             ecccch-HHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~~~-l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      |||+++ |...       .+.+++..++.++.||+.||+|||++ |||||||||+|||++.+++.+||+|||+|......
T Consensus       112 e~~~~~~L~~~-------~~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQL-------YQTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGT-------TTSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHH-------hcCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999964 3221       35699999999999999999999998 99999999999999977767999999999887666


Q ss_pred             CCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhccCcCcc
Q 015615          222 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPNYT  300 (403)
Q Consensus       222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~  300 (403)
                      .......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.... ..++...+...++.+....+........
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence            666777899999999999877778999999999999999999999997654 4556666767666555443322111100


Q ss_pred             ccc----CCCccCCCcccc----cccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCC
Q 015615          301 EFK----FPQIKAHPWHKI----FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  356 (403)
Q Consensus       301 ~~~----~~~~~~~~~~~~----~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~  356 (403)
                      ...    ........+...    ....+|+++.|||++||++||++|||++|+|+||||+.+.+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            000    011111111111    22457899999999999999999999999999999998754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-56  Score=417.89  Aligned_cols=263  Identities=26%  Similarity=0.361  Sum_probs=209.3

Q ss_pred             ccceEEEe-EeeeCCcEEEEEEEEccCCcEEEEEEeccchhhhHHHHHHHHH-cCCCCeeecceeeeecCCCCceEEEEE
Q 015615           64 TISYMAER-VVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRYKNRELQTMRL-LDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        64 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .++|.+.. .||+|+||+||+|++..+|+.||||++.. .....+|+.++.+ .+|||||+++++|.... ....++|||
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence            45798875 69999999999999999999999999864 4456689988654 58999999999874422 345678999


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC--CceEEeecCCceec
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKVL  218 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~a~~~  218 (403)
                      ||||+ |+|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++  ..+||+|||+|+..
T Consensus        88 mEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          88 MECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeeec
Confidence            99998 58988887532  35799999999999999999999998 999999999999998532  36999999999887


Q ss_pred             ccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          219 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ..........||+.|||||++.+.. |+.++|||||||++|+|+||++||.+.+.......+......            
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~------------  231 (335)
T d2ozaa1         165 TSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM------------  231 (335)
T ss_dssp             CCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS------------
T ss_pred             cCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc------------
Confidence            6666666788999999999996544 899999999999999999999999876654443333221100            


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCcc
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  353 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~  353 (403)
                       ..+.++        ......+|+++.+||++||+.||++|||+.|+|+||||++
T Consensus       232 -~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 -GQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             -CSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             -CCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence             001111        1112357999999999999999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=417.91  Aligned_cols=284  Identities=31%  Similarity=0.540  Sum_probs=220.7

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....      ....+|+.+++.++||||++++++|..... +...+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            46999999999999999999999999999999986431      235589999999999999999999854332 34567


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      +|+|||||.+++.+.+.      ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~-~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCcccccccccc-ceeeechhhhhc
Confidence            89999999998776552      5689999999999999999999998 999999999999999888 699999999987


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ...........+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+.......+....+.+..+.+.....
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            7666666677899999999999765 589999999999999999999999999999999999999999888877655443


Q ss_pred             Cccccc--CCCccCCCcc-----------cccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          298 NYTEFK--FPQIKAHPWH-----------KIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       298 ~~~~~~--~~~~~~~~~~-----------~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      .+..+.  .+......+.           .......|+++.+||++||.+||++||||+|+|+||||++..++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence            221110  0001111111           11122346789999999999999999999999999999987554

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-55  Score=403.89  Aligned_cols=283  Identities=34%  Similarity=0.556  Sum_probs=224.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      .+|++.+.||+|+||+||+|++..+|+.||||+++...      ....+|+.+++.++||||+++++++.     +..+.
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence            37999999999999999999999999999999985432      34468999999999999999999883     34457


Q ss_pred             EEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          139 NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       139 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      ++||+++.++.+..+...   .+.+++..++.++.|++.||+|||++ |||||||||+|||++.++ .+||+|||.|+..
T Consensus        77 ~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            899999997655444432   46789999999999999999999998 999999999999999887 7999999999876


Q ss_pred             ccCC-CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          219 VKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       219 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      .... ......+++.|+|||++.....++.++|||||||++|||++|+.|| .+.+..+.+..+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            5433 2334466888999999877666799999999999999999999774 5566677777788877777665443322


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCC
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  357 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~  357 (403)
                      ........+..............+++.+.+||++||++||.+|||++|+|+||||++...|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            1111111222222222223345689999999999999999999999999999999987544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-55  Score=410.04  Aligned_cols=286  Identities=29%  Similarity=0.475  Sum_probs=221.9

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCC---CC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTE---KD  134 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  134 (403)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...      .....+|+.+|+.++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            56899999999999999999999999999999987433      1234589999999999999999998754321   22


Q ss_pred             ceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          135 ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       135 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..++|+|||||.+++.......   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCC-cEEeeecce
Confidence            3457899999998766655433   46789999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecccCC-----CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015615          215 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  289 (403)
Q Consensus       215 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  289 (403)
                      ++......     ......||+.|+|||++.+...++.++||||+||++|||++|++||.+.+..+.+..+....+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97653221     2234578999999999987767899999999999999999999999999999999999998888776


Q ss_pred             HHHhccCcCc--ccccCCCccCCCccccc-ccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccC
Q 015615          290 EEIKCMNPNY--TEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  354 (403)
Q Consensus       290 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~  354 (403)
                      +.+......-  ..+.............+ ....+++++|||.+||++||++|||++|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            5433222111  11111111111111111 11247889999999999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=411.52  Aligned_cols=314  Identities=32%  Similarity=0.556  Sum_probs=241.1

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch------hhhHHHHHHHHHcCCCCeeecceeeeecCC-CCceE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTE-KDELY  137 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  137 (403)
                      .+|++.+.||+|+||+||+|++..+|+.||||++....      ....+|+.+|+.++|||||++++++..... .+..+
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            47999999999999999999999999999999986432      234589999999999999999998754433 22334


Q ss_pred             EEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          138 LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       138 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      .++++++++++|.+++.     .+++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+|++|||++..
T Consensus        98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~-~~kl~dfg~a~~  170 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  170 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred             EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccc-cccccccchhcc
Confidence            45566555578887764     25799999999999999999999998 999999999999999888 799999999875


Q ss_pred             cccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          218 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ..  ....+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+.......
T Consensus       171 ~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             CT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            42  2344567899999999987777689999999999999999999999999999999999999988888765543322


Q ss_pred             Cccc---ccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCccCCCCCCCCCCCCCCCCCCCCC
Q 015615          298 NYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFK  374 (403)
Q Consensus       298 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~  374 (403)
                      ....   ...+......+...+ ..+++++++||++||+.||.+|||++|+|+||||++..++....     ....+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~-----~~~~~~~~  322 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYDQS  322 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC-----CCCCCCCG
T ss_pred             hhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC-----CCCCCCCc
Confidence            1110   012222223333322 46899999999999999999999999999999999987665321     11222222


Q ss_pred             hhhcCCCChHHHhhcchHHH
Q 015615          375 PHELKGVPVDMLVKLIPEHA  394 (403)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~  394 (403)
                       .+-.....+.++.+.-+|.
T Consensus       323 -~~~~~~~~~~~k~~~~~e~  341 (348)
T d2gfsa1         323 -FESRDLLIDEWKSLTYDEV  341 (348)
T ss_dssp             -GGGCCCCHHHHHHHHHHHH
T ss_pred             -ccchhcCHHHHHHHHHHHh
Confidence             3445566677777665554

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.8e-54  Score=393.68  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=202.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch-------hhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            357999999999999999999999999999999985431       23468999999999999999999875543 3445


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+|||||||+| +|.+.+...    +.+++..++.++.||+.||+|||++ |||||||||+|||++.++ .++|+|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~-~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTS-CEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccc-cceeehhhhh
Confidence            67899999995 677666553    6799999999999999999999998 999999999999999887 7999999998


Q ss_pred             eecccCC----CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          216 KVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       216 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      .......    ......||+.|||||++.+. .++.++|||||||++|+|+||++||.+.+..+.+..+......++   
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~---  234 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---  234 (277)
T ss_dssp             EECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG---
T ss_pred             hhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC---
Confidence            7553322    23356789999999999765 489999999999999999999999999887777766655211111   


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcCCCCc
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  352 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~hp~f~  352 (403)
                                            ....+.+|+++.+||++||+.||++||+..+.+.|+|.+
T Consensus       235 ----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                  112356899999999999999999999544444566543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-53  Score=392.84  Aligned_cols=247  Identities=19%  Similarity=0.277  Sum_probs=201.2

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++..+   ...+.+|+.+|+.++|||||++++++..     ...+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee-----CCeeEE
Confidence            45799999999999999999999999999999998654   3445689999999999999999998843     233689


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      |||||+ |++...+....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCC-cEEEccccceeecC
Confidence            999999 57887776532  46789999999999999999999998 999999999999999887 79999999998654


Q ss_pred             cCCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          220 KGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       220 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      .....  ....||+.|+|||++.+.. ++.++|||||||++|||++|..||........+.++......+          
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~----------  235 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM----------  235 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred             CCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC----------
Confidence            43322  2345789999999997654 8999999999999999999766655544444444433311000          


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                       .++..+|+++.+||.+||+.||++|||++++++
T Consensus       236 -----------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         236 -----------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                             123457999999999999999999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=387.71  Aligned_cols=248  Identities=21%  Similarity=0.279  Sum_probs=197.3

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY  137 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  137 (403)
                      ..+|++.+.||+|+||+||+|+.   +..||||++...      ...+.+|+.++++++|||||++++++..    +  .
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--Q   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred             cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--E
Confidence            45799999999999999999985   335999998532      2345689999999999999999886521    1  2


Q ss_pred             EEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCce
Q 015615          138 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       138 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      +++|||||+ |+|.+.+...   ...+++..+..++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCC-CEEEcccccee
Confidence            679999999 5888887643   35699999999999999999999998 999999999999999887 79999999997


Q ss_pred             ecccCC---CcceeeecccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          217 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       217 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      ......   ......||+.|||||++.+.  ..++.++|||||||++|||+||+.||.+.+....+.........++.  
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~--  230 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD--  230 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC--
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc--
Confidence            654322   22345789999999998643  24789999999999999999999999988777666555543211110  


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                           ....+..+|+++.+|+.+||..||++|||+++++++
T Consensus       231 ---------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         231 ---------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ---------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                 011235678999999999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-53  Score=396.67  Aligned_cols=250  Identities=21%  Similarity=0.307  Sum_probs=202.8

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCc-----EEEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGE-----AVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||+|+||+||+|++..+++     .||+|.+...     .....+|+.++..+ +|||||++++++..   
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---  112 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---  112 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee---
Confidence            3579999999999999999999876543     6999988532     23456799999988 89999999998843   


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcc-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYK-------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD  192 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~D  192 (403)
                        ...+++|||||+ |+|.+++.....                   ....+++..++.++.||+.||+|||++ ||||||
T Consensus       113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRD  189 (325)
T d1rjba_         113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRD  189 (325)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETT
T ss_pred             --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-Ceeecc
Confidence              334789999998 588888875431                   124588999999999999999999998 999999


Q ss_pred             CCCCceEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 015615          193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  268 (403)
Q Consensus       193 lkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf  268 (403)
                      |||+|||++.++ .+||+|||+|+........   ....||+.|||||++.+.. ++.++|||||||++|||+| |.+||
T Consensus       190 lKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         190 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCC
Confidence            999999999887 7999999999876544332   2456799999999997654 8999999999999999998 89999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          269 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       269 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .+.+..+.+.++......+                           ..+..+|+++.+||.+||+.||++|||++|+++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9877666666655421111                           1234578999999999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-53  Score=391.40  Aligned_cols=246  Identities=24%  Similarity=0.344  Sum_probs=190.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCc---EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGE---AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||+||+|+++.+|+   .||||.+...     .+.+.+|+.+|+.++|||||++++++...     
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence            3579999999999999999999877664   5899987532     23456899999999999999999987432     


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+++|||||++ +|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGl  174 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNL-VCKVSDFGL  174 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred             CEEEEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCC-cEEECCccc
Confidence            237899999995 677766543   35689999999999999999999998 999999999999999888 799999999


Q ss_pred             ceecccCCCc------ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          215 AKVLVKGEPN------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       215 a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      |+........      ....+|+.|||||++.+. .++.++|||||||++|||+| |++||.+.+..+.+..+......+
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~  253 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP  253 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9876433221      124568899999999765 48999999999999999998 899999887766655554321111


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                                  .+..+++++.+|+.+||+.||++|||+.+++++
T Consensus       254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                        124578999999999999999999999998864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-53  Score=384.22  Aligned_cols=244  Identities=20%  Similarity=0.326  Sum_probs=191.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|+||+||+|++. +++.||||++..+   .....+|+.+++.++|||||++++++...     ..+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEE
Confidence            36999999999999999999975 5778999998643   34556899999999999999999988432     236799


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      ||||+ |+|.+++...   ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus        79 ~E~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred             EEecCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCC-CeEecccchheeccC
Confidence            99998 5787777653   35688999999999999999999998 999999999999999887 799999999987644


Q ss_pred             CCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  ....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||...+..+.+..+......           
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-----------  221 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-----------  221 (263)
T ss_dssp             -----------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-----------
T ss_pred             CCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence            3322  2356899999999997654 8999999999999999999 56777766665555555442110           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                       ..+...++++.+|+.+||+.||++|||++++++|
T Consensus       222 -----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 -----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             0123468999999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-53  Score=385.91  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=201.0

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ..+|++.+.||+|+||.||+|+++ ++..||||++...   ...+.+|+.++++++|||||++++++..    +.  +++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~--~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----EP--IYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----CC--eEE
Confidence            457999999999999999999974 6788999998653   3446689999999999999999997621    12  578


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      |||||+ |+|.+.+....  ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus        85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~  160 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLIE  160 (272)
T ss_dssp             EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeeccc-ceeeccccceEEcc
Confidence            999999 47766654332  24589999999999999999999998 999999999999999887 79999999998764


Q ss_pred             cCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          220 KGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       220 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ....  .....||+.|||||++.+.. ++.++|||||||++|||+|| .+||...+..+.+..+..... +         
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-~---------  229 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-M---------  229 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-C---------
T ss_pred             CCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-C---------
Confidence            4322  23456889999999997654 89999999999999999995 566666655555444432110 0         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc--CCCCcc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDE  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~--hp~f~~  353 (403)
                                        ..+..+|+++.+|+.+||+.||++|||++++++  |+||..
T Consensus       230 ------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         230 ------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                              122457899999999999999999999999998  788764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-53  Score=396.03  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=207.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEc---cCCcEEEEEEeccc--------hhhhHHHHHHHHHcCC-CCeeecceeeeecC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCL---ETGEAVAIKKVLQD--------KRYKNRELQTMRLLDH-PNVVSLKHCFFSTT  131 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~  131 (403)
                      ..+|++.+.||+|+||+||+|++.   .+|+.||||.+...        .....+|++++++++| |||+++++++.   
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---   99 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---   99 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec---
Confidence            357999999999999999999974   46899999988532        2345579999999987 79999988873   


Q ss_pred             CCCceEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEe
Q 015615          132 EKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC  210 (403)
Q Consensus       132 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~  210 (403)
                        +..+++++|||+.+ +|.+.+...    ..+++..++.++.||+.||.|||+. |||||||||+|||++.++ .+||+
T Consensus       100 --~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~vkL~  171 (322)
T d1vzoa_         100 --TETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLT  171 (322)
T ss_dssp             --ETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEES
T ss_pred             --cCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCC-CEEEe
Confidence              33458899999995 787777654    5678899999999999999999998 999999999999999887 79999


Q ss_pred             ecCCceecccCC--CcceeeecccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015615          211 DFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP  287 (403)
Q Consensus       211 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  287 (403)
                      |||+|+......  ......|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+.....
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            999998653322  234567899999999996543 46889999999999999999999998876554444444321000


Q ss_pred             CHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCC-----CHHHHhcCCCCccCCC
Q 015615          288 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIHPFFDELRD  356 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----s~~ell~hp~f~~~~~  356 (403)
                      .                         ..++..+|+++.+||++||++||++||     |++|+++||||+++.+
T Consensus       252 ~-------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         252 E-------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             C-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             C-------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence            0                         012345899999999999999999999     5899999999998753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=384.68  Aligned_cols=249  Identities=25%  Similarity=0.326  Sum_probs=201.5

Q ss_pred             cceEEEeE-eeeCCcEEEEEEEEcc--CCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           65 ISYMAERV-VGHGSFGVVFQAKCLE--TGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        65 ~~y~~~~~-lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .+|.+.+. ||+|+||.||+|.++.  ++..||||++...     ...+.+|+++|+.++|||||++++++..    +. 
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~-   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----EA-   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----SS-
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----Ce-
Confidence            46888885 9999999999998754  4557999998543     2345689999999999999999997632    11 


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                       +|||||||++ +|.+++...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        83 -~~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGla  156 (285)
T d1u59a_          83 -LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGLS  156 (285)
T ss_dssp             -EEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred             -EEEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCC-ceeeccchhh
Confidence             6799999995 777766432   35799999999999999999999998 999999999999999887 7999999999


Q ss_pred             eecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          216 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       216 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      +........    ....||+.|||||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+.+... +   
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-~---  231 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-M---  231 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-C---
T ss_pred             hcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C---
Confidence            876443322    2346789999999997654 8999999999999999998 9999998877666555543110 0   


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHH---hcCCCCcc
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA---LIHPFFDE  353 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~el---l~hp~f~~  353 (403)
                                              .+++.+|+++.+||.+||..||++|||+.++   |+|+|+.-
T Consensus       232 ------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         232 ------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             ------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                                    1234689999999999999999999999887   67887753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=378.81  Aligned_cols=244  Identities=20%  Similarity=0.283  Sum_probs=202.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|++.+.||+|+||+||+|++ .++..||||.+...   ...+.+|+.++++++||||+++++++..     ...+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEEE
Confidence            3688999999999999999997 47889999998653   3456789999999999999999998843     2237899


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceeccc
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK  220 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~  220 (403)
                      |||++ |++...+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence            99998 5677665543   35688889999999999999999998 999999999999999887 799999999976544


Q ss_pred             CCCc--ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCc
Q 015615          221 GEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  297 (403)
Q Consensus       221 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  297 (403)
                      ....  ....+|+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------  220 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-----------  220 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred             CCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            3322  2356899999999997654 8999999999999999998 89999998877666555432111           


Q ss_pred             CcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          298 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                       ..+...++++.+||++||+.||++|||++++++|
T Consensus       221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             0123578899999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=383.08  Aligned_cols=241  Identities=22%  Similarity=0.317  Sum_probs=193.8

Q ss_pred             eEeeeCCcEEEEEEEEc--cCCcEEEEEEeccc------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           71 RVVGHGSFGVVFQAKCL--ETGEAVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      +.||+|+||+||+|.+.  .+++.||||++...      ...+.+|+.+|++++|||||++++++..    +.  .+|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~----~~--~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----ES--WMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----SS--EEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc----CC--EEEEE
Confidence            57999999999999864  35678999998542      2345689999999999999999998721    11  57999


Q ss_pred             eccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecccC
Q 015615          143 EYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG  221 (403)
Q Consensus       143 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~  221 (403)
                      |||+ |+|.+++..    ...+++..+..++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+.....
T Consensus        87 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          87 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD  160 (277)
T ss_dssp             ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred             EcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccC-cccccchhhhhhcccc
Confidence            9998 478877765    36799999999999999999999998 999999999999999887 7999999999876443


Q ss_pred             CCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccC
Q 015615          222 EPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  296 (403)
Q Consensus       222 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  296 (403)
                      ...    ....||+.|||||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+.+.. .+         
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~---------  229 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RM---------  229 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC---------
T ss_pred             ccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CC---------
Confidence            322    2346789999999997654 8999999999999999998 899999887666555443310 00         


Q ss_pred             cCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHH---hcCCCCc
Q 015615          297 PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA---LIHPFFD  352 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~el---l~hp~f~  352 (403)
                                        .++..+|+++.+|+.+||+.||++|||++++   |+|+|++
T Consensus       230 ------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         230 ------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                              1234578999999999999999999999998   4666654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=376.80  Aligned_cols=252  Identities=24%  Similarity=0.322  Sum_probs=197.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLN  139 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  139 (403)
                      ...+|++.+.||+|+||+||+|++..+ ..||||++...   ...+.+|+.++++++|||||++++++..    +.  ++
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~----~~--~~   87 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EP--IY   87 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS--CE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec----CC--eE
Confidence            346899999999999999999998654 67999998643   3456789999999999999999997621    22  57


Q ss_pred             EEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceec
Q 015615          140 LVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  218 (403)
Q Consensus       140 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~  218 (403)
                      +|||||++ ++...+....  ...+++..+..++.||+.||+|||++ ||+||||||+||||+.++ .+||+|||+|+..
T Consensus        88 lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~  163 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLI  163 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred             EEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCC-cEEEcccchhhhc
Confidence            89999995 5666654432  35689999999999999999999998 999999999999999887 7999999999865


Q ss_pred             ccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHHHHhcc
Q 015615          219 VKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCM  295 (403)
Q Consensus       219 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  295 (403)
                      .....  .....||+.|+|||++.... ++.++|||||||++|||++|. +||.+....+.+..+......         
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---------  233 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------  233 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             cCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---------
Confidence            43322  23456899999999997654 899999999999999999954 555555555555444332110         


Q ss_pred             CcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc--CCCCccC
Q 015615          296 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFDEL  354 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~--hp~f~~~  354 (403)
                                         ..+..+|+++.+||.+||+.||++|||++++++  ++||...
T Consensus       234 -------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                               123457899999999999999999999999988  8899775

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=373.29  Aligned_cols=243  Identities=21%  Similarity=0.292  Sum_probs=185.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCC----cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCce
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETG----EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL  136 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  136 (403)
                      .|++.++||+|+||.||+|.++.++    ..||||++...     ...+.+|+.+++.++|||||++++++..     ..
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----~~   82 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----YK   82 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SS
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----CC
Confidence            5999999999999999999987654    47999998542     1234589999999999999999998843     23


Q ss_pred             EEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCc
Q 015615          137 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  215 (403)
Q Consensus       137 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a  215 (403)
                      .+++|||||.+ ++.+.+...   ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGla  157 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  157 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred             ceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCC-eEEEcccchh
Confidence            37899999996 555555443   36789999999999999999999998 999999999999999888 7999999999


Q ss_pred             eecccCCC----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          216 KVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       216 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      +.......    .....||+.|||||++.+. .++.++|||||||++|||++|. +||.+.+..+.+..+.... .+   
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~---  232 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RL---  232 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CC---
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-CC---
Confidence            87644322    1234578999999999765 4899999999999999999965 4455444444333332211 00   


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                              ..+..++.++.+||.+||..||++|||+.++++
T Consensus       233 ------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         233 ------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                    122457899999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=376.02  Aligned_cols=245  Identities=27%  Similarity=0.367  Sum_probs=190.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEccC---CcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLET---GEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      ..+|++.+.||+|+||.||+|++..+   +..||||.+...     .....+|+.+++.++||||+++++++..      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            35799999999999999999998654   356899987532     2335589999999999999999998721      


Q ss_pred             eEEEEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                      ..+++|||||++ ++.+.+...   ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~-~~Kl~DfG~  154 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDFGL  154 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred             CeEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCC-cEEEccchh
Confidence            126799999994 666665543   35789999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCC--cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015615          215 AKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  291 (403)
Q Consensus       215 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  291 (403)
                      |+.......  .....||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+.+..+......     
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-----  228 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----  228 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----
T ss_pred             heeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            986543322  23456789999999997654 8999999999999999998 89999988777666555432100     


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                             .+++.+|+++.+||.+||+.||++|||+.++++|
T Consensus       229 -----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 -----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                   1235689999999999999999999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=379.72  Aligned_cols=244  Identities=23%  Similarity=0.361  Sum_probs=194.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCc----EEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCc
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGE----AVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  135 (403)
                      .+|++.+.||+|+||+||+|.+..+|+    .||+|.+...     .+.+.+|+.+++.++|||||++++++...    .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----T   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----S
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----C
Confidence            369999999999999999999988876    5888877532     23456899999999999999999987431    1


Q ss_pred             eEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCC
Q 015615          136 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  214 (403)
Q Consensus       136 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~  214 (403)
                        .+++|+|+. ++|.+.+...   ...+++..+..++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+
T Consensus        85 --~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~-~~kl~DFGl  157 (317)
T d1xkka_          85 --VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFGL  157 (317)
T ss_dssp             --EEEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred             --eeEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCC-CeEeecccc
Confidence              456777776 6787776654   46789999999999999999999998 999999999999999887 799999999


Q ss_pred             ceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015615          215 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  290 (403)
Q Consensus       215 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~  290 (403)
                      |+........   ....||+.|||||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+.+.. .++  
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~--  233 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLP--  233 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CCC--
T ss_pred             ceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC--
Confidence            9876443322   2345799999999997654 8999999999999999998 899998877655544443311 110  


Q ss_pred             HHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          291 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                               .+..+++++.+|+.+||..||.+|||+.++++|
T Consensus       234 -------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         234 -------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             -------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                     124578999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=374.72  Aligned_cols=250  Identities=23%  Similarity=0.342  Sum_probs=190.6

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  133 (403)
                      .+|++.+.||+|+||.||+|.+..     +++.||||++....     ....+|...+.++ .|+||+.+++++...   
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~---   89 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---   89 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC---
Confidence            579999999999999999999754     45789999985432     2334566666666 688999988876432   


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEe
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV  200 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll  200 (403)
                       ...+++|||||+ |+|.+++.....            ....+++..+..++.||+.||+|||++ |||||||||+|||+
T Consensus        90 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl  167 (299)
T d1ywna1          90 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILL  167 (299)
T ss_dssp             -TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEE
T ss_pred             -CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeE
Confidence             223679999999 588888876432            134588999999999999999999998 99999999999999


Q ss_pred             cCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHH
Q 015615          201 NPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQ  276 (403)
Q Consensus       201 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~  276 (403)
                      +.++ .+||+|||+|+.......   .....||+.|||||++.+.. ++.++|||||||++|||+|| .+||.+....+.
T Consensus       168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9887 799999999986543322   23457899999999997654 89999999999999999986 578988766565


Q ss_pred             HHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          277 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       277 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      +..+......+                           ..+..+++++.+||.+||+.||++|||++++++|
T Consensus       246 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            55554421111                           0224578999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=369.09  Aligned_cols=245  Identities=21%  Similarity=0.310  Sum_probs=194.8

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEE
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      ...+|++.+.||+|+||.||+|++  .|..||||+++.+  .+.+.+|++++++++||||+++++++....    ..+++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~l   78 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI   78 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEE
Confidence            345799999999999999999997  5789999999654  345678999999999999999999874322    22689


Q ss_pred             EEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCceecc
Q 015615          141 VLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV  219 (403)
Q Consensus       141 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~  219 (403)
                      ||||++ |+|.+++....  ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++...
T Consensus        79 v~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~  154 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS  154 (262)
T ss_dssp             EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC-----
T ss_pred             EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCC-CEeecccccceecC
Confidence            999998 58888886542  23578999999999999999999997 999999999999999888 79999999998653


Q ss_pred             cCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhccCcC
Q 015615          220 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  298 (403)
Q Consensus       220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  298 (403)
                      ..  .....+|+.|+|||++.+.. ++.++|||||||++|||+| |++||...+..+....+.+..              
T Consensus       155 ~~--~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--------------  217 (262)
T d1byga_         155 ST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------  217 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------------
T ss_pred             CC--CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            32  33456789999999997654 8999999999999999998 789998877666555443210              


Q ss_pred             cccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          299 YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                    ...++..+++++.+||++||..||.+|||+.+++++
T Consensus       218 --------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         218 --------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                          001234578999999999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=367.90  Aligned_cols=244  Identities=25%  Similarity=0.335  Sum_probs=190.9

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccC-C--cEEEEEEeccc-------hhhhHHHHHHHHHcCCCCeeecceeeeecCCCC
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLET-G--EAVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  134 (403)
                      .+|++.+.||+|+||.||+|++..+ +  ..||||++..+       ...+.+|+.+++.++||||+++++++..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            4699999999999999999986533 3  36899987532       1345689999999999999999998732     


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecC
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      . .+++|||||+ +++.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             c-chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhcccccc-ceeeccch
Confidence            1 2578999998 5777666554   35689999999999999999999998 999999999999999887 89999999


Q ss_pred             CceecccCCCc----ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015615          214 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  288 (403)
Q Consensus       214 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~  288 (403)
                      +++........    ....+|..|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+.+..+.+....+ 
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-  234 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-  234 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-
Confidence            99876444322    2235678899999997654 8999999999999999998 899999988877776665421111 


Q ss_pred             HHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          289 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                                                ..+..+|+++.+||.+||..||++|||++++++
T Consensus       235 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         235 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                      022457899999999999999999999999863

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-50  Score=374.32  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=201.7

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCCcE--EEEEEeccc-----hhhhHHHHHHHHHc-CCCCeeecceeeeecCCCC
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETGEA--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTEKD  134 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  134 (403)
                      ...+|++.+.||+|+||.||+|+++.+|..  ||||.+...     .....+|+.+|..+ +|||||++++++..     
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----   82 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----   82 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----
Confidence            345899999999999999999999888874  678876432     23467899999998 79999999998854     


Q ss_pred             ceEEEEEEeccc-chHHHHHHhhc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEec
Q 015615          135 ELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN  201 (403)
Q Consensus       135 ~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~  201 (403)
                      ...+++||||++ |+|.+++....            .....+++..+..++.||+.||.|||++ +|+||||||+|||++
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVG  161 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEc
Confidence            334889999999 58888886532            2346799999999999999999999998 999999999999999


Q ss_pred             CCCCceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHH
Q 015615          202 PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEI  280 (403)
Q Consensus       202 ~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i  280 (403)
                      .++ .+||+|||+|+............||+.|+|||.+.+.. ++.++|||||||++|||++|. +||.+.+..+....+
T Consensus       162 ~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i  239 (309)
T d1fvra_         162 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  239 (309)
T ss_dssp             GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CCC-ceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            887 79999999998665444444567899999999997654 899999999999999999965 678777665555443


Q ss_pred             HHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          281 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      .+.. .                           ...+..+++++.+||.+||+.||++|||+.++++|
T Consensus       240 ~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         240 PQGY-R---------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGTC-C---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcC-C---------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3210 0                           01224578999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-49  Score=370.47  Aligned_cols=248  Identities=22%  Similarity=0.280  Sum_probs=199.6

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ..+|++.+.||+|+||+||+|+++     .+++.||||++...     ...+.+|+.+++.++||||+++++++...   
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~---   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG---   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence            357999999999999999999975     35678999998543     23456899999999999999999988432   


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhc--------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHY--------------------KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD  192 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~D  192 (403)
                        ..++++|||++ ++|.+.+....                    .....++...+..++.||+.||+|||++ +|||||
T Consensus        89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrD  165 (301)
T d1lufa_          89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRD  165 (301)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSC
T ss_pred             --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeE
Confidence              23679999998 58888876432                    1233588889999999999999999998 999999


Q ss_pred             CCCCceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCC
Q 015615          193 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLF  268 (403)
Q Consensus       193 lkp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf  268 (403)
                      |||+|||++.++ .+||+|||+|+.......   ..+..+|+.|+|||.+.+.. ++.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCC
Confidence            999999999887 799999999976533322   23456789999999997654 899999999999999999985 788


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          269 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       269 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .+.+..+....+.+.. .                  +         ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~~e~~~~v~~~~-~------------------~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGN-I------------------L---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTSCHHHHHHHHHTTC-C------------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCC-C------------------C---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8887777666554311 0                  0         023467899999999999999999999999964

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=367.17  Aligned_cols=249  Identities=21%  Similarity=0.320  Sum_probs=195.3

Q ss_pred             cccceEEEeEeeeCCcEEEEEEEEccCC-------cEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeee
Q 015615           63 QTISYMAERVVGHGSFGVVFQAKCLETG-------EAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  129 (403)
Q Consensus        63 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~  129 (403)
                      ...+|++++.||+|+||.||+|++..++       ..||||++..+.     ....+|...+.++ +|||||++++++..
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3468999999999999999999976554       479999985432     2334688888777 79999999998843


Q ss_pred             cCCCCceEEEEEEeccc-chHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 015615          130 TTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ  196 (403)
Q Consensus       130 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~  196 (403)
                           ...+++|||||. |+|.+.+.....            ....+++..+..++.||+.||+|||++ +||||||||+
T Consensus        91 -----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~  164 (299)
T d1fgka_          91 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAAR  164 (299)
T ss_dssp             -----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             -----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeeccc
Confidence                 334789999999 588888865432            235689999999999999999999998 9999999999


Q ss_pred             ceEecCCCCceEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 015615          197 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGES  272 (403)
Q Consensus       197 NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~  272 (403)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||.+.+.. |+.++|||||||++|||++ |.+||.+.+
T Consensus       165 NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         165 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            99999888 799999999987644332   23457899999999997654 9999999999999999998 789998877


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          273 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       273 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ..+....+... ..+                           .++..+|+++.+||.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         243 VEELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            65544433221 110                           123457899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-49  Score=365.32  Aligned_cols=256  Identities=21%  Similarity=0.256  Sum_probs=199.0

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVL  142 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  142 (403)
                      ++|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+++++.++|+|++..+..+...    ....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEE
Confidence            4699999999999999999999999999999987543  34567899999999988877665544332    23477999


Q ss_pred             ecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC--CCceEEeecCCceeccc
Q 015615          143 EYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVK  220 (403)
Q Consensus       143 e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG~a~~~~~  220 (403)
                      ||+++++...+...   ...+++..+..++.|++.||+|||++ |||||||||+|||++..  ...+||+|||+|+....
T Consensus        83 e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcCCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            99999887766543   46799999999999999999999998 99999999999998642  23699999999987654


Q ss_pred             CCC--------cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC---CCCH
Q 015615          221 GEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG---TPTR  289 (403)
Q Consensus       221 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---~~~~  289 (403)
                      ...        .....||+.|||||++.+.. ++.++|||||||++|||+||..||.+....+....+.+...   .++.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            322        23457899999999997654 89999999999999999999999988665544433322110   0111


Q ss_pred             HHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHH---HhcCCCCcc
Q 015615          290 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE---ALIHPFFDE  353 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~e---ll~hp~f~~  353 (403)
                      .                        .+...+|+++.+|+.+||+.||++||++++   +|+|+|.+.
T Consensus       238 ~------------------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 E------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             H------------------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             h------------------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            1                        122468999999999999999999999874   567776544

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-49  Score=366.02  Aligned_cols=255  Identities=22%  Similarity=0.272  Sum_probs=205.1

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEcc-----CCcEEEEEEeccch-----hhhHHHHHHHHHcCCCCeeecceeeeecCCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCLE-----TGEAVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTEK  133 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  133 (403)
                      ..+|++.+.||+|+||.||+|.+..     ++..||||++....     ..+.+|+.++++++||||+++++++..    
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----   94 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----   94 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec----
Confidence            4689999999999999999999753     35789999986432     234589999999999999999998733    


Q ss_pred             CceEEEEEEeccc-chHHHHHHhhcc------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCc
Q 015615          134 DELYLNLVLEYVP-ETVHRVIKHHYK------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ  206 (403)
Q Consensus       134 ~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~  206 (403)
                       ....++|||||. |+|.+++.....      ....++...+..++.|++.||.|||++ +|+||||||+|||++.++ .
T Consensus        95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~-~  171 (308)
T d1p4oa_          95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-T  171 (308)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC-C
T ss_pred             -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCc-e
Confidence             223689999998 578777764331      224578889999999999999999998 999999999999999887 7


Q ss_pred             eEEeecCCceecccCCC---cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHH
Q 015615          207 LKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIK  282 (403)
Q Consensus       207 vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~  282 (403)
                      +||+|||+|+.......   .....+|+.|+|||.+.+.. ++.++|||||||++|||+|| .+||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999986644322   23346899999999997654 89999999999999999998 588988877776665543


Q ss_pred             HhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc------CCCCccC
Q 015615          283 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI------HPFFDEL  354 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~------hp~f~~~  354 (403)
                      ... +                           ..+..+|+.+.+||.+||+.||++|||++++++      +|+|+++
T Consensus       251 ~~~-~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         251 GGL-L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             TCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             CCC-C---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            110 0                           012457899999999999999999999999987      6666653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=364.87  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=201.4

Q ss_pred             ccceEEEeEeeeCCcEEEEEEEEc-----cCCcEEEEEEeccch-----hhhHHHHHHHHHc-CCCCeeecceeeeecCC
Q 015615           64 TISYMAERVVGHGSFGVVFQAKCL-----ETGEAVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTE  132 (403)
Q Consensus        64 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  132 (403)
                      ..+|++.+.||+|+||.||+|++.     .+++.||||++....     ..+.+|+.+++.+ +|||||++++++..   
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~---   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence            468999999999999999999863     466799999986432     2345799999999 69999999998843   


Q ss_pred             CCceEEEEEEeccc-chHHHHHHhhcc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 015615          133 KDELYLNLVLEYVP-ETVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN  197 (403)
Q Consensus       133 ~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~N  197 (403)
                        ...+++|||||+ ++|.+.+.....              ....+++..+..++.||+.||+|||++ +||||||||+|
T Consensus        99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~N  175 (311)
T d1t46a_          99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARN  175 (311)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGG
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-Ceeeccccccc
Confidence              233789999998 578888765431              234688999999999999999999998 99999999999


Q ss_pred             eEecCCCCceEEeecCCceecccCCCc---ceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCc
Q 015615          198 LLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESG  273 (403)
Q Consensus       198 Ill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  273 (403)
                      ||++.++ .+||+|||+++........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+.
T Consensus       176 Il~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            9999887 7999999999876543322   235789999999999765 48999999999999999998 6777877776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          274 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       274 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      .+.+.++......+.                           .+...|+++.+||.+||+.||++|||++++++
T Consensus       254 ~~~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         254 DSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            666666654321111                           12357899999999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-48  Score=372.42  Aligned_cols=285  Identities=29%  Similarity=0.477  Sum_probs=209.4

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch---hhhHHHHHHHHHcC-----------CCCeeecceeeeec
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCFFST  130 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~  130 (403)
                      ++|++++.||+|+||+||+|++..+|+.||||+++.+.   ....+|+.+++.+.           |+||+++++++...
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            46999999999999999999999999999999997653   33457888888875           57899998877442


Q ss_pred             CCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCC-----
Q 015615          131 TEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-----  205 (403)
Q Consensus       131 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~-----  205 (403)
                      . ....+.++.++++.++.......  .....+++..++.++.||+.||+|||+..||+||||||+|||++.++.     
T Consensus        93 ~-~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 G-PNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             E-TTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             c-ccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            2 22333333333444443333332  235678999999999999999999998449999999999999976542     


Q ss_pred             ceEEeecCCceecccCCCcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHH
Q 015615          206 QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQLVE  279 (403)
Q Consensus       206 ~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~  279 (403)
                      .++++|||.|.....  ......||+.|+|||++.... ++.++|+||+||++++|++|+.||...+      ..+.+..
T Consensus       170 ~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         170 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            499999999976532  334568999999999997654 8999999999999999999999997543      3456677


Q ss_pred             HHHHhCCCCHHHHhccCcCcccc-------cCCCccCCCccc------ccccCCChHHHHHHHHhhccCCCCCCCHHHHh
Q 015615          280 IIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHK------IFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  346 (403)
Q Consensus       280 i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell  346 (403)
                      ....+|.++...+.........+       ........++..      .+....++++.|||.+||++||.+|||++|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            77888888776654322111000       111111111111      11233567899999999999999999999999


Q ss_pred             cCCCCccCC
Q 015615          347 IHPFFDELR  355 (403)
Q Consensus       347 ~hp~f~~~~  355 (403)
                      +||||++..
T Consensus       327 ~Hp~f~~~~  335 (362)
T d1q8ya_         327 NHPWLKDTL  335 (362)
T ss_dssp             TCGGGTTCT
T ss_pred             cCcccCCCC
Confidence            999999754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-48  Score=359.16  Aligned_cols=244  Identities=20%  Similarity=0.274  Sum_probs=188.7

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCC---cEEEEEEeccc-----hhhhHHHHHHHHHcCCCCeeecceeeeecCCCCceEE
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETG---EAVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYL  138 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  138 (403)
                      +...++||+|+||+||+|++..++   ..||||++...     ...+.+|++++++++||||+++++++...    ...+
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence            444688999999999999986543   36999998532     23456899999999999999999987542    2347


Q ss_pred             EEEEecccc-hHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCCCceEEeecCCcee
Q 015615          139 NLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  217 (403)
Q Consensus       139 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~  217 (403)
                      ++|||||++ ++.+++...   ...++...+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~lv~E~~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~  179 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFGLARD  179 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSSGGGCC
T ss_pred             EEEEEEeecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCC-CEEEecccchhh
Confidence            899999995 666665543   35677888999999999999999988 999999999999999887 799999999987


Q ss_pred             cccCCC-----cceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHH
Q 015615          218 LVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREE  291 (403)
Q Consensus       218 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~  291 (403)
                      ......     .....||+.|+|||.+.+.. ++.++|||||||++|||+||..||...... +....+... ..+    
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~----  253 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRL----  253 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCC----
T ss_pred             ccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCC----
Confidence            643322     22356799999999987654 899999999999999999977776654322 222222211 000    


Q ss_pred             HhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          292 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                                             ..+..+++++.+||.+||..||++|||+.|+++|
T Consensus       254 -----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         254 -----------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                   0124578999999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-47  Score=352.24  Aligned_cols=249  Identities=20%  Similarity=0.234  Sum_probs=198.5

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc--hhhhHHHHHHHHHcCC-CCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD--KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++| +|++.+++++.     .....++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEEE
Confidence            4799999999999999999999999999999987543  3456789999999976 89998887763     33457899


Q ss_pred             EecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCC----CCceEEeecCCcee
Q 015615          142 LEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----THQLKLCDFGSAKV  217 (403)
Q Consensus       142 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~----~~~vkl~DfG~a~~  217 (403)
                      |||++++|.+.+...   ...++...+..++.|++.||+|||++ ||+||||||+|||++.+    .+.+||+|||+|+.
T Consensus        80 me~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999999988887654   35689999999999999999999988 99999999999999642    23799999999987


Q ss_pred             cccCC--------CcceeeecccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCC
Q 015615          218 LVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGT  286 (403)
Q Consensus       218 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~  286 (403)
                      .....        ......||+.|||||++.+. .++.++|||||||++|||+||..||.+....   .....+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            64322        12345799999999999765 4899999999999999999999999865432   223333322111


Q ss_pred             CCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhc
Q 015615          287 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  347 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~  347 (403)
                      ++...                        +.+.+|+++.+++..|+..+|++||+.+.+.+
T Consensus       235 ~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 TPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            11111                        22457899999999999999999999776643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=355.28  Aligned_cols=268  Identities=19%  Similarity=0.199  Sum_probs=188.3

Q ss_pred             cceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccchhh---hHHHHHHHHHcCCCCeeecceeeeecCCCCceEEEEE
Q 015615           65 ISYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDKRY---KNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLV  141 (403)
Q Consensus        65 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  141 (403)
                      .+|.+.+.||+|+||.||+|++  +|+.||||++..+...   .+.|+..+..++||||+++++++.... .....+|+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            3699999999999999999986  7899999998654322   233555556789999999999886544 344568899


Q ss_pred             Eeccc-chHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCccccCCCCCceEecCCCCceEEeecC
Q 015615          142 LEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-------IGVCHRDIKPQNLLVNPHTHQLKLCDFG  213 (403)
Q Consensus       142 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-------~~ivH~Dlkp~NIll~~~~~~vkl~DfG  213 (403)
                      ||||+ |+|.+.+..     ..++......++.|++.||+|||+.       .|||||||||+||||+.++ .+||+|||
T Consensus        80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFG  153 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecC
Confidence            99998 588888864     4688999999999999999999962       3999999999999999887 79999999


Q ss_pred             CceecccCCC-----cceeeecccccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 015615          214 SAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  283 (403)
Q Consensus       214 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~  283 (403)
                      +++.......     .....||+.|+|||++.+..     .++.++|||||||++|||+||.+||......+.... ...
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~  232 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLV  232 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTS
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hcc
Confidence            9987654432     22457899999999986432     156789999999999999999988743221100000 000


Q ss_pred             hCCCCHHHHhccCcCcccccCCCccCCCcccccccCCChHHHHHHHHhhccCCCCCCCHHHHhcC
Q 015615          284 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  348 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~s~~ell~h  348 (403)
                      ...+....+.....  .....|.++    ........+..+.+|+.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~--~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         233 PSDPSVEEMRKVVC--EQKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSCCHHHHHHHHT--TSCCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHh--ccccCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            00011111100000  000000000    000011223468999999999999999999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=5.6e-26  Score=195.77  Aligned_cols=163  Identities=17%  Similarity=0.139  Sum_probs=114.7

Q ss_pred             eEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccch----------------------hhhHHHHHHHHHcCCCCeeecc
Q 015615           67 YMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSLK  124 (403)
Q Consensus        67 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~niv~~~  124 (403)
                      |.+++.||+|+||.||+|.+ .+|+.||||+++...                      ....+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            56899999999999999997 478999999864211                      1123578889999999988875


Q ss_pred             eeeeecCCCCceEEEEEEecccchHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCceEecCCC
Q 015615          125 HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT  204 (403)
Q Consensus       125 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH~Dlkp~NIll~~~~  204 (403)
                      ++.     .    .+++|||+++...          ..++...+..++.|++.+|+|||++ ||+||||||+|||++.+ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-
Confidence            532     2    2589999996421          1233445678899999999999998 99999999999999954 


Q ss_pred             CceEEeecCCceecccCCCcceeee-cccccccccccCCCCCCCchhHHHHHH
Q 015615          205 HQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGC  256 (403)
Q Consensus       205 ~~vkl~DfG~a~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~  256 (403)
                       .++|+|||+|......... .... ... .-.+.+ . ..|+.++|+||+.-
T Consensus       140 -~~~liDFG~a~~~~~~~~~-~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~  187 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWR-EILERDVR-NIITYF-S-RTYRTEKDINSAID  187 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHH-HHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcH-HHHHHHHH-HHHHHH-c-CCCCCcccHHHHHH
Confidence             4999999999765322211 0000 000 001222 1 23788999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.17  E-value=4e-06  Score=73.22  Aligned_cols=76  Identities=17%  Similarity=0.122  Sum_probs=47.7

Q ss_pred             ceEEEeEeeeCCcEEEEEEEEccCCcEEEEEEeccc----hhhhHHHHHHHHHcC-CCCeeecceeeeecCCCCceEEEE
Q 015615           66 SYMAERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        66 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  140 (403)
                      .|++.+..+.++.+.||+..  .++..+++|+....    .....+|...+..+. +--+.+++...     .+....++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            46766665556667899876  36667888987543    234568888888774 22233333322     12234678


Q ss_pred             EEecccch
Q 015615          141 VLEYVPET  148 (403)
Q Consensus       141 v~e~~~~~  148 (403)
                      ||++++|.
T Consensus        88 v~~~l~G~   95 (263)
T d1j7la_          88 LMSEADGV   95 (263)
T ss_dssp             EEECCSSE
T ss_pred             EEEecccc
Confidence            99999873

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.92  E-value=3.7e-05  Score=71.30  Aligned_cols=71  Identities=18%  Similarity=0.154  Sum_probs=42.6

Q ss_pred             EeEeeeCCcEEEEEEEEccCCcEEEEEEeccc-----------hhhhHHHHHHHHHcC-C--CCeeecceeeeecCCCCc
Q 015615           70 ERVVGHGSFGVVFQAKCLETGEAVAIKKVLQD-----------KRYKNRELQTMRLLD-H--PNVVSLKHCFFSTTEKDE  135 (403)
Q Consensus        70 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~  135 (403)
                      .+.||.|....||++.+..+|+.|++|.-...           ......|.+.|+.+. +  ..+.+++.+  .   .+.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence            44689999999999998777889999964321           122345888887763 2  234444322  1   122


Q ss_pred             eEEEEEEecccc
Q 015615          136 LYLNLVLEYVPE  147 (403)
Q Consensus       136 ~~~~lv~e~~~~  147 (403)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              2479999874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.82  E-value=4.9e-05  Score=65.68  Aligned_cols=69  Identities=16%  Similarity=0.117  Sum_probs=42.3

Q ss_pred             eeeCC-cEEEEEEEEccCCcEEEEEEeccch-hhhHHHHHHHHHcCCCC--eeecceeeeecCCCCceEEEEEEecccc
Q 015615           73 VGHGS-FGVVFQAKCLETGEAVAIKKVLQDK-RYKNRELQTMRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYVPE  147 (403)
Q Consensus        73 lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~  147 (403)
                      +..|. .+.||+... .++..+++|...... ....+|...++.+....  +.+++.+..     +....++||++++|
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence            34444 467998874 456678899765443 34667888888775333  333333321     12235789999975

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.98  E-value=0.0025  Score=58.59  Aligned_cols=68  Identities=18%  Similarity=0.242  Sum_probs=43.6

Q ss_pred             eEeeeCCcEEEEEEEEcc-------CCcEEEEEEeccc--hhhhHHHHHHHHHcCCCCe-eecceeeeecCCCCceEEEE
Q 015615           71 RVVGHGSFGVVFQAKCLE-------TGEAVAIKKVLQD--KRYKNRELQTMRLLDHPNV-VSLKHCFFSTTEKDELYLNL  140 (403)
Q Consensus        71 ~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~l  140 (403)
                      +.|+.|-.-.+|++....       .+..|.+++.-..  .....+|..+++.+.-.++ .++++++     .+    ++
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----ce
Confidence            568889999999998643       2456777766422  2334578888888753333 3554443     22    46


Q ss_pred             EEecccc
Q 015615          141 VLEYVPE  147 (403)
Q Consensus       141 v~e~~~~  147 (403)
                      ||||++|
T Consensus       119 I~efi~g  125 (395)
T d1nw1a_         119 LEEYIPS  125 (395)
T ss_dssp             EECCCCE
T ss_pred             EEEEecc
Confidence            8999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.87  E-value=0.00066  Score=60.84  Aligned_cols=38  Identities=18%  Similarity=-0.013  Sum_probs=28.3

Q ss_pred             cEEEEEEEEccCCcEEEEEEeccc---hhhhHHHHHHHHHcC
Q 015615           78 FGVVFQAKCLETGEAVAIKKVLQD---KRYKNRELQTMRLLD  116 (403)
Q Consensus        78 ~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~  116 (403)
                      --.||++.. .+|..|++|+.+..   ...+..|...+..|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLV   75 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence            358999985 67889999988653   344567888887774

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.19  E-value=0.01  Score=52.29  Aligned_cols=29  Identities=31%  Similarity=0.291  Sum_probs=25.4

Q ss_pred             CccccCCCCCceEecCCCCceEEeecCCce
Q 015615          187 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  216 (403)
Q Consensus       187 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~  216 (403)
                      |+||+|+.++||+++.+. ..-|+||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~-v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDE-LSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             ccccCCcchhhhhccccc-ceeEecccccc
Confidence            799999999999999765 56799999875